	STUDY ACCESSION	DISEASE/TRAIT	Disease trait	Parent term
0	GCST006394	Intraocular pressure	Intraocular pressure	Other measurement
1	GCST006433	Heel bone mineral density	Heel bone mineral density	Other measurement
2	GCST006473	Diffusing capacity of the lung for carbon monoxide traits	Diffusing capacity of the lung for carbon monoxide traits	Other measurement
3	GCST007045	PR interval	PR interval	Cardiovascular measurement
4	GCST006275	Vestibular neuritis	Vestibular neuritis	Neurological disorder
5	GCST006272	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
6	GCST006271	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
7	GCST006467	Ewing sarcoma	Ewing sarcoma	Cancer
8	GCST008056	Alzheimer's disease (SNP x SNP interaction)	Alzheimer's disease (SNP x SNP interaction)	Neurological disorder
9	GCST006418	Progressive supranuclear palsy	Progressive supranuclear palsy	Neurological disorder
10	GCST006957	Severe aortic features in Marfan syndrome	Severe aortic features in Marfan syndrome	Neurological disorder
11	GCST006957	Severe aortic features in Marfan syndrome	Severe aortic features in Marfan syndrome	Cardiovascular disease
12	GCST006576	Anorexia nervosa or obsessive-compulsive disorder	Anorexia nervosa or obsessive-compulsive disorder	Neurological disorder
13	GCST006576	Anorexia nervosa or obsessive-compulsive disorder	Anorexia nervosa or obsessive-compulsive disorder	Metabolic disorder
14	GCST008308	Infection persistence (>18 months) in genital human papillomavirus 16 infection	Infection persistence (>18 months) in genital human papillomavirus 16 infection	Other disease
15	GCST006387	Thyroid nodules	Thyroid nodules	Other disease
16	GCST006585	Blood protein levels	Blood protein levels	Other measurement
17	GCST006585	Blood protein levels	Blood protein levels	Other measurement
18	GCST006585	Blood protein levels	Blood protein levels	Other measurement
19	GCST006585	Blood protein levels	Blood protein levels	Other measurement
20	GCST006585	Blood protein levels	Blood protein levels	Other measurement
21	GCST006585	Blood protein levels	Blood protein levels	Other measurement
22	GCST006585	Blood protein levels	Blood protein levels	Other measurement
23	GCST006585	Blood protein levels	Blood protein levels	Other measurement
24	GCST006585	Blood protein levels	Blood protein levels	Other measurement
25	GCST006585	Blood protein levels	Blood protein levels	Other measurement
26	GCST006585	Blood protein levels	Blood protein levels	Other measurement
27	GCST006585	Blood protein levels	Blood protein levels	Other measurement
28	GCST006585	Blood protein levels	Blood protein levels	Other measurement
29	GCST006585	Blood protein levels	Blood protein levels	Other measurement
30	GCST006585	Blood protein levels	Blood protein levels	Other measurement
31	GCST006585	Blood protein levels	Blood protein levels	Other measurement
32	GCST006585	Blood protein levels	Blood protein levels	Other measurement
33	GCST006585	Blood protein levels	Blood protein levels	Other measurement
34	GCST006585	Blood protein levels	Blood protein levels	Other measurement
35	GCST006585	Blood protein levels	Blood protein levels	Other measurement
36	GCST006585	Blood protein levels	Blood protein levels	Other measurement
37	GCST006585	Blood protein levels	Blood protein levels	Other measurement
38	GCST006585	Blood protein levels	Blood protein levels	Other measurement
39	GCST006585	Blood protein levels	Blood protein levels	Other measurement
40	GCST006585	Blood protein levels	Blood protein levels	Other measurement
41	GCST006585	Blood protein levels	Blood protein levels	Other measurement
42	GCST006585	Blood protein levels	Blood protein levels	Other measurement
43	GCST006585	Blood protein levels	Blood protein levels	Other measurement
44	GCST006585	Blood protein levels	Blood protein levels	Other measurement
45	GCST006585	Blood protein levels	Blood protein levels	Other measurement
46	GCST006585	Blood protein levels	Blood protein levels	Other measurement
47	GCST006585	Blood protein levels	Blood protein levels	Other measurement
48	GCST006585	Blood protein levels	Blood protein levels	Other measurement
49	GCST006585	Blood protein levels	Blood protein levels	Other measurement
50	GCST006585	Blood protein levels	Blood protein levels	Other measurement
51	GCST006585	Blood protein levels	Blood protein levels	Other measurement
52	GCST006585	Blood protein levels	Blood protein levels	Other measurement
53	GCST006585	Blood protein levels	Blood protein levels	Other measurement
54	GCST006585	Blood protein levels	Blood protein levels	Other measurement
55	GCST006585	Blood protein levels	Blood protein levels	Other measurement
56	GCST006585	Blood protein levels	Blood protein levels	Other measurement
57	GCST006585	Blood protein levels	Blood protein levels	Other measurement
58	GCST006585	Blood protein levels	Blood protein levels	Other measurement
59	GCST006585	Blood protein levels	Blood protein levels	Other measurement
60	GCST006585	Blood protein levels	Blood protein levels	Other measurement
61	GCST006585	Blood protein levels	Blood protein levels	Other measurement
62	GCST006585	Blood protein levels	Blood protein levels	Other measurement
63	GCST006585	Blood protein levels	Blood protein levels	Other measurement
64	GCST006585	Blood protein levels	Blood protein levels	Other measurement
65	GCST006585	Blood protein levels	Blood protein levels	Other measurement
66	GCST006585	Blood protein levels	Blood protein levels	Other measurement
67	GCST006585	Blood protein levels	Blood protein levels	Other measurement
68	GCST006585	Blood protein levels	Blood protein levels	Other measurement
69	GCST006585	Blood protein levels	Blood protein levels	Other measurement
70	GCST006585	Blood protein levels	Blood protein levels	Other measurement
71	GCST006585	Blood protein levels	Blood protein levels	Other measurement
72	GCST006585	Blood protein levels	Blood protein levels	Other measurement
73	GCST006585	Blood protein levels	Blood protein levels	Other measurement
74	GCST006585	Blood protein levels	Blood protein levels	Other measurement
75	GCST006585	Blood protein levels	Blood protein levels	Other measurement
76	GCST006585	Blood protein levels	Blood protein levels	Other measurement
77	GCST006585	Blood protein levels	Blood protein levels	Other measurement
78	GCST006585	Blood protein levels	Blood protein levels	Other measurement
79	GCST006585	Blood protein levels	Blood protein levels	Other measurement
80	GCST006585	Blood protein levels	Blood protein levels	Other measurement
81	GCST006585	Blood protein levels	Blood protein levels	Other measurement
82	GCST006585	Blood protein levels	Blood protein levels	Other measurement
83	GCST006585	Blood protein levels	Blood protein levels	Other measurement
84	GCST006585	Blood protein levels	Blood protein levels	Other measurement
85	GCST006585	Blood protein levels	Blood protein levels	Other measurement
86	GCST006585	Blood protein levels	Blood protein levels	Other measurement
87	GCST006585	Blood protein levels	Blood protein levels	Other measurement
88	GCST006585	Blood protein levels	Blood protein levels	Other measurement
89	GCST006585	Blood protein levels	Blood protein levels	Other measurement
90	GCST006585	Blood protein levels	Blood protein levels	Other measurement
91	GCST006585	Blood protein levels	Blood protein levels	Other measurement
92	GCST006585	Blood protein levels	Blood protein levels	Other measurement
93	GCST006585	Blood protein levels	Blood protein levels	Other measurement
94	GCST006585	Blood protein levels	Blood protein levels	Other measurement
95	GCST006585	Blood protein levels	Blood protein levels	Other measurement
96	GCST006585	Blood protein levels	Blood protein levels	Other measurement
97	GCST006585	Blood protein levels	Blood protein levels	Other measurement
98	GCST006585	Blood protein levels	Blood protein levels	Other measurement
99	GCST006585	Blood protein levels	Blood protein levels	Other measurement
100	GCST006585	Blood protein levels	Blood protein levels	Other measurement
101	GCST006585	Blood protein levels	Blood protein levels	Other measurement
102	GCST006585	Blood protein levels	Blood protein levels	Other measurement
103	GCST006585	Blood protein levels	Blood protein levels	Other measurement
104	GCST006585	Blood protein levels	Blood protein levels	Other measurement
105	GCST006585	Blood protein levels	Blood protein levels	Other measurement
106	GCST006585	Blood protein levels	Blood protein levels	Other measurement
107	GCST006585	Blood protein levels	Blood protein levels	Other measurement
108	GCST006585	Blood protein levels	Blood protein levels	Other measurement
109	GCST006585	Blood protein levels	Blood protein levels	Other measurement
110	GCST006585	Blood protein levels	Blood protein levels	Other measurement
111	GCST006585	Blood protein levels	Blood protein levels	Other measurement
112	GCST006585	Blood protein levels	Blood protein levels	Other measurement
113	GCST006585	Blood protein levels	Blood protein levels	Other measurement
114	GCST006585	Blood protein levels	Blood protein levels	Other measurement
115	GCST006585	Blood protein levels	Blood protein levels	Other measurement
116	GCST006585	Blood protein levels	Blood protein levels	Other measurement
117	GCST006585	Blood protein levels	Blood protein levels	Other measurement
118	GCST006585	Blood protein levels	Blood protein levels	Other measurement
119	GCST006585	Blood protein levels	Blood protein levels	Other measurement
120	GCST006585	Blood protein levels	Blood protein levels	Other measurement
121	GCST006585	Blood protein levels	Blood protein levels	Other measurement
122	GCST006585	Blood protein levels	Blood protein levels	Other measurement
123	GCST006585	Blood protein levels	Blood protein levels	Other measurement
124	GCST006585	Blood protein levels	Blood protein levels	Other measurement
125	GCST006585	Blood protein levels	Blood protein levels	Other measurement
126	GCST006585	Blood protein levels	Blood protein levels	Other measurement
127	GCST006585	Blood protein levels	Blood protein levels	Other measurement
128	GCST006585	Blood protein levels	Blood protein levels	Hematological measurement
129	GCST006585	Blood protein levels	Blood protein levels	Other measurement
130	GCST006585	Blood protein levels	Blood protein levels	Other measurement
131	GCST006585	Blood protein levels	Blood protein levels	Other measurement
132	GCST006585	Blood protein levels	Blood protein levels	Other measurement
133	GCST006585	Blood protein levels	Blood protein levels	Lipid or lipoprotein measurement
134	GCST006585	Blood protein levels	Blood protein levels	Other measurement
135	GCST006585	Blood protein levels	Blood protein levels	Hematological measurement
136	GCST006585	Blood protein levels	Blood protein levels	Hematological measurement
137	GCST006585	Blood protein levels	Blood protein levels	Other measurement
138	GCST006585	Blood protein levels	Blood protein levels	Other measurement
139	GCST006585	Blood protein levels	Blood protein levels	Other measurement
140	GCST006585	Blood protein levels	Blood protein levels	Other measurement
141	GCST006585	Blood protein levels	Blood protein levels	Other measurement
142	GCST006585	Blood protein levels	Blood protein levels	Other measurement
143	GCST006585	Blood protein levels	Blood protein levels	Other measurement
144	GCST006585	Blood protein levels	Blood protein levels	Other measurement
145	GCST006585	Blood protein levels	Blood protein levels	Other measurement
146	GCST006585	Blood protein levels	Blood protein levels	Other measurement
147	GCST006585	Blood protein levels	Blood protein levels	Other measurement
148	GCST006585	Blood protein levels	Blood protein levels	Other measurement
149	GCST006585	Blood protein levels	Blood protein levels	Other measurement
150	GCST006585	Blood protein levels	Blood protein levels	Other measurement
151	GCST006585	Blood protein levels	Blood protein levels	Other measurement
152	GCST006585	Blood protein levels	Blood protein levels	Other measurement
153	GCST006585	Blood protein levels	Blood protein levels	Other measurement
154	GCST006585	Blood protein levels	Blood protein levels	Other measurement
155	GCST006585	Blood protein levels	Blood protein levels	Other measurement
156	GCST006585	Blood protein levels	Blood protein levels	Other measurement
157	GCST006585	Blood protein levels	Blood protein levels	Other measurement
158	GCST006585	Blood protein levels	Blood protein levels	Other measurement
159	GCST006585	Blood protein levels	Blood protein levels	Other measurement
160	GCST006585	Blood protein levels	Blood protein levels	Other measurement
161	GCST006585	Blood protein levels	Blood protein levels	Other measurement
162	GCST006585	Blood protein levels	Blood protein levels	Other measurement
163	GCST006585	Blood protein levels	Blood protein levels	Other measurement
164	GCST006585	Blood protein levels	Blood protein levels	Other measurement
165	GCST006585	Blood protein levels	Blood protein levels	Other measurement
166	GCST006585	Blood protein levels	Blood protein levels	Other measurement
167	GCST006585	Blood protein levels	Blood protein levels	Other measurement
168	GCST006585	Blood protein levels	Blood protein levels	Other measurement
169	GCST006585	Blood protein levels	Blood protein levels	Other measurement
170	GCST006585	Blood protein levels	Blood protein levels	Other measurement
171	GCST006585	Blood protein levels	Blood protein levels	Other measurement
172	GCST006585	Blood protein levels	Blood protein levels	Other measurement
173	GCST006585	Blood protein levels	Blood protein levels	Other measurement
174	GCST006585	Blood protein levels	Blood protein levels	Other measurement
175	GCST006585	Blood protein levels	Blood protein levels	Other measurement
176	GCST006585	Blood protein levels	Blood protein levels	Other measurement
177	GCST006585	Blood protein levels	Blood protein levels	Other measurement
178	GCST006585	Blood protein levels	Blood protein levels	Other measurement
179	GCST006585	Blood protein levels	Blood protein levels	Other measurement
180	GCST006585	Blood protein levels	Blood protein levels	Other measurement
181	GCST006585	Blood protein levels	Blood protein levels	Other measurement
182	GCST006585	Blood protein levels	Blood protein levels	Other measurement
183	GCST006585	Blood protein levels	Blood protein levels	Other measurement
184	GCST006585	Blood protein levels	Blood protein levels	Other measurement
185	GCST006585	Blood protein levels	Blood protein levels	Other measurement
186	GCST006585	Blood protein levels	Blood protein levels	Other measurement
187	GCST006585	Blood protein levels	Blood protein levels	Other measurement
188	GCST006585	Blood protein levels	Blood protein levels	Other measurement
189	GCST006585	Blood protein levels	Blood protein levels	Other measurement
190	GCST006585	Blood protein levels	Blood protein levels	Other measurement
191	GCST006585	Blood protein levels	Blood protein levels	Other measurement
192	GCST006585	Blood protein levels	Blood protein levels	Other measurement
193	GCST006585	Blood protein levels	Blood protein levels	Other measurement
194	GCST006585	Blood protein levels	Blood protein levels	Other measurement
195	GCST006585	Blood protein levels	Blood protein levels	Other measurement
196	GCST006585	Blood protein levels	Blood protein levels	Other measurement
197	GCST006585	Blood protein levels	Blood protein levels	Other measurement
198	GCST006585	Blood protein levels	Blood protein levels	Other measurement
199	GCST006585	Blood protein levels	Blood protein levels	Other measurement
200	GCST006585	Blood protein levels	Blood protein levels	Other measurement
201	GCST006585	Blood protein levels	Blood protein levels	Other measurement
202	GCST006585	Blood protein levels	Blood protein levels	Other measurement
203	GCST006585	Blood protein levels	Blood protein levels	Other measurement
204	GCST006585	Blood protein levels	Blood protein levels	Other measurement
205	GCST006585	Blood protein levels	Blood protein levels	Other measurement
206	GCST006585	Blood protein levels	Blood protein levels	Other measurement
207	GCST006585	Blood protein levels	Blood protein levels	Other measurement
208	GCST006585	Blood protein levels	Blood protein levels	Other measurement
209	GCST006585	Blood protein levels	Blood protein levels	Other measurement
210	GCST006585	Blood protein levels	Blood protein levels	Other measurement
211	GCST006585	Blood protein levels	Blood protein levels	Other measurement
212	GCST006585	Blood protein levels	Blood protein levels	Other measurement
213	GCST006585	Blood protein levels	Blood protein levels	Other measurement
214	GCST006585	Blood protein levels	Blood protein levels	Other measurement
215	GCST006585	Blood protein levels	Blood protein levels	Other measurement
216	GCST006585	Blood protein levels	Blood protein levels	Other measurement
217	GCST006585	Blood protein levels	Blood protein levels	Other measurement
218	GCST006585	Blood protein levels	Blood protein levels	Other measurement
219	GCST006585	Blood protein levels	Blood protein levels	Other measurement
220	GCST006585	Blood protein levels	Blood protein levels	Other measurement
221	GCST006585	Blood protein levels	Blood protein levels	Other measurement
222	GCST006585	Blood protein levels	Blood protein levels	Other measurement
223	GCST006585	Blood protein levels	Blood protein levels	Other measurement
224	GCST006585	Blood protein levels	Blood protein levels	Other measurement
225	GCST006585	Blood protein levels	Blood protein levels	Other measurement
226	GCST006585	Blood protein levels	Blood protein levels	Other measurement
227	GCST006585	Blood protein levels	Blood protein levels	Other measurement
228	GCST006585	Blood protein levels	Blood protein levels	Other measurement
229	GCST006585	Blood protein levels	Blood protein levels	Other measurement
230	GCST006585	Blood protein levels	Blood protein levels	Other measurement
231	GCST006585	Blood protein levels	Blood protein levels	Other measurement
232	GCST006585	Blood protein levels	Blood protein levels	Other measurement
233	GCST006585	Blood protein levels	Blood protein levels	Other measurement
234	GCST006585	Blood protein levels	Blood protein levels	Other measurement
235	GCST006585	Blood protein levels	Blood protein levels	Other measurement
236	GCST006585	Blood protein levels	Blood protein levels	Other measurement
237	GCST006585	Blood protein levels	Blood protein levels	Other measurement
238	GCST006585	Blood protein levels	Blood protein levels	Other measurement
239	GCST006585	Blood protein levels	Blood protein levels	Other measurement
240	GCST006585	Blood protein levels	Blood protein levels	Other measurement
241	GCST006585	Blood protein levels	Blood protein levels	Hematological measurement
242	GCST006585	Blood protein levels	Blood protein levels	Other measurement
243	GCST006585	Blood protein levels	Blood protein levels	Other measurement
244	GCST006585	Blood protein levels	Blood protein levels	Other measurement
245	GCST006585	Blood protein levels	Blood protein levels	Other measurement
246	GCST006585	Blood protein levels	Blood protein levels	Other measurement
247	GCST006585	Blood protein levels	Blood protein levels	Other measurement
248	GCST006585	Blood protein levels	Blood protein levels	Other measurement
249	GCST006585	Blood protein levels	Blood protein levels	Other measurement
250	GCST006585	Blood protein levels	Blood protein levels	Other measurement
251	GCST006585	Blood protein levels	Blood protein levels	Other measurement
252	GCST006585	Blood protein levels	Blood protein levels	Cardiovascular measurement
253	GCST006585	Blood protein levels	Blood protein levels	Liver enzyme measurement
254	GCST006585	Blood protein levels	Blood protein levels	Other measurement
255	GCST006585	Blood protein levels	Blood protein levels	Inflammatory measurement
256	GCST006585	Blood protein levels	Blood protein levels	Other measurement
257	GCST006585	Blood protein levels	Blood protein levels	Other measurement
258	GCST006585	Blood protein levels	Blood protein levels	Other measurement
259	GCST006585	Blood protein levels	Blood protein levels	Other measurement
260	GCST006585	Blood protein levels	Blood protein levels	Other measurement
261	GCST006585	Blood protein levels	Blood protein levels	Other measurement
262	GCST006585	Blood protein levels	Blood protein levels	Other measurement
263	GCST006585	Blood protein levels	Blood protein levels	Other measurement
264	GCST006585	Blood protein levels	Blood protein levels	Other measurement
265	GCST006585	Blood protein levels	Blood protein levels	Other measurement
266	GCST006585	Blood protein levels	Blood protein levels	Other measurement
267	GCST006585	Blood protein levels	Blood protein levels	Other measurement
268	GCST006585	Blood protein levels	Blood protein levels	Other measurement
269	GCST006585	Blood protein levels	Blood protein levels	Other measurement
270	GCST006585	Blood protein levels	Blood protein levels	Other measurement
271	GCST006585	Blood protein levels	Blood protein levels	Other measurement
272	GCST006585	Blood protein levels	Blood protein levels	Other measurement
273	GCST006585	Blood protein levels	Blood protein levels	Other measurement
274	GCST006585	Blood protein levels	Blood protein levels	Other measurement
275	GCST006585	Blood protein levels	Blood protein levels	Other measurement
276	GCST006585	Blood protein levels	Blood protein levels	Other measurement
277	GCST006585	Blood protein levels	Blood protein levels	Other measurement
278	GCST006585	Blood protein levels	Blood protein levels	Other measurement
279	GCST006585	Blood protein levels	Blood protein levels	Other measurement
280	GCST006585	Blood protein levels	Blood protein levels	Other measurement
281	GCST006585	Blood protein levels	Blood protein levels	Other measurement
282	GCST006585	Blood protein levels	Blood protein levels	Other measurement
283	GCST006585	Blood protein levels	Blood protein levels	Other measurement
284	GCST006585	Blood protein levels	Blood protein levels	Other measurement
285	GCST006585	Blood protein levels	Blood protein levels	Other measurement
286	GCST006585	Blood protein levels	Blood protein levels	Other measurement
287	GCST006585	Blood protein levels	Blood protein levels	Inflammatory measurement
288	GCST006585	Blood protein levels	Blood protein levels	Other measurement
289	GCST006585	Blood protein levels	Blood protein levels	Other measurement
290	GCST006585	Blood protein levels	Blood protein levels	Other measurement
291	GCST006585	Blood protein levels	Blood protein levels	Other measurement
292	GCST006585	Blood protein levels	Blood protein levels	Other measurement
293	GCST006585	Blood protein levels	Blood protein levels	Other measurement
294	GCST006585	Blood protein levels	Blood protein levels	Other measurement
295	GCST006585	Blood protein levels	Blood protein levels	Other measurement
296	GCST006585	Blood protein levels	Blood protein levels	Other measurement
297	GCST006585	Blood protein levels	Blood protein levels	Other measurement
298	GCST006585	Blood protein levels	Blood protein levels	Other measurement
299	GCST006585	Blood protein levels	Blood protein levels	Other measurement
300	GCST006585	Blood protein levels	Blood protein levels	Other measurement
301	GCST006585	Blood protein levels	Blood protein levels	Other measurement
302	GCST006585	Blood protein levels	Blood protein levels	Other measurement
303	GCST006585	Blood protein levels	Blood protein levels	Other measurement
304	GCST006585	Blood protein levels	Blood protein levels	Other measurement
305	GCST006585	Blood protein levels	Blood protein levels	Other measurement
306	GCST006585	Blood protein levels	Blood protein levels	Other measurement
307	GCST006428	Suicide attempts	Suicide attempts	Biological process
308	GCST006429	Suicidal ideation	Suicidal ideation	Biological process
309	GCST006429	Suicidal ideation	Suicidal ideation	Other measurement
310	GCST006287	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
311	GCST006287	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
312	GCST006270	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Immune system disorder
313	GCST006270	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Response to drug
314	GCST006270	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Drug-induced liver injury in interferon-beta-treated multiple sclerosis	Digestive system disorder
315	GCST006474	Non-allergic rhinitis	Non-allergic rhinitis	Neurological disorder
316	GCST006408	Allergic sensitization	Allergic sensitization	Other measurement
317	GCST006286	Age at loss of ambulation in Duchenne muscular dystrophy	Age at loss of ambulation in Duchenne muscular dystrophy	Neurological disorder
318	GCST006286	Age at loss of ambulation in Duchenne muscular dystrophy	Age at loss of ambulation in Duchenne muscular dystrophy	Other measurement
319	GCST006246	Childhood steroid-sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	Other disease
320	GCST006567	Response to ketogenic dietary therapies in epilepsy	Response to ketogenic dietary therapies in epilepsy	Biological process
321	GCST006567	Response to ketogenic dietary therapies in epilepsy	Response to ketogenic dietary therapies in epilepsy	Neurological disorder
322	GCST006409	Allergic rhinitis	Allergic rhinitis	Immune system disorder
323	GCST006409	Allergic rhinitis	Allergic rhinitis	Immune system disorder
324	GCST006395	Glaucoma	Glaucoma	Neurological disorder
325	GCST006483	Lung function (FVC)	Lung function (FVC)	Other measurement
326	GCST006414	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
327	GCST006482	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
328	GCST006277	Response to ranibizumab in age-related macular degeneration (exudative)	Response to ranibizumab in age-related macular degeneration (exudative)	Neurological disorder
329	GCST006277	Response to ranibizumab in age-related macular degeneration (exudative)	Response to ranibizumab in age-related macular degeneration (exudative)	Response to drug
330	GCST006310	Post bronchodilator FEV1/FVC ratio in smoking	Post bronchodilator FEV1/FVC ratio in smoking	Other measurement
331	GCST006310	Post bronchodilator FEV1/FVC ratio in smoking	Post bronchodilator FEV1/FVC ratio in smoking	Biological process
332	GCST006415	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
333	GCST006415	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
334	GCST006278	Adverse response to antithyroid drugs in Graves disease	Adverse response to antithyroid drugs in Graves disease	Response to drug
335	GCST006278	Adverse response to antithyroid drugs in Graves disease	Adverse response to antithyroid drugs in Graves disease	Immune system disorder
336	GCST006407	Philtrum width	Philtrum width	Other measurement
337	GCST006309	Post bronchodilator percent predicted FEV1 in smoking	Post bronchodilator percent predicted FEV1 in smoking	Other measurement
338	GCST006309	Post bronchodilator percent predicted FEV1 in smoking	Post bronchodilator percent predicted FEV1 in smoking	Biological process
339	GCST006276	Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy	Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy	Neurological disorder
340	GCST006481	Lung function (FEV1)	Lung function (FEV1)	Other measurement
341	GCST006927	Anhedonia in major depressive disorder	Anhedonia in major depressive disorder	Other measurement
342	GCST006927	Anhedonia in major depressive disorder	Anhedonia in major depressive disorder	Neurological disorder
343	GCST006390	Biliary atresia	Biliary atresia	Digestive system disorder
344	GCST006399	Lung cancer	Lung cancer	Cancer
345	GCST006399	Lung cancer	Lung cancer	Cancer
346	GCST006399	Lung cancer	Lung cancer	Cancer
347	GCST006435	Thrombocytopenia in coronary artery bypass surgery	Thrombocytopenia in coronary artery bypass surgery	Other trait
348	GCST006435	Thrombocytopenia in coronary artery bypass surgery	Thrombocytopenia in coronary artery bypass surgery	Other trait
349	GCST006398	Lung cancer (SNP x SNP interaction)	Lung cancer (SNP x SNP interaction)	Cancer
350	GCST006857	Leisure-time exercise behaviour	Leisure-time exercise behaviour	Biological process
351	GCST006858	Leisure-time exercise behaviour (age-stratified)	Leisure-time exercise behaviour (age-stratified)	Biological process
352	GCST006400	Lung cancer in ever smokers	Lung cancer in ever smokers	Other measurement
353	GCST006400	Lung cancer in ever smokers	Lung cancer in ever smokers	Cancer
354	GCST006416	Chronic central serous retinopathy	Chronic central serous retinopathy	Neurological disorder
355	GCST006417	Plasma factor VII activating protease levels	Plasma factor VII activating protease levels	Other measurement
356	GCST006836	Guillain-Barré syndrome	Guillain-Barré syndrome	Immune system disorder
357	GCST006477	Depression	Depression	Neurological disorder
358	GCST006477	Depression	Depression	Other measurement
359	GCST006137	Serum folate levels	Serum folate levels	Other measurement
360	GCST006250	Intelligence	Intelligence	Biological process
361	GCST006476	Neuroticism	Neuroticism	Neurological disorder
362	GCST006476	Neuroticism	Neuroticism	Other measurement
363	GCST006478	Worry	Worry	Other measurement
364	GCST006478	Worry	Worry	Other trait
365	GCST006475	Depressed affect	Depressed affect	Neurological disorder
366	GCST006475	Depressed affect	Depressed affect	Neurological disorder
367	GCST007422	Socioeconomic status of place of residence	Socioeconomic status of place of residence	Other measurement
368	GCST007421	Population density of place of residence	Population density of place of residence	Other measurement
369	GCST006144	Heparin-induced thrombocytopenia	Heparin-induced thrombocytopenia	Response to drug
370	GCST006144	Heparin-induced thrombocytopenia	Heparin-induced thrombocytopenia	Other trait
371	GCST006312	Childhood dental caries in primary teeth	Childhood dental caries in primary teeth	Digestive system disorder
372	GCST006140	Hematoma volume in non-lobar spontaneous intracerebral hemorrhage	Hematoma volume in non-lobar spontaneous intracerebral hemorrhage	Cardiovascular disease
373	GCST006131	Colorectal cancer	Colorectal cancer	Cancer
374	GCST006252	Childhood steroid-sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	Other disease
375	GCST006088	Familial squamous cell lung carcinoma	Familial squamous cell lung carcinoma	Other measurement
376	GCST006088	Familial squamous cell lung carcinoma	Familial squamous cell lung carcinoma	Cancer
377	GCST006087	Familial lung adenocarcinoma	Familial lung adenocarcinoma	Other measurement
378	GCST006087	Familial lung adenocarcinoma	Familial lung adenocarcinoma	Cancer
379	GCST006086	Familial lung cancer	Familial lung cancer	Other measurement
380	GCST006086	Familial lung cancer	Familial lung cancer	Cancer
381	GCST006139	Hematoma volume in lobar spontaneous intracerebral hemorrhage	Hematoma volume in lobar spontaneous intracerebral hemorrhage	Cardiovascular disease
382	GCST006386	Cannabis use (age at onset)	Cannabis use (age at onset)	Biological process
383	GCST006386	Cannabis use (age at onset)	Cannabis use (age at onset)	Other measurement
384	GCST006405	Coronary artery disease in diabetes	Coronary artery disease in diabetes	Cardiovascular disease
385	GCST006405	Coronary artery disease in diabetes	Coronary artery disease in diabetes	Metabolic disorder
386	GCST006388	Dietary macronutrient intake	Dietary macronutrient intake	Biological process
387	GCST008493	Prostate cancer mortality	Prostate cancer mortality	Cancer
388	GCST008493	Prostate cancer mortality	Prostate cancer mortality	Other measurement
389	GCST008493	Prostate cancer mortality	Prostate cancer mortality	Cancer
390	GCST006267	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Response to drug
391	GCST006267	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Neurological disorder
392	GCST006267	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Neurological disorder
393	GCST006266	Remission after SSRI treatment in major depression	Remission after SSRI treatment in major depression	Response to drug
394	GCST006266	Remission after SSRI treatment in major depression	Remission after SSRI treatment in major depression	Neurological disorder
395	GCST008138	Allergic rhinitis x sex interaction	Allergic rhinitis x sex interaction	Immune system disorder
396	GCST008138	Allergic rhinitis x sex interaction	Allergic rhinitis x sex interaction	Other measurement
397	GCST006364	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	Digestive system disorder
398	GCST006364	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	Other measurement
399	GCST006274	Systolic blood pressure night-to-day ratio in hypertension	Systolic blood pressure night-to-day ratio in hypertension	Other measurement
400	GCST006274	Systolic blood pressure night-to-day ratio in hypertension	Systolic blood pressure night-to-day ratio in hypertension	Cardiovascular disease
401	GCST006273	Diastolic blood pressure night-to-day ratio in hypertension	Diastolic blood pressure night-to-day ratio in hypertension	Other measurement
402	GCST006273	Diastolic blood pressure night-to-day ratio in hypertension	Diastolic blood pressure night-to-day ratio in hypertension	Cardiovascular disease
403	GCST006411	Mucinous adenocarcinoma in colorectal cancer	Mucinous adenocarcinoma in colorectal cancer	Cancer
404	GCST006411	Mucinous adenocarcinoma in colorectal cancer	Mucinous adenocarcinoma in colorectal cancer	Cancer
405	GCST006099	Accelerometer-based physical activity measurement (average acceleration)	Accelerometer-based physical activity measurement (average acceleration)	Other measurement
406	GCST006100	Strenuous sports or other exercises	Strenuous sports or other exercises	Other measurement
407	GCST006098	Vigorous physical activity	Vigorous physical activity	Other measurement
408	GCST006097	Moderate to vigorous physical activity levels	Moderate to vigorous physical activity levels	Other measurement
409	GCST006079	Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)	Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)	Other measurement
410	GCST006260	Childhood onset systemic lupus erythematosus	Childhood onset systemic lupus erythematosus	Immune system disorder
411	GCST006260	Childhood onset systemic lupus erythematosus	Childhood onset systemic lupus erythematosus	Other measurement
412	GCST006257	Elevated fasting plasma glucose	Elevated fasting plasma glucose	Other measurement
413	GCST006406	Cognitive flexibility	Cognitive flexibility	Other measurement
414	GCST006369	Body mass index	Body mass index	Body measurement
415	GCST006369	Body mass index	Body mass index	Body measurement
416	GCST006369	Body mass index	Body mass index	Other measurement
417	GCST006809	Kawasaki disease	Kawasaki disease	Immune system disorder
418	GCST006279	Cerebrospinal fluid α-synuclein levels	Cerebrospinal fluid α-synuclein levels	Other measurement
419	GCST006279	Cerebrospinal fluid α-synuclein levels	Cerebrospinal fluid α-synuclein levels	Other measurement
420	GCST006939	Skin hydration	Skin hydration	Other measurement
421	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
422	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
423	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
424	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
425	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
426	GCST006684	Electroencephalogram traits	Electroencephalogram traits	Other measurement
427	GCST006413	Lung cancer x radon exposure interaction (1df)	Lung cancer x radon exposure interaction (1df)	Cancer
428	GCST006413	Lung cancer x radon exposure interaction (1df)	Lung cancer x radon exposure interaction (1df)	Other measurement
429	GCST006311	Childhood dental caries in permanent teeth	Childhood dental caries in permanent teeth	Digestive system disorder
430	GCST005934	Neuropathic pain in head and neck cancer	Neuropathic pain in head and neck cancer	Cancer
431	GCST005934	Neuropathic pain in head and neck cancer	Neuropathic pain in head and neck cancer	Other trait
432	GCST005806	Blood protein levels	Blood protein levels	Other measurement
433	GCST005806	Blood protein levels	Blood protein levels	Other measurement
434	GCST005806	Blood protein levels	Blood protein levels	Other measurement
435	GCST005806	Blood protein levels	Blood protein levels	Other measurement
436	GCST005806	Blood protein levels	Blood protein levels	Other measurement
437	GCST005806	Blood protein levels	Blood protein levels	Other measurement
438	GCST005806	Blood protein levels	Blood protein levels	Other measurement
439	GCST005806	Blood protein levels	Blood protein levels	Other measurement
440	GCST005806	Blood protein levels	Blood protein levels	Other measurement
441	GCST005806	Blood protein levels	Blood protein levels	Other measurement
442	GCST005806	Blood protein levels	Blood protein levels	Other measurement
443	GCST005806	Blood protein levels	Blood protein levels	Other measurement
444	GCST005806	Blood protein levels	Blood protein levels	Other measurement
445	GCST005806	Blood protein levels	Blood protein levels	Other measurement
446	GCST005806	Blood protein levels	Blood protein levels	Other measurement
447	GCST005806	Blood protein levels	Blood protein levels	Other measurement
448	GCST005806	Blood protein levels	Blood protein levels	Other measurement
449	GCST005806	Blood protein levels	Blood protein levels	Other measurement
450	GCST005806	Blood protein levels	Blood protein levels	Other measurement
451	GCST005806	Blood protein levels	Blood protein levels	Other measurement
452	GCST005806	Blood protein levels	Blood protein levels	Other measurement
453	GCST005806	Blood protein levels	Blood protein levels	Other measurement
454	GCST005806	Blood protein levels	Blood protein levels	Other measurement
455	GCST005806	Blood protein levels	Blood protein levels	Other measurement
456	GCST005806	Blood protein levels	Blood protein levels	Other measurement
457	GCST005806	Blood protein levels	Blood protein levels	Other measurement
458	GCST005806	Blood protein levels	Blood protein levels	Other measurement
459	GCST005806	Blood protein levels	Blood protein levels	Other measurement
460	GCST005806	Blood protein levels	Blood protein levels	Other measurement
461	GCST005806	Blood protein levels	Blood protein levels	Other measurement
462	GCST005806	Blood protein levels	Blood protein levels	Other measurement
463	GCST005806	Blood protein levels	Blood protein levels	Other measurement
464	GCST005806	Blood protein levels	Blood protein levels	Other measurement
465	GCST005806	Blood protein levels	Blood protein levels	Other measurement
466	GCST005806	Blood protein levels	Blood protein levels	Other measurement
467	GCST005806	Blood protein levels	Blood protein levels	Other measurement
468	GCST005806	Blood protein levels	Blood protein levels	Other measurement
469	GCST005806	Blood protein levels	Blood protein levels	Other measurement
470	GCST005806	Blood protein levels	Blood protein levels	Other measurement
471	GCST005806	Blood protein levels	Blood protein levels	Other measurement
472	GCST005806	Blood protein levels	Blood protein levels	Other measurement
473	GCST005806	Blood protein levels	Blood protein levels	Other measurement
474	GCST005806	Blood protein levels	Blood protein levels	Other measurement
475	GCST005806	Blood protein levels	Blood protein levels	Other measurement
476	GCST005806	Blood protein levels	Blood protein levels	Other measurement
477	GCST005806	Blood protein levels	Blood protein levels	Other measurement
478	GCST005806	Blood protein levels	Blood protein levels	Other measurement
479	GCST005806	Blood protein levels	Blood protein levels	Other measurement
480	GCST005806	Blood protein levels	Blood protein levels	Other measurement
481	GCST005806	Blood protein levels	Blood protein levels	Other measurement
482	GCST005806	Blood protein levels	Blood protein levels	Other measurement
483	GCST005806	Blood protein levels	Blood protein levels	Other measurement
484	GCST005806	Blood protein levels	Blood protein levels	Other measurement
485	GCST005806	Blood protein levels	Blood protein levels	Other measurement
486	GCST005806	Blood protein levels	Blood protein levels	Other measurement
487	GCST005806	Blood protein levels	Blood protein levels	Other measurement
488	GCST005806	Blood protein levels	Blood protein levels	Other measurement
489	GCST005806	Blood protein levels	Blood protein levels	Other measurement
490	GCST005806	Blood protein levels	Blood protein levels	Other measurement
491	GCST005806	Blood protein levels	Blood protein levels	Other measurement
492	GCST005806	Blood protein levels	Blood protein levels	Other measurement
493	GCST005806	Blood protein levels	Blood protein levels	Other measurement
494	GCST005806	Blood protein levels	Blood protein levels	Other measurement
495	GCST005806	Blood protein levels	Blood protein levels	Other measurement
496	GCST005806	Blood protein levels	Blood protein levels	Other measurement
497	GCST005806	Blood protein levels	Blood protein levels	Other measurement
498	GCST005806	Blood protein levels	Blood protein levels	Other measurement
499	GCST005806	Blood protein levels	Blood protein levels	Other measurement
500	GCST005806	Blood protein levels	Blood protein levels	Other measurement
501	GCST005806	Blood protein levels	Blood protein levels	Other measurement
502	GCST005806	Blood protein levels	Blood protein levels	Other measurement
503	GCST005806	Blood protein levels	Blood protein levels	Other measurement
504	GCST005806	Blood protein levels	Blood protein levels	Other measurement
505	GCST005806	Blood protein levels	Blood protein levels	Other measurement
506	GCST005806	Blood protein levels	Blood protein levels	Other measurement
507	GCST005806	Blood protein levels	Blood protein levels	Other measurement
508	GCST005806	Blood protein levels	Blood protein levels	Other measurement
509	GCST005806	Blood protein levels	Blood protein levels	Other measurement
510	GCST005806	Blood protein levels	Blood protein levels	Other measurement
511	GCST005806	Blood protein levels	Blood protein levels	Other measurement
512	GCST005806	Blood protein levels	Blood protein levels	Other measurement
513	GCST005806	Blood protein levels	Blood protein levels	Other measurement
514	GCST005806	Blood protein levels	Blood protein levels	Other measurement
515	GCST005806	Blood protein levels	Blood protein levels	Other measurement
516	GCST005806	Blood protein levels	Blood protein levels	Other measurement
517	GCST005806	Blood protein levels	Blood protein levels	Other measurement
518	GCST005806	Blood protein levels	Blood protein levels	Other measurement
519	GCST005806	Blood protein levels	Blood protein levels	Other measurement
520	GCST005806	Blood protein levels	Blood protein levels	Other measurement
521	GCST005806	Blood protein levels	Blood protein levels	Other measurement
522	GCST005806	Blood protein levels	Blood protein levels	Other measurement
523	GCST005806	Blood protein levels	Blood protein levels	Other measurement
524	GCST005806	Blood protein levels	Blood protein levels	Other measurement
525	GCST005806	Blood protein levels	Blood protein levels	Other measurement
526	GCST005806	Blood protein levels	Blood protein levels	Other measurement
527	GCST005806	Blood protein levels	Blood protein levels	Other measurement
528	GCST005806	Blood protein levels	Blood protein levels	Other measurement
529	GCST005806	Blood protein levels	Blood protein levels	Other measurement
530	GCST005806	Blood protein levels	Blood protein levels	Other measurement
531	GCST005806	Blood protein levels	Blood protein levels	Other measurement
532	GCST005806	Blood protein levels	Blood protein levels	Other measurement
533	GCST005806	Blood protein levels	Blood protein levels	Other measurement
534	GCST005806	Blood protein levels	Blood protein levels	Other measurement
535	GCST005806	Blood protein levels	Blood protein levels	Other measurement
536	GCST005806	Blood protein levels	Blood protein levels	Other measurement
537	GCST005806	Blood protein levels	Blood protein levels	Other measurement
538	GCST005806	Blood protein levels	Blood protein levels	Other measurement
539	GCST005806	Blood protein levels	Blood protein levels	Other measurement
540	GCST005806	Blood protein levels	Blood protein levels	Other measurement
541	GCST005806	Blood protein levels	Blood protein levels	Other measurement
542	GCST005806	Blood protein levels	Blood protein levels	Other measurement
543	GCST005806	Blood protein levels	Blood protein levels	Other measurement
544	GCST005806	Blood protein levels	Blood protein levels	Hematological measurement
545	GCST005806	Blood protein levels	Blood protein levels	Other measurement
546	GCST005806	Blood protein levels	Blood protein levels	Other measurement
547	GCST005806	Blood protein levels	Blood protein levels	Other measurement
548	GCST005806	Blood protein levels	Blood protein levels	Other measurement
549	GCST005806	Blood protein levels	Blood protein levels	Lipid or lipoprotein measurement
550	GCST005806	Blood protein levels	Blood protein levels	Other measurement
551	GCST005806	Blood protein levels	Blood protein levels	Hematological measurement
552	GCST005806	Blood protein levels	Blood protein levels	Hematological measurement
553	GCST005806	Blood protein levels	Blood protein levels	Other measurement
554	GCST005806	Blood protein levels	Blood protein levels	Other measurement
555	GCST005806	Blood protein levels	Blood protein levels	Other measurement
556	GCST005806	Blood protein levels	Blood protein levels	Other measurement
557	GCST005806	Blood protein levels	Blood protein levels	Other measurement
558	GCST005806	Blood protein levels	Blood protein levels	Other measurement
559	GCST005806	Blood protein levels	Blood protein levels	Other measurement
560	GCST005806	Blood protein levels	Blood protein levels	Other measurement
561	GCST005806	Blood protein levels	Blood protein levels	Other measurement
562	GCST005806	Blood protein levels	Blood protein levels	Other measurement
563	GCST005806	Blood protein levels	Blood protein levels	Other measurement
564	GCST005806	Blood protein levels	Blood protein levels	Other measurement
565	GCST005806	Blood protein levels	Blood protein levels	Other measurement
566	GCST005806	Blood protein levels	Blood protein levels	Other measurement
567	GCST005806	Blood protein levels	Blood protein levels	Other measurement
568	GCST005806	Blood protein levels	Blood protein levels	Other measurement
569	GCST005806	Blood protein levels	Blood protein levels	Other measurement
570	GCST005806	Blood protein levels	Blood protein levels	Other measurement
571	GCST005806	Blood protein levels	Blood protein levels	Other measurement
572	GCST005806	Blood protein levels	Blood protein levels	Other measurement
573	GCST005806	Blood protein levels	Blood protein levels	Other measurement
574	GCST005806	Blood protein levels	Blood protein levels	Other measurement
575	GCST005806	Blood protein levels	Blood protein levels	Other measurement
576	GCST005806	Blood protein levels	Blood protein levels	Other measurement
577	GCST005806	Blood protein levels	Blood protein levels	Other measurement
578	GCST005806	Blood protein levels	Blood protein levels	Other measurement
579	GCST005806	Blood protein levels	Blood protein levels	Other measurement
580	GCST005806	Blood protein levels	Blood protein levels	Other measurement
581	GCST005806	Blood protein levels	Blood protein levels	Other measurement
582	GCST005806	Blood protein levels	Blood protein levels	Other measurement
583	GCST005806	Blood protein levels	Blood protein levels	Other measurement
584	GCST005806	Blood protein levels	Blood protein levels	Other measurement
585	GCST005806	Blood protein levels	Blood protein levels	Other measurement
586	GCST005806	Blood protein levels	Blood protein levels	Other measurement
587	GCST005806	Blood protein levels	Blood protein levels	Other measurement
588	GCST005806	Blood protein levels	Blood protein levels	Other measurement
589	GCST005806	Blood protein levels	Blood protein levels	Other measurement
590	GCST005806	Blood protein levels	Blood protein levels	Other measurement
591	GCST005806	Blood protein levels	Blood protein levels	Other measurement
592	GCST005806	Blood protein levels	Blood protein levels	Other measurement
593	GCST005806	Blood protein levels	Blood protein levels	Other measurement
594	GCST005806	Blood protein levels	Blood protein levels	Other measurement
595	GCST005806	Blood protein levels	Blood protein levels	Other measurement
596	GCST005806	Blood protein levels	Blood protein levels	Other measurement
597	GCST005806	Blood protein levels	Blood protein levels	Other measurement
598	GCST005806	Blood protein levels	Blood protein levels	Other measurement
599	GCST005806	Blood protein levels	Blood protein levels	Other measurement
600	GCST005806	Blood protein levels	Blood protein levels	Other measurement
601	GCST005806	Blood protein levels	Blood protein levels	Other measurement
602	GCST005806	Blood protein levels	Blood protein levels	Other measurement
603	GCST005806	Blood protein levels	Blood protein levels	Other measurement
604	GCST005806	Blood protein levels	Blood protein levels	Other measurement
605	GCST005806	Blood protein levels	Blood protein levels	Other measurement
606	GCST005806	Blood protein levels	Blood protein levels	Other measurement
607	GCST005806	Blood protein levels	Blood protein levels	Other measurement
608	GCST005806	Blood protein levels	Blood protein levels	Other measurement
609	GCST005806	Blood protein levels	Blood protein levels	Other measurement
610	GCST005806	Blood protein levels	Blood protein levels	Other measurement
611	GCST005806	Blood protein levels	Blood protein levels	Other measurement
612	GCST005806	Blood protein levels	Blood protein levels	Other measurement
613	GCST005806	Blood protein levels	Blood protein levels	Other measurement
614	GCST005806	Blood protein levels	Blood protein levels	Other measurement
615	GCST005806	Blood protein levels	Blood protein levels	Other measurement
616	GCST005806	Blood protein levels	Blood protein levels	Other measurement
617	GCST005806	Blood protein levels	Blood protein levels	Other measurement
618	GCST005806	Blood protein levels	Blood protein levels	Other measurement
619	GCST005806	Blood protein levels	Blood protein levels	Other measurement
620	GCST005806	Blood protein levels	Blood protein levels	Other measurement
621	GCST005806	Blood protein levels	Blood protein levels	Other measurement
622	GCST005806	Blood protein levels	Blood protein levels	Other measurement
623	GCST005806	Blood protein levels	Blood protein levels	Other measurement
624	GCST005806	Blood protein levels	Blood protein levels	Other measurement
625	GCST005806	Blood protein levels	Blood protein levels	Other measurement
626	GCST005806	Blood protein levels	Blood protein levels	Other measurement
627	GCST005806	Blood protein levels	Blood protein levels	Other measurement
628	GCST005806	Blood protein levels	Blood protein levels	Other measurement
629	GCST005806	Blood protein levels	Blood protein levels	Other measurement
630	GCST005806	Blood protein levels	Blood protein levels	Other measurement
631	GCST005806	Blood protein levels	Blood protein levels	Other measurement
632	GCST005806	Blood protein levels	Blood protein levels	Other measurement
633	GCST005806	Blood protein levels	Blood protein levels	Other measurement
634	GCST005806	Blood protein levels	Blood protein levels	Other measurement
635	GCST005806	Blood protein levels	Blood protein levels	Other measurement
636	GCST005806	Blood protein levels	Blood protein levels	Other measurement
637	GCST005806	Blood protein levels	Blood protein levels	Other measurement
638	GCST005806	Blood protein levels	Blood protein levels	Other measurement
639	GCST005806	Blood protein levels	Blood protein levels	Other measurement
640	GCST005806	Blood protein levels	Blood protein levels	Other measurement
641	GCST005806	Blood protein levels	Blood protein levels	Other measurement
642	GCST005806	Blood protein levels	Blood protein levels	Other measurement
643	GCST005806	Blood protein levels	Blood protein levels	Other measurement
644	GCST005806	Blood protein levels	Blood protein levels	Other measurement
645	GCST005806	Blood protein levels	Blood protein levels	Other measurement
646	GCST005806	Blood protein levels	Blood protein levels	Other measurement
647	GCST005806	Blood protein levels	Blood protein levels	Other measurement
648	GCST005806	Blood protein levels	Blood protein levels	Other measurement
649	GCST005806	Blood protein levels	Blood protein levels	Other measurement
650	GCST005806	Blood protein levels	Blood protein levels	Other measurement
651	GCST005806	Blood protein levels	Blood protein levels	Other measurement
652	GCST005806	Blood protein levels	Blood protein levels	Other measurement
653	GCST005806	Blood protein levels	Blood protein levels	Other measurement
654	GCST005806	Blood protein levels	Blood protein levels	Other measurement
655	GCST005806	Blood protein levels	Blood protein levels	Other measurement
656	GCST005806	Blood protein levels	Blood protein levels	Other measurement
657	GCST005806	Blood protein levels	Blood protein levels	Hematological measurement
658	GCST005806	Blood protein levels	Blood protein levels	Other measurement
659	GCST005806	Blood protein levels	Blood protein levels	Other measurement
660	GCST005806	Blood protein levels	Blood protein levels	Other measurement
661	GCST005806	Blood protein levels	Blood protein levels	Other measurement
662	GCST005806	Blood protein levels	Blood protein levels	Other measurement
663	GCST005806	Blood protein levels	Blood protein levels	Other measurement
664	GCST005806	Blood protein levels	Blood protein levels	Other measurement
665	GCST005806	Blood protein levels	Blood protein levels	Other measurement
666	GCST005806	Blood protein levels	Blood protein levels	Other measurement
667	GCST005806	Blood protein levels	Blood protein levels	Other measurement
668	GCST005806	Blood protein levels	Blood protein levels	Cardiovascular measurement
669	GCST005806	Blood protein levels	Blood protein levels	Liver enzyme measurement
670	GCST005806	Blood protein levels	Blood protein levels	Other measurement
671	GCST005806	Blood protein levels	Blood protein levels	Inflammatory measurement
672	GCST005806	Blood protein levels	Blood protein levels	Other measurement
673	GCST005806	Blood protein levels	Blood protein levels	Other measurement
674	GCST005806	Blood protein levels	Blood protein levels	Other measurement
675	GCST005806	Blood protein levels	Blood protein levels	Other measurement
676	GCST005806	Blood protein levels	Blood protein levels	Other measurement
677	GCST005806	Blood protein levels	Blood protein levels	Other measurement
678	GCST005806	Blood protein levels	Blood protein levels	Other measurement
679	GCST005806	Blood protein levels	Blood protein levels	Other measurement
680	GCST005806	Blood protein levels	Blood protein levels	Other measurement
681	GCST005806	Blood protein levels	Blood protein levels	Other measurement
682	GCST005806	Blood protein levels	Blood protein levels	Other measurement
683	GCST005806	Blood protein levels	Blood protein levels	Other measurement
684	GCST005806	Blood protein levels	Blood protein levels	Other measurement
685	GCST005806	Blood protein levels	Blood protein levels	Other measurement
686	GCST005806	Blood protein levels	Blood protein levels	Other measurement
687	GCST005806	Blood protein levels	Blood protein levels	Other measurement
688	GCST005806	Blood protein levels	Blood protein levels	Other measurement
689	GCST005806	Blood protein levels	Blood protein levels	Other measurement
690	GCST005806	Blood protein levels	Blood protein levels	Other measurement
691	GCST005806	Blood protein levels	Blood protein levels	Other measurement
692	GCST005806	Blood protein levels	Blood protein levels	Other measurement
693	GCST005806	Blood protein levels	Blood protein levels	Other measurement
694	GCST005806	Blood protein levels	Blood protein levels	Other measurement
695	GCST005806	Blood protein levels	Blood protein levels	Other measurement
696	GCST005806	Blood protein levels	Blood protein levels	Other measurement
697	GCST005806	Blood protein levels	Blood protein levels	Other measurement
698	GCST005806	Blood protein levels	Blood protein levels	Other measurement
699	GCST005806	Blood protein levels	Blood protein levels	Other measurement
700	GCST005806	Blood protein levels	Blood protein levels	Other measurement
701	GCST005806	Blood protein levels	Blood protein levels	Other measurement
702	GCST005806	Blood protein levels	Blood protein levels	Other measurement
703	GCST005806	Blood protein levels	Blood protein levels	Inflammatory measurement
704	GCST005806	Blood protein levels	Blood protein levels	Other measurement
705	GCST005806	Blood protein levels	Blood protein levels	Other measurement
706	GCST005806	Blood protein levels	Blood protein levels	Other measurement
707	GCST005806	Blood protein levels	Blood protein levels	Other measurement
708	GCST005806	Blood protein levels	Blood protein levels	Other measurement
709	GCST005806	Blood protein levels	Blood protein levels	Other measurement
710	GCST005806	Blood protein levels	Blood protein levels	Other measurement
711	GCST005806	Blood protein levels	Blood protein levels	Other measurement
712	GCST005806	Blood protein levels	Blood protein levels	Other measurement
713	GCST005806	Blood protein levels	Blood protein levels	Other measurement
714	GCST005806	Blood protein levels	Blood protein levels	Other measurement
715	GCST005806	Blood protein levels	Blood protein levels	Other measurement
716	GCST005806	Blood protein levels	Blood protein levels	Other measurement
717	GCST005806	Blood protein levels	Blood protein levels	Other measurement
718	GCST005806	Blood protein levels	Blood protein levels	Other measurement
719	GCST005806	Blood protein levels	Blood protein levels	Other measurement
720	GCST005806	Blood protein levels	Blood protein levels	Other measurement
721	GCST005806	Blood protein levels	Blood protein levels	Other measurement
722	GCST005806	Blood protein levels	Blood protein levels	Other measurement
723	GCST006814	End-stage renal disease	End-stage renal disease	Other disease
724	GCST006175	Cannabis-related aggression	Cannabis-related aggression	Biological process
725	GCST006175	Cannabis-related aggression	Cannabis-related aggression	Biological process
726	GCST006816	End stage renal disease in APOL1 risk genotype-positive individuals	End stage renal disease in APOL1 risk genotype-positive individuals	Other disease
727	GCST006816	End stage renal disease in APOL1 risk genotype-positive individuals	End stage renal disease in APOL1 risk genotype-positive individuals	Other measurement
728	GCST006815	End stage renal disease in APOL1 risk genotype-negative individuals	End stage renal disease in APOL1 risk genotype-negative individuals	Other disease
729	GCST006815	End stage renal disease in APOL1 risk genotype-negative individuals	End stage renal disease in APOL1 risk genotype-negative individuals	Other measurement
730	GCST006813	End stage renal disease x APOL1 genotype interaction	End stage renal disease x APOL1 genotype interaction	Other disease
731	GCST006813	End stage renal disease x APOL1 genotype interaction	End stage renal disease x APOL1 genotype interaction	Other measurement
732	GCST006143	Bone mineral density (total hip)	Bone mineral density (total hip)	Other measurement
733	GCST006269	General cognitive ability	General cognitive ability	Biological process
734	GCST006268	Reaction time	Reaction time	Other measurement
735	GCST006289	Spherical equivalent	Spherical equivalent	Other measurement
736	GCST006291	Spherical equivalent or myopia (age of diagnosis)	Spherical equivalent or myopia (age of diagnosis)	Other measurement
737	GCST006291	Spherical equivalent or myopia (age of diagnosis)	Spherical equivalent or myopia (age of diagnosis)	Other measurement
738	GCST006291	Spherical equivalent or myopia (age of diagnosis)	Spherical equivalent or myopia (age of diagnosis)	Other trait
739	GCST006290	Myopia (age of diagnosis)	Myopia (age of diagnosis)	Other measurement
740	GCST006290	Myopia (age of diagnosis)	Myopia (age of diagnosis)	Other trait
741	GCST007423	Clinical remission in asthma	Clinical remission in asthma	Other disease
742	GCST007423	Clinical remission in asthma	Clinical remission in asthma	Other trait
743	GCST005864	Late age at menarche	Late age at menarche	Other measurement
744	GCST005865	Early age at menarche	Early age at menarche	Other measurement
745	GCST005867	Menarche (age at onset)	Menarche (age at onset)	Other measurement
746	GCST005787	Heart rate response to exercise	Heart rate response to exercise	Cardiovascular measurement
747	GCST006219	Executive function in ADHD	Executive function in ADHD	Neurological disorder
748	GCST006219	Executive function in ADHD	Executive function in ADHD	Other measurement
749	GCST005790	Rosacea symptom severity	Rosacea symptom severity	Other measurement
750	GCST006134	Hippocampal volume	Hippocampal volume	Other measurement
751	GCST005831	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
752	GCST006136	Alzheimer's disease progression score	Alzheimer's disease progression score	Other measurement
753	GCST006135	Cortical amyloid beta load	Cortical amyloid beta load	Other measurement
754	GCST007250	Nonunion in individuals with fractures	Nonunion in individuals with fractures	Other disease
755	GCST007250	Nonunion in individuals with fractures	Nonunion in individuals with fractures	Other disease
756	GCST007424	Complete remission in asthma	Complete remission in asthma	Other disease
757	GCST007424	Complete remission in asthma	Complete remission in asthma	Other trait
758	GCST007562	Asthma	Asthma	Other disease
759	GCST005928	Refractory celiac disease type II	Refractory celiac disease type II	Digestive system disorder
760	GCST005908	Height	Height	Other measurement
761	GCST005908	Height	Height	Body measurement
762	GCST007564	Asthma or allergic disease (pleiotropy)	Asthma or allergic disease (pleiotropy)	Other disease
763	GCST007564	Asthma or allergic disease (pleiotropy)	Asthma or allergic disease (pleiotropy)	Immune system disorder
764	GCST005746	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Digestive system disorder
765	GCST005746	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Cancer
766	GCST006412	Intraocular pressure	Intraocular pressure	Other measurement
767	GCST007563	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Other disease
768	GCST007563	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Immune system disorder
769	GCST005920	Paternal history of Alzheimer's disease	Paternal history of Alzheimer's disease	Other measurement
770	GCST006393	Serum creatinine levels	Serum creatinine levels	Other measurement
771	GCST006392	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
772	GCST005923	Maternal history of Alzheimer's disease	Maternal history of Alzheimer's disease	Other measurement
773	GCST006391	Chronic kidney disease	Chronic kidney disease	Other disease
774	GCST006391	Chronic kidney disease	Chronic kidney disease	Other measurement
775	GCST006391	Chronic kidney disease	Chronic kidney disease	Other measurement
776	GCST005922	Alzheimer's disease or family history of Alzheimer's disease	Alzheimer's disease or family history of Alzheimer's disease	Neurological disorder
777	GCST005922	Alzheimer's disease or family history of Alzheimer's disease	Alzheimer's disease or family history of Alzheimer's disease	Other measurement
778	GCST005921	Family history of Alzheimer's disease	Family history of Alzheimer's disease	Other measurement
779	GCST005863	Menopause (age at onset)	Menopause (age at onset)	Other measurement
780	GCST006061	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
781	GCST006917	Monoclonal gammopathy of undetermined significance	Monoclonal gammopathy of undetermined significance	Other disease
782	GCST006142	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
783	GCST006142	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
784	GCST006141	High bone mineral density	High bone mineral density	Other measurement
785	GCST006225	Chlamydia trachomatis seropositivity	Chlamydia trachomatis seropositivity	Other measurement
786	GCST007046	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Response to drug
787	GCST007046	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Cancer
788	GCST007046	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Disease-free survival in breast cancer treated with chemotherapy with or without bevacizumab	Other measurement
789	GCST007047	Pathological complete response in breast cancer treated with or without bevacizumab	Pathological complete response in breast cancer treated with or without bevacizumab	Other measurement
790	GCST007047	Pathological complete response in breast cancer treated with or without bevacizumab	Pathological complete response in breast cancer treated with or without bevacizumab	Response to drug
791	GCST007047	Pathological complete response in breast cancer treated with or without bevacizumab	Pathological complete response in breast cancer treated with or without bevacizumab	Cancer
792	GCST007048	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Other measurement
793	GCST007048	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Response to drug
794	GCST007048	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Cancer
795	GCST007048	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Pathological complete response in breast cancer treated with chemotherapy with bevacizumab	Response to drug
796	GCST007049	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Response to drug
797	GCST007049	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Cancer
798	GCST007049	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Overall survival in breast cancer treated with chemotherapy with or without bevacizumab	Other measurement
799	GCST006281	Coronary artery disease in type 1 diabetes	Coronary artery disease in type 1 diabetes	Cardiovascular disease
800	GCST006281	Coronary artery disease in type 1 diabetes	Coronary artery disease in type 1 diabetes	Metabolic disorder
801	GCST005830	Hand grip strength	Hand grip strength	Other measurement
802	GCST006494	Type 2 diabetes (SNP x SNP interaction, 1df)	Type 2 diabetes (SNP x SNP interaction, 1df)	Metabolic disorder
803	GCST006495	Type 2 diabetes (SNP x SNP interaction, 2df)	Type 2 diabetes (SNP x SNP interaction, 2df)	Metabolic disorder
804	GCST005829	Hand grip strength	Hand grip strength	Other measurement
805	GCST006220	Basal ganglia growth	Basal ganglia growth	Other measurement
806	GCST006224	Right lateral prefrontal cortical growth	Right lateral prefrontal cortical growth	Other measurement
807	GCST006223	Cerebral cortical growth	Cerebral cortical growth	Other measurement
808	GCST006222	Cerebellum growth	Cerebellum growth	Other measurement
809	GCST006221	White matter growth	White matter growth	Other measurement
810	GCST005938	Maximum cranial length	Maximum cranial length	Other measurement
811	GCST005839	Depression	Depression	Neurological disorder
812	GCST005839	Depression	Depression	Other measurement
813	GCST006035	Breast cancer and/or colorectal cancer	Breast cancer and/or colorectal cancer	Cancer
814	GCST006035	Breast cancer and/or colorectal cancer	Breast cancer and/or colorectal cancer	Cancer
815	GCST005940	Maximum cranial width	Maximum cranial width	Other measurement
816	GCST005939	Cephalic index	Cephalic index	Other measurement
817	GCST005896	Non-melanoma skin cancer	Non-melanoma skin cancer	Other trait
818	GCST005896	Non-melanoma skin cancer	Non-melanoma skin cancer	Cancer
819	GCST005897	Low tan response	Low tan response	Other trait
820	GCST006818	Remission after antidepressant treatment in major depression	Remission after antidepressant treatment in major depression	Neurological disorder
821	GCST006818	Remission after antidepressant treatment in major depression	Remission after antidepressant treatment in major depression	Response to drug
822	GCST005789	Resting heart rate	Resting heart rate	Cardiovascular measurement
823	GCST005788	Heart rate response to recovery post exercise	Heart rate response to recovery post exercise	Cardiovascular measurement
824	GCST006042	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other disease
825	GCST006042	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
826	GCST006042	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
827	GCST005747	Non-small cell lung cancer in heavy smokers	Non-small cell lung cancer in heavy smokers	Biological process
828	GCST005747	Non-small cell lung cancer in heavy smokers	Non-small cell lung cancer in heavy smokers	Cancer
829	GCST005667	Central corneal thickness	Central corneal thickness	Other measurement
830	GCST005667	Central corneal thickness	Central corneal thickness	Other measurement
831	GCST006367	Central corneal thickness	Central corneal thickness	Other measurement
832	GCST006367	Central corneal thickness	Central corneal thickness	Other measurement
833	GCST006366	Central corneal thickness	Central corneal thickness	Other measurement
834	GCST006366	Central corneal thickness	Central corneal thickness	Other measurement
835	GCST005870	Meningioma	Meningioma	Cancer
836	GCST007113	Huntington's disease (age at onset)	Huntington's disease (age at onset)	Neurological disorder
837	GCST007113	Huntington's disease (age at onset)	Huntington's disease (age at onset)	Other measurement
838	GCST006817	Response to antidepressants in depression	Response to antidepressants in depression	Neurological disorder
839	GCST006817	Response to antidepressants in depression	Response to antidepressants in depression	Neurological disorder
840	GCST006817	Response to antidepressants in depression	Response to antidepressants in depression	Response to drug
841	GCST006248	Response to lurasidone in schizophrenia	Response to lurasidone in schizophrenia	Response to drug
842	GCST006248	Response to lurasidone in schizophrenia	Response to lurasidone in schizophrenia	Neurological disorder
843	GCST006284	Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease	Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease	Other measurement
844	GCST006049	Central corneal thickness	Central corneal thickness	Other measurement
845	GCST006049	Central corneal thickness	Central corneal thickness	Other measurement
846	GCST005672	Cholesteryl ester transfer protein levels	Cholesteryl ester transfer protein levels	Hematological measurement
847	GCST006050	Central corneal thickness	Central corneal thickness	Other measurement
848	GCST006050	Central corneal thickness	Central corneal thickness	Other measurement
849	GCST006535	Irritable bowel syndrome	Irritable bowel syndrome	Digestive system disorder
850	GCST008368	Plasma anti-thyroid peroxidase levels	Plasma anti-thyroid peroxidase levels	Other measurement
851	GCST008369	Plasma anti-thyroglobulin levels	Plasma anti-thyroglobulin levels	Other measurement
852	GCST007732	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Other disease
853	GCST007732	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Immune system disorder
854	GCST008367	Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	Other measurement
855	GCST008367	Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)	Other measurement
856	GCST005714	Cerebrospinal fluid beta-site APP cleaving enzyme levels	Cerebrospinal fluid beta-site APP cleaving enzyme levels	Other measurement
857	GCST005713	Plasma neurofilament light levels	Plasma neurofilament light levels	Other measurement
858	GCST005931	Glioma	Glioma	Cancer
859	GCST005931	Glioma	Glioma	Cancer
860	GCST005933	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
861	GCST005933	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
862	GCST005932	Glioblastoma	Glioblastoma	Cancer
863	GCST005932	Glioblastoma	Glioblastoma	Cancer
864	GCST005932	Glioblastoma	Glioblastoma	Cancer
865	GCST005783	Bone mineral density (lumbar spine) in inflammatory bowel disease	Bone mineral density (lumbar spine) in inflammatory bowel disease	Digestive system disorder
866	GCST005783	Bone mineral density (lumbar spine) in inflammatory bowel disease	Bone mineral density (lumbar spine) in inflammatory bowel disease	Other measurement
867	GCST005784	Bone mineral density (femoral neck) in inflammatory bowel disease	Bone mineral density (femoral neck) in inflammatory bowel disease	Other measurement
868	GCST005784	Bone mineral density (femoral neck) in inflammatory bowel disease	Bone mineral density (femoral neck) in inflammatory bowel disease	Digestive system disorder
869	GCST005688	Idiopathic intracranial hypertension	Idiopathic intracranial hypertension	Cardiovascular disease
870	GCST005579	Low white blood cell count	Low white blood cell count	Hematological measurement
871	GCST005578	Low white blood cell count (conditioned on rs2814778)	Low white blood cell count (conditioned on rs2814778)	Hematological measurement
872	GCST005580	Intraocular pressure	Intraocular pressure	Other measurement
873	GCST005686	Clostridium difficile infection in multiple myeloma	Clostridium difficile infection in multiple myeloma	Other disease
874	GCST005686	Clostridium difficile infection in multiple myeloma	Clostridium difficile infection in multiple myeloma	Cancer
875	GCST005646	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Cardiovascular measurement
876	GCST005646	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Response to drug
877	GCST005646	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	Cardiovascular disease
878	GCST005687	Aortic coarctation	Aortic coarctation	Cardiovascular disease
879	GCST005807	Urinary haptoglobin levels in type 2 diabetes	Urinary haptoglobin levels in type 2 diabetes	Hematological measurement
880	GCST005807	Urinary haptoglobin levels in type 2 diabetes	Urinary haptoglobin levels in type 2 diabetes	Metabolic disorder
881	GCST005904	Major depressive disorder (probable)	Major depressive disorder (probable)	Neurological disorder
882	GCST005844	Placental abruption	Placental abruption	Other disease
883	GCST005902	Depression (broad)	Depression (broad)	Neurological disorder
884	GCST006075	Hair color	Hair color	Other measurement
885	GCST006075	Hair color	Hair color	Other trait
886	GCST005903	Major depressive disorder (ICD-10 coded)	Major depressive disorder (ICD-10 coded)	Neurological disorder
887	GCST006365	Upper eyelid sagging severity	Upper eyelid sagging severity	Other measurement
888	GCST005748	Digit length ratio (right hand)	Digit length ratio (right hand)	Body measurement
889	GCST007518	Type 2 diabetes (adjusted for BMI)	Type 2 diabetes (adjusted for BMI)	Metabolic disorder
890	GCST007516	Type 2 diabetes (adjusted for BMI)	Type 2 diabetes (adjusted for BMI)	Metabolic disorder
891	GCST007517	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
892	GCST005832	Acute lymphoblastic leukemia in childhood (B cell precursor)	Acute lymphoblastic leukemia in childhood (B cell precursor)	Cancer
893	GCST005878	Metabolic syndrome (multivariate analysis)	Metabolic syndrome (multivariate analysis)	Metabolic disorder
894	GCST005905	Global electrical heterogeneity phenotypes	Global electrical heterogeneity phenotypes	Cardiovascular measurement
895	GCST005912	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
896	GCST005914	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
897	GCST005915	Fasting blood insulin	Fasting blood insulin	Other measurement
898	GCST005913	Fasting blood glucose	Fasting blood glucose	Other measurement
899	GCST005671	Cholesterol efflux capacity	Cholesterol efflux capacity	Lipid or lipoprotein measurement
900	GCST005753	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Response to drug
901	GCST005753	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Other measurement
902	GCST005753	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	Metabolic disorder
903	GCST005749	Digit length ratio (left hand)	Digit length ratio (left hand)	Body measurement
904	GCST005750	Digit length ratio	Digit length ratio	Body measurement
905	GCST006431	Plasma parathyroid hormone levels	Plasma parathyroid hormone levels	Other measurement
906	GCST005916	Cotinine levels in smokers with chronic obstructive pulmonary disease	Cotinine levels in smokers with chronic obstructive pulmonary disease	Other disease
907	GCST005916	Cotinine levels in smokers with chronic obstructive pulmonary disease	Cotinine levels in smokers with chronic obstructive pulmonary disease	Other measurement
908	GCST005916	Cotinine levels in smokers with chronic obstructive pulmonary disease	Cotinine levels in smokers with chronic obstructive pulmonary disease	Other measurement
909	GCST005919	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Other disease
910	GCST005919	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Other measurement
911	GCST005919	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	Other measurement
912	GCST005918	Smoking cessation in chronic obstructive pulmonary disease	Smoking cessation in chronic obstructive pulmonary disease	Other disease
913	GCST005918	Smoking cessation in chronic obstructive pulmonary disease	Smoking cessation in chronic obstructive pulmonary disease	Biological process
914	GCST005917	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other disease
915	GCST005917	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
916	GCST005917	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
917	GCST007515	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
918	GCST006531	Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	Cancer
919	GCST006531	Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	Digestive system disorder
920	GCST006532	Esophageal adenocarcinoma x pack-years of smoking exposure interaction	Esophageal adenocarcinoma x pack-years of smoking exposure interaction	Other measurement
921	GCST006532	Esophageal adenocarcinoma x pack-years of smoking exposure interaction	Esophageal adenocarcinoma x pack-years of smoking exposure interaction	Cancer
922	GCST006530	Esophageal adenocarcinoma x smoking interaction	Esophageal adenocarcinoma x smoking interaction	Other measurement
923	GCST006530	Esophageal adenocarcinoma x smoking interaction	Esophageal adenocarcinoma x smoking interaction	Cancer
924	GCST006525	Esophageal adenocarcinoma x BMI interaction	Esophageal adenocarcinoma x BMI interaction	Body measurement
925	GCST006525	Esophageal adenocarcinoma x BMI interaction	Esophageal adenocarcinoma x BMI interaction	Cancer
926	GCST005800	Surgical necrotising enterocolitis in extremely premature birth	Surgical necrotising enterocolitis in extremely premature birth	Other trait
927	GCST005800	Surgical necrotising enterocolitis in extremely premature birth	Surgical necrotising enterocolitis in extremely premature birth	Digestive system disorder
928	GCST005761	Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels	Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels	Other measurement
929	GCST006299	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
930	GCST005811	Osteoarthritis (self-reported)	Osteoarthritis (self-reported)	Other disease
931	GCST005812	Osteoarthritis of the hip or knee (hospital diagnosed)	Osteoarthritis of the hip or knee (hospital diagnosed)	Other disease
932	GCST005812	Osteoarthritis of the hip or knee (hospital diagnosed)	Osteoarthritis of the hip or knee (hospital diagnosed)	Other disease
933	GCST005813	Osteoarthritis of the knee (hospital diagnosed)	Osteoarthritis of the knee (hospital diagnosed)	Other disease
934	GCST005814	Osteoarthritis (hospital diagnosed)	Osteoarthritis (hospital diagnosed)	Other disease
935	GCST005810	Osteoarthritis of the hip (hospital diagnosed)	Osteoarthritis of the hip (hospital diagnosed)	Other disease
936	GCST006404	Glycemic traits (multi-trait analysis)	Glycemic traits (multi-trait analysis)	Other measurement
937	GCST006404	Glycemic traits (multi-trait analysis)	Glycemic traits (multi-trait analysis)	Other measurement
938	GCST006404	Glycemic traits (multi-trait analysis)	Glycemic traits (multi-trait analysis)	Other measurement
939	GCST006981	Facial wrinkles	Facial wrinkles	Other trait
940	GCST005808	Plasma haptoglobin levels in type 2 diabetes	Plasma haptoglobin levels in type 2 diabetes	Hematological measurement
941	GCST005808	Plasma haptoglobin levels in type 2 diabetes	Plasma haptoglobin levels in type 2 diabetes	Metabolic disorder
942	GCST005711	Growth differentiation factor-15 levels	Growth differentiation factor-15 levels	Hematological measurement
943	GCST005712	Growth differentiation factor-15 levels (conditioned on rs888663)	Growth differentiation factor-15 levels (conditioned on rs888663)	Hematological measurement
944	GCST005670	Plasma trimethyllysine levels	Plasma trimethyllysine levels	Hematological measurement
945	GCST005929	Severity of nausea and vomiting of pregnancy	Severity of nausea and vomiting of pregnancy	Other measurement
946	GCST005647	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
947	GCST005930	Hyperemesis gravidarum	Hyperemesis gravidarum	Other disease
948	GCST006805	Infective endocarditis in Staphylococcus aureus infection	Infective endocarditis in Staphylococcus aureus infection	Other disease
949	GCST006805	Infective endocarditis in Staphylococcus aureus infection	Infective endocarditis in Staphylococcus aureus infection	Cardiovascular disease
950	GCST005936	Supraventricular ectopy	Supraventricular ectopy	Cardiovascular disease
951	GCST005937	Ventricular ectopy	Ventricular ectopy	Cardiovascular disease
952	GCST005935	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Cardiovascular disease
953	GCST005935	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Cardiovascular disease
954	GCST005935	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Ventricular ectopy or supraventricular ectopy (pleiotropy)	Cardiovascular disease
955	GCST005906	Endometriosis or endometrial cancer (pleiotropy)	Endometriosis or endometrial cancer (pleiotropy)	Cancer
956	GCST005906	Endometriosis or endometrial cancer (pleiotropy)	Endometriosis or endometrial cancer (pleiotropy)	Other disease
957	GCST006043	Plasma renin activity levels	Plasma renin activity levels	Cardiovascular measurement
958	GCST005718	Anhedonia	Anhedonia	Other measurement
959	GCST005717	Paranoia and hallucinations	Paranoia and hallucinations	Other measurement
960	GCST005720	Parent-rated negative symptoms	Parent-rated negative symptoms	Other measurement
961	GCST005719	Cognitive disorganisation	Cognitive disorganisation	Other measurement
962	GCST005836	Response to SSRI in MDD or conscientiouness	Response to SSRI in MDD or conscientiouness	Response to drug
963	GCST005836	Response to SSRI in MDD or conscientiouness	Response to SSRI in MDD or conscientiouness	Neurological disorder
964	GCST005836	Response to SSRI in MDD or conscientiouness	Response to SSRI in MDD or conscientiouness	Other measurement
965	GCST005834	Response to SSRI in MDD or openness	Response to SSRI in MDD or openness	Response to drug
966	GCST005834	Response to SSRI in MDD or openness	Response to SSRI in MDD or openness	Neurological disorder
967	GCST005834	Response to SSRI in MDD or openness	Response to SSRI in MDD or openness	Other measurement
968	GCST005557	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
969	GCST005833	Remission after SSRI treatment in MDD or openness	Remission after SSRI treatment in MDD or openness	Response to drug
970	GCST005833	Remission after SSRI treatment in MDD or openness	Remission after SSRI treatment in MDD or openness	Neurological disorder
971	GCST005833	Remission after SSRI treatment in MDD or openness	Remission after SSRI treatment in MDD or openness	Other measurement
972	GCST005835	Remission after SSRI treatment in MDD or neuroticism	Remission after SSRI treatment in MDD or neuroticism	Response to drug
973	GCST005835	Remission after SSRI treatment in MDD or neuroticism	Remission after SSRI treatment in MDD or neuroticism	Neurological disorder
974	GCST005835	Remission after SSRI treatment in MDD or neuroticism	Remission after SSRI treatment in MDD or neuroticism	Other measurement
975	GCST005576	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
976	GCST005851	Delirium	Delirium	Neurological disorder
977	GCST005577	Change in glucose in response to thiazide diuretic treatment in hypertension	Change in glucose in response to thiazide diuretic treatment in hypertension	Cardiovascular disease
978	GCST005577	Change in glucose in response to thiazide diuretic treatment in hypertension	Change in glucose in response to thiazide diuretic treatment in hypertension	Other measurement
979	GCST005577	Change in glucose in response to thiazide diuretic treatment in hypertension	Change in glucose in response to thiazide diuretic treatment in hypertension	Response to drug
980	GCST005590	Nontyphoidal Salmonella bacteraemia	Nontyphoidal Salmonella bacteraemia	Cardiovascular disease
981	GCST006133	Bone mineral density x blood lead interaction in current smokers (2df test)	Bone mineral density x blood lead interaction in current smokers (2df test)	Biological process
982	GCST006133	Bone mineral density x blood lead interaction in current smokers (2df test)	Bone mineral density x blood lead interaction in current smokers (2df test)	Other measurement
983	GCST006133	Bone mineral density x blood lead interaction in current smokers (2df test)	Bone mineral density x blood lead interaction in current smokers (2df test)	Other measurement
984	GCST005559	Virologic severity in Herpes simplex virus type 2 infection	Virologic severity in Herpes simplex virus type 2 infection	Other measurement
985	GCST005795	Femoral neck bone mineral density	Femoral neck bone mineral density	Other measurement
986	GCST005796	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
987	GCST005796	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
988	GCST005588	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
989	GCST005588	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
990	GCST006803	Schizophrenia	Schizophrenia	Neurological disorder
991	GCST005653	Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	Other measurement
992	GCST005653	Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	Other trait
993	GCST005654	Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	Other measurement
994	GCST005654	Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	Other trait
995	GCST005656	IgG glycosylation patterns	IgG glycosylation patterns	Other measurement
996	GCST005652	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	Other measurement
997	GCST005652	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	Other trait
998	GCST006869	Nicotine withdrawal	Nicotine withdrawal	Other measurement
999	GCST006303	Nicotine withdrawal symptom count	Nicotine withdrawal symptom count	Other measurement
1000	GCST006302	Nicotine dependence	Nicotine dependence	Neurological disorder
1001	GCST006301	Nicotine dependence symptom count	Nicotine dependence symptom count	Other measurement
1002	GCST006300	Smoking behaviour (maximum cigarettes in a 24 hour period)	Smoking behaviour (maximum cigarettes in a 24 hour period)	Other measurement
1003	GCST005606	Response to hepatitis B vaccine	Response to hepatitis B vaccine	Response to drug
1004	GCST005606	Response to hepatitis B vaccine	Response to hepatitis B vaccine	Other measurement
1005	GCST005751	Empathy quotient	Empathy quotient	Other measurement
1006	GCST006132	Bone mineral density x blood lead interaction in current smokers (1df test)	Bone mineral density x blood lead interaction in current smokers (1df test)	Biological process
1007	GCST006132	Bone mineral density x blood lead interaction in current smokers (1df test)	Bone mineral density x blood lead interaction in current smokers (1df test)	Other measurement
1008	GCST006132	Bone mineral density x blood lead interaction in current smokers (1df test)	Bone mineral density x blood lead interaction in current smokers (1df test)	Other measurement
1009	GCST007044	Extremely high intelligence	Extremely high intelligence	Biological process
1010	GCST005566	Insomnia	Insomnia	Neurological disorder
1011	GCST005566	Insomnia	Insomnia	Other measurement
1012	GCST005785	Calcific aortic valve stenosis	Calcific aortic valve stenosis	Cardiovascular disease
1013	GCST005785	Calcific aortic valve stenosis	Calcific aortic valve stenosis	Cardiovascular disease
1014	GCST005587	Breast milk fatty acid composition (infant genotype effect)	Breast milk fatty acid composition (infant genotype effect)	Lipid or lipoprotein measurement
1015	GCST005587	Breast milk fatty acid composition (infant genotype effect)	Breast milk fatty acid composition (infant genotype effect)	Other measurement
1016	GCST005587	Breast milk fatty acid composition (infant genotype effect)	Breast milk fatty acid composition (infant genotype effect)	Other measurement
1017	GCST006126	Uveitis in juvenile idiopathic arthritis	Uveitis in juvenile idiopathic arthritis	Neurological disorder
1018	GCST006126	Uveitis in juvenile idiopathic arthritis	Uveitis in juvenile idiopathic arthritis	Immune system disorder
1019	GCST006127	Uveitis (juvenile idiopathic arthritis-associated)	Uveitis (juvenile idiopathic arthritis-associated)	Neurological disorder
1020	GCST006127	Uveitis (juvenile idiopathic arthritis-associated)	Uveitis (juvenile idiopathic arthritis-associated)	Immune system disorder
1021	GCST006128	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
1022	GCST005586	Breast milk fatty acid composition (maternal genotype effect)	Breast milk fatty acid composition (maternal genotype effect)	Lipid or lipoprotein measurement
1023	GCST005586	Breast milk fatty acid composition (maternal genotype effect)	Breast milk fatty acid composition (maternal genotype effect)	Other measurement
1024	GCST005586	Breast milk fatty acid composition (maternal genotype effect)	Breast milk fatty acid composition (maternal genotype effect)	Other measurement
1025	GCST005561	Aortic valve stenosis	Aortic valve stenosis	Cardiovascular disease
1026	GCST005729	Serum 25-Hydroxyvitamin D levels	Serum 25-Hydroxyvitamin D levels	Other measurement
1027	GCST005754	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
1028	GCST006526	Barrett's esophagus x gastroesophageal reflux disease interaction	Barrett's esophagus x gastroesophageal reflux disease interaction	Digestive system disorder
1029	GCST006526	Barrett's esophagus x gastroesophageal reflux disease interaction	Barrett's esophagus x gastroesophageal reflux disease interaction	Digestive system disorder
1030	GCST006527	Barrett's esophagus x smoking interaction	Barrett's esophagus x smoking interaction	Other measurement
1031	GCST006527	Barrett's esophagus x smoking interaction	Barrett's esophagus x smoking interaction	Digestive system disorder
1032	GCST006528	Barrett's esophagus x pack-years of smoking exposure interaction	Barrett's esophagus x pack-years of smoking exposure interaction	Other measurement
1033	GCST006528	Barrett's esophagus x pack-years of smoking exposure interaction	Barrett's esophagus x pack-years of smoking exposure interaction	Digestive system disorder
1034	GCST006529	Barrett's esophagus x BMI interaction	Barrett's esophagus x BMI interaction	Body measurement
1035	GCST006529	Barrett's esophagus x BMI interaction	Barrett's esophagus x BMI interaction	Digestive system disorder
1036	GCST005436	C-peptide levels in type I diabetes	C-peptide levels in type I diabetes	Other measurement
1037	GCST005436	C-peptide levels in type I diabetes	C-peptide levels in type I diabetes	Metabolic disorder
1038	GCST005437	Random C-peptide levels in type I diabetes	Random C-peptide levels in type I diabetes	Other measurement
1039	GCST005437	Random C-peptide levels in type I diabetes	Random C-peptide levels in type I diabetes	Metabolic disorder
1040	GCST005438	Fasting C-peptide levels in type I diabetes	Fasting C-peptide levels in type I diabetes	Other measurement
1041	GCST005438	Fasting C-peptide levels in type I diabetes	Fasting C-peptide levels in type I diabetes	Metabolic disorder
1042	GCST005803	Corneal astigmatism	Corneal astigmatism	Neurological disorder
1043	GCST005803	Corneal astigmatism	Corneal astigmatism	Other trait
1044	GCST005407	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
1045	GCST005408	Open-angle glaucoma and intra-ocular pressure	Open-angle glaucoma and intra-ocular pressure	Other measurement
1046	GCST005408	Open-angle glaucoma and intra-ocular pressure	Open-angle glaucoma and intra-ocular pressure	Neurological disorder
1047	GCST005409	Open-angle glaucoma and vertical cup-disc ratio	Open-angle glaucoma and vertical cup-disc ratio	Other measurement
1048	GCST005409	Open-angle glaucoma and vertical cup-disc ratio	Open-angle glaucoma and vertical cup-disc ratio	Neurological disorder
1049	GCST005410	Open-angle glaucoma and optic disc area	Open-angle glaucoma and optic disc area	Other measurement
1050	GCST005410	Open-angle glaucoma and optic disc area	Open-angle glaucoma and optic disc area	Neurological disorder
1051	GCST005570	Hepatitis B virus-related hepatocellular carcinoma	Hepatitis B virus-related hepatocellular carcinoma	Digestive system disorder
1052	GCST005570	Hepatitis B virus-related hepatocellular carcinoma	Hepatitis B virus-related hepatocellular carcinoma	Cancer
1053	GCST005406	Open-angle glaucoma and optic cup area	Open-angle glaucoma and optic cup area	Other measurement
1054	GCST005406	Open-angle glaucoma and optic cup area	Open-angle glaucoma and optic cup area	Neurological disorder
1055	GCST005388	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
1056	GCST005805	Acute respiratory distress syndrome	Acute respiratory distress syndrome	Other disease
1057	GCST005518	Premature menopause in childhood cancer survivors	Premature menopause in childhood cancer survivors	Other disease
1058	GCST005434	Pancreatic cancer	Pancreatic cancer	Cancer
1059	GCST005571	Osteoarthritis of the hip or knee (with total joint replacement)	Osteoarthritis of the hip or knee (with total joint replacement)	Other disease
1060	GCST005571	Osteoarthritis of the hip or knee (with total joint replacement)	Osteoarthritis of the hip or knee (with total joint replacement)	Other disease
1061	GCST005574	Osteoarthritis of the knee (with total joint replacement)	Osteoarthritis of the knee (with total joint replacement)	Other disease
1062	GCST005572	Osteoarthritis of the hip (with total joint replacement)	Osteoarthritis of the hip (with total joint replacement)	Other disease
1063	GCST005573	Osteoarthritis of the hip or knee	Osteoarthritis of the hip or knee	Other disease
1064	GCST005573	Osteoarthritis of the hip or knee	Osteoarthritis of the hip or knee	Other disease
1065	GCST005435	Stimulated C-peptide levels in type I diabetes	Stimulated C-peptide levels in type I diabetes	Other measurement
1066	GCST005435	Stimulated C-peptide levels in type I diabetes	Stimulated C-peptide levels in type I diabetes	Metabolic disorder
1067	GCST005439	Response to alcohol consumption (flushing response)	Response to alcohol consumption (flushing response)	Biological process
1068	GCST005441	Alcohol consumption (max-drinks)	Alcohol consumption (max-drinks)	Biological process
1069	GCST005441	Alcohol consumption (max-drinks)	Alcohol consumption (max-drinks)	Other measurement
1070	GCST007989	Facial morphology traits (63 three-dimensional facial segments)	Facial morphology traits (63 three-dimensional facial segments)	Other measurement
1071	GCST005591	Colorectal cancer	Colorectal cancer	Cancer
1072	GCST005798	Sperm motility	Sperm motility	Other measurement
1073	GCST005804	Taxane-induced peripheral neuropathy in breast cancer	Taxane-induced peripheral neuropathy in breast cancer	Cancer
1074	GCST005804	Taxane-induced peripheral neuropathy in breast cancer	Taxane-induced peripheral neuropathy in breast cancer	Response to drug
1075	GCST005804	Taxane-induced peripheral neuropathy in breast cancer	Taxane-induced peripheral neuropathy in breast cancer	Neurological disorder
1076	GCST005309	Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	Cancer
1077	GCST005309	Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	Digestive system disorder
1078	GCST005337	Headache	Headache	Other trait
1079	GCST005308	Nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	Digestive system disorder
1080	GCST005311	Hepatocyte fat droplet content in nonalcoholic fatty liver disease	Hepatocyte fat droplet content in nonalcoholic fatty liver disease	Other measurement
1081	GCST005310	Brunt grade in nonalcoholic fatty liver disease	Brunt grade in nonalcoholic fatty liver disease	Other measurement
1082	GCST005307	Brunt stage in nonalcoholic fatty liver disease	Brunt stage in nonalcoholic fatty liver disease	Other measurement
1083	GCST005357	Severe malaria (adjusted for sickle cell variant rs334)	Severe malaria (adjusted for sickle cell variant rs334)	Digestive system disorder
1084	GCST005356	Severe malaria	Severe malaria	Digestive system disorder
1085	GCST005318	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	Neurological disorder
1086	GCST005318	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	Response to drug
1087	GCST005369	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
1088	GCST005417	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
1089	GCST005416	Airflow obstruction	Airflow obstruction	Other measurement
1090	GCST005419	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
1091	GCST005418	FEV1	FEV1	Other measurement
1092	GCST005386	Binge eating behaviour and bipolar disorder	Binge eating behaviour and bipolar disorder	Metabolic disorder
1093	GCST005386	Binge eating behaviour and bipolar disorder	Binge eating behaviour and bipolar disorder	Neurological disorder
1094	GCST005387	Binge eating behaviour in bipolar disorder	Binge eating behaviour in bipolar disorder	Metabolic disorder
1095	GCST005387	Binge eating behaviour in bipolar disorder	Binge eating behaviour in bipolar disorder	Neurological disorder
1096	GCST005415	Self-reported risk-taking behaviour	Self-reported risk-taking behaviour	Biological process
1097	GCST005412	Thrombin-activatable fibrinolysis inhibitor levels	Thrombin-activatable fibrinolysis inhibitor levels	Other measurement
1098	GCST005365	Serum C3d:C3 ratio (systemic complement activation)	Serum C3d:C3 ratio (systemic complement activation)	Hematological measurement
1099	GCST005411	Thrombin-activatable fibrinolysis inhibitor activation peptide	Thrombin-activatable fibrinolysis inhibitor activation peptide	Hematological measurement
1100	GCST005521	Heart rate response to beta blockers (atenolol monotherapy)	Heart rate response to beta blockers (atenolol monotherapy)	Cardiovascular measurement
1101	GCST005521	Heart rate response to beta blockers (atenolol monotherapy)	Heart rate response to beta blockers (atenolol monotherapy)	Response to drug
1102	GCST005519	Heart rate response to beta blockers	Heart rate response to beta blockers	Cardiovascular measurement
1103	GCST005519	Heart rate response to beta blockers	Heart rate response to beta blockers	Response to drug
1104	GCST005520	Heart rate response to beta blockers (atenolol add-on therapy)	Heart rate response to beta blockers (atenolol add-on therapy)	Cardiovascular measurement
1105	GCST005520	Heart rate response to beta blockers (atenolol add-on therapy)	Heart rate response to beta blockers (atenolol add-on therapy)	Response to drug
1106	GCST005582	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1107	GCST005582	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1108	GCST005797	Theory of mind score in adolescence (Emotional Triangles Task)	Theory of mind score in adolescence (Emotional Triangles Task)	Other measurement
1109	GCST005440	Alcohol dependence symptom count	Alcohol dependence symptom count	Other measurement
1110	GCST005802	Hyperuricemia	Hyperuricemia	Cardiovascular measurement
1111	GCST005802	Hyperuricemia	Hyperuricemia	Metabolic disorder
1112	GCST005801	Gout vs. Hyperuricemia	Gout vs. Hyperuricemia	Metabolic disorder
1113	GCST005801	Gout vs. Hyperuricemia	Gout vs. Hyperuricemia	Metabolic disorder
1114	GCST005799	Gout	Gout	Metabolic disorder
1115	GCST005267	Schizophrenia or lung cancer (pleiotropy)	Schizophrenia or lung cancer (pleiotropy)	Neurological disorder
1116	GCST005267	Schizophrenia or lung cancer (pleiotropy)	Schizophrenia or lung cancer (pleiotropy)	Cancer
1117	GCST005266	Schizophrenia or cigarettes per day (pleiotropy)	Schizophrenia or cigarettes per day (pleiotropy)	Other measurement
1118	GCST005266	Schizophrenia or cigarettes per day (pleiotropy)	Schizophrenia or cigarettes per day (pleiotropy)	Neurological disorder
1119	GCST005368	Opioid dependence	Opioid dependence	Neurological disorder
1120	GCST005316	Intelligence (MTAG)	Intelligence (MTAG)	Biological process
1121	GCST005317	Femoral neck bone mineral density or plasma lipids (pleiotropy)	Femoral neck bone mineral density or plasma lipids (pleiotropy)	Other measurement
1122	GCST005317	Femoral neck bone mineral density or plasma lipids (pleiotropy)	Femoral neck bone mineral density or plasma lipids (pleiotropy)	Other measurement
1123	GCST005355	Helping behaviour (self reported)	Helping behaviour (self reported)	Other measurement
1124	GCST005313	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other measurement
1125	GCST005313	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other trait
1126	GCST006196	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Other measurement
1127	GCST006196	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Metabolic disorder
1128	GCST006196	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Type 1 diabetes in high risk HLA genotype individuals (time to event)	Other measurement
1129	GCST006197	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Other measurement
1130	GCST006197	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Other measurement
1131	GCST006197	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Metabolic disorder
1132	GCST006197	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	Other measurement
1133	GCST005306	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
1134	GCST005349	Total body bone mineral density (age over 60)	Total body bone mineral density (age over 60)	Other measurement
1135	GCST005350	Total body bone mineral density (age 45-60)	Total body bone mineral density (age 45-60)	Other measurement
1136	GCST005346	Total body bone mineral density (age 30-45)	Total body bone mineral density (age 30-45)	Other measurement
1137	GCST005344	Total body bone mineral density (age 15-30)	Total body bone mineral density (age 15-30)	Other measurement
1138	GCST005345	Total body bone mineral density (age 0-15)	Total body bone mineral density (age 0-15)	Other measurement
1139	GCST005348	Total body bone mineral density	Total body bone mineral density	Other measurement
1140	GCST005276	Dementia with Lewy bodies	Dementia with Lewy bodies	Other trait
1141	GCST005197	Antiepileptic drug-induced maculopapular exanthema	Antiepileptic drug-induced maculopapular exanthema	Other disease
1142	GCST005197	Antiepileptic drug-induced maculopapular exanthema	Antiepileptic drug-induced maculopapular exanthema	Response to drug
1143	GCST005200	Phenytoin-induced maculopapular exanthema	Phenytoin-induced maculopapular exanthema	Response to drug
1144	GCST005200	Phenytoin-induced maculopapular exanthema	Phenytoin-induced maculopapular exanthema	Other disease
1145	GCST005199	Lamotrigine-induced maculopapular exanthema	Lamotrigine-induced maculopapular exanthema	Response to drug
1146	GCST005199	Lamotrigine-induced maculopapular exanthema	Lamotrigine-induced maculopapular exanthema	Other disease
1147	GCST005198	Carbamazepine-induced maculopapular exanthema	Carbamazepine-induced maculopapular exanthema	Other disease
1148	GCST005198	Carbamazepine-induced maculopapular exanthema	Carbamazepine-induced maculopapular exanthema	Response to drug
1149	GCST005287	Intrinsic epigenetic age acceleration	Intrinsic epigenetic age acceleration	Biological process
1150	GCST005352	Paclitaxel disposition in epithelial ovarian cancer	Paclitaxel disposition in epithelial ovarian cancer	Cancer
1151	GCST005352	Paclitaxel disposition in epithelial ovarian cancer	Paclitaxel disposition in epithelial ovarian cancer	Response to drug
1152	GCST005330	Coffee consumption	Coffee consumption	Biological process
1153	GCST005330	Coffee consumption	Coffee consumption	Other measurement
1154	GCST005330	Coffee consumption	Coffee consumption	Other measurement
1155	GCST005329	Coffee consumption	Coffee consumption	Biological process
1156	GCST005329	Coffee consumption	Coffee consumption	Other measurement
1157	GCST005329	Coffee consumption	Coffee consumption	Other measurement
1158	GCST005351	Carboplatin disposition in epthelial ovarian cancer	Carboplatin disposition in epthelial ovarian cancer	Cancer
1159	GCST005351	Carboplatin disposition in epthelial ovarian cancer	Carboplatin disposition in epthelial ovarian cancer	Response to drug
1160	GCST005331	CSF tryptophan concentration in tuberculous meningitis	CSF tryptophan concentration in tuberculous meningitis	Other measurement
1161	GCST005331	CSF tryptophan concentration in tuberculous meningitis	CSF tryptophan concentration in tuberculous meningitis	Neurological disorder
1162	GCST005414	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1163	GCST005898	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1164	GCST005899	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1165	GCST005413	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1166	GCST005786	Prostate cancer	Prostate cancer	Cancer
1167	GCST006806	Late-onset Alzheimer's disease	Late-onset Alzheimer's disease	Neurological disorder
1168	GCST005315	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
1169	GCST005366	Vitamin D levels (dietary vitamin D intake interaction)	Vitamin D levels (dietary vitamin D intake interaction)	Other measurement
1170	GCST005366	Vitamin D levels (dietary vitamin D intake interaction)	Vitamin D levels (dietary vitamin D intake interaction)	Other measurement
1171	GCST005367	Vitamin D levels	Vitamin D levels	Other measurement
1172	GCST005359	Disease progression in age-related macular degeneration	Disease progression in age-related macular degeneration	Neurological disorder
1173	GCST005359	Disease progression in age-related macular degeneration	Disease progression in age-related macular degeneration	Other measurement
1174	GCST005358	Disease progression to choroidal neovascularization form in age-related macular degeneration	Disease progression to choroidal neovascularization form in age-related macular degeneration	Neurological disorder
1175	GCST005358	Disease progression to choroidal neovascularization form in age-related macular degeneration	Disease progression to choroidal neovascularization form in age-related macular degeneration	Other measurement
1176	GCST005360	Disease progression to geographic atrophy form in age-related macular degeneration	Disease progression to geographic atrophy form in age-related macular degeneration	Neurological disorder
1177	GCST005360	Disease progression to geographic atrophy form in age-related macular degeneration	Disease progression to geographic atrophy form in age-related macular degeneration	Other measurement
1178	GCST005343	Plasma kynurenine to tryptophan ratio in major depressive disorder	Plasma kynurenine to tryptophan ratio in major depressive disorder	Neurological disorder
1179	GCST005343	Plasma kynurenine to tryptophan ratio in major depressive disorder	Plasma kynurenine to tryptophan ratio in major depressive disorder	Other measurement
1180	GCST005342	Plasma kynurenine levels in major depressive disorder	Plasma kynurenine levels in major depressive disorder	Neurological disorder
1181	GCST005342	Plasma kynurenine levels in major depressive disorder	Plasma kynurenine levels in major depressive disorder	Other measurement
1182	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Digestive system disorder
1183	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Immune system disorder
1184	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Immune system disorder
1185	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Neurological disorder
1186	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Immune system disorder
1187	GCST005319	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Frontotemporal dementia and immune-mediated diseases (pleiotropy)	Immune system disorder
1188	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Digestive system disorder
1189	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Immune system disorder
1190	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Immune system disorder
1191	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Neurological disorder
1192	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Immune system disorder
1193	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Immune system disorder
1194	GCST005322	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Metabolic disorder
1195	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Digestive system disorder
1196	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Immune system disorder
1197	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Immune system disorder
1198	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Neurological disorder
1199	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Immune system disorder
1200	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Immune system disorder
1201	GCST005321	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	Metabolic disorder
1202	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Digestive system disorder
1203	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Immune system disorder
1204	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Immune system disorder
1205	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Neurological disorder
1206	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Immune system disorder
1207	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Immune system disorder
1208	GCST005320	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	Metabolic disorder
1209	GCST006203	Atazanavir levels	Atazanavir levels	Other measurement
1210	GCST005782	Serum 25-Hydroxyvitamin D levels	Serum 25-Hydroxyvitamin D levels	Other measurement
1211	GCST005314	Offspring birth weight	Offspring birth weight	Body measurement
1212	GCST005314	Offspring birth weight	Offspring birth weight	Other measurement
1213	GCST005353	GLP-1-stimulated insulin secretion	GLP-1-stimulated insulin secretion	Other measurement
1214	GCST006305	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
1215	GCST006472	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
1216	GCST006471	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
1217	GCST006471	LDL cholesterol	LDL cholesterol	Other measurement
1218	GCST006471	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
1219	GCST006470	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
1220	GCST006469	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
1221	GCST006308	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
1222	GCST006307	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
1223	GCST006307	LDL cholesterol	LDL cholesterol	Other measurement
1224	GCST006307	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
1225	GCST006306	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
1226	GCST005289	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
1227	GCST005288	Extrinsic epigenetic age acceleration	Extrinsic epigenetic age acceleration	Biological process
1228	GCST005190	Nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	Digestive system disorder
1229	GCST005347	Pseudoexfoliation syndrome	Pseudoexfoliation syndrome	Neurological disorder
1230	GCST005575	Moyamoya disease	Moyamoya disease	Cardiovascular disease
1231	GCST006862	Asthma	Asthma	Other disease
1232	GCST005206	B-type natriuretic peptide levels	B-type natriuretic peptide levels	Cardiovascular measurement
1233	GCST005246	Inhibitory control	Inhibitory control	Other measurement
1234	GCST005187	Matrix metalloproteinase-8 levels	Matrix metalloproteinase-8 levels	Inflammatory measurement
1235	GCST005205	N-terminal pro B-type natriuretic peptide levels	N-terminal pro B-type natriuretic peptide levels	Cardiovascular measurement
1236	GCST005207	Midregional pro atrial natriuretic peptide levels	Midregional pro atrial natriuretic peptide levels	Cardiovascular measurement
1237	GCST005208	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio	Cardiovascular measurement
1238	GCST005209	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
1239	GCST005210	Mixed cellularity Hodgkin lymphoma	Mixed cellularity Hodgkin lymphoma	Cancer
1240	GCST005214	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Cancer
1241	GCST005214	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Other measurement
1242	GCST005214	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	Response to drug
1243	GCST005268	Chronic rhinosinusitis with nasal polyps	Chronic rhinosinusitis with nasal polyps	Neurological disorder
1244	GCST005232	Neuroticism	Neuroticism	Neurological disorder
1245	GCST005232	Neuroticism	Neuroticism	Other measurement
1246	GCST005247	Male sexual orientation	Male sexual orientation	Other trait
1247	GCST005169	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1248	GCST005169	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1249	GCST005191	Hair shape	Hair shape	Other measurement
1250	GCST006174	Depressive symptoms	Depressive symptoms	Neurological disorder
1251	GCST006174	Depressive symptoms	Depressive symptoms	Other measurement
1252	GCST005177	Rubella-specific interferon-gamma secretion	Rubella-specific interferon-gamma secretion	Response to drug
1253	GCST005177	Rubella-specific interferon-gamma secretion	Rubella-specific interferon-gamma secretion	Other measurement
1254	GCST006130	Pediatric areal bone mineral density (concordant skeletal phenotype)	Pediatric areal bone mineral density (concordant skeletal phenotype)	Other measurement
1255	GCST006129	Pediatric areal bone mineral density (spine vs radius & hip discordant skeletal phenotype)	Pediatric areal bone mineral density (spine vs radius & hip discordant skeletal phenotype)	Other measurement
1256	GCST006247	Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype)	Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype)	Other measurement
1257	GCST005176	Rubella-specific interleukin-6 secretion	Rubella-specific interleukin-6 secretion	Response to drug
1258	GCST005176	Rubella-specific interleukin-6 secretion	Rubella-specific interleukin-6 secretion	Inflammatory measurement
1259	GCST005170	Intraocular pressure	Intraocular pressure	Other measurement
1260	GCST005248	Delayed reward discounting	Delayed reward discounting	Other measurement
1261	GCST005168	Systolic blood pressure	Systolic blood pressure	Other measurement
1262	GCST005168	Systolic blood pressure	Systolic blood pressure	Other measurement
1263	GCST005171	QT interval	QT interval	Cardiovascular measurement
1264	GCST005364	Opioid requirements during laparoscopic-assisted colectomy	Opioid requirements during laparoscopic-assisted colectomy	Response to drug
1265	GCST005364	Opioid requirements during laparoscopic-assisted colectomy	Opioid requirements during laparoscopic-assisted colectomy	Other measurement
1266	GCST005182	Common carotid intima-media thickness in HIV negative individuals	Common carotid intima-media thickness in HIV negative individuals	Cardiovascular measurement
1267	GCST005183	Common carotid intima-media thickness	Common carotid intima-media thickness	Cardiovascular measurement
1268	GCST005184	Common carotid intima-media thickness in HIV infection	Common carotid intima-media thickness in HIV infection	Other disease
1269	GCST005184	Common carotid intima-media thickness in HIV infection	Common carotid intima-media thickness in HIV infection	Cardiovascular measurement
1270	GCST005213	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
1271	GCST005213	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
1272	GCST005212	Asthma	Asthma	Other disease
1273	GCST005172	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1274	GCST005172	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1275	GCST005655	Seborrheic dermatitis	Seborrheic dermatitis	Other disease
1276	GCST005211	Nodular sclerosis Hodgkin lymphoma	Nodular sclerosis Hodgkin lymphoma	Cancer
1277	GCST005108	Major depressive disorder	Major depressive disorder	Neurological disorder
1278	GCST005238	Mood instability	Mood instability	Other measurement
1279	GCST006800	Childhood insulin resistance	Childhood insulin resistance	Other trait
1280	GCST008171	Platelet aggregation	Platelet aggregation	Biological process
1281	GCST005142	Cognitive ability	Cognitive ability	Biological process
1282	GCST005900	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Other measurement
1283	GCST005900	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Cancer
1284	GCST005900	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Cancer
1285	GCST005900	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Response to drug
1286	GCST005900	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Other measurement
1287	GCST005901	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Other measurement
1288	GCST005901	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Cancer
1289	GCST005901	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Cancer
1290	GCST005901	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Other measurement
1291	GCST005141	Cognitive ability (MTAG)	Cognitive ability (MTAG)	Other measurement
1292	GCST005141	Cognitive ability (MTAG)	Cognitive ability (MTAG)	Biological process
1293	GCST005080	PR interval	PR interval	Cardiovascular measurement
1294	GCST005079	Orofacial clefts (cleft lip vs. cleft lip and palate)	Orofacial clefts (cleft lip vs. cleft lip and palate)	Other trait
1295	GCST005079	Orofacial clefts (cleft lip vs. cleft lip and palate)	Orofacial clefts (cleft lip vs. cleft lip and palate)	Other disease
1296	GCST005079	Orofacial clefts (cleft lip vs. cleft lip and palate)	Orofacial clefts (cleft lip vs. cleft lip and palate)	Other trait
1297	GCST005057	Small vessel stroke	Small vessel stroke	Cardiovascular disease
1298	GCST007919	Creatinine levels	Creatinine levels	Other measurement
1299	GCST007917	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
1300	GCST007918	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
1301	GCST007916	Hyperuricemia	Hyperuricemia	Cardiovascular measurement
1302	GCST007916	Hyperuricemia	Hyperuricemia	Metabolic disorder
1303	GCST007920	Chronic kidney disease	Chronic kidney disease	Other disease
1304	GCST007920	Chronic kidney disease	Chronic kidney disease	Other measurement
1305	GCST007920	Chronic kidney disease	Chronic kidney disease	Other measurement
1306	GCST005082	Bipolar disorder lithium response (categorical) or schizophrenia	Bipolar disorder lithium response (categorical) or schizophrenia	Response to drug
1307	GCST005082	Bipolar disorder lithium response (categorical) or schizophrenia	Bipolar disorder lithium response (categorical) or schizophrenia	Neurological disorder
1308	GCST005082	Bipolar disorder lithium response (categorical) or schizophrenia	Bipolar disorder lithium response (categorical) or schizophrenia	Neurological disorder
1309	GCST005081	Bipolar disorder lithium response (continuous) or schizophrenia	Bipolar disorder lithium response (continuous) or schizophrenia	Response to drug
1310	GCST005081	Bipolar disorder lithium response (continuous) or schizophrenia	Bipolar disorder lithium response (continuous) or schizophrenia	Neurological disorder
1311	GCST005081	Bipolar disorder lithium response (continuous) or schizophrenia	Bipolar disorder lithium response (continuous) or schizophrenia	Neurological disorder
1312	GCST006216	Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	Neurological disorder
1313	GCST006216	Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	Other measurement
1314	GCST005275	Cancer	Cancer	Cancer
1315	GCST005275	Cancer	Cancer	Cancer
1316	GCST005275	Cancer	Cancer	Cancer
1317	GCST005275	Cancer	Cancer	Cancer
1318	GCST005275	Cancer	Cancer	Cancer
1319	GCST005275	Cancer	Cancer	Cancer
1320	GCST005275	Cancer	Cancer	Cancer
1321	GCST005275	Cancer	Cancer	Cancer
1322	GCST005275	Cancer	Cancer	Cancer
1323	GCST005275	Cancer	Cancer	Cancer
1324	GCST005275	Cancer	Cancer	Cancer
1325	GCST005145	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
1326	GCST005097	Fractures (vertebral)	Fractures (vertebral)	Other disease
1327	GCST005143	Telomere length	Telomere length	Other measurement
1328	GCST005116	Male-pattern baldness	Male-pattern baldness	Other measurement
1329	GCST005116	Male-pattern baldness	Male-pattern baldness	Other disease
1330	GCST005116	Male-pattern baldness	Male-pattern baldness	Other disease
1331	GCST005083	Putamen volume	Putamen volume	Other measurement
1332	GCST005114	Osteoporosis or obesity (pleiotropy)	Osteoporosis or obesity (pleiotropy)	Other disease
1333	GCST005114	Osteoporosis or obesity (pleiotropy)	Osteoporosis or obesity (pleiotropy)	Metabolic disorder
1334	GCST006632	Decline in glucose metabolism in posterior cingulate cortex	Decline in glucose metabolism in posterior cingulate cortex	Other measurement
1335	GCST006632	Decline in glucose metabolism in posterior cingulate cortex	Decline in glucose metabolism in posterior cingulate cortex	Other measurement
1336	GCST005106	Breast cancer (survival)	Breast cancer (survival)	Other measurement
1337	GCST005106	Breast cancer (survival)	Breast cancer (survival)	Cancer
1338	GCST005106	Breast cancer (survival)	Breast cancer (survival)	Cancer
1339	GCST005106	Breast cancer (survival)	Breast cancer (survival)	Cancer
1340	GCST005106	Breast cancer (survival)	Breast cancer (survival)	Other measurement
1341	GCST007061	Response to antidepressants (symptom remission)	Response to antidepressants (symptom remission)	Response to drug
1342	GCST007060	Response to SSRI (symptom remission)	Response to SSRI (symptom remission)	Response to drug
1343	GCST007059	Response to antidepressants (symptom improvement)	Response to antidepressants (symptom improvement)	Response to drug
1344	GCST007042	Response to SSRI (symptom improvement)	Response to SSRI (symptom improvement)	Response to drug
1345	GCST005144	Tacrolimus trough concentration in kidney transplant patients	Tacrolimus trough concentration in kidney transplant patients	Other measurement
1346	GCST005144	Tacrolimus trough concentration in kidney transplant patients	Tacrolimus trough concentration in kidney transplant patients	Other measurement
1347	GCST005048	Idiopathic osteonecrosis of the femoral head	Idiopathic osteonecrosis of the femoral head	Other disease
1348	GCST005128	Cannabis dependence symptom count	Cannabis dependence symptom count	Other measurement
1349	GCST005133	Cannabis dependence	Cannabis dependence	Neurological disorder
1350	GCST005107	Restless legs syndrome	Restless legs syndrome	Neurological disorder
1351	GCST005044	Primary vesicoureteric reflux	Primary vesicoureteric reflux	Other disease
1352	GCST005045	Primary vesicoureteric reflux	Primary vesicoureteric reflux	Other disease
1353	GCST005237	Mood instability	Mood instability	Other measurement
1354	GCST005109	Progranulin levels	Progranulin levels	Other measurement
1355	GCST004988	Breast cancer	Breast cancer	Cancer
1356	GCST004985	White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)	White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)	Other measurement
1357	GCST005075	Breast Cancer in BRCA1 mutation carriers	Breast Cancer in BRCA1 mutation carriers	Cancer
1358	GCST005075	Breast Cancer in BRCA1 mutation carriers	Breast Cancer in BRCA1 mutation carriers	Other measurement
1359	GCST005077	Breast cancer	Breast cancer	Cancer
1360	GCST004989	Early childhood caries	Early childhood caries	Digestive system disorder
1361	GCST004990	Alcohol consumption over the past year	Alcohol consumption over the past year	Other measurement
1362	GCST004984	White coat effect (clinic systolic blood pressure minus home systolic blood pressure)	White coat effect (clinic systolic blood pressure minus home systolic blood pressure)	Other measurement
1363	GCST005038	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Other disease
1364	GCST005038	Allergic disease (asthma, hay fever or eczema)	Allergic disease (asthma, hay fever or eczema)	Immune system disorder
1365	GCST005051	Obstructive sleep apnea trait (apnea hypopnea index)	Obstructive sleep apnea trait (apnea hypopnea index)	Other measurement
1366	GCST005051	Obstructive sleep apnea trait (apnea hypopnea index)	Obstructive sleep apnea trait (apnea hypopnea index)	Neurological disorder
1367	GCST005050	Obstructive sleep apnea during REM sleep (apnea hypopnea index)	Obstructive sleep apnea during REM sleep (apnea hypopnea index)	Other measurement
1368	GCST005049	Obstructive sleep apnea during non-REM sleep (apnea hypopnea index)	Obstructive sleep apnea during non-REM sleep (apnea hypopnea index)	Other measurement
1369	GCST004981	Curve progression in adolescent idiopathic scoliosis	Curve progression in adolescent idiopathic scoliosis	Other disease
1370	GCST004981	Curve progression in adolescent idiopathic scoliosis	Curve progression in adolescent idiopathic scoliosis	Other measurement
1371	GCST004983	Parental lifespan	Parental lifespan	Other measurement
1372	GCST006036	Psoriasis vulgaris	Psoriasis vulgaris	Immune system disorder
1373	GCST006039	Peanut allergy	Peanut allergy	Other measurement
1374	GCST006038	Food allergy	Food allergy	Other measurement
1375	GCST004951	Post-term birth	Post-term birth	Other measurement
1376	GCST004951	Post-term birth	Post-term birth	Other measurement
1377	GCST005148	Colorectal cancer	Colorectal cancer	Cancer
1378	GCST005076	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
1379	GCST005076	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
1380	GCST004978	Cow's milk allergy	Cow's milk allergy	Other measurement
1381	GCST005911	Smoking interaction in squamous cell lung cancer (1df test)	Smoking interaction in squamous cell lung cancer (1df test)	Biological process
1382	GCST005911	Smoking interaction in squamous cell lung cancer (1df test)	Smoking interaction in squamous cell lung cancer (1df test)	Cancer
1383	GCST005909	Smoking interaction in lung adenocarcinoma (1df test)	Smoking interaction in lung adenocarcinoma (1df test)	Biological process
1384	GCST005909	Smoking interaction in lung adenocarcinoma (1df test)	Smoking interaction in lung adenocarcinoma (1df test)	Cancer
1385	GCST004977	Hen's egg allergy	Hen's egg allergy	Other measurement
1386	GCST004980	Peanut allergy	Peanut allergy	Other measurement
1387	GCST004979	Food allergy	Food allergy	Other measurement
1388	GCST004986	Idiopathic pulmonary fibrosis	Idiopathic pulmonary fibrosis	Cancer
1389	GCST005910	Smoking interaction in non-small cell lung cancer (1df test)	Smoking interaction in non-small cell lung cancer (1df test)	Biological process
1390	GCST005910	Smoking interaction in non-small cell lung cancer (1df test)	Smoking interaction in non-small cell lung cancer (1df test)	Cancer
1391	GCST007577	Blood pressure (parental or offspring effect)	Blood pressure (parental or offspring effect)	Other measurement
1392	GCST006121	Alzheimer's disease	Alzheimer's disease	Neurological disorder
1393	GCST006120	Alzheimer's disease (age of onset)	Alzheimer's disease (age of onset)	Neurological disorder
1394	GCST006120	Alzheimer's disease (age of onset)	Alzheimer's disease (age of onset)	Other measurement
1395	GCST005115	Response to mepolizumab in severe asthma	Response to mepolizumab in severe asthma	Other disease
1396	GCST005115	Response to mepolizumab in severe asthma	Response to mepolizumab in severe asthma	Response to drug
1397	GCST005022	Major depression and alcohol dependence	Major depression and alcohol dependence	Neurological disorder
1398	GCST005022	Major depression and alcohol dependence	Major depression and alcohol dependence	Neurological disorder
1399	GCST004998	Severe progression in rheumatoid arthritis	Severe progression in rheumatoid arthritis	Immune system disorder
1400	GCST004998	Severe progression in rheumatoid arthritis	Severe progression in rheumatoid arthritis	Other measurement
1401	GCST005035	Fasting growth hormone levels	Fasting growth hormone levels	Other measurement
1402	GCST005124	Urinary magnesium-to-creatinine ratio	Urinary magnesium-to-creatinine ratio	Other measurement
1403	GCST005236	Problematic alcohol use in trauma-exposed individuals	Problematic alcohol use in trauma-exposed individuals	Other measurement
1404	GCST005236	Problematic alcohol use in trauma-exposed individuals	Problematic alcohol use in trauma-exposed individuals	Biological process
1405	GCST005042	Restless legs syndrome	Restless legs syndrome	Neurological disorder
1406	GCST005125	Serum magnesium levels	Serum magnesium levels	Other measurement
1407	GCST005126	Fractional excretion of magnesium	Fractional excretion of magnesium	Other measurement
1408	GCST005111	Breast cancer in childhood cancer survivors	Breast cancer in childhood cancer survivors	Cancer
1409	GCST005111	Breast cancer in childhood cancer survivors	Breast cancer in childhood cancer survivors	Cancer
1410	GCST005112	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Cancer
1411	GCST005112	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Biological process
1412	GCST005112	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	Cancer
1413	GCST005110	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	Cancer
1414	GCST005110	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	Cancer
1415	GCST005043	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
1416	GCST004972	Putamen actvity during disappointment	Putamen actvity during disappointment	Other measurement
1417	GCST004972	Putamen actvity during disappointment	Putamen actvity during disappointment	Other measurement
1418	GCST004972	Putamen actvity during disappointment	Putamen actvity during disappointment	Biological process
1419	GCST004971	Putamen activity during reward	Putamen activity during reward	Other measurement
1420	GCST004971	Putamen activity during reward	Putamen activity during reward	Other measurement
1421	GCST004971	Putamen activity during reward	Putamen activity during reward	Biological process
1422	GCST004970	Caudate activity during reward	Caudate activity during reward	Other measurement
1423	GCST004970	Caudate activity during reward	Caudate activity during reward	Other measurement
1424	GCST004970	Caudate activity during reward	Caudate activity during reward	Biological process
1425	GCST007953	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
1426	GCST007952	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
1427	GCST007954	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
1428	GCST007951	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
1429	GCST004904	Body mass index	Body mass index	Body measurement
1430	GCST004904	Body mass index	Body mass index	Body measurement
1431	GCST004904	Body mass index	Body mass index	Other measurement
1432	GCST004902	Parkinson's disease	Parkinson's disease	Neurological disorder
1433	GCST004895	Colorectal cancer	Colorectal cancer	Cancer
1434	GCST006804	Red cell distribution width	Red cell distribution width	Hematological measurement
1435	GCST004944	Migraine or coronary artery disease	Migraine or coronary artery disease	Cardiovascular disease
1436	GCST004944	Migraine or coronary artery disease	Migraine or coronary artery disease	Cardiovascular disease
1437	GCST004952	Ankle injury	Ankle injury	Other disease
1438	GCST004922	Tuberculosis	Tuberculosis	Other disease
1439	GCST004922	Tuberculosis	Tuberculosis	Other measurement
1440	GCST004922	Tuberculosis	Tuberculosis	Other measurement
1441	GCST004923	Tuberculosis	Tuberculosis	Other disease
1442	GCST004923	Tuberculosis	Tuberculosis	Other measurement
1443	GCST004923	Tuberculosis	Tuberculosis	Other measurement
1444	GCST006173	BMI x dairy intake interaction (1df interaction test)	BMI x dairy intake interaction (1df interaction test)	Body measurement
1445	GCST006173	BMI x dairy intake interaction (1df interaction test)	BMI x dairy intake interaction (1df interaction test)	Biological process
1446	GCST005147	Colonoscopy-negative controls vs population controls	Colonoscopy-negative controls vs population controls	Other trait
1447	GCST005153	Colorectal adenoma (advanced)	Colorectal adenoma (advanced)	Cancer
1448	GCST005152	Colorectal cancer	Colorectal cancer	Cancer
1449	GCST005151	Colorectal adenoma (advanced)	Colorectal adenoma (advanced)	Cancer
1450	GCST004901	Amyotrophic lateral sclerosis (sporadic)	Amyotrophic lateral sclerosis (sporadic)	Neurological disorder
1451	GCST008472	Amyotrophic lateral sclerosis (sporadic)	Amyotrophic lateral sclerosis (sporadic)	Neurological disorder
1452	GCST004918	Coronary artery disease severity measurement	Coronary artery disease severity measurement	Cardiovascular disease
1453	GCST004969	Caudate activity during disappointment	Caudate activity during disappointment	Other measurement
1454	GCST004969	Caudate activity during disappointment	Caudate activity during disappointment	Other measurement
1455	GCST004969	Caudate activity during disappointment	Caudate activity during disappointment	Biological process
1456	GCST006040	Atopy	Atopy	Immune system disorder
1457	GCST004976	nicotine metabolite ratio in current smokers	nicotine metabolite ratio in current smokers	Biological process
1458	GCST004976	nicotine metabolite ratio in current smokers	nicotine metabolite ratio in current smokers	Other measurement
1459	GCST004881	Knee osteoarthritis	Knee osteoarthritis	Other disease
1460	GCST004942	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Cancer
1461	GCST004942	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Other measurement
1462	GCST004942	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Digestive system disorder
1463	GCST004943	Pediatric nonalcoholic steatohepatitis	Pediatric nonalcoholic steatohepatitis	Digestive system disorder
1464	GCST004938	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	Other trait
1465	GCST004938	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	Digestive system disorder
1466	GCST004893	Suicide attempts	Suicide attempts	Biological process
1467	GCST004903	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
1468	GCST005150	Colorectal cancer	Colorectal cancer	Cancer
1469	GCST005149	Colorectal cancer	Colorectal cancer	Cancer
1470	GCST004945	Lumbar spinal stenosis	Lumbar spinal stenosis	Other disease
1471	GCST004954	Antisocial behavior	Antisocial behavior	Other measurement
1472	GCST006489	Antisocial behavior	Antisocial behavior	Other measurement
1473	GCST006490	Antisocial behavior	Antisocial behavior	Other measurement
1474	GCST008496	Nicotine dependence	Nicotine dependence	Neurological disorder
1475	GCST004953	Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	Neurological disorder
1476	GCST004953	Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	Other measurement
1477	GCST004897	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
1478	GCST004897	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
1479	GCST004897	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Other measurement
1480	GCST004897	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
1481	GCST004897	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Cancer
1482	GCST004896	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Response to drug
1483	GCST004896	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Other measurement
1484	GCST004896	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Response to drug
1485	GCST004896	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	Cancer
1486	GCST006037	Hepatocellular carcinoma in hepatitis C infection	Hepatocellular carcinoma in hepatitis C infection	Cancer
1487	GCST006037	Hepatocellular carcinoma in hepatitis C infection	Hepatocellular carcinoma in hepatitis C infection	Digestive system disorder
1488	GCST004840	Colorectal cancer	Colorectal cancer	Cancer
1489	GCST006288	Heel bone mineral density	Heel bone mineral density	Other measurement
1490	GCST004894	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1491	GCST004839	Colorectal cancer	Colorectal cancer	Cancer
1492	GCST004873	Endometriosis	Endometriosis	Other disease
1493	GCST004825	Hyperuricemia	Hyperuricemia	Cardiovascular measurement
1494	GCST004825	Hyperuricemia	Hyperuricemia	Metabolic disorder
1495	GCST005549	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
1496	GCST005549	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
1497	GCST004947	Pulmonary arterial hypertension	Pulmonary arterial hypertension	Cardiovascular disease
1498	GCST006145	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1499	GCST004783	Bronchopulmonary dysplasia in preterm infants	Bronchopulmonary dysplasia in preterm infants	Other disease
1500	GCST004783	Bronchopulmonary dysplasia in preterm infants	Bronchopulmonary dysplasia in preterm infants	Other trait
1501	GCST004801	Response to ranibizumab in age-related macular degeneration (visual acuity)	Response to ranibizumab in age-related macular degeneration (visual acuity)	Neurological disorder
1502	GCST004801	Response to ranibizumab in age-related macular degeneration (visual acuity)	Response to ranibizumab in age-related macular degeneration (visual acuity)	Response to drug
1503	GCST004801	Response to ranibizumab in age-related macular degeneration (visual acuity)	Response to ranibizumab in age-related macular degeneration (visual acuity)	Other measurement
1504	GCST004782	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1505	GCST007727	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
1506	GCST004778	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
1507	GCST004823	Cognitive function	Cognitive function	Biological process
1508	GCST004823	Cognitive function	Cognitive function	Biological process
1509	GCST004823	Cognitive function	Cognitive function	Other measurement
1510	GCST004823	Cognitive function	Cognitive function	Biological process
1511	GCST004833	Cervical cancer	Cervical cancer	Cancer
1512	GCST004780	Cortisol levels (saliva)	Cortisol levels (saliva)	Other measurement
1513	GCST004831	Verbal memory performance (delayed recall level)	Verbal memory performance (delayed recall level)	Other measurement
1514	GCST004859	Kawasaki disease	Kawasaki disease	Immune system disorder
1515	GCST004898	Preterm birth (maternal effect)	Preterm birth (maternal effect)	Other measurement
1516	GCST004898	Preterm birth (maternal effect)	Preterm birth (maternal effect)	Other trait
1517	GCST004899	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
1518	GCST004899	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
1519	GCST004899	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
1520	GCST004858	Dupuytren's disease	Dupuytren's disease	Other disease
1521	GCST004827	Verbal memory performance (immediate recall change)	Verbal memory performance (immediate recall change)	Other measurement
1522	GCST004830	Verbal memory performance (residualized delayed recall change)	Verbal memory performance (residualized delayed recall change)	Other measurement
1523	GCST004786	Thiazide-induced hyponatremia	Thiazide-induced hyponatremia	Other trait
1524	GCST004784	Alcoholic hepatitis	Alcoholic hepatitis	Digestive system disorder
1525	GCST004838	Coronary artery disease and/or body mass index (pleiotropy)	Coronary artery disease and/or body mass index (pleiotropy)	Cardiovascular disease
1526	GCST004838	Coronary artery disease and/or body mass index (pleiotropy)	Coronary artery disease and/or body mass index (pleiotropy)	Body measurement
1527	GCST004779	Uterine fibroids	Uterine fibroids	Cancer
1528	GCST004802	Response to ranibizumab in age-related macular degeneration (dry maculae)	Response to ranibizumab in age-related macular degeneration (dry maculae)	Neurological disorder
1529	GCST004802	Response to ranibizumab in age-related macular degeneration (dry maculae)	Response to ranibizumab in age-related macular degeneration (dry maculae)	Response to drug
1530	GCST004802	Response to ranibizumab in age-related macular degeneration (dry maculae)	Response to ranibizumab in age-related macular degeneration (dry maculae)	Other measurement
1531	GCST004803	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Neurological disorder
1532	GCST004803	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Response to drug
1533	GCST004803	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	Other measurement
1534	GCST004832	Verbal memory performance (delayed recall change)	Verbal memory performance (delayed recall change)	Other measurement
1535	GCST004828	Verbal memory performance (immediate recall level)	Verbal memory performance (immediate recall level)	Other measurement
1536	GCST004829	Verbal memory performance (residualized delayed recall level)	Verbal memory performance (residualized delayed recall level)	Other measurement
1537	GCST005036	Lean body mass	Lean body mass	Other measurement
1538	GCST004756	Alcohol dependence	Alcohol dependence	Other measurement
1539	GCST004756	Alcohol dependence	Alcohol dependence	Neurological disorder
1540	GCST005752	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
1541	GCST007400	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
1542	GCST007990	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1543	GCST007990	Coronary artery disease	Coronary artery disease	Cardiovascular disease
1544	GCST004755	Chronic alcoholic pancreatitis or alcohol-related cirrhosis	Chronic alcoholic pancreatitis or alcohol-related cirrhosis	Digestive system disorder
1545	GCST004755	Chronic alcoholic pancreatitis or alcohol-related cirrhosis	Chronic alcoholic pancreatitis or alcohol-related cirrhosis	Cancer
1546	GCST004757	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Neurological disorder
1547	GCST004757	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Digestive system disorder
1548	GCST004757	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	Cancer
1549	GCST004787	Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)	Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)	Cardiovascular disease
1550	GCST004737	Neovascular age-related macular degeneration	Neovascular age-related macular degeneration	Neurological disorder
1551	GCST004737	Neovascular age-related macular degeneration	Neovascular age-related macular degeneration	Neurological disorder
1552	GCST004766	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
1553	GCST004766	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Lipid or lipoprotein measurement
1554	GCST004766	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Metabolic disorder
1555	GCST004766	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
1556	GCST004765	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Lipid or lipoprotein measurement
1557	GCST004765	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
1558	GCST004765	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Metabolic disorder
1559	GCST004765	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
1560	GCST004764	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Lipid or lipoprotein measurement
1561	GCST004764	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
1562	GCST004764	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Metabolic disorder
1563	GCST004764	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
1564	GCST004800	Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	Other measurement
1565	GCST004800	Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	Other measurement
1566	GCST004775	Pulse pressure	Pulse pressure	Cardiovascular measurement
1567	GCST004776	Systolic blood pressure	Systolic blood pressure	Other measurement
1568	GCST004776	Systolic blood pressure	Systolic blood pressure	Other measurement
1569	GCST004752	Relapse in multiple sclerosis	Relapse in multiple sclerosis	Immune system disorder
1570	GCST004752	Relapse in multiple sclerosis	Relapse in multiple sclerosis	Other measurement
1571	GCST004763	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Lipid or lipoprotein measurement
1572	GCST004763	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
1573	GCST004763	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Metabolic disorder
1574	GCST004763	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	Response to drug
1575	GCST004726	Vitamin D levels	Vitamin D levels	Other measurement
1576	GCST005037	Appendicular lean mass	Appendicular lean mass	Other measurement
1577	GCST004860	Alcoholic chronic pancreatitis	Alcoholic chronic pancreatitis	Digestive system disorder
1578	GCST004975	Schizophrenia or general cognitive function (pleiotropy)	Schizophrenia or general cognitive function (pleiotropy)	Neurological disorder
1579	GCST004975	Schizophrenia or general cognitive function (pleiotropy)	Schizophrenia or general cognitive function (pleiotropy)	Other measurement
1580	GCST004973	Schizophrenia or verbal-numerical reasoning (pleiotropy)	Schizophrenia or verbal-numerical reasoning (pleiotropy)	Neurological disorder
1581	GCST004973	Schizophrenia or verbal-numerical reasoning (pleiotropy)	Schizophrenia or verbal-numerical reasoning (pleiotropy)	Other measurement
1582	GCST004974	Schizophrenia or reaction time (pleiotropy)	Schizophrenia or reaction time (pleiotropy)	Neurological disorder
1583	GCST004974	Schizophrenia or reaction time (pleiotropy)	Schizophrenia or reaction time (pleiotropy)	Other measurement
1584	GCST004886	Alcohol consumption	Alcohol consumption	Biological process
1585	GCST004886	Alcohol consumption	Alcohol consumption	Other measurement
1586	GCST004887	Alcohol consumption in current drinkers	Alcohol consumption in current drinkers	Other measurement
1587	GCST004772	Bone mineral density (paediatric, total body less head)	Bone mineral density (paediatric, total body less head)	Other measurement
1588	GCST004770	Lean body mass	Lean body mass	Other measurement
1589	GCST004767	Schizophrenia (age at onset)	Schizophrenia (age at onset)	Neurological disorder
1590	GCST004767	Schizophrenia (age at onset)	Schizophrenia (age at onset)	Other measurement
1591	GCST004771	TB-LM or TBLH-BMD (pleiotropy)	TB-LM or TBLH-BMD (pleiotropy)	Other measurement
1592	GCST004771	TB-LM or TBLH-BMD (pleiotropy)	TB-LM or TBLH-BMD (pleiotropy)	Other measurement
1593	GCST004777	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1594	GCST004777	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1595	GCST004789	Change in LVEF in response to paclitaxel in HER2+ breast cancer	Change in LVEF in response to paclitaxel in HER2+ breast cancer	Cardiovascular measurement
1596	GCST004789	Change in LVEF in response to paclitaxel in HER2+ breast cancer	Change in LVEF in response to paclitaxel in HER2+ breast cancer	Response to drug
1597	GCST004788	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Cardiovascular measurement
1598	GCST004788	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Response to drug
1599	GCST004788	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	Response to drug
1600	GCST004836	Femoral neck bone mineral density or breast cancer (pleiotropy)	Femoral neck bone mineral density or breast cancer (pleiotropy)	Other measurement
1601	GCST004836	Femoral neck bone mineral density or breast cancer (pleiotropy)	Femoral neck bone mineral density or breast cancer (pleiotropy)	Cancer
1602	GCST004837	Lumbar spine bone mineral density or breast cancer (pleiotropy)	Lumbar spine bone mineral density or breast cancer (pleiotropy)	Cancer
1603	GCST004837	Lumbar spine bone mineral density or breast cancer (pleiotropy)	Lumbar spine bone mineral density or breast cancer (pleiotropy)	Other measurement
1604	GCST004790	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Cardiovascular measurement
1605	GCST004790	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Response to drug
1606	GCST004790	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	Response to drug
1607	GCST004826	P wave duration	P wave duration	Cardiovascular measurement
1608	GCST004880	Alzheimer's disease or type 2 diabetes (pleiotropy)	Alzheimer's disease or type 2 diabetes (pleiotropy)	Neurological disorder
1609	GCST004880	Alzheimer's disease or type 2 diabetes (pleiotropy)	Alzheimer's disease or type 2 diabetes (pleiotropy)	Metabolic disorder
1610	GCST004824	P wave terminal force	P wave terminal force	Cardiovascular measurement
1611	GCST008374	Warfarin maintenance dose (adjusted for clinical factors)	Warfarin maintenance dose (adjusted for clinical factors)	Response to drug
1612	GCST004799	Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	Cancer
1613	GCST004799	Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	Other trait
1614	GCST007514	Hepatitis B virus-related hepatocellular carcinoma	Hepatitis B virus-related hepatocellular carcinoma	Digestive system disorder
1615	GCST007514	Hepatitis B virus-related hepatocellular carcinoma	Hepatitis B virus-related hepatocellular carcinoma	Cancer
1616	GCST004754	Follicular thyroid cancer	Follicular thyroid cancer	Cancer
1617	GCST004753	Papillary thyroid cancer	Papillary thyroid cancer	Cancer
1618	GCST004798	Differentiated thyroid cancer	Differentiated thyroid cancer	Cancer
1619	GCST005235	Hand grip strength	Hand grip strength	Other measurement
1620	GCST005234	Lean mass index	Lean mass index	Other measurement
1621	GCST005233	Fat mass index	Fat mass index	Other measurement
1622	GCST004835	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
1623	GCST004835	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
1624	GCST004834	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
1625	GCST004834	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
1626	GCST004813	Laterality in neovascular age-related macular degeneration	Laterality in neovascular age-related macular degeneration	Neurological disorder
1627	GCST004813	Laterality in neovascular age-related macular degeneration	Laterality in neovascular age-related macular degeneration	Other measurement
1628	GCST004982	Prostate cancer	Prostate cancer	Cancer
1629	GCST004644	Vaso-occlusive pain in sickle-cell anemia	Vaso-occlusive pain in sickle-cell anemia	Neurological disorder
1630	GCST004644	Vaso-occlusive pain in sickle-cell anemia	Vaso-occlusive pain in sickle-cell anemia	Other measurement
1631	GCST004713	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
1632	GCST004713	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
1633	GCST004715	Heart rate	Heart rate	Cardiovascular measurement
1634	GCST004714	Heart rate variability traits (SDNN)	Heart rate variability traits (SDNN)	Cardiovascular measurement
1635	GCST004716	Heart rate variability traits (RMSSD)	Heart rate variability traits (RMSSD)	Cardiovascular measurement
1636	GCST004842	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Body measurement
1637	GCST004842	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Other measurement
1638	GCST004842	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Other trait
1639	GCST004727	Facial emotion recognition	Facial emotion recognition	Other measurement
1640	GCST004731	Facial emotion recognition (fearful faces)	Facial emotion recognition (fearful faces)	Other measurement
1641	GCST004728	Facial emotion recognition (angry faces)	Facial emotion recognition (angry faces)	Other measurement
1642	GCST004730	Facial emotion recognition (sad faces)	Facial emotion recognition (sad faces)	Other measurement
1643	GCST004729	Facial emotion recognition (happy faces)	Facial emotion recognition (happy faces)	Other measurement
1644	GCST004635	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
1645	GCST004635	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
1646	GCST004843	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Body measurement
1647	GCST004843	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Other measurement
1648	GCST004843	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	Other trait
1649	GCST004844	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
1650	GCST004844	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
1651	GCST004844	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
1652	GCST004845	Spontaneous preterm birth (maternal effect)	Spontaneous preterm birth (maternal effect)	Other trait
1653	GCST004845	Spontaneous preterm birth (maternal effect)	Spontaneous preterm birth (maternal effect)	Other measurement
1654	GCST004710	Renal cell carcinoma	Renal cell carcinoma	Cancer
1655	GCST004841	Preterm birth (maternal effect)	Preterm birth (maternal effect)	Other measurement
1656	GCST004841	Preterm birth (maternal effect)	Preterm birth (maternal effect)	Other trait
1657	GCST004642	QT interval (ambient particulate matter interaction)	QT interval (ambient particulate matter interaction)	Other measurement
1658	GCST004642	QT interval (ambient particulate matter interaction)	QT interval (ambient particulate matter interaction)	Cardiovascular measurement
1659	GCST004643	1,5-anhydroglucitol levels	1,5-anhydroglucitol levels	Other measurement
1660	GCST005755	Cognitive empathy	Cognitive empathy	Other measurement
1661	GCST008256	Diverticulitis	Diverticulitis	Digestive system disorder
1662	GCST008257	Diverticular disease	Diverticular disease	Digestive system disorder
1663	GCST004736	Familial hepatitis B virus-related hepatocellular carcinoma	Familial hepatitis B virus-related hepatocellular carcinoma	Digestive system disorder
1664	GCST004736	Familial hepatitis B virus-related hepatocellular carcinoma	Familial hepatitis B virus-related hepatocellular carcinoma	Cancer
1665	GCST004638	Benign prostatic hyperplasia and/or lower urinary tract symptoms	Benign prostatic hyperplasia and/or lower urinary tract symptoms	Other disease
1666	GCST004638	Benign prostatic hyperplasia and/or lower urinary tract symptoms	Benign prostatic hyperplasia and/or lower urinary tract symptoms	Other trait
1667	GCST005837	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
1668	GCST005837	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
1669	GCST005837	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
1670	GCST004735	Epstein-Barr virus copy number in lymphoblastoid cell lines	Epstein-Barr virus copy number in lymphoblastoid cell lines	Other disease
1671	GCST004640	Western dietary pattern	Western dietary pattern	Other measurement
1672	GCST004639	Prudent dietary pattern	Prudent dietary pattern	Other measurement
1673	GCST004717	Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	Cardiovascular disease
1674	GCST004717	Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	Other measurement
1675	GCST004641	Borderline personality disorder	Borderline personality disorder	Other trait
1676	GCST004691	Huntington's disease progression	Huntington's disease progression	Neurological disorder
1677	GCST004691	Huntington's disease progression	Huntington's disease progression	Other measurement
1678	GCST005945	ADAMTS13 levels	ADAMTS13 levels	Other measurement
1679	GCST004690	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	Other measurement
1680	GCST004690	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	Other trait
1681	GCST004585	Anorexia nervosa (excluding migration to or from binge-eating disorder or bulimia nervosa)	Anorexia nervosa (excluding migration to or from binge-eating disorder or bulimia nervosa)	Metabolic disorder
1682	GCST004689	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	Other measurement
1683	GCST004689	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	Other trait
1684	GCST004709	Fear of severe pain	Fear of severe pain	Other measurement
1685	GCST004706	Fear of pain	Fear of pain	Other measurement
1686	GCST004707	Fear of medical pain (dental)	Fear of medical pain (dental)	Other measurement
1687	GCST004708	Fear of minor pain	Fear of minor pain	Other measurement
1688	GCST004724	Foot ulcer in diabetes and neuropathy	Foot ulcer in diabetes and neuropathy	Cancer
1689	GCST004724	Foot ulcer in diabetes and neuropathy	Foot ulcer in diabetes and neuropathy	Neurological disorder
1690	GCST004724	Foot ulcer in diabetes and neuropathy	Foot ulcer in diabetes and neuropathy	Metabolic disorder
1691	GCST004724	Foot ulcer in diabetes and neuropathy	Foot ulcer in diabetes and neuropathy	Metabolic disorder
1692	GCST004725	Foot ulcer and neuropathy in diabetes	Foot ulcer and neuropathy in diabetes	Cancer
1693	GCST004725	Foot ulcer and neuropathy in diabetes	Foot ulcer and neuropathy in diabetes	Neurological disorder
1694	GCST004725	Foot ulcer and neuropathy in diabetes	Foot ulcer and neuropathy in diabetes	Metabolic disorder
1695	GCST004725	Foot ulcer and neuropathy in diabetes	Foot ulcer and neuropathy in diabetes	Metabolic disorder
1696	GCST004703	Obsessive-compulsive disorder or autism spectrum disorder	Obsessive-compulsive disorder or autism spectrum disorder	Neurological disorder
1697	GCST004703	Obsessive-compulsive disorder or autism spectrum disorder	Obsessive-compulsive disorder or autism spectrum disorder	Neurological disorder
1698	GCST004376	Cerebral blood flow	Cerebral blood flow	Other measurement
1699	GCST004598	vWF levels in ischaemic stroke and hyperhomocysteinaemia	vWF levels in ischaemic stroke and hyperhomocysteinaemia	Hematological measurement
1700	GCST004598	vWF levels in ischaemic stroke and hyperhomocysteinaemia	vWF levels in ischaemic stroke and hyperhomocysteinaemia	Cardiovascular measurement
1701	GCST004598	vWF levels in ischaemic stroke and hyperhomocysteinaemia	vWF levels in ischaemic stroke and hyperhomocysteinaemia	Other trait
1702	GCST004377	Restricted and repetitive behaviours in autism spectrum disorder	Restricted and repetitive behaviours in autism spectrum disorder	Other measurement
1703	GCST004377	Restricted and repetitive behaviours in autism spectrum disorder	Restricted and repetitive behaviours in autism spectrum disorder	Neurological disorder
1704	GCST004521	Autism spectrum disorder or schizophrenia	Autism spectrum disorder or schizophrenia	Neurological disorder
1705	GCST004521	Autism spectrum disorder or schizophrenia	Autism spectrum disorder or schizophrenia	Neurological disorder
1706	GCST004364	Intelligence	Intelligence	Biological process
1707	GCST004520	Autism spectrum disorder	Autism spectrum disorder	Neurological disorder
1708	GCST004773	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1709	GCST004774	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1710	GCST004372	Language performance in older adults (adjusted for episodic memory)	Language performance in older adults (adjusted for episodic memory)	Other measurement
1711	GCST004372	Language performance in older adults (adjusted for episodic memory)	Language performance in older adults (adjusted for episodic memory)	Other measurement
1712	GCST004372	Language performance in older adults (adjusted for episodic memory)	Language performance in older adults (adjusted for episodic memory)	Other measurement
1713	GCST004378	Mean corpuscular hemoglobin concentration in sickle cell disease	Mean corpuscular hemoglobin concentration in sickle cell disease	Neurological disorder
1714	GCST004378	Mean corpuscular hemoglobin concentration in sickle cell disease	Mean corpuscular hemoglobin concentration in sickle cell disease	Hematological measurement
1715	GCST004379	Red blood cell density in sickle cell anemia	Red blood cell density in sickle cell anemia	Neurological disorder
1716	GCST004379	Red blood cell density in sickle cell anemia	Red blood cell density in sickle cell anemia	Hematological measurement
1717	GCST004367	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
1718	GCST004367	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
1719	GCST004366	Rheumatic heart disease	Rheumatic heart disease	Cardiovascular disease
1720	GCST004574	Skin aging (microtopography measurement)	Skin aging (microtopography measurement)	Other measurement
1721	GCST004514	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Biological process
1722	GCST004514	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Other measurement
1723	GCST004513	Smoking status (current vs former)	Smoking status (current vs former)	Other measurement
1724	GCST004512	Smoking status (heavy vs light)	Smoking status (heavy vs light)	Other measurement
1725	GCST004399	Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	Lipid or lipoprotein measurement
1726	GCST004399	Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	Lipid or lipoprotein measurement
1727	GCST004400	Bone erosion in rheumatoid arthritis	Bone erosion in rheumatoid arthritis	Other measurement
1728	GCST004398	Lipoprotein (a) levels	Lipoprotein (a) levels	Lipid or lipoprotein measurement
1729	GCST004486	Major depressive disorder	Major depressive disorder	Neurological disorder
1730	GCST004346	Psoriasis	Psoriasis	Immune system disorder
1731	GCST004353	Left ventricular function change in anthracycline treatment	Left ventricular function change in anthracycline treatment	Other trait
1732	GCST004353	Left ventricular function change in anthracycline treatment	Left ventricular function change in anthracycline treatment	Response to drug
1733	GCST004549	Endometriosis	Endometriosis	Other disease
1734	GCST004526	Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan)	Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan)	Other measurement
1735	GCST004510	Sporadic neuroblastoma	Sporadic neuroblastoma	Cancer
1736	GCST004527	Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)	Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)	Other measurement
1737	GCST004525	Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)	Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)	Other measurement
1738	GCST004511	Smoking status (daily vs non-daily)	Smoking status (daily vs non-daily)	Other measurement
1739	GCST008595	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Other measurement
1740	GCST008595	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Biological process
1741	GCST008595	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	Neurological disorder
1742	GCST008642	Annualised percent change of cerebrospinal fluid AB1-42 levels	Annualised percent change of cerebrospinal fluid AB1-42 levels	Other measurement
1743	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1744	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1745	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1746	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1747	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1748	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1749	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1750	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1751	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1752	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1753	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1754	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1755	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1756	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1757	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1758	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1759	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1760	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1761	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1762	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1763	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1764	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1765	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1766	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1767	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1768	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1769	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1770	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1771	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1772	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1773	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Body measurement
1774	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1775	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1776	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1777	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1778	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1779	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1780	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1781	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1782	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1783	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1784	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1785	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1786	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1787	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1788	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1789	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Cardiovascular measurement
1790	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1791	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1792	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1793	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Inflammatory measurement
1794	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Other measurement
1795	GCST008673	Cardiometabolic traits	Cardiometabolic traits	Lipid or lipoprotein measurement
1796	GCST008708	Chronic mountain sickness		
1797	GCST008596	Opioid overdose severity score		
1798	GCST008757	Alcohol consumption	Alcohol consumption	Biological process
1799	GCST008757	Alcohol consumption	Alcohol consumption	Other measurement
1800	GCST008490	Post-traumatic stress disorder (re-experiencing symptoms)	Post-traumatic stress disorder (re-experiencing symptoms)	Other measurement
1801	GCST008487	Coffee consumption	Coffee consumption	Biological process
1802	GCST008487	Coffee consumption	Coffee consumption	Other measurement
1803	GCST008487	Coffee consumption	Coffee consumption	Other measurement
1804	GCST008477	Emphysema annual change measurement in smokers (adjusted lung density)	Emphysema annual change measurement in smokers (adjusted lung density)	Other measurement
1805	GCST008477	Emphysema annual change measurement in smokers (adjusted lung density)	Emphysema annual change measurement in smokers (adjusted lung density)	Other measurement
1806	GCST008668	Proliferative diabetic retinopathy	Proliferative diabetic retinopathy	Metabolic disorder
1807	GCST008755	Phenylephrine infusion rate during anesthesia		
1808	GCST008672	Knee pain	Knee pain	Other trait
1809	GCST008645	Alcohol dependence or heroin dependence or methamphetamine dependence	Alcohol dependence or heroin dependence or methamphetamine dependence	Neurological disorder
1810	GCST008645	Alcohol dependence or heroin dependence or methamphetamine dependence	Alcohol dependence or heroin dependence or methamphetamine dependence	Neurological disorder
1811	GCST008645	Alcohol dependence or heroin dependence or methamphetamine dependence	Alcohol dependence or heroin dependence or methamphetamine dependence	Neurological disorder
1812	GCST008746	Estimated glomerular filtration rate in diabetes	Estimated glomerular filtration rate in diabetes	Other measurement
1813	GCST008746	Estimated glomerular filtration rate in diabetes	Estimated glomerular filtration rate in diabetes	Metabolic disorder
1814	GCST008747	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
1815	GCST008745	Estimated glomerular filtration rate in non-diabetics	Estimated glomerular filtration rate in non-diabetics	Other measurement
1816	GCST008488	Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	Other disease
1817	GCST008488	Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	Early progression to active pulmonary tuberculosis in Mycobacterium tuberculosis-infected individuals	Other measurement
1818	GCST008736	Response to beta blocker use in hypertension (systolic blood pressure)	Response to beta blocker use in hypertension (systolic blood pressure)	Other measurement
1819	GCST008736	Response to beta blocker use in hypertension (systolic blood pressure)	Response to beta blocker use in hypertension (systolic blood pressure)	Response to drug
1820	GCST008736	Response to beta blocker use in hypertension (systolic blood pressure)	Response to beta blocker use in hypertension (systolic blood pressure)	Cardiovascular disease
1821	GCST008735	Response to beta blocker use in hypertension (diastolic blood pressure)	Response to beta blocker use in hypertension (diastolic blood pressure)	Other measurement
1822	GCST008735	Response to beta blocker use in hypertension (diastolic blood pressure)	Response to beta blocker use in hypertension (diastolic blood pressure)	Response to drug
1823	GCST008735	Response to beta blocker use in hypertension (diastolic blood pressure)	Response to beta blocker use in hypertension (diastolic blood pressure)	Cardiovascular disease
1824	GCST008743	Predicted visceral adipose tissue	Predicted visceral adipose tissue	Other measurement
1825	GCST008744	Predicted visceral adipose tissue	Predicted visceral adipose tissue	Other measurement
1826	GCST008742	Predicted visceral adipose tissue	Predicted visceral adipose tissue	Other measurement
1827	GCST008754	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other measurement
1828	GCST008754	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other trait
1829	GCST008751	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
1830	GCST008751	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
1831	GCST008752	Post-term birth	Post-term birth	Other measurement
1832	GCST008752	Post-term birth	Post-term birth	Other measurement
1833	GCST008753	Early spontaneous preterm birth	Early spontaneous preterm birth	Other trait
1834	GCST008749	Systolic blood pressure	Systolic blood pressure	Other measurement
1835	GCST008749	Systolic blood pressure	Systolic blood pressure	Other measurement
1836	GCST008750	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1837	GCST008750	Diastolic blood pressure	Diastolic blood pressure	Other measurement
1838	GCST008748	Epigenetic age acceleration in alcohol use disorder	Epigenetic age acceleration in alcohol use disorder	Biological process
1839	GCST008748	Epigenetic age acceleration in alcohol use disorder	Epigenetic age acceleration in alcohol use disorder	Other measurement
1840	GCST008519	Skin pigmentation	Skin pigmentation	Other trait
1841	GCST008519	Skin pigmentation	Skin pigmentation	Other measurement
1842	GCST008484	Autistic traits score (Social and Communication Disorders Checklist)	Autistic traits score (Social and Communication Disorders Checklist)	Other measurement
1843	GCST008518	Skin pigmentation	Skin pigmentation	Other trait
1844	GCST008518	Skin pigmentation	Skin pigmentation	Other measurement
1845	GCST008465	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
1846	GCST008465	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
1847	GCST008497	Change in neurofilament light levels	Change in neurofilament light levels	Other measurement
1848	GCST008547	Time to smoke first cigarette in the morning	Time to smoke first cigarette in the morning	Other measurement
1849	GCST008756	Serum platinum levels after completion of cisplatin chemotherapy	Serum platinum levels after completion of cisplatin chemotherapy	Response to drug
1850	GCST008548	Fagerstrӧm test for nicotine dependence	Fagerstrӧm test for nicotine dependence	Other measurement
1851	GCST008460	Gout vs. Hyperuricemia	Gout vs. Hyperuricemia	Metabolic disorder
1852	GCST008460	Gout vs. Hyperuricemia	Gout vs. Hyperuricemia	Metabolic disorder
1853	GCST008475	Minimum ankle–brachial index	Minimum ankle–brachial index	Cardiovascular measurement
1854	GCST008474	Peripheral artery disease	Peripheral artery disease	Cardiovascular disease
1855	GCST008269	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Other disease
1856	GCST008269	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Response to drug
1857	GCST008269	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease	Other measurement
1858	GCST008597	Fish intake frequency		
1859	GCST008268	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Other disease
1860	GCST008268	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Response to drug
1861	GCST008268	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease	Other measurement
1862	GCST008461	Plasma factor V levels in venous thrombosis	Plasma factor V levels in venous thrombosis	Cardiovascular disease
1863	GCST008461	Plasma factor V levels in venous thrombosis	Plasma factor V levels in venous thrombosis	Other measurement
1864	GCST008462	Plasma factor V levels in venous thrombosis (conditioned on rs6027)	Plasma factor V levels in venous thrombosis (conditioned on rs6027)	Cardiovascular disease
1865	GCST008462	Plasma factor V levels in venous thrombosis (conditioned on rs6027)	Plasma factor V levels in venous thrombosis (conditioned on rs6027)	Other measurement
1866	GCST008448	Diabetes (gestational)	Diabetes (gestational)	Metabolic disorder
1867	GCST008706	Cerebrospinal fluid sTREM-2 levels		
1868	GCST008463	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1869	GCST008476	Emphysema annual change measurement in smokers (percent low attenuation area)	Emphysema annual change measurement in smokers (percent low attenuation area)	Other measurement
1870	GCST008476	Emphysema annual change measurement in smokers (percent low attenuation area)	Emphysema annual change measurement in smokers (percent low attenuation area)	Other measurement
1871	GCST008464	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
1872	GCST008478	Neurological blood protein biomarker levels	Neurological blood protein biomarker levels	Other measurement
1873	GCST008516	Skin pigmentation (conditioned on rs1426654 and rs35397)	Skin pigmentation (conditioned on rs1426654 and rs35397)	Other measurement
1874	GCST008598	Longevity (age >90th survival percentile)	Longevity (age >90th survival percentile)	Other measurement
1875	GCST008599	Longevity (age >99th survival percentile)	Longevity (age >99th survival percentile)	Other measurement
1876	GCST008600	Longevity (age >90th survival percentile)	Longevity (age >90th survival percentile)	Other measurement
1877	GCST008601	Longevity (age >99th survival percentile)	Longevity (age >99th survival percentile)	Other measurement
1878	GCST008646	Gastric cancer	Gastric cancer	Cancer
1879	GCST008758	Pre-treatment viral load in HIV-1 infection	Pre-treatment viral load in HIV-1 infection	Other measurement
1880	GCST008758	Pre-treatment viral load in HIV-1 infection	Pre-treatment viral load in HIV-1 infection	Other disease
1881	GCST008181	Spontaneous preterm birth without premature rupture of membranes	Spontaneous preterm birth without premature rupture of membranes	Other trait
1882	GCST008180	Spontaneous preterm birth with premature rupture of membranes	Spontaneous preterm birth with premature rupture of membranes	Other trait
1883	GCST008180	Spontaneous preterm birth with premature rupture of membranes	Spontaneous preterm birth with premature rupture of membranes	Other disease
1884	GCST008179	Moderate-to-late spontaneous preterm birth	Moderate-to-late spontaneous preterm birth	Other trait
1885	GCST008178	Early spontaneous preterm birth	Early spontaneous preterm birth	Other trait
1886	GCST008177	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other measurement
1887	GCST008177	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other trait
1888	GCST008512	Multisite chronic pain	Multisite chronic pain	Other trait
1889	GCST008388	Acute post-radiotherapy pain in breast cancer	Acute post-radiotherapy pain in breast cancer	Other trait
1890	GCST008388	Acute post-radiotherapy pain in breast cancer	Acute post-radiotherapy pain in breast cancer	Cancer
1891	GCST008388	Acute post-radiotherapy pain in breast cancer	Acute post-radiotherapy pain in breast cancer	Biological process
1892	GCST008511	Chronic widespread pain	Chronic widespread pain	Other trait
1893	GCST008459	Schizophrenia	Schizophrenia	Neurological disorder
1894	GCST008545	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Metabolic disorder
1895	GCST008545	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Metabolic disorder
1896	GCST008545	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Diabetic maculopathy with decreased visual acuity in type 2 diabetes	Other measurement
1897	GCST008546	Diabetic maculopathy in type 2 diabetes	Diabetic maculopathy in type 2 diabetes	Metabolic disorder
1898	GCST008546	Diabetic maculopathy in type 2 diabetes	Diabetic maculopathy in type 2 diabetes	Metabolic disorder
1899	GCST008503	Fasting glucose change	Fasting glucose change	Other measurement
1900	GCST008550	Mental health study participation (completed survey)	Mental health study participation (completed survey)	Other trait
1901	GCST008505	Fasting glucose change (short-term)	Fasting glucose change (short-term)	Other measurement
1902	GCST008504	Fasting glucose change (long-term)	Fasting glucose change (long-term)	Other measurement
1903	GCST008456	Childhood steroid-sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	Other disease
1904	GCST008225	Renal cell carcinoma	Renal cell carcinoma	Cancer
1905	GCST008226	Renal cell carcinoma	Renal cell carcinoma	Cancer
1906	GCST008224	Renal cell carcinoma x sex interaction	Renal cell carcinoma x sex interaction	Cancer
1907	GCST008224	Renal cell carcinoma x sex interaction	Renal cell carcinoma x sex interaction	Other measurement
1908	GCST008231	Prostate cancer	Prostate cancer	Cancer
1909	GCST008551	Simvastatin-induced myopathy	Simvastatin-induced myopathy	Other disease
1910	GCST008551	Simvastatin-induced myopathy	Simvastatin-induced myopathy	Response to drug
1911	GCST008274	Cerebral microbleed progression	Cerebral microbleed progression	Other trait
1912	GCST008274	Cerebral microbleed progression	Cerebral microbleed progression	Other measurement
1913	GCST008172	Liver iron content	Liver iron content	Other measurement
1914	GCST008275	Cerebral microbleeds	Cerebral microbleeds	Other trait
1915	GCST008398	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
1916	GCST008444	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
1917	GCST008502	Low susceptibility to hepatitis C infection	Low susceptibility to hepatitis C infection	Other trait
1918	GCST008549	Mental health study participation (provided email address)	Mental health study participation (provided email address)	Other trait
1919	GCST008458	Platelet reactivity measurement (collagen-ADP)	Platelet reactivity measurement (collagen-ADP)	Cardiovascular measurement
1920	GCST008457	Platelet reactivity measurement (collagen-epinephrine)	Platelet reactivity measurement (collagen-epinephrine)	Cardiovascular measurement
1921	GCST008292	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other disease
1922	GCST008292	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1923	GCST008292	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other measurement
1924	GCST008292	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1925	GCST008293	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other disease
1926	GCST008293	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1927	GCST008293	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other measurement
1928	GCST008293	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1929	GCST008294	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other disease
1930	GCST008294	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1931	GCST008294	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to drug
1932	GCST008294	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease	Other measurement
1933	GCST008422	QRS duration	QRS duration	Cardiovascular measurement
1934	GCST008422	QRS duration	QRS duration	Cardiovascular measurement
1935	GCST008422	QRS duration	QRS duration	Cardiovascular measurement
1936	GCST008276	Corneal resistance factor	Corneal resistance factor	Other measurement
1937	GCST008108	N-glycan levels	N-glycan levels	Other measurement
1938	GCST008399	Cocaine dependence	Cocaine dependence	Neurological disorder
1939	GCST008445	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
1940	GCST008176	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
1941	GCST008176	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
1942	GCST008552	Statin-induced myopathy	Statin-induced myopathy	Other disease
1943	GCST008552	Statin-induced myopathy	Statin-induced myopathy	Response to drug
1944	GCST008553	Statin-induced myopathy (severe)	Statin-induced myopathy (severe)	Other disease
1945	GCST008553	Statin-induced myopathy (severe)	Statin-induced myopathy (severe)	Response to drug
1946	GCST008554	Atorvastatin-induced myopathy	Atorvastatin-induced myopathy	Response to drug
1947	GCST008554	Atorvastatin-induced myopathy	Atorvastatin-induced myopathy	Other disease
1948	GCST008277	Corneal hysteresis	Corneal hysteresis	Other measurement
1949	GCST008377	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
1950	GCST008395	End-stage kidney disease	End-stage kidney disease	Other disease
1951	GCST008223	Diabetic peripheral neuropathy in type 2 diabetes	Diabetic peripheral neuropathy in type 2 diabetes	Metabolic disorder
1952	GCST008223	Diabetic peripheral neuropathy in type 2 diabetes	Diabetic peripheral neuropathy in type 2 diabetes	Neurological disorder
1953	GCST008394	Mild to moderate chronic kidney disease	Mild to moderate chronic kidney disease	Other disease
1954	GCST008356	Geographic atrophy lesion growth rate in age-related macular degeneration	Geographic atrophy lesion growth rate in age-related macular degeneration	Other measurement
1955	GCST008356	Geographic atrophy lesion growth rate in age-related macular degeneration	Geographic atrophy lesion growth rate in age-related macular degeneration	Neurological disorder
1956	GCST008361	Response to cognitive-behavioural therapy in major depressive disorder	Response to cognitive-behavioural therapy in major depressive disorder	Other trait
1957	GCST008361	Response to cognitive-behavioural therapy in major depressive disorder	Response to cognitive-behavioural therapy in major depressive disorder	Neurological disorder
1958	GCST008360	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Other trait
1959	GCST008360	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Neurological disorder
1960	GCST008359	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Other trait
1961	GCST008359	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Neurological disorder
1962	GCST008358	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Other trait
1963	GCST008358	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Neurological disorder
1964	GCST008358	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Response to cognitive-behavioural therapy in anxiety and major depressive disorders	Neurological disorder
1965	GCST007897	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Response to drug
1966	GCST007897	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Other disease
1967	GCST007897	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Digestive system disorder
1968	GCST007897	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Response to drug
1969	GCST007896	Primary central nervous system lymphoma	Primary central nervous system lymphoma	Cancer
1970	GCST008381	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Cancer
1971	GCST008381	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Biological process
1972	GCST008381	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	Other trait
1973	GCST008382	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Cancer
1974	GCST008382	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Biological process
1975	GCST008382	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	Other trait
1976	GCST008379	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Cancer
1977	GCST008379	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Biological process
1978	GCST008379	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Other disease
1979	GCST008380	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Cancer
1980	GCST008380	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Other trait
1981	GCST008380	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	Biological process
1982	GCST008378	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Cancer
1983	GCST008378	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Biological process
1984	GCST008378	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Other trait
1985	GCST007949	Type 2 diabetes and end-stage kidney disease	Type 2 diabetes and end-stage kidney disease	Metabolic disorder
1986	GCST007950	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	Metabolic disorder
1987	GCST007950	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	Other measurement
1988	GCST007992	Colorectal cancer	Colorectal cancer	Cancer
1989	GCST008559	Anxiety and stress-related disorders	Anxiety and stress-related disorders	Neurological disorder
1990	GCST008559	Anxiety and stress-related disorders	Anxiety and stress-related disorders	Neurological disorder
1991	GCST008560	Anxiety and stress-related disorders (propensity-score-matching design)	Anxiety and stress-related disorders (propensity-score-matching design)	Neurological disorder
1992	GCST008560	Anxiety and stress-related disorders (propensity-score-matching design)	Anxiety and stress-related disorders (propensity-score-matching design)	Neurological disorder
1993	GCST008561	Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	Neurological disorder
1994	GCST008561	Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)	Neurological disorder
1995	GCST008562	Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	Neurological disorder
1996	GCST008562	Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)	Neurological disorder
1997	GCST008563	Anxiety and stress-related disorders (including obsessive-compulsive disorder)	Anxiety and stress-related disorders (including obsessive-compulsive disorder)	Neurological disorder
1998	GCST008563	Anxiety and stress-related disorders (including obsessive-compulsive disorder)	Anxiety and stress-related disorders (including obsessive-compulsive disorder)	Neurological disorder
1999	GCST008564	Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	Neurological disorder
2000	GCST008564	Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	Anxiety and stress-related disorders (excluding co-morbid schizophrenia)	Neurological disorder
2001	GCST008565	Anxiety and stress-related disorders (excluding adjustment disorder)	Anxiety and stress-related disorders (excluding adjustment disorder)	Neurological disorder
2002	GCST008565	Anxiety and stress-related disorders (excluding adjustment disorder)	Anxiety and stress-related disorders (excluding adjustment disorder)	Neurological disorder
2003	GCST008566	Anxiety disorders	Anxiety disorders	Neurological disorder
2004	GCST008567	Stress-related disorders	Stress-related disorders	Neurological disorder
2005	GCST007999	Heart rate in heart failure with reduced ejection fraction	Heart rate in heart failure with reduced ejection fraction	Other trait
2006	GCST007999	Heart rate in heart failure with reduced ejection fraction	Heart rate in heart failure with reduced ejection fraction	Cardiovascular measurement
2007	GCST007999	Heart rate in heart failure with reduced ejection fraction	Heart rate in heart failure with reduced ejection fraction	Cardiovascular disease
2008	GCST008557	Dentate gyrus volume x schizophrenia interaction	Dentate gyrus volume x schizophrenia interaction	Neurological disorder
2009	GCST008557	Dentate gyrus volume x schizophrenia interaction	Dentate gyrus volume x schizophrenia interaction	Other measurement
2010	GCST008558	Dentate gyrus volume	Dentate gyrus volume	Other measurement
2011	GCST008423	Uterine fibroids	Uterine fibroids	Cancer
2012	GCST008433	Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	Lipid or lipoprotein measurement
2013	GCST008433	Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)	Cardiovascular disease
2014	GCST008149	Age at menopause	Age at menopause	Other measurement
2015	GCST008291	Alcohol dependence (drinking despite problems)	Alcohol dependence (drinking despite problems)	Other measurement
2016	GCST008290	Alcohol dependence (time spent drinking)	Alcohol dependence (time spent drinking)	Other measurement
2017	GCST008289	Alcohol dependence (giving up activities)	Alcohol dependence (giving up activities)	Other measurement
2018	GCST008288	Alcohol dependence (desire to cut drinking)	Alcohol dependence (desire to cut drinking)	Other measurement
2019	GCST008287	Alcohol dependence (drinking more than intended)	Alcohol dependence (drinking more than intended)	Other measurement
2020	GCST008286	Alcohol dependence (withdrawal)	Alcohol dependence (withdrawal)	Other measurement
2021	GCST008285	Alcohol dependence (tolerance)	Alcohol dependence (tolerance)	Other measurement
2022	GCST008283	Alcohol dependence symptom count	Alcohol dependence symptom count	Other measurement
2023	GCST007921	Right-sided colonic diverticulosis	Right-sided colonic diverticulosis	Other trait
2024	GCST008284	Alcohol dependence	Alcohol dependence	Other measurement
2025	GCST008284	Alcohol dependence	Alcohol dependence	Neurological disorder
2026	GCST008366	Leukocyte telomere length	Leukocyte telomere length	Other measurement
2027	GCST008357	Mood instability	Mood instability	Other measurement
2028	GCST008115	Bipolar I disorder	Bipolar I disorder	Neurological disorder
2029	GCST008115	Bipolar I disorder	Bipolar I disorder	Neurological disorder
2030	GCST008362	Birth weight	Birth weight	Body measurement
2031	GCST008103	Bipolar disorder	Bipolar disorder	Neurological disorder
2032	GCST008363	Offspring birth weight	Offspring birth weight	Body measurement
2033	GCST008363	Offspring birth weight	Offspring birth weight	Other measurement
2034	GCST008117	Schizoaffective disorder-bipolar type	Schizoaffective disorder-bipolar type	Neurological disorder
2035	GCST008116	Bipolar II disorder	Bipolar II disorder	Neurological disorder
2036	GCST008397	Infliximab-induced mucosal healing in Crohn's disease	Infliximab-induced mucosal healing in Crohn's disease	Digestive system disorder
2037	GCST008397	Infliximab-induced mucosal healing in Crohn's disease	Infliximab-induced mucosal healing in Crohn's disease	Response to drug
2038	GCST007948	KANNO antigen negativity	KANNO antigen negativity	Other measurement
2039	GCST008309	Cardiac troponin-I levels	Cardiac troponin-I levels	Cardiovascular measurement
2040	GCST007845	Progressive supranuclear palsy	Progressive supranuclear palsy	Neurological disorder
2041	GCST008437	Alzheimer's disease in hypertension-negative individuals	Alzheimer's disease in hypertension-negative individuals	Neurological disorder
2042	GCST008438	Alzheimer's disease in hypertension	Alzheimer's disease in hypertension	Neurological disorder
2043	GCST008438	Alzheimer's disease in hypertension	Alzheimer's disease in hypertension	Cardiovascular disease
2044	GCST008674	Glycemic traits (pleiotropy)	Glycemic traits (pleiotropy)	Other measurement
2045	GCST008674	Glycemic traits (pleiotropy)	Glycemic traits (pleiotropy)	Other measurement
2046	GCST008674	Glycemic traits (pleiotropy)	Glycemic traits (pleiotropy)	Other measurement
2047	GCST008310	Cardiac Troponin-T levels	Cardiac Troponin-T levels	Cardiovascular measurement
2048	GCST007945	Psychological resilience (outcome-based) in high deployment stress exposure	Psychological resilience (outcome-based) in high deployment stress exposure	Other measurement
2049	GCST007945	Psychological resilience (outcome-based) in high deployment stress exposure	Psychological resilience (outcome-based) in high deployment stress exposure	Other measurement
2050	GCST007947	Psychological resilience (outcome-based)	Psychological resilience (outcome-based)	Other measurement
2051	GCST007946	Psychological resilience (self-assessed)	Psychological resilience (self-assessed)	Other measurement
2052	GCST007880	Emotional lability in attention deficit hyperactivity disorder	Emotional lability in attention deficit hyperactivity disorder	Neurological disorder
2053	GCST007880	Emotional lability in attention deficit hyperactivity disorder	Emotional lability in attention deficit hyperactivity disorder	Other measurement
2054	GCST007838	Glycine levels	Glycine levels	Other measurement
2055	GCST007836	Glycine levels	Glycine levels	Other measurement
2056	GCST007837	Glycine levels	Glycine levels	Other measurement
2057	GCST007840	Low HDL-cholesterol levels	Low HDL-cholesterol levels	Lipid or lipoprotein measurement
2058	GCST007844	Ankylosing spondylitis	Ankylosing spondylitis	Immune system disorder
2059	GCST008097	Bisphosphonate-associated atypical femoral fracture	Bisphosphonate-associated atypical femoral fracture	Response to drug
2060	GCST008097	Bisphosphonate-associated atypical femoral fracture	Bisphosphonate-associated atypical femoral fracture	Other disease
2061	GCST008098	Atypical femoral fracture in phosphonate treatment	Atypical femoral fracture in phosphonate treatment	Response to drug
2062	GCST008098	Atypical femoral fracture in phosphonate treatment	Atypical femoral fracture in phosphonate treatment	Other disease
2063	GCST007846	Arterial stiffness	Arterial stiffness	Cardiovascular measurement
2064	GCST007833	Urolithiasis	Urolithiasis	Other disease
2065	GCST008514	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	Response to drug
2066	GCST008514	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	Peginterferon alfa-2a treatment response in chronic hepatitis B infection	Digestive system disorder
2067	GCST008270	Post-traumatic stress disorder symptoms in trauma-exposed soldiers	Post-traumatic stress disorder symptoms in trauma-exposed soldiers	Other measurement
2068	GCST008270	Post-traumatic stress disorder symptoms in trauma-exposed soldiers	Post-traumatic stress disorder symptoms in trauma-exposed soldiers	Biological process
2069	GCST008675	Maximum habitual alcohol consumption	Maximum habitual alcohol consumption	Other measurement
2070	GCST008312	Sural nerve amplitude potential	Sural nerve amplitude potential	Other measurement
2071	GCST008313	Sural nerve conduction velocity	Sural nerve conduction velocity	Other measurement
2072	GCST007832	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
2073	GCST008169	Benign prostatic hyperplasia	Benign prostatic hyperplasia	Other disease
2074	GCST007592	Handedness (Left-handed vs. non-left-handed)	Handedness (Left-handed vs. non-left-handed)	Other trait
2075	GCST007593	Ambidextrousness	Ambidextrousness	Other trait
2076	GCST007594	Handedness (Right-handed vs. non-right-handed)	Handedness (Right-handed vs. non-right-handed)	Other trait
2077	GCST008314	Response to intravenous immunoglobulin treatment in Kawasaki disease	Response to intravenous immunoglobulin treatment in Kawasaki disease	Immune system disorder
2078	GCST008314	Response to intravenous immunoglobulin treatment in Kawasaki disease	Response to intravenous immunoglobulin treatment in Kawasaki disease	Other trait
2079	GCST007780	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Neurological disorder
2080	GCST007780	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Other measurement
2081	GCST007734	Incident chronic kidney disease	Incident chronic kidney disease	Other disease
2082	GCST007796	Tinnitus in cisplatin-treated testicular cancer	Tinnitus in cisplatin-treated testicular cancer	Cancer
2083	GCST007796	Tinnitus in cisplatin-treated testicular cancer	Tinnitus in cisplatin-treated testicular cancer	Response to drug
2084	GCST007796	Tinnitus in cisplatin-treated testicular cancer	Tinnitus in cisplatin-treated testicular cancer	Other trait
2085	GCST008375	Adenocarcinoma in never smokers	Adenocarcinoma in never smokers	Other measurement
2086	GCST008375	Adenocarcinoma in never smokers	Adenocarcinoma in never smokers	Cancer
2087	GCST008376	Lung cancer in never smokers	Lung cancer in never smokers	Other measurement
2088	GCST008376	Lung cancer in never smokers	Lung cancer in never smokers	Cancer
2089	GCST008311	Lymphangioleiomyomatosis (sporadic)		
2090	GCST008057	Varicose veins	Varicose veins	Other trait
2091	GCST007731	Postoperative survival time in hepatocellular carcinoma	Postoperative survival time in hepatocellular carcinoma	Other measurement
2092	GCST007731	Postoperative survival time in hepatocellular carcinoma	Postoperative survival time in hepatocellular carcinoma	Cancer
2093	GCST008148	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Cardiovascular measurement
2094	GCST008148	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Metabolic disorder
2095	GCST008148	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Response to drug
2096	GCST007797	Asthma onset (childhood vs adult)	Asthma onset (childhood vs adult)	Other disease
2097	GCST007797	Asthma onset (childhood vs adult)	Asthma onset (childhood vs adult)	Other measurement
2098	GCST007798	Asthma	Asthma	Other disease
2099	GCST008147	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Cardiovascular measurement
2100	GCST008147	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Metabolic disorder
2101	GCST008147	Response to allopurinol in gout (change in serum uric acid levels)	Response to allopurinol in gout (change in serum uric acid levels)	Response to drug
2102	GCST007711	Severe coronary artery calcification	Severe coronary artery calcification	Other trait
2103	GCST008096	Psoriasis	Psoriasis	Immune system disorder
2104	GCST007799	Asthma (adult onset)	Asthma (adult onset)	Other disease
2105	GCST007800	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
2106	GCST007800	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
2107	GCST007728	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
2108	GCST007728	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
2109	GCST007677	Rumination (response to stress)	Rumination (response to stress)	Biological process
2110	GCST007679	Reflection (response to stress)	Reflection (response to stress)	Biological process
2111	GCST007678	Brooding (response to stress)	Brooding (response to stress)	Biological process
2112	GCST007643	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Immune system disorder
2113	GCST007643	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Response to drug
2114	GCST007643	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Gemcitabine-induced early high-grade neutropenia in pancreatic cancer	Cancer
2115	GCST007708	Worry/vulnerability (special factor of neuroticism)	Worry/vulnerability (special factor of neuroticism)	Other measurement
2116	GCST007709	General factor of neuroticism	General factor of neuroticism	Other measurement
2117	GCST007710	Anxiety/tension (special factor of neuroticism)	Anxiety/tension (special factor of neuroticism)	Other measurement
2118	GCST007718	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
2119	GCST008139	Gout	Gout	Metabolic disorder
2120	GCST007742	Iris heterochromicity	Iris heterochromicity	Other measurement
2121	GCST007742	Iris heterochromicity	Iris heterochromicity	Other trait
2122	GCST007743	Iris color (L* coordinate)	Iris color (L* coordinate)	Other measurement
2123	GCST007743	Iris color (L* coordinate)	Iris color (L* coordinate)	Other trait
2124	GCST007741	Iris color (b* coordinate)	Iris color (b* coordinate)	Other measurement
2125	GCST007741	Iris color (b* coordinate)	Iris color (b* coordinate)	Other trait
2126	GCST007740	Iris color (a* coordinate)	Iris color (a* coordinate)	Other measurement
2127	GCST007740	Iris color (a* coordinate)	Iris color (a* coordinate)	Other trait
2128	GCST007739	Skin reflectance (Melanin index)	Skin reflectance (Melanin index)	Other measurement
2129	GCST007687	Photic sneeze reflex	Photic sneeze reflex	Other trait
2130	GCST008315	Corneal hysteresis	Corneal hysteresis	Other measurement
2131	GCST008258	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
2132	GCST008258	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
2133	GCST008258	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
2134	GCST007656	Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	Other disease
2135	GCST007656	Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)	Cardiovascular measurement
2136	GCST008259	Alcohol use disorder	Alcohol use disorder	Neurological disorder
2137	GCST008259	Alcohol use disorder	Alcohol use disorder	Other measurement
2138	GCST007613	Chronic obstructive pulmonary disease or stroke (pleiotropy)	Chronic obstructive pulmonary disease or stroke (pleiotropy)	Other disease
2139	GCST007613	Chronic obstructive pulmonary disease or stroke (pleiotropy)	Chronic obstructive pulmonary disease or stroke (pleiotropy)	Cardiovascular disease
2140	GCST007612	Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	Other disease
2141	GCST007612	Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	Chronic obstructive pulmonary disease or coronary artery disease (pleiotropy)	Cardiovascular disease
2142	GCST007611	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Other disease
2143	GCST007611	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Other measurement
2144	GCST007611	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)	Cardiovascular disease
2145	GCST007610	Hypertension	Hypertension	Cardiovascular disease
2146	GCST007609	Resting heart rate	Resting heart rate	Cardiovascular measurement
2147	GCST008321	Corneal endothelial cell shape (percentage of hexagonally shaped cells)	Corneal endothelial cell shape (percentage of hexagonally shaped cells)	Other measurement
2148	GCST008316	Corneal endothelial cell size variation coefficient	Corneal endothelial cell size variation coefficient	Other measurement
2149	GCST008339	Corneal endothelial cell density	Corneal endothelial cell density	Other measurement
2150	GCST008317	Central corneal thickness	Central corneal thickness	Other measurement
2151	GCST008317	Central corneal thickness	Central corneal thickness	Other measurement
2152	GCST008320	Intraocular pressure (Goldman correlated)	Intraocular pressure (Goldman correlated)	Other measurement
2153	GCST008319	Intraocular pressure (corneal compensated)	Intraocular pressure (corneal compensated)	Other measurement
2154	GCST008318	Corneal resistance factor	Corneal resistance factor	Other measurement
2155	GCST008170	Thyroglobulin plasma levels	Thyroglobulin plasma levels	Other measurement
2156	GCST007816	Trunk fat mass adjusted for trunk lean mass	Trunk fat mass adjusted for trunk lean mass	Other measurement
2157	GCST008473	Visceral fat	Visceral fat	Other measurement
2158	GCST007712	Cortical brain region measurements (area, volume and thickness)	Cortical brain region measurements (area, volume and thickness)	Other measurement
2159	GCST007712	Cortical brain region measurements (area, volume and thickness)	Cortical brain region measurements (area, volume and thickness)	Other measurement
2160	GCST007431	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
2161	GCST007432	FEV1	FEV1	Other measurement
2162	GCST007354	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
2163	GCST007692	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
2164	GCST007429	Lung function (FVC)	Lung function (FVC)	Other measurement
2165	GCST008770	Sleep duration	Sleep duration	Other measurement
2166	GCST007367	Meconium ileus in cystic fibrosis	Meconium ileus in cystic fibrosis	Digestive system disorder
2167	GCST007495	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Cardiovascular disease
2168	GCST007495	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Other disease
2169	GCST007495	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	Other measurement
2170	GCST007536	Serum urea levels	Serum urea levels	Other measurement
2171	GCST007537	Modic changes	Modic changes	Other trait
2172	GCST007638	Glycine levels	Glycine levels	Other measurement
2173	GCST007839	Mouth ulcers	Mouth ulcers	Other trait
2174	GCST007581	Carpal tunnel syndrome	Carpal tunnel syndrome	Neurological disorder
2175	GCST008641	C-peptide levels	C-peptide levels	Other measurement
2176	GCST008603	Total body bone mineral density (MTAG)	Total body bone mineral density (MTAG)	Other measurement
2177	GCST008602	Heel bone mineral density (MTAG)	Heel bone mineral density (MTAG)	Other measurement
2178	GCST007511	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
2179	GCST007511	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
2180	GCST007644	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Other measurement
2181	GCST007644	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Other measurement
2182	GCST007644	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)	Other measurement
2183	GCST007645	Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)	Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)	Other measurement
2184	GCST007645	Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)	Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)	Other measurement
2185	GCST007646	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Other measurement
2186	GCST007646	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Other measurement
2187	GCST007646	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Estimated glomerular filtration rate change in renal transplantation (donor effect)	Other measurement
2188	GCST007647	Estimated glomerular filtration rate change in renal transplantation (recipient effect)	Estimated glomerular filtration rate change in renal transplantation (recipient effect)	Other measurement
2189	GCST007647	Estimated glomerular filtration rate change in renal transplantation (recipient effect)	Estimated glomerular filtration rate change in renal transplantation (recipient effect)	Other measurement
2190	GCST007648	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Other measurement
2191	GCST007648	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Other measurement
2192	GCST007648	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)	Other measurement
2193	GCST007649	Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)	Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)	Other measurement
2194	GCST007649	Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)	Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)	Other measurement
2195	GCST007719	Albuminuria	Albuminuria	Other trait
2196	GCST007717	Urinary sodium to potassium ratio	Urinary sodium to potassium ratio	Other measurement
2197	GCST007778	Urinary sodium to creatinine ratio	Urinary sodium to creatinine ratio	Other measurement
2198	GCST007721	Urinary potassium to creatinine ratio	Urinary potassium to creatinine ratio	Other measurement
2199	GCST007737	Anti-sp100 seropositivity in primary biliary cholangitis	Anti-sp100 seropositivity in primary biliary cholangitis	Cancer
2200	GCST007737	Anti-sp100 seropositivity in primary biliary cholangitis	Anti-sp100 seropositivity in primary biliary cholangitis	Other measurement
2201	GCST007736	Anti-gp210 seropositivity in primary biliary cholangitis	Anti-gp210 seropositivity in primary biliary cholangitis	Cancer
2202	GCST007736	Anti-gp210 seropositivity in primary biliary cholangitis	Anti-gp210 seropositivity in primary biliary cholangitis	Other measurement
2203	GCST007690	Metabolic coherence (transcriptomic)	Metabolic coherence (transcriptomic)	Other measurement
2204	GCST007690	Metabolic coherence (transcriptomic)	Metabolic coherence (transcriptomic)	Other measurement
2205	GCST007713	Frontal fibrosing alopecia	Frontal fibrosing alopecia	Other disease
2206	GCST007650	Postoperative survival time in hepatocellular carcinoma	Postoperative survival time in hepatocellular carcinoma	Other measurement
2207	GCST007650	Postoperative survival time in hepatocellular carcinoma	Postoperative survival time in hepatocellular carcinoma	Cancer
2208	GCST007427	Triiodothyronine/thyroxine ratio	Triiodothyronine/thyroxine ratio	Other measurement
2209	GCST007426	Triiodothyronine levels	Triiodothyronine levels	Other measurement
2210	GCST007277	Tourette syndrome	Tourette syndrome	Neurological disorder
2211	GCST007428	Thyroxine levels	Thyroxine levels	Other measurement
2212	GCST007430	Peak expiratory flow	Peak expiratory flow	Other measurement
2213	GCST007561	Sleep duration	Sleep duration	Other measurement
2214	GCST007560	Sleep duration (long sleep)	Sleep duration (long sleep)	Other measurement
2215	GCST007559	Sleep duration (short sleep)	Sleep duration (short sleep)	Other measurement
2216	GCST007900	Chemerin levels	Chemerin levels	Cardiovascular measurement
2217	GCST007406	Healthspan	Healthspan	Other measurement
2218	GCST007538	Cellular nuclear factor (erythroid-derived 2)-like 2 levels	Cellular nuclear factor (erythroid-derived 2)-like 2 levels	Other measurement
2219	GCST007280	Number of twin births	Number of twin births	Other measurement
2220	GCST007676	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other trait
2221	GCST007676	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other measurement
2222	GCST007675	3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)	3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)	Other trait
2223	GCST007675	3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)	3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score)	Other measurement
2224	GCST007674	3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)	3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)	Cardiovascular disease
2225	GCST007674	3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)	3-month functional outcome in lacunar ischaemic stroke (modified Rankin score)	Other measurement
2226	GCST007673	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other trait
2227	GCST007673	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other measurement
2228	GCST007672	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other trait
2229	GCST007672	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other measurement
2230	GCST007477	Breast cancer specific mortality in breast cancer	Breast cancer specific mortality in breast cancer	Other measurement
2231	GCST007477	Breast cancer specific mortality in breast cancer	Breast cancer specific mortality in breast cancer	Cancer
2232	GCST007475	Breast cancer specific mortality in estrogen receptor positive breast cancer	Breast cancer specific mortality in estrogen receptor positive breast cancer	Other measurement
2233	GCST007475	Breast cancer specific mortality in estrogen receptor positive breast cancer	Breast cancer specific mortality in estrogen receptor positive breast cancer	Cancer
2234	GCST007476	Breast cancer specific mortality in estrogen receptor negative breast cancer	Breast cancer specific mortality in estrogen receptor negative breast cancer	Other measurement
2235	GCST007476	Breast cancer specific mortality in estrogen receptor negative breast cancer	Breast cancer specific mortality in estrogen receptor negative breast cancer	Cancer
2236	GCST007266	Adult asthma	Adult asthma	Other disease
2237	GCST008577	Tacrolimus trough concentration in kidney transplant patients	Tacrolimus trough concentration in kidney transplant patients	Other measurement
2238	GCST008577	Tacrolimus trough concentration in kidney transplant patients	Tacrolimus trough concentration in kidney transplant patients	Other measurement
2239	GCST007437	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
2240	GCST007847	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
2241	GCST007342	Depression	Depression	Neurological disorder
2242	GCST007342	Depression	Depression	Other measurement
2243	GCST007549	Osteolysis in total hip arthroplasty	Osteolysis in total hip arthroplasty	Other trait
2244	GCST007549	Osteolysis in total hip arthroplasty	Osteolysis in total hip arthroplasty	Other disease
2245	GCST007550	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Other trait
2246	GCST007550	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Other disease
2247	GCST007550	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Osteolysis in total hip arthroplasty (time to prosthesis revision)	Other measurement
2248	GCST007392	Mitochondrial DNA copy number (white blood cells)	Mitochondrial DNA copy number (white blood cells)	Other measurement
2249	GCST007469	Rapid automised naming of digits	Rapid automised naming of digits	Biological process
2250	GCST007470	Rapid automised naming of letters	Rapid automised naming of letters	Biological process
2251	GCST007479	Reading ability (multivariate)	Reading ability (multivariate)	Biological process
2252	GCST007465	Phoneme awareness	Phoneme awareness	Biological process
2253	GCST007466	Word reading	Word reading	Biological process
2254	GCST007467	Word spelling	Word spelling	Biological process
2255	GCST007478	Non-word reading	Non-word reading	Biological process
2256	GCST007471	Short-term memory (digit-span task)	Short-term memory (digit-span task)	Biological process
2257	GCST007471	Short-term memory (digit-span task)	Short-term memory (digit-span task)	Other measurement
2258	GCST007473	Rapid automised naming of pictures	Rapid automised naming of pictures	Biological process
2259	GCST007434	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Cancer
2260	GCST007434	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Other measurement
2261	GCST007434	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)	Other measurement
2262	GCST007616	Calcaneus stiffness index	Calcaneus stiffness index	Other measurement
2263	GCST008578	New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	Response to drug
2264	GCST008578	New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)	Metabolic disorder
2265	GCST008579	Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	Response to drug
2266	GCST008579	Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)	Other trait
2267	GCST008580	Anemia in mycophenolic acid treated kidney transplant patients (time to event)	Anemia in mycophenolic acid treated kidney transplant patients (time to event)	Other trait
2268	GCST008580	Anemia in mycophenolic acid treated kidney transplant patients (time to event)	Anemia in mycophenolic acid treated kidney transplant patients (time to event)	Response to drug
2269	GCST008581	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Other measurement
2270	GCST008581	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Other trait
2271	GCST008581	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)	Response to drug
2272	GCST008582	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Other measurement
2273	GCST008582	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Other trait
2274	GCST008582	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)	Response to drug
2275	GCST007440	Alanine aminotransferase levels	Alanine aminotransferase levels	Liver enzyme measurement
2276	GCST007439	Aspartate aminotransferase levels	Aspartate aminotransferase levels	Liver enzyme measurement
2277	GCST007441	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
2278	GCST007438	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
2279	GCST007442	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
2280	GCST007297	Psychological distress	Psychological distress	Other measurement
2281	GCST007399	Mitochondrial DNA copy number	Mitochondrial DNA copy number	Other measurement
2282	GCST007304	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Neurological disorder
2283	GCST007304	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Other measurement
2284	GCST007398	Mitochondrial DNA copy number (white blood cells)	Mitochondrial DNA copy number (white blood cells)	Other measurement
2285	GCST007397	Mitochondrial DNA copy number (white blood cells)	Mitochondrial DNA copy number (white blood cells)	Other measurement
2286	GCST007396	Mitochondrial DNA copy number (white blood cells)	Mitochondrial DNA copy number (white blood cells)	Other measurement
2287	GCST007395	Mitochondrial DNA copy number	Mitochondrial DNA copy number	Other measurement
2288	GCST007394	Mitochondrial DNA copy number	Mitochondrial DNA copy number	Other measurement
2289	GCST007393	Mitochondrial DNA copy number	Mitochondrial DNA copy number	Other measurement
2290	GCST007779	Pandemrix-induced narcolepsy	Pandemrix-induced narcolepsy	Neurological disorder
2291	GCST007779	Pandemrix-induced narcolepsy	Pandemrix-induced narcolepsy	Response to drug
2292	GCST008716	Anti-Helicobacter pylori IgG seropositivity	Anti-Helicobacter pylori IgG seropositivity	Other measurement
2293	GCST007824	Monoclonal gammopathy of undetermined significance	Monoclonal gammopathy of undetermined significance	Other disease
2294	GCST008714	Gastric atrophy	Gastric atrophy	Digestive system disorder
2295	GCST008712	Pepsinogen I/II ratio		
2296	GCST008709	Pepsinogen-I levels		
2297	GCST008713	Severe gastric atrophy	Severe gastric atrophy	Digestive system disorder
2298	GCST007391	Deliberate self-harm	Deliberate self-harm	Other measurement
2299	GCST007389	Suicidality	Suicidality	Other measurement
2300	GCST007390	Suicidality (suicidal ideation/attempts)	Suicidality (suicidal ideation/attempts)	Other measurement
2301	GCST007842	Glioma	Glioma	Cancer
2302	GCST007842	Glioma	Glioma	Cancer
2303	GCST007357	Voxel-wise structural brain imaging measurements	Voxel-wise structural brain imaging measurements	Other measurement
2304	GCST007730	Brain infarct	Brain infarct	Cardiovascular disease
2305	GCST006987	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Response to drug
2306	GCST006987	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Neurological disorder
2307	GCST006987	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Neutrophil level response to clozapine in treatment-resistant schizophrenia	Hematological measurement
2308	GCST007576	Chronotype	Chronotype	Biological process
2309	GCST007576	Chronotype	Chronotype	Other measurement
2310	GCST007565	Morning person	Morning person	Other measurement
2311	GCST007605	Glycated hemoglobin levels in type 1 diabetes	Glycated hemoglobin levels in type 1 diabetes	Other measurement
2312	GCST007605	Glycated hemoglobin levels in type 1 diabetes	Glycated hemoglobin levels in type 1 diabetes	Metabolic disorder
2313	GCST007111	Vitiligo (early onset)	Vitiligo (early onset)	Immune system disorder
2314	GCST007282	HDL cholesterol x physical activity interaction (2df test)	HDL cholesterol x physical activity interaction (2df test)	Lipid or lipoprotein measurement
2315	GCST007282	HDL cholesterol x physical activity interaction (2df test)	HDL cholesterol x physical activity interaction (2df test)	Biological process
2316	GCST007285	Triglycerides x physical activity interaction (1df test)	Triglycerides x physical activity interaction (1df test)	Lipid or lipoprotein measurement
2317	GCST007285	Triglycerides x physical activity interaction (1df test)	Triglycerides x physical activity interaction (1df test)	Biological process
2318	GCST007281	HDL cholesterol x physical activity interaction (1df test)	HDL cholesterol x physical activity interaction (1df test)	Lipid or lipoprotein measurement
2319	GCST007281	HDL cholesterol x physical activity interaction (1df test)	HDL cholesterol x physical activity interaction (1df test)	Biological process
2320	GCST007283	LDL cholesterol x physical activity interaction (1df test)	LDL cholesterol x physical activity interaction (1df test)	Lipid or lipoprotein measurement
2321	GCST007283	LDL cholesterol x physical activity interaction (1df test)	LDL cholesterol x physical activity interaction (1df test)	Biological process
2322	GCST007286	Triglycerides x physical activity interaction (2df test)	Triglycerides x physical activity interaction (2df test)	Lipid or lipoprotein measurement
2323	GCST007286	Triglycerides x physical activity interaction (2df test)	Triglycerides x physical activity interaction (2df test)	Biological process
2324	GCST007284	LDL cholesterol x physical activity interaction (2df test)	LDL cholesterol x physical activity interaction (2df test)	Lipid or lipoprotein measurement
2325	GCST007284	LDL cholesterol x physical activity interaction (2df test)	LDL cholesterol x physical activity interaction (2df test)	Biological process
2326	GCST007050	Gallstone disease	Gallstone disease	Digestive system disorder
2327	GCST007050	Gallstone disease	Gallstone disease	Digestive system disorder
2328	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
2329	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
2330	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
2331	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
2332	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
2333	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
2334	GCST007777	Psychiatric disorder	Psychiatric disorder	Metabolic disorder
2335	GCST007777	Psychiatric disorder	Psychiatric disorder	Neurological disorder
2336	GCST007093	Osteoarthritis	Osteoarthritis	Other disease
2337	GCST007092	Osteoarthritis of the hip or knee	Osteoarthritis of the hip or knee	Other disease
2338	GCST007092	Osteoarthritis of the hip or knee	Osteoarthritis of the hip or knee	Other disease
2339	GCST007091	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
2340	GCST007091	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
2341	GCST007217	RR interval (heart rate)	RR interval (heart rate)	Cardiovascular measurement
2342	GCST007218	QT interval	QT interval	Cardiovascular measurement
2343	GCST007227	QRS duration	QRS duration	Cardiovascular measurement
2344	GCST007227	QRS duration	QRS duration	Cardiovascular measurement
2345	GCST007227	QRS duration	QRS duration	Cardiovascular measurement
2346	GCST007226	PR interval	PR interval	Cardiovascular measurement
2347	GCST007242	Normal body mass index vs. thin	Normal body mass index vs. thin	Body measurement
2348	GCST007241	Obesity (extreme)	Obesity (extreme)	Metabolic disorder
2349	GCST007241	Obesity (extreme)	Obesity (extreme)	Body measurement
2350	GCST007240	Obese vs. thin	Obese vs. thin	Body measurement
2351	GCST007112	Vitiligo (late onset)	Vitiligo (late onset)	Immune system disorder
2352	GCST007521	Asthma-chronic obstructive  pulmonary disease overlap syndrome	Asthma-chronic obstructive  pulmonary disease overlap syndrome	Other disease
2353	GCST007279	Attention deficit hyperactivity disorder symptom score	Attention deficit hyperactivity disorder symptom score	Other measurement
2354	GCST007305	White matter hyperintensity volume	White matter hyperintensity volume	Other measurement
2355	GCST007843	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
2356	GCST007520	Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma	Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma	Other disease
2357	GCST007520	Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma	Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma	Other disease
2358	GCST007519	Adult asthma	Adult asthma	Other disease
2359	GCST007774	Drug-induced liver injury	Drug-induced liver injury	Response to drug
2360	GCST007774	Drug-induced liver injury	Drug-induced liver injury	Digestive system disorder
2361	GCST007814	Sodium levels in epilepsy	Sodium levels in epilepsy	Other measurement
2362	GCST007814	Sodium levels in epilepsy	Sodium levels in epilepsy	Neurological disorder
2363	GCST007813	Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy	Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy	Other measurement
2364	GCST007813	Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy	Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy	Neurological disorder
2365	GCST007812	Oxcarbazepine-induced hyponatremia in epilepsy	Oxcarbazepine-induced hyponatremia in epilepsy	Response to drug
2366	GCST007812	Oxcarbazepine-induced hyponatremia in epilepsy	Oxcarbazepine-induced hyponatremia in epilepsy	Other trait
2367	GCST007812	Oxcarbazepine-induced hyponatremia in epilepsy	Oxcarbazepine-induced hyponatremia in epilepsy	Neurological disorder
2368	GCST007811	Carbamazepine-induced hyponatremia in epilepsy	Carbamazepine-induced hyponatremia in epilepsy	Other trait
2369	GCST007811	Carbamazepine-induced hyponatremia in epilepsy	Carbamazepine-induced hyponatremia in epilepsy	Response to drug
2370	GCST007811	Carbamazepine-induced hyponatremia in epilepsy	Carbamazepine-induced hyponatremia in epilepsy	Neurological disorder
2371	GCST007810	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Response to drug
2372	GCST007810	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Other trait
2373	GCST007810	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Other trait
2374	GCST007810	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Response to drug
2375	GCST007810	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Neurological disorder
2376	GCST007809	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Response to drug
2377	GCST007809	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Other trait
2378	GCST007809	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Other trait
2379	GCST007809	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Response to drug
2380	GCST007809	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy	Neurological disorder
2381	GCST007019	Suicide attempt severity	Suicide attempt severity	Other measurement
2382	GCST007729	Small subcortical brain infarct	Small subcortical brain infarct	Cardiovascular disease
2383	GCST007090	Knee osteoarthritis	Knee osteoarthritis	Other disease
2384	GCST007606	Drug-induced liver injury (flucloxacillin)	Drug-induced liver injury (flucloxacillin)	Digestive system disorder
2385	GCST007607	Drug-induced liver injury (amoxicillin)	Drug-induced liver injury (amoxicillin)	Digestive system disorder
2386	GCST007608	Drug-induced liver injury (isoxazolyl penicillins)	Drug-induced liver injury (isoxazolyl penicillins)	Digestive system disorder
2387	GCST008105	Diverticular disease	Diverticular disease	Digestive system disorder
2388	GCST007064	Body fat percentage	Body fat percentage	Body measurement
2389	GCST007063	Fat-free mass	Fat-free mass	Other measurement
2390	GCST007955	Low density lipoprotein triglyceride levels	Low density lipoprotein triglyceride levels	Lipid or lipoprotein measurement
2391	GCST007272	Pulse pressure	Pulse pressure	Cardiovascular measurement
2392	GCST007271	Diastolic blood pressure	Diastolic blood pressure	Other measurement
2393	GCST007271	Diastolic blood pressure	Diastolic blood pressure	Other measurement
2394	GCST007270	Systolic blood pressure	Systolic blood pressure	Other measurement
2395	GCST007270	Systolic blood pressure	Systolic blood pressure	Other measurement
2396	GCST007269	Pulse pressure	Pulse pressure	Cardiovascular measurement
2397	GCST007268	Diastolic blood pressure	Diastolic blood pressure	Other measurement
2398	GCST007268	Diastolic blood pressure	Diastolic blood pressure	Other measurement
2399	GCST007267	Systolic blood pressure	Systolic blood pressure	Other measurement
2400	GCST007267	Systolic blood pressure	Systolic blood pressure	Other measurement
2401	GCST007782	Schizophrenia or intelligence (pleiotropy)	Schizophrenia or intelligence (pleiotropy)	Biological process
2402	GCST007782	Schizophrenia or intelligence (pleiotropy)	Schizophrenia or intelligence (pleiotropy)	Neurological disorder
2403	GCST007781	Bipolar disorder or intelligence (pleiotropy)	Bipolar disorder or intelligence (pleiotropy)	Biological process
2404	GCST007781	Bipolar disorder or intelligence (pleiotropy)	Bipolar disorder or intelligence (pleiotropy)	Neurological disorder
2405	GCST006983	Attention deficit hyperactivity disorder or cannabis use	Attention deficit hyperactivity disorder or cannabis use	Neurological disorder
2406	GCST006983	Attention deficit hyperactivity disorder or cannabis use	Attention deficit hyperactivity disorder or cannabis use	Biological process
2407	GCST007344	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
2408	GCST007726	Anti-Toxoplasma gondii IgG seropositivity	Anti-Toxoplasma gondii IgG seropositivity	Other measurement
2409	GCST006935	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other trait
2410	GCST006935	3-month functional outcome in ischaemic stroke (modified Rankin score)	3-month functional outcome in ischaemic stroke (modified Rankin score)	Other measurement
2411	GCST006979	Heel bone mineral density	Heel bone mineral density	Other measurement
2412	GCST006980	Fractures	Fractures	Other disease
2413	GCST007600	Alzheimer's disease	Alzheimer's disease	Neurological disorder
2414	GCST007254	Broad depression or major depressive disorder (self-reported)	Broad depression or major depressive disorder (self-reported)	Neurological disorder
2415	GCST007257	Broad depression or schizophrenia	Broad depression or schizophrenia	Neurological disorder
2416	GCST007257	Broad depression or schizophrenia	Broad depression or schizophrenia	Neurological disorder
2417	GCST007255	Broad depression or bipolar disorder	Broad depression or bipolar disorder	Neurological disorder
2418	GCST007255	Broad depression or bipolar disorder	Broad depression or bipolar disorder	Neurological disorder
2419	GCST007256	Broad depression or major depressive disorder (recurrent)	Broad depression or major depressive disorder (recurrent)	Neurological disorder
2420	GCST007603	Smoking initiation	Smoking initiation	Biological process
2421	GCST007604	Smoking cessation	Smoking cessation	Biological process
2422	GCST007601	Smoking behaviour (cigarette pack-years)	Smoking behaviour (cigarette pack-years)	Other measurement
2423	GCST007601	Smoking behaviour (cigarette pack-years)	Smoking behaviour (cigarette pack-years)	Other measurement
2424	GCST007602	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
2425	GCST007320	Alzheimer's disease or family history of Alzheimer's disease	Alzheimer's disease or family history of Alzheimer's disease	Neurological disorder
2426	GCST007320	Alzheimer's disease or family history of Alzheimer's disease	Alzheimer's disease or family history of Alzheimer's disease	Other measurement
2427	GCST007321	Family history of Alzheimer's disease	Family history of Alzheimer's disease	Other measurement
2428	GCST007319	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
2429	GCST007319	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
2430	GCST007998	Intraocular pressure	Intraocular pressure	Other measurement
2431	GCST007260	B6 vitamer levels (multivariate analysis)	B6 vitamer levels (multivariate analysis)	Other measurement
2432	GCST007265	Plasma pyridoxic acid to pyridoxal phosphate ratio	Plasma pyridoxic acid to pyridoxal phosphate ratio	Other measurement
2433	GCST007264	Plasma pyridoxal phosphate to pyridoxal ratio	Plasma pyridoxal phosphate to pyridoxal ratio	Other measurement
2434	GCST007263	Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio	Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio	Other measurement
2435	GCST007262	Plasma pyridoxal phosphate levels	Plasma pyridoxal phosphate levels	Other measurement
2436	GCST007261	Cerebrospinal fluid pyridoxal phosphate levels	Cerebrospinal fluid pyridoxal phosphate levels	Other measurement
2437	GCST006956	Erectile dysfunction	Erectile dysfunction	Other disease
2438	GCST006989	Brown vs. black hair color	Brown vs. black hair color	Other trait
2439	GCST006988	Blond vs. brown/black hair color	Blond vs. brown/black hair color	Other trait
2440	GCST006976	Macular thickness	Macular thickness	Other measurement
2441	GCST007233	Fragile X syndrome	Fragile X syndrome	Metabolic disorder
2442	GCST007552	Colorectal cancer	Colorectal cancer	Cancer
2443	GCST007228	Pulmonary arterial hypertension	Pulmonary arterial hypertension	Cardiovascular disease
2444	GCST007230	Severe depressive disorders in coronary artery disease	Severe depressive disorders in coronary artery disease	Cardiovascular disease
2445	GCST007230	Severe depressive disorders in coronary artery disease	Severe depressive disorders in coronary artery disease	Neurological disorder
2446	GCST007330	Alzheimer's disease with memory domain impairment	Alzheimer's disease with memory domain impairment	Neurological disorder
2447	GCST007330	Alzheimer's disease with memory domain impairment	Alzheimer's disease with memory domain impairment	Other trait
2448	GCST007278	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Neurological disorder
2449	GCST007278	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Immune system disorder
2450	GCST007278	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Immune system disorder
2451	GCST007278	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)	Immune system disorder
2452	GCST007020	Male-pattern baldness	Male-pattern baldness	Other measurement
2453	GCST007020	Male-pattern baldness	Male-pattern baldness	Other disease
2454	GCST007020	Male-pattern baldness	Male-pattern baldness	Other disease
2455	GCST007596	Adult asthma	Adult asthma	Other disease
2456	GCST007022	Type 2 diabetes nephropathy including microalbuminuria	Type 2 diabetes nephropathy including microalbuminuria	Other trait
2457	GCST007022	Type 2 diabetes nephropathy including microalbuminuria	Type 2 diabetes nephropathy including microalbuminuria	Metabolic disorder
2458	GCST007597	Adult asthma	Adult asthma	Other disease
2459	GCST007598	Adult asthma	Adult asthma	Other disease
2460	GCST007599	Adult asthma	Adult asthma	Other disease
2461	GCST007089	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
2462	GCST007021	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
2463	GCST007021	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
2464	GCST008733	Waist-to-hip ratio adjusted for BMI	Waist-to-hip ratio adjusted for BMI	Body measurement
2465	GCST007544	Coronary artery disease and total cholesterol levels (multivariate analysis)	Coronary artery disease and total cholesterol levels (multivariate analysis)	Cardiovascular disease
2466	GCST007544	Coronary artery disease and total cholesterol levels (multivariate analysis)	Coronary artery disease and total cholesterol levels (multivariate analysis)	Lipid or lipoprotein measurement
2467	GCST007545	Coronary artery disease and triglyceride levels (multivariate analysis)	Coronary artery disease and triglyceride levels (multivariate analysis)	Cardiovascular disease
2468	GCST007545	Coronary artery disease and triglyceride levels (multivariate analysis)	Coronary artery disease and triglyceride levels (multivariate analysis)	Lipid or lipoprotein measurement
2469	GCST007546	Coronary artery disease and LDL cholesterol levels (multivariate analysis)	Coronary artery disease and LDL cholesterol levels (multivariate analysis)	Cardiovascular disease
2470	GCST007546	Coronary artery disease and LDL cholesterol levels (multivariate analysis)	Coronary artery disease and LDL cholesterol levels (multivariate analysis)	Lipid or lipoprotein measurement
2471	GCST007547	Coronary artery disease and HDL cholesterol levels (multivariate analysis)	Coronary artery disease and HDL cholesterol levels (multivariate analysis)	Cardiovascular disease
2472	GCST007547	Coronary artery disease and HDL cholesterol levels (multivariate analysis)	Coronary artery disease and HDL cholesterol levels (multivariate analysis)	Lipid or lipoprotein measurement
2473	GCST007225	Varicose veins	Varicose veins	Other trait
2474	GCST008734	Waist-hip ratio	Waist-hip ratio	Other measurement
2475	GCST008734	Waist-hip ratio	Waist-hip ratio	Body measurement
2476	GCST007210	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Neurological disorder
2477	GCST007210	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Biological process
2478	GCST007210	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Biological process
2479	GCST007209	Gallstone disease	Gallstone disease	Digestive system disorder
2480	GCST007209	Gallstone disease	Gallstone disease	Digestive system disorder
2481	GCST006984	Takayasu arteritis	Takayasu arteritis	Cardiovascular disease
2482	GCST007216	Crohn's disease	Crohn's disease	Digestive system disorder
2483	GCST007292	Diabetic retinopathy (all NPDR and PDR)	Diabetic retinopathy (all NPDR and PDR)	Metabolic disorder
2484	GCST007291	Proliferative diabetic retinopathy (vs no DR)	Proliferative diabetic retinopathy (vs no DR)	Metabolic disorder
2485	GCST007290	Diabetic retinopathy (moderate NPDR and PDR)	Diabetic retinopathy (moderate NPDR and PDR)	Metabolic disorder
2486	GCST007289	Proliferative diabetic retinopathy (vs NPDR and no DR)	Proliferative diabetic retinopathy (vs NPDR and no DR)	Metabolic disorder
2487	GCST007433	Fulminant type 1 diabetes	Fulminant type 1 diabetes	Metabolic disorder
2488	GCST007317	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Neurological disorder
2489	GCST007317	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Neurological disorder
2490	GCST007317	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Response to drug
2491	GCST007317	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Response to ketamine in bipolar disorder or major depression (dissociation effects)	Other measurement
2492	GCST007235	Pancreatic ductal adenocarcinoma	Pancreatic ductal adenocarcinoma	Cancer
2493	GCST008491	Whole-brain volume	Whole-brain volume	Other measurement
2494	GCST007234	Acne (severe)	Acne (severe)	Other disease
2495	GCST006911	Asthma (moderate or severe)	Asthma (moderate or severe)	Other disease
2496	GCST006986	Red vs. brown/black hair color	Red vs. brown/black hair color	Other trait
2497	GCST007331	Alzheimer's disease	Alzheimer's disease	Neurological disorder
2498	GCST007333	Alzheimer's disease with no specific cognitive domain impairment	Alzheimer's disease with no specific cognitive domain impairment	Neurological disorder
2499	GCST007332	Alzheimer's disease with multiple cognitive domain impairments	Alzheimer's disease with multiple cognitive domain impairments	Neurological disorder
2500	GCST007332	Alzheimer's disease with multiple cognitive domain impairments	Alzheimer's disease with multiple cognitive domain impairments	Other trait
2501	GCST007318	Alzheimer's disease with visuospatial domain impairment	Alzheimer's disease with visuospatial domain impairment	Neurological disorder
2502	GCST007318	Alzheimer's disease with visuospatial domain impairment	Alzheimer's disease with visuospatial domain impairment	Neurological disorder
2503	GCST007334	Alzheimer's disease with language domain impairment	Alzheimer's disease with language domain impairment	Neurological disorder
2504	GCST007334	Alzheimer's disease with language domain impairment	Alzheimer's disease with language domain impairment	Neurological disorder
2505	GCST007856	Colorectal cancer or advanced adenoma	Colorectal cancer or advanced adenoma	Cancer
2506	GCST007856	Colorectal cancer or advanced adenoma	Colorectal cancer or advanced adenoma	Cancer
2507	GCST007435	Carotid plaque	Carotid plaque	Cardiovascular disease
2508	GCST007436	Carotid intima media thickness	Carotid intima media thickness	Other measurement
2509	GCST007436	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular measurement
2510	GCST007436	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular disease
2511	GCST007699	Developmental dysplasia of the hip	Developmental dysplasia of the hip	Other disease
2512	GCST007276	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
2513	GCST007276	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
2514	GCST007448	Normal facial asymmetry (angle of surface orientation score)	Normal facial asymmetry (angle of surface orientation score)	Other measurement
2515	GCST007450	Normal facial asymmetry (deformation magnitude)	Normal facial asymmetry (deformation magnitude)	Other measurement
2516	GCST006916	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
2517	GCST008104	Nucleoside diphosphate kinase A levels in hepatocellular carcinoma	Nucleoside diphosphate kinase A levels in hepatocellular carcinoma	Other measurement
2518	GCST008104	Nucleoside diphosphate kinase A levels in hepatocellular carcinoma	Nucleoside diphosphate kinase A levels in hepatocellular carcinoma	Cancer
2519	GCST007449	Normal facial asymmetry (angle of deformation score)	Normal facial asymmetry (angle of deformation score)	Other measurement
2520	GCST007239	Ovarian cancer	Ovarian cancer	Cancer
2521	GCST007259	Severe skin toxicity response to cetuximab in colorectal cancer	Severe skin toxicity response to cetuximab in colorectal cancer	Other disease
2522	GCST007259	Severe skin toxicity response to cetuximab in colorectal cancer	Severe skin toxicity response to cetuximab in colorectal cancer	Response to drug
2523	GCST007259	Severe skin toxicity response to cetuximab in colorectal cancer	Severe skin toxicity response to cetuximab in colorectal cancer	Cancer
2524	GCST007700	Substance use disorder	Substance use disorder	Neurological disorder
2525	GCST007316	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Neurological disorder
2526	GCST007316	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Neurological disorder
2527	GCST007316	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Response to drug
2528	GCST007316	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Response to ketamine in bipolar disorder or major depression (antidepressant effects)	Other measurement
2529	GCST007657	Alcohol and nicotine co-dependence	Alcohol and nicotine co-dependence	Neurological disorder
2530	GCST007543	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
2531	GCST007716	Frailty index	Frailty index	Other measurement
2532	GCST007665	Treatment resistant depression	Treatment resistant depression	Neurological disorder
2533	GCST007665	Treatment resistant depression	Treatment resistant depression	Response to drug
2534	GCST007666	Depressive symptom improvement	Depressive symptom improvement	Other measurement
2535	GCST007666	Depressive symptom improvement	Depressive symptom improvement	Response to drug
2536	GCST007667	Treatment resistant depression	Treatment resistant depression	Neurological disorder
2537	GCST007667	Treatment resistant depression	Treatment resistant depression	Response to drug
2538	GCST007364	Gallstone disease	Gallstone disease	Digestive system disorder
2539	GCST007364	Gallstone disease	Gallstone disease	Digestive system disorder
2540	GCST006903	Hip shape (DXA scan)	Hip shape (DXA scan)	Body measurement
2541	GCST006719	BRCA1/2-negative high-risk breast cancer	BRCA1/2-negative high-risk breast cancer	Cancer
2542	GCST007199	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
2543	GCST007023	Psoriasis	Psoriasis	Immune system disorder
2544	GCST006982	Waldenström macroglobulinemia / lymphoplasmacytic lymphoma	Waldenström macroglobulinemia / lymphoplasmacytic lymphoma	Cancer
2545	GCST006777	Brain imaging measurements	Brain imaging measurements	Other measurement
2546	GCST007558	Response to long-term oxygen therapy in chronic obstructive pulmonary disease	Response to long-term oxygen therapy in chronic obstructive pulmonary disease	Other disease
2547	GCST007558	Response to long-term oxygen therapy in chronic obstructive pulmonary disease	Response to long-term oxygen therapy in chronic obstructive pulmonary disease	Response to drug
2548	GCST006660	DNA methylation variation (age effect)	DNA methylation variation (age effect)	Biological process
2549	GCST006716	Alcohol use disorder (total score)	Alcohol use disorder (total score)	Other measurement
2550	GCST006659	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
2551	GCST006717	Alcohol use disorder (dependence and problematic use scores)	Alcohol use disorder (dependence and problematic use scores)	Other measurement
2552	GCST006718	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
2553	GCST006718	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
2554	GCST006718	Alcohol use disorder (consumption score)	Alcohol use disorder (consumption score)	Other measurement
2555	GCST007578	Plasma homocysteine levels	Plasma homocysteine levels	Cardiovascular measurement
2556	GCST007579	Serum folate levels	Serum folate levels	Other measurement
2557	GCST007580	Red blood cell folate levels	Red blood cell folate levels	Other measurement
2558	GCST006936	Mitochondrial DNA levels	Mitochondrial DNA levels	Other measurement
2559	GCST007651	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
2560	GCST007208	Obsessive-compulsive disorder	Obsessive-compulsive disorder	Neurological disorder
2561	GCST007447	vWF and FVIII levels	vWF and FVIII levels	Hematological measurement
2562	GCST007447	vWF and FVIII levels	vWF and FVIII levels	Other measurement
2563	GCST007447	vWF and FVIII levels	vWF and FVIII levels	Hematological measurement
2564	GCST007446	vWF levels	vWF levels	Hematological measurement
2565	GCST007207	Obsessive-compulsive disorder x sex interaction	Obsessive-compulsive disorder x sex interaction	Neurological disorder
2566	GCST007207	Obsessive-compulsive disorder x sex interaction	Obsessive-compulsive disorder x sex interaction	Other measurement
2567	GCST007445	Factor VIII levels	Factor VIII levels	Hematological measurement
2568	GCST007510	Cleft lip with or without cleft palate	Cleft lip with or without cleft palate	Other trait
2569	GCST007510	Cleft lip with or without cleft palate	Cleft lip with or without cleft palate	Other trait
2570	GCST006926	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
2571	GCST006926	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
2572	GCST007508	Self-reported childhood asthma in adult smokers	Self-reported childhood asthma in adult smokers	Other measurement
2573	GCST007508	Self-reported childhood asthma in adult smokers	Self-reported childhood asthma in adult smokers	Other disease
2574	GCST006896	Free thyroxine concentration	Free thyroxine concentration	Other measurement
2575	GCST006897	Hyperthyroidism	Hyperthyroidism	Other disease
2576	GCST006898	Hypothyroidism	Hypothyroidism	Other disease
2577	GCST006899	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other measurement
2578	GCST006899	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other trait
2579	GCST006904	Cerebral amyloid deposition (PET imaging)	Cerebral amyloid deposition (PET imaging)	Other measurement
2580	GCST008230	Asthma control x inhaled corticosteroid treatment interaction (2df)	Asthma control x inhaled corticosteroid treatment interaction (2df)	Response to drug
2581	GCST008230	Asthma control x inhaled corticosteroid treatment interaction (2df)	Asthma control x inhaled corticosteroid treatment interaction (2df)	Other measurement
2582	GCST008228	Asthma control	Asthma control	Other measurement
2583	GCST008229	Asthma control x inhaled corticosteroid treatment interaction (1df)	Asthma control x inhaled corticosteroid treatment interaction (1df)	Response to drug
2584	GCST008229	Asthma control x inhaled corticosteroid treatment interaction (1df)	Asthma control x inhaled corticosteroid treatment interaction (1df)	Other measurement
2585	GCST008671	Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
2586	GCST008671	Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
2587	GCST008670	Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
2588	GCST008670	Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
2589	GCST007505	Nevus count or cutaneous melanoma	Nevus count or cutaneous melanoma	Cancer
2590	GCST007505	Nevus count or cutaneous melanoma	Nevus count or cutaneous melanoma	Other measurement
2591	GCST007504	Nevus count	Nevus count	Other measurement
2592	GCST007619	Temporomandibular joint disorder	Temporomandibular joint disorder	Other disease
2593	GCST007776	Post-traumatic stress disorder or brain volume (pleiotropy)	Post-traumatic stress disorder or brain volume (pleiotropy)	Other measurement
2594	GCST007776	Post-traumatic stress disorder or brain volume (pleiotropy)	Post-traumatic stress disorder or brain volume (pleiotropy)	Neurological disorder
2595	GCST007775	Anxiety disorder or brain volume (pleiotropy)	Anxiety disorder or brain volume (pleiotropy)	Other measurement
2596	GCST007775	Anxiety disorder or brain volume (pleiotropy)	Anxiety disorder or brain volume (pleiotropy)	Neurological disorder
2597	GCST006959	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
2598	GCST007715	Heart failure	Heart failure	Cardiovascular disease
2599	GCST007714	Nonischemic cardiomyopathy	Nonischemic cardiomyopathy	Cardiovascular disease
2600	GCST007119	Cervical cancer	Cervical cancer	Cancer
2601	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Cardiovascular disease
2602	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Body measurement
2603	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Body measurement
2604	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Neurological disorder
2605	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Lipid or lipoprotein measurement
2606	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Lipid or lipoprotein measurement
2607	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Lipid or lipoprotein measurement
2608	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Lipid or lipoprotein measurement
2609	GCST007303	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Alzheimer's disease or cardiovascular risk factors (pleiotropy)	Metabolic disorder
2610	GCST007507	Benign prostatic hyperplasia and lower urinary tract symptoms	Benign prostatic hyperplasia and lower urinary tract symptoms	Other disease
2611	GCST007507	Benign prostatic hyperplasia and lower urinary tract symptoms	Benign prostatic hyperplasia and lower urinary tract symptoms	Other trait
2612	GCST007513	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
2613	GCST007506	Prostate cancer	Prostate cancer	Cancer
2614	GCST007512	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	Other disease
2615	GCST007512	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	Other trait
2616	GCST007595	Appendicitis	Appendicitis	Immune system disorder
2617	GCST007206	Brain glucose metabolism (fluorodeoxyglucose uptake)	Brain glucose metabolism (fluorodeoxyglucose uptake)	Other measurement
2618	GCST007738	Metabolic syndrome	Metabolic syndrome	Body measurement
2619	GCST007738	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
2620	GCST007738	Metabolic syndrome	Metabolic syndrome	Other measurement
2621	GCST007738	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
2622	GCST007738	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
2623	GCST007248	Stroke	Stroke	Cardiovascular disease
2624	GCST007249	Ischemic stroke	Ischemic stroke	Cardiovascular disease
2625	GCST007249	Ischemic stroke	Ischemic stroke	Other trait
2626	GCST006902	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
2627	GCST006902	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
2628	GCST007296	Chronic central serous retinopathy	Chronic central serous retinopathy	Neurological disorder
2629	GCST007403	Verbal intelligence quotient (cesarean section interaction)	Verbal intelligence quotient (cesarean section interaction)	Biological process
2630	GCST007403	Verbal intelligence quotient (cesarean section interaction)	Verbal intelligence quotient (cesarean section interaction)	Other trait
2631	GCST007405	Full scale intelligence quotient (cesarean section interaction)	Full scale intelligence quotient (cesarean section interaction)	Biological process
2632	GCST007405	Full scale intelligence quotient (cesarean section interaction)	Full scale intelligence quotient (cesarean section interaction)	Other trait
2633	GCST007404	Performance intelligence quotient (cesarean section interaction)	Performance intelligence quotient (cesarean section interaction)	Biological process
2634	GCST007404	Performance intelligence quotient (cesarean section interaction)	Performance intelligence quotient (cesarean section interaction)	Other trait
2635	GCST007258	Non-steroidal anti-inflammatory drug-induced enteropathy	Non-steroidal anti-inflammatory drug-induced enteropathy	Response to drug
2636	GCST007258	Non-steroidal anti-inflammatory drug-induced enteropathy	Non-steroidal anti-inflammatory drug-induced enteropathy	Digestive system disorder
2637	GCST006925	Knee osteoarthritis	Knee osteoarthritis	Other disease
2638	GCST007509	Cleft palate	Cleft palate	Other trait
2639	GCST007540	PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	Cancer
2640	GCST007540	PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia	Response to drug
2641	GCST007541	PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)	PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)	Cancer
2642	GCST007541	PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)	PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)	Response to drug
2643	GCST007539	Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia	Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia	Cancer
2644	GCST007539	Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia	Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia	Other measurement
2645	GCST007635	Fatty acid desaturase activity (serum)	Fatty acid desaturase activity (serum)	Other measurement
2646	GCST007636	Fatty acid desaturase activity (adipose tissue)	Fatty acid desaturase activity (adipose tissue)	Other measurement
2647	GCST008669	Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
2648	GCST008669	Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction	Other measurement
2649	GCST006634	Hedonic well-being	Hedonic well-being	Other measurement
2650	GCST006705	Infantile hypertrophic pyloric stenosis	Infantile hypertrophic pyloric stenosis	Digestive system disorder
2651	GCST006905	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
2652	GCST007137	Warfarin-associated bleeding	Warfarin-associated bleeding	Response to drug
2653	GCST006614	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
2654	GCST006613	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
2655	GCST006612	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
2656	GCST006612	LDL cholesterol	LDL cholesterol	Other measurement
2657	GCST006612	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
2658	GCST006611	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
2659	GCST006633	Initial alcohol sensitivity	Initial alcohol sensitivity	Biological process
2660	GCST007201	Schizophrenia	Schizophrenia	Neurological disorder
2661	GCST007138	Hashimoto thyroiditis	Hashimoto thyroiditis	Immune system disorder
2662	GCST007205	Schizophrenia	Schizophrenia	Neurological disorder
2663	GCST006635	Eudaimonic well-being	Eudaimonic well-being	Other measurement
2664	GCST007118	Erectile dysfunction	Erectile dysfunction	Other disease
2665	GCST007200	Radiation-induced brain injury in nasopharyngeal carcinoma	Radiation-induced brain injury in nasopharyngeal carcinoma	Cancer
2666	GCST007200	Radiation-induced brain injury in nasopharyngeal carcinoma	Radiation-induced brain injury in nasopharyngeal carcinoma	Biological process
2667	GCST007200	Radiation-induced brain injury in nasopharyngeal carcinoma	Radiation-induced brain injury in nasopharyngeal carcinoma	Neurological disorder
2668	GCST007139	Shingles	Shingles	Other disease
2669	GCST007139	Shingles	Shingles	Other measurement
2670	GCST007198	Parkinson's disease (age at diagnosis)	Parkinson's disease (age at diagnosis)	Neurological disorder
2671	GCST007198	Parkinson's disease (age at diagnosis)	Parkinson's disease (age at diagnosis)	Other measurement
2672	GCST006668	Psychiatric diseases (pleiotropy) (HIPO component 1)	Psychiatric diseases (pleiotropy) (HIPO component 1)	Neurological disorder
2673	GCST006668	Psychiatric diseases (pleiotropy) (HIPO component 1)	Psychiatric diseases (pleiotropy) (HIPO component 1)	Neurological disorder
2674	GCST006668	Psychiatric diseases (pleiotropy) (HIPO component 1)	Psychiatric diseases (pleiotropy) (HIPO component 1)	Neurological disorder
2675	GCST006668	Psychiatric diseases (pleiotropy) (HIPO component 1)	Psychiatric diseases (pleiotropy) (HIPO component 1)	Neurological disorder
2676	GCST006668	Psychiatric diseases (pleiotropy) (HIPO component 1)	Psychiatric diseases (pleiotropy) (HIPO component 1)	Neurological disorder
2677	GCST006665	Social science traits (pleiotropy) (HIPO component 1)	Social science traits (pleiotropy) (HIPO component 1)	Other measurement
2678	GCST006665	Social science traits (pleiotropy) (HIPO component 1)	Social science traits (pleiotropy) (HIPO component 1)	Other measurement
2679	GCST006665	Social science traits (pleiotropy) (HIPO component 1)	Social science traits (pleiotropy) (HIPO component 1)	Other measurement
2680	GCST006667	Lipid traits (pleiotropy) (HIPO component 2)	Lipid traits (pleiotropy) (HIPO component 2)	Lipid or lipoprotein measurement
2681	GCST006667	Lipid traits (pleiotropy) (HIPO component 2)	Lipid traits (pleiotropy) (HIPO component 2)	Lipid or lipoprotein measurement
2682	GCST006667	Lipid traits (pleiotropy) (HIPO component 2)	Lipid traits (pleiotropy) (HIPO component 2)	Lipid or lipoprotein measurement
2683	GCST006667	Lipid traits (pleiotropy) (HIPO component 2)	Lipid traits (pleiotropy) (HIPO component 2)	Lipid or lipoprotein measurement
2684	GCST006666	Lipid traits (pleiotropy) (HIPO component 1)	Lipid traits (pleiotropy) (HIPO component 1)	Lipid or lipoprotein measurement
2685	GCST006666	Lipid traits (pleiotropy) (HIPO component 1)	Lipid traits (pleiotropy) (HIPO component 1)	Lipid or lipoprotein measurement
2686	GCST006666	Lipid traits (pleiotropy) (HIPO component 1)	Lipid traits (pleiotropy) (HIPO component 1)	Lipid or lipoprotein measurement
2687	GCST006666	Lipid traits (pleiotropy) (HIPO component 1)	Lipid traits (pleiotropy) (HIPO component 1)	Lipid or lipoprotein measurement
2688	GCST007244	Intra-individual response time variability (response selection)	Intra-individual response time variability (response selection)	Other measurement
2689	GCST006706	Eyebrow thickness	Eyebrow thickness	Other measurement
2690	GCST006671	Cognitive impairment test score	Cognitive impairment test score	Other measurement
2691	GCST006674	Cerebrospinal fluid p-Tau181p:AB1-42 ratio	Cerebrospinal fluid p-Tau181p:AB1-42 ratio	Other measurement
2692	GCST006673	Cerebrospinal fluid t-tau:AB1-42 ratio	Cerebrospinal fluid t-tau:AB1-42 ratio	Other measurement
2693	GCST006493	Systemic sclerosis	Systemic sclerosis	Neurological disorder
2694	GCST007107	Diastolic blood pressure x sodium interaction (1df test)	Diastolic blood pressure x sodium interaction (1df test)	Other measurement
2695	GCST007107	Diastolic blood pressure x sodium interaction (1df test)	Diastolic blood pressure x sodium interaction (1df test)	Other measurement
2696	GCST007108	Systolic blood pressure x sodium interaction (1df test)	Systolic blood pressure x sodium interaction (1df test)	Other measurement
2697	GCST007108	Systolic blood pressure x sodium interaction (1df test)	Systolic blood pressure x sodium interaction (1df test)	Other measurement
2698	GCST007177	Perceptual rivalry (binocular rivalry task)	Perceptual rivalry (binocular rivalry task)	Other measurement
2699	GCST007178	Perceptual rivalry (voluntary modulation strength)	Perceptual rivalry (voluntary modulation strength)	Other measurement
2700	GCST007176	Perceptual rivalry (Necker cube stimulus)	Perceptual rivalry (Necker cube stimulus)	Other measurement
2701	GCST007154	Paediatric migraine	Paediatric migraine	Cardiovascular disease
2702	GCST007192	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Immune system disorder
2703	GCST007192	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Cardiovascular disease
2704	GCST007191	Hypersomnia (HLA-DQB1*06:02 negative)	Hypersomnia (HLA-DQB1*06:02 negative)	Neurological disorder
2705	GCST007152	Chronic back pain	Chronic back pain	Other trait
2706	GCST007189	visceral adipose tissue/total adipose tissue ratio	visceral adipose tissue/total adipose tissue ratio	Other measurement
2707	GCST007188	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
2708	GCST007188	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
2709	GCST007187	Visceral adipose tissue	Visceral adipose tissue	Other measurement
2710	GCST007190	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
2711	GCST007153	Delayed reward discounting	Delayed reward discounting	Other measurement
2712	GCST007147	Lateral ventricular volume in normal aging	Lateral ventricular volume in normal aging	Other measurement
2713	GCST006631	Nicotine dependence and major depression (severity of comorbidity)	Nicotine dependence and major depression (severity of comorbidity)	Other measurement
2714	GCST006631	Nicotine dependence and major depression (severity of comorbidity)	Nicotine dependence and major depression (severity of comorbidity)	Other measurement
2715	GCST007243	Intra-individual response time variability (selective attention)	Intra-individual response time variability (selective attention)	Other measurement
2716	GCST007197	Chronic periodontitis (localised)	Chronic periodontitis (localised)	Digestive system disorder
2717	GCST006619	Tuberculosis	Tuberculosis	Other disease
2718	GCST006619	Tuberculosis	Tuberculosis	Other measurement
2719	GCST006619	Tuberculosis	Tuberculosis	Other measurement
2720	GCST007193	Chronic periodontitis (generalised)	Chronic periodontitis (generalised)	Digestive system disorder
2721	GCST007194	Chronic periodontitis (severe)	Chronic periodontitis (severe)	Digestive system disorder
2722	GCST007195	Chronic periodontitis (slight)	Chronic periodontitis (slight)	Digestive system disorder
2723	GCST007196	Chronic periodontitis	Chronic periodontitis	Digestive system disorder
2724	GCST006707	Gastric cancer	Gastric cancer	Cancer
2725	GCST007135	Resistant hypertension	Resistant hypertension	Cardiovascular disease
2726	GCST007136	Resistant hypertension	Resistant hypertension	Cardiovascular disease
2727	GCST008067	Pemphigus foliaceus	Pemphigus foliaceus	Immune system disorder
2728	GCST008068	Pemphigus vulgaris	Pemphigus vulgaris	Immune system disorder
2729	GCST008069	Pemphigus	Pemphigus	Immune system disorder
2730	GCST008136	Alcohol withdrawal symptoms	Alcohol withdrawal symptoms	Neurological disorder
2731	GCST007247	Latent autoimmune diabetes vs. type 1 diabetes	Latent autoimmune diabetes vs. type 1 diabetes	Metabolic disorder
2732	GCST007247	Latent autoimmune diabetes vs. type 1 diabetes	Latent autoimmune diabetes vs. type 1 diabetes	Metabolic disorder
2733	GCST007246	Latent autoimmune diabetes vs. type 2 diabetes	Latent autoimmune diabetes vs. type 2 diabetes	Metabolic disorder
2734	GCST007246	Latent autoimmune diabetes vs. type 2 diabetes	Latent autoimmune diabetes vs. type 2 diabetes	Metabolic disorder
2735	GCST008137	Alcohol withdrawal symptoms	Alcohol withdrawal symptoms	Neurological disorder
2736	GCST007245	Latent autoimmune diabetes	Latent autoimmune diabetes	Metabolic disorder
2737	GCST006672	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
2738	GCST006672	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
2739	GCST006485	Telomere length	Telomere length	Other measurement
2740	GCST006424	Severe diabetic retinopathy in type 2 diabetes	Severe diabetic retinopathy in type 2 diabetes	Metabolic disorder
2741	GCST006424	Severe diabetic retinopathy in type 2 diabetes	Severe diabetic retinopathy in type 2 diabetes	Metabolic disorder
2742	GCST006425	Gout in chronic kidney disease	Gout in chronic kidney disease	Other disease
2743	GCST006425	Gout in chronic kidney disease	Gout in chronic kidney disease	Metabolic disorder
2744	GCST006461	Self-reported risk-taking behaviour	Self-reported risk-taking behaviour	Biological process
2745	GCST006426	Serum urate levels in chronic kidney disease	Serum urate levels in chronic kidney disease	Other disease
2746	GCST006426	Serum urate levels in chronic kidney disease	Serum urate levels in chronic kidney disease	Other measurement
2747	GCST006479	Diverticular disease	Diverticular disease	Digestive system disorder
2748	GCST006616	Uterine fibroid number (single vs multiple)	Uterine fibroid number (single vs multiple)	Other measurement
2749	GCST006617	Uterine fibroid size (maximum volume)	Uterine fibroid size (maximum volume)	Other measurement
2750	GCST006618	Uterine fibroid size (maximum dimension)	Uterine fibroid size (maximum dimension)	Other measurement
2751	GCST008492	Severe cutaneous adverse drug reactions	Severe cutaneous adverse drug reactions	Other disease
2752	GCST007359	Type 2 diabetes or coronary artery disease (pleiotropy)	Type 2 diabetes or coronary artery disease (pleiotropy)	Cardiovascular disease
2753	GCST007359	Type 2 diabetes or coronary artery disease (pleiotropy)	Type 2 diabetes or coronary artery disease (pleiotropy)	Metabolic disorder
2754	GCST006958	Length of menstrual cycle	Length of menstrual cycle	Other measurement
2755	GCST007062	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
2756	GCST006432	Multiple myeloma	Multiple myeloma	Cancer
2757	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Biological process
2758	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
2759	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
2760	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
2761	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
2762	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
2763	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
2764	GCST007618	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
2765	GCST007617	Blood pressure x alcohol consumption interaction	Blood pressure x alcohol consumption interaction	Other measurement
2766	GCST007617	Blood pressure x alcohol consumption interaction	Blood pressure x alcohol consumption interaction	Other measurement
2767	GCST007360	Bronchodilator response in asthma	Bronchodilator response in asthma	Response to drug
2768	GCST007360	Bronchodilator response in asthma	Bronchodilator response in asthma	Other disease
2769	GCST007542	High IL-1beta levels in gingival crevicular fluid	High IL-1beta levels in gingival crevicular fluid	Inflammatory measurement
2770	GCST006680	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Other trait
2771	GCST006680	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Other trait
2772	GCST006680	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	Other measurement
2773	GCST007101	Seasonality in depression	Seasonality in depression	Neurological disorder
2774	GCST007101	Seasonality in depression	Seasonality in depression	Neurological disorder
2775	GCST007101	Seasonality in depression	Seasonality in depression	Other measurement
2776	GCST007106	Response to opioid analgesics in cancer (pain decrease)	Response to opioid analgesics in cancer (pain decrease)	Cancer
2777	GCST007106	Response to opioid analgesics in cancer (pain decrease)	Response to opioid analgesics in cancer (pain decrease)	Response to drug
2778	GCST006486	Periodontitis	Periodontitis	Digestive system disorder
2779	GCST006491	Circulating fibroblast growth factor 23 levels	Circulating fibroblast growth factor 23 levels	Other measurement
2780	GCST007102	Seasonality and depression	Seasonality and depression	Neurological disorder
2781	GCST007102	Seasonality and depression	Seasonality and depression	Neurological disorder
2782	GCST007102	Seasonality and depression	Seasonality and depression	Other measurement
2783	GCST006682	HDL cholesterol and triglyceride levels	HDL cholesterol and triglyceride levels	Lipid or lipoprotein measurement
2784	GCST006682	HDL cholesterol and triglyceride levels	HDL cholesterol and triglyceride levels	Lipid or lipoprotein measurement
2785	GCST006669	HDL cholesterol and triglyceride levels (pleiotropy)	HDL cholesterol and triglyceride levels (pleiotropy)	Lipid or lipoprotein measurement
2786	GCST006669	HDL cholesterol and triglyceride levels (pleiotropy)	HDL cholesterol and triglyceride levels (pleiotropy)	Lipid or lipoprotein measurement
2787	GCST006663	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
2788	GCST006664	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
2789	GCST006683	Response to fenofibrate	Response to fenofibrate	Response to drug
2790	GCST006462	Uterine fibroids	Uterine fibroids	Cancer
2791	GCST006443	Total body bone mineral density	Total body bone mineral density	Other measurement
2792	GCST006423	Fractures	Fractures	Other disease
2793	GCST006422	Fractures	Fractures	Other disease
2794	GCST007130	Cerebrospinal fluid t-tau:AB1-42 ratio	Cerebrospinal fluid t-tau:AB1-42 ratio	Other measurement
2795	GCST007129	Cerebrospinal fluid t-tau:AB1-42 ratio	Cerebrospinal fluid t-tau:AB1-42 ratio	Other measurement
2796	GCST006401	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
2797	GCST006421	Cannabis use	Cannabis use	Biological process
2798	GCST006480	Glioblastoma (age-stratified)	Glioblastoma (age-stratified)	Cancer
2799	GCST006480	Glioblastoma (age-stratified)	Glioblastoma (age-stratified)	Other measurement
2800	GCST006607	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Inflammatory measurement
2801	GCST006607	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Immune system disorder
2802	GCST006607	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	Response to drug
2803	GCST006520	Pemphigus foliaceus	Pemphigus foliaceus	Immune system disorder
2804	GCST006521	Pemphigus vulgaris	Pemphigus vulgaris	Immune system disorder
2805	GCST006610	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Immune system disorder
2806	GCST006610	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Response to drug
2807	GCST006610	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	Other measurement
2808	GCST006609	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Immune system disorder
2809	GCST006609	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Response to drug
2810	GCST006609	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	Other measurement
2811	GCST006608	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Other trait
2812	GCST006608	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Immune system disorder
2813	GCST006608	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	Response to drug
2814	GCST006606	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Immune system disorder
2815	GCST006606	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Response to drug
2816	GCST006606	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	Other measurement
2817	GCST006861	Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	Other measurement
2818	GCST006861	Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	Metabolic disorder
2819	GCST006901	Height	Height	Other measurement
2820	GCST006901	Height	Height	Body measurement
2821	GCST006460	Bronchopulmonary dysplasia in preterm infants	Bronchopulmonary dysplasia in preterm infants	Other disease
2822	GCST006460	Bronchopulmonary dysplasia in preterm infants	Bronchopulmonary dysplasia in preterm infants	Other trait
2823	GCST006419	Suicide attempts	Suicide attempts	Biological process
2824	GCST006420	Affective disorder and suicide attempts	Affective disorder and suicide attempts	Biological process
2825	GCST006420	Affective disorder and suicide attempts	Affective disorder and suicide attempts	Neurological disorder
2826	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2827	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2828	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2829	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2830	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2831	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2832	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2833	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2834	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2835	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2836	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2837	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2838	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2839	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2840	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2841	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2842	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2843	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2844	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2845	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2846	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2847	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2848	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2849	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2850	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2851	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2852	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2853	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2854	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2855	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2856	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2857	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2858	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2859	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2860	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2861	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2862	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2863	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2864	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2865	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2866	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2867	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2868	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2869	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2870	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2871	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2872	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2873	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2874	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2875	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2876	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2877	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2878	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2879	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2880	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2881	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2882	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2883	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2884	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2885	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2886	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2887	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2888	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2889	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2890	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2891	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2892	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2893	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2894	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2895	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2896	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2897	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2898	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2899	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2900	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2901	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2902	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2903	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2904	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2905	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2906	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2907	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2908	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2909	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2910	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2911	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2912	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2913	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2914	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2915	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2916	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2917	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2918	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2919	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2920	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2921	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2922	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2923	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2924	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2925	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2926	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2927	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2928	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2929	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2930	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2931	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2932	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2933	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2934	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2935	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2936	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2937	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2938	GCST007128	Blood protein levels	Blood protein levels	Hematological measurement
2939	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2940	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2941	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2942	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2943	GCST007128	Blood protein levels	Blood protein levels	Lipid or lipoprotein measurement
2944	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2945	GCST007128	Blood protein levels	Blood protein levels	Hematological measurement
2946	GCST007128	Blood protein levels	Blood protein levels	Hematological measurement
2947	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2948	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2949	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2950	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2951	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2952	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2953	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2954	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2955	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2956	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2957	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2958	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2959	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2960	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2961	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2962	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2963	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2964	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2965	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2966	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2967	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2968	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2969	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2970	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2971	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2972	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2973	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2974	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2975	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2976	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2977	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2978	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2979	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2980	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2981	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2982	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2983	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2984	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2985	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2986	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2987	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2988	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2989	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2990	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2991	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2992	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2993	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2994	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2995	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2996	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2997	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2998	GCST007128	Blood protein levels	Blood protein levels	Other measurement
2999	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3000	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3001	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3002	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3003	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3004	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3005	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3006	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3007	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3008	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3009	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3010	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3011	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3012	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3013	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3014	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3015	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3016	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3017	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3018	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3019	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3020	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3021	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3022	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3023	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3024	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3025	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3026	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3027	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3028	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3029	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3030	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3031	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3032	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3033	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3034	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3035	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3036	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3037	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3038	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3039	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3040	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3041	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3042	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3043	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3044	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3045	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3046	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3047	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3048	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3049	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3050	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3051	GCST007128	Blood protein levels	Blood protein levels	Hematological measurement
3052	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3053	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3054	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3055	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3056	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3057	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3058	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3059	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3060	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3061	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3062	GCST007128	Blood protein levels	Blood protein levels	Cardiovascular measurement
3063	GCST007128	Blood protein levels	Blood protein levels	Liver enzyme measurement
3064	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3065	GCST007128	Blood protein levels	Blood protein levels	Inflammatory measurement
3066	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3067	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3068	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3069	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3070	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3071	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3072	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3073	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3074	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3075	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3076	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3077	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3078	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3079	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3080	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3081	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3082	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3083	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3084	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3085	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3086	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3087	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3088	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3089	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3090	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3091	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3092	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3093	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3094	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3095	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3096	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3097	GCST007128	Blood protein levels	Blood protein levels	Inflammatory measurement
3098	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3099	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3100	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3101	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3102	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3103	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3104	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3105	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3106	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3107	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3108	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3109	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3110	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3111	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3112	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3113	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3114	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3115	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3116	GCST007128	Blood protein levels	Blood protein levels	Other measurement
3117	GCST006658	Longevity	Longevity	Other measurement
3118	GCST006860	Low HDL-cholesterol levels	Low HDL-cholesterol levels	Lipid or lipoprotein measurement
3119	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3120	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Inflammatory measurement
3121	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3122	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3123	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3124	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3125	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3126	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3127	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3128	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3129	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3130	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3131	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3132	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3133	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3134	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3135	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3136	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3137	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Inflammatory measurement
3138	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Inflammatory measurement
3139	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3140	GCST006622	Neonatal cytokine/chemokine levels (fetal genetic effect)	Neonatal cytokine/chemokine levels (fetal genetic effect)	Other measurement
3141	GCST006623	Midgestational cytokine/chemokine levels (fetal genetic effect)	Midgestational cytokine/chemokine levels (fetal genetic effect)	Other measurement
3142	GCST006623	Midgestational cytokine/chemokine levels (fetal genetic effect)	Midgestational cytokine/chemokine levels (fetal genetic effect)	Other measurement
3143	GCST006623	Midgestational cytokine/chemokine levels (fetal genetic effect)	Midgestational cytokine/chemokine levels (fetal genetic effect)	Other measurement
3144	GCST006623	Midgestational cytokine/chemokine levels (fetal genetic effect)	Midgestational cytokine/chemokine levels (fetal genetic effect)	Other measurement
3145	GCST006625	Neonatal cytokine/chemokine levels (maternal genetic effect)	Neonatal cytokine/chemokine levels (maternal genetic effect)	Other measurement
3146	GCST006625	Neonatal cytokine/chemokine levels (maternal genetic effect)	Neonatal cytokine/chemokine levels (maternal genetic effect)	Other measurement
3147	GCST006625	Neonatal cytokine/chemokine levels (maternal genetic effect)	Neonatal cytokine/chemokine levels (maternal genetic effect)	Other measurement
3148	GCST006625	Neonatal cytokine/chemokine levels (maternal genetic effect)	Neonatal cytokine/chemokine levels (maternal genetic effect)	Other measurement
3149	GCST006625	Neonatal cytokine/chemokine levels (maternal genetic effect)	Neonatal cytokine/chemokine levels (maternal genetic effect)	Other measurement
3150	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Other measurement
3151	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Inflammatory measurement
3152	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Other measurement
3153	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Other measurement
3154	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Other measurement
3155	GCST006621	Midgestational cytokine/chemokine levels (maternal genetic effect)	Midgestational cytokine/chemokine levels (maternal genetic effect)	Other measurement
3156	GCST006484	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
3157	GCST006615	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Other measurement
3158	GCST006615	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Cancer
3159	GCST006615	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	Response to drug
3160	GCST006496	Glomerular filtration rate change in heart transplantation	Glomerular filtration rate change in heart transplantation	Other measurement
3161	GCST006496	Glomerular filtration rate change in heart transplantation	Glomerular filtration rate change in heart transplantation	Biological process
3162	GCST006447	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
3163	GCST006447	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
3164	GCST006446	Ulna and radius bone mineral density	Ulna and radius bone mineral density	Other measurement
3165	GCST006445	Femoral neck bone mineral density	Femoral neck bone mineral density	Other measurement
3166	GCST006444	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
3167	GCST006444	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
3168	GCST006900	Body mass index	Body mass index	Body measurement
3169	GCST006900	Body mass index	Body mass index	Body measurement
3170	GCST006900	Body mass index	Body mass index	Other measurement
3171	GCST004290	Multiple sclerosis	Multiple sclerosis	Immune system disorder
3172	GCST004352	Early onset atrial fibrillation	Early onset atrial fibrillation	Cardiovascular disease
3173	GCST004292	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
3174	GCST004292	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
3175	GCST004291	Residual cognition	Residual cognition	Biological process
3176	GCST004291	Residual cognition	Residual cognition	Biological process
3177	GCST004303	Aggressive periodontitis	Aggressive periodontitis	Digestive system disorder
3178	GCST004253	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Neurological disorder
3179	GCST004253	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Other measurement
3180	GCST004253	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	Other trait
3181	GCST004518	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
3182	GCST004518	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
3183	GCST004405	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Biological process
3184	GCST004405	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Other measurement
3185	GCST004404	Alcohol consumption (drinkers vs non-drinkers)	Alcohol consumption (drinkers vs non-drinkers)	Biological process
3186	GCST004404	Alcohol consumption (drinkers vs non-drinkers)	Alcohol consumption (drinkers vs non-drinkers)	Other measurement
3187	GCST004524	Energy expenditure (24h)	Energy expenditure (24h)	Other measurement
3188	GCST004523	Resting metabolic rate	Resting metabolic rate	Other measurement
3189	GCST004350	Bone ultrasound measurement (velocity of sound)	Bone ultrasound measurement (velocity of sound)	Other measurement
3190	GCST004351	Bone ultrasound measurement (broadband ultrasound attenuation)	Bone ultrasound measurement (broadband ultrasound attenuation)	Other measurement
3191	GCST004345	Elevated serum prostate-specific antigen levels in healthy men	Elevated serum prostate-specific antigen levels in healthy men	Other measurement
3192	GCST004485	Survival in pancreatic cancer	Survival in pancreatic cancer	Other measurement
3193	GCST004485	Survival in pancreatic cancer	Survival in pancreatic cancer	Cancer
3194	GCST004390	Asthma	Asthma	Other disease
3195	GCST004293	Glomerular filtration rate (cystatin C)	Glomerular filtration rate (cystatin C)	Other measurement
3196	GCST004293	Glomerular filtration rate (cystatin C)	Glomerular filtration rate (cystatin C)	Other measurement
3197	GCST004294	Nicotine dependence	Nicotine dependence	Neurological disorder
3198	GCST004370	Deep ovarian and/or rectovaginal disease with dense adhesions	Deep ovarian and/or rectovaginal disease with dense adhesions	Other disease
3199	GCST004369	Ovarian disease with few adhesions	Ovarian disease with few adhesions	Other disease
3200	GCST004268	Immune response to measles vaccine (measles-induced IFN gamma)	Immune response to measles vaccine (measles-induced IFN gamma)	Response to drug
3201	GCST004266	Response to clopidogrel therapy	Response to clopidogrel therapy	Response to drug
3202	GCST004266	Response to clopidogrel therapy	Response to clopidogrel therapy	Cardiovascular measurement
3203	GCST004266	Response to clopidogrel therapy	Response to clopidogrel therapy	Response to drug
3204	GCST004368	Endometriosis	Endometriosis	Other disease
3205	GCST004256	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
3206	GCST004269	Immune response to measles vaccine (measles-specific neutralising antibody titre)	Immune response to measles vaccine (measles-specific neutralising antibody titre)	Response to drug
3207	GCST004217	Fuchs's corneal dystrophy	Fuchs's corneal dystrophy	Neurological disorder
3208	GCST004224	Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	Other measurement
3209	GCST004224	Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	Other measurement
3210	GCST004226	Tuberculosis	Tuberculosis	Other disease
3211	GCST004226	Tuberculosis	Tuberculosis	Other measurement
3212	GCST004226	Tuberculosis	Tuberculosis	Other measurement
3213	GCST004347	Glioma	Glioma	Cancer
3214	GCST004347	Glioma	Glioma	Cancer
3215	GCST004519	Body mass index (adult)	Body mass index (adult)	Body measurement
3216	GCST004360	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Cancer
3217	GCST004360	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Other measurement
3218	GCST004360	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	Other measurement
3219	GCST004359	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	Cancer
3220	GCST004359	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	Other measurement
3221	GCST004302	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
3222	GCST004302	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
3223	GCST004227	Obstetric antiphospholipid syndrome	Obstetric antiphospholipid syndrome	Immune system disorder
3224	GCST004363	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	Cancer
3225	GCST004363	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	Other measurement
3226	GCST004362	Plasma estrone levels in resected estrogen-receptor positive breast cancer	Plasma estrone levels in resected estrogen-receptor positive breast cancer	Cancer
3227	GCST004362	Plasma estrone levels in resected estrogen-receptor positive breast cancer	Plasma estrone levels in resected estrogen-receptor positive breast cancer	Other measurement
3228	GCST004361	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Cancer
3229	GCST004361	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Other measurement
3230	GCST004361	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	Other measurement
3231	GCST004336	Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	Neurological disorder
3232	GCST004336	Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	Other measurement
3233	GCST004344	Tissue factor pathway inhibitor levels	Tissue factor pathway inhibitor levels	Other measurement
3234	GCST004373	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
3235	GCST004301	Prevalent atrial fibrillation	Prevalent atrial fibrillation	Cardiovascular disease
3236	GCST004300	Incident atrial fibrillation	Incident atrial fibrillation	Cardiovascular disease
3237	GCST004295	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
3238	GCST004299	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
3239	GCST004298	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
3240	GCST004297	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
3241	GCST004296	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
3242	GCST004287	Monoclonal gammopathy of undetermined significance	Monoclonal gammopathy of undetermined significance	Other disease
3243	GCST004343	Chronic venous disease	Chronic venous disease	Other trait
3244	GCST004343	Chronic venous disease	Chronic venous disease	Other trait
3245	GCST004281	Midgestational circulating levels of organochlorine pesticides	Midgestational circulating levels of organochlorine pesticides	Other measurement
3246	GCST004281	Midgestational circulating levels of organochlorine pesticides	Midgestational circulating levels of organochlorine pesticides	Other measurement
3247	GCST004283	Midgestational circulating levels of PCBs	Midgestational circulating levels of PCBs	Other measurement
3248	GCST004283	Midgestational circulating levels of PCBs	Midgestational circulating levels of PCBs	Other measurement
3249	GCST004282	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Other measurement
3250	GCST004282	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Other measurement
3251	GCST004282	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	Other measurement
3252	GCST004286	Midgestational circulating levels of PBDEs (fetal genetic effect)	Midgestational circulating levels of PBDEs (fetal genetic effect)	Other measurement
3253	GCST004286	Midgestational circulating levels of PBDEs (fetal genetic effect)	Midgestational circulating levels of PBDEs (fetal genetic effect)	Other measurement
3254	GCST004286	Midgestational circulating levels of PBDEs (fetal genetic effect)	Midgestational circulating levels of PBDEs (fetal genetic effect)	Other measurement
3255	GCST004286	Midgestational circulating levels of PBDEs (fetal genetic effect)	Midgestational circulating levels of PBDEs (fetal genetic effect)	Other measurement
3256	GCST004285	Midgestational circulating levels of PBDEs	Midgestational circulating levels of PBDEs	Other measurement
3257	GCST004285	Midgestational circulating levels of PBDEs	Midgestational circulating levels of PBDEs	Other measurement
3258	GCST004285	Midgestational circulating levels of PBDEs	Midgestational circulating levels of PBDEs	Other measurement
3259	GCST004265	Anterior cruciate ligament rupture	Anterior cruciate ligament rupture	Other disease
3260	GCST004263	Achilles tendinopathy	Achilles tendinopathy	Other disease
3261	GCST004267	Blood osmolality (transformed sodium)	Blood osmolality (transformed sodium)	Other measurement
3262	GCST004304	Prevalent type 2 diabetes	Prevalent type 2 diabetes	Metabolic disorder
3263	GCST004305	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
3264	GCST004284	Midgestational circulating levels of PCBs (fetal genetic effect)	Midgestational circulating levels of PCBs (fetal genetic effect)	Other measurement
3265	GCST004284	Midgestational circulating levels of PCBs (fetal genetic effect)	Midgestational circulating levels of PCBs (fetal genetic effect)	Other measurement
3266	GCST004284	Midgestational circulating levels of PCBs (fetal genetic effect)	Midgestational circulating levels of PCBs (fetal genetic effect)	Other measurement
3267	GCST004264	Clopidogrel active metabolite levels	Clopidogrel active metabolite levels	Other measurement
3268	GCST004758	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
3269	GCST004069	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
3270	GCST004069	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
3271	GCST004071	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
3272	GCST004071	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
3273	GCST004070	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
3274	GCST004070	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
3275	GCST004288	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
3276	GCST004288	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
3277	GCST004171	Macular telangiectasia type 2	Macular telangiectasia type 2	Neurological disorder
3278	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3279	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3280	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3281	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3282	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3283	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3284	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3285	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3286	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3287	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3288	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3289	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3290	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3291	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3292	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3293	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3294	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3295	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3296	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3297	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3298	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3299	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3300	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3301	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3302	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3303	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3304	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3305	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3306	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3307	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3308	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3309	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3310	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3311	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3312	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3313	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3314	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3315	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3316	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3317	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3318	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3319	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3320	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3321	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3322	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3323	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3324	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3325	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3326	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3327	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3328	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3329	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3330	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3331	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3332	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3333	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3334	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3335	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3336	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3337	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3338	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3339	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3340	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3341	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3342	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3343	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3344	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3345	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3346	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3347	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3348	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3349	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3350	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3351	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3352	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3353	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3354	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3355	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3356	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3357	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3358	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3359	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3360	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3361	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3362	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3363	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3364	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3365	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3366	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3367	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3368	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3369	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3370	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3371	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3372	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3373	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3374	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3375	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3376	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3377	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3378	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3379	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3380	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3381	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3382	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3383	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3384	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3385	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3386	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3387	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3388	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3389	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3390	GCST004365	Blood protein levels	Blood protein levels	Hematological measurement
3391	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3392	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3393	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3394	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3395	GCST004365	Blood protein levels	Blood protein levels	Lipid or lipoprotein measurement
3396	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3397	GCST004365	Blood protein levels	Blood protein levels	Hematological measurement
3398	GCST004365	Blood protein levels	Blood protein levels	Hematological measurement
3399	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3400	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3401	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3402	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3403	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3404	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3405	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3406	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3407	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3408	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3409	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3410	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3411	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3412	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3413	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3414	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3415	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3416	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3417	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3418	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3419	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3420	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3421	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3422	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3423	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3424	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3425	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3426	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3427	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3428	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3429	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3430	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3431	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3432	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3433	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3434	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3435	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3436	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3437	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3438	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3439	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3440	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3441	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3442	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3443	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3444	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3445	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3446	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3447	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3448	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3449	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3450	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3451	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3452	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3453	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3454	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3455	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3456	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3457	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3458	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3459	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3460	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3461	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3462	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3463	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3464	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3465	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3466	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3467	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3468	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3469	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3470	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3471	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3472	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3473	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3474	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3475	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3476	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3477	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3478	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3479	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3480	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3481	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3482	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3483	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3484	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3485	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3486	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3487	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3488	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3489	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3490	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3491	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3492	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3493	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3494	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3495	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3496	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3497	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3498	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3499	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3500	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3501	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3502	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3503	GCST004365	Blood protein levels	Blood protein levels	Hematological measurement
3504	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3505	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3506	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3507	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3508	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3509	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3510	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3511	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3512	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3513	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3514	GCST004365	Blood protein levels	Blood protein levels	Cardiovascular measurement
3515	GCST004365	Blood protein levels	Blood protein levels	Liver enzyme measurement
3516	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3517	GCST004365	Blood protein levels	Blood protein levels	Inflammatory measurement
3518	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3519	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3520	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3521	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3522	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3523	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3524	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3525	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3526	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3527	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3528	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3529	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3530	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3531	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3532	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3533	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3534	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3535	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3536	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3537	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3538	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3539	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3540	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3541	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3542	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3543	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3544	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3545	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3546	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3547	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3548	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3549	GCST004365	Blood protein levels	Blood protein levels	Inflammatory measurement
3550	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3551	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3552	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3553	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3554	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3555	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3556	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3557	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3558	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3559	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3560	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3561	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3562	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3563	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3564	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3565	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3566	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3567	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3568	GCST004365	Blood protein levels	Blood protein levels	Other measurement
3569	GCST004161	Vitamin B12 levels	Vitamin B12 levels	Other measurement
3570	GCST004166	Nonsyndromic cleft lip with cleft palate	Nonsyndromic cleft lip with cleft palate	Other trait
3571	GCST004166	Nonsyndromic cleft lip with cleft palate	Nonsyndromic cleft lip with cleft palate	Other trait
3572	GCST004162	Carotid plaque burden	Carotid plaque burden	Cardiovascular measurement
3573	GCST004068	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	Cardiovascular disease
3574	GCST004170	Monocyte-lymphocyte ratio	Monocyte-lymphocyte ratio	Hematological measurement
3575	GCST006661	Male-pattern baldness	Male-pattern baldness	Other measurement
3576	GCST006661	Male-pattern baldness	Male-pattern baldness	Other disease
3577	GCST006661	Male-pattern baldness	Male-pattern baldness	Other disease
3578	GCST004164	Monocyte count	Monocyte count	Hematological measurement
3579	GCST004158	Self-reported tiredness	Self-reported tiredness	Other measurement
3580	GCST004144	Thyroid cancer	Thyroid cancer	Cancer
3581	GCST004159	Serum galactose-deficient IgA1 levels	Serum galactose-deficient IgA1 levels	Other measurement
3582	GCST004142	Melanoma	Melanoma	Cancer
3583	GCST004349	Glioblastoma	Glioblastoma	Cancer
3584	GCST004349	Glioblastoma	Glioblastoma	Cancer
3585	GCST004349	Glioblastoma	Glioblastoma	Cancer
3586	GCST004348	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
3587	GCST004348	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
3588	GCST004528	HER2 status in breast cancer	HER2 status in breast cancer	Cancer
3589	GCST004528	HER2 status in breast cancer	HER2 status in breast cancer	Other measurement
3590	GCST004098	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Other trait
3591	GCST004098	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Other disease
3592	GCST004098	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	Other measurement
3593	GCST004113	Basal cell carcinoma	Basal cell carcinoma	Cancer
3594	GCST004141	Body fat mass	Body fat mass	Other measurement
3595	GCST004168	Colorectal cancer	Colorectal cancer	Cancer
3596	GCST004167	Colon cancer	Colon cancer	Cancer
3597	GCST004169	Rectal cancer	Rectal cancer	Cancer
3598	GCST004255	Body mass index	Body mass index	Body measurement
3599	GCST004255	Body mass index	Body mass index	Body measurement
3600	GCST004255	Body mass index	Body mass index	Other measurement
3601	GCST004230	Sepsis in extremely premature infants	Sepsis in extremely premature infants	Other trait
3602	GCST004661	Uveal melanoma	Uveal melanoma	Cancer
3603	GCST004484	Plasma trimethylamine N-oxide levels	Plasma trimethylamine N-oxide levels	Other measurement
3604	GCST007815	Male-pattern baldness	Male-pattern baldness	Other measurement
3605	GCST007815	Male-pattern baldness	Male-pattern baldness	Other disease
3606	GCST007815	Male-pattern baldness	Male-pattern baldness	Other disease
3607	GCST004251	Paneth cell defects in Crohn's disease	Paneth cell defects in Crohn's disease	Digestive system disorder
3608	GCST004251	Paneth cell defects in Crohn's disease	Paneth cell defects in Crohn's disease	Other measurement
3609	GCST004277	Free thyroxine concentration	Free thyroxine concentration	Other measurement
3610	GCST004223	Attention deficit hyperactivity disorder and obsessive compulsive disorder	Attention deficit hyperactivity disorder and obsessive compulsive disorder	Neurological disorder
3611	GCST004223	Attention deficit hyperactivity disorder and obsessive compulsive disorder	Attention deficit hyperactivity disorder and obsessive compulsive disorder	Neurological disorder
3612	GCST004276	Plasma thyroid-stimulating hormone levels	Plasma thyroid-stimulating hormone levels	Other measurement
3613	GCST004218	Lean body mass	Lean body mass	Other measurement
3614	GCST004252	Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	Neurological disorder
3615	GCST004252	Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	Neurological disorder
3616	GCST004199	Osteoarthritis (with total hip replacement)	Osteoarthritis (with total hip replacement)	Other disease
3617	GCST004199	Osteoarthritis (with total hip replacement)	Osteoarthritis (with total hip replacement)	Other measurement
3618	GCST004289	Adiponectin levels in pregnancy	Adiponectin levels in pregnancy	Other measurement
3619	GCST004200	High-altitude pulmonary edema	High-altitude pulmonary edema	Other disease
3620	GCST004202	Systemic sclerosis	Systemic sclerosis	Neurological disorder
3621	GCST004219	Skin pigmentation	Skin pigmentation	Other trait
3622	GCST004219	Skin pigmentation	Skin pigmentation	Other measurement
3623	GCST004339	Palmitoleic acid (16:1n-7) levels	Palmitoleic acid (16:1n-7) levels	Lipid or lipoprotein measurement
3624	GCST004339	Palmitoleic acid (16:1n-7) levels	Palmitoleic acid (16:1n-7) levels	Lipid or lipoprotein measurement
3625	GCST004341	Nervonic acid (24:1n-9) levels	Nervonic acid (24:1n-9) levels	Lipid or lipoprotein measurement
3626	GCST004340	Erucic acid (22:1n-9) levels	Erucic acid (22:1n-9) levels	Lipid or lipoprotein measurement
3627	GCST004337	Gondoic acid (20:1n-9) levels	Gondoic acid (20:1n-9) levels	Lipid or lipoprotein measurement
3628	GCST004338	Oleic acid (18:1n-9) levels	Oleic acid (18:1n-9) levels	Lipid or lipoprotein measurement
3629	GCST004338	Oleic acid (18:1n-9) levels	Oleic acid (18:1n-9) levels	Lipid or lipoprotein measurement
3630	GCST004342	Vaccenic acid (18:1n-7) levels	Vaccenic acid (18:1n-7) levels	Lipid or lipoprotein measurement
3631	GCST004254	Urinary 1,3-butadiene metabolite levels in smokers	Urinary 1,3-butadiene metabolite levels in smokers	Other measurement
3632	GCST004254	Urinary 1,3-butadiene metabolite levels in smokers	Urinary 1,3-butadiene metabolite levels in smokers	Other measurement
3633	GCST004228	Survival in TP53 positive breast cancer	Survival in TP53 positive breast cancer	Cancer
3634	GCST004228	Survival in TP53 positive breast cancer	Survival in TP53 positive breast cancer	Other measurement
3635	GCST004229	Survival in breast cancer (TP53 expression interaction)	Survival in breast cancer (TP53 expression interaction)	Cancer
3636	GCST004229	Survival in breast cancer (TP53 expression interaction)	Survival in breast cancer (TP53 expression interaction)	Other measurement
3637	GCST004229	Survival in breast cancer (TP53 expression interaction)	Survival in breast cancer (TP53 expression interaction)	Other measurement
3638	GCST004225	Alcohol misuse (trauma interaction)	Alcohol misuse (trauma interaction)	Other measurement
3639	GCST004225	Alcohol misuse (trauma interaction)	Alcohol misuse (trauma interaction)	Other measurement
3640	GCST005550	Post traumatic stress disorder symptom count in trauma-exposed individuals	Post traumatic stress disorder symptom count in trauma-exposed individuals	Other measurement
3641	GCST005550	Post traumatic stress disorder symptom count in trauma-exposed individuals	Post traumatic stress disorder symptom count in trauma-exposed individuals	Biological process
3642	GCST007991	Large artery stroke	Large artery stroke	Cardiovascular disease
3643	GCST004143	Hypertension	Hypertension	Cardiovascular disease
3644	GCST004201	Gallbladder cancer	Gallbladder cancer	Cancer
3645	GCST004093	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
3646	GCST004140	Bronchiolitis	Bronchiolitis	Other trait
3647	GCST004094	Prostate-specific antigen levels (conditioned on lead SNPs)	Prostate-specific antigen levels (conditioned on lead SNPs)	Other measurement
3648	GCST008413	Core binding factor acute myeloid leukemia	Core binding factor acute myeloid leukemia	Cancer
3649	GCST004280	Diastolic blood pressure	Diastolic blood pressure	Other measurement
3650	GCST004280	Diastolic blood pressure	Diastolic blood pressure	Other measurement
3651	GCST004279	Systolic blood pressure	Systolic blood pressure	Other measurement
3652	GCST004279	Systolic blood pressure	Systolic blood pressure	Other measurement
3653	GCST004278	Pulse pressure	Pulse pressure	Cardiovascular measurement
3654	GCST004165	Acute-on-chronic liver failure in hepatitis B	Acute-on-chronic liver failure in hepatitis B	Digestive system disorder
3655	GCST004165	Acute-on-chronic liver failure in hepatitis B	Acute-on-chronic liver failure in hepatitis B	Digestive system disorder
3656	GCST004097	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	Cancer
3657	GCST004097	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	Response to drug
3658	GCST004172	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
3659	GCST004075	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
3660	GCST004075	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
3661	GCST004132	Crohn's disease	Crohn's disease	Digestive system disorder
3662	GCST008658	Ulcerative colitis	Ulcerative colitis	Immune system disorder
3663	GCST004053	Poor prognosis in Crohn's disease	Poor prognosis in Crohn's disease	Digestive system disorder
3664	GCST004053	Poor prognosis in Crohn's disease	Poor prognosis in Crohn's disease	Other measurement
3665	GCST004131	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
3666	GCST004131	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
3667	GCST004131	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
3668	GCST004133	Ulcerative colitis	Ulcerative colitis	Immune system disorder
3669	GCST004120	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
3670	GCST004120	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
3671	GCST004091	Palmar length-width ratio in Kashin-Beck disease	Palmar length-width ratio in Kashin-Beck disease	Other disease
3672	GCST004119	Primary sclerosing cholangitis	Primary sclerosing cholangitis	Digestive system disorder
3673	GCST004114	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Other disease
3674	GCST004114	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Digestive system disorder
3675	GCST004114	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	Response to drug
3676	GCST004249	Alzheimer's disease in APOE e4- carriers	Alzheimer's disease in APOE e4- carriers	Neurological disorder
3677	GCST004248	Alzheimer's disease in APOE e4+ carriers	Alzheimer's disease in APOE e4+ carriers	Neurological disorder
3678	GCST004185	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
3679	GCST004247	Alzheimer's disease (APOE e4 interaction)	Alzheimer's disease (APOE e4 interaction)	Neurological disorder
3680	GCST004247	Alzheimer's disease (APOE e4 interaction)	Alzheimer's disease (APOE e4 interaction)	Other measurement
3681	GCST004184	Lung function (FVC)	Lung function (FVC)	Other measurement
3682	GCST004246	Alzheimer's disease	Alzheimer's disease	Neurological disorder
3683	GCST004147	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
3684	GCST004183	Lung function (FEV1)	Lung function (FEV1)	Other measurement
3685	GCST004108	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Other measurement
3686	GCST004108	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Other disease
3687	GCST004108	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	Other measurement
3688	GCST004107	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Other measurement
3689	GCST004107	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Other disease
3690	GCST004107	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	Other measurement
3691	GCST004173	Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative)	Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative)	Immune system disorder
3692	GCST004174	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Other measurement
3693	GCST004174	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Other measurement
3694	GCST004174	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	Immune system disorder
3695	GCST004139	Bipolar disorder	Bipolar disorder	Neurological disorder
3696	GCST004136	Methadone dose in opioid dependence	Methadone dose in opioid dependence	Neurological disorder
3697	GCST004136	Methadone dose in opioid dependence	Methadone dose in opioid dependence	Other measurement
3698	GCST004096	Frontotemporal dementia (age at onset)	Frontotemporal dementia (age at onset)	Neurological disorder
3699	GCST004096	Frontotemporal dementia (age at onset)	Frontotemporal dementia (age at onset)	Other measurement
3700	GCST004099	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	Cancer
3701	GCST004099	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	Cancer
3702	GCST004099	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)	Cancer
3703	GCST004122	Fibrinogen levels	Fibrinogen levels	Hematological measurement
3704	GCST004121	Fibrinogen levels	Fibrinogen levels	Hematological measurement
3705	GCST004072	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Other disease
3706	GCST004072	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Response to drug
3707	GCST004072	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Other disease
3708	GCST004060	Exhaled nitric oxide output	Exhaled nitric oxide output	Other measurement
3709	GCST004250	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Liver enzyme measurement
3710	GCST004250	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Cancer
3711	GCST004250	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	Response to drug
3712	GCST004095	Takotsubo syndrome	Takotsubo syndrome	Cardiovascular disease
3713	GCST004088	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
3714	GCST004088	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
3715	GCST004049	Cough in response to angiotensin-converting enzyme inhibitor drugs	Cough in response to angiotensin-converting enzyme inhibitor drugs	Other trait
3716	GCST004049	Cough in response to angiotensin-converting enzyme inhibitor drugs	Cough in response to angiotensin-converting enzyme inhibitor drugs	Response to drug
3717	GCST004089	Cleft palate	Cleft palate	Other trait
3718	GCST006119	Protein C levels	Protein C levels	Hematological measurement
3719	GCST004134	Multiple keratinocyte cancers	Multiple keratinocyte cancers	Cancer
3720	GCST004134	Multiple keratinocyte cancers	Multiple keratinocyte cancers	Cancer
3721	GCST004134	Multiple keratinocyte cancers	Multiple keratinocyte cancers	Other measurement
3722	GCST004034	Temporomandibular joint disorder	Temporomandibular joint disorder	Other disease
3723	GCST003881	Peanut allergy	Peanut allergy	Other measurement
3724	GCST004180	Pediatric bone mineral content (hip)	Pediatric bone mineral content (hip)	Other measurement
3725	GCST004182	Pediatric bone mineral content (spine)	Pediatric bone mineral content (spine)	Other measurement
3726	GCST004175	Pediatric bone mineral content (radius)	Pediatric bone mineral content (radius)	Other measurement
3727	GCST004178	Pediatric bone mineral density (hip)	Pediatric bone mineral density (hip)	Other measurement
3728	GCST004177	Pediatric bone mineral density (femoral neck)	Pediatric bone mineral density (femoral neck)	Other measurement
3729	GCST004179	Pediatric bone mineral content (femoral neck)	Pediatric bone mineral content (femoral neck)	Other measurement
3730	GCST004181	Pediatric bone mineral density (spine)	Pediatric bone mineral density (spine)	Other measurement
3731	GCST004176	Pediatric areal bone mineral density (radius)	Pediatric areal bone mineral density (radius)	Other measurement
3732	GCST004109	Agoraphobic traits	Agoraphobic traits	Other measurement
3733	GCST004146	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
3734	GCST004059	Exhaled nitric oxide levels	Exhaled nitric oxide levels	Other measurement
3735	GCST004092	Plasma t-tau levels	Plasma t-tau levels	Other measurement
3736	GCST003961	Hippocampal volume	Hippocampal volume	Other measurement
3737	GCST004054	Glomerular load of uric acid	Glomerular load of uric acid	Cardiovascular measurement
3738	GCST004077	Cognitive function	Cognitive function	Biological process
3739	GCST004077	Cognitive function	Cognitive function	Biological process
3740	GCST004077	Cognitive function	Cognitive function	Other measurement
3741	GCST004077	Cognitive function	Cognitive function	Biological process
3742	GCST004056	Urinary uric acid to urinary creatinine ratio	Urinary uric acid to urinary creatinine ratio	Other measurement
3743	GCST004057	Creatinine clearance	Creatinine clearance	Other measurement
3744	GCST004055	Fractional excretion of uric acid	Fractional excretion of uric acid	Cardiovascular measurement
3745	GCST004058	Uric acid clearance	Uric acid clearance	Cardiovascular measurement
3746	GCST004125	Type 2 diabetes (age of onset)	Type 2 diabetes (age of onset)	Metabolic disorder
3747	GCST004137	Optic cup area	Optic cup area	Other measurement
3748	GCST004074	Intraocular pressure	Intraocular pressure	Other measurement
3749	GCST004073	Cough	Cough	Other measurement
3750	GCST004048	Fast beta electroencephalogram	Fast beta electroencephalogram	Other measurement
3751	GCST004048	Fast beta electroencephalogram	Fast beta electroencephalogram	Other measurement
3752	GCST003962	Bipolar disorder	Bipolar disorder	Neurological disorder
3753	GCST004112	Dyspnea	Dyspnea	Other measurement
3754	GCST004111	Phlegm	Phlegm	Other measurement
3755	GCST004076	Optic disc area	Optic disc area	Other measurement
3756	GCST004076	Optic disc area	Optic disc area	Other measurement
3757	GCST004123	Mathematical ability	Mathematical ability	Biological process
3758	GCST004138	Early-onset Parkinson's disease	Early-onset Parkinson's disease	Neurological disorder
3759	GCST004160	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Other measurement
3760	GCST004160	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Response to drug
3761	GCST004160	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	Cancer
3762	GCST004126	White blood cell count	White blood cell count	Hematological measurement
3763	GCST004126	White blood cell count	White blood cell count	Inflammatory measurement
3764	GCST004126	White blood cell count	White blood cell count	Hematological measurement
3765	GCST004126	White blood cell count	White blood cell count	Hematological measurement
3766	GCST004126	White blood cell count	White blood cell count	Hematological measurement
3767	GCST004124	Factor XI	Factor XI	Hematological measurement
3768	GCST004128	White blood cell count (neutrophil)	White blood cell count (neutrophil)	Hematological measurement
3769	GCST004129	White blood cell count (monocyte)	White blood cell count (monocyte)	Hematological measurement
3770	GCST004130	White blood cell count (lymphocyte)	White blood cell count (lymphocyte)	Hematological measurement
3771	GCST004135	White blood cell count (eosinophil)	White blood cell count (eosinophil)	Hematological measurement
3772	GCST004127	White blood cell count (basophil)	White blood cell count (basophil)	Inflammatory measurement
3773	GCST004009	Leprosy	Leprosy	Neurological disorder
3774	GCST003918	Idiopathic osteonecrosis of the femoral head	Idiopathic osteonecrosis of the femoral head	Other disease
3775	GCST003900	Cluster headache	Cluster headache	Other measurement
3776	GCST003900	Cluster headache	Cluster headache	Other trait
3777	GCST004038	Circulating chromogranin peptide levels	Circulating chromogranin peptide levels	Other measurement
3778	GCST004038	Circulating chromogranin peptide levels	Circulating chromogranin peptide levels	Other measurement
3779	GCST003940	Trans-epidermal water loss	Trans-epidermal water loss	Other measurement
3780	GCST003901	Cognitive decline (age-related)	Cognitive decline (age-related)	Other trait
3781	GCST004023	Ischemic stroke	Ischemic stroke	Cardiovascular disease
3782	GCST004023	Ischemic stroke	Ischemic stroke	Other trait
3783	GCST003902	Fast beta electroencephalogram	Fast beta electroencephalogram	Other measurement
3784	GCST003902	Fast beta electroencephalogram	Fast beta electroencephalogram	Other measurement
3785	GCST003976	Antineutrophil cytoplasmic antibody-associated vasculitis	Antineutrophil cytoplasmic antibody-associated vasculitis	Immune system disorder
3786	GCST003978	Vasculitis associated with antineutrophil cytoplasmic antibody reactive to proteinase-3	Vasculitis associated with antineutrophil cytoplasmic antibody reactive to proteinase-3	Immune system disorder
3787	GCST004028	Immunoglobulin light chain (AL) amyloidosis	Immunoglobulin light chain (AL) amyloidosis	Metabolic disorder
3788	GCST003959	Crohn's disease	Crohn's disease	Digestive system disorder
3789	GCST003958	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
3790	GCST003958	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
3791	GCST003958	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
3792	GCST004012	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
3793	GCST004145	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
3794	GCST004145	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
3795	GCST004090	Lichen planus in hepatitis C	Lichen planus in hepatitis C	Other disease
3796	GCST004090	Lichen planus in hepatitis C	Lichen planus in hepatitis C	Digestive system disorder
3797	GCST004118	Nevirapine-induced hypersensitivity in HIV	Nevirapine-induced hypersensitivity in HIV	Other disease
3798	GCST004118	Nevirapine-induced hypersensitivity in HIV	Nevirapine-induced hypersensitivity in HIV	Immune system disorder
3799	GCST004118	Nevirapine-induced hypersensitivity in HIV	Nevirapine-induced hypersensitivity in HIV	Response to drug
3800	GCST004117	Nevirapine-induced hypersensitivity in HIV (rash)	Nevirapine-induced hypersensitivity in HIV (rash)	Other disease
3801	GCST004117	Nevirapine-induced hypersensitivity in HIV (rash)	Nevirapine-induced hypersensitivity in HIV (rash)	Response to drug
3802	GCST004117	Nevirapine-induced hypersensitivity in HIV (rash)	Nevirapine-induced hypersensitivity in HIV (rash)	Other disease
3803	GCST004116	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Other disease
3804	GCST004116	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Immune system disorder
3805	GCST004116	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	Response to drug
3806	GCST004115	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Other disease
3807	GCST004115	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Other disease
3808	GCST004115	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Other disease
3809	GCST004115	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	Response to drug
3810	GCST004050	Cleft lip with or without cleft palate	Cleft lip with or without cleft palate	Other trait
3811	GCST004050	Cleft lip with or without cleft palate	Cleft lip with or without cleft palate	Other trait
3812	GCST003963	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	Other disease
3813	GCST003963	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	Other trait
3814	GCST004051	Orofacial clefts	Orofacial clefts	Other trait
3815	GCST004051	Orofacial clefts	Orofacial clefts	Other measurement
3816	GCST004051	Orofacial clefts	Orofacial clefts	Other disease
3817	GCST004051	Orofacial clefts	Orofacial clefts	Other trait
3818	GCST004052	Cleft palate	Cleft palate	Other trait
3819	GCST004022	Large artery stroke	Large artery stroke	Cardiovascular disease
3820	GCST004020	Small vessel stroke	Small vessel stroke	Cardiovascular disease
3821	GCST004021	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
3822	GCST004021	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
3823	GCST004021	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
3824	GCST003979	Excessive daytime sleepiness	Excessive daytime sleepiness	Other measurement
3825	GCST003939	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Cardiovascular disease
3826	GCST003939	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Cancer
3827	GCST003939	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Response to drug
3828	GCST003939	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Adverse response to chemotherapy (congestive heart failure) in breast cancer	Response to drug
3829	GCST003981	Insomnia	Insomnia	Neurological disorder
3830	GCST003981	Insomnia	Insomnia	Other measurement
3831	GCST004030	Primary sclerosing cholangitis	Primary sclerosing cholangitis	Digestive system disorder
3832	GCST003982	Sleep traits (multi-trait analysis)	Sleep traits (multi-trait analysis)	Biological process
3833	GCST003982	Sleep traits (multi-trait analysis)	Sleep traits (multi-trait analysis)	Other measurement
3834	GCST003982	Sleep traits (multi-trait analysis)	Sleep traits (multi-trait analysis)	Other measurement
3835	GCST003982	Sleep traits (multi-trait analysis)	Sleep traits (multi-trait analysis)	Other measurement
3836	GCST003980	Sleep duration	Sleep duration	Other measurement
3837	GCST003899	Response to clopidogrel therapy in coronary heart disease	Response to clopidogrel therapy in coronary heart disease	Cardiovascular disease
3838	GCST003899	Response to clopidogrel therapy in coronary heart disease	Response to clopidogrel therapy in coronary heart disease	Cardiovascular measurement
3839	GCST003899	Response to clopidogrel therapy in coronary heart disease	Response to clopidogrel therapy in coronary heart disease	Response to drug
3840	GCST003928	Giant cell arteritis	Giant cell arteritis	Cardiovascular disease
3841	GCST003977	Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase	Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase	Immune system disorder
3842	GCST004035	NHDL cholesterol to HDL cholesterol ratio	NHDL cholesterol to HDL cholesterol ratio	Lipid or lipoprotein measurement
3843	GCST004019	Behcet's disease	Behcet's disease	Cardiovascular disease
3844	GCST004037	Triglyceride to HDL cholesterol ratio	Triglyceride to HDL cholesterol ratio	Lipid or lipoprotein measurement
3845	GCST004036	LDL cholesterol to HDL cholesterol ratio	LDL cholesterol to HDL cholesterol ratio	Lipid or lipoprotein measurement
3846	GCST003960	Ulcerative colitis	Ulcerative colitis	Immune system disorder
3847	GCST003922	Parkinson's disease	Parkinson's disease	Neurological disorder
3848	GCST004163	Resistance to antihypertensive treatment in hypertension	Resistance to antihypertensive treatment in hypertension	Cardiovascular disease
3849	GCST004047	Optic nerve measurement (cup-to-disc ratio)	Optic nerve measurement (cup-to-disc ratio)	Other measurement
3850	GCST004047	Optic nerve measurement (cup-to-disc ratio)	Optic nerve measurement (cup-to-disc ratio)	Other measurement
3851	GCST004900	Migraine without aura	Migraine without aura	Cardiovascular disease
3852	GCST004900	Migraine without aura	Migraine without aura	Cardiovascular disease
3853	GCST003964	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Response to drug
3854	GCST003964	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Neurological disorder
3855	GCST003964	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Cancer
3856	GCST003856	Central corneal thickness	Central corneal thickness	Other measurement
3857	GCST003856	Central corneal thickness	Central corneal thickness	Other measurement
3858	GCST003943	Hepcidin levels	Hepcidin levels	Other measurement
3859	GCST003944	Hepcidin/ferritin ratio	Hepcidin/ferritin ratio	Other measurement
3860	GCST003945	Hepcidin/transferrin saturation ratio	Hepcidin/transferrin saturation ratio	Other measurement
3861	GCST006078	Branched-chain amino acid levels (Valine)	Branched-chain amino acid levels (Valine)	Other measurement
3862	GCST006076	Branched-chain amino acid levels (Leucine)	Branched-chain amino acid levels (Leucine)	Other measurement
3863	GCST006077	Branched-chain amino acid levels (Isoleucine)	Branched-chain amino acid levels (Isoleucine)	Other measurement
3864	GCST004026	Alcohol consumption	Alcohol consumption	Biological process
3865	GCST004026	Alcohol consumption	Alcohol consumption	Other measurement
3866	GCST004027	Alcohol consumption (heavy vs. light/non-drinkers)	Alcohol consumption (heavy vs. light/non-drinkers)	Other measurement
3867	GCST004000	Cerebrospinal fluid biomarker levels	Cerebrospinal fluid biomarker levels	Other measurement
3868	GCST004040	Response to paliperidone in schizophrenia (positive Marder score)	Response to paliperidone in schizophrenia (positive Marder score)	Neurological disorder
3869	GCST004040	Response to paliperidone in schizophrenia (positive Marder score)	Response to paliperidone in schizophrenia (positive Marder score)	Other measurement
3870	GCST004040	Response to paliperidone in schizophrenia (positive Marder score)	Response to paliperidone in schizophrenia (positive Marder score)	Response to drug
3871	GCST003923	DDT metabolite (p,p'-DDE levels)	DDT metabolite (p,p'-DDE levels)	Other measurement
3872	GCST004039	Response to paliperidone in schizophrenia (CGI-S score)	Response to paliperidone in schizophrenia (CGI-S score)	Neurological disorder
3873	GCST004039	Response to paliperidone in schizophrenia (CGI-S score)	Response to paliperidone in schizophrenia (CGI-S score)	Other measurement
3874	GCST004039	Response to paliperidone in schizophrenia (CGI-S score)	Response to paliperidone in schizophrenia (CGI-S score)	Response to drug
3875	GCST004043	Response to paliperidone in schizophrenia (Multivariate)	Response to paliperidone in schizophrenia (Multivariate)	Neurological disorder
3876	GCST004043	Response to paliperidone in schizophrenia (Multivariate)	Response to paliperidone in schizophrenia (Multivariate)	Other measurement
3877	GCST004043	Response to paliperidone in schizophrenia (Multivariate)	Response to paliperidone in schizophrenia (Multivariate)	Response to drug
3878	GCST004042	Response to paliperidone in schizophrenia (PANSS score)	Response to paliperidone in schizophrenia (PANSS score)	Neurological disorder
3879	GCST004042	Response to paliperidone in schizophrenia (PANSS score)	Response to paliperidone in schizophrenia (PANSS score)	Other measurement
3880	GCST004042	Response to paliperidone in schizophrenia (PANSS score)	Response to paliperidone in schizophrenia (PANSS score)	Response to drug
3881	GCST004041	Response to paliperidone in schizophrenia (negative Marder score)	Response to paliperidone in schizophrenia (negative Marder score)	Neurological disorder
3882	GCST004041	Response to paliperidone in schizophrenia (negative Marder score)	Response to paliperidone in schizophrenia (negative Marder score)	Other measurement
3883	GCST004041	Response to paliperidone in schizophrenia (negative Marder score)	Response to paliperidone in schizophrenia (negative Marder score)	Response to drug
3884	GCST004018	Atrial fibrillation (SNPxSNP interaction)	Atrial fibrillation (SNPxSNP interaction)	Cardiovascular disease
3885	GCST003974	Tonsillectomy	Tonsillectomy	Other measurement
3886	GCST003878	Heroin dependence	Heroin dependence	Neurological disorder
3887	GCST004024	Depressive symptom measurement or major depressive disorder	Depressive symptom measurement or major depressive disorder	Neurological disorder
3888	GCST004024	Depressive symptom measurement or major depressive disorder	Depressive symptom measurement or major depressive disorder	Other measurement
3889	GCST004014	Conscientiousness	Conscientiousness	Other measurement
3890	GCST004013	Agreeableness	Agreeableness	Other measurement
3891	GCST003929	Urinary electrolytes (magnesium/calcium ratio)	Urinary electrolytes (magnesium/calcium ratio)	Other measurement
3892	GCST003975	Childhood onset asthma (traffic air pollution exposure interaction)	Childhood onset asthma (traffic air pollution exposure interaction)	Other disease
3893	GCST003975	Childhood onset asthma (traffic air pollution exposure interaction)	Childhood onset asthma (traffic air pollution exposure interaction)	Other measurement
3894	GCST003877	Abdominal aortic aneurysm	Abdominal aortic aneurysm	Cardiovascular disease
3895	GCST004025	Systemic juvenile idiopathic arthritis	Systemic juvenile idiopathic arthritis	Immune system disorder
3896	GCST003879	Serum parathyroid hormone levels	Serum parathyroid hormone levels	Other measurement
3897	GCST003880	Schizophrenia	Schizophrenia	Neurological disorder
3898	GCST004016	Openness	Openness	Other measurement
3899	GCST004017	Neuroticism	Neuroticism	Neurological disorder
3900	GCST004017	Neuroticism	Neuroticism	Other measurement
3901	GCST004015	Extraversion	Extraversion	Biological process
3902	GCST004015	Extraversion	Extraversion	Other measurement
3903	GCST006023	Hypertension	Hypertension	Cardiovascular disease
3904	GCST006022	Pulse pressure	Pulse pressure	Cardiovascular measurement
3905	GCST006021	Systolic blood pressure	Systolic blood pressure	Other measurement
3906	GCST006021	Systolic blood pressure	Systolic blood pressure	Other measurement
3907	GCST006020	Diastolic blood pressure	Diastolic blood pressure	Other measurement
3908	GCST006020	Diastolic blood pressure	Diastolic blood pressure	Other measurement
3909	GCST003820	Knee osteoarthritis	Knee osteoarthritis	Other disease
3910	GCST003805	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Other measurement
3911	GCST003805	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Response to drug
3912	GCST003805	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Diastolic blood pressure response to hydrochlorothiazide in hypertension	Cardiovascular disease
3913	GCST006045	Age at first birth	Age at first birth	Other measurement
3914	GCST006044	Age at first birth	Age at first birth	Other measurement
3915	GCST006047	Number of children ever born	Number of children ever born	Other measurement
3916	GCST006046	Number of children ever born	Number of children ever born	Other measurement
3917	GCST003795	Age at first birth	Age at first birth	Other measurement
3918	GCST003818	Resting heart rate	Resting heart rate	Cardiovascular measurement
3919	GCST003807	Systolic blood pressure response to hydrochlorothiazide in hypertension	Systolic blood pressure response to hydrochlorothiazide in hypertension	Other measurement
3920	GCST003807	Systolic blood pressure response to hydrochlorothiazide in hypertension	Systolic blood pressure response to hydrochlorothiazide in hypertension	Response to drug
3921	GCST003807	Systolic blood pressure response to hydrochlorothiazide in hypertension	Systolic blood pressure response to hydrochlorothiazide in hypertension	Cardiovascular disease
3922	GCST003796	Number of children ever born	Number of children ever born	Other measurement
3923	GCST003830	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Other disease
3924	GCST003830	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Response to drug
3925	GCST003830	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	Other measurement
3926	GCST003882	Parental longevity (at least one long-lived parent)	Parental longevity (at least one long-lived parent)	Other measurement
3927	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Other measurement
3928	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Cardiovascular disease
3929	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Cancer
3930	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Cardiovascular disease
3931	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Cardiovascular disease
3932	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Cardiovascular disease
3933	GCST004044	Age-related diseases and mortality	Age-related diseases and mortality	Metabolic disorder
3934	GCST007156	Social deprivation	Social deprivation	Other trait
3935	GCST007155	Household income	Household income	Other trait
3936	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Hematological measurement
3937	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Body measurement
3938	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Lipid or lipoprotein measurement
3939	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Other measurement
3940	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Other measurement
3941	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Lipid or lipoprotein measurement
3942	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Lipid or lipoprotein measurement
3943	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Cardiovascular measurement
3944	GCST004046	Age-related disease endophenotypes	Age-related disease endophenotypes	Other measurement
3945	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Hematological measurement
3946	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Body measurement
3947	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Other measurement
3948	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cardiovascular disease
3949	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cancer
3950	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cardiovascular disease
3951	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cardiovascular disease
3952	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Lipid or lipoprotein measurement
3953	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Other measurement
3954	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Other measurement
3955	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Lipid or lipoprotein measurement
3956	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Lipid or lipoprotein measurement
3957	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cardiovascular measurement
3958	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Other measurement
3959	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Cardiovascular disease
3960	GCST004045	Age-related diseases, mortality and associated endophenotypes	Age-related diseases, mortality and associated endophenotypes	Metabolic disorder
3961	GCST004785	Vitiligo	Vitiligo	Immune system disorder
3962	GCST006468	Straight vs curly hair	Straight vs curly hair	Other measurement
3963	GCST006468	Straight vs curly hair	Straight vs curly hair	Other trait
3964	GCST003927	Dysmenorrheic pain	Dysmenorrheic pain	Other measurement
3965	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Hematological measurement
3966	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Hematological measurement
3967	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Cardiovascular measurement
3968	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Hematological measurement
3969	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Lipid or lipoprotein measurement
3970	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Other measurement
3971	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Hematological measurement
3972	GCST006101	Cardiometabolic and hematological traits	Cardiometabolic and hematological traits	Hematological measurement
3973	GCST003742	Bipolar disorder (early onset)	Bipolar disorder (early onset)	Neurological disorder
3974	GCST003760	Pre-treatment pain in head and neck squamous cell carcinoma	Pre-treatment pain in head and neck squamous cell carcinoma	Other trait
3975	GCST003760	Pre-treatment pain in head and neck squamous cell carcinoma	Pre-treatment pain in head and neck squamous cell carcinoma	Cancer
3976	GCST003870	QRS complex (Sokolow-Lyon)	QRS complex (Sokolow-Lyon)	Cardiovascular measurement
3977	GCST003870	QRS complex (Sokolow-Lyon)	QRS complex (Sokolow-Lyon)	Cardiovascular measurement
3978	GCST003871	QRS complex (Cornell)	QRS complex (Cornell)	Cardiovascular measurement
3979	GCST003871	QRS complex (Cornell)	QRS complex (Cornell)	Cardiovascular measurement
3980	GCST003872	QRS complex (12-leadsum)	QRS complex (12-leadsum)	Cardiovascular measurement
3981	GCST003872	QRS complex (12-leadsum)	QRS complex (12-leadsum)	Cardiovascular measurement
3982	GCST003844	QRS duration	QRS duration	Cardiovascular measurement
3983	GCST003844	QRS duration	QRS duration	Cardiovascular measurement
3984	GCST003844	QRS duration	QRS duration	Cardiovascular measurement
3985	GCST003797	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Response to drug
3986	GCST003797	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Response to drug
3987	GCST003797	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Response to drug
3988	GCST003797	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Cardiovascular disease
3989	GCST003797	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	Metabolic disorder
3990	GCST003794	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Response to drug
3991	GCST003794	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Response to drug
3992	GCST003794	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Other measurement
3993	GCST003794	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	Cancer
3994	GCST003858	Oral cavity cancer	Oral cavity cancer	Cancer
3995	GCST003859	Oropharynx cancer	Oropharynx cancer	Cancer
3996	GCST003821	Estrogen receptor status in breast cancer	Estrogen receptor status in breast cancer	Cancer
3997	GCST003821	Estrogen receptor status in breast cancer	Estrogen receptor status in breast cancer	Other measurement
3998	GCST003843	Petaloid toenail	Petaloid toenail	Other trait
3999	GCST003823	Estrogen receptor status in HER2 negative breast cancer	Estrogen receptor status in HER2 negative breast cancer	Cancer
4000	GCST003823	Estrogen receptor status in HER2 negative breast cancer	Estrogen receptor status in HER2 negative breast cancer	Other measurement
4001	GCST003823	Estrogen receptor status in HER2 negative breast cancer	Estrogen receptor status in HER2 negative breast cancer	Other measurement
4002	GCST003822	Estrogen receptor status in HER2 positive breast cancer	Estrogen receptor status in HER2 positive breast cancer	Cancer
4003	GCST003822	Estrogen receptor status in HER2 positive breast cancer	Estrogen receptor status in HER2 positive breast cancer	Other measurement
4004	GCST003822	Estrogen receptor status in HER2 positive breast cancer	Estrogen receptor status in HER2 positive breast cancer	Other measurement
4005	GCST005146	Birth weight	Birth weight	Body measurement
4006	GCST007237	Systolic blood pressure	Systolic blood pressure	Other measurement
4007	GCST007237	Systolic blood pressure	Systolic blood pressure	Other measurement
4008	GCST007557	Birth weight	Birth weight	Body measurement
4009	GCST007238	Diastolic blood pressure	Diastolic blood pressure	Other measurement
4010	GCST007238	Diastolic blood pressure	Diastolic blood pressure	Other measurement
4011	GCST005547	Major depressive disorder	Major depressive disorder	Neurological disorder
4012	GCST003841	Thiopurine S-methyltransferase activity	Thiopurine S-methyltransferase activity	Other measurement
4013	GCST003762	Essential tremor	Essential tremor	Other trait
4014	GCST003815	Late-onset Alzheimer's disease	Late-onset Alzheimer's disease	Neurological disorder
4015	GCST003763	Age-related hearing impairment	Age-related hearing impairment	Neurological disorder
4016	GCST003869	Sciatica	Sciatica	Other trait
4017	GCST004002	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	Neurological disorder
4018	GCST004002	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	Neurological disorder
4019	GCST003825	Systolic blood pressure change trajectories	Systolic blood pressure change trajectories	Other measurement
4020	GCST004001	Bipolar disorder or attention deficit hyperactivity disorder	Bipolar disorder or attention deficit hyperactivity disorder	Neurological disorder
4021	GCST004001	Bipolar disorder or attention deficit hyperactivity disorder	Bipolar disorder or attention deficit hyperactivity disorder	Neurological disorder
4022	GCST003857	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
4023	GCST003857	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
4024	GCST003857	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
4025	GCST003764	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
4026	GCST003798	Acute lymphoblastic leukemia in childhood (B cell precursor)	Acute lymphoblastic leukemia in childhood (B cell precursor)	Cancer
4027	GCST003855	Gut microbiota (bacterial taxa)	Gut microbiota (bacterial taxa)	Other measurement
4028	GCST003855	Gut microbiota (bacterial taxa)	Gut microbiota (bacterial taxa)	Other measurement
4029	GCST003834	Intracranial volume	Intracranial volume	Other measurement
4030	GCST003854	Gut microbiota (functional units)	Gut microbiota (functional units)	Other measurement
4031	GCST003876	Gut microbiota (beta diversity)	Gut microbiota (beta diversity)	Other measurement
4032	GCST003875	Gut microbiota (bacterial taxa)	Gut microbiota (bacterial taxa)	Other measurement
4033	GCST003875	Gut microbiota (bacterial taxa)	Gut microbiota (bacterial taxa)	Other measurement
4034	GCST003874	Colorectal cancer (smoking interaction)	Colorectal cancer (smoking interaction)	Other measurement
4035	GCST003874	Colorectal cancer (smoking interaction)	Colorectal cancer (smoking interaction)	Cancer
4036	GCST003873	Colorectal cancer (alcohol consumption interaction)	Colorectal cancer (alcohol consumption interaction)	Cancer
4037	GCST003873	Colorectal cancer (alcohol consumption interaction)	Colorectal cancer (alcohol consumption interaction)	Other measurement
4038	GCST003824	Depression in response to interferon-based therapy in chronic hepatitis C	Depression in response to interferon-based therapy in chronic hepatitis C	Response to drug
4039	GCST003824	Depression in response to interferon-based therapy in chronic hepatitis C	Depression in response to interferon-based therapy in chronic hepatitis C	Digestive system disorder
4040	GCST003824	Depression in response to interferon-based therapy in chronic hepatitis C	Depression in response to interferon-based therapy in chronic hepatitis C	Other measurement
4041	GCST003814	Selective IgA deficiency	Selective IgA deficiency	Immune system disorder
4042	GCST003816	Breast cancer-free interval (treatment with aromatase inhibitor)	Breast cancer-free interval (treatment with aromatase inhibitor)	Cancer
4043	GCST003816	Breast cancer-free interval (treatment with aromatase inhibitor)	Breast cancer-free interval (treatment with aromatase inhibitor)	Response to drug
4044	GCST003816	Breast cancer-free interval (treatment with aromatase inhibitor)	Breast cancer-free interval (treatment with aromatase inhibitor)	Other measurement
4045	GCST003868	Job-related exhaustion in shift workers	Job-related exhaustion in shift workers	Other measurement
4046	GCST003852	Response to dendritic cell-based immunotherapy in HIV infection	Response to dendritic cell-based immunotherapy in HIV infection	Other disease
4047	GCST003852	Response to dendritic cell-based immunotherapy in HIV infection	Response to dendritic cell-based immunotherapy in HIV infection	Response to drug
4048	GCST003853	Hip minimal joint space width	Hip minimal joint space width	Other measurement
4049	GCST003827	Otitis media	Otitis media	Neurological disorder
4050	GCST003829	Otitis media (recurrent)	Otitis media (recurrent)	Neurological disorder
4051	GCST003828	Otitis media (chronic)	Otitis media (chronic)	Neurological disorder
4052	GCST003773	Loneliness (multivariate analysis)	Loneliness (multivariate analysis)	Other measurement
4053	GCST003772	Loneliness (linear analysis)	Loneliness (linear analysis)	Other measurement
4054	GCST003761	Emphysema distribution in smoking	Emphysema distribution in smoking	Biological process
4055	GCST003761	Emphysema distribution in smoking	Emphysema distribution in smoking	Other measurement
4056	GCST003792	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Response to drug
4057	GCST003792	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Other disease
4058	GCST003792	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Digestive system disorder
4059	GCST003792	Liver injury in anti-tuberculosis drug treatment	Liver injury in anti-tuberculosis drug treatment	Response to drug
4060	GCST003698	Brain activation in response to working memory task	Brain activation in response to working memory task	Other measurement
4061	GCST003698	Brain activation in response to working memory task	Brain activation in response to working memory task	Biological process
4062	GCST003698	Brain activation in response to working memory task	Brain activation in response to working memory task	Other measurement
4063	GCST003759	Resistin levels	Resistin levels	Other measurement
4064	GCST003719	Attention function	Attention function	Other measurement
4065	GCST003793	L-arginine levels	L-arginine levels	Other measurement
4066	GCST003774	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
4067	GCST006258	Diastolic blood pressure	Diastolic blood pressure	Other measurement
4068	GCST006258	Diastolic blood pressure	Diastolic blood pressure	Other measurement
4069	GCST006259	Systolic blood pressure	Systolic blood pressure	Other measurement
4070	GCST006259	Systolic blood pressure	Systolic blood pressure	Other measurement
4071	GCST003791	Response to metformin (IC50)	Response to metformin (IC50)	Other measurement
4072	GCST003791	Response to metformin (IC50)	Response to metformin (IC50)	Response to drug
4073	GCST003765	Emotional dysregulation	Emotional dysregulation	Other measurement
4074	GCST003832	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
4075	GCST003832	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
4076	GCST003831	Asthma	Asthma	Other disease
4077	GCST003833	Adult asthma	Adult asthma	Other disease
4078	GCST003743	Hypertriglyceridemia	Hypertriglyceridemia	Metabolic disorder
4079	GCST003743	Hypertriglyceridemia	Hypertriglyceridemia	Lipid or lipoprotein measurement
4080	GCST003744	Chronic periodontitis (mean interproximal clinical attachment level)	Chronic periodontitis (mean interproximal clinical attachment level)	Other measurement
4081	GCST007015	Lumbar spine bone mineral density (integral)	Lumbar spine bone mineral density (integral)	Other measurement
4082	GCST007014	Lumbar spine bone mineral density (trabecular)	Lumbar spine bone mineral density (trabecular)	Other measurement
4083	GCST003826	Pre bronchodilator FEV1/FVC ratio in never-smokers	Pre bronchodilator FEV1/FVC ratio in never-smokers	Other measurement
4084	GCST003826	Pre bronchodilator FEV1/FVC ratio in never-smokers	Pre bronchodilator FEV1/FVC ratio in never-smokers	Other measurement
4085	GCST003941	Acute graft versus host disease in bone marrow transplantation (recipient effect)	Acute graft versus host disease in bone marrow transplantation (recipient effect)	Immune system disorder
4086	GCST003942	Acute graft versus host disease in bone marrow transplantation (donor effect)	Acute graft versus host disease in bone marrow transplantation (donor effect)	Immune system disorder
4087	GCST003942	Acute graft versus host disease in bone marrow transplantation (donor effect)	Acute graft versus host disease in bone marrow transplantation (donor effect)	Other measurement
4088	GCST003782	Breast cancer	Breast cancer	Cancer
4089	GCST003780	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
4090	GCST003780	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
4091	GCST003781	Breast cancer (estrogen-receptor positive)	Breast cancer (estrogen-receptor positive)	Cancer
4092	GCST003617	Response to statins (HDL cholesterol change)	Response to statins (HDL cholesterol change)	Lipid or lipoprotein measurement
4093	GCST003617	Response to statins (HDL cholesterol change)	Response to statins (HDL cholesterol change)	Response to drug
4094	GCST004522	Response to metformin in type 2 diabetes (HbA1c reduction)	Response to metformin in type 2 diabetes (HbA1c reduction)	Response to drug
4095	GCST004522	Response to metformin in type 2 diabetes (HbA1c reduction)	Response to metformin in type 2 diabetes (HbA1c reduction)	Other measurement
4096	GCST004522	Response to metformin in type 2 diabetes (HbA1c reduction)	Response to metformin in type 2 diabetes (HbA1c reduction)	Metabolic disorder
4097	GCST003790	Glomerular filtration rate	Glomerular filtration rate	Other measurement
4098	GCST003656	Acute kidney injury in critical illness	Acute kidney injury in critical illness	Other measurement
4099	GCST003656	Acute kidney injury in critical illness	Acute kidney injury in critical illness	Other trait
4100	GCST003598	QRS duration	QRS duration	Cardiovascular measurement
4101	GCST003598	QRS duration	QRS duration	Cardiovascular measurement
4102	GCST003598	QRS duration	QRS duration	Cardiovascular measurement
4103	GCST004403	Bone fracture in osteoporosis	Bone fracture in osteoporosis	Other disease
4104	GCST004403	Bone fracture in osteoporosis	Bone fracture in osteoporosis	Other disease
4105	GCST003626	diarrhoeal disease at age 1	diarrhoeal disease at age 1	Other trait
4106	GCST003624	diarrhoeal disease at age 2 with doctor diagnosis	diarrhoeal disease at age 2 with doctor diagnosis	Other trait
4107	GCST003623	diarrhoeal disease at age 2	diarrhoeal disease at age 2	Other trait
4108	GCST003625	diarrhoeal disease at age 1 with doctor diagnosis	diarrhoeal disease at age 1 with doctor diagnosis	Other trait
4109	GCST003727	Joint destruction and growth retardation	Joint destruction and growth retardation	Body measurement
4110	GCST003727	Joint destruction and growth retardation	Joint destruction and growth retardation	Other disease
4111	GCST003727	Joint destruction and growth retardation	Joint destruction and growth retardation	Other measurement
4112	GCST007551	Behcet's disease	Behcet's disease	Cardiovascular disease
4113	GCST003741	Sleep duration	Sleep duration	Other measurement
4114	GCST003726	Basal cell carcinoma	Basal cell carcinoma	Cancer
4115	GCST003860	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Other measurement
4116	GCST003860	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Neurological disorder
4117	GCST003860	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Other measurement
4118	GCST003836	Depressive symptoms	Depressive symptoms	Neurological disorder
4119	GCST003836	Depressive symptoms	Depressive symptoms	Other measurement
4120	GCST003835	Depressive symptoms (stressful life events interaction)	Depressive symptoms (stressful life events interaction)	Other measurement
4121	GCST003835	Depressive symptoms (stressful life events interaction)	Depressive symptoms (stressful life events interaction)	Other measurement
4122	GCST003738	Barrett's esophagus	Barrett's esophagus	Digestive system disorder
4123	GCST003740	Barrett's esophagus  or Esophageal adenocarcinoma	Barrett's esophagus  or Esophageal adenocarcinoma	Digestive system disorder
4124	GCST003740	Barrett's esophagus  or Esophageal adenocarcinoma	Barrett's esophagus  or Esophageal adenocarcinoma	Cancer
4125	GCST003739	Esophageal adenocarcinoma	Esophageal adenocarcinoma	Cancer
4126	GCST003605	EGFR mutation-positive lung adenocarcinoma	EGFR mutation-positive lung adenocarcinoma	Cancer
4127	GCST003819	Endometriosis	Endometriosis	Other disease
4128	GCST003604	Sjögren's syndrome	Sjögren's syndrome	Neurological disorder
4129	GCST003609	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Response to drug
4130	GCST003609	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Other measurement
4131	GCST003609	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	Cancer
4132	GCST003641	Cranial base width	Cranial base width	Other measurement
4133	GCST003646	Facial depth	Facial depth	Other measurement
4134	GCST003645	Lower facial height	Lower facial height	Other measurement
4135	GCST003644	Lip morphology	Lip morphology	Other measurement
4136	GCST003643	Nose morphology	Nose morphology	Other measurement
4137	GCST003642	Eye morphology	Eye morphology	Other measurement
4138	GCST003602	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4139	GCST003602	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
4140	GCST003602	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4141	GCST003621	Coffee consumption	Coffee consumption	Biological process
4142	GCST003621	Coffee consumption	Coffee consumption	Other measurement
4143	GCST003621	Coffee consumption	Coffee consumption	Other measurement
4144	GCST003603	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Digestive system disorder
4145	GCST003603	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Other trait
4146	GCST003603	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Response to drug
4147	GCST003631	Gastroesophageal reflux disease	Gastroesophageal reflux disease	Digestive system disorder
4148	GCST003600	Parkinson's disease (pesticide exposure interaction)	Parkinson's disease (pesticide exposure interaction)	Neurological disorder
4149	GCST003600	Parkinson's disease (pesticide exposure interaction)	Parkinson's disease (pesticide exposure interaction)	Other measurement
4150	GCST003629	nicotine metabolite ratio in current smokers	nicotine metabolite ratio in current smokers	Biological process
4151	GCST003629	nicotine metabolite ratio in current smokers	nicotine metabolite ratio in current smokers	Other measurement
4152	GCST003613	Hypertension	Hypertension	Cardiovascular disease
4153	GCST003785	Neuroendocrine tumor	Neuroendocrine tumor	Cancer
4154	GCST003657	Attention deficit hyperactivity disorder symptom score	Attention deficit hyperactivity disorder symptom score	Other measurement
4155	GCST003688	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
4156	GCST003688	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
4157	GCST003688	Gestational age at birth (maternal effect)	Gestational age at birth (maternal effect)	Other measurement
4158	GCST003686	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
4159	GCST003686	Gestational age at birth (child effect)	Gestational age at birth (child effect)	Other measurement
4160	GCST003685	Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	Other measurement
4161	GCST003685	Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	Other measurement
4162	GCST003684	Gestational age at birth in labor-initiated deliveries (maternal effect)	Gestational age at birth in labor-initiated deliveries (maternal effect)	Other measurement
4163	GCST003684	Gestational age at birth in labor-initiated deliveries (maternal effect)	Gestational age at birth in labor-initiated deliveries (maternal effect)	Other measurement
4164	GCST003689	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	Other measurement
4165	GCST003689	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	Other measurement
4166	GCST003687	Gestational age at birth in labor-initiated deliveries (child effect)	Gestational age at birth in labor-initiated deliveries (child effect)	Other measurement
4167	GCST003687	Gestational age at birth in labor-initiated deliveries (child effect)	Gestational age at birth in labor-initiated deliveries (child effect)	Other measurement
4168	GCST003771	Loneliness	Loneliness	Other measurement
4169	GCST003789	Body mass index	Body mass index	Body measurement
4170	GCST003789	Body mass index	Body mass index	Body measurement
4171	GCST003789	Body mass index	Body mass index	Other measurement
4172	GCST003784	Multiple system atrophy	Multiple system atrophy	Neurological disorder
4173	GCST003783	Multiple system atrophy (pathologically confirmed)	Multiple system atrophy (pathologically confirmed)	Neurological disorder
4174	GCST003565	Cervical cancer	Cervical cancer	Cancer
4175	GCST003586	Prostate cancer	Prostate cancer	Cancer
4176	GCST003585	Aggressive prostate cancer	Aggressive prostate cancer	Cancer
4177	GCST003585	Aggressive prostate cancer	Aggressive prostate cancer	Other measurement
4178	GCST003649	Pneumococcal bacteremia	Pneumococcal bacteremia	Other disease
4179	GCST003650	Bacteremia	Bacteremia	Other disease
4180	GCST003640	Thyroid-associated orbitopathy in graves' disease	Thyroid-associated orbitopathy in graves' disease	Neurological disorder
4181	GCST003640	Thyroid-associated orbitopathy in graves' disease	Thyroid-associated orbitopathy in graves' disease	Immune system disorder
4182	GCST003615	Susceptibility to persistent hepatitis B virus infection	Susceptibility to persistent hepatitis B virus infection	Digestive system disorder
4183	GCST003615	Susceptibility to persistent hepatitis B virus infection	Susceptibility to persistent hepatitis B virus infection	Immune system disorder
4184	GCST003632	Survival in sporadic amyotrophic lateral sclerosis	Survival in sporadic amyotrophic lateral sclerosis	Other measurement
4185	GCST003632	Survival in sporadic amyotrophic lateral sclerosis	Survival in sporadic amyotrophic lateral sclerosis	Neurological disorder
4186	GCST003676	Educational attainment (years of education)	Educational attainment (years of education)	Other measurement
4187	GCST003619	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
4188	GCST003620	Systemic lupus erythematosus or rheumatoid arthritis	Systemic lupus erythematosus or rheumatoid arthritis	Immune system disorder
4189	GCST003620	Systemic lupus erythematosus or rheumatoid arthritis	Systemic lupus erythematosus or rheumatoid arthritis	Immune system disorder
4190	GCST003566	Multiple sclerosis	Multiple sclerosis	Immune system disorder
4191	GCST003559	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
4192	GCST003559	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
4193	GCST003648	Pathological gambling	Pathological gambling	Neurological disorder
4194	GCST003647	Body mass index	Body mass index	Body measurement
4195	GCST003647	Body mass index	Body mass index	Body measurement
4196	GCST003647	Body mass index	Body mass index	Other measurement
4197	GCST003681	C-reactive protein levels or triglyceride levels (pleiotropy)	C-reactive protein levels or triglyceride levels (pleiotropy)	Lipid or lipoprotein measurement
4198	GCST003681	C-reactive protein levels or triglyceride levels (pleiotropy)	C-reactive protein levels or triglyceride levels (pleiotropy)	Inflammatory measurement
4199	GCST003678	C-reactive protein levels or total cholesterol levels (pleiotropy)	C-reactive protein levels or total cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
4200	GCST003678	C-reactive protein levels or total cholesterol levels (pleiotropy)	C-reactive protein levels or total cholesterol levels (pleiotropy)	Inflammatory measurement
4201	GCST003930	Complex regional pain syndrome	Complex regional pain syndrome	Neurological disorder
4202	GCST003679	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
4203	GCST003679	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	Inflammatory measurement
4204	GCST003680	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
4205	GCST003680	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	Inflammatory measurement
4206	GCST004692	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
4207	GCST003601	Drug abuse	Drug abuse	Neurological disorder
4208	GCST003589	Bronchial hyperresponsiveness in asthma	Bronchial hyperresponsiveness in asthma	Other disease
4209	GCST003584	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	Cancer
4210	GCST003584	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	Biological process
4211	GCST003583	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Cancer
4212	GCST003583	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Biological process
4213	GCST003583	Response to radiotherapy in prostate cancer (overall toxicity)	Response to radiotherapy in prostate cancer (overall toxicity)	Other disease
4214	GCST003581	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Cancer
4215	GCST003581	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Biological process
4216	GCST003581	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	Other trait
4217	GCST003582	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	Cancer
4218	GCST003582	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	Biological process
4219	GCST003578	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
4220	GCST003655	Cutaneous squamous cell carcinoma	Cutaneous squamous cell carcinoma	Cancer
4221	GCST003612	Bone mineral density (femoral neck)	Bone mineral density (femoral neck)	Other measurement
4222	GCST003486	Response to fenofibrate (LDL cholesterol levels)	Response to fenofibrate (LDL cholesterol levels)	Lipid or lipoprotein measurement
4223	GCST003486	Response to fenofibrate (LDL cholesterol levels)	Response to fenofibrate (LDL cholesterol levels)	Response to drug
4224	GCST005716	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
4225	GCST003639	Breslow thickness in cutaneous melanoma	Breslow thickness in cutaneous melanoma	Cancer
4226	GCST003639	Breslow thickness in cutaneous melanoma	Breslow thickness in cutaneous melanoma	Other measurement
4227	GCST003520	Breast cancer	Breast cancer	Cancer
4228	GCST003724	Bipolar disorder	Bipolar disorder	Neurological disorder
4229	GCST004493	Lower body strength	Lower body strength	Other measurement
4230	GCST004494	Hand grip strength	Hand grip strength	Other measurement
4231	GCST003591	Severity of facial solar lentigines	Severity of facial solar lentigines	Other measurement
4232	GCST003677	Educational attainment (college completion)	Educational attainment (college completion)	Other measurement
4233	GCST003558	Major depressive disorder	Major depressive disorder	Neurological disorder
4234	GCST003618	Primary spontaneous pneumothorax	Primary spontaneous pneumothorax	Other trait
4235	GCST003630	Left ventricular QRS voltage	Left ventricular QRS voltage	Cardiovascular measurement
4236	GCST003630	Left ventricular QRS voltage	Left ventricular QRS voltage	Cardiovascular measurement
4237	GCST003630	Left ventricular QRS voltage	Left ventricular QRS voltage	Cardiovascular measurement
4238	GCST003564	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
4239	GCST003564	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
4240	GCST003622	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
4241	GCST003652	Parkinson's disease (familial, age at onset)	Parkinson's disease (familial, age at onset)	Neurological disorder
4242	GCST003652	Parkinson's disease (familial, age at onset)	Parkinson's disease (familial, age at onset)	Other measurement
4243	GCST003653	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Neurological disorder
4244	GCST003653	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Other measurement
4245	GCST003682	Asthma (SNP x SNP interaction)	Asthma (SNP x SNP interaction)	Other disease
4246	GCST003654	Bone mineral density (Ward's triangle area)	Bone mineral density (Ward's triangle area)	Other measurement
4247	GCST003567	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to drug
4248	GCST003567	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Other measurement
4249	GCST003567	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Other disease
4250	GCST003485	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Lipid or lipoprotein measurement
4251	GCST003485	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Response to drug
4252	GCST003485	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Lipid or lipoprotein measurement
4253	GCST003488	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Response to drug
4254	GCST003488	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Lipid or lipoprotein measurement
4255	GCST003488	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Lipid or lipoprotein measurement
4256	GCST003487	Response to fenofibrate (total cholesterol levels)	Response to fenofibrate (total cholesterol levels)	Lipid or lipoprotein measurement
4257	GCST003487	Response to fenofibrate (total cholesterol levels)	Response to fenofibrate (total cholesterol levels)	Response to drug
4258	GCST003610	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
4259	GCST003610	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
4260	GCST003611	Bone mineral density (total hip)	Bone mineral density (total hip)	Other measurement
4261	GCST003683	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Cardiovascular disease
4262	GCST003683	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Cardiovascular disease
4263	GCST003683	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)	Cardiovascular disease
4264	GCST003658	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	Body measurement
4265	GCST003658	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	Other measurement
4266	GCST005178	Modified Stumvoll Insulin Sensitivity Index	Modified Stumvoll Insulin Sensitivity Index	Other measurement
4267	GCST003659	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	Body measurement
4268	GCST003659	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	Other measurement
4269	GCST003723	Serum sulfate level	Serum sulfate level	Other measurement
4270	GCST003628	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Response to drug
4271	GCST003628	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Neurological disorder
4272	GCST003628	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Other trait
4273	GCST003590	Apolipoprotein A-IV levels	Apolipoprotein A-IV levels	Lipid or lipoprotein measurement
4274	GCST003651	Parkinson's disease (non-familial, age at onset)	Parkinson's disease (non-familial, age at onset)	Neurological disorder
4275	GCST003651	Parkinson's disease (non-familial, age at onset)	Parkinson's disease (non-familial, age at onset)	Other measurement
4276	GCST003758	Pancreatic cancer	Pancreatic cancer	Cancer
4277	GCST003787	Bronchial neuroendocrine tumor	Bronchial neuroendocrine tumor	Cancer
4278	GCST003788	Pancreatic neuroendocrine tumor	Pancreatic neuroendocrine tumor	Cancer
4279	GCST003786	Small intestine neuroendocrine tumor	Small intestine neuroendocrine tumor	Cancer
4280	GCST003606	Liver fibrosis severity in HIV/hepatitis C co-infection	Liver fibrosis severity in HIV/hepatitis C co-infection	Other disease
4281	GCST003606	Liver fibrosis severity in HIV/hepatitis C co-infection	Liver fibrosis severity in HIV/hepatitis C co-infection	Digestive system disorder
4282	GCST003606	Liver fibrosis severity in HIV/hepatitis C co-infection	Liver fibrosis severity in HIV/hepatitis C co-infection	Other trait
4283	GCST005181	Body mass index	Body mass index	Body measurement
4284	GCST005181	Body mass index	Body mass index	Body measurement
4285	GCST005181	Body mass index	Body mass index	Other measurement
4286	GCST003482	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
4287	GCST003482	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
4288	GCST003672	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Cancer
4289	GCST003672	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Neurological disorder
4290	GCST003672	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	Response to drug
4291	GCST003525	Endometrial endometrioid carcinoma	Endometrial endometrioid carcinoma	Cancer
4292	GCST003524	Endometrial cancer	Endometrial cancer	Cancer
4293	GCST003524	Endometrial cancer	Endometrial cancer	Cancer
4294	GCST003599	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
4295	GCST005540	Sarcoidosis (Lofgren's syndrome)	Sarcoidosis (Lofgren's syndrome)	Other disease
4296	GCST005540	Sarcoidosis (Lofgren's syndrome)	Sarcoidosis (Lofgren's syndrome)	Other disease
4297	GCST005541	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	Other disease
4298	GCST005542	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	Other disease
4299	GCST005543	Sarcoidosis (non-Lofgren's syndrome)	Sarcoidosis (non-Lofgren's syndrome)	Other disease
4300	GCST003518	Daytime sleep phenotypes	Daytime sleep phenotypes	Other measurement
4301	GCST003542	Night sleep phenotypes	Night sleep phenotypes	Other measurement
4302	GCST003542	Night sleep phenotypes	Night sleep phenotypes	Other measurement
4303	GCST003542	Night sleep phenotypes	Night sleep phenotypes	Other measurement
4304	GCST003542	Night sleep phenotypes	Night sleep phenotypes	Other measurement
4305	GCST003845	Breast cancer	Breast cancer	Cancer
4306	GCST003842	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
4307	GCST003842	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
4308	GCST003500	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	Cancer
4309	GCST003500	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	Digestive system disorder
4310	GCST003501	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	Cancer
4311	GCST003501	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	Digestive system disorder
4312	GCST003489	Food addiction	Food addiction	Biological process
4313	GCST003489	Food addiction	Food addiction	Other measurement
4314	GCST003563	Presence of antiphospholipid antibodies	Presence of antiphospholipid antibodies	Other measurement
4315	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4316	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4317	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4318	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4319	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4320	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4321	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4322	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4323	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4324	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4325	GCST003588	Cancer (pleiotropy)	Cancer (pleiotropy)	Cancer
4326	GCST003587	Cancer	Cancer	Cancer
4327	GCST003587	Cancer	Cancer	Cancer
4328	GCST003587	Cancer	Cancer	Cancer
4329	GCST003587	Cancer	Cancer	Cancer
4330	GCST003587	Cancer	Cancer	Cancer
4331	GCST003587	Cancer	Cancer	Cancer
4332	GCST003587	Cancer	Cancer	Cancer
4333	GCST003587	Cancer	Cancer	Cancer
4334	GCST003587	Cancer	Cancer	Cancer
4335	GCST003587	Cancer	Cancer	Cancer
4336	GCST003587	Cancer	Cancer	Cancer
4337	GCST004198	Severe gingival inflammation	Severe gingival inflammation	Other trait
4338	GCST003766	Subjective well-being	Subjective well-being	Other measurement
4339	GCST007335	Age at first sexual intercourse	Age at first sexual intercourse	Other measurement
4340	GCST007336	Age at first birth	Age at first birth	Other measurement
4341	GCST003770	Neuroticism	Neuroticism	Neurological disorder
4342	GCST003770	Neuroticism	Neuroticism	Other measurement
4343	GCST003769	Depression	Depression	Neurological disorder
4344	GCST003769	Depression	Depression	Other measurement
4345	GCST003420	Colorectal cancer	Colorectal cancer	Cancer
4346	GCST003768	Positive affect	Positive affect	Other measurement
4347	GCST003767	Life satisfaction	Life satisfaction	Other measurement
4348	GCST003725	Gallstone disease	Gallstone disease	Digestive system disorder
4349	GCST003725	Gallstone disease	Gallstone disease	Digestive system disorder
4350	GCST004482	Peripheral arterial disease (traffic-related air pollution interaction)	Peripheral arterial disease (traffic-related air pollution interaction)	Cardiovascular disease
4351	GCST004482	Peripheral arterial disease (traffic-related air pollution interaction)	Peripheral arterial disease (traffic-related air pollution interaction)	Other measurement
4352	GCST005078	Mortality	Mortality	Other measurement
4353	GCST003465	Cannabis dependence symptom count	Cannabis dependence symptom count	Other measurement
4354	GCST003455	Spherical equivalent (joint analysis main effects and education interaction)	Spherical equivalent (joint analysis main effects and education interaction)	Other measurement
4355	GCST003455	Spherical equivalent (joint analysis main effects and education interaction)	Spherical equivalent (joint analysis main effects and education interaction)	Other measurement
4356	GCST003384	Bladder cancer	Bladder cancer	Cancer
4357	GCST003456	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Other trait
4358	GCST003456	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Response to drug
4359	GCST003456	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Response to drug
4360	GCST003456	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	Cancer
4361	GCST003472	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Neurological disorder
4362	GCST003472	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Other measurement
4363	GCST003382	Cannabis use	Cannabis use	Biological process
4364	GCST003399	Cognitive impairment (brain beta-amyloid deposition interaction)	Cognitive impairment (brain beta-amyloid deposition interaction)	Other measurement
4365	GCST003399	Cognitive impairment (brain beta-amyloid deposition interaction)	Cognitive impairment (brain beta-amyloid deposition interaction)	Other trait
4366	GCST003473	Aggressiveness in attention deficit hyperactivity disorder	Aggressiveness in attention deficit hyperactivity disorder	Neurological disorder
4367	GCST003473	Aggressiveness in attention deficit hyperactivity disorder	Aggressiveness in attention deficit hyperactivity disorder	Other measurement
4368	GCST003473	Aggressiveness in attention deficit hyperactivity disorder	Aggressiveness in attention deficit hyperactivity disorder	Other measurement
4369	GCST003522	Dermatomyositis	Dermatomyositis	Neurological disorder
4370	GCST004413	Spontaneous dizygotic twinning	Spontaneous dizygotic twinning	Biological process
4371	GCST003538	Alcohol dependence symptom count	Alcohol dependence symptom count	Other measurement
4372	GCST003494	Colorectal cancer	Colorectal cancer	Cancer
4373	GCST003539	Mortality in heart failure	Mortality in heart failure	Other measurement
4374	GCST003539	Mortality in heart failure	Mortality in heart failure	Cardiovascular disease
4375	GCST003523	Coenzyme Q10 levels	Coenzyme Q10 levels	Other measurement
4376	GCST003521	Asthma	Asthma	Other disease
4377	GCST003481	Sleep latency	Sleep latency	Other measurement
4378	GCST003490	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
4379	GCST003490	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
4380	GCST003490	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
4381	GCST003497	Memory performance	Memory performance	Other measurement
4382	GCST003499	Reaction time	Reaction time	Other measurement
4383	GCST003437	Discordance in emotional problems in monozygotic twins	Discordance in emotional problems in monozygotic twins	Other measurement
4384	GCST003496	Educational attainment	Educational attainment	Other measurement
4385	GCST003498	Verbal-numerical reasoning	Verbal-numerical reasoning	Biological process
4386	GCST003467	Glaucoma (primary angle closure)	Glaucoma (primary angle closure)	Neurological disorder
4387	GCST003467	Glaucoma (primary angle closure)	Glaucoma (primary angle closure)	Neurological disorder
4388	GCST003447	Neuroticism	Neuroticism	Neurological disorder
4389	GCST003447	Neuroticism	Neuroticism	Other measurement
4390	GCST003418	Skin fluorescence in type 1 diabetes	Skin fluorescence in type 1 diabetes	Metabolic disorder
4391	GCST003418	Skin fluorescence in type 1 diabetes	Skin fluorescence in type 1 diabetes	Other measurement
4392	GCST003421	Mosaic loss of chromosome Y	Mosaic loss of chromosome Y	Other measurement
4393	GCST003438	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Response to drug
4394	GCST003438	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Neurological disorder
4395	GCST003438	Bortezomib-induced peripheral neuropathy in multiple myeloma	Bortezomib-induced peripheral neuropathy in multiple myeloma	Cancer
4396	GCST003492	Ischemic stroke	Ischemic stroke	Cardiovascular disease
4397	GCST003492	Ischemic stroke	Ischemic stroke	Other trait
4398	GCST003491	Stroke	Stroke	Cardiovascular disease
4399	GCST003493	Ischemic stroke (non-cardioembolic)	Ischemic stroke (non-cardioembolic)	Other trait
4400	GCST003775	Lung cancer	Lung cancer	Cancer
4401	GCST003775	Lung cancer	Lung cancer	Cancer
4402	GCST003775	Lung cancer	Lung cancer	Cancer
4403	GCST003777	Squamous cell lung carcinoma	Squamous cell lung carcinoma	Cancer
4404	GCST003776	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
4405	GCST003561	Coronary artery disease	Coronary artery disease	Cardiovascular disease
4406	GCST003561	Coronary artery disease	Coronary artery disease	Cardiovascular disease
4407	GCST003779	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
4408	GCST003778	Smoking status (current vs former)	Smoking status (current vs former)	Other measurement
4409	GCST003560	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Immune system disorder
4410	GCST003560	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Cardiovascular disease
4411	GCST003495	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
4412	GCST003541	Survival in head and neck cancer	Survival in head and neck cancer	Other measurement
4413	GCST003541	Survival in head and neck cancer	Survival in head and neck cancer	Cancer
4414	GCST003562	Anxiety	Anxiety	Other measurement
4415	GCST003562	Anxiety	Anxiety	Other trait
4416	GCST003452	Posterior cortical atrophy and Alzheimer's disease	Posterior cortical atrophy and Alzheimer's disease	Neurological disorder
4417	GCST003452	Posterior cortical atrophy and Alzheimer's disease	Posterior cortical atrophy and Alzheimer's disease	Neurological disorder
4418	GCST003445	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Immune system disorder
4419	GCST003445	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Immune system disorder
4420	GCST003445	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	Response to drug
4421	GCST005537	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Immune system disorder
4422	GCST005537	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Digestive system disorder
4423	GCST005537	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Digestive system disorder
4424	GCST005537	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Immune system disorder
4425	GCST005537	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	Immune system disorder
4426	GCST003671	Diastolic blood pressure	Diastolic blood pressure	Other measurement
4427	GCST003671	Diastolic blood pressure	Diastolic blood pressure	Other measurement
4428	GCST003670	Systolic blood pressure	Systolic blood pressure	Other measurement
4429	GCST003670	Systolic blood pressure	Systolic blood pressure	Other measurement
4430	GCST006802	Body mass index	Body mass index	Body measurement
4431	GCST006802	Body mass index	Body mass index	Body measurement
4432	GCST006802	Body mass index	Body mass index	Other measurement
4433	GCST006801	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
4434	GCST003426	Drug-induced liver injury	Drug-induced liver injury	Response to drug
4435	GCST003426	Drug-induced liver injury	Drug-induced liver injury	Digestive system disorder
4436	GCST003391	Low high density lipoprotein cholesterol levels	Low high density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
4437	GCST003422	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
4438	GCST003422	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
4439	GCST003450	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Response to drug
4440	GCST003450	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Neurological disorder
4441	GCST003450	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	Other trait
4442	GCST003390	Thrombosis	Thrombosis	Other trait
4443	GCST003390	Thrombosis	Thrombosis	Cardiovascular disease
4444	GCST003390	Thrombosis	Thrombosis	Cardiovascular disease
4445	GCST003390	Thrombosis	Thrombosis	Cardiovascular disease
4446	GCST003390	Thrombosis	Thrombosis	Other trait
4447	GCST003390	Thrombosis	Thrombosis	Other trait
4448	GCST003434	Obsessive-compulsive symptoms	Obsessive-compulsive symptoms	Other measurement
4449	GCST003432	Early response to risperidone in schizophrenia	Early response to risperidone in schizophrenia	Response to drug
4450	GCST004412	Craniofacial microsomia	Craniofacial microsomia	Other disease
4451	GCST003433	Serum lycopene concentrations	Serum lycopene concentrations	Other measurement
4452	GCST003402	Membranous nephropathy	Membranous nephropathy	Other disease
4453	GCST003427	Alzheimer disease and age of onset	Alzheimer disease and age of onset	Neurological disorder
4454	GCST003427	Alzheimer disease and age of onset	Alzheimer disease and age of onset	Other measurement
4455	GCST006251	High fetal hemoglobin in sickle cell disease	High fetal hemoglobin in sickle cell disease	Hematological measurement
4456	GCST006251	High fetal hemoglobin in sickle cell disease	High fetal hemoglobin in sickle cell disease	Other disease
4457	GCST003396	Developmental language disorder	Developmental language disorder	Neurological disorder
4458	GCST003398	Developmental language disorder (syntactic complexity)	Developmental language disorder (syntactic complexity)	Other measurement
4459	GCST003398	Developmental language disorder (syntactic complexity)	Developmental language disorder (syntactic complexity)	Neurological disorder
4460	GCST003397	Developmental language disorder (linguistic errors)	Developmental language disorder (linguistic errors)	Other measurement
4461	GCST003397	Developmental language disorder (linguistic errors)	Developmental language disorder (linguistic errors)	Neurological disorder
4462	GCST003436	Endometrial cancer	Endometrial cancer	Cancer
4463	GCST003436	Endometrial cancer	Endometrial cancer	Cancer
4464	GCST003665	Metabolite levels (lipoprotein measures)	Metabolite levels (lipoprotein measures)	Other measurement
4465	GCST003665	Metabolite levels (lipoprotein measures)	Metabolite levels (lipoprotein measures)	Other measurement
4466	GCST003483	S-phenylmercapturic acid levels in smokers	S-phenylmercapturic acid levels in smokers	Biological process
4467	GCST003483	S-phenylmercapturic acid levels in smokers	S-phenylmercapturic acid levels in smokers	Other measurement
4468	GCST003468	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
4469	GCST003419	Congenital left-sided heart lesions	Congenital left-sided heart lesions	Cardiovascular disease
4470	GCST003799	Colorectal cancer	Colorectal cancer	Cancer
4471	GCST003430	Incident myocardial infarction	Incident myocardial infarction	Cardiovascular disease
4472	GCST003431	Incident coronary heart disease	Incident coronary heart disease	Cardiovascular disease
4473	GCST003474	Scalp hair shape	Scalp hair shape	Other measurement
4474	GCST003480	Balding	Balding	Other measurement
4475	GCST003479	Hair color	Hair color	Other measurement
4476	GCST003479	Hair color	Hair color	Other trait
4477	GCST003478	Hair greying	Hair greying	Other measurement
4478	GCST003477	Monobrow thickness	Monobrow thickness	Other measurement
4479	GCST003476	Eyebrow thickness	Eyebrow thickness	Other measurement
4480	GCST003475	Beard thickness	Beard thickness	Other measurement
4481	GCST003381	Bone mineral density (femoral neck)	Bone mineral density (femoral neck)	Other measurement
4482	GCST003379	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
4483	GCST003379	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
4484	GCST003380	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
4485	GCST003380	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
4486	GCST003403	Vascular endothelial growth factor levels	Vascular endothelial growth factor levels	Cardiovascular measurement
4487	GCST003359	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
4488	GCST003457	Advanced glycation end-product levels	Advanced glycation end-product levels	Other measurement
4489	GCST003457	Advanced glycation end-product levels	Advanced glycation end-product levels	Other measurement
4490	GCST003457	Advanced glycation end-product levels	Advanced glycation end-product levels	Metabolic disorder
4491	GCST003423	Alzheimer's disease or small vessel stroke	Alzheimer's disease or small vessel stroke	Neurological disorder
4492	GCST003423	Alzheimer's disease or small vessel stroke	Alzheimer's disease or small vessel stroke	Cardiovascular disease
4493	GCST003360	Crohn's disease	Crohn's disease	Digestive system disorder
4494	GCST008016	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
4495	GCST003377	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
4496	GCST003446	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
4497	GCST003667	Depressive symptoms measurement (somatic complaints domain)	Depressive symptoms measurement (somatic complaints domain)	Other measurement
4498	GCST003668	Depressive symptoms measurement (lack of positive affect domain)	Depressive symptoms measurement (lack of positive affect domain)	Other measurement
4499	GCST003669	Depressive symptoms measurement (lack of negative affect domain)	Depressive symptoms measurement (lack of negative affect domain)	Other measurement
4500	GCST003607	knee peak torque response	knee peak torque response	Other measurement
4501	GCST003608	Maximal oxygen uptake response	Maximal oxygen uptake response	Other measurement
4502	GCST003469	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Other trait
4503	GCST003469	Response to cognitive-behavioural therapy in anxiety disorder	Response to cognitive-behavioural therapy in anxiety disorder	Neurological disorder
4504	GCST003666	Metabolite levels (small molecules and protein measures)	Metabolite levels (small molecules and protein measures)	Other measurement
4505	GCST003666	Metabolite levels (small molecules and protein measures)	Metabolite levels (small molecules and protein measures)	Other measurement
4506	GCST003666	Metabolite levels (small molecules and protein measures)	Metabolite levels (small molecules and protein measures)	Other measurement
4507	GCST003664	Metabolite levels (lipid measures)	Metabolite levels (lipid measures)	Other measurement
4508	GCST003664	Metabolite levels (lipid measures)	Metabolite levels (lipid measures)	Other measurement
4509	GCST003424	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
4510	GCST003376	Nicotine metabolite ratio	Nicotine metabolite ratio	Other measurement
4511	GCST007125	Multiple sclerosis and systolic blood pressure (pleiotropy)	Multiple sclerosis and systolic blood pressure (pleiotropy)	Immune system disorder
4512	GCST007125	Multiple sclerosis and systolic blood pressure (pleiotropy)	Multiple sclerosis and systolic blood pressure (pleiotropy)	Other measurement
4513	GCST007124	Multiple sclerosis and HDL levels (pleiotropy)	Multiple sclerosis and HDL levels (pleiotropy)	Immune system disorder
4514	GCST007124	Multiple sclerosis and HDL levels (pleiotropy)	Multiple sclerosis and HDL levels (pleiotropy)	Lipid or lipoprotein measurement
4515	GCST007123	Multiple sclerosis and LDL levels (pleiotropy)	Multiple sclerosis and LDL levels (pleiotropy)	Immune system disorder
4516	GCST007123	Multiple sclerosis and LDL levels (pleiotropy)	Multiple sclerosis and LDL levels (pleiotropy)	Lipid or lipoprotein measurement
4517	GCST007122	Multiple sclerosis and triglyceride levels (pleiotropy)	Multiple sclerosis and triglyceride levels (pleiotropy)	Immune system disorder
4518	GCST007122	Multiple sclerosis and triglyceride levels (pleiotropy)	Multiple sclerosis and triglyceride levels (pleiotropy)	Lipid or lipoprotein measurement
4519	GCST007121	Multiple sclerosis and C-reactive protein levels (pleiotropy)	Multiple sclerosis and C-reactive protein levels (pleiotropy)	Immune system disorder
4520	GCST007121	Multiple sclerosis and C-reactive protein levels (pleiotropy)	Multiple sclerosis and C-reactive protein levels (pleiotropy)	Inflammatory measurement
4521	GCST007120	Multiple sclerosis and type 2 diabetes (pleiotropy)	Multiple sclerosis and type 2 diabetes (pleiotropy)	Immune system disorder
4522	GCST007120	Multiple sclerosis and type 2 diabetes (pleiotropy)	Multiple sclerosis and type 2 diabetes (pleiotropy)	Metabolic disorder
4523	GCST007127	Multiple sclerosis and waist-to-hip-ratio (pleiotropy)	Multiple sclerosis and waist-to-hip-ratio (pleiotropy)	Immune system disorder
4524	GCST007127	Multiple sclerosis and waist-to-hip-ratio (pleiotropy)	Multiple sclerosis and waist-to-hip-ratio (pleiotropy)	Body measurement
4525	GCST007126	Multiple sclerosis and body mass index (pleiotropy)	Multiple sclerosis and body mass index (pleiotropy)	Immune system disorder
4526	GCST007126	Multiple sclerosis and body mass index (pleiotropy)	Multiple sclerosis and body mass index (pleiotropy)	Body measurement
4527	GCST003425	Longevity	Longevity	Other measurement
4528	GCST003428	Chronotype	Chronotype	Biological process
4529	GCST003428	Chronotype	Chronotype	Other measurement
4530	GCST003429	Morning vs. evening chronotype	Morning vs. evening chronotype	Biological process
4531	GCST003368	circulating leptin levels adjusted for BMI	circulating leptin levels adjusted for BMI	Other measurement
4532	GCST003471	Myocardial infarction	Myocardial infarction	Cardiovascular disease
4533	GCST003470	Coronary artery disease	Coronary artery disease	Cardiovascular disease
4534	GCST003470	Coronary artery disease	Coronary artery disease	Cardiovascular disease
4535	GCST003435	Body fat percentage	Body fat percentage	Body measurement
4536	GCST003466	Cotinine levels in current smokers	Cotinine levels in current smokers	Other measurement
4537	GCST003367	circulating leptin levels	circulating leptin levels	Other measurement
4538	GCST003328	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
4539	GCST003328	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
4540	GCST003328	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Other measurement
4541	GCST003328	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Response to drug
4542	GCST003328	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	Cancer
4543	GCST003358	Betaine levels in individuals undergoing cardiac evaluation	Betaine levels in individuals undergoing cardiac evaluation	Cardiovascular measurement
4544	GCST003358	Betaine levels in individuals undergoing cardiac evaluation	Betaine levels in individuals undergoing cardiac evaluation	Cardiovascular measurement
4545	GCST003459	Endurance athleticism	Endurance athleticism	Other measurement
4546	GCST003327	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
4547	GCST003327	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
4548	GCST003458	World class endurance athleticism	World class endurance athleticism	Other measurement
4549	GCST003400	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
4550	GCST003341	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	Other measurement
4551	GCST003341	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	Neurological disorder
4552	GCST003341	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	Neurological disorder
4553	GCST003339	Epstein Barr virus nuclear antigen 1 IgG levels	Epstein Barr virus nuclear antigen 1 IgG levels	Other measurement
4554	GCST003340	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	Immune system disorder
4555	GCST003340	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	Other measurement
4556	GCST003330	Rheumatoid factor seropositivity in rheumatoid arthritis	Rheumatoid factor seropositivity in rheumatoid arthritis	Other measurement
4557	GCST003330	Rheumatoid factor seropositivity in rheumatoid arthritis	Rheumatoid factor seropositivity in rheumatoid arthritis	Immune system disorder
4558	GCST003330	Rheumatoid factor seropositivity in rheumatoid arthritis	Rheumatoid factor seropositivity in rheumatoid arthritis	Other measurement
4559	GCST003318	Brain arteriovenous malformations (sporadic)	Brain arteriovenous malformations (sporadic)	Cancer
4560	GCST003300	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Cardiovascular disease
4561	GCST003300	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Cancer
4562	GCST003300	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	Response to drug
4563	GCST003211	C-reactive protein levels in ischemic stroke	C-reactive protein levels in ischemic stroke	Other trait
4564	GCST003211	C-reactive protein levels in ischemic stroke	C-reactive protein levels in ischemic stroke	Inflammatory measurement
4565	GCST003235	Prothrombin fragments F1+2 levels in ischemic stroke	Prothrombin fragments F1+2 levels in ischemic stroke	Other measurement
4566	GCST003235	Prothrombin fragments F1+2 levels in ischemic stroke	Prothrombin fragments F1+2 levels in ischemic stroke	Other trait
4567	GCST003212	Fibrinogen levels in ischemic stroke	Fibrinogen levels in ischemic stroke	Hematological measurement
4568	GCST003212	Fibrinogen levels in ischemic stroke	Fibrinogen levels in ischemic stroke	Other trait
4569	GCST003233	Thrombin-antithrombin complex levels in ischemic stroke	Thrombin-antithrombin complex levels in ischemic stroke	Other measurement
4570	GCST003233	Thrombin-antithrombin complex levels in ischemic stroke	Thrombin-antithrombin complex levels in ischemic stroke	Other trait
4571	GCST003213	Creatinine levels in ischemic stroke	Creatinine levels in ischemic stroke	Other measurement
4572	GCST003213	Creatinine levels in ischemic stroke	Creatinine levels in ischemic stroke	Other trait
4573	GCST003234	Thrombomodulin levels in ischemic stroke	Thrombomodulin levels in ischemic stroke	Other measurement
4574	GCST003234	Thrombomodulin levels in ischemic stroke	Thrombomodulin levels in ischemic stroke	Other trait
4575	GCST003218	Non-cardia gastric cancer	Non-cardia gastric cancer	Cancer
4576	GCST003383	Platelet count	Platelet count	Hematological measurement
4577	GCST003335	Waist circumference	Waist circumference	Body measurement
4578	GCST003337	Waist-hip ratio	Waist-hip ratio	Other measurement
4579	GCST003337	Waist-hip ratio	Waist-hip ratio	Body measurement
4580	GCST003336	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Body measurement
4581	GCST003336	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Other measurement
4582	GCST003338	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
4583	GCST003338	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
4584	GCST003302	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
4585	GCST003304	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
4586	GCST003301	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
4587	GCST003303	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4588	GCST003303	LDL cholesterol	LDL cholesterol	Other measurement
4589	GCST003303	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4590	GCST003299	Cardiomyopathy in childhood cancer survivors	Cardiomyopathy in childhood cancer survivors	Cardiovascular disease
4591	GCST003299	Cardiomyopathy in childhood cancer survivors	Cardiomyopathy in childhood cancer survivors	Cancer
4592	GCST003278	Ideal cardiovascular health (clinical and behavioural)	Ideal cardiovascular health (clinical and behavioural)	Other trait
4593	GCST003279	Ideal cardiovascular health (clinical)	Ideal cardiovascular health (clinical)	Other trait
4594	GCST003378	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Response to drug
4595	GCST003378	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Neurological disorder
4596	GCST003298	NT-proBNP levels in acute coronary syndrome	NT-proBNP levels in acute coronary syndrome	Cardiovascular measurement
4597	GCST003325	Lung cancer	Lung cancer	Cancer
4598	GCST003325	Lung cancer	Lung cancer	Cancer
4599	GCST003325	Lung cancer	Lung cancer	Cancer
4600	GCST003326	Adenocarcinoma	Adenocarcinoma	Cancer
4601	GCST003334	Length of menstrual cycle	Length of menstrual cycle	Other measurement
4602	GCST003319	Major depressive disorder (stressful life events interaction)	Major depressive disorder (stressful life events interaction)	Other trait
4603	GCST003319	Major depressive disorder (stressful life events interaction)	Major depressive disorder (stressful life events interaction)	Other measurement
4604	GCST003319	Major depressive disorder (stressful life events interaction)	Major depressive disorder (stressful life events interaction)	Neurological disorder
4605	GCST008483	Ulcerative colitis	Ulcerative colitis	Immune system disorder
4606	GCST005113	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
4607	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Other measurement
4608	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Hematological measurement
4609	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Hematological measurement
4610	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Hematological measurement
4611	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Liver enzyme measurement
4612	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Other measurement
4613	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Other measurement
4614	GCST003540	Clinical laboratory measurements	Clinical laboratory measurements	Other measurement
4615	GCST008644	Celiac disease and Rheumatoid arthritis	Celiac disease and Rheumatoid arthritis	Immune system disorder
4616	GCST008644	Celiac disease and Rheumatoid arthritis	Celiac disease and Rheumatoid arthritis	Immune system disorder
4617	GCST003370	Anxiety disorder	Anxiety disorder	Neurological disorder
4618	GCST003369	Anxiety disorder (factor score)	Anxiety disorder (factor score)	Other measurement
4619	GCST003580	Antithyroid drug-induced agranulocytosis	Antithyroid drug-induced agranulocytosis	Response to drug
4620	GCST003580	Antithyroid drug-induced agranulocytosis	Antithyroid drug-induced agranulocytosis	Other trait
4621	GCST003365	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
4622	GCST003365	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
4623	GCST003365	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
4624	GCST003366	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
4625	GCST003366	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
4626	GCST003366	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
4627	GCST003344	Glaucoma (high intraocular pressure)	Glaucoma (high intraocular pressure)	Neurological disorder
4628	GCST003343	Glaucoma (low intraocular pressure)	Glaucoma (low intraocular pressure)	Neurological disorder
4629	GCST003342	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
4630	GCST003332	Rapid functional decline in sporadic amyotrophic lateral sclerosis	Rapid functional decline in sporadic amyotrophic lateral sclerosis	Other measurement
4631	GCST003332	Rapid functional decline in sporadic amyotrophic lateral sclerosis	Rapid functional decline in sporadic amyotrophic lateral sclerosis	Neurological disorder
4632	GCST003333	Moderate functional decline in sporadic amyotrophic lateral sclerosis	Moderate functional decline in sporadic amyotrophic lateral sclerosis	Other measurement
4633	GCST003333	Moderate functional decline in sporadic amyotrophic lateral sclerosis	Moderate functional decline in sporadic amyotrophic lateral sclerosis	Neurological disorder
4634	GCST003329	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Immune system disorder
4635	GCST003329	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Response to drug
4636	GCST003385	Colorectal cancer (menopausal hormone therapy interaction)	Colorectal cancer (menopausal hormone therapy interaction)	Cancer
4637	GCST003385	Colorectal cancer (menopausal hormone therapy interaction)	Colorectal cancer (menopausal hormone therapy interaction)	Other trait
4638	GCST003362	Phospholipid levels	Phospholipid levels	Lipid or lipoprotein measurement
4639	GCST003361	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
4640	GCST003361	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
4641	GCST003363	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
4642	GCST003387	Colorectal cancer (oestrogen hormone therapy interaction)	Colorectal cancer (oestrogen hormone therapy interaction)	Cancer
4643	GCST003387	Colorectal cancer (oestrogen hormone therapy interaction)	Colorectal cancer (oestrogen hormone therapy interaction)	Other trait
4644	GCST003386	Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	Cancer
4645	GCST003386	Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	Other trait
4646	GCST003451	Tuberculosis	Tuberculosis	Other disease
4647	GCST003451	Tuberculosis	Tuberculosis	Other measurement
4648	GCST003451	Tuberculosis	Tuberculosis	Other measurement
4649	GCST003364	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
4650	GCST003331	Sex ratio	Sex ratio	Other measurement
4651	GCST003460	IgG1 response to Plasmodium falciparum antigen (GLURP)	IgG1 response to Plasmodium falciparum antigen (GLURP)	Other measurement
4652	GCST003464	IgG3 response to Plasmodium falciparum antigen (MSP2 FC27)	IgG3 response to Plasmodium falciparum antigen (MSP2 FC27)	Other measurement
4653	GCST003463	IgG3 response to Plasmodium falciparum antigen (MSP2 3D7)	IgG3 response to Plasmodium falciparum antigen (MSP2 3D7)	Other measurement
4654	GCST003462	IgG1 response to Plasmodium falciparum antigen (MSP1)	IgG1 response to Plasmodium falciparum antigen (MSP1)	Other measurement
4655	GCST003461	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7)	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7)	Other measurement
4656	GCST003388	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
4657	GCST003388	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
4658	GCST003389	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
4659	GCST003389	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
4660	GCST003250	Urinary albumin-to-creatinine ratio in diabetes	Urinary albumin-to-creatinine ratio in diabetes	Other measurement
4661	GCST003250	Urinary albumin-to-creatinine ratio in diabetes	Urinary albumin-to-creatinine ratio in diabetes	Metabolic disorder
4662	GCST003255	Urinary albumin-to-creatinine ratio	Urinary albumin-to-creatinine ratio	Other measurement
4663	GCST003253	Microalbuminuria	Microalbuminuria	Other trait
4664	GCST003254	Urinary albumin-to-creatinine ratio in non-diabetics	Urinary albumin-to-creatinine ratio in non-diabetics	Other measurement
4665	GCST003209	Colorectal or endometrial cancer	Colorectal or endometrial cancer	Cancer
4666	GCST003209	Colorectal or endometrial cancer	Colorectal or endometrial cancer	Cancer
4667	GCST003208	Colorectal or endometrial cancer	Colorectal or endometrial cancer	Cancer
4668	GCST003208	Colorectal or endometrial cancer	Colorectal or endometrial cancer	Cancer
4669	GCST003269	Cutaneous psoriasis	Cutaneous psoriasis	Other measurement
4670	GCST003269	Cutaneous psoriasis	Cutaneous psoriasis	Immune system disorder
4671	GCST003191	Vitamin D levels	Vitamin D levels	Other measurement
4672	GCST003196	Calcaneal bone ultrasound measurement (speed of sound)	Calcaneal bone ultrasound measurement (speed of sound)	Other measurement
4673	GCST003579	Antipsychotic drug-induced weight gain in schizophrenia	Antipsychotic drug-induced weight gain in schizophrenia	Neurological disorder
4674	GCST003579	Antipsychotic drug-induced weight gain in schizophrenia	Antipsychotic drug-induced weight gain in schizophrenia	Other trait
4675	GCST003193	Response to interferon beta in multiple sclerosis	Response to interferon beta in multiple sclerosis	Immune system disorder
4676	GCST003193	Response to interferon beta in multiple sclerosis	Response to interferon beta in multiple sclerosis	Response to drug
4677	GCST008482	Lung function (FVC)	Lung function (FVC)	Other measurement
4678	GCST008480	Lung function (FEV1)	Lung function (FEV1)	Other measurement
4679	GCST008481	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
4680	GCST003198	Inguinal hernia	Inguinal hernia	Other trait
4681	GCST003195	Magnesium levels	Magnesium levels	Other measurement
4682	GCST003219	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
4683	GCST003219	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
4684	GCST003219	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
4685	GCST003258	Ischemic stroke	Ischemic stroke	Cardiovascular disease
4686	GCST003258	Ischemic stroke	Ischemic stroke	Other trait
4687	GCST003261	Ischemic stroke (undetermined subtype)	Ischemic stroke (undetermined subtype)	Other trait
4688	GCST003260	Ischemic stroke (small artery occlusion)	Ischemic stroke (small artery occlusion)	Cardiovascular disease
4689	GCST003260	Ischemic stroke (small artery occlusion)	Ischemic stroke (small artery occlusion)	Other trait
4690	GCST003259	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Cardiovascular disease
4691	GCST003259	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Other trait
4692	GCST003257	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
4693	GCST003257	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
4694	GCST003257	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
4695	GCST003245	White matter hyperintensities in ischemic stroke	White matter hyperintensities in ischemic stroke	Other measurement
4696	GCST003245	White matter hyperintensities in ischemic stroke	White matter hyperintensities in ischemic stroke	Other trait
4697	GCST003197	Thoracic-to-hip circumference ratio	Thoracic-to-hip circumference ratio	Body measurement
4698	GCST003222	Gut microbiome composition (summer and winter)	Gut microbiome composition (summer and winter)	Other measurement
4699	GCST005879	Collagenous colitis	Collagenous colitis	Immune system disorder
4700	GCST003192	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Immune system disorder
4701	GCST003192	Coronary artery aneurysm in Kawasaki disease	Coronary artery aneurysm in Kawasaki disease	Cardiovascular disease
4702	GCST008732	Ulcerative colitis	Ulcerative colitis	Immune system disorder
4703	GCST008730	Crohn's disease	Crohn's disease	Digestive system disorder
4704	GCST008731	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4705	GCST008731	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
4706	GCST008731	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4707	GCST005560	Menopause (age at onset)	Menopause (age at onset)	Other measurement
4708	GCST005354	Height	Height	Other measurement
4709	GCST005354	Height	Height	Body measurement
4710	GCST005312	Menopause (age at onset)	Menopause (age at onset)	Other measurement
4711	GCST003174	Sense of smell	Sense of smell	Biological process
4712	GCST003271	Psoriatic arthritis vs Cutaneous psoriasis	Psoriatic arthritis vs Cutaneous psoriasis	Other measurement
4713	GCST003271	Psoriatic arthritis vs Cutaneous psoriasis	Psoriatic arthritis vs Cutaneous psoriasis	Immune system disorder
4714	GCST003271	Psoriatic arthritis vs Cutaneous psoriasis	Psoriatic arthritis vs Cutaneous psoriasis	Immune system disorder
4715	GCST003270	Psoriatic arthritis	Psoriatic arthritis	Immune system disorder
4716	GCST003268	Psoriasis vulgaris	Psoriasis vulgaris	Immune system disorder
4717	GCST003252	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
4718	GCST003188	Acute mountain sickness	Acute mountain sickness	Cardiovascular disease
4719	GCST003176	Asthma	Asthma	Other disease
4720	GCST003177	Childhood body mass index	Childhood body mass index	Body measurement
4721	GCST003189	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Digestive system disorder
4722	GCST003189	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Cancer
4723	GCST003241	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	Lipid or lipoprotein measurement
4724	GCST003224	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Other measurement
4725	GCST003224	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Cancer
4726	GCST003224	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	Response to drug
4727	GCST003183	Setpoint viral load in HIV-1 infection	Setpoint viral load in HIV-1 infection	Other measurement
4728	GCST003183	Setpoint viral load in HIV-1 infection	Setpoint viral load in HIV-1 infection	Other disease
4729	GCST003232	Response to Pazopanib in cancer (hepatotoxicity)	Response to Pazopanib in cancer (hepatotoxicity)	Liver enzyme measurement
4730	GCST003232	Response to Pazopanib in cancer (hepatotoxicity)	Response to Pazopanib in cancer (hepatotoxicity)	Response to drug
4731	GCST003232	Response to Pazopanib in cancer (hepatotoxicity)	Response to Pazopanib in cancer (hepatotoxicity)	Cancer
4732	GCST003225	Pelvic organ prolapse (moderate/severe)	Pelvic organ prolapse (moderate/severe)	Other disease
4733	GCST003180	Atopic march	Atopic march	Biological process
4734	GCST003180	Atopic march	Atopic march	Immune system disorder
4735	GCST003180	Atopic march	Atopic march	Other disease
4736	GCST003226	Pelvic organ prolapse	Pelvic organ prolapse	Other disease
4737	GCST003179	Multiple system atrophy	Multiple system atrophy	Neurological disorder
4738	GCST003221	Gut microbiome composition (summer)	Gut microbiome composition (summer)	Other measurement
4739	GCST003223	Gut microbiome composition (winter)	Gut microbiome composition (winter)	Other measurement
4740	GCST003175	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
4741	GCST003217	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
4742	GCST003215	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
4743	GCST003216	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4744	GCST003216	LDL cholesterol	LDL cholesterol	Other measurement
4745	GCST003216	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
4746	GCST003214	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
4747	GCST003182	Staphylococcus aureus nasal carriage (persistent)	Staphylococcus aureus nasal carriage (persistent)	Other measurement
4748	GCST003181	Staphylococcus aureus nasal carriage (intermittent)	Staphylococcus aureus nasal carriage (intermittent)	Other measurement
4749	GCST003190	Schizophrenia	Schizophrenia	Neurological disorder
4750	GCST003200	Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)	Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)	Other measurement
4751	GCST003194	Fibrinogen levels	Fibrinogen levels	Hematological measurement
4752	GCST003242	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	Lipid or lipoprotein measurement
4753	GCST003244	Delta-6 desaturase activity	Delta-6 desaturase activity	Other measurement
4754	GCST003243	Delta-5 desaturase activity	Delta-5 desaturase activity	Other measurement
4755	GCST003236	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Lipid or lipoprotein measurement
4756	GCST003236	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Lipid or lipoprotein measurement
4757	GCST003237	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Lipid or lipoprotein measurement
4758	GCST003237	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Lipid or lipoprotein measurement
4759	GCST003238	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Lipid or lipoprotein measurement
4760	GCST003238	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Lipid or lipoprotein measurement
4761	GCST003239	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Lipid or lipoprotein measurement
4762	GCST003239	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Lipid or lipoprotein measurement
4763	GCST003240	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	Lipid or lipoprotein measurement
4764	GCST003186	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Other disease
4765	GCST003186	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Cardiovascular disease
4766	GCST003186	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Cardiovascular disease in hypertension (ACE inhibitor interaction)	Response to drug
4767	GCST003202	Myocardial infarction in hypertension (diuretic interaction)	Myocardial infarction in hypertension (diuretic interaction)	Cardiovascular disease
4768	GCST003202	Myocardial infarction in hypertension (diuretic interaction)	Myocardial infarction in hypertension (diuretic interaction)	Cardiovascular disease
4769	GCST003202	Myocardial infarction in hypertension (diuretic interaction)	Myocardial infarction in hypertension (diuretic interaction)	Response to drug
4770	GCST003201	Myocardial infarction in hypertension (beta blocker interaction)	Myocardial infarction in hypertension (beta blocker interaction)	Response to drug
4771	GCST003201	Myocardial infarction in hypertension (beta blocker interaction)	Myocardial infarction in hypertension (beta blocker interaction)	Cardiovascular disease
4772	GCST003201	Myocardial infarction in hypertension (beta blocker interaction)	Myocardial infarction in hypertension (beta blocker interaction)	Cardiovascular disease
4773	GCST003187	Myocardial infarction in hypertension (ACE inhibitor interaction)	Myocardial infarction in hypertension (ACE inhibitor interaction)	Cardiovascular disease
4774	GCST003187	Myocardial infarction in hypertension (ACE inhibitor interaction)	Myocardial infarction in hypertension (ACE inhibitor interaction)	Cardiovascular disease
4775	GCST003187	Myocardial infarction in hypertension (ACE inhibitor interaction)	Myocardial infarction in hypertension (ACE inhibitor interaction)	Response to drug
4776	GCST003203	Cardiovascular disease in hypertension (beta blocker interaction)	Cardiovascular disease in hypertension (beta blocker interaction)	Response to drug
4777	GCST003203	Cardiovascular disease in hypertension (beta blocker interaction)	Cardiovascular disease in hypertension (beta blocker interaction)	Other disease
4778	GCST003203	Cardiovascular disease in hypertension (beta blocker interaction)	Cardiovascular disease in hypertension (beta blocker interaction)	Cardiovascular disease
4779	GCST003204	Cardiovascular disease in hypertension (diuretic interaction)	Cardiovascular disease in hypertension (diuretic interaction)	Other disease
4780	GCST003204	Cardiovascular disease in hypertension (diuretic interaction)	Cardiovascular disease in hypertension (diuretic interaction)	Cardiovascular disease
4781	GCST003204	Cardiovascular disease in hypertension (diuretic interaction)	Cardiovascular disease in hypertension (diuretic interaction)	Response to drug
4782	GCST003206	Myocardial infarction in hypertension (calcium channel blocker interaction)	Myocardial infarction in hypertension (calcium channel blocker interaction)	Response to drug
4783	GCST003206	Myocardial infarction in hypertension (calcium channel blocker interaction)	Myocardial infarction in hypertension (calcium channel blocker interaction)	Cardiovascular disease
4784	GCST003206	Myocardial infarction in hypertension (calcium channel blocker interaction)	Myocardial infarction in hypertension (calcium channel blocker interaction)	Cardiovascular disease
4785	GCST003205	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Response to drug
4786	GCST003205	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Other disease
4787	GCST003205	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Cardiovascular disease in hypertension (calcium channel blocker interaction)	Cardiovascular disease
4788	GCST003157	Plasma homocysteine levels	Plasma homocysteine levels	Cardiovascular measurement
4789	GCST003247	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
4790	GCST003247	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
4791	GCST003130	Autism spectrum disorder	Autism spectrum disorder	Neurological disorder
4792	GCST003129	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
4793	GCST003129	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
4794	GCST003128	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
4795	GCST003128	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
4796	GCST003272	Systolic blood pressure	Systolic blood pressure	Other measurement
4797	GCST003272	Systolic blood pressure	Systolic blood pressure	Other measurement
4798	GCST003273	Diastolic blood pressure	Diastolic blood pressure	Other measurement
4799	GCST003273	Diastolic blood pressure	Diastolic blood pressure	Other measurement
4800	GCST003275	Mean arterial pressure	Mean arterial pressure	Other measurement
4801	GCST003274	Pulse pressure	Pulse pressure	Cardiovascular measurement
4802	GCST003276	Hypertension	Hypertension	Cardiovascular disease
4803	GCST003127	Lipoprotein (a) levels	Lipoprotein (a) levels	Lipid or lipoprotein measurement
4804	GCST003246	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
4805	GCST003246	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
4806	GCST003161	Objective response to lithium treatment in bipolar disorder	Objective response to lithium treatment in bipolar disorder	Response to drug
4807	GCST003161	Objective response to lithium treatment in bipolar disorder	Objective response to lithium treatment in bipolar disorder	Neurological disorder
4808	GCST003159	Objective response to lithium treatment	Objective response to lithium treatment	Response to drug
4809	GCST003159	Objective response to lithium treatment	Objective response to lithium treatment	Neurological disorder
4810	GCST003160	Subjective response to lithium treatment in bipolar disorder	Subjective response to lithium treatment in bipolar disorder	Response to drug
4811	GCST003160	Subjective response to lithium treatment in bipolar disorder	Subjective response to lithium treatment in bipolar disorder	Neurological disorder
4812	GCST003158	Subjective response to lithium treatment	Subjective response to lithium treatment	Response to drug
4813	GCST003158	Subjective response to lithium treatment	Subjective response to lithium treatment	Neurological disorder
4814	GCST003156	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
4815	GCST003155	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
4816	GCST003154	Peripheral artery disease	Peripheral artery disease	Cardiovascular disease
4817	GCST003207	Response to exercise (triglyceride level interaction)	Response to exercise (triglyceride level interaction)	Biological process
4818	GCST003207	Response to exercise (triglyceride level interaction)	Response to exercise (triglyceride level interaction)	Lipid or lipoprotein measurement
4819	GCST003210	Low vWF levels	Low vWF levels	Hematological measurement
4820	GCST003153	Cirrhosis (alcohol related)	Cirrhosis (alcohol related)	Cancer
4821	GCST003184	Atopic dermatitis	Atopic dermatitis	Immune system disorder
4822	GCST006960	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4823	GCST006960	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
4824	GCST006960	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
4825	GCST003178	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Response to drug
4826	GCST003178	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Other measurement
4827	GCST003178	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	Cancer
4828	GCST003251	Late-onset myasthenia gravis	Late-onset myasthenia gravis	Neurological disorder
4829	GCST003151	White matter lesion progression	White matter lesion progression	Other measurement
4830	GCST003152	White matter lesion progression (adjusted for white matter lesion burden at baseline)	White matter lesion progression (adjusted for white matter lesion burden at baseline)	Other measurement
4831	GCST005546	Forearm bone mineral density	Forearm bone mineral density	Other measurement
4832	GCST005545	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
4833	GCST005545	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
4834	GCST005544	Femoral neck bone mineral density	Femoral neck bone mineral density	Other measurement
4835	GCST003228	Glioma	Glioma	Cancer
4836	GCST003228	Glioma	Glioma	Cancer
4837	GCST003146	Postburn hypertrophic scarring severity	Postburn hypertrophic scarring severity	Other measurement
4838	GCST003227	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
4839	GCST003227	Non-glioblastoma glioma	Non-glioblastoma glioma	Cancer
4840	GCST003145	Severe malaria	Severe malaria	Digestive system disorder
4841	GCST003143	Lung disease severity in cystic fibrosis	Lung disease severity in cystic fibrosis	Digestive system disorder
4842	GCST003143	Lung disease severity in cystic fibrosis	Lung disease severity in cystic fibrosis	Other measurement
4843	GCST003143	Lung disease severity in cystic fibrosis	Lung disease severity in cystic fibrosis	Other disease
4844	GCST003144	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
4845	GCST003142	Proteinuria in chronic kidney disease	Proteinuria in chronic kidney disease	Other disease
4846	GCST003142	Proteinuria in chronic kidney disease	Proteinuria in chronic kidney disease	Other trait
4847	GCST003132	Eating disorder in bipolar disorder	Eating disorder in bipolar disorder	Metabolic disorder
4848	GCST003132	Eating disorder in bipolar disorder	Eating disorder in bipolar disorder	Neurological disorder
4849	GCST003131	Cerebrospinal fluid clusterin levels in APOEe4+ carriers	Cerebrospinal fluid clusterin levels in APOEe4+ carriers	Other measurement
4850	GCST003131	Cerebrospinal fluid clusterin levels in APOEe4+ carriers	Cerebrospinal fluid clusterin levels in APOEe4+ carriers	Lipid or lipoprotein measurement
4851	GCST003137	Cerebrospinal fluid clusterin levels in APOEe4- carriers	Cerebrospinal fluid clusterin levels in APOEe4- carriers	Neurological disorder
4852	GCST003137	Cerebrospinal fluid clusterin levels in APOEe4- carriers	Cerebrospinal fluid clusterin levels in APOEe4- carriers	Lipid or lipoprotein measurement
4853	GCST003133	Plasma clusterin levels	Plasma clusterin levels	Lipid or lipoprotein measurement
4854	GCST003136	Bipolar disorder	Bipolar disorder	Neurological disorder
4855	GCST003135	Bipolar disorder and eating disorder	Bipolar disorder and eating disorder	Metabolic disorder
4856	GCST003135	Bipolar disorder and eating disorder	Bipolar disorder and eating disorder	Neurological disorder
4857	GCST003134	Cerebrospinal fluid clusterin levels	Cerebrospinal fluid clusterin levels	Lipid or lipoprotein measurement
4858	GCST006879	Blood metabolite levels	Blood metabolite levels	Other measurement
4859	GCST006879	Blood metabolite levels	Blood metabolite levels	Other measurement
4860	GCST006879	Blood metabolite levels	Blood metabolite levels	Other measurement
4861	GCST006879	Blood metabolite levels	Blood metabolite levels	Other measurement
4862	GCST003148	Prostate cancer	Prostate cancer	Cancer
4863	GCST003185	Nicotine dependence	Nicotine dependence	Neurological disorder
4864	GCST003147	Plasma lactate levels	Plasma lactate levels	Other measurement
4865	GCST003220	Glioblastoma	Glioblastoma	Cancer
4866	GCST003220	Glioblastoma	Glioblastoma	Cancer
4867	GCST003220	Glioblastoma	Glioblastoma	Cancer
4868	GCST003139	Glomerular filtration rate in chronic kidney disease	Glomerular filtration rate in chronic kidney disease	Other disease
4869	GCST003139	Glomerular filtration rate in chronic kidney disease	Glomerular filtration rate in chronic kidney disease	Other measurement
4870	GCST003141	Proteinuria and chronic kidney disease	Proteinuria and chronic kidney disease	Other disease
4871	GCST003141	Proteinuria and chronic kidney disease	Proteinuria and chronic kidney disease	Other trait
4872	GCST003140	Chronic kidney disease	Chronic kidney disease	Other disease
4873	GCST003140	Chronic kidney disease	Chronic kidney disease	Other measurement
4874	GCST003140	Chronic kidney disease	Chronic kidney disease	Other measurement
4875	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
4876	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Digestive system disorder
4877	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
4878	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
4879	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
4880	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
4881	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
4882	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
4883	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Metabolic disorder
4884	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
4885	GCST003097	Pediatric autoimmune diseases	Pediatric autoimmune diseases	Immune system disorder
4886	GCST003095	Adiponectin levels (BMI-adjusted)	Adiponectin levels (BMI-adjusted)	Other measurement
4887	GCST003096	Adiponectin levels	Adiponectin levels	Other measurement
4888	GCST003094	Mitral valve prolapse	Mitral valve prolapse	Cardiovascular disease
4889	GCST003089	Manic episodes in bipolar disorder	Manic episodes in bipolar disorder	Other trait
4890	GCST003089	Manic episodes in bipolar disorder	Manic episodes in bipolar disorder	Neurological disorder
4891	GCST003090	Depressive and manic episodes in bipolar disorder	Depressive and manic episodes in bipolar disorder	Other measurement
4892	GCST003090	Depressive and manic episodes in bipolar disorder	Depressive and manic episodes in bipolar disorder	Other measurement
4893	GCST003090	Depressive and manic episodes in bipolar disorder	Depressive and manic episodes in bipolar disorder	Neurological disorder
4894	GCST003088	Soluble interleukin-2 receptor subunit alpha	Soluble interleukin-2 receptor subunit alpha	Other measurement
4895	GCST003092	Myositis	Myositis	Immune system disorder
4896	GCST003093	Nicotine dependence	Nicotine dependence	Neurological disorder
4897	GCST003091	Depressive episodes in bipolar disorder	Depressive episodes in bipolar disorder	Other measurement
4898	GCST003091	Depressive episodes in bipolar disorder	Depressive episodes in bipolar disorder	Neurological disorder
4899	GCST005538	Sarcoidosis	Sarcoidosis	Other disease
4900	GCST003121	Alcohol dependence	Alcohol dependence	Other measurement
4901	GCST003121	Alcohol dependence	Alcohol dependence	Neurological disorder
4902	GCST003122	Hemoglobin levels	Hemoglobin levels	Hematological measurement
4903	GCST003122	Hemoglobin levels	Hemoglobin levels	Hematological measurement
4904	GCST003122	Hemoglobin levels	Hemoglobin levels	Hematological measurement
4905	GCST003122	Hemoglobin levels	Hemoglobin levels	Hematological measurement
4906	GCST003120	Extraversion	Extraversion	Biological process
4907	GCST003120	Extraversion	Extraversion	Other measurement
4908	GCST006051	Idiopathic inflammatory myopathy	Idiopathic inflammatory myopathy	Immune system disorder
4909	GCST006052	Polymyositis	Polymyositis	Neurological disorder
4910	GCST006053	Dermatomyositis or juvenile dermatomyositis	Dermatomyositis or juvenile dermatomyositis	Neurological disorder
4911	GCST006053	Dermatomyositis or juvenile dermatomyositis	Dermatomyositis or juvenile dermatomyositis	Neurological disorder
4912	GCST003106	Low bone mineral density (spine)	Low bone mineral density (spine)	Other measurement
4913	GCST003105	Low bone mineral density (hip)	Low bone mineral density (hip)	Other measurement
4914	GCST003104	Autism spectrum disorder	Autism spectrum disorder	Neurological disorder
4915	GCST003103	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
4916	GCST003101	Bone mineral density (spine) and age at menarche	Bone mineral density (spine) and age at menarche	Other measurement
4917	GCST003101	Bone mineral density (spine) and age at menarche	Bone mineral density (spine) and age at menarche	Other measurement
4918	GCST003102	Bone mineral density (hip) and age at menarche	Bone mineral density (hip) and age at menarche	Other measurement
4919	GCST003102	Bone mineral density (hip) and age at menarche	Bone mineral density (hip) and age at menarche	Other measurement
4920	GCST008643	Joint damage in rheumatoid arthritis	Joint damage in rheumatoid arthritis	Immune system disorder
4921	GCST008643	Joint damage in rheumatoid arthritis	Joint damage in rheumatoid arthritis	Other measurement
4922	GCST003098	Diabetic kidney disease	Diabetic kidney disease	Metabolic disorder
4923	GCST003099	Diabetic kidney disease	Diabetic kidney disease	Metabolic disorder
4924	GCST003100	Prostate cancer (survival)	Prostate cancer (survival)	Cancer
4925	GCST003100	Prostate cancer (survival)	Prostate cancer (survival)	Other measurement
4926	GCST003119	Urinary metabolites	Urinary metabolites	Other measurement
4927	GCST003119	Urinary metabolites	Urinary metabolites	Other measurement
4928	GCST003118	Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	Response to drug
4929	GCST003118	Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	Neurological disorder
4930	GCST003116	Coronary artery disease	Coronary artery disease	Cardiovascular disease
4931	GCST003116	Coronary artery disease	Coronary artery disease	Cardiovascular disease
4932	GCST003117	Myocardial infarction	Myocardial infarction	Cardiovascular disease
4933	GCST003115	Rotator cuff tears	Rotator cuff tears	Other disease
4934	GCST003114	Carotid intima media thickness	Carotid intima media thickness	Other measurement
4935	GCST003114	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular measurement
4936	GCST003114	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular disease
4937	GCST003112	Sleep duration	Sleep duration	Other measurement
4938	GCST003111	Sleep duration	Sleep duration	Other measurement
4939	GCST003113	Cingulate cortical amyloid beta load	Cingulate cortical amyloid beta load	Other measurement
4940	GCST003113	Cingulate cortical amyloid beta load	Cingulate cortical amyloid beta load	Other measurement
4941	GCST003110	Post-bronchodilator lung function in asthma (FEV1)	Post-bronchodilator lung function in asthma (FEV1)	Other measurement
4942	GCST003110	Post-bronchodilator lung function in asthma (FEV1)	Post-bronchodilator lung function in asthma (FEV1)	Response to drug
4943	GCST003110	Post-bronchodilator lung function in asthma (FEV1)	Post-bronchodilator lung function in asthma (FEV1)	Other measurement
4944	GCST003110	Post-bronchodilator lung function in asthma (FEV1)	Post-bronchodilator lung function in asthma (FEV1)	Other disease
4945	GCST006583	Ulcerative colitis	Ulcerative colitis	Immune system disorder
4946	GCST006074	Bilirubin levels in tenofovir-treated HIV infection	Bilirubin levels in tenofovir-treated HIV infection	Other disease
4947	GCST006074	Bilirubin levels in tenofovir-treated HIV infection	Bilirubin levels in tenofovir-treated HIV infection	Other measurement
4948	GCST006074	Bilirubin levels in tenofovir-treated HIV infection	Bilirubin levels in tenofovir-treated HIV infection	Response to drug
4949	GCST006073	Tenofovir clearance in HIV infection	Tenofovir clearance in HIV infection	Other disease
4950	GCST006073	Tenofovir clearance in HIV infection	Tenofovir clearance in HIV infection	Response to drug
4951	GCST003107	Post-bronchodilator lung function in asthma (FEV1/FVC)	Post-bronchodilator lung function in asthma (FEV1/FVC)	Other measurement
4952	GCST003107	Post-bronchodilator lung function in asthma (FEV1/FVC)	Post-bronchodilator lung function in asthma (FEV1/FVC)	Other measurement
4953	GCST003107	Post-bronchodilator lung function in asthma (FEV1/FVC)	Post-bronchodilator lung function in asthma (FEV1/FVC)	Response to drug
4954	GCST003107	Post-bronchodilator lung function in asthma (FEV1/FVC)	Post-bronchodilator lung function in asthma (FEV1/FVC)	Other disease
4955	GCST006072	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	Other disease
4956	GCST006072	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	Response to drug
4957	GCST006072	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	Other measurement
4958	GCST006069	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Other disease
4959	GCST006069	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Response to drug
4960	GCST006069	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	Other measurement
4961	GCST006071	Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	Other disease
4962	GCST006071	Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	Response to drug
4963	GCST006070	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	Other disease
4964	GCST006070	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	Response to drug
4965	GCST006070	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	Other measurement
4966	GCST003108	Antipsychotic drug-induced weight gain (time interaction)	Antipsychotic drug-induced weight gain (time interaction)	Body measurement
4967	GCST003108	Antipsychotic drug-induced weight gain (time interaction)	Antipsychotic drug-induced weight gain (time interaction)	Other trait
4968	GCST003109	Antipsychotic drug-induced weight gain	Antipsychotic drug-induced weight gain	Other trait
4969	GCST003069	Left superior temporal gyrus thickness (schizophrenia interaction)	Left superior temporal gyrus thickness (schizophrenia interaction)	Neurological disorder
4970	GCST003069	Left superior temporal gyrus thickness (schizophrenia interaction)	Left superior temporal gyrus thickness (schizophrenia interaction)	Other measurement
4971	GCST003063	Neuropathic pain in type 2 diabetes	Neuropathic pain in type 2 diabetes	Metabolic disorder
4972	GCST003063	Neuropathic pain in type 2 diabetes	Neuropathic pain in type 2 diabetes	Other trait
4973	GCST003614	Opioid dependence	Opioid dependence	Neurological disorder
4974	GCST003062	Anthracycline-induced cardiotoxicity in childhood cancer	Anthracycline-induced cardiotoxicity in childhood cancer	Cardiovascular disease
4975	GCST003062	Anthracycline-induced cardiotoxicity in childhood cancer	Anthracycline-induced cardiotoxicity in childhood cancer	Cancer
4976	GCST003062	Anthracycline-induced cardiotoxicity in childhood cancer	Anthracycline-induced cardiotoxicity in childhood cancer	Response to drug
4977	GCST003061	Cutaneous malignant melanoma	Cutaneous malignant melanoma	Cancer
4978	GCST003060	Parkinson's disease in GBA mutation carriers (age at onset)	Parkinson's disease in GBA mutation carriers (age at onset)	Neurological disorder
4979	GCST003060	Parkinson's disease in GBA mutation carriers (age at onset)	Parkinson's disease in GBA mutation carriers (age at onset)	Other measurement
4980	GCST003060	Parkinson's disease in GBA mutation carriers (age at onset)	Parkinson's disease in GBA mutation carriers (age at onset)	Other measurement
4981	GCST003059	Parkinson's disease	Parkinson's disease	Neurological disorder
4982	GCST003058	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Cancer
4983	GCST003058	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Response to drug
4984	GCST003058	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Response to drug
4985	GCST003058	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	Other measurement
4986	GCST005548	Parkinson's disease	Parkinson's disease	Neurological disorder
4987	GCST003085	Warfarin maintenance dose	Warfarin maintenance dose	Response to drug
4988	GCST003083	Glucocorticoid-induced osteonecrosis (time dependent analysis)	Glucocorticoid-induced osteonecrosis (time dependent analysis)	Other disease
4989	GCST003083	Glucocorticoid-induced osteonecrosis (time dependent analysis)	Glucocorticoid-induced osteonecrosis (time dependent analysis)	Response to drug
4990	GCST003084	Glucocorticoid-induced osteonecrosis	Glucocorticoid-induced osteonecrosis	Other disease
4991	GCST003084	Glucocorticoid-induced osteonecrosis	Glucocorticoid-induced osteonecrosis	Response to drug
4992	GCST003082	Longitudinal change in brain amyloid plaque burden	Longitudinal change in brain amyloid plaque burden	Other measurement
4993	GCST003081	Glucocorticoid-induced osteonecrosis (age 10 years and older)	Glucocorticoid-induced osteonecrosis (age 10 years and older)	Other disease
4994	GCST003081	Glucocorticoid-induced osteonecrosis (age 10 years and older)	Glucocorticoid-induced osteonecrosis (age 10 years and older)	Response to drug
4995	GCST003080	Glucocorticoid-induced osteonecrosis (time independent analysis)	Glucocorticoid-induced osteonecrosis (time independent analysis)	Other disease
4996	GCST003080	Glucocorticoid-induced osteonecrosis (time independent analysis)	Glucocorticoid-induced osteonecrosis (time independent analysis)	Response to drug
4997	GCST003057	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Cancer
4998	GCST003057	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Response to drug
4999	GCST003057	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Response to drug
5000	GCST003057	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	Other measurement
5001	GCST003054	Gait rhythm	Gait rhythm	Other measurement
5002	GCST003056	Gait variability	Gait variability	Other measurement
5003	GCST003055	Tandem gait	Tandem gait	Other measurement
5004	GCST003053	Cryptorchidism	Cryptorchidism	Other disease
5005	GCST003052	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
5006	GCST003052	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
5007	GCST003051	Multiple myeloma (survival)	Multiple myeloma (survival)	Other measurement
5008	GCST003051	Multiple myeloma (survival)	Multiple myeloma (survival)	Cancer
5009	GCST003050	Schizophrenia	Schizophrenia	Neurological disorder
5010	GCST003048	Schizophrenia	Schizophrenia	Neurological disorder
5011	GCST003049	Lung cancer (asbestos exposure interaction)	Lung cancer (asbestos exposure interaction)	Cancer
5012	GCST003049	Lung cancer (asbestos exposure interaction)	Lung cancer (asbestos exposure interaction)	Other measurement
5013	GCST003045	Ulcerative colitis	Ulcerative colitis	Immune system disorder
5014	GCST003043	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
5015	GCST003043	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
5016	GCST003043	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
5017	GCST003046	Trichloroethylene-induced hypersensitivity syndrome	Trichloroethylene-induced hypersensitivity syndrome	Biological process
5018	GCST003047	Atrioventricular septal defects in Down syndrome	Atrioventricular septal defects in Down syndrome	Cardiovascular disease
5019	GCST003047	Atrioventricular septal defects in Down syndrome	Atrioventricular septal defects in Down syndrome	Other trait
5020	GCST003044	Crohn's disease	Crohn's disease	Digestive system disorder
5021	GCST003042	Sight-threatening diabetic retinopathy in type 2 diabetes	Sight-threatening diabetic retinopathy in type 2 diabetes	Metabolic disorder
5022	GCST003042	Sight-threatening diabetic retinopathy in type 2 diabetes	Sight-threatening diabetic retinopathy in type 2 diabetes	Metabolic disorder
5023	GCST003018	Thionamide-induced agranulocytosis in Graves' disease	Thionamide-induced agranulocytosis in Graves' disease	Immune system disorder
5024	GCST003018	Thionamide-induced agranulocytosis in Graves' disease	Thionamide-induced agranulocytosis in Graves' disease	Response to drug
5025	GCST003018	Thionamide-induced agranulocytosis in Graves' disease	Thionamide-induced agranulocytosis in Graves' disease	Other trait
5026	GCST003016	Hypersomnia during a major depressive episode in bipolar disorder	Hypersomnia during a major depressive episode in bipolar disorder	Neurological disorder
5027	GCST003016	Hypersomnia during a major depressive episode in bipolar disorder	Hypersomnia during a major depressive episode in bipolar disorder	Other trait
5028	GCST003016	Hypersomnia during a major depressive episode in bipolar disorder	Hypersomnia during a major depressive episode in bipolar disorder	Neurological disorder
5029	GCST003015	Alcohol consumption	Alcohol consumption	Biological process
5030	GCST003015	Alcohol consumption	Alcohol consumption	Other measurement
5031	GCST003014	Postprandial triglyceride response to high fat diet meal	Postprandial triglyceride response to high fat diet meal	Lipid or lipoprotein measurement
5032	GCST003014	Postprandial triglyceride response to high fat diet meal	Postprandial triglyceride response to high fat diet meal	Biological process
5033	GCST003013	White matter hyperintensity burden	White matter hyperintensity burden	Other measurement
5034	GCST003013	White matter hyperintensity burden	White matter hyperintensity burden	Other measurement
5035	GCST003627	Neuropathy in taxane-treated breast cancer	Neuropathy in taxane-treated breast cancer	Cancer
5036	GCST003627	Neuropathy in taxane-treated breast cancer	Neuropathy in taxane-treated breast cancer	Response to drug
5037	GCST003627	Neuropathy in taxane-treated breast cancer	Neuropathy in taxane-treated breast cancer	Neurological disorder
5038	GCST003627	Neuropathy in taxane-treated breast cancer	Neuropathy in taxane-treated breast cancer	Response to drug
5039	GCST003012	Obstructive sleep apnea	Obstructive sleep apnea	Neurological disorder
5040	GCST003011	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
5041	GCST002995	Dysphagia	Dysphagia	Other trait
5042	GCST002993	Platinum-induced hepatotoxicity in non-small cell lung cancer	Platinum-induced hepatotoxicity in non-small cell lung cancer	Response to drug
5043	GCST002993	Platinum-induced hepatotoxicity in non-small cell lung cancer	Platinum-induced hepatotoxicity in non-small cell lung cancer	Digestive system disorder
5044	GCST002993	Platinum-induced hepatotoxicity in non-small cell lung cancer	Platinum-induced hepatotoxicity in non-small cell lung cancer	Cancer
5045	GCST002991	Pancreatic cancer	Pancreatic cancer	Cancer
5046	GCST002990	Gastric adenocarcinoma (histologically verified)	Gastric adenocarcinoma (histologically verified)	Cancer
5047	GCST002992	Gastric cancer	Gastric cancer	Cancer
5048	GCST002989	LDL peak particle diameter (total fat intake interaction)	LDL peak particle diameter (total fat intake interaction)	Lipid or lipoprotein measurement
5049	GCST002989	LDL peak particle diameter (total fat intake interaction)	LDL peak particle diameter (total fat intake interaction)	Other measurement
5050	GCST003026	Yu-Zhi constitution type in type 2 diabetes	Yu-Zhi constitution type in type 2 diabetes	Other trait
5051	GCST003026	Yu-Zhi constitution type in type 2 diabetes	Yu-Zhi constitution type in type 2 diabetes	Metabolic disorder
5052	GCST003024	Ultraviolet-induced skin pigmentation (minimal erythema dose)	Ultraviolet-induced skin pigmentation (minimal erythema dose)	Other measurement
5053	GCST003025	Attention function in attention deficit hyperactive disorder	Attention function in attention deficit hyperactive disorder	Neurological disorder
5054	GCST003025	Attention function in attention deficit hyperactive disorder	Attention function in attention deficit hyperactive disorder	Other measurement
5055	GCST003027	Cough in response to angiotensin-converting enzyme inhibitor drugs	Cough in response to angiotensin-converting enzyme inhibitor drugs	Other trait
5056	GCST003027	Cough in response to angiotensin-converting enzyme inhibitor drugs	Cough in response to angiotensin-converting enzyme inhibitor drugs	Response to drug
5057	GCST003023	Blond vs non-blond hair color	Blond vs non-blond hair color	Other trait
5058	GCST003019	Black vs. non-black hair color	Black vs. non-black hair color	Other trait
5059	GCST003020	Red vs non-red hair color	Red vs non-red hair color	Other trait
5060	GCST003022	Light vs. dark hair color	Light vs. dark hair color	Other trait
5061	GCST003021	Brown vs. non-brown hair color	Brown vs. non-brown hair color	Other trait
5062	GCST003017	Colorectal cancer	Colorectal cancer	Cancer
5063	GCST002984	Early childhood aggressive behavior	Early childhood aggressive behavior	Other measurement
5064	GCST002987	Stroke	Stroke	Cardiovascular disease
5065	GCST002988	Ischemic stroke	Ischemic stroke	Cardiovascular disease
5066	GCST002988	Ischemic stroke	Ischemic stroke	Other trait
5067	GCST002986	Childhood and early adolescence aggressive behavior	Childhood and early adolescence aggressive behavior	Other measurement
5068	GCST002983	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
5069	GCST002983	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
5070	GCST002985	Middle childhood and early adolescence aggressive behavior	Middle childhood and early adolescence aggressive behavior	Other measurement
5071	GCST002976	HIV-1 viral setpoint	HIV-1 viral setpoint	Biological process
5072	GCST002976	HIV-1 viral setpoint	HIV-1 viral setpoint	Other measurement
5073	GCST002976	HIV-1 viral setpoint	HIV-1 viral setpoint	Other disease
5074	GCST002980	Arterial stiffness (pulse-wave velocity)	Arterial stiffness (pulse-wave velocity)	Cardiovascular measurement
5075	GCST002981	Longitudinal alcohol consumption	Longitudinal alcohol consumption	Other measurement
5076	GCST002982	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Other trait
5077	GCST002982	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Other trait
5078	GCST002982	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	Other measurement
5079	GCST002975	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	Other trait
5080	GCST002975	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	Postoperative atrial fibrillation in coronary artery bypass grafting surgery	Cardiovascular disease
5081	GCST002971	Corticobasal degeneration	Corticobasal degeneration	Neurological disorder
5082	GCST002972	Suicide attempts in major depressive disorder	Suicide attempts in major depressive disorder	Biological process
5083	GCST002972	Suicide attempts in major depressive disorder	Suicide attempts in major depressive disorder	Neurological disorder
5084	GCST002973	Suicide	Suicide	Biological process
5085	GCST002974	Suicide ideation score in major depressive disorder	Suicide ideation score in major depressive disorder	Neurological disorder
5086	GCST002974	Suicide ideation score in major depressive disorder	Suicide ideation score in major depressive disorder	Other measurement
5087	GCST002970	Corticobasal degeneration	Corticobasal degeneration	Neurological disorder
5088	GCST002969	Suicide behavior	Suicide behavior	Biological process
5089	GCST005269	Luteinizing hormone levels in polycystic ovary syndrome	Luteinizing hormone levels in polycystic ovary syndrome	Other disease
5090	GCST005269	Luteinizing hormone levels in polycystic ovary syndrome	Luteinizing hormone levels in polycystic ovary syndrome	Other measurement
5091	GCST005274	DHEAS levels in polycystic ovary syndrome	DHEAS levels in polycystic ovary syndrome	Other disease
5092	GCST005274	DHEAS levels in polycystic ovary syndrome	DHEAS levels in polycystic ovary syndrome	Other measurement
5093	GCST005273	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
5094	GCST005272	Testosterone levels in polycystic ovary syndrome	Testosterone levels in polycystic ovary syndrome	Other disease
5095	GCST005272	Testosterone levels in polycystic ovary syndrome	Testosterone levels in polycystic ovary syndrome	Other measurement
5096	GCST005271	Sex hormone-binding globulin levels in polycystic ovary syndrome	Sex hormone-binding globulin levels in polycystic ovary syndrome	Other measurement
5097	GCST005271	Sex hormone-binding globulin levels in polycystic ovary syndrome	Sex hormone-binding globulin levels in polycystic ovary syndrome	Other disease
5098	GCST005270	Follicule stimulating hormone levels in polycystic ovary syndrome	Follicule stimulating hormone levels in polycystic ovary syndrome	Other measurement
5099	GCST005270	Follicule stimulating hormone levels in polycystic ovary syndrome	Follicule stimulating hormone levels in polycystic ovary syndrome	Other disease
5100	GCST003087	Body mass index variance	Body mass index variance	Body measurement
5101	GCST003086	Kidney stones	Kidney stones	Other disease
5102	GCST003038	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
5103	GCST003030	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Neurological disorder
5104	GCST003030	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	Other measurement
5105	GCST003031	MGMT methylation in smokers	MGMT methylation in smokers	Biological process
5106	GCST003031	MGMT methylation in smokers	MGMT methylation in smokers	Other measurement
5107	GCST003028	Serum alpha1-antitrypsin levels	Serum alpha1-antitrypsin levels	Other measurement
5108	GCST003029	Asperger syndrome	Asperger syndrome	Neurological disorder
5109	GCST003008	Triptolide cytotoxicity	Triptolide cytotoxicity	Other measurement
5110	GCST003008	Triptolide cytotoxicity	Triptolide cytotoxicity	Response to drug
5111	GCST003008	Triptolide cytotoxicity	Triptolide cytotoxicity	Other trait
5112	GCST003008	Triptolide cytotoxicity	Triptolide cytotoxicity	Other measurement
5113	GCST003006	Noise-induced hearing loss	Noise-induced hearing loss	Neurological disorder
5114	GCST002962	Asthma exacerbations	Asthma exacerbations	Other measurement
5115	GCST002958	Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	Immune system disorder
5116	GCST002958	Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	Biological process
5117	GCST002956	3-hydroxypropylmercapturic acid levels in smokers	3-hydroxypropylmercapturic acid levels in smokers	Biological process
5118	GCST002956	3-hydroxypropylmercapturic acid levels in smokers	3-hydroxypropylmercapturic acid levels in smokers	Biological process
5119	GCST002956	3-hydroxypropylmercapturic acid levels in smokers	3-hydroxypropylmercapturic acid levels in smokers	Other measurement
5120	GCST002957	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	Biological process
5121	GCST002957	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	Other measurement
5122	GCST002954	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
5123	GCST002954	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
5124	GCST002955	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Other measurement
5125	GCST002955	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Biological process
5126	GCST002955	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Biological process
5127	GCST002955	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Forced expiratory volume in 1 second (occupational environmental exposures interaction)	Biological process
5128	GCST002953	Pediatric areal bone mineral density (radius)	Pediatric areal bone mineral density (radius)	Other measurement
5129	GCST002952	Pediatric bone mineral content (radius)	Pediatric bone mineral content (radius)	Other measurement
5130	GCST002951	Response to zileuton treatment in asthma (FEV1 change interaction)	Response to zileuton treatment in asthma (FEV1 change interaction)	Other measurement
5131	GCST002951	Response to zileuton treatment in asthma (FEV1 change interaction)	Response to zileuton treatment in asthma (FEV1 change interaction)	Other disease
5132	GCST002951	Response to zileuton treatment in asthma (FEV1 change interaction)	Response to zileuton treatment in asthma (FEV1 change interaction)	Response to drug
5133	GCST002942	Percentage gas trapping	Percentage gas trapping	Other measurement
5134	GCST002947	Renal elimination rate in vancomycin therapy	Renal elimination rate in vancomycin therapy	Response to drug
5135	GCST002947	Renal elimination rate in vancomycin therapy	Renal elimination rate in vancomycin therapy	Other measurement
5136	GCST002946	Vancomycin trough in vancomycin therapy	Vancomycin trough in vancomycin therapy	Other measurement
5137	GCST002946	Vancomycin trough in vancomycin therapy	Vancomycin trough in vancomycin therapy	Response to drug
5138	GCST002943	IgA nephropathy	IgA nephropathy	Other disease
5139	GCST002944	Prostate cancer	Prostate cancer	Cancer
5140	GCST002948	Peak creatinine levels in vancomycin therapy	Peak creatinine levels in vancomycin therapy	Response to drug
5141	GCST002948	Peak creatinine levels in vancomycin therapy	Peak creatinine levels in vancomycin therapy	Other measurement
5142	GCST002940	Sporadic pituitary adenoma	Sporadic pituitary adenoma	Cancer
5143	GCST002945	Emphysema imaging phenotypes	Emphysema imaging phenotypes	Other measurement
5144	GCST002941	Airway imaging phenotypes	Airway imaging phenotypes	Other measurement
5145	GCST002892	Perioperative myocardial infarction in coronary artery bypass surgery	Perioperative myocardial infarction in coronary artery bypass surgery	Other trait
5146	GCST002892	Perioperative myocardial infarction in coronary artery bypass surgery	Perioperative myocardial infarction in coronary artery bypass surgery	Cardiovascular disease
5147	GCST002889	Psoriasis	Psoriasis	Immune system disorder
5148	GCST002885	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Response to drug
5149	GCST002885	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Neurological disorder
5150	GCST002885	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Neurological disorder
5151	GCST002885	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Neurological disorder
5152	GCST002885	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	Other measurement
5153	GCST002888	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Response to drug
5154	GCST002888	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
5155	GCST002888	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
5156	GCST002888	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
5157	GCST002888	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	Other measurement
5158	GCST002887	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
5159	GCST002887	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
5160	GCST002887	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Neurological disorder
5161	GCST002887	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Other measurement
5162	GCST002887	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	Response to drug
5163	GCST002886	Prostate cancer aggressiveness	Prostate cancer aggressiveness	Cancer
5164	GCST002886	Prostate cancer aggressiveness	Prostate cancer aggressiveness	Other measurement
5165	GCST002886	Prostate cancer aggressiveness	Prostate cancer aggressiveness	Other measurement
5166	GCST002891	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Neurological disorder
5167	GCST002891	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Neurological disorder
5168	GCST002891	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Neurological disorder
5169	GCST002891	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Other measurement
5170	GCST002891	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	Response to drug
5171	GCST002890	Prostate cancer	Prostate cancer	Cancer
5172	GCST002884	Cutaneous lupus erythematosus	Cutaneous lupus erythematosus	Immune system disorder
5173	GCST002882	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	Cardiovascular disease
5174	GCST002882	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	Other measurement
5175	GCST002904	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	Cancer
5176	GCST002904	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	Metabolic disorder
5177	GCST002900	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Biological process
5178	GCST002900	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Cancer
5179	GCST002900	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Obesity in adult survivors of childhood cancer exposed to cranial radiation	Metabolic disorder
5180	GCST002901	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Other measurement
5181	GCST002901	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Cancer
5182	GCST002901	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Cancer
5183	GCST002901	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Response to drug
5184	GCST002901	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Survival in endocrine treated breast cancer (estrogen-receptor positive)	Other measurement
5185	GCST002902	Survival in breast cancer (estrogen-receptor negative)	Survival in breast cancer (estrogen-receptor negative)	Other measurement
5186	GCST002902	Survival in breast cancer (estrogen-receptor negative)	Survival in breast cancer (estrogen-receptor negative)	Cancer
5187	GCST002902	Survival in breast cancer (estrogen-receptor negative)	Survival in breast cancer (estrogen-receptor negative)	Cancer
5188	GCST002895	Breast cancer	Breast cancer	Cancer
5189	GCST002893	Body mass index (age interaction)	Body mass index (age interaction)	Body measurement
5190	GCST002894	Body mass index	Body mass index	Body measurement
5191	GCST002894	Body mass index	Body mass index	Body measurement
5192	GCST002894	Body mass index	Body mass index	Other measurement
5193	GCST002920	Neuroticism	Neuroticism	Neurological disorder
5194	GCST002920	Neuroticism	Neuroticism	Other measurement
5195	GCST002918	Lapatinib-induced hepatotoxicity	Lapatinib-induced hepatotoxicity	Digestive system disorder
5196	GCST002918	Lapatinib-induced hepatotoxicity	Lapatinib-induced hepatotoxicity	Response to drug
5197	GCST002916	Cannabis use (initiation)	Cannabis use (initiation)	Neurological disorder
5198	GCST002916	Cannabis use (initiation)	Cannabis use (initiation)	Biological process
5199	GCST002917	Cannabis use (age at onset)	Cannabis use (age at onset)	Biological process
5200	GCST002917	Cannabis use (age at onset)	Cannabis use (age at onset)	Other measurement
5201	GCST002913	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Immune system disorder
5202	GCST002913	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Other trait
5203	GCST002913	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	Other trait
5204	GCST002914	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
5205	GCST002915	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Cancer
5206	GCST002915	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Response to drug
5207	GCST002912	Narcolepsy with cataplexy	Narcolepsy with cataplexy	Neurological disorder
5208	GCST002910	Response to interferon beta in multiple sclerosis	Response to interferon beta in multiple sclerosis	Immune system disorder
5209	GCST002910	Response to interferon beta in multiple sclerosis	Response to interferon beta in multiple sclerosis	Response to drug
5210	GCST002911	Calcium levels	Calcium levels	Other measurement
5211	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
5212	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
5213	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
5214	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
5215	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
5216	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
5217	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
5218	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
5219	GCST002925	Sex hormone levels	Sex hormone levels	Other measurement
5220	GCST002926	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Response to drug
5221	GCST002926	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Other disease
5222	GCST002926	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Bone mineral accretion in asthma (oral corticosteroid dose interaction)	Other measurement
5223	GCST002921	Multiple myeloma	Multiple myeloma	Cancer
5224	GCST002924	Paclitaxel-induced cytotoxicity	Paclitaxel-induced cytotoxicity	Other measurement
5225	GCST002924	Paclitaxel-induced cytotoxicity	Paclitaxel-induced cytotoxicity	Response to drug
5226	GCST002922	Multiple myeloma and monoclonal gammopathy	Multiple myeloma and monoclonal gammopathy	Other disease
5227	GCST002922	Multiple myeloma and monoclonal gammopathy	Multiple myeloma and monoclonal gammopathy	Cancer
5228	GCST002923	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Response to drug
5229	GCST002923	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
5230	GCST002923	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Other measurement
5231	GCST002923	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
5232	GCST002919	Colorectal cancer	Colorectal cancer	Cancer
5233	GCST002968	Response to stavudine in HIV (lipoatrophy)	Response to stavudine in HIV (lipoatrophy)	Response to drug
5234	GCST002968	Response to stavudine in HIV (lipoatrophy)	Response to stavudine in HIV (lipoatrophy)	Other disease
5235	GCST002968	Response to stavudine in HIV (lipoatrophy)	Response to stavudine in HIV (lipoatrophy)	Other trait
5236	GCST002967	Mucinous ovarian carcinoma	Mucinous ovarian carcinoma	Cancer
5237	GCST003256	Joint damage progression in ACPA-negative rheumatoid arthritis	Joint damage progression in ACPA-negative rheumatoid arthritis	Immune system disorder
5238	GCST003256	Joint damage progression in ACPA-negative rheumatoid arthritis	Joint damage progression in ACPA-negative rheumatoid arthritis	Other measurement
5239	GCST002960	Frontotemporal dementia	Frontotemporal dementia	Neurological disorder
5240	GCST002963	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
5241	GCST002909	Gout	Gout	Metabolic disorder
5242	GCST006799	Pyridoxal 5'-phosphate levels	Pyridoxal 5'-phosphate levels	Other measurement
5243	GCST006798	4-pyridoxic acid levels	4-pyridoxic acid levels	Other measurement
5244	GCST006797	Pyridoxal levels	Pyridoxal levels	Other measurement
5245	GCST002906	Skin colour saturation	Skin colour saturation	Other trait
5246	GCST002908	Skin sensitivity to sun	Skin sensitivity to sun	Immune system disorder
5247	GCST002907	Perceived skin darkness	Perceived skin darkness	Other trait
5248	GCST002905	Endophenotypes for schizophrenia in healthy individuals	Endophenotypes for schizophrenia in healthy individuals	Other trait
5249	GCST002903	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Other measurement
5250	GCST002903	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Cancer
5251	GCST002903	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Cancer
5252	GCST002903	Survival in breast cancer (estrogen-receptor positive)	Survival in breast cancer (estrogen-receptor positive)	Other measurement
5253	GCST002939	Platelet aggregation	Platelet aggregation	Biological process
5254	GCST002883	AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	Cardiovascular disease
5255	GCST002883	AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	Other measurement
5256	GCST002881	ADAMTS13 activity	ADAMTS13 activity	Other measurement
5257	GCST004751	Serum uric acid levels in response to allopurinol in gout	Serum uric acid levels in response to allopurinol in gout	Cardiovascular measurement
5258	GCST004751	Serum uric acid levels in response to allopurinol in gout	Serum uric acid levels in response to allopurinol in gout	Metabolic disorder
5259	GCST004751	Serum uric acid levels in response to allopurinol in gout	Serum uric acid levels in response to allopurinol in gout	Response to drug
5260	GCST002880	Recalcitrant atopic dermatitis	Recalcitrant atopic dermatitis	Immune system disorder
5261	GCST008489	Celiac disease	Celiac disease	Immune system disorder
5262	GCST002879	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
5263	GCST002879	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
5264	GCST002877	Adult antisocial behavior	Adult antisocial behavior	Other measurement
5265	GCST002878	Creutzfeldt-Jakob disease (sporadic)	Creutzfeldt-Jakob disease (sporadic)	Neurological disorder
5266	GCST002876	Type 1 diabetes and autoimmune thyroid diseases	Type 1 diabetes and autoimmune thyroid diseases	Immune system disorder
5267	GCST002876	Type 1 diabetes and autoimmune thyroid diseases	Type 1 diabetes and autoimmune thyroid diseases	Metabolic disorder
5268	GCST002875	Diisocyanate-induced asthma	Diisocyanate-induced asthma	Biological process
5269	GCST002875	Diisocyanate-induced asthma	Diisocyanate-induced asthma	Other disease
5270	GCST005536	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
5271	GCST002837	Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	Response to drug
5272	GCST002837	Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	Other measurement
5273	GCST002833	Platinum-induced myelosuppression in non-small cell lung cancer	Platinum-induced myelosuppression in non-small cell lung cancer	Response to drug
5274	GCST002833	Platinum-induced myelosuppression in non-small cell lung cancer	Platinum-induced myelosuppression in non-small cell lung cancer	Cancer
5275	GCST002833	Platinum-induced myelosuppression in non-small cell lung cancer	Platinum-induced myelosuppression in non-small cell lung cancer	Other trait
5276	GCST002834	Corneal curvature	Corneal curvature	Other measurement
5277	GCST002836	Axial length	Axial length	Other measurement
5278	GCST002835	Renal cell carcinoma	Renal cell carcinoma	Cancer
5279	GCST002831	Lead levels in blood	Lead levels in blood	Other measurement
5280	GCST002830	Urate levels in lean individuals	Urate levels in lean individuals	Body measurement
5281	GCST002830	Urate levels in lean individuals	Urate levels in lean individuals	Other measurement
5282	GCST008391	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
5283	GCST002845	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
5284	GCST002842	Basal cell carcinoma	Basal cell carcinoma	Cancer
5285	GCST008479	Psoriasis	Psoriasis	Immune system disorder
5286	GCST002843	Sitting height ratio	Sitting height ratio	Body measurement
5287	GCST002841	Developmental dysplasia of the hip	Developmental dysplasia of the hip	Other disease
5288	GCST002840	Myeloproliferative neoplasms	Myeloproliferative neoplasms	Cancer
5289	GCST002839	Polychlorinated biphenyl levels	Polychlorinated biphenyl levels	Other measurement
5290	GCST002838	Myasthenia gravis	Myasthenia gravis	Neurological disorder
5291	GCST002838	Myasthenia gravis	Myasthenia gravis	Other disease
5292	GCST002827	Urate levels (BMI interaction)	Urate levels (BMI interaction)	Body measurement
5293	GCST002827	Urate levels (BMI interaction)	Urate levels (BMI interaction)	Other measurement
5294	GCST002828	Urate levels in obese individuals	Urate levels in obese individuals	Other measurement
5295	GCST002828	Urate levels in obese individuals	Urate levels in obese individuals	Body measurement
5296	GCST002829	Urate levels in overweight individuals	Urate levels in overweight individuals	Body measurement
5297	GCST002829	Urate levels in overweight individuals	Urate levels in overweight individuals	Other measurement
5298	GCST002826	Urate levels (BMI interaction)	Urate levels (BMI interaction)	Body measurement
5299	GCST002826	Urate levels (BMI interaction)	Urate levels (BMI interaction)	Other measurement
5300	GCST002823	Behcet's disease	Behcet's disease	Cardiovascular disease
5301	GCST002824	Behcet's disease	Behcet's disease	Cardiovascular disease
5302	GCST002825	Insulin resistance/response	Insulin resistance/response	Other trait
5303	GCST002820	Survival in microsatellite instability low/stable colorectal cancer	Survival in microsatellite instability low/stable colorectal cancer	Other measurement
5304	GCST002820	Survival in microsatellite instability low/stable colorectal cancer	Survival in microsatellite instability low/stable colorectal cancer	Cancer
5305	GCST002820	Survival in microsatellite instability low/stable colorectal cancer	Survival in microsatellite instability low/stable colorectal cancer	Other measurement
5306	GCST002820	Survival in microsatellite instability low/stable colorectal cancer	Survival in microsatellite instability low/stable colorectal cancer	Other measurement
5307	GCST002821	Survival in rectal cancer	Survival in rectal cancer	Other measurement
5308	GCST002821	Survival in rectal cancer	Survival in rectal cancer	Cancer
5309	GCST002821	Survival in rectal cancer	Survival in rectal cancer	Other measurement
5310	GCST002822	Survival in colon cancer	Survival in colon cancer	Cancer
5311	GCST002822	Survival in colon cancer	Survival in colon cancer	Other measurement
5312	GCST002822	Survival in colon cancer	Survival in colon cancer	Other measurement
5313	GCST002819	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
5314	GCST002819	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
5315	GCST002818	HIV-1 susceptibility	HIV-1 susceptibility	Immune system disorder
5316	GCST002818	HIV-1 susceptibility	HIV-1 susceptibility	Other disease
5317	GCST002814	Alzheimer's disease (APOE e4 interaction)	Alzheimer's disease (APOE e4 interaction)	Neurological disorder
5318	GCST002814	Alzheimer's disease (APOE e4 interaction)	Alzheimer's disease (APOE e4 interaction)	Other measurement
5319	GCST002817	Alzheimer's disease in APOE e4- carriers	Alzheimer's disease in APOE e4- carriers	Neurological disorder
5320	GCST002813	Alzheimer's disease in APOE e4+ carriers	Alzheimer's disease in APOE e4+ carriers	Neurological disorder
5321	GCST002815	Bipolar disorder (inflammation and infection response interaction)	Bipolar disorder (inflammation and infection response interaction)	Neurological disorder
5322	GCST002815	Bipolar disorder (inflammation and infection response interaction)	Bipolar disorder (inflammation and infection response interaction)	Other measurement
5323	GCST002815	Bipolar disorder (inflammation and infection response interaction)	Bipolar disorder (inflammation and infection response interaction)	Other measurement
5324	GCST002816	Colorectal cancer (aspirin and/or NSAID use interaction)	Colorectal cancer (aspirin and/or NSAID use interaction)	Cancer
5325	GCST002816	Colorectal cancer (aspirin and/or NSAID use interaction)	Colorectal cancer (aspirin and/or NSAID use interaction)	Other measurement
5326	GCST002816	Colorectal cancer (aspirin and/or NSAID use interaction)	Colorectal cancer (aspirin and/or NSAID use interaction)	Other measurement
5327	GCST002816	Colorectal cancer (aspirin and/or NSAID use interaction)	Colorectal cancer (aspirin and/or NSAID use interaction)	Other measurement
5328	GCST002812	Schizophrenia (inflammation and infection response interaction)	Schizophrenia (inflammation and infection response interaction)	Neurological disorder
5329	GCST002812	Schizophrenia (inflammation and infection response interaction)	Schizophrenia (inflammation and infection response interaction)	Other measurement
5330	GCST002812	Schizophrenia (inflammation and infection response interaction)	Schizophrenia (inflammation and infection response interaction)	Other measurement
5331	GCST002812	Schizophrenia (inflammation and infection response interaction)	Schizophrenia (inflammation and infection response interaction)	Other measurement
5332	GCST002811	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
5333	GCST002811	Nonsyndromic cleft lip with or without cleft palate	Nonsyndromic cleft lip with or without cleft palate	Other trait
5334	GCST002810	Tuberculosis	Tuberculosis	Other disease
5335	GCST002810	Tuberculosis	Tuberculosis	Other measurement
5336	GCST002810	Tuberculosis	Tuberculosis	Other measurement
5337	GCST002809	Bipolar disorder	Bipolar disorder	Neurological disorder
5338	GCST002808	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
5339	GCST002807	Classic bladder exstrophy	Classic bladder exstrophy	Other disease
5340	GCST002803	Red wine liking	Red wine liking	Other measurement
5341	GCST002802	White wine liking	White wine liking	Other measurement
5342	GCST002806	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5343	GCST002805	Body mass index	Body mass index	Body measurement
5344	GCST002805	Body mass index	Body mass index	Body measurement
5345	GCST002805	Body mass index	Body mass index	Other measurement
5346	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
5347	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
5348	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
5349	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
5350	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
5351	GCST002804	Antibody level in response to infection	Antibody level in response to infection	Other measurement
5352	GCST008165	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other measurement
5353	GCST008165	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other trait
5354	GCST008164	Free thyroxine concentration	Free thyroxine concentration	Other measurement
5355	GCST002869	Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis	Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis	Immune system disorder
5356	GCST002869	Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis	Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis	Response to drug
5357	GCST002861	Breast cancer (survival)	Breast cancer (survival)	Other measurement
5358	GCST002861	Breast cancer (survival)	Breast cancer (survival)	Cancer
5359	GCST002861	Breast cancer (survival)	Breast cancer (survival)	Cancer
5360	GCST002861	Breast cancer (survival)	Breast cancer (survival)	Cancer
5361	GCST002861	Breast cancer (survival)	Breast cancer (survival)	Other measurement
5362	GCST002860	Magnesium levels	Magnesium levels	Other measurement
5363	GCST002858	Cytokine and corticosteroid-stimulated IL-6 production	Cytokine and corticosteroid-stimulated IL-6 production	Response to drug
5364	GCST002858	Cytokine and corticosteroid-stimulated IL-6 production	Cytokine and corticosteroid-stimulated IL-6 production	Inflammatory measurement
5365	GCST002858	Cytokine and corticosteroid-stimulated IL-6 production	Cytokine and corticosteroid-stimulated IL-6 production	Response to drug
5366	GCST002857	Calcium levels	Calcium levels	Other measurement
5367	GCST002859	Cytokine-stimulated IL-6 production	Cytokine-stimulated IL-6 production	Inflammatory measurement
5368	GCST002859	Cytokine-stimulated IL-6 production	Cytokine-stimulated IL-6 production	Response to drug
5369	GCST002856	Carotid artery intima media thickness (sex interaction)	Carotid artery intima media thickness (sex interaction)	Other measurement
5370	GCST002856	Carotid artery intima media thickness (sex interaction)	Carotid artery intima media thickness (sex interaction)	Other measurement
5371	GCST002855	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
5372	GCST002855	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
5373	GCST002851	Sasang constitutional medicine type (Tae-Yang)	Sasang constitutional medicine type (Tae-Yang)	Other trait
5374	GCST002851	Sasang constitutional medicine type (Tae-Yang)	Sasang constitutional medicine type (Tae-Yang)	Other trait
5375	GCST002852	Sasang constitutional medicine type (So-Yang)	Sasang constitutional medicine type (So-Yang)	Other trait
5376	GCST002852	Sasang constitutional medicine type (So-Yang)	Sasang constitutional medicine type (So-Yang)	Other trait
5377	GCST002853	Sasang constitutional medicine type (Tae-Eum)	Sasang constitutional medicine type (Tae-Eum)	Other trait
5378	GCST002853	Sasang constitutional medicine type (Tae-Eum)	Sasang constitutional medicine type (Tae-Eum)	Other trait
5379	GCST002854	Sasang constitutional medicine type (So-Eum)	Sasang constitutional medicine type (So-Eum)	Other trait
5380	GCST002854	Sasang constitutional medicine type (So-Eum)	Sasang constitutional medicine type (So-Eum)	Other trait
5381	GCST002850	Information processing speed	Information processing speed	Biological process
5382	GCST002849	Executive function	Executive function	Biological process
5383	GCST002847	Disease-free survival in breast cancer	Disease-free survival in breast cancer	Cancer
5384	GCST002847	Disease-free survival in breast cancer	Disease-free survival in breast cancer	Other measurement
5385	GCST002846	Lifespan	Lifespan	Other measurement
5386	GCST002848	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
5387	GCST002844	Atopic dermatitis	Atopic dermatitis	Immune system disorder
5388	GCST002874	Psoriasis	Psoriasis	Immune system disorder
5389	GCST002873	Thyroid cancer	Thyroid cancer	Cancer
5390	GCST002872	Blood metabolite levels	Blood metabolite levels	Other measurement
5391	GCST002872	Blood metabolite levels	Blood metabolite levels	Other measurement
5392	GCST002872	Blood metabolite levels	Blood metabolite levels	Other measurement
5393	GCST002872	Blood metabolite levels	Blood metabolite levels	Other measurement
5394	GCST002868	Response to serotonin reuptake inhibitors in major depressive disorder	Response to serotonin reuptake inhibitors in major depressive disorder	Response to drug
5395	GCST002868	Response to serotonin reuptake inhibitors in major depressive disorder	Response to serotonin reuptake inhibitors in major depressive disorder	Neurological disorder
5396	GCST002782	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
5397	GCST002782	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
5398	GCST004066	Hip circumference	Hip circumference	Body measurement
5399	GCST004063	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Body measurement
5400	GCST004063	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Other measurement
5401	GCST004067	Hip circumference adjusted for BMI	Hip circumference adjusted for BMI	Body measurement
5402	GCST004065	Waist circumference	Waist circumference	Body measurement
5403	GCST004064	Waist-hip ratio	Waist-hip ratio	Other measurement
5404	GCST004064	Waist-hip ratio	Waist-hip ratio	Body measurement
5405	GCST002783	Body mass index	Body mass index	Body measurement
5406	GCST002783	Body mass index	Body mass index	Body measurement
5407	GCST002783	Body mass index	Body mass index	Other measurement
5408	GCST002781	Periodontitis	Periodontitis	Digestive system disorder
5409	GCST002780	Cisplatin-induced hearing loss in brain tumor patients	Cisplatin-induced hearing loss in brain tumor patients	Other trait
5410	GCST002780	Cisplatin-induced hearing loss in brain tumor patients	Cisplatin-induced hearing loss in brain tumor patients	Neurological disorder
5411	GCST002780	Cisplatin-induced hearing loss in brain tumor patients	Cisplatin-induced hearing loss in brain tumor patients	Response to drug
5412	GCST002779	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Other disease
5413	GCST002779	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Response to drug
5414	GCST002779	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Other disease
5415	GCST007858	Fasting blood glucose adjusted for BMI	Fasting blood glucose adjusted for BMI	Other measurement
5416	GCST007858	Fasting blood glucose adjusted for BMI	Fasting blood glucose adjusted for BMI	Other measurement
5417	GCST007857	Fasting blood insulin adjusted for BMI	Fasting blood insulin adjusted for BMI	Other measurement
5418	GCST007857	Fasting blood insulin adjusted for BMI	Fasting blood insulin adjusted for BMI	Other measurement
5419	GCST002761	Hippocampal volume	Hippocampal volume	Other measurement
5420	GCST002759	Motion sickness	Motion sickness	Other trait
5421	GCST002758	Oligoclonal band status in multiple sclerosis	Oligoclonal band status in multiple sclerosis	Immune system disorder
5422	GCST002758	Oligoclonal band status in multiple sclerosis	Oligoclonal band status in multiple sclerosis	Other measurement
5423	GCST004866	Alopecia areata	Alopecia areata	Other disease
5424	GCST002757	Immunoglobulin G index levels in multiple sclerosis	Immunoglobulin G index levels in multiple sclerosis	Other measurement
5425	GCST002757	Immunoglobulin G index levels in multiple sclerosis	Immunoglobulin G index levels in multiple sclerosis	Immune system disorder
5426	GCST002756	Subcortical brain region volumes	Subcortical brain region volumes	Other measurement
5427	GCST002756	Subcortical brain region volumes	Subcortical brain region volumes	Other measurement
5428	GCST002756	Subcortical brain region volumes	Subcortical brain region volumes	Other measurement
5429	GCST002756	Subcortical brain region volumes	Subcortical brain region volumes	Other measurement
5430	GCST002756	Subcortical brain region volumes	Subcortical brain region volumes	Other measurement
5431	GCST002755	Depressive symptoms (SSRI exposure interaction)	Depressive symptoms (SSRI exposure interaction)	Other measurement
5432	GCST002755	Depressive symptoms (SSRI exposure interaction)	Depressive symptoms (SSRI exposure interaction)	Other measurement
5433	GCST002755	Depressive symptoms (SSRI exposure interaction)	Depressive symptoms (SSRI exposure interaction)	Other measurement
5434	GCST006575	Takayasu arteritis	Takayasu arteritis	Cardiovascular disease
5435	GCST002751	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other measurement
5436	GCST002751	Spontaneous preterm birth (preterm birth)	Spontaneous preterm birth (preterm birth)	Other trait
5437	GCST002752	Spontaneous preterm birth (preterm delivery)	Spontaneous preterm birth (preterm delivery)	Other measurement
5438	GCST002752	Spontaneous preterm birth (preterm delivery)	Spontaneous preterm birth (preterm delivery)	Other trait
5439	GCST002753	Lung cancer and family history of lung cancer	Lung cancer and family history of lung cancer	Other measurement
5440	GCST002753	Lung cancer and family history of lung cancer	Lung cancer and family history of lung cancer	Cancer
5441	GCST002750	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
5442	GCST002749	Response to Homoharringtonine (cytotoxicity)	Response to Homoharringtonine (cytotoxicity)	Other measurement
5443	GCST002749	Response to Homoharringtonine (cytotoxicity)	Response to Homoharringtonine (cytotoxicity)	Response to drug
5444	GCST002748	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
5445	GCST002748	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
5446	GCST002747	Response to Dalcetrapib treatment in acute coronary syndrome	Response to Dalcetrapib treatment in acute coronary syndrome	Response to drug
5447	GCST002747	Response to Dalcetrapib treatment in acute coronary syndrome	Response to Dalcetrapib treatment in acute coronary syndrome	Cardiovascular measurement
5448	GCST002747	Response to Dalcetrapib treatment in acute coronary syndrome	Response to Dalcetrapib treatment in acute coronary syndrome	Cardiovascular disease
5449	GCST002746	Lipoprotein (a) - cholesterol levels	Lipoprotein (a) - cholesterol levels	Lipid or lipoprotein measurement
5450	GCST002742	Marginal zone lymphoma	Marginal zone lymphoma	Cancer
5451	GCST002738	Psoriasis	Psoriasis	Immune system disorder
5452	GCST002737	Atopic dermatitis	Atopic dermatitis	Immune system disorder
5453	GCST002739	Lung cancer (household air pollution interaction)	Lung cancer (household air pollution interaction)	Other measurement
5454	GCST002739	Lung cancer (household air pollution interaction)	Lung cancer (household air pollution interaction)	Cancer
5455	GCST002740	Inflammatory skin disease	Inflammatory skin disease	Immune system disorder
5456	GCST002740	Inflammatory skin disease	Inflammatory skin disease	Other disease
5457	GCST002740	Inflammatory skin disease	Inflammatory skin disease	Immune system disorder
5458	GCST002741	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
5459	GCST002736	B-type natriuretic peptide levels	B-type natriuretic peptide levels	Cardiovascular measurement
5460	GCST002735	Breast cancer	Breast cancer	Cancer
5461	GCST002778	Parkinson disease and lewy body pathology	Parkinson disease and lewy body pathology	Neurological disorder
5462	GCST002778	Parkinson disease and lewy body pathology	Parkinson disease and lewy body pathology	Other measurement
5463	GCST002777	Clozapine-induced cytotoxicity	Clozapine-induced cytotoxicity	Response to drug
5464	GCST002777	Clozapine-induced cytotoxicity	Clozapine-induced cytotoxicity	Other measurement
5465	GCST002776	Endometriosis	Endometriosis	Other disease
5466	GCST002775	Alzheimer's disease (survival time)	Alzheimer's disease (survival time)	Other measurement
5467	GCST002775	Alzheimer's disease (survival time)	Alzheimer's disease (survival time)	Neurological disorder
5468	GCST002774	Cognitive function	Cognitive function	Biological process
5469	GCST002774	Cognitive function	Cognitive function	Biological process
5470	GCST002774	Cognitive function	Cognitive function	Other measurement
5471	GCST002774	Cognitive function	Cognitive function	Biological process
5472	GCST002773	Gout	Gout	Metabolic disorder
5473	GCST002772	Leprosy	Leprosy	Neurological disorder
5474	GCST002771	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Response to drug
5475	GCST002771	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Other measurement
5476	GCST002771	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	Other disease
5477	GCST002769	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Response to drug
5478	GCST002769	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Other measurement
5479	GCST002769	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	Other disease
5480	GCST002770	Hand grip strength	Hand grip strength	Other measurement
5481	GCST002768	Behavioral disinhibition	Behavioral disinhibition	Other measurement
5482	GCST002767	Intraocular pressure	Intraocular pressure	Other measurement
5483	GCST007898	Fasting blood insulin	Fasting blood insulin	Other measurement
5484	GCST007899	Fasting blood glucose	Fasting blood glucose	Other measurement
5485	GCST002766	Exudative age-related macular degeneration	Exudative age-related macular degeneration	Neurological disorder
5486	GCST002763	Optic disc area	Optic disc area	Other measurement
5487	GCST002763	Optic disc area	Optic disc area	Other measurement
5488	GCST002762	Optic cup area	Optic cup area	Other measurement
5489	GCST002764	Optic cup area	Optic cup area	Other measurement
5490	GCST002765	Optic disc area	Optic disc area	Other measurement
5491	GCST002765	Optic disc area	Optic disc area	Other measurement
5492	GCST002760	Hippocampal atrophy	Hippocampal atrophy	Neurological disorder
5493	GCST008485	Crohn's disease	Crohn's disease	Digestive system disorder
5494	GCST002731	Endothelial growth factor levels	Endothelial growth factor levels	Cardiovascular measurement
5495	GCST002731	Endothelial growth factor levels	Endothelial growth factor levels	Cardiovascular measurement
5496	GCST002731	Endothelial growth factor levels	Endothelial growth factor levels	Cardiovascular measurement
5497	GCST002731	Endothelial growth factor levels	Endothelial growth factor levels	Cardiovascular measurement
5498	GCST002733	Platelet count	Platelet count	Hematological measurement
5499	GCST002730	Hepatitis	Hepatitis	Other trait
5500	GCST002732	Metabolic syndrome	Metabolic syndrome	Body measurement
5501	GCST002732	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
5502	GCST002732	Metabolic syndrome	Metabolic syndrome	Other measurement
5503	GCST002732	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
5504	GCST002732	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
5505	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Digestive system disorder
5506	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Immune system disorder
5507	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Immune system disorder
5508	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Other trait
5509	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Biological process
5510	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Biological process
5511	GCST002729	Crohn's disease-related phenotypes	Crohn's disease-related phenotypes	Other trait
5512	GCST002734	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Other measurement
5513	GCST002734	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Body measurement
5514	GCST002734	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Biological process
5515	GCST002734	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)	Hematological measurement
5516	GCST002728	Yang-deficiency constitution	Yang-deficiency constitution	Other trait
5517	GCST002727	Breast cancer (survival)	Breast cancer (survival)	Other measurement
5518	GCST002727	Breast cancer (survival)	Breast cancer (survival)	Cancer
5519	GCST002727	Breast cancer (survival)	Breast cancer (survival)	Cancer
5520	GCST002727	Breast cancer (survival)	Breast cancer (survival)	Cancer
5521	GCST002727	Breast cancer (survival)	Breast cancer (survival)	Other measurement
5522	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
5523	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
5524	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
5525	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
5526	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
5527	GCST002726	Glucose homeostasis traits	Glucose homeostasis traits	Other measurement
5528	GCST008434	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5529	GCST002792	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Response to drug
5530	GCST002792	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Cancer
5531	GCST002792	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	Neurological disorder
5532	GCST002790	Food allergy	Food allergy	Other measurement
5533	GCST002789	Egg allergy	Egg allergy	Other measurement
5534	GCST002788	Milk allergy	Milk allergy	Other measurement
5535	GCST002791	Peanut allergy	Peanut allergy	Other measurement
5536	GCST002786	Gene methylation in lung tissue	Gene methylation in lung tissue	Other measurement
5537	GCST002785	Facial pigmentation	Facial pigmentation	Other measurement
5538	GCST002787	Exfoliation syndrome	Exfoliation syndrome	Neurological disorder
5539	GCST002784	Blood pressure response to hydrochlorothiazide in hypertension	Blood pressure response to hydrochlorothiazide in hypertension	Other measurement
5540	GCST002784	Blood pressure response to hydrochlorothiazide in hypertension	Blood pressure response to hydrochlorothiazide in hypertension	Other measurement
5541	GCST002784	Blood pressure response to hydrochlorothiazide in hypertension	Blood pressure response to hydrochlorothiazide in hypertension	Response to drug
5542	GCST002784	Blood pressure response to hydrochlorothiazide in hypertension	Blood pressure response to hydrochlorothiazide in hypertension	Cardiovascular disease
5543	GCST002800	Number of children (6+ vs. 0 or 1)	Number of children (6+ vs. 0 or 1)	Other measurement
5544	GCST002800	Number of children (6+ vs. 0 or 1)	Number of children (6+ vs. 0 or 1)	Other trait
5545	GCST002799	Number of pregnancies	Number of pregnancies	Other measurement
5546	GCST002799	Number of pregnancies	Number of pregnancies	Other trait
5547	GCST002799	Number of pregnancies	Number of pregnancies	Other measurement
5548	GCST002801	Number of children	Number of children	Other measurement
5549	GCST002801	Number of children	Number of children	Other trait
5550	GCST002796	Bronchodilator response in asthma	Bronchodilator response in asthma	Response to drug
5551	GCST002796	Bronchodilator response in asthma	Bronchodilator response in asthma	Other disease
5552	GCST005539	Alopecia areata	Alopecia areata	Other disease
5553	GCST002795	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
5554	GCST002797	Pulmonary artery enlargement in chronic obstructive pulmonary disease	Pulmonary artery enlargement in chronic obstructive pulmonary disease	Other disease
5555	GCST002797	Pulmonary artery enlargement in chronic obstructive pulmonary disease	Pulmonary artery enlargement in chronic obstructive pulmonary disease	Other trait
5556	GCST002798	Pulmonary artery enlargement and chronic obstructive pulmonary disease	Pulmonary artery enlargement and chronic obstructive pulmonary disease	Other disease
5557	GCST002798	Pulmonary artery enlargement and chronic obstructive pulmonary disease	Pulmonary artery enlargement and chronic obstructive pulmonary disease	Other trait
5558	GCST002794	Airway wall thickness	Airway wall thickness	Other measurement
5559	GCST002793	Vein graft stenosis in coronary artery bypass grafting	Vein graft stenosis in coronary artery bypass grafting	Other trait
5560	GCST002793	Vein graft stenosis in coronary artery bypass grafting	Vein graft stenosis in coronary artery bypass grafting	Other trait
5561	GCST002656	Migraine in bipolar disorder	Migraine in bipolar disorder	Cardiovascular disease
5562	GCST002656	Migraine in bipolar disorder	Migraine in bipolar disorder	Neurological disorder
5563	GCST002655	IgA nephropathy	IgA nephropathy	Other disease
5564	GCST002654	Shingles	Shingles	Other disease
5565	GCST002654	Shingles	Shingles	Other measurement
5566	GCST002653	Circulating phylloquinone levels	Circulating phylloquinone levels	Other measurement
5567	GCST002652	Cotinine glucuronidation	Cotinine glucuronidation	Other measurement
5568	GCST002649	Nicotine glucouronidation	Nicotine glucouronidation	Other measurement
5569	GCST002651	Coffee consumption	Coffee consumption	Biological process
5570	GCST002651	Coffee consumption	Coffee consumption	Other measurement
5571	GCST002651	Coffee consumption	Coffee consumption	Other measurement
5572	GCST002650	Coffee consumption (cups per day)	Coffee consumption (cups per day)	Biological process
5573	GCST002650	Coffee consumption (cups per day)	Coffee consumption (cups per day)	Other measurement
5574	GCST002648	Persistent attention-deficit hyperactivity disorder	Persistent attention-deficit hyperactivity disorder	Neurological disorder
5575	GCST002647	Height	Height	Other measurement
5576	GCST002647	Height	Height	Body measurement
5577	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
5578	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
5579	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
5580	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
5581	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
5582	GCST002709	Electroencephalogram traits	Electroencephalogram traits	Other measurement
5583	GCST002705	Hashimoto thyroiditis versus Graves' disease	Hashimoto thyroiditis versus Graves' disease	Immune system disorder
5584	GCST002705	Hashimoto thyroiditis versus Graves' disease	Hashimoto thyroiditis versus Graves' disease	Immune system disorder
5585	GCST002705	Hashimoto thyroiditis versus Graves' disease	Hashimoto thyroiditis versus Graves' disease	Immune system disorder
5586	GCST002703	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
5587	GCST002704	Fractional exhaled nitric oxide levels	Fractional exhaled nitric oxide levels	Other measurement
5588	GCST002702	Height	Height	Other measurement
5589	GCST002702	Height	Height	Body measurement
5590	GCST002701	Verbal declarative memory	Verbal declarative memory	Other measurement
5591	GCST002701	Verbal declarative memory	Verbal declarative memory	Other measurement
5592	GCST002701	Verbal declarative memory	Verbal declarative memory	Other measurement
5593	GCST002700	Cervical artery dissection	Cervical artery dissection	Cardiovascular disease
5594	GCST002699	Suicide in bipolar disorder	Suicide in bipolar disorder	Biological process
5595	GCST002699	Suicide in bipolar disorder	Suicide in bipolar disorder	Neurological disorder
5596	GCST002699	Suicide in bipolar disorder	Suicide in bipolar disorder	Other measurement
5597	GCST002697	Eosinophilic esophagitis	Eosinophilic esophagitis	Digestive system disorder
5598	GCST002698	Serum VEGFR2 concentration	Serum VEGFR2 concentration	Other measurement
5599	GCST004389	Circulating chemerin levels	Circulating chemerin levels	Cardiovascular measurement
5600	GCST002725	Sepsis from pneumonia (survival)	Sepsis from pneumonia (survival)	Other measurement
5601	GCST002725	Sepsis from pneumonia (survival)	Sepsis from pneumonia (survival)	Other trait
5602	GCST002725	Sepsis from pneumonia (survival)	Sepsis from pneumonia (survival)	Other trait
5603	GCST002725	Sepsis from pneumonia (survival)	Sepsis from pneumonia (survival)	Other disease
5604	GCST002724	Airway responsiveness in chronic obstructive pulmonary disease	Airway responsiveness in chronic obstructive pulmonary disease	Other disease
5605	GCST002724	Airway responsiveness in chronic obstructive pulmonary disease	Airway responsiveness in chronic obstructive pulmonary disease	Other measurement
5606	GCST002723	Urgency urinary incontinence	Urgency urinary incontinence	Other trait
5607	GCST002722	Heparin-induced thrombocytopenia	Heparin-induced thrombocytopenia	Response to drug
5608	GCST002722	Heparin-induced thrombocytopenia	Heparin-induced thrombocytopenia	Other trait
5609	GCST002720	Kidney function decline traits	Kidney function decline traits	Other disease
5610	GCST002720	Kidney function decline traits	Kidney function decline traits	Other measurement
5611	GCST002720	Kidney function decline traits	Kidney function decline traits	Other trait
5612	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
5613	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
5614	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
5615	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
5616	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
5617	GCST002721	Trans fatty acid levels	Trans fatty acid levels	Lipid or lipoprotein measurement
5618	GCST002719	Seasonality	Seasonality	Other measurement
5619	GCST002718	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5620	GCST002716	Diabetic nephropathy in type 1 diabetes	Diabetic nephropathy in type 1 diabetes	Metabolic disorder
5621	GCST002716	Diabetic nephropathy in type 1 diabetes	Diabetic nephropathy in type 1 diabetes	Metabolic disorder
5622	GCST002645	Bladder cancer	Bladder cancer	Cancer
5623	GCST002646	Infant length	Infant length	Body measurement
5624	GCST002644	Birth length	Birth length	Body measurement
5625	GCST002643	Follicular lymphoma	Follicular lymphoma	Cancer
5626	GCST002641	Hip circumference (psychosocial stress interaction)	Hip circumference (psychosocial stress interaction)	Other measurement
5627	GCST002641	Hip circumference (psychosocial stress interaction)	Hip circumference (psychosocial stress interaction)	Body measurement
5628	GCST002642	Response to simvastatin treatment (PCSK9 protein level change)	Response to simvastatin treatment (PCSK9 protein level change)	Other measurement
5629	GCST002642	Response to simvastatin treatment (PCSK9 protein level change)	Response to simvastatin treatment (PCSK9 protein level change)	Response to drug
5630	GCST002639	Autism spectrum disorder-related traits	Autism spectrum disorder-related traits	Neurological disorder
5631	GCST002639	Autism spectrum disorder-related traits	Autism spectrum disorder-related traits	Neurological disorder
5632	GCST002639	Autism spectrum disorder-related traits	Autism spectrum disorder-related traits	Other measurement
5633	GCST002638	Gastritis	Gastritis	Digestive system disorder
5634	GCST002640	Inflammatory biomarkers in Kawasaki disease	Inflammatory biomarkers in Kawasaki disease	Immune system disorder
5635	GCST002640	Inflammatory biomarkers in Kawasaki disease	Inflammatory biomarkers in Kawasaki disease	Other measurement
5636	GCST002640	Inflammatory biomarkers in Kawasaki disease	Inflammatory biomarkers in Kawasaki disease	Inflammatory measurement
5637	GCST002637	Medication adherence in chronic diseases	Medication adherence in chronic diseases	Biological process
5638	GCST002637	Medication adherence in chronic diseases	Medication adherence in chronic diseases	Cardiovascular disease
5639	GCST002637	Medication adherence in chronic diseases	Medication adherence in chronic diseases	Metabolic disorder
5640	GCST002717	Serum IgE levels	Serum IgE levels	Other measurement
5641	GCST002715	Breastfeeding duration	Breastfeeding duration	Other measurement
5642	GCST002714	Plasma renin activity levels	Plasma renin activity levels	Cardiovascular measurement
5643	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
5644	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
5645	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
5646	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
5647	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
5648	GCST002712	Red blood cell fatty acid levels	Red blood cell fatty acid levels	Lipid or lipoprotein measurement
5649	GCST002713	Acute lymphoblastic leukemia (adolescents and young adults)	Acute lymphoblastic leukemia (adolescents and young adults)	Cancer
5650	GCST002711	Sleep duration	Sleep duration	Other measurement
5651	GCST002706	Electrodermal activity	Electrodermal activity	Other measurement
5652	GCST002706	Electrodermal activity	Electrodermal activity	Other measurement
5653	GCST002706	Electrodermal activity	Electrodermal activity	Other measurement
5654	GCST002706	Electrodermal activity	Electrodermal activity	Other measurement
5655	GCST002710	Anti-saccade response	Anti-saccade response	Other measurement
5656	GCST002707	Serum thyroid-stimulating hormone levels	Serum thyroid-stimulating hormone levels	Other measurement
5657	GCST002687	Fetal hemoglobin levels in sickle cell anemia	Fetal hemoglobin levels in sickle cell anemia	Neurological disorder
5658	GCST002687	Fetal hemoglobin levels in sickle cell anemia	Fetal hemoglobin levels in sickle cell anemia	Hematological measurement
5659	GCST002685	Refractive astigmatism	Refractive astigmatism	Other trait
5660	GCST002684	Diabetic retinopathy in type 2 diabetes	Diabetic retinopathy in type 2 diabetes	Metabolic disorder
5661	GCST002684	Diabetic retinopathy in type 2 diabetes	Diabetic retinopathy in type 2 diabetes	Metabolic disorder
5662	GCST002683	Pulmonary function	Pulmonary function	Other measurement
5663	GCST002683	Pulmonary function	Pulmonary function	Other measurement
5664	GCST002683	Pulmonary function	Pulmonary function	Other measurement
5665	GCST002683	Pulmonary function	Pulmonary function	Other measurement
5666	GCST002682	Tourette's syndrome or obsessive-compulsive disorder	Tourette's syndrome or obsessive-compulsive disorder	Neurological disorder
5667	GCST002682	Tourette's syndrome or obsessive-compulsive disorder	Tourette's syndrome or obsessive-compulsive disorder	Neurological disorder
5668	GCST002681	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
5669	GCST002676	Mammographic density	Mammographic density	Other measurement
5670	GCST002675	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Lipid or lipoprotein measurement
5671	GCST002675	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Lipid or lipoprotein measurement
5672	GCST002675	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Response to drug
5673	GCST002672	Febrile seizures	Febrile seizures	Other trait
5674	GCST002672	Febrile seizures	Febrile seizures	Other trait
5675	GCST002674	Febrile seizures (MMR vaccine-related)	Febrile seizures (MMR vaccine-related)	Other trait
5676	GCST002673	Febrile seizures (MMR vaccine-unrelated)	Febrile seizures (MMR vaccine-unrelated)	Other trait
5677	GCST002671	Toenail selenium levels	Toenail selenium levels	Other measurement
5678	GCST002670	Blood and toenail selenium levels	Blood and toenail selenium levels	Other measurement
5679	GCST002669	Percent mammographic density	Percent mammographic density	Other measurement
5680	GCST002669	Percent mammographic density	Percent mammographic density	Cancer
5681	GCST002669	Percent mammographic density	Percent mammographic density	Other measurement
5682	GCST002668	Mammographic density (non-dense area)	Mammographic density (non-dense area)	Other measurement
5683	GCST002668	Mammographic density (non-dense area)	Mammographic density (non-dense area)	Other measurement
5684	GCST002667	Mammographic density (dense area)	Mammographic density (dense area)	Other measurement
5685	GCST002667	Mammographic density (dense area)	Mammographic density (dense area)	Other measurement
5686	GCST002666	Interferon alpha levels in systemic lupus erythematosus	Interferon alpha levels in systemic lupus erythematosus	Other measurement
5687	GCST002666	Interferon alpha levels in systemic lupus erythematosus	Interferon alpha levels in systemic lupus erythematosus	Immune system disorder
5688	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Other measurement
5689	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Other measurement
5690	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Other measurement
5691	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Other measurement
5692	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Other measurement
5693	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Neurological disorder
5694	GCST002665	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	Inflammatory measurement
5695	GCST002663	Superior frontal gyrus grey matter volume	Superior frontal gyrus grey matter volume	Other measurement
5696	GCST002664	Maximal oxygen uptake response	Maximal oxygen uptake response	Other measurement
5697	GCST002662	Breast cancer	Breast cancer	Cancer
5698	GCST002661	HDL cholesterol (SNP x SNP interaction)	HDL cholesterol (SNP x SNP interaction)	Lipid or lipoprotein measurement
5699	GCST002660	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Metabolic disorder
5700	GCST002660	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Other measurement
5701	GCST002660	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	Other measurement
5702	GCST002659	Coronary artery disease-related phenotypes	Coronary artery disease-related phenotypes	Cardiovascular measurement
5703	GCST002659	Coronary artery disease-related phenotypes	Coronary artery disease-related phenotypes	Cardiovascular disease
5704	GCST002657	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
5705	GCST002658	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
5706	GCST002696	Anxiety disorder	Anxiety disorder	Neurological disorder
5707	GCST002695	Episodic memory	Episodic memory	Biological process
5708	GCST002693	Enteric fever	Enteric fever	Other disease
5709	GCST002694	General cognitive ability	General cognitive ability	Biological process
5710	GCST002692	Body mass index (change over time)	Body mass index (change over time)	Body measurement
5711	GCST002691	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Neurological disorder
5712	GCST002691	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Biological process
5713	GCST002691	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Alloimmunization response to red blood cell transfusion in sickle cell anemia	Biological process
5714	GCST002690	Very long-chain saturated fatty acid levels (fatty acid 20:0)	Very long-chain saturated fatty acid levels (fatty acid 20:0)	Lipid or lipoprotein measurement
5715	GCST002689	Very long-chain saturated fatty acid levels (fatty acid 24:0)	Very long-chain saturated fatty acid levels (fatty acid 24:0)	Lipid or lipoprotein measurement
5716	GCST002688	Very long-chain saturated fatty acid levels (fatty acid 22:0)	Very long-chain saturated fatty acid levels (fatty acid 22:0)	Lipid or lipoprotein measurement
5717	GCST002686	Protein C levels	Protein C levels	Hematological measurement
5718	GCST002598	Educational attainment	Educational attainment	Other measurement
5719	GCST002597	Laryngeal squamous cell carcinoma	Laryngeal squamous cell carcinoma	Cancer
5720	GCST007144	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
5721	GCST007145	Amyotrophic lateral sclerosis (age of onset)	Amyotrophic lateral sclerosis (age of onset)	Neurological disorder
5722	GCST007145	Amyotrophic lateral sclerosis (age of onset)	Amyotrophic lateral sclerosis (age of onset)	Other measurement
5723	GCST007146	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
5724	GCST002596	Colorectal cancer (calcium intake interaction)	Colorectal cancer (calcium intake interaction)	Other measurement
5725	GCST002596	Colorectal cancer (calcium intake interaction)	Colorectal cancer (calcium intake interaction)	Cancer
5726	GCST002595	Clozapine-induced agranulocytosis	Clozapine-induced agranulocytosis	Response to drug
5727	GCST002595	Clozapine-induced agranulocytosis	Clozapine-induced agranulocytosis	Other trait
5728	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Biological process
5729	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
5730	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
5731	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
5732	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
5733	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
5734	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
5735	GCST002587	Blood pressure (smoking interaction)	Blood pressure (smoking interaction)	Other measurement
5736	GCST002585	Antinuclear antibody levels	Antinuclear antibody levels	Other measurement
5737	GCST002586	Fasting plasma glucose	Fasting plasma glucose	Other measurement
5738	GCST002583	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Other measurement
5739	GCST002583	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Response to drug
5740	GCST002583	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	Other measurement
5741	GCST002584	Exhaled carbon monoxide levels	Exhaled carbon monoxide levels	Biological process
5742	GCST002584	Exhaled carbon monoxide levels	Exhaled carbon monoxide levels	Other measurement
5743	GCST002563	Hypospadias	Hypospadias	Other disease
5744	GCST002563	Hypospadias	Hypospadias	Other disease
5745	GCST007229	Thiopurine-induced early leukopenia in Crohn's disease	Thiopurine-induced early leukopenia in Crohn's disease	Digestive system disorder
5746	GCST007229	Thiopurine-induced early leukopenia in Crohn's disease	Thiopurine-induced early leukopenia in Crohn's disease	Other trait
5747	GCST007229	Thiopurine-induced early leukopenia in Crohn's disease	Thiopurine-induced early leukopenia in Crohn's disease	Response to drug
5748	GCST002562	Vogt-Koyanagi-Harada syndrome	Vogt-Koyanagi-Harada syndrome	Neurological disorder
5749	GCST002561	Colorectal cancer	Colorectal cancer	Cancer
5750	GCST002560	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
5751	GCST002558	Phenytoin-induced severe cutaneous adverse reactions	Phenytoin-induced severe cutaneous adverse reactions	Response to drug
5752	GCST002558	Phenytoin-induced severe cutaneous adverse reactions	Phenytoin-induced severe cutaneous adverse reactions	Other disease
5753	GCST002559	Vitamin B levels in ischemic stroke	Vitamin B levels in ischemic stroke	Other measurement
5754	GCST002559	Vitamin B levels in ischemic stroke	Vitamin B levels in ischemic stroke	Cardiovascular disease
5755	GCST002559	Vitamin B levels in ischemic stroke	Vitamin B levels in ischemic stroke	Other measurement
5756	GCST002559	Vitamin B levels in ischemic stroke	Vitamin B levels in ischemic stroke	Other measurement
5757	GCST002559	Vitamin B levels in ischemic stroke	Vitamin B levels in ischemic stroke	Other measurement
5758	GCST002556	White blood cell count	White blood cell count	Hematological measurement
5759	GCST002556	White blood cell count	White blood cell count	Inflammatory measurement
5760	GCST002556	White blood cell count	White blood cell count	Hematological measurement
5761	GCST002556	White blood cell count	White blood cell count	Hematological measurement
5762	GCST002556	White blood cell count	White blood cell count	Hematological measurement
5763	GCST002555	Monocyte count	Monocyte count	Hematological measurement
5764	GCST002557	Neutrophil count	Neutrophil count	Hematological measurement
5765	GCST002636	Diffuse large B cell lymphoma	Diffuse large B cell lymphoma	Cancer
5766	GCST002633	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
5767	GCST002635	Aggressive periodontitis (sex interaction)	Aggressive periodontitis (sex interaction)	Digestive system disorder
5768	GCST002635	Aggressive periodontitis (sex interaction)	Aggressive periodontitis (sex interaction)	Other measurement
5769	GCST002634	Kashin-Beck disease	Kashin-Beck disease	Other disease
5770	GCST002630	Systolic blood pressure	Systolic blood pressure	Other measurement
5771	GCST002630	Systolic blood pressure	Systolic blood pressure	Other measurement
5772	GCST002627	Hypertension	Hypertension	Cardiovascular disease
5773	GCST002631	Diastolic blood pressure	Diastolic blood pressure	Other measurement
5774	GCST002631	Diastolic blood pressure	Diastolic blood pressure	Other measurement
5775	GCST002628	Bilirubin levels in extreme obesity	Bilirubin levels in extreme obesity	Metabolic disorder
5776	GCST002628	Bilirubin levels in extreme obesity	Bilirubin levels in extreme obesity	Other measurement
5777	GCST002632	Hepatic lipid content in extreme obesity	Hepatic lipid content in extreme obesity	Lipid or lipoprotein measurement
5778	GCST002632	Hepatic lipid content in extreme obesity	Hepatic lipid content in extreme obesity	Metabolic disorder
5779	GCST002629	Irritable bowel syndrome	Irritable bowel syndrome	Digestive system disorder
5780	GCST002613	Chronic mucus hypersecretion	Chronic mucus hypersecretion	Other trait
5781	GCST002614	Multiple myeloma	Multiple myeloma	Cancer
5782	GCST002615	Myopia	Myopia	Other trait
5783	GCST002612	Chronic mucus hypersecretion in chronic obstructive pulmonary disease	Chronic mucus hypersecretion in chronic obstructive pulmonary disease	Other disease
5784	GCST002612	Chronic mucus hypersecretion in chronic obstructive pulmonary disease	Chronic mucus hypersecretion in chronic obstructive pulmonary disease	Other trait
5785	GCST002617	Hyperopia	Hyperopia	Other trait
5786	GCST002617	Hyperopia	Hyperopia	Neurological disorder
5787	GCST002610	Fasting plasma glucose (childhood)	Fasting plasma glucose (childhood)	Other measurement
5788	GCST002611	Expressive vocabulary in infants	Expressive vocabulary in infants	Biological process
5789	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
5790	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
5791	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
5792	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
5793	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
5794	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
5795	GCST002609	Iron status biomarkers	Iron status biomarkers	Other measurement
5796	GCST002608	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
5797	GCST002608	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
5798	GCST002608	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
5799	GCST002608	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other disease
5800	GCST002606	Prostate cancer	Prostate cancer	Cancer
5801	GCST002607	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Digestive system disorder
5802	GCST002607	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Response to drug
5803	GCST002607	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	Digestive system disorder
5804	GCST002605	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Digestive system disorder
5805	GCST002605	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Response to drug
5806	GCST002605	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	Cancer
5807	GCST002604	Schizophrenia (treatment resistant)	Schizophrenia (treatment resistant)	Neurological disorder
5808	GCST007161	beta-lactam allergy measurement	beta-lactam allergy measurement	Other measurement
5809	GCST002603	Creatine kinase in statin users	Creatine kinase in statin users	Cardiovascular measurement
5810	GCST002603	Creatine kinase in statin users	Creatine kinase in statin users	Response to drug
5811	GCST002602	Vitamin D levels	Vitamin D levels	Other measurement
5812	GCST002601	Plasma plasminogen levels	Plasma plasminogen levels	Other measurement
5813	GCST002600	Response to thiazide diuretic treatment (hypokalemia)	Response to thiazide diuretic treatment (hypokalemia)	Response to drug
5814	GCST002600	Response to thiazide diuretic treatment (hypokalemia)	Response to thiazide diuretic treatment (hypokalemia)	Other trait
5815	GCST002599	Longevity (90 years and older)	Longevity (90 years and older)	Other measurement
5816	GCST002572	Congenital left-sided heart lesions	Congenital left-sided heart lesions	Cardiovascular disease
5817	GCST002568	Esophageal squamous cell carcinoma	Esophageal squamous cell carcinoma	Cancer
5818	GCST005562	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
5819	GCST002567	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Cancer
5820	GCST002567	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Cardiovascular disease
5821	GCST002567	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	Response to drug
5822	GCST002566	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Cancer
5823	GCST002566	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Cardiovascular disease
5824	GCST002566	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	Response to drug
5825	GCST002564	Bipolar disorder (early onset)	Bipolar disorder (early onset)	Neurological disorder
5826	GCST002565	Sleep duration	Sleep duration	Other measurement
5827	GCST002626	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
5828	GCST002626	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
5829	GCST002623	L-arginine levels	L-arginine levels	Other measurement
5830	GCST002621	Chronic bronchitis in chronic obstructive pulmonary disease	Chronic bronchitis in chronic obstructive pulmonary disease	Other disease
5831	GCST002621	Chronic bronchitis in chronic obstructive pulmonary disease	Chronic bronchitis in chronic obstructive pulmonary disease	Other disease
5832	GCST002625	Chronic bronchitis and chronic obstructive pulmonary disease	Chronic bronchitis and chronic obstructive pulmonary disease	Other disease
5833	GCST002625	Chronic bronchitis and chronic obstructive pulmonary disease	Chronic bronchitis and chronic obstructive pulmonary disease	Other disease
5834	GCST002622	Symmetrical dimethylarginine levels	Symmetrical dimethylarginine levels	Cardiovascular measurement
5835	GCST002622	Symmetrical dimethylarginine levels	Symmetrical dimethylarginine levels	Other measurement
5836	GCST002620	Asymmetrical dimethylarginine levels	Asymmetrical dimethylarginine levels	Cardiovascular measurement
5837	GCST002620	Asymmetrical dimethylarginine levels	Asymmetrical dimethylarginine levels	Other measurement
5838	GCST002624	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
5839	GCST002619	Age-related cataracts	Age-related cataracts	Other trait
5840	GCST002618	Age-related cataracts (age at onset)	Age-related cataracts (age at onset)	Other measurement
5841	GCST002618	Age-related cataracts (age at onset)	Age-related cataracts (age at onset)	Other trait
5842	GCST002616	Mitochondrial DNA levels	Mitochondrial DNA levels	Other measurement
5843	GCST002581	Glaucoma (high intraocular pressure)	Glaucoma (high intraocular pressure)	Neurological disorder
5844	GCST002580	Intraocular pressure	Intraocular pressure	Other measurement
5845	GCST002582	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
5846	GCST002579	Heschl's gyrus morphology	Heschl's gyrus morphology	Other measurement
5847	GCST002578	Ferritin levels	Ferritin levels	Other measurement
5848	GCST002577	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Other measurement
5849	GCST002577	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Cancer
5850	GCST002576	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
5851	GCST002576	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
5852	GCST002574	Congenital left-sided heart lesions (maternal effect)	Congenital left-sided heart lesions (maternal effect)	Cardiovascular disease
5853	GCST002574	Congenital left-sided heart lesions (maternal effect)	Congenital left-sided heart lesions (maternal effect)	Other measurement
5854	GCST004401	Reading disability or specific language impairment (pleiotropy)	Reading disability or specific language impairment (pleiotropy)	Neurological disorder
5855	GCST004401	Reading disability or specific language impairment (pleiotropy)	Reading disability or specific language impairment (pleiotropy)	Neurological disorder
5856	GCST004402	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Biological process
5857	GCST004402	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Neurological disorder
5858	GCST004402	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	Neurological disorder
5859	GCST002544	Parkinson's disease	Parkinson's disease	Neurological disorder
5860	GCST002545	Ossification of the posterior longitudinal ligament of the spine	Ossification of the posterior longitudinal ligament of the spine	Other disease
5861	GCST002543	Hearing function	Hearing function	Biological process
5862	GCST002540	Osteoarthritis biomarkers	Osteoarthritis biomarkers	Other measurement
5863	GCST002541	Menarche (age at onset)	Menarche (age at onset)	Other measurement
5864	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
5865	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
5866	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
5867	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
5868	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
5869	GCST002542	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
5870	GCST002539	Schizophrenia	Schizophrenia	Neurological disorder
5871	GCST002538	Height adjusted BMI	Height adjusted BMI	Body measurement
5872	GCST002488	Anti-citrullinated peptide antibody	Anti-citrullinated peptide antibody	Other measurement
5873	GCST002487	Age-related hearing impairment (SNP x SNP interaction)	Age-related hearing impairment (SNP x SNP interaction)	Neurological disorder
5874	GCST002485	Elevated serum carcinoembryonic antigen levels	Elevated serum carcinoembryonic antigen levels	Other measurement
5875	GCST002489	Rheumatoid factor	Rheumatoid factor	Other measurement
5876	GCST002486	Exfoliation glaucoma or exfoliation syndrome	Exfoliation glaucoma or exfoliation syndrome	Neurological disorder
5877	GCST002491	Age-related hearing impairment	Age-related hearing impairment	Neurological disorder
5878	GCST002484	Skin fluorescence	Skin fluorescence	Other measurement
5879	GCST002483	Lung function (forced vital capacity)	Lung function (forced vital capacity)	Other measurement
5880	GCST002482	Carotid plaque burden (smoking interaction)	Carotid plaque burden (smoking interaction)	Other measurement
5881	GCST002482	Carotid plaque burden (smoking interaction)	Carotid plaque burden (smoking interaction)	Cardiovascular measurement
5882	GCST002481	Acne (severe)	Acne (severe)	Other disease
5883	GCST002479	Lupus nephritis in systemic lupus erythematosus	Lupus nephritis in systemic lupus erythematosus	Immune system disorder
5884	GCST002479	Lupus nephritis in systemic lupus erythematosus	Lupus nephritis in systemic lupus erythematosus	Immune system disorder
5885	GCST002480	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
5886	GCST002476	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
5887	GCST002475	Myocardial infarction	Myocardial infarction	Cardiovascular disease
5888	GCST002477	Alcohol dependence (age at onset)	Alcohol dependence (age at onset)	Neurological disorder
5889	GCST002477	Alcohol dependence (age at onset)	Alcohol dependence (age at onset)	Other measurement
5890	GCST002478	Coronary heart disease in familial hypercholesterolemia	Coronary heart disease in familial hypercholesterolemia	Cardiovascular disease
5891	GCST002478	Coronary heart disease in familial hypercholesterolemia	Coronary heart disease in familial hypercholesterolemia	Metabolic disorder
5892	GCST002474	Glioma (high-grade)	Glioma (high-grade)	Cancer
5893	GCST002473	Response to rate control therapy in atrial fibrillation	Response to rate control therapy in atrial fibrillation	Cardiovascular disease
5894	GCST002473	Response to rate control therapy in atrial fibrillation	Response to rate control therapy in atrial fibrillation	Response to drug
5895	GCST002472	Morphine dose requirement in tonsillectomy and adenoidectomy surgery	Morphine dose requirement in tonsillectomy and adenoidectomy surgery	Response to drug
5896	GCST002554	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Other measurement
5897	GCST002554	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Other measurement
5898	GCST002554	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Other measurement
5899	GCST002554	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	Other measurement
5900	GCST002553	Pancreatic cancer	Pancreatic cancer	Cancer
5901	GCST002552	Allergic rhinitis in asthma	Allergic rhinitis in asthma	Other disease
5902	GCST002552	Allergic rhinitis in asthma	Allergic rhinitis in asthma	Immune system disorder
5903	GCST002550	Allergic rhinitis	Allergic rhinitis	Immune system disorder
5904	GCST002550	Allergic rhinitis	Allergic rhinitis	Immune system disorder
5905	GCST002551	Allergic rhinitis in non-asthmatics	Allergic rhinitis in non-asthmatics	Immune system disorder
5906	GCST002549	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	Response to drug
5907	GCST002549	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)	Neurological disorder
5908	GCST006522	Upper eyelid sagging severity	Upper eyelid sagging severity	Other measurement
5909	GCST002548	Ulcerative colitis	Ulcerative colitis	Immune system disorder
5910	GCST002546	Osteoprotegerin levels	Osteoprotegerin levels	Cardiovascular measurement
5911	GCST002547	Epilepsy	Epilepsy	Neurological disorder
5912	GCST002547	Epilepsy	Epilepsy	Neurological disorder
5913	GCST002547	Epilepsy	Epilepsy	Neurological disorder
5914	GCST002507	Neuropathic pain in type 2 diabetes	Neuropathic pain in type 2 diabetes	Metabolic disorder
5915	GCST002507	Neuropathic pain in type 2 diabetes	Neuropathic pain in type 2 diabetes	Other trait
5916	GCST002506	Blood pressure	Blood pressure	Other measurement
5917	GCST002506	Blood pressure	Blood pressure	Other measurement
5918	GCST002506	Blood pressure	Blood pressure	Other measurement
5919	GCST002506	Blood pressure	Blood pressure	Other measurement
5920	GCST002506	Blood pressure	Blood pressure	Cardiovascular measurement
5921	GCST002505	Suicidal ideation in depression or bipolar disorder	Suicidal ideation in depression or bipolar disorder	Biological process
5922	GCST002505	Suicidal ideation in depression or bipolar disorder	Suicidal ideation in depression or bipolar disorder	Neurological disorder
5923	GCST002505	Suicidal ideation in depression or bipolar disorder	Suicidal ideation in depression or bipolar disorder	Neurological disorder
5924	GCST002503	Suicide attempts in depression or bipolar disorder	Suicide attempts in depression or bipolar disorder	Biological process
5925	GCST002503	Suicide attempts in depression or bipolar disorder	Suicide attempts in depression or bipolar disorder	Neurological disorder
5926	GCST002503	Suicide attempts in depression or bipolar disorder	Suicide attempts in depression or bipolar disorder	Neurological disorder
5927	GCST002504	Peripheral artery disease	Peripheral artery disease	Cardiovascular disease
5928	GCST002502	Corneal curvature	Corneal curvature	Other measurement
5929	GCST002500	QT interval	QT interval	Cardiovascular measurement
5930	GCST002501	Birdshot chorioretinopathy	Birdshot chorioretinopathy	Cardiovascular disease
5931	GCST002498	Age-related nuclear cataracts	Age-related nuclear cataracts	Other trait
5932	GCST002499	Birth weight	Birth weight	Body measurement
5933	GCST002496	Bone mineral density (paediatric, upper limb)	Bone mineral density (paediatric, upper limb)	Other measurement
5934	GCST002493	Bone mineral density (paediatric, skull)	Bone mineral density (paediatric, skull)	Other measurement
5935	GCST002495	Blood pressure (age interaction)	Blood pressure (age interaction)	Other measurement
5936	GCST002495	Blood pressure (age interaction)	Blood pressure (age interaction)	Other measurement
5937	GCST002495	Blood pressure (age interaction)	Blood pressure (age interaction)	Other measurement
5938	GCST002495	Blood pressure (age interaction)	Blood pressure (age interaction)	Other measurement
5939	GCST002495	Blood pressure (age interaction)	Blood pressure (age interaction)	Cardiovascular measurement
5940	GCST002497	Blood pressure	Blood pressure	Other measurement
5941	GCST002497	Blood pressure	Blood pressure	Other measurement
5942	GCST002497	Blood pressure	Blood pressure	Other measurement
5943	GCST002497	Blood pressure	Blood pressure	Other measurement
5944	GCST002497	Blood pressure	Blood pressure	Cardiovascular measurement
5945	GCST002492	Bone mineral density (paediatric, lower limb)	Bone mineral density (paediatric, lower limb)	Other measurement
5946	GCST002494	Bone mineral density (paediatric, total body less head)	Bone mineral density (paediatric, total body less head)	Other measurement
5947	GCST002490	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
5948	GCST002490	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
5949	GCST002518	Food antigen IgG levels	Food antigen IgG levels	Biological process
5950	GCST002518	Food antigen IgG levels	Food antigen IgG levels	Other measurement
5951	GCST002515	Pneumoconiosis in silica exposure	Pneumoconiosis in silica exposure	Other disease
5952	GCST002515	Pneumoconiosis in silica exposure	Pneumoconiosis in silica exposure	Biological process
5953	GCST002516	Frontotemporal dementia	Frontotemporal dementia	Neurological disorder
5954	GCST002514	Melanoma	Melanoma	Cancer
5955	GCST002512	Colorectal cancer	Colorectal cancer	Cancer
5956	GCST002513	Colorectal cancer (SNP x SNP interaction)	Colorectal cancer (SNP x SNP interaction)	Cancer
5957	GCST002511	Response to radiotherapy in prostate cancer (toxicity)	Response to radiotherapy in prostate cancer (toxicity)	Cancer
5958	GCST002511	Response to radiotherapy in prostate cancer (toxicity)	Response to radiotherapy in prostate cancer (toxicity)	Biological process
5959	GCST002510	Amyotrophic lateral sclerosis or frontotemporal dementia	Amyotrophic lateral sclerosis or frontotemporal dementia	Neurological disorder
5960	GCST002510	Amyotrophic lateral sclerosis or frontotemporal dementia	Amyotrophic lateral sclerosis or frontotemporal dementia	Neurological disorder
5961	GCST002509	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
5962	GCST002508	Frontotemporal dementia	Frontotemporal dementia	Neurological disorder
5963	GCST002527	Eosinophilic esophagitis	Eosinophilic esophagitis	Digestive system disorder
5964	GCST002526	Cortisol levels (plasma)	Cortisol levels (plasma)	Other measurement
5965	GCST002525	Local histogram emphysema pattern	Local histogram emphysema pattern	Other measurement
5966	GCST002524	Chronic periodontitis	Chronic periodontitis	Digestive system disorder
5967	GCST002522	Reading or mathematical ability	Reading or mathematical ability	Biological process
5968	GCST002522	Reading or mathematical ability	Reading or mathematical ability	Biological process
5969	GCST002523	Alzheimer's disease	Alzheimer's disease	Neurological disorder
5970	GCST002521	Lung function (forced expiratory volume in 1 second)	Lung function (forced expiratory volume in 1 second)	Other measurement
5971	GCST002520	Celiac disease	Celiac disease	Immune system disorder
5972	GCST002519	Asthma or chronic obstructive pulmonary disease	Asthma or chronic obstructive pulmonary disease	Other disease
5973	GCST002519	Asthma or chronic obstructive pulmonary disease	Asthma or chronic obstructive pulmonary disease	Other disease
5974	GCST002517	Rate of change of FEV1 (time interaction)	Rate of change of FEV1 (time interaction)	Other measurement
5975	GCST002517	Rate of change of FEV1 (time interaction)	Rate of change of FEV1 (time interaction)	Other measurement
5976	GCST002537	Breast cancer	Breast cancer	Cancer
5977	GCST002536	Hemoglobin A2 levels in sickle cell anemia	Hemoglobin A2 levels in sickle cell anemia	Neurological disorder
5978	GCST002536	Hemoglobin A2 levels in sickle cell anemia	Hemoglobin A2 levels in sickle cell anemia	Hematological measurement
5979	GCST002535	PR interval	PR interval	Cardiovascular measurement
5980	GCST002533	QRS duration	QRS duration	Cardiovascular measurement
5981	GCST002533	QRS duration	QRS duration	Cardiovascular measurement
5982	GCST002533	QRS duration	QRS duration	Cardiovascular measurement
5983	GCST002534	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	Digestive system disorder
5984	GCST002534	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	Immune system disorder
5985	GCST002529	Glaucoma	Glaucoma	Neurological disorder
5986	GCST002532	High serum lipase activity	High serum lipase activity	Other measurement
5987	GCST002531	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Neurological disorder
5988	GCST002531	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Other measurement
5989	GCST002530	Serum lipase activity	Serum lipase activity	Other measurement
5990	GCST002528	Colorectal cancer	Colorectal cancer	Cancer
5991	GCST002442	Blood metabolite ratios	Blood metabolite ratios	Other measurement
5992	GCST002443	Blood metabolite levels	Blood metabolite levels	Other measurement
5993	GCST002443	Blood metabolite levels	Blood metabolite levels	Other measurement
5994	GCST002443	Blood metabolite levels	Blood metabolite levels	Other measurement
5995	GCST002443	Blood metabolite levels	Blood metabolite levels	Other measurement
5996	GCST002440	Staphylococcus aureus infection	Staphylococcus aureus infection	Other disease
5997	GCST002441	Immune response to measles-mumps-rubella vaccine	Immune response to measles-mumps-rubella vaccine	Response to drug
5998	GCST002439	Mathematical ability	Mathematical ability	Biological process
5999	GCST002438	Conotruncal heart defects	Conotruncal heart defects	Cardiovascular disease
6000	GCST002438	Conotruncal heart defects	Conotruncal heart defects	Other measurement
6001	GCST002437	Telomere length	Telomere length	Other measurement
6002	GCST002435	Body mass index	Body mass index	Body measurement
6003	GCST002435	Body mass index	Body mass index	Body measurement
6004	GCST002435	Body mass index	Body mass index	Other measurement
6005	GCST002452	Substance dependence phenotypes	Substance dependence phenotypes	Neurological disorder
6006	GCST002453	Ulcerative colitis	Ulcerative colitis	Immune system disorder
6007	GCST002450	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Lipid or lipoprotein measurement
6008	GCST002450	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	Lipid or lipoprotein measurement
6009	GCST002444	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Lipid or lipoprotein measurement
6010	GCST002444	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	Lipid or lipoprotein measurement
6011	GCST002451	Obsessive-compulsive disorder	Obsessive-compulsive disorder	Neurological disorder
6012	GCST002445	Asthma (sex interaction)	Asthma (sex interaction)	Other disease
6013	GCST002445	Asthma (sex interaction)	Asthma (sex interaction)	Other measurement
6014	GCST002446	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Lipid or lipoprotein measurement
6015	GCST002446	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	Lipid or lipoprotein measurement
6016	GCST002447	Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	Other disease
6017	GCST002447	Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)	Other measurement
6018	GCST002448	Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	Lipid or lipoprotein measurement
6019	GCST002449	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Lipid or lipoprotein measurement
6020	GCST002449	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	Lipid or lipoprotein measurement
6021	GCST002462	Alzheimer's disease (SNP x SNP interaction)	Alzheimer's disease (SNP x SNP interaction)	Neurological disorder
6022	GCST002460	Urinary bladder cancer	Urinary bladder cancer	Cancer
6023	GCST002461	Body mass index	Body mass index	Body measurement
6024	GCST002461	Body mass index	Body mass index	Body measurement
6025	GCST002461	Body mass index	Body mass index	Other measurement
6026	GCST002459	Lean body mass	Lean body mass	Other measurement
6027	GCST002458	Serum thyroid-stimulating hormone levels	Serum thyroid-stimulating hormone levels	Other measurement
6028	GCST002457	P wave duration	P wave duration	Cardiovascular measurement
6029	GCST002456	PR segment	PR segment	Cardiovascular measurement
6030	GCST002455	Parkinson's disease	Parkinson's disease	Neurological disorder
6031	GCST006055	Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	Lipid or lipoprotein measurement
6032	GCST006055	Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	Biological process
6033	GCST002454	Colorectal cancer	Colorectal cancer	Cancer
6034	GCST004705	Blood pressure	Blood pressure	Other measurement
6035	GCST004705	Blood pressure	Blood pressure	Other measurement
6036	GCST004705	Blood pressure	Blood pressure	Other measurement
6037	GCST004705	Blood pressure	Blood pressure	Other measurement
6038	GCST004705	Blood pressure	Blood pressure	Cardiovascular measurement
6039	GCST002471	Blood pressure (anthropometric measures interaction)	Blood pressure (anthropometric measures interaction)	Other measurement
6040	GCST002471	Blood pressure (anthropometric measures interaction)	Blood pressure (anthropometric measures interaction)	Body measurement
6041	GCST002471	Blood pressure (anthropometric measures interaction)	Blood pressure (anthropometric measures interaction)	Body measurement
6042	GCST002471	Blood pressure (anthropometric measures interaction)	Blood pressure (anthropometric measures interaction)	Other measurement
6043	GCST002471	Blood pressure (anthropometric measures interaction)	Blood pressure (anthropometric measures interaction)	Other measurement
6044	GCST002470	Pulse pressure in young-onset hypertension	Pulse pressure in young-onset hypertension	Cardiovascular disease
6045	GCST002470	Pulse pressure in young-onset hypertension	Pulse pressure in young-onset hypertension	Cardiovascular measurement
6046	GCST002467	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
6047	GCST002468	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
6048	GCST002469	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
6049	GCST002465	Response to haloperidol in psychosis	Response to haloperidol in psychosis	Response to drug
6050	GCST002465	Response to haloperidol in psychosis	Response to haloperidol in psychosis	Neurological disorder
6051	GCST002466	Lung cancer	Lung cancer	Cancer
6052	GCST002466	Lung cancer	Lung cancer	Cancer
6053	GCST002466	Lung cancer	Lung cancer	Cancer
6054	GCST002464	End-stage renal disease or diabetic nephropathy in type 1 diabetes	End-stage renal disease or diabetic nephropathy in type 1 diabetes	Other disease
6055	GCST002464	End-stage renal disease or diabetic nephropathy in type 1 diabetes	End-stage renal disease or diabetic nephropathy in type 1 diabetes	Metabolic disorder
6056	GCST002464	End-stage renal disease or diabetic nephropathy in type 1 diabetes	End-stage renal disease or diabetic nephropathy in type 1 diabetes	Metabolic disorder
6057	GCST002463	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
6058	GCST002423	Autoimmune hepatitis type-1	Autoimmune hepatitis type-1	Immune system disorder
6059	GCST002422	Alzheimer's disease	Alzheimer's disease	Neurological disorder
6060	GCST002421	Prostate cancer	Prostate cancer	Cancer
6061	GCST002420	Binge eating behaviour in bipolar disorder	Binge eating behaviour in bipolar disorder	Metabolic disorder
6062	GCST002420	Binge eating behaviour in bipolar disorder	Binge eating behaviour in bipolar disorder	Neurological disorder
6063	GCST002419	Binge eating behaviour and bipolar disorder	Binge eating behaviour and bipolar disorder	Metabolic disorder
6064	GCST002419	Binge eating behaviour and bipolar disorder	Binge eating behaviour and bipolar disorder	Neurological disorder
6065	GCST002415	Colorectal cancer (diet interaction)	Colorectal cancer (diet interaction)	Other measurement
6066	GCST002415	Colorectal cancer (diet interaction)	Colorectal cancer (diet interaction)	Cancer
6067	GCST002417	Plasma thyroid-stimulating hormone levels	Plasma thyroid-stimulating hormone levels	Other measurement
6068	GCST002416	Thyroid peroxidase antibody positivity	Thyroid peroxidase antibody positivity	Other measurement
6069	GCST002418	Free thyroxine concentration	Free thyroxine concentration	Other measurement
6070	GCST002414	Serum vitamin D-binding protein levels	Serum vitamin D-binding protein levels	Other measurement
6071	GCST002436	Irritable bowel syndrome	Irritable bowel syndrome	Digestive system disorder
6072	GCST002432	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to drug
6073	GCST002432	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Other measurement
6074	GCST002432	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Response to inhaled corticosteroid treatment in asthma (change in FEV1)	Other disease
6075	GCST002431	Response to radiotherapy in cancer (late toxicity)	Response to radiotherapy in cancer (late toxicity)	Cancer
6076	GCST002431	Response to radiotherapy in cancer (late toxicity)	Response to radiotherapy in cancer (late toxicity)	Cancer
6077	GCST002431	Response to radiotherapy in cancer (late toxicity)	Response to radiotherapy in cancer (late toxicity)	Biological process
6078	GCST002430	Hippocampal sclerosis of aging	Hippocampal sclerosis of aging	Neurological disorder
6079	GCST002429	Alzheimer's disease	Alzheimer's disease	Neurological disorder
6080	GCST002428	Cardiovascular event reduction in the elderly at risk for vascular disease (statin therapy interaction)	Cardiovascular event reduction in the elderly at risk for vascular disease (statin therapy interaction)	Response to drug
6081	GCST002426	Puberty onset (genital enlargement)	Puberty onset (genital enlargement)	Other measurement
6082	GCST002425	Puberty onset	Puberty onset	Other measurement
6083	GCST002427	Puberty onset (breast development)	Puberty onset (breast development)	Other measurement
6084	GCST002424	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
6085	GCST002404	Longevity (90 years and older)	Longevity (90 years and older)	Other measurement
6086	GCST002403	Longevity (85 years and older)	Longevity (85 years and older)	Other measurement
6087	GCST002401	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
6088	GCST002402	Serum IgA levels	Serum IgA levels	Other measurement
6089	GCST002400	Plasma trimethylamine N-oxide levels	Plasma trimethylamine N-oxide levels	Other measurement
6090	GCST002399	Clubfoot	Clubfoot	Other disease
6091	GCST002413	Prostate cancer (early onset)	Prostate cancer (early onset)	Cancer
6092	GCST002412	Non-small cell lung cancer (recurrence rate)	Non-small cell lung cancer (recurrence rate)	Other measurement
6093	GCST002412	Non-small cell lung cancer (recurrence rate)	Non-small cell lung cancer (recurrence rate)	Cancer
6094	GCST002411	Colorectal cancer	Colorectal cancer	Cancer
6095	GCST002409	White matter microstructure (global fractional anisotropy)	White matter microstructure (global fractional anisotropy)	Other measurement
6096	GCST002410	Osteoarthritis (hand, severe)	Osteoarthritis (hand, severe)	Other disease
6097	GCST002407	Chronic mucus hypersecretion	Chronic mucus hypersecretion	Other trait
6098	GCST002408	Response to methotrexate in juvenile idiopathic arthritis	Response to methotrexate in juvenile idiopathic arthritis	Response to drug
6099	GCST002408	Response to methotrexate in juvenile idiopathic arthritis	Response to methotrexate in juvenile idiopathic arthritis	Immune system disorder
6100	GCST002406	Plasma cystastin c levels in acute coronary syndrome	Plasma cystastin c levels in acute coronary syndrome	Cardiovascular disease
6101	GCST002406	Plasma cystastin c levels in acute coronary syndrome	Plasma cystastin c levels in acute coronary syndrome	Other measurement
6102	GCST002405	Cervical cancer	Cervical cancer	Cancer
6103	GCST002357	Rheumatoid arthritis (ACPA-negative)	Rheumatoid arthritis (ACPA-negative)	Immune system disorder
6104	GCST006048	Rheumatoid arthritis (ACPA-positive)	Rheumatoid arthritis (ACPA-positive)	Immune system disorder
6105	GCST002355	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
6106	GCST002356	Intraocular pressure	Intraocular pressure	Other measurement
6107	GCST002354	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
6108	GCST002354	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
6109	GCST002353	Parkinson's disease	Parkinson's disease	Neurological disorder
6110	GCST002352	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6111	GCST002351	Chronic obstructive pulmonary disease (moderate to severe)	Chronic obstructive pulmonary disease (moderate to severe)	Other disease
6112	GCST002350	Chronic obstructive pulmonary disease (severe)	Chronic obstructive pulmonary disease (severe)	Other disease
6113	GCST002325	Memory performance	Memory performance	Other measurement
6114	GCST002323	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
6115	GCST004712	Alcohol dependence	Alcohol dependence	Other measurement
6116	GCST004712	Alcohol dependence	Alcohol dependence	Neurological disorder
6117	GCST004711	Alcohol dependence	Alcohol dependence	Other measurement
6118	GCST004711	Alcohol dependence	Alcohol dependence	Neurological disorder
6119	GCST002324	Anger	Anger	Biological process
6120	GCST002321	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6121	GCST002321	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6122	GCST002321	Lipid traits	Lipid traits	Other measurement
6123	GCST002321	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6124	GCST002321	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6125	GCST002322	Asthma and hay fever	Asthma and hay fever	Other disease
6126	GCST002322	Asthma and hay fever	Asthma and hay fever	Immune system disorder
6127	GCST002320	Cognitive decline (age-related)	Cognitive decline (age-related)	Other trait
6128	GCST002319	Musician's dystonia	Musician's dystonia	Neurological disorder
6129	GCST002343	Response to cytidine analogues (gemcitabine)	Response to cytidine analogues (gemcitabine)	Response to drug
6130	GCST002342	Asthma (corticosteroid response)	Asthma (corticosteroid response)	Response to drug
6131	GCST002342	Asthma (corticosteroid response)	Asthma (corticosteroid response)	Other disease
6132	GCST002340	Colorectal cancer	Colorectal cancer	Cancer
6133	GCST002341	Telomere length	Telomere length	Other measurement
6134	GCST002339	Type 2 diabetes (young onset) and obesity	Type 2 diabetes (young onset) and obesity	Metabolic disorder
6135	GCST002339	Type 2 diabetes (young onset) and obesity	Type 2 diabetes (young onset) and obesity	Metabolic disorder
6136	GCST002338	Bipolar I disorder	Bipolar I disorder	Neurological disorder
6137	GCST002338	Bipolar I disorder	Bipolar I disorder	Neurological disorder
6138	GCST002337	Amyotrophic lateral sclerosis (sporadic)	Amyotrophic lateral sclerosis (sporadic)	Neurological disorder
6139	GCST002336	Telomere length	Telomere length	Other measurement
6140	GCST002376	Urinary uromodulin levels	Urinary uromodulin levels	Other measurement
6141	GCST002374	Plasma plasminogen activator levels	Plasma plasminogen activator levels	Cardiovascular measurement
6142	GCST002377	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	Cardiovascular disease
6143	GCST002377	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy	Other measurement
6144	GCST002375	Response to methotrexate in rheumatoid arthritis	Response to methotrexate in rheumatoid arthritis	Immune system disorder
6145	GCST002375	Response to methotrexate in rheumatoid arthritis	Response to methotrexate in rheumatoid arthritis	Response to drug
6146	GCST002373	Thyroid peroxidase antibody levels	Thyroid peroxidase antibody levels	Other measurement
6147	GCST002378	Thyroid peroxidase antibody positivity	Thyroid peroxidase antibody positivity	Other measurement
6148	GCST002371	Parent of origin effect on language impairment (paternal)	Parent of origin effect on language impairment (paternal)	Neurological disorder
6149	GCST002370	Fibromyalgia	Fibromyalgia	Immune system disorder
6150	GCST002369	Parent of origin effect on language impairment (maternal)	Parent of origin effect on language impairment (maternal)	Neurological disorder
6151	GCST002372	Political ideology	Political ideology	Other trait
6152	GCST002368	Maternal genotype effects in autism spectrum disorder families	Maternal genotype effects in autism spectrum disorder families	Neurological disorder
6153	GCST002368	Maternal genotype effects in autism spectrum disorder families	Maternal genotype effects in autism spectrum disorder families	Other measurement
6154	GCST002367	Social communication problems	Social communication problems	Other measurement
6155	GCST002366	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Response to drug
6156	GCST002366	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Other disease
6157	GCST002366	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)	Neurological disorder
6158	GCST002365	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Response to drug
6159	GCST002365	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Other disease
6160	GCST002365	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)	Neurological disorder
6161	GCST002363	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Response to drug
6162	GCST002363	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Other disease
6163	GCST002363	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)	Neurological disorder
6164	GCST002364	Urinary metabolites (H-NMR features)	Urinary metabolites (H-NMR features)	Other measurement
6165	GCST002362	Preschool internalizing problems	Preschool internalizing problems	Other measurement
6166	GCST002358	Pit-and-Fissure caries	Pit-and-Fissure caries	Digestive system disorder
6167	GCST002361	Smooth-surface caries	Smooth-surface caries	Digestive system disorder
6168	GCST002398	Resting heart rate	Resting heart rate	Cardiovascular measurement
6169	GCST002393	Smoking quantity	Smoking quantity	Other measurement
6170	GCST002397	Bladder cancer (smoking interaction)	Bladder cancer (smoking interaction)	Cancer
6171	GCST002395	Smoking cessation	Smoking cessation	Biological process
6172	GCST002394	Age of smoking initiation	Age of smoking initiation	Biological process
6173	GCST002394	Age of smoking initiation	Age of smoking initiation	Other measurement
6174	GCST002396	Smoking initiation	Smoking initiation	Biological process
6175	GCST002392	Lung cancer (smoking interaction)	Lung cancer (smoking interaction)	Other measurement
6176	GCST002392	Lung cancer (smoking interaction)	Lung cancer (smoking interaction)	Cancer
6177	GCST002391	Plasma homocysteine levels (post-methionine load test)	Plasma homocysteine levels (post-methionine load test)	Cardiovascular measurement
6178	GCST002390	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
6179	GCST002389	Intracerebral hemorrhage	Intracerebral hemorrhage	Cardiovascular disease
6180	GCST002388	Serum metabolite levels	Serum metabolite levels	Other measurement
6181	GCST002387	Musical aptitude	Musical aptitude	Biological process
6182	GCST002386	Cognitive function	Cognitive function	Biological process
6183	GCST002386	Cognitive function	Cognitive function	Biological process
6184	GCST002386	Cognitive function	Cognitive function	Other measurement
6185	GCST002386	Cognitive function	Cognitive function	Biological process
6186	GCST002385	Bipolar disorder	Bipolar disorder	Neurological disorder
6187	GCST002384	NHDL cholesterol	NHDL cholesterol	Lipid or lipoprotein measurement
6188	GCST002383	Anterior chamber depth	Anterior chamber depth	Other measurement
6189	GCST002382	Urinary albumin excretion rate in type 1 diabetes	Urinary albumin excretion rate in type 1 diabetes	Other measurement
6190	GCST002382	Urinary albumin excretion rate in type 1 diabetes	Urinary albumin excretion rate in type 1 diabetes	Metabolic disorder
6191	GCST002381	Resistin levels	Resistin levels	Other measurement
6192	GCST002379	Pyoderma gangrenosum in inflammatory bowel disease	Pyoderma gangrenosum in inflammatory bowel disease	Digestive system disorder
6193	GCST002379	Pyoderma gangrenosum in inflammatory bowel disease	Pyoderma gangrenosum in inflammatory bowel disease	Other trait
6194	GCST002380	Erythema nodosum in inflammatory bowel disease	Erythema nodosum in inflammatory bowel disease	Digestive system disorder
6195	GCST002380	Erythema nodosum in inflammatory bowel disease	Erythema nodosum in inflammatory bowel disease	Other trait
6196	GCST002347	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Response to drug
6197	GCST002347	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Other measurement
6198	GCST002347	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)	Digestive system disorder
6199	GCST002349	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Response to drug
6200	GCST002349	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Other measurement
6201	GCST002349	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)	Digestive system disorder
6202	GCST002348	Cleft plate (environmental tobacco smoke interaction)	Cleft plate (environmental tobacco smoke interaction)	Other trait
6203	GCST002348	Cleft plate (environmental tobacco smoke interaction)	Cleft plate (environmental tobacco smoke interaction)	Other measurement
6204	GCST002346	Breast cancer (early onset)	Breast cancer (early onset)	Cancer
6205	GCST002344	Receptive language ability	Receptive language ability	Biological process
6206	GCST006523	General cognitive ability	General cognitive ability	Biological process
6207	GCST002345	Response to cytadine analogues (cytosine arabinoside)	Response to cytadine analogues (cytosine arabinoside)	Response to drug
6208	GCST002332	Hypertension (young onset)	Hypertension (young onset)	Cardiovascular disease
6209	GCST002331	Basal cell carcinoma	Basal cell carcinoma	Cancer
6210	GCST002329	Acne (severe)	Acne (severe)	Other disease
6211	GCST002330	Asthma	Asthma	Other disease
6212	GCST002328	Lung function	Lung function	Other measurement
6213	GCST002327	Bipolar disorder	Bipolar disorder	Neurological disorder
6214	GCST002326	Pulmonary emphysema	Pulmonary emphysema	Other disease
6215	GCST002318	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
6216	GCST002317	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6217	GCST006524	Nasopharyngeal carcinoma (SNP x SNP interaction)	Nasopharyngeal carcinoma (SNP x SNP interaction)	Cancer
6218	GCST002316	Chronic hepatitis C infection	Chronic hepatitis C infection	Digestive system disorder
6219	GCST002315	Thrombin generation potential phenotypes	Thrombin generation potential phenotypes	Other measurement
6220	GCST002313	Chronic kidney disease	Chronic kidney disease	Other disease
6221	GCST002313	Chronic kidney disease	Chronic kidney disease	Other measurement
6222	GCST002313	Chronic kidney disease	Chronic kidney disease	Other measurement
6223	GCST002314	Glomerular filtration rate	Glomerular filtration rate	Other measurement
6224	GCST002312	Periodontal disease-related phenotype (Socransky)	Periodontal disease-related phenotype (Socransky)	Other measurement
6225	GCST002312	Periodontal disease-related phenotype (Socransky)	Periodontal disease-related phenotype (Socransky)	Digestive system disorder
6226	GCST002311	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
6227	GCST002310	Pulse pressure (alcohol consumption interaction)	Pulse pressure (alcohol consumption interaction)	Biological process
6228	GCST002310	Pulse pressure (alcohol consumption interaction)	Pulse pressure (alcohol consumption interaction)	Cardiovascular measurement
6229	GCST002254	Schizophrenia, schizoaffective disorder or bipolar disorder	Schizophrenia, schizoaffective disorder or bipolar disorder	Neurological disorder
6230	GCST002254	Schizophrenia, schizoaffective disorder or bipolar disorder	Schizophrenia, schizoaffective disorder or bipolar disorder	Neurological disorder
6231	GCST002254	Schizophrenia, schizoaffective disorder or bipolar disorder	Schizophrenia, schizoaffective disorder or bipolar disorder	Neurological disorder
6232	GCST002251	Homeostasis model assessment of beta-cell function (dietary factor interaction)	Homeostasis model assessment of beta-cell function (dietary factor interaction)	Other measurement
6233	GCST002251	Homeostasis model assessment of beta-cell function (dietary factor interaction)	Homeostasis model assessment of beta-cell function (dietary factor interaction)	Other measurement
6234	GCST002253	Homeostasis model assessment of insulin resistance (dietary factor interaction)	Homeostasis model assessment of insulin resistance (dietary factor interaction)	Other measurement
6235	GCST002253	Homeostasis model assessment of insulin resistance (dietary factor interaction)	Homeostasis model assessment of insulin resistance (dietary factor interaction)	Other measurement
6236	GCST002248	Fasting insulin (dietary factor interaction)	Fasting insulin (dietary factor interaction)	Other measurement
6237	GCST002248	Fasting insulin (dietary factor interaction)	Fasting insulin (dietary factor interaction)	Other measurement
6238	GCST002249	Blood pressure measurement (high sodium intervention)	Blood pressure measurement (high sodium intervention)	Other measurement
6239	GCST002249	Blood pressure measurement (high sodium intervention)	Blood pressure measurement (high sodium intervention)	Other measurement
6240	GCST002249	Blood pressure measurement (high sodium intervention)	Blood pressure measurement (high sodium intervention)	Other measurement
6241	GCST002249	Blood pressure measurement (high sodium intervention)	Blood pressure measurement (high sodium intervention)	Other measurement
6242	GCST002249	Blood pressure measurement (high sodium intervention)	Blood pressure measurement (high sodium intervention)	Biological process
6243	GCST002250	Blood pressure measurement (low sodium intervention)	Blood pressure measurement (low sodium intervention)	Other measurement
6244	GCST002250	Blood pressure measurement (low sodium intervention)	Blood pressure measurement (low sodium intervention)	Other measurement
6245	GCST002250	Blood pressure measurement (low sodium intervention)	Blood pressure measurement (low sodium intervention)	Other measurement
6246	GCST002250	Blood pressure measurement (low sodium intervention)	Blood pressure measurement (low sodium intervention)	Other measurement
6247	GCST002250	Blood pressure measurement (low sodium intervention)	Blood pressure measurement (low sodium intervention)	Biological process
6248	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Other measurement
6249	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Other measurement
6250	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Other measurement
6251	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Other measurement
6252	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Biological process
6253	GCST002252	Blood pressure measurement (high sodium and potassium intervention)	Blood pressure measurement (high sodium and potassium intervention)	Biological process
6254	GCST002247	Blood pressure measurement (cold pressor test)	Blood pressure measurement (cold pressor test)	Other measurement
6255	GCST002247	Blood pressure measurement (cold pressor test)	Blood pressure measurement (cold pressor test)	Other measurement
6256	GCST002247	Blood pressure measurement (cold pressor test)	Blood pressure measurement (cold pressor test)	Other measurement
6257	GCST002247	Blood pressure measurement (cold pressor test)	Blood pressure measurement (cold pressor test)	Other measurement
6258	GCST002247	Blood pressure measurement (cold pressor test)	Blood pressure measurement (cold pressor test)	Biological process
6259	GCST002245	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
6260	GCST002245	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
6261	GCST002246	Hepatitis B	Hepatitis B	Digestive system disorder
6262	GCST002246	Hepatitis B	Hepatitis B	Other measurement
6263	GCST002244	Fractures (vertebral)	Fractures (vertebral)	Other disease
6264	GCST002243	Bladder cancer	Bladder cancer	Cancer
6265	GCST002240	Bladder cancer	Bladder cancer	Cancer
6266	GCST002242	Serum dimethylarginine levels (asymmetric/symetric ratio)	Serum dimethylarginine levels (asymmetric/symetric ratio)	Other measurement
6267	GCST002239	Symmetrical dimethylarginine levels	Symmetrical dimethylarginine levels	Cardiovascular measurement
6268	GCST002239	Symmetrical dimethylarginine levels	Symmetrical dimethylarginine levels	Other measurement
6269	GCST002241	Asymmetrical dimethylarginine levels	Asymmetrical dimethylarginine levels	Cardiovascular measurement
6270	GCST002241	Asymmetrical dimethylarginine levels	Asymmetrical dimethylarginine levels	Other measurement
6271	GCST002238	Contrast sensitivity	Contrast sensitivity	Other measurement
6272	GCST002237	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
6273	GCST002236	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
6274	GCST002235	Opioid sensitivity	Opioid sensitivity	Response to drug
6275	GCST002308	Mean arterial pressure (alcohol consumption interaction)	Mean arterial pressure (alcohol consumption interaction)	Biological process
6276	GCST002308	Mean arterial pressure (alcohol consumption interaction)	Mean arterial pressure (alcohol consumption interaction)	Other measurement
6277	GCST002308	Mean arterial pressure (alcohol consumption interaction)	Mean arterial pressure (alcohol consumption interaction)	Other measurement
6278	GCST002309	Diastolic blood pressure (alcohol consumption interaction)	Diastolic blood pressure (alcohol consumption interaction)	Biological process
6279	GCST002309	Diastolic blood pressure (alcohol consumption interaction)	Diastolic blood pressure (alcohol consumption interaction)	Other measurement
6280	GCST002307	Systolic blood pressure (alcohol consumption interaction)	Systolic blood pressure (alcohol consumption interaction)	Biological process
6281	GCST002307	Systolic blood pressure (alcohol consumption interaction)	Systolic blood pressure (alcohol consumption interaction)	Other measurement
6282	GCST002306	Bipolar disorder (body mass index interaction)	Bipolar disorder (body mass index interaction)	Body measurement
6283	GCST002306	Bipolar disorder (body mass index interaction)	Bipolar disorder (body mass index interaction)	Neurological disorder
6284	GCST002305	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)	Cancer
6285	GCST006866	Lung cancer (SNP x SNP interaction)	Lung cancer (SNP x SNP interaction)	Cancer
6286	GCST002304	Fractional exhaled nitric oxide (childhood)	Fractional exhaled nitric oxide (childhood)	Other measurement
6287	GCST002303	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
6288	GCST002302	IgE levels	IgE levels	Other measurement
6289	GCST002301	Body mass index	Body mass index	Body measurement
6290	GCST002301	Body mass index	Body mass index	Body measurement
6291	GCST002301	Body mass index	Body mass index	Other measurement
6292	GCST002283	Amyotrophic lateral sclerosis (sporadic)	Amyotrophic lateral sclerosis (sporadic)	Neurological disorder
6293	GCST002277	Schizophrenia	Schizophrenia	Neurological disorder
6294	GCST002276	Bone mineral density	Bone mineral density	Other measurement
6295	GCST002275	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
6296	GCST002275	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
6297	GCST002274	Multiple sclerosis or amyotrophic lateral sclerosis	Multiple sclerosis or amyotrophic lateral sclerosis	Immune system disorder
6298	GCST002274	Multiple sclerosis or amyotrophic lateral sclerosis	Multiple sclerosis or amyotrophic lateral sclerosis	Neurological disorder
6299	GCST002273	Renal cell carcinoma	Renal cell carcinoma	Cancer
6300	GCST002272	Renal cell carcinoma	Renal cell carcinoma	Cancer
6301	GCST002271	Delayed encephalopathy in acute carbon monoxide poisoning	Delayed encephalopathy in acute carbon monoxide poisoning	Neurological disorder
6302	GCST002262	Blood pressure (response to antihypertensive medication)	Blood pressure (response to antihypertensive medication)	Other measurement
6303	GCST002262	Blood pressure (response to antihypertensive medication)	Blood pressure (response to antihypertensive medication)	Response to drug
6304	GCST002257	Tooth agenesis (maxillary third molar)	Tooth agenesis (maxillary third molar)	Digestive system disorder
6305	GCST002256	Tooth agenesis (third molar)	Tooth agenesis (third molar)	Digestive system disorder
6306	GCST002261	Narcolepsy (age of onset)	Narcolepsy (age of onset)	Neurological disorder
6307	GCST002261	Narcolepsy (age of onset)	Narcolepsy (age of onset)	Other measurement
6308	GCST002259	Narcolepsy (onset before 2009 H1N1 influenza pandemic)	Narcolepsy (onset before 2009 H1N1 influenza pandemic)	Neurological disorder
6309	GCST002260	Narcolepsy	Narcolepsy	Neurological disorder
6310	GCST002258	Tooth agenesis (mandibular third molar)	Tooth agenesis (mandibular third molar)	Digestive system disorder
6311	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Other measurement
6312	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
6313	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
6314	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Response to drug
6315	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
6316	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
6317	GCST002255	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
6318	GCST002270	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
6319	GCST002269	Drug-induced torsades de pointes	Drug-induced torsades de pointes	Biological process
6320	GCST002269	Drug-induced torsades de pointes	Drug-induced torsades de pointes	Cardiovascular disease
6321	GCST002268	Autism	Autism	Neurological disorder
6322	GCST002267	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
6323	GCST002267	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
6324	GCST002265	Breast cancer (menopausal hormone therapy interaction)	Breast cancer (menopausal hormone therapy interaction)	Cancer
6325	GCST002265	Breast cancer (menopausal hormone therapy interaction)	Breast cancer (menopausal hormone therapy interaction)	Other trait
6326	GCST002266	Lobular breast cancer (menopausal hormone therapy interaction)	Lobular breast cancer (menopausal hormone therapy interaction)	Cancer
6327	GCST002266	Lobular breast cancer (menopausal hormone therapy interaction)	Lobular breast cancer (menopausal hormone therapy interaction)	Other trait
6328	GCST002264	Prostate cancer	Prostate cancer	Cancer
6329	GCST002263	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Other disease
6330	GCST002263	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Cardiovascular disease
6331	GCST002263	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	Response to drug
6332	GCST002300	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
6333	GCST002298	Coronary heart disease	Coronary heart disease	Cardiovascular disease
6334	GCST002299	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
6335	GCST002297	Hepatitis B vaccine response	Hepatitis B vaccine response	Response to drug
6336	GCST002296	Body mass index (education interaction)	Body mass index (education interaction)	Body measurement
6337	GCST002293	Alcohol dependence	Alcohol dependence	Other measurement
6338	GCST002293	Alcohol dependence	Alcohol dependence	Neurological disorder
6339	GCST002295	Schizophrenia or bipolar disorder	Schizophrenia or bipolar disorder	Neurological disorder
6340	GCST002295	Schizophrenia or bipolar disorder	Schizophrenia or bipolar disorder	Neurological disorder
6341	GCST002294	Alcohol consumption (max-drinks)	Alcohol consumption (max-drinks)	Biological process
6342	GCST002294	Alcohol consumption (max-drinks)	Alcohol consumption (max-drinks)	Other measurement
6343	GCST002292	Response to alcohol consumption (flushing response)	Response to alcohol consumption (flushing response)	Biological process
6344	GCST002291	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Response to drug
6345	GCST002291	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Response to drug
6346	GCST002291	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	Other disease
6347	GCST002289	Coronary artery disease	Coronary artery disease	Cardiovascular disease
6348	GCST002289	Coronary artery disease	Coronary artery disease	Cardiovascular disease
6349	GCST002290	Coronary artery disease or large artery stroke	Coronary artery disease or large artery stroke	Cardiovascular disease
6350	GCST002290	Coronary artery disease or large artery stroke	Coronary artery disease or large artery stroke	Cardiovascular disease
6351	GCST002287	Coronary artery disease or ischemic stroke	Coronary artery disease or ischemic stroke	Cardiovascular disease
6352	GCST002287	Coronary artery disease or ischemic stroke	Coronary artery disease or ischemic stroke	Cardiovascular disease
6353	GCST002288	Large artery stroke	Large artery stroke	Cardiovascular disease
6354	GCST002286	Ischemic stroke	Ischemic stroke	Cardiovascular disease
6355	GCST002286	Ischemic stroke	Ischemic stroke	Other trait
6356	GCST002224	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6357	GCST002217	Sjögren's syndrome	Sjögren's syndrome	Neurological disorder
6358	GCST002216	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
6359	GCST002221	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
6360	GCST002222	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
6361	GCST002222	LDL cholesterol	LDL cholesterol	Other measurement
6362	GCST002222	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
6363	GCST002223	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
6364	GCST002215	Endometrial cancer	Endometrial cancer	Cancer
6365	GCST002215	Endometrial cancer	Endometrial cancer	Cancer
6366	GCST002218	Endometrial cancer	Endometrial cancer	Cancer
6367	GCST002218	Endometrial cancer	Endometrial cancer	Cancer
6368	GCST002219	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
6369	GCST002220	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
6370	GCST002220	LDL cholesterol	LDL cholesterol	Other measurement
6371	GCST002220	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
6372	GCST002154	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Response to drug
6373	GCST002154	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Other disease
6374	GCST002153	Cardiovascular heart disease in diabetics	Cardiovascular heart disease in diabetics	Other disease
6375	GCST002153	Cardiovascular heart disease in diabetics	Cardiovascular heart disease in diabetics	Metabolic disorder
6376	GCST002152	Airway hyperresponsiveness	Airway hyperresponsiveness	Other trait
6377	GCST002151	Dermatomyositis	Dermatomyositis	Neurological disorder
6378	GCST002150	Borderline personality disorder features	Borderline personality disorder features	Other trait
6379	GCST002149	Schizophrenia	Schizophrenia	Neurological disorder
6380	GCST002148	Otitis media (chronic/recurrent)	Otitis media (chronic/recurrent)	Neurological disorder
6381	GCST002147	Fibrinogen	Fibrinogen	Hematological measurement
6382	GCST002146	Serum alpha1-antitrypsin levels	Serum alpha1-antitrypsin levels	Other measurement
6383	GCST002145	Infantile hypertrophic pyloric stenosis	Infantile hypertrophic pyloric stenosis	Digestive system disorder
6384	GCST002174	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6385	GCST002174	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6386	GCST002174	Lipid traits	Lipid traits	Other measurement
6387	GCST002174	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6388	GCST002174	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6389	GCST002173	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6390	GCST002173	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6391	GCST002173	Lipid traits	Lipid traits	Other measurement
6392	GCST002173	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6393	GCST002173	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
6394	GCST002172	Alcohol dependence	Alcohol dependence	Other measurement
6395	GCST002172	Alcohol dependence	Alcohol dependence	Neurological disorder
6396	GCST002171	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
6397	GCST002170	Mesial temporal lobe epilepsy with hippocampal sclerosis	Mesial temporal lobe epilepsy with hippocampal sclerosis	Neurological disorder
6398	GCST002169	Adolescent idiopathic scoliosis (severe)	Adolescent idiopathic scoliosis (severe)	Other disease
6399	GCST002168	Intraocular pressure	Intraocular pressure	Other measurement
6400	GCST002166	Serum protein levels (sST2)	Serum protein levels (sST2)	Cardiovascular measurement
6401	GCST002167	Blood pressure	Blood pressure	Other measurement
6402	GCST002167	Blood pressure	Blood pressure	Other measurement
6403	GCST002167	Blood pressure	Blood pressure	Other measurement
6404	GCST002167	Blood pressure	Blood pressure	Other measurement
6405	GCST002167	Blood pressure	Blood pressure	Cardiovascular measurement
6406	GCST002165	Lung function (FEV1)	Lung function (FEV1)	Other measurement
6407	GCST002163	Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)	Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)	Other measurement
6408	GCST002162	Lung function (FVC)	Lung function (FVC)	Other measurement
6409	GCST002164	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
6410	GCST002160	Wegener's granulomatosis	Wegener's granulomatosis	Cardiovascular disease
6411	GCST002159	Wegener's granulomatosis	Wegener's granulomatosis	Cardiovascular disease
6412	GCST002161	Alzheimer's disease (neuritic plaque pathology)	Alzheimer's disease (neuritic plaque pathology)	Neurological disorder
6413	GCST002157	Response to mTOR inhibitor (everolimus)	Response to mTOR inhibitor (everolimus)	Response to drug
6414	GCST002158	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
6415	GCST002158	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
6416	GCST002156	Response to mTOR inhibitor (rapamycin)	Response to mTOR inhibitor (rapamycin)	Response to drug
6417	GCST002155	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
6418	GCST002155	Osteoarthritis (hip)	Osteoarthritis (hip)	Other disease
6419	GCST002204	Liver disease in chronic hepatitis B virus infection	Liver disease in chronic hepatitis B virus infection	Digestive system disorder
6420	GCST002204	Liver disease in chronic hepatitis B virus infection	Liver disease in chronic hepatitis B virus infection	Digestive system disorder
6421	GCST002203	Gray matter volume (schizophrenia interaction)	Gray matter volume (schizophrenia interaction)	Neurological disorder
6422	GCST002203	Gray matter volume (schizophrenia interaction)	Gray matter volume (schizophrenia interaction)	Other measurement
6423	GCST002201	Calcium levels	Calcium levels	Other measurement
6424	GCST002200	Anxiety and major depressive disorder	Anxiety and major depressive disorder	Neurological disorder
6425	GCST002200	Anxiety and major depressive disorder	Anxiety and major depressive disorder	Other trait
6426	GCST002202	Anxiety in major depressive disorder	Anxiety in major depressive disorder	Neurological disorder
6427	GCST002202	Anxiety in major depressive disorder	Anxiety in major depressive disorder	Other trait
6428	GCST002199	Follicule stimulating hormone	Follicule stimulating hormone	Other measurement
6429	GCST002195	Hormone measurements	Hormone measurements	Other measurement
6430	GCST002195	Hormone measurements	Hormone measurements	Other measurement
6431	GCST002195	Hormone measurements	Hormone measurements	Other measurement
6432	GCST002197	Tuberculosis	Tuberculosis	Other disease
6433	GCST002197	Tuberculosis	Tuberculosis	Other measurement
6434	GCST002197	Tuberculosis	Tuberculosis	Other measurement
6435	GCST002198	Tuberculosis	Tuberculosis	Other disease
6436	GCST002198	Tuberculosis	Tuberculosis	Other measurement
6437	GCST002198	Tuberculosis	Tuberculosis	Other measurement
6438	GCST002214	Serum alkaline phosphatase levels	Serum alkaline phosphatase levels	Liver enzyme measurement
6439	GCST002213	Coronary artery calcification (smoking interaction)	Coronary artery calcification (smoking interaction)	Other trait
6440	GCST002213	Coronary artery calcification (smoking interaction)	Coronary artery calcification (smoking interaction)	Other measurement
6441	GCST002212	Colorectal adenoma (advanced)	Colorectal adenoma (advanced)	Cancer
6442	GCST002210	Acute myeloid leukemia	Acute myeloid leukemia	Cancer
6443	GCST002211	Psychosis (atypical)	Psychosis (atypical)	Neurological disorder
6444	GCST002207	Liver enzyme levels (alanine transaminase)	Liver enzyme levels (alanine transaminase)	Liver enzyme measurement
6445	GCST002208	Liver enzyme levels (aspartate transaminase)	Liver enzyme levels (aspartate transaminase)	Liver enzyme measurement
6446	GCST002209	Orthostatic hypotension	Orthostatic hypotension	Cardiovascular disease
6447	GCST002205	Handedness	Handedness	Other trait
6448	GCST002206	Handedness	Handedness	Other trait
6449	GCST002076	Hippocampal volume in schizophrenia	Hippocampal volume in schizophrenia	Neurological disorder
6450	GCST002076	Hippocampal volume in schizophrenia	Hippocampal volume in schizophrenia	Other measurement
6451	GCST002077	Parkinson's disease	Parkinson's disease	Neurological disorder
6452	GCST002075	Lipopolysaccharide induced cytokine levels	Lipopolysaccharide induced cytokine levels	Other measurement
6453	GCST002074	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Response to drug
6454	GCST002074	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
6455	GCST002074	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Other measurement
6456	GCST002074	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
6457	GCST002073	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
6458	GCST002072	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Immune system disorder
6459	GCST002072	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Other measurement
6460	GCST002071	Retinal arteriolar caliber	Retinal arteriolar caliber	Other measurement
6461	GCST002070	Smoking behavior	Smoking behavior	Biological process
6462	GCST002068	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
6463	GCST002068	Chronic hepatitis B infection	Chronic hepatitis B infection	Digestive system disorder
6464	GCST002094	Crohn's disease	Crohn's disease	Digestive system disorder
6465	GCST002093	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
6466	GCST002093	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
6467	GCST002092	Callous-unemotional behaviour	Callous-unemotional behaviour	Biological process
6468	GCST002090	Sensory disturbances after bilateral sagittal split ramus osteotomy	Sensory disturbances after bilateral sagittal split ramus osteotomy	Other trait
6469	GCST002091	Angioedema in response to angiotensin-converting enzyme inhibitor	Angioedema in response to angiotensin-converting enzyme inhibitor	Cardiovascular disease
6470	GCST002091	Angioedema in response to angiotensin-converting enzyme inhibitor	Angioedema in response to angiotensin-converting enzyme inhibitor	Response to drug
6471	GCST002089	Intraocular pressure	Intraocular pressure	Other measurement
6472	GCST002088	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
6473	GCST002088	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
6474	GCST002087	Homocysteine levels	Homocysteine levels	Cardiovascular measurement
6475	GCST006863	Takayasu arteritis	Takayasu arteritis	Cardiovascular disease
6476	GCST002086	C-reactive protein	C-reactive protein	Inflammatory measurement
6477	GCST002142	Cocaine dependence	Cocaine dependence	Neurological disorder
6478	GCST002143	Blood pressure	Blood pressure	Other measurement
6479	GCST002143	Blood pressure	Blood pressure	Other measurement
6480	GCST002143	Blood pressure	Blood pressure	Other measurement
6481	GCST002143	Blood pressure	Blood pressure	Other measurement
6482	GCST002143	Blood pressure	Blood pressure	Cardiovascular measurement
6483	GCST002144	Bitter taste perception	Bitter taste perception	Biological process
6484	GCST002141	Epilepsy (remission after treatment)	Epilepsy (remission after treatment)	Biological process
6485	GCST002141	Epilepsy (remission after treatment)	Epilepsy (remission after treatment)	Neurological disorder
6486	GCST002140	Multiple myeloma	Multiple myeloma	Cancer
6487	GCST002139	Joint damage progression in ACPA-positive rheumatoid arthritis	Joint damage progression in ACPA-positive rheumatoid arthritis	Immune system disorder
6488	GCST002139	Joint damage progression in ACPA-positive rheumatoid arthritis	Joint damage progression in ACPA-positive rheumatoid arthritis	Other measurement
6489	GCST002137	Waist circumference	Waist circumference	Body measurement
6490	GCST002138	Waist-hip ratio	Waist-hip ratio	Other measurement
6491	GCST002138	Waist-hip ratio	Waist-hip ratio	Body measurement
6492	GCST002129	Periodontitis (DPAL)	Periodontitis (DPAL)	Digestive system disorder
6493	GCST002067	Response to diuretic therapy in hypertension	Response to diuretic therapy in hypertension	Response to drug
6494	GCST002066	B cell non-Hodgkin lymphoma	B cell non-Hodgkin lymphoma	Cancer
6495	GCST002065	Alcohol consumption	Alcohol consumption	Biological process
6496	GCST002065	Alcohol consumption	Alcohol consumption	Other measurement
6497	GCST002063	Sexual dimorphism in anthropometric traits	Sexual dimorphism in anthropometric traits	Other measurement
6498	GCST002063	Sexual dimorphism in anthropometric traits	Sexual dimorphism in anthropometric traits	Body measurement
6499	GCST002063	Sexual dimorphism in anthropometric traits	Sexual dimorphism in anthropometric traits	Body measurement
6500	GCST002063	Sexual dimorphism in anthropometric traits	Sexual dimorphism in anthropometric traits	Other trait
6501	GCST002064	Corneal astigmatism	Corneal astigmatism	Neurological disorder
6502	GCST002064	Corneal astigmatism	Corneal astigmatism	Other trait
6503	GCST002061	Warfarin maintenance dose	Warfarin maintenance dose	Response to drug
6504	GCST002059	Non-word repetition	Non-word repetition	Biological process
6505	GCST002062	Reading and spelling	Reading and spelling	Biological process
6506	GCST002060	Word reading	Word reading	Biological process
6507	GCST002057	DNA methylation (parent-of-origin)	DNA methylation (parent-of-origin)	Biological process
6508	GCST002121	Alcohol consumption	Alcohol consumption	Biological process
6509	GCST002121	Alcohol consumption	Alcohol consumption	Other measurement
6510	GCST002125	IgE levels in asthmatics (D.f. specific)	IgE levels in asthmatics (D.f. specific)	Other disease
6511	GCST002125	IgE levels in asthmatics (D.f. specific)	IgE levels in asthmatics (D.f. specific)	Other measurement
6512	GCST002124	IgE levels in asthmatics (D.p. specific)	IgE levels in asthmatics (D.p. specific)	Other disease
6513	GCST002124	IgE levels in asthmatics (D.p. specific)	IgE levels in asthmatics (D.p. specific)	Other measurement
6514	GCST002122	IgE levels in asthmatics	IgE levels in asthmatics	Other disease
6515	GCST002122	IgE levels in asthmatics	IgE levels in asthmatics	Other measurement
6516	GCST002120	Metabolite levels (Dihydroxy docosatrienoic acid)	Metabolite levels (Dihydroxy docosatrienoic acid)	Other measurement
6517	GCST002119	Metabolite levels  (X-11787)	Metabolite levels  (X-11787)	Other measurement
6518	GCST002118	Metabolite levels (Pyroglutamine)	Metabolite levels (Pyroglutamine)	Other measurement
6519	GCST002117	Myopia (severe)	Myopia (severe)	Other trait
6520	GCST002115	Axial length	Axial length	Other measurement
6521	GCST002116	Blood pressure variability	Blood pressure variability	Other measurement
6522	GCST002126	Periodontitis (CDC/AAP)	Periodontitis (CDC/AAP)	Digestive system disorder
6523	GCST002127	Periodontitis (Mean PAL)	Periodontitis (Mean PAL)	Digestive system disorder
6524	GCST002136	Periodontitis (PAL4Q3)	Periodontitis (PAL4Q3)	Digestive system disorder
6525	GCST002128	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6526	GCST002123	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6527	GCST002114	Molar-incisor hypomineralization	Molar-incisor hypomineralization	Other disease
6528	GCST002113	Pulmonary function	Pulmonary function	Other measurement
6529	GCST002113	Pulmonary function	Pulmonary function	Other measurement
6530	GCST002113	Pulmonary function	Pulmonary function	Other measurement
6531	GCST002113	Pulmonary function	Pulmonary function	Other measurement
6532	GCST002112	Celiac disease	Celiac disease	Immune system disorder
6533	GCST002111	Personality dimensions	Personality dimensions	Other trait
6534	GCST002105	Odorant perception (isobutyraldehyde)	Odorant perception (isobutyraldehyde)	Biological process
6535	GCST002108	Allergic dermatitis (nickel)	Allergic dermatitis (nickel)	Immune system disorder
6536	GCST002107	Odorant perception (&beta;-ionone)	Odorant perception (&beta;-ionone)	Biological process
6537	GCST002106	Odorant perception (&beta;-damascenone)	Odorant perception (&beta;-damascenone)	Biological process
6538	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
6539	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
6540	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
6541	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
6542	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
6543	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
6544	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
6545	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
6546	GCST002109	Red blood cell traits	Red blood cell traits	Hematological measurement
6547	GCST002110	Glycemic traits (pregnancy)	Glycemic traits (pregnancy)	Other measurement
6548	GCST002110	Glycemic traits (pregnancy)	Glycemic traits (pregnancy)	Other measurement
6549	GCST002110	Glycemic traits (pregnancy)	Glycemic traits (pregnancy)	Other measurement
6550	GCST002194	Social communication problems	Social communication problems	Other measurement
6551	GCST002193	Abdominal aortic aneurysm	Abdominal aortic aneurysm	Cardiovascular disease
6552	GCST002192	Menopause (age at onset)	Menopause (age at onset)	Other measurement
6553	GCST002190	Schizophrenia	Schizophrenia	Neurological disorder
6554	GCST002191	Menarche (age at onset)	Menarche (age at onset)	Other measurement
6555	GCST002187	Systolic blood pressure in sickle cell anemia	Systolic blood pressure in sickle cell anemia	Neurological disorder
6556	GCST002187	Systolic blood pressure in sickle cell anemia	Systolic blood pressure in sickle cell anemia	Other measurement
6557	GCST002188	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Neurological disorder
6558	GCST002188	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Neurological disorder
6559	GCST002188	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Neurological disorder
6560	GCST002188	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia	Other measurement
6561	GCST002189	Skin youthfulness	Skin youthfulness	Biological process
6562	GCST002183	Relative hand skill in reading disability	Relative hand skill in reading disability	Other trait
6563	GCST002183	Relative hand skill in reading disability	Relative hand skill in reading disability	Neurological disorder
6564	GCST002234	Breast cancer	Breast cancer	Cancer
6565	GCST002233	Adiponectin levels	Adiponectin levels	Other measurement
6566	GCST002232	Esophageal adenocarcinoma	Esophageal adenocarcinoma	Cancer
6567	GCST002230	Barrett's esophagus	Barrett's esophagus	Digestive system disorder
6568	GCST002231	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Digestive system disorder
6569	GCST002231	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Cancer
6570	GCST002231	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	Other disease
6571	GCST002229	Acne (severe teenage)	Acne (severe teenage)	Other disease
6572	GCST002228	Social autistic-like traits	Social autistic-like traits	Other measurement
6573	GCST002227	Body mass index	Body mass index	Body measurement
6574	GCST002227	Body mass index	Body mass index	Body measurement
6575	GCST002227	Body mass index	Body mass index	Other measurement
6576	GCST002226	Fat body mass	Fat body mass	Other measurement
6577	GCST002225	Disc degeneration (lumbar)	Disc degeneration (lumbar)	Other disease
6578	GCST002184	Mean platelet volume	Mean platelet volume	Hematological measurement
6579	GCST002185	Relative hand skill	Relative hand skill	Other trait
6580	GCST002186	Platelet count	Platelet count	Hematological measurement
6581	GCST002181	Adverse response to chemotherapy in breast cancer (alopecia)	Adverse response to chemotherapy in breast cancer (alopecia)	Other disease
6582	GCST002177	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	Other disease
6583	GCST002177	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	Response to drug
6584	GCST002175	Reading disability and language impairment	Reading disability and language impairment	Neurological disorder
6585	GCST002175	Reading disability and language impairment	Reading disability and language impairment	Neurological disorder
6586	GCST002180	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	Other disease
6587	GCST002180	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	Response to drug
6588	GCST002179	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	Response to drug
6589	GCST002179	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	Other disease
6590	GCST002178	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Other disease
6591	GCST002178	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Response to drug
6592	GCST002178	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Response to drug
6593	GCST002178	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	Response to drug
6594	GCST002176	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Other disease
6595	GCST002176	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Response to drug
6596	GCST002176	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Response to drug
6597	GCST002176	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	Response to drug
6598	GCST001769	Alcohol and nicotine co-dependence	Alcohol and nicotine co-dependence	Neurological disorder
6599	GCST001768	Behcet's disease	Behcet's disease	Cardiovascular disease
6600	GCST001766	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Liver enzyme measurement
6601	GCST001766	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Cancer
6602	GCST001766	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Digestive system disorder
6603	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
6604	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
6605	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
6606	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
6607	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
6608	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
6609	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
6610	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
6611	GCST001765	Red blood cell traits	Red blood cell traits	Hematological measurement
6612	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6613	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6614	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6615	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6616	GCST001762	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
6617	GCST001762	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
6618	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6619	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6620	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6621	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6622	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6623	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6624	GCST001762	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
6625	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6626	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6627	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
6628	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6629	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6630	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6631	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6632	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6633	GCST001762	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
6634	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6635	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6636	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6637	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6638	GCST001762	Obesity-related traits	Obesity-related traits	Biological process
6639	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6640	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6641	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
6642	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6643	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6644	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6645	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6646	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6647	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6648	GCST001762	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
6649	GCST001762	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
6650	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6651	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
6652	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6653	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6654	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6655	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6656	GCST001762	Obesity-related traits	Obesity-related traits	Body measurement
6657	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6658	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6659	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6660	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6661	GCST001762	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
6662	GCST001762	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
6663	GCST001762	Obesity-related traits	Obesity-related traits	Metabolic disorder
6664	GCST001762	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
6665	GCST001762	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
6666	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6667	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
6668	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
6669	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6670	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6671	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6672	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6673	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6674	GCST001762	Obesity-related traits	Obesity-related traits	Inflammatory measurement
6675	GCST001762	Obesity-related traits	Obesity-related traits	Biological process
6676	GCST001762	Obesity-related traits	Obesity-related traits	Biological process
6677	GCST001762	Obesity-related traits	Obesity-related traits	Other measurement
6678	GCST001764	White matter integrity (bipolar disorder risk interaction)	White matter integrity (bipolar disorder risk interaction)	Neurological disorder
6679	GCST001764	White matter integrity (bipolar disorder risk interaction)	White matter integrity (bipolar disorder risk interaction)	Other measurement
6680	GCST001761	Cognitive decline	Cognitive decline	Other trait
6681	GCST001761	Cognitive decline	Cognitive decline	Biological process
6682	GCST001760	White matter integrity	White matter integrity	Other measurement
6683	GCST001763	Asthma	Asthma	Other disease
6684	GCST001759	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6685	GCST001788	Digit length ratio	Digit length ratio	Body measurement
6686	GCST001785	Crohn's disease	Crohn's disease	Digestive system disorder
6687	GCST001787	Colorectal cancer	Colorectal cancer	Cancer
6688	GCST001786	Dental caries	Dental caries	Digestive system disorder
6689	GCST001784	Pulmonary function (smoking interaction)	Pulmonary function (smoking interaction)	Other measurement
6690	GCST001784	Pulmonary function (smoking interaction)	Pulmonary function (smoking interaction)	Other measurement
6691	GCST001784	Pulmonary function (smoking interaction)	Pulmonary function (smoking interaction)	Other measurement
6692	GCST001784	Pulmonary function (smoking interaction)	Pulmonary function (smoking interaction)	Other measurement
6693	GCST001783	Platelet count	Platelet count	Hematological measurement
6694	GCST001781	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
6695	GCST001782	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
6696	GCST001782	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
6697	GCST001779	Hematology traits	Hematology traits	Hematological measurement
6698	GCST001779	Hematology traits	Hematology traits	Hematological measurement
6699	GCST001779	Hematology traits	Hematology traits	Hematological measurement
6700	GCST001779	Hematology traits	Hematology traits	Cardiovascular measurement
6701	GCST001779	Hematology traits	Hematology traits	Hematological measurement
6702	GCST001780	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
6703	GCST001780	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
6704	GCST001733	Schizophrenia	Schizophrenia	Neurological disorder
6705	GCST001732	Obesity	Obesity	Other measurement
6706	GCST001732	Obesity	Obesity	Metabolic disorder
6707	GCST001731	Colorectal cancer (environment interaction)	Colorectal cancer (environment interaction)	Other measurement
6708	GCST001731	Colorectal cancer (environment interaction)	Colorectal cancer (environment interaction)	Body measurement
6709	GCST001731	Colorectal cancer (environment interaction)	Colorectal cancer (environment interaction)	Cancer
6710	GCST001731	Colorectal cancer (environment interaction)	Colorectal cancer (environment interaction)	Other measurement
6711	GCST001726	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	Lipid or lipoprotein measurement
6712	GCST001725	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
6713	GCST001725	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
6714	GCST001725	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
6715	GCST001730	Response to temozolomide	Response to temozolomide	Response to drug
6716	GCST001728	Ulcerative colitis	Ulcerative colitis	Immune system disorder
6717	GCST001729	Crohn's disease	Crohn's disease	Digestive system disorder
6718	GCST001727	Lipoprotein-associated phospholipase A2 activity and mass	Lipoprotein-associated phospholipase A2 activity and mass	Lipid or lipoprotein measurement
6719	GCST001723	Eye color	Eye color	Other measurement
6720	GCST001723	Eye color	Eye color	Other trait
6721	GCST001758	Birth weight	Birth weight	Body measurement
6722	GCST001757	Schizophrenia	Schizophrenia	Neurological disorder
6723	GCST005568	Rheumatoid arthritis (ACPA-positive)	Rheumatoid arthritis (ACPA-positive)	Immune system disorder
6724	GCST005567	Rheumatoid arthritis (ACPA-negative)	Rheumatoid arthritis (ACPA-negative)	Immune system disorder
6725	GCST005569	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
6726	GCST005524	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Immune system disorder
6727	GCST005524	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Immune system disorder
6728	GCST005524	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	Immune system disorder
6729	GCST005527	Psoriasis	Psoriasis	Immune system disorder
6730	GCST005525	Hashimoto thyroiditis	Hashimoto thyroiditis	Immune system disorder
6731	GCST005526	Graves' disease	Graves' disease	Immune system disorder
6732	GCST001756	Spine bone size	Spine bone size	Other measurement
6733	GCST001743	Alzheimer's disease	Alzheimer's disease	Neurological disorder
6734	GCST001742	Panic disorder	Panic disorder	Neurological disorder
6735	GCST001741	Pancreatitis	Pancreatitis	Digestive system disorder
6736	GCST001740	Lung cancer	Lung cancer	Cancer
6737	GCST001740	Lung cancer	Lung cancer	Cancer
6738	GCST001740	Lung cancer	Lung cancer	Cancer
6739	GCST001738	Response to fenofibrate (adiponectin levels)	Response to fenofibrate (adiponectin levels)	Response to drug
6740	GCST001739	IgE levels	IgE levels	Other measurement
6741	GCST001736	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Neurological disorder
6742	GCST001736	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Neurological disorder
6743	GCST001736	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Metabolic disorder
6744	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Other disease
6745	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Hematological measurement
6746	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Inflammatory measurement
6747	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Other measurement
6748	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Other measurement
6749	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Inflammatory measurement
6750	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Inflammatory measurement
6751	GCST001737	Chronic obstructive pulmonary disease-related biomarkers	Chronic obstructive pulmonary disease-related biomarkers	Inflammatory measurement
6752	GCST001734	Non-small cell lung cancer	Non-small cell lung cancer	Cancer
6753	GCST001735	PR interval	PR interval	Cardiovascular measurement
6754	GCST001793	Coagulation factor levels	Coagulation factor levels	Other measurement
6755	GCST001791	Urate levels	Urate levels	Metabolic disorder
6756	GCST001791	Urate levels	Urate levels	Other measurement
6757	GCST008112	Proinsulin levels (early-phase conversion)	Proinsulin levels (early-phase conversion)	Other measurement
6758	GCST008113	Proinsulin levels (late-phase conversion)	Proinsulin levels (late-phase conversion)	Other measurement
6759	GCST008111	Insulin disposition index	Insulin disposition index	Other measurement
6760	GCST008110	Insulinogenic index	Insulinogenic index	Other measurement
6761	GCST008109	Fasting blood proinsulin levels	Fasting blood proinsulin levels	Other measurement
6762	GCST001792	Colorectal cancer	Colorectal cancer	Cancer
6763	GCST001790	Gout	Gout	Metabolic disorder
6764	GCST001789	Lipoprotein diameter	Lipoprotein diameter	Other disease
6765	GCST001752	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
6766	GCST001751	Opioid sensitivity	Opioid sensitivity	Response to drug
6767	GCST001750	Renal cell carcinoma	Renal cell carcinoma	Cancer
6768	GCST001749	Pancreatic cancer	Pancreatic cancer	Cancer
6769	GCST001748	Resting heart rate	Resting heart rate	Cardiovascular measurement
6770	GCST001747	Aspirin exacerbated respiratory disease in asthmatics	Aspirin exacerbated respiratory disease in asthmatics	Other trait
6771	GCST001746	QT interval	QT interval	Cardiovascular measurement
6772	GCST001745	Sagittal craniosynostosis	Sagittal craniosynostosis	Neurological disorder
6773	GCST001744	Serum tamsulosin hydrochloride concentration	Serum tamsulosin hydrochloride concentration	Response to drug
6774	GCST001778	Hypertrophic cardiomyopathy	Hypertrophic cardiomyopathy	Cardiovascular disease
6775	GCST001777	LDL (oxidized)	LDL (oxidized)	Lipid or lipoprotein measurement
6776	GCST001775	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Digestive system disorder
6777	GCST001775	Hepatocellular carcinoma in hepatitis B infection	Hepatocellular carcinoma in hepatitis B infection	Cancer
6778	GCST001776	Cardiac Troponin-T levels	Cardiac Troponin-T levels	Cardiovascular measurement
6779	GCST001774	Reporting of stressful life event	Reporting of stressful life event	Other trait
6780	GCST001774	Reporting of stressful life event	Reporting of stressful life event	Other measurement
6781	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6782	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6783	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6784	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6785	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6786	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6787	GCST001773	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6788	GCST001770	Methotrexate clearance (acute lymphoblastic leukemia)	Methotrexate clearance (acute lymphoblastic leukemia)	Response to drug
6789	GCST001771	Neuroticism	Neuroticism	Neurological disorder
6790	GCST001771	Neuroticism	Neuroticism	Other measurement
6791	GCST001772	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to TNF-alpha inhibitors in rheumatoid arthritis	Immune system disorder
6792	GCST001772	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to drug
6793	GCST001767	Aging (facial)	Aging (facial)	Biological process
6794	GCST001755	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Response to drug
6795	GCST001755	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
6796	GCST001755	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Other measurement
6797	GCST001755	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
6798	GCST001473	Crohn's disease and psoriasis	Crohn's disease and psoriasis	Digestive system disorder
6799	GCST001473	Crohn's disease and psoriasis	Crohn's disease and psoriasis	Immune system disorder
6800	GCST001472	C-reactive protein	C-reactive protein	Inflammatory measurement
6801	GCST001471	Alcohol and nicotine co-dependence	Alcohol and nicotine co-dependence	Neurological disorder
6802	GCST001470	Glioblastoma	Glioblastoma	Cancer
6803	GCST001470	Glioblastoma	Glioblastoma	Cancer
6804	GCST001470	Glioblastoma	Glioblastoma	Cancer
6805	GCST001469	Major depressive disorder	Major depressive disorder	Neurological disorder
6806	GCST001468	Cystic fibrosis (meconium ileus)	Cystic fibrosis (meconium ileus)	Digestive system disorder
6807	GCST001462	Brachial circumference	Brachial circumference	Body measurement
6808	GCST001465	Adiponectin levels	Adiponectin levels	Other measurement
6809	GCST001483	Intracranial volume	Intracranial volume	Other measurement
6810	GCST001485	Hippocampal volume	Hippocampal volume	Other measurement
6811	GCST001479	Type 1 diabetes autoantibodies	Type 1 diabetes autoantibodies	Other measurement
6812	GCST001479	Type 1 diabetes autoantibodies	Type 1 diabetes autoantibodies	Metabolic disorder
6813	GCST001480	Oral cancers (chewing tobacco related)	Oral cancers (chewing tobacco related)	Cancer
6814	GCST001480	Oral cancers (chewing tobacco related)	Oral cancers (chewing tobacco related)	Other measurement
6815	GCST001478	Circulating cell-free DNA	Circulating cell-free DNA	Other measurement
6816	GCST001477	Sexual dysfunction (female)	Sexual dysfunction (female)	Other trait
6817	GCST001476	Response to tocilizumab in rheumatoid arthritis	Response to tocilizumab in rheumatoid arthritis	Immune system disorder
6818	GCST001476	Response to tocilizumab in rheumatoid arthritis	Response to tocilizumab in rheumatoid arthritis	Biological process
6819	GCST001475	Obesity	Obesity	Other measurement
6820	GCST001475	Obesity	Obesity	Metabolic disorder
6821	GCST001474	Hypothyroidism	Hypothyroidism	Other disease
6822	GCST001531	Temperament	Temperament	Other measurement
6823	GCST001528	Response to antidepressants	Response to antidepressants	Response to drug
6824	GCST001529	Alzheimer's disease	Alzheimer's disease	Neurological disorder
6825	GCST001526	Fasting blood insulin (BMI interaction)	Fasting blood insulin (BMI interaction)	Body measurement
6826	GCST001526	Fasting blood insulin (BMI interaction)	Fasting blood insulin (BMI interaction)	Other measurement
6827	GCST005186	Fasting blood glucose	Fasting blood glucose	Other measurement
6828	GCST005185	Fasting blood insulin	Fasting blood insulin	Other measurement
6829	GCST001527	Fasting blood glucose (BMI interaction)	Fasting blood glucose (BMI interaction)	Body measurement
6830	GCST001527	Fasting blood glucose (BMI interaction)	Fasting blood glucose (BMI interaction)	Other measurement
6831	GCST001491	Immune response to smallpox vaccine (IL-6)	Immune response to smallpox vaccine (IL-6)	Response to drug
6832	GCST001491	Immune response to smallpox vaccine (IL-6)	Immune response to smallpox vaccine (IL-6)	Other measurement
6833	GCST001492	Longevity	Longevity	Other measurement
6834	GCST001490	Nicotine dependence	Nicotine dependence	Neurological disorder
6835	GCST001489	Percent mammographic density	Percent mammographic density	Other measurement
6836	GCST001489	Percent mammographic density	Percent mammographic density	Cancer
6837	GCST001489	Percent mammographic density	Percent mammographic density	Other measurement
6838	GCST001488	Gout	Gout	Metabolic disorder
6839	GCST001486	Fasting plasma glucose	Fasting plasma glucose	Other measurement
6840	GCST001487	Thyroid function	Thyroid function	Other trait
6841	GCST001484	Head circumference (infant)	Head circumference (infant)	Body measurement
6842	GCST001540	Male fertility	Male fertility	Other measurement
6843	GCST001540	Male fertility	Male fertility	Other trait
6844	GCST001540	Male fertility	Male fertility	Other measurement
6845	GCST001539	Smoking behavior	Smoking behavior	Biological process
6846	GCST001537	Immune reponse to smallpox (secreted IL-12p40)	Immune reponse to smallpox (secreted IL-12p40)	Response to drug
6847	GCST001537	Immune reponse to smallpox (secreted IL-12p40)	Immune reponse to smallpox (secreted IL-12p40)	Other measurement
6848	GCST001538	Immune reponse to smallpox (secreted IFN-alpha)	Immune reponse to smallpox (secreted IFN-alpha)	Response to drug
6849	GCST001538	Immune reponse to smallpox (secreted IFN-alpha)	Immune reponse to smallpox (secreted IFN-alpha)	Other measurement
6850	GCST001536	Immune reponse to smallpox (secreted TNF-alpha)	Immune reponse to smallpox (secreted TNF-alpha)	Response to drug
6851	GCST001536	Immune reponse to smallpox (secreted TNF-alpha)	Immune reponse to smallpox (secreted TNF-alpha)	Other measurement
6852	GCST001532	Immune response to smallpox vaccine (IL-6)	Immune response to smallpox vaccine (IL-6)	Response to drug
6853	GCST001532	Immune response to smallpox vaccine (IL-6)	Immune response to smallpox vaccine (IL-6)	Other measurement
6854	GCST001533	Immune reponse to smallpox (secreted IL-1beta)	Immune reponse to smallpox (secreted IL-1beta)	Response to drug
6855	GCST001533	Immune reponse to smallpox (secreted IL-1beta)	Immune reponse to smallpox (secreted IL-1beta)	Other measurement
6856	GCST001534	Immune reponse to smallpox (secreted IL-10)	Immune reponse to smallpox (secreted IL-10)	Response to drug
6857	GCST001534	Immune reponse to smallpox (secreted IL-10)	Immune reponse to smallpox (secreted IL-10)	Other measurement
6858	GCST001535	Immune reponse to smallpox (secreted IL-2)	Immune reponse to smallpox (secreted IL-2)	Response to drug
6859	GCST001535	Immune reponse to smallpox (secreted IL-2)	Immune reponse to smallpox (secreted IL-2)	Other measurement
6860	GCST001530	Hippocampal atrophy	Hippocampal atrophy	Neurological disorder
6861	GCST001549	Formal thought disorder in schizophrenia	Formal thought disorder in schizophrenia	Other trait
6862	GCST001550	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
6863	GCST001548	Male-pattern baldness	Male-pattern baldness	Other measurement
6864	GCST001548	Male-pattern baldness	Male-pattern baldness	Other disease
6865	GCST001548	Male-pattern baldness	Male-pattern baldness	Other disease
6866	GCST001547	Immune response to anthrax vaccine	Immune response to anthrax vaccine	Response to drug
6867	GCST001545	Coronary heart disease event reduction (statin therapy interaction)	Coronary heart disease event reduction (statin therapy interaction)	Cardiovascular disease
6868	GCST001545	Coronary heart disease event reduction (statin therapy interaction)	Coronary heart disease event reduction (statin therapy interaction)	Response to drug
6869	GCST001546	Parkinson's disease (motor and cognition)	Parkinson's disease (motor and cognition)	Neurological disorder
6870	GCST001543	Lung cancer (asbestos exposure interaction)	Lung cancer (asbestos exposure interaction)	Cancer
6871	GCST001543	Lung cancer (asbestos exposure interaction)	Lung cancer (asbestos exposure interaction)	Other measurement
6872	GCST001544	Colorectal cancer	Colorectal cancer	Cancer
6873	GCST001541	Personality dimensions	Personality dimensions	Other trait
6874	GCST001542	HIV-associated dementia	HIV-associated dementia	Neurological disorder
6875	GCST001502	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
6876	GCST001502	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
6877	GCST001501	Platelet thrombus formation	Platelet thrombus formation	Cardiovascular measurement
6878	GCST001501	Platelet thrombus formation	Platelet thrombus formation	Hematological measurement
6879	GCST001500	Wilms tumor	Wilms tumor	Cancer
6880	GCST001499	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
6881	GCST001498	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
6882	GCST001496	Non-albumin protein levels	Non-albumin protein levels	Other measurement
6883	GCST001496	Non-albumin protein levels	Non-albumin protein levels	Other measurement
6884	GCST001496	Non-albumin protein levels	Non-albumin protein levels	Other measurement
6885	GCST001497	Cholelithiasis-related traits in sickle cell anemia	Cholelithiasis-related traits in sickle cell anemia	Digestive system disorder
6886	GCST001497	Cholelithiasis-related traits in sickle cell anemia	Cholelithiasis-related traits in sickle cell anemia	Neurological disorder
6887	GCST001497	Cholelithiasis-related traits in sickle cell anemia	Cholelithiasis-related traits in sickle cell anemia	Other measurement
6888	GCST001495	Asthma	Asthma	Other disease
6889	GCST001493	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
6890	GCST001494	Non-obstructive azoospermia	Non-obstructive azoospermia	Other disease
6891	GCST001516	Osteoarthritis	Osteoarthritis	Other disease
6892	GCST001509	Vitiligo	Vitiligo	Immune system disorder
6893	GCST001510	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to TNF-alpha inhibitors in rheumatoid arthritis	Immune system disorder
6894	GCST001510	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to TNF-alpha inhibitors in rheumatoid arthritis	Response to drug
6895	GCST001508	Asthma	Asthma	Other disease
6896	GCST001507	Hair color	Hair color	Other measurement
6897	GCST001507	Hair color	Hair color	Other trait
6898	GCST001503	Electroencephalographic traits in alcoholism	Electroencephalographic traits in alcoholism	Neurological disorder
6899	GCST001503	Electroencephalographic traits in alcoholism	Electroencephalographic traits in alcoholism	Other measurement
6900	GCST001506	Intraocular pressure	Intraocular pressure	Other measurement
6901	GCST001504	Tuberculosis	Tuberculosis	Other disease
6902	GCST001504	Tuberculosis	Tuberculosis	Other measurement
6903	GCST001504	Tuberculosis	Tuberculosis	Other measurement
6904	GCST001505	Multiple sclerosis	Multiple sclerosis	Immune system disorder
6905	GCST001522	Pericardial fat	Pericardial fat	Other measurement
6906	GCST001520	Response to angiotensin II receptor blocker therapy	Response to angiotensin II receptor blocker therapy	Response to drug
6907	GCST001520	Response to angiotensin II receptor blocker therapy	Response to angiotensin II receptor blocker therapy	Cardiovascular disease
6908	GCST001518	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	Response to drug
6909	GCST001518	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	Cardiovascular disease
6910	GCST001517	Antipsychotic drug-induced weight gain	Antipsychotic drug-induced weight gain	Other trait
6911	GCST000887	Myocardial infarction	Myocardial infarction	Cardiovascular disease
6912	GCST000886	Alzheimer's disease	Alzheimer's disease	Neurological disorder
6913	GCST000883	Response to antipsychotic treatment in schizophrenia (working memory)	Response to antipsychotic treatment in schizophrenia (working memory)	Biological process
6914	GCST000885	Response to antipsychotic treatment in schizophrenia (reasoning)	Response to antipsychotic treatment in schizophrenia (reasoning)	Biological process
6915	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6916	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6917	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6918	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6919	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6920	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6921	GCST000884	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
6922	GCST000882	Response to bleomycin (chromatid breaks)	Response to bleomycin (chromatid breaks)	Response to drug
6923	GCST000882	Response to bleomycin (chromatid breaks)	Response to bleomycin (chromatid breaks)	Response to drug
6924	GCST000882	Response to bleomycin (chromatid breaks)	Response to bleomycin (chromatid breaks)	Other measurement
6925	GCST000881	Bone mineral density (wrist)	Bone mineral density (wrist)	Other measurement
6926	GCST000879	Crohn's disease	Crohn's disease	Digestive system disorder
6927	GCST000880	Menarche (age at onset)	Menarche (age at onset)	Other measurement
6928	GCST000878	Myopia (pathological)	Myopia (pathological)	Other trait
6929	GCST000868	Handedness in dyslexia	Handedness in dyslexia	Other trait
6930	GCST000868	Handedness in dyslexia	Handedness in dyslexia	Neurological disorder
6931	GCST000865	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Immune system disorder
6932	GCST000865	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Response to drug
6933	GCST000864	Alzheimer's disease	Alzheimer's disease	Neurological disorder
6934	GCST000866	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
6935	GCST000866	LDL cholesterol	LDL cholesterol	Other measurement
6936	GCST000866	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
6937	GCST000862	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
6938	GCST000862	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
6939	GCST000862	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
6940	GCST000861	Cannabis dependence	Cannabis dependence	Neurological disorder
6941	GCST000860	Moyamoya disease	Moyamoya disease	Cardiovascular disease
6942	GCST000863	HIV-1 control	HIV-1 control	Other disease
6943	GCST000859	Aspirin intolerance in asthmatics	Aspirin intolerance in asthmatics	Other trait
6944	GCST000858	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
6945	GCST000907	Renal cell carcinoma	Renal cell carcinoma	Cancer
6946	GCST000905	Information processing speed	Information processing speed	Biological process
6947	GCST000906	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
6948	GCST000904	Asperger disorder	Asperger disorder	Neurological disorder
6949	GCST000901	Neuroblastoma	Neuroblastoma	Cancer
6950	GCST000902	Hepatocellular carcinoma	Hepatocellular carcinoma	Cancer
6951	GCST000900	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
6952	GCST000900	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
6953	GCST000900	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
6954	GCST000900	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Neurological disorder
6955	GCST000900	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
6956	GCST000903	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	Response to drug
6957	GCST000896	Small-cell lung cancer (survival)	Small-cell lung cancer (survival)	Cancer
6958	GCST000855	Parkinson's disease	Parkinson's disease	Neurological disorder
6959	GCST000856	Major depressive disorder	Major depressive disorder	Neurological disorder
6960	GCST000857	Event-related brain oscillations	Event-related brain oscillations	Other measurement
6961	GCST000854	Suicide risk	Suicide risk	Biological process
6962	GCST000854	Suicide risk	Suicide risk	Neurological disorder
6963	GCST000853	Ulcerative colitis	Ulcerative colitis	Immune system disorder
6964	GCST000852	Atrioventricular conduction	Atrioventricular conduction	Cardiovascular measurement
6965	GCST000851	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
6966	GCST000850	Body mass in chronic obstructive pulmonary disease	Body mass in chronic obstructive pulmonary disease	Other disease
6967	GCST000850	Body mass in chronic obstructive pulmonary disease	Body mass in chronic obstructive pulmonary disease	Body measurement
6968	GCST000847	Retinal vascular caliber	Retinal vascular caliber	Other measurement
6969	GCST000846	Breast cancer in BRCA2 mutation carriers	Breast cancer in BRCA2 mutation carriers	Cancer
6970	GCST000849	Hypertension	Hypertension	Cardiovascular disease
6971	GCST000844	Prostate cancer mortality	Prostate cancer mortality	Cancer
6972	GCST000844	Prostate cancer mortality	Prostate cancer mortality	Other measurement
6973	GCST000844	Prostate cancer mortality	Prostate cancer mortality	Cancer
6974	GCST000843	Colorectal cancer	Colorectal cancer	Cancer
6975	GCST000842	Bladder cancer	Bladder cancer	Cancer
6976	GCST000841	Dupuytren's disease	Dupuytren's disease	Other disease
6977	GCST000877	Bone mineral density	Bone mineral density	Other measurement
6978	GCST000876	Amyloid A serum levels	Amyloid A serum levels	Lipid or lipoprotein measurement
6979	GCST000875	Coronary heart disease	Coronary heart disease	Cardiovascular disease
6980	GCST000874	Parkinson's disease	Parkinson's disease	Neurological disorder
6981	GCST000873	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
6982	GCST000873	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
6983	GCST000872	QRS duration	QRS duration	Cardiovascular measurement
6984	GCST000872	QRS duration	QRS duration	Cardiovascular measurement
6985	GCST000872	QRS duration	QRS duration	Cardiovascular measurement
6986	GCST000871	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Other measurement
6987	GCST000871	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Cancer
6988	GCST000870	Atopy	Atopy	Immune system disorder
6989	GCST000869	Osteoarthritis	Osteoarthritis	Other disease
6990	GCST000867	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
6991	GCST000867	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
6992	GCST000917	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
6993	GCST000914	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
6994	GCST000915	Primary sclerosing cholangitis	Primary sclerosing cholangitis	Digestive system disorder
6995	GCST000916	Endometriosis	Endometriosis	Other disease
6996	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
6997	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
6998	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
6999	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
7000	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
7001	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
7002	GCST000913	Iron status biomarkers	Iron status biomarkers	Other measurement
7003	GCST000912	Adverse response to carbamazepine	Adverse response to carbamazepine	Response to drug
7004	GCST000911	Progranulin levels	Progranulin levels	Other measurement
7005	GCST000909	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
7006	GCST000909	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
7007	GCST000910	Asthma	Asthma	Other disease
7008	GCST000908	Ileal carcinoids	Ileal carcinoids	Cancer
7009	GCST000923	Osteoarthritis	Osteoarthritis	Other disease
7010	GCST006329	Agreeableness	Agreeableness	Other measurement
7011	GCST006328	Extraversion	Extraversion	Biological process
7012	GCST006328	Extraversion	Extraversion	Other measurement
7013	GCST006327	Neuroticism	Neuroticism	Neurological disorder
7014	GCST006327	Neuroticism	Neuroticism	Other measurement
7015	GCST006326	Conscientiousness	Conscientiousness	Other measurement
7016	GCST000922	Openness	Openness	Other measurement
7017	GCST000921	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
7018	GCST000921	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
7019	GCST000919	Serum prostate-specific antigen levels	Serum prostate-specific antigen levels	Other measurement
7020	GCST000920	Myocardial infarction	Myocardial infarction	Cardiovascular disease
7021	GCST000918	HIV-1 susceptibility	HIV-1 susceptibility	Immune system disorder
7022	GCST000918	HIV-1 susceptibility	HIV-1 susceptibility	Other disease
7023	GCST000888	Hypospadias	Hypospadias	Other disease
7024	GCST000888	Hypospadias	Hypospadias	Other disease
7025	GCST000571	Fasting blood insulin	Fasting blood insulin	Other measurement
7026	GCST005180	Homeostasis model assessment of beta-cell function	Homeostasis model assessment of beta-cell function	Other measurement
7027	GCST005179	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other measurement
7028	GCST005179	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other trait
7029	GCST000568	Fasting blood glucose	Fasting blood glucose	Other measurement
7030	GCST000569	Two-hour glucose challenge	Two-hour glucose challenge	Other measurement
7031	GCST000570	Major mood disorders	Major mood disorders	Neurological disorder
7032	GCST000567	Parkinson's disease	Parkinson's disease	Neurological disorder
7033	GCST000566	Hearing impairment	Hearing impairment	Neurological disorder
7034	GCST000565	Angiotensin-converting enzyme activity	Angiotensin-converting enzyme activity	Other measurement
7035	GCST000563	Ankylosing spondylitis	Ankylosing spondylitis	Immune system disorder
7036	GCST008640	CD56-positive NK-lymphocyte cell count	CD56-positive NK-lymphocyte cell count	Hematological measurement
7037	GCST008639	CD19-positive B-lymphocyte count	CD19-positive B-lymphocyte count	Hematological measurement
7038	GCST008638	CD8-positive T-lymphocyte count	CD8-positive T-lymphocyte count	Hematological measurement
7039	GCST008637	CD4-positive T-lymphocyte count	CD4-positive T-lymphocyte count	Hematological measurement
7040	GCST008636	CD3-positive T-lymphocyte count	CD3-positive T-lymphocyte count	Hematological measurement
7041	GCST000553	CD4:CD8 lymphocyte ratio	CD4:CD8 lymphocyte ratio	Inflammatory measurement
7042	GCST000552	Memory (short-term)	Memory (short-term)	Biological process
7043	GCST000551	Major depressive disorder (broad)	Major depressive disorder (broad)	Neurological disorder
7044	GCST000550	Metabolite levels	Metabolite levels	Other trait
7045	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7046	GCST000550	Metabolite levels	Metabolite levels	Liver enzyme measurement
7047	GCST000550	Metabolite levels	Metabolite levels	Cardiovascular measurement
7048	GCST000550	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
7049	GCST000550	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
7050	GCST000550	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
7051	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7052	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7053	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7054	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7055	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7056	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7057	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7058	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7059	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7060	GCST000550	Metabolite levels	Metabolite levels	Other measurement
7061	GCST000549	HIV-1 control	HIV-1 control	Other disease
7062	GCST000512	Body mass index	Body mass index	Body measurement
7063	GCST000512	Body mass index	Body mass index	Body measurement
7064	GCST000512	Body mass index	Body mass index	Other measurement
7065	GCST000508	Neuromyelitis optica	Neuromyelitis optica	Immune system disorder
7066	GCST000509	Response to citalopram treatment	Response to citalopram treatment	Response to drug
7067	GCST000507	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7068	GCST000506	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
7069	GCST000548	Asthma	Asthma	Other disease
7070	GCST000547	Orofacial clefts	Orofacial clefts	Other trait
7071	GCST000547	Orofacial clefts	Orofacial clefts	Other measurement
7072	GCST000547	Orofacial clefts	Orofacial clefts	Other disease
7073	GCST000547	Orofacial clefts	Orofacial clefts	Other trait
7074	GCST000546	Leprosy	Leprosy	Neurological disorder
7075	GCST000545	Fetal hemoglobin levels	Fetal hemoglobin levels	Hematological measurement
7076	GCST000544	Pulmonary function	Pulmonary function	Other measurement
7077	GCST000544	Pulmonary function	Pulmonary function	Other measurement
7078	GCST000544	Pulmonary function	Pulmonary function	Other measurement
7079	GCST000544	Pulmonary function	Pulmonary function	Other measurement
7080	GCST000542	Pulmonary function	Pulmonary function	Other measurement
7081	GCST000542	Pulmonary function	Pulmonary function	Other measurement
7082	GCST000542	Pulmonary function	Pulmonary function	Other measurement
7083	GCST000542	Pulmonary function	Pulmonary function	Other measurement
7084	GCST000543	Social and non-social autistic-like traits	Social and non-social autistic-like traits	Other measurement
7085	GCST000541	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
7086	GCST000541	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
7087	GCST000540	Atopy	Atopy	Immune system disorder
7088	GCST000539	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
7089	GCST000529	Ulcerative colitis	Ulcerative colitis	Immune system disorder
7090	GCST000530	Parkinson's disease	Parkinson's disease	Neurological disorder
7091	GCST000524	Mathematical ability	Mathematical ability	Biological process
7092	GCST000525	Asthma	Asthma	Other disease
7093	GCST000526	Insulin-related traits	Insulin-related traits	Other measurement
7094	GCST000526	Insulin-related traits	Insulin-related traits	Other measurement
7095	GCST000526	Insulin-related traits	Insulin-related traits	Other trait
7096	GCST000523	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	Methotrexate phramacokinetics (acute lymphoblastic leukemia)	Response to drug
7097	GCST000522	Height	Height	Other measurement
7098	GCST000522	Height	Height	Body measurement
7099	GCST000521	Periodontitis	Periodontitis	Digestive system disorder
7100	GCST000520	Vitiligo	Vitiligo	Immune system disorder
7101	GCST000519	Hair morphology	Hair morphology	Other trait
7102	GCST000562	PR interval	PR interval	Cardiovascular measurement
7103	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7104	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7105	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7106	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7107	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7108	GCST000561	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7109	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7110	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7111	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7112	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7113	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7114	GCST000564	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
7115	GCST000560	Osteoporosis	Osteoporosis	Other disease
7116	GCST000559	Cholesterol	Cholesterol	Lipid or lipoprotein measurement
7117	GCST000558	Osteoarthritis	Osteoarthritis	Other disease
7118	GCST000557	Chronic hepatitis C infection	Chronic hepatitis C infection	Digestive system disorder
7119	GCST000556	Functional MRI	Functional MRI	Other measurement
7120	GCST000555	Carotid atherosclerosis in HIV infection	Carotid atherosclerosis in HIV infection	Cardiovascular disease
7121	GCST000555	Carotid atherosclerosis in HIV infection	Carotid atherosclerosis in HIV infection	Cardiovascular measurement
7122	GCST000555	Carotid atherosclerosis in HIV infection	Carotid atherosclerosis in HIV infection	Other disease
7123	GCST000555	Carotid atherosclerosis in HIV infection	Carotid atherosclerosis in HIV infection	Cardiovascular measurement
7124	GCST000554	Subclinical brain infarct	Subclinical brain infarct	Cardiovascular disease
7125	GCST000538	Adiponectin levels	Adiponectin levels	Other measurement
7126	GCST000537	Adiponectin levels	Adiponectin levels	Other measurement
7127	GCST000536	Sasang constitutional medicine type	Sasang constitutional medicine type	Other trait
7128	GCST000535	Systemic sclerosis	Systemic sclerosis	Neurological disorder
7129	GCST000534	Primary sclerosing cholangitis	Primary sclerosing cholangitis	Digestive system disorder
7130	GCST000533	Lipid metabolism phenotypes	Lipid metabolism phenotypes	Other measurement
7131	GCST000532	Beta thalassemia/hemoglobin E disease	Beta thalassemia/hemoglobin E disease	Other disease
7132	GCST000528	Parkinson's disease	Parkinson's disease	Neurological disorder
7133	GCST000518	End-stage renal disease	End-stage renal disease	Other disease
7134	GCST004867	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7135	GCST000517	Iron levels	Iron levels	Other measurement
7136	GCST000515	Bone mineral density	Bone mineral density	Other measurement
7137	GCST000516	Glycemic control in type 1 diabetes (HbA1c)	Glycemic control in type 1 diabetes (HbA1c)	Other measurement
7138	GCST000514	Response to antipsychotic therapy (extrapyramidal side effects)	Response to antipsychotic therapy (extrapyramidal side effects)	Response to drug
7139	GCST000513	Sickle cell anemia (severity)	Sickle cell anemia (severity)	Neurological disorder
7140	GCST000511	Weight	Weight	Body measurement
7141	GCST000344	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
7142	GCST000344	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
7143	GCST000344	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
7144	GCST000344	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
7145	GCST000344	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
7146	GCST000342	Mean platelet volume	Mean platelet volume	Hematological measurement
7147	GCST000341	Coronary heart disease	Coronary heart disease	Cardiovascular disease
7148	GCST000338	Coronary heart disease	Coronary heart disease	Cardiovascular disease
7149	GCST000340	Myocardial infarction (early onset)	Myocardial infarction (early onset)	Cardiovascular disease
7150	GCST000339	Eosinophil counts	Eosinophil counts	Hematological measurement
7151	GCST000337	Quantitative traits	Quantitative traits	Other measurement
7152	GCST000337	Quantitative traits	Quantitative traits	Body measurement
7153	GCST000337	Quantitative traits	Quantitative traits	Body measurement
7154	GCST000337	Quantitative traits	Quantitative traits	Body measurement
7155	GCST000337	Quantitative traits	Quantitative traits	Body measurement
7156	GCST000337	Quantitative traits	Quantitative traits	Body measurement
7157	GCST000337	Quantitative traits	Quantitative traits	Lipid or lipoprotein measurement
7158	GCST000337	Quantitative traits	Quantitative traits	Lipid or lipoprotein measurement
7159	GCST000337	Quantitative traits	Quantitative traits	Other measurement
7160	GCST000337	Quantitative traits	Quantitative traits	Other measurement
7161	GCST000337	Quantitative traits	Quantitative traits	Lipid or lipoprotein measurement
7162	GCST000337	Quantitative traits	Quantitative traits	Lipid or lipoprotein measurement
7163	GCST000337	Quantitative traits	Quantitative traits	Inflammatory measurement
7164	GCST000335	Thyroid cancer	Thyroid cancer	Cancer
7165	GCST000336	Schizophrenia	Schizophrenia	Neurological disorder
7166	GCST000334	Hirschsprung disease	Hirschsprung disease	Digestive system disorder
7167	GCST000401	Menopause (age at onset)	Menopause (age at onset)	Other measurement
7168	GCST000402	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Response to drug
7169	GCST000402	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Neurological disorder
7170	GCST000399	Behcet's disease	Behcet's disease	Cardiovascular disease
7171	GCST000398	Hypertension	Hypertension	Cardiovascular disease
7172	GCST000397	Renal function and chronic kidney disease	Renal function and chronic kidney disease	Other measurement
7173	GCST000397	Renal function and chronic kidney disease	Renal function and chronic kidney disease	Other disease
7174	GCST000392	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
7175	GCST000394	Diastolic blood pressure	Diastolic blood pressure	Other measurement
7176	GCST000394	Diastolic blood pressure	Diastolic blood pressure	Other measurement
7177	GCST000395	Systolic blood pressure	Systolic blood pressure	Other measurement
7178	GCST000395	Systolic blood pressure	Systolic blood pressure	Other measurement
7179	GCST000396	Diastolic blood pressure	Diastolic blood pressure	Other measurement
7180	GCST000396	Diastolic blood pressure	Diastolic blood pressure	Other measurement
7181	GCST000393	Systolic blood pressure	Systolic blood pressure	Other measurement
7182	GCST000393	Systolic blood pressure	Systolic blood pressure	Other measurement
7183	GCST000411	Autism	Autism	Neurological disorder
7184	GCST000410	Malaria	Malaria	Digestive system disorder
7185	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7186	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7187	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7188	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7189	GCST000409	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
7190	GCST000409	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
7191	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7192	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7193	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7194	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7195	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7196	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7197	GCST000409	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
7198	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7199	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7200	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7201	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7202	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7203	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7204	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7205	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7206	GCST000409	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7207	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7208	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7209	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7210	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7211	GCST000409	Obesity-related traits	Obesity-related traits	Biological process
7212	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7213	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7214	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7215	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7216	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7217	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7218	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7219	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7220	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7221	GCST000409	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7222	GCST000409	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7223	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7224	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7225	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7226	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7227	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7228	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7229	GCST000409	Obesity-related traits	Obesity-related traits	Body measurement
7230	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7231	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7232	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7233	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7234	GCST000409	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
7235	GCST000409	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7236	GCST000409	Obesity-related traits	Obesity-related traits	Metabolic disorder
7237	GCST000409	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
7238	GCST000409	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7239	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7240	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7241	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7242	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7243	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7244	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7245	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7246	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7247	GCST000409	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7248	GCST000409	Obesity-related traits	Obesity-related traits	Biological process
7249	GCST000409	Obesity-related traits	Obesity-related traits	Biological process
7250	GCST000409	Obesity-related traits	Obesity-related traits	Other measurement
7251	GCST000408	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
7252	GCST000408	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
7253	GCST000407	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
7254	GCST000407	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
7255	GCST000406	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
7256	GCST000405	Menarche (age at onset)	Menarche (age at onset)	Other measurement
7257	GCST000403	Menarche and menopause (age at onset)	Menarche and menopause (age at onset)	Other measurement
7258	GCST000403	Menarche and menopause (age at onset)	Menarche and menopause (age at onset)	Other measurement
7259	GCST000404	Menarche (age at onset)	Menarche (age at onset)	Other measurement
7260	GCST000400	Menarche (age at onset)	Menarche (age at onset)	Other measurement
7261	GCST000391	Insulin resistance/response	Insulin resistance/response	Other trait
7262	GCST000389	Asthma	Asthma	Other disease
7263	GCST000390	Hypertension (young onset)	Hypertension (young onset)	Cardiovascular disease
7264	GCST000388	Bilirubin levels	Bilirubin levels	Other measurement
7265	GCST000387	Bipolar disorder	Bipolar disorder	Neurological disorder
7266	GCST000386	Bilirubin levels	Bilirubin levels	Other measurement
7267	GCST000384	Neuroblastoma (high-risk)	Neuroblastoma (high-risk)	Cancer
7268	GCST000385	Narcolepsy	Narcolepsy	Neurological disorder
7269	GCST004948	Breast cancer	Breast cancer	Cancer
7270	GCST004949	Breast cancer	Breast cancer	Cancer
7271	GCST000373	Stroke (ischemic)	Stroke (ischemic)	Cardiovascular disease
7272	GCST000372	Height	Height	Other measurement
7273	GCST000372	Height	Height	Body measurement
7274	GCST000371	Tanning	Tanning	Other trait
7275	GCST000366	Fibrinogen	Fibrinogen	Hematological measurement
7276	GCST000367	Homocysteine levels	Homocysteine levels	Cardiovascular measurement
7277	GCST000368	Fibrinogen	Fibrinogen	Hematological measurement
7278	GCST000370	Arterial stiffness	Arterial stiffness	Cardiovascular measurement
7279	GCST000369	Response to statin therapy	Response to statin therapy	Response to drug
7280	GCST000365	Breast cancer	Breast cancer	Cancer
7281	GCST000364	QT interval	QT interval	Cardiovascular measurement
7282	GCST000333	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
7283	GCST000332	Smoking behavior	Smoking behavior	Biological process
7284	GCST000327	Anthropometric traits	Anthropometric traits	Other measurement
7285	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
7286	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
7287	GCST000327	Anthropometric traits	Anthropometric traits	Other measurement
7288	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
7289	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
7290	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
7291	GCST000327	Anthropometric traits	Anthropometric traits	Body measurement
7292	GCST000331	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
7293	GCST000330	Asthma (toluene diisocyanate-induced)	Asthma (toluene diisocyanate-induced)	Other disease
7294	GCST000328	Biochemical measures	Biochemical measures	Cardiovascular measurement
7295	GCST000328	Biochemical measures	Biochemical measures	Hematological measurement
7296	GCST000328	Biochemical measures	Biochemical measures	Lipid or lipoprotein measurement
7297	GCST000328	Biochemical measures	Biochemical measures	Lipid or lipoprotein measurement
7298	GCST000328	Biochemical measures	Biochemical measures	Other measurement
7299	GCST000328	Biochemical measures	Biochemical measures	Lipid or lipoprotein measurement
7300	GCST000328	Biochemical measures	Biochemical measures	Lipid or lipoprotein measurement
7301	GCST000326	Pain	Pain	Other trait
7302	GCST000329	Essential tremor	Essential tremor	Other trait
7303	GCST000325	Bone mineral density	Bone mineral density	Other measurement
7304	GCST000324	Carotenoid and tocopherol levels	Carotenoid and tocopherol levels	Other measurement
7305	GCST000324	Carotenoid and tocopherol levels	Carotenoid and tocopherol levels	Other measurement
7306	GCST000383	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7307	GCST000382	Autism	Autism	Neurological disorder
7308	GCST000380	Height	Height	Other measurement
7309	GCST000380	Height	Height	Body measurement
7310	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Body measurement
7311	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Body measurement
7312	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Cardiovascular measurement
7313	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Other measurement
7314	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Other measurement
7315	GCST000381	Biomedical quantitative traits	Biomedical quantitative traits	Other measurement
7316	GCST000379	Stroke	Stroke	Cardiovascular disease
7317	GCST000378	Aging	Aging	Biological process
7318	GCST000377	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
7319	GCST000376	Telomere length	Telomere length	Other measurement
7320	GCST000375	Hepatitis B	Hepatitis B	Digestive system disorder
7321	GCST000375	Hepatitis B	Hepatitis B	Other measurement
7322	GCST000374	Atopic dermatitis	Atopic dermatitis	Immune system disorder
7323	GCST000363	QT interval	QT interval	Cardiovascular measurement
7324	GCST000362	Pulmonary function	Pulmonary function	Other measurement
7325	GCST000362	Pulmonary function	Pulmonary function	Other measurement
7326	GCST000362	Pulmonary function	Pulmonary function	Other measurement
7327	GCST000362	Pulmonary function	Pulmonary function	Other measurement
7328	GCST000360	Warfarin maintenance dose	Warfarin maintenance dose	Response to drug
7329	GCST000359	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
7330	GCST000361	Hypertension	Hypertension	Cardiovascular disease
7331	GCST000358	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
7332	GCST000358	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
7333	GCST000358	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
7334	GCST000358	Folate pathway vitamin levels	Folate pathway vitamin levels	Cardiovascular measurement
7335	GCST000358	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
7336	GCST000357	Myeloproliferative neoplasms	Myeloproliferative neoplasms	Cancer
7337	GCST000356	Anti-cyclic Citrullinated Peptide Antibody	Anti-cyclic Citrullinated Peptide Antibody	Other measurement
7338	GCST000355	Menarche (age at onset)	Menarche (age at onset)	Other measurement
7339	GCST000354	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
7340	GCST000353	Orofacial clefts	Orofacial clefts	Other trait
7341	GCST000353	Orofacial clefts	Orofacial clefts	Other measurement
7342	GCST000353	Orofacial clefts	Orofacial clefts	Other disease
7343	GCST000353	Orofacial clefts	Orofacial clefts	Other trait
7344	GCST000352	Body mass (lean)	Body mass (lean)	Other measurement
7345	GCST000351	Smoking behavior	Smoking behavior	Biological process
7346	GCST000350	Bipolar disorder	Bipolar disorder	Neurological disorder
7347	GCST000348	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
7348	GCST000348	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
7349	GCST000349	Smoking behavior	Smoking behavior	Biological process
7350	GCST000347	Bone mineral density	Bone mineral density	Other measurement
7351	GCST000346	Cystic fibrosis severity	Cystic fibrosis severity	Digestive system disorder
7352	GCST000345	Otosclerosis	Otosclerosis	Neurological disorder
7353	GCST000343	Breast cancer	Breast cancer	Cancer
7354	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7355	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7356	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7357	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7358	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7359	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7360	GCST000473	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7361	GCST000470	Response to antidepressant treatment	Response to antidepressant treatment	Response to drug
7362	GCST000468	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
7363	GCST000468	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
7364	GCST000469	Obesity and osteoporosis	Obesity and osteoporosis	Other disease
7365	GCST000469	Obesity and osteoporosis	Obesity and osteoporosis	Metabolic disorder
7366	GCST000467	Response to clopidogrel therapy	Response to clopidogrel therapy	Response to drug
7367	GCST000467	Response to clopidogrel therapy	Response to clopidogrel therapy	Cardiovascular measurement
7368	GCST000467	Response to clopidogrel therapy	Response to clopidogrel therapy	Response to drug
7369	GCST000466	Esophageal cancer	Esophageal cancer	Cancer
7370	GCST000465	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
7371	GCST000464	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
7372	GCST000463	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
7373	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7374	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7375	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7376	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7377	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7378	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7379	GCST000462	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
7380	GCST000286	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
7381	GCST000287	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7382	GCST000287	LDL cholesterol	LDL cholesterol	Other measurement
7383	GCST000287	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7384	GCST000279	Inattentive symptoms	Inattentive symptoms	Biological process
7385	GCST000281	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
7386	GCST000278	Hyperactive-impulsive symptoms	Hyperactive-impulsive symptoms	Biological process
7387	GCST000280	Attention deficit hyperactivity disorder (time to onset)	Attention deficit hyperactivity disorder (time to onset)	Neurological disorder
7388	GCST000277	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7389	GCST000275	Hearing impairment	Hearing impairment	Neurological disorder
7390	GCST000276	Fasting plasma glucose	Fasting plasma glucose	Other measurement
7391	GCST000274	Metabolite levels	Metabolite levels	Other trait
7392	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7393	GCST000274	Metabolite levels	Metabolite levels	Liver enzyme measurement
7394	GCST000274	Metabolite levels	Metabolite levels	Cardiovascular measurement
7395	GCST000274	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
7396	GCST000274	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
7397	GCST000274	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
7398	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7399	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7400	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7401	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7402	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7403	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7404	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7405	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7406	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7407	GCST000274	Metabolite levels	Metabolite levels	Other measurement
7408	GCST000303	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
7409	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
7410	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
7411	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
7412	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
7413	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
7414	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
7415	GCST000302	Iron status biomarkers	Iron status biomarkers	Other measurement
7416	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
7417	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
7418	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
7419	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
7420	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
7421	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
7422	GCST000301	Iron status biomarkers	Iron status biomarkers	Other measurement
7423	GCST000300	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
7424	GCST000299	Weight	Weight	Body measurement
7425	GCST000295	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
7426	GCST000295	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
7427	GCST000297	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
7428	GCST000297	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
7429	GCST000296	Body mass index	Body mass index	Body measurement
7430	GCST000296	Body mass index	Body mass index	Body measurement
7431	GCST000296	Body mass index	Body mass index	Other measurement
7432	GCST000298	Body mass index	Body mass index	Body measurement
7433	GCST000298	Body mass index	Body mass index	Body measurement
7434	GCST000298	Body mass index	Body mass index	Other measurement
7435	GCST000294	Creutzfeldt-Jakob disease	Creutzfeldt-Jakob disease	Neurological disorder
7436	GCST000253	Attention deficit hyperactivity disorder and conduct disorder	Attention deficit hyperactivity disorder and conduct disorder	Neurological disorder
7437	GCST000253	Attention deficit hyperactivity disorder and conduct disorder	Attention deficit hyperactivity disorder and conduct disorder	Neurological disorder
7438	GCST000252	Multiple sclerosis	Multiple sclerosis	Immune system disorder
7439	GCST000249	Basal cell carcinoma	Basal cell carcinoma	Cancer
7440	GCST000251	Male-pattern baldness	Male-pattern baldness	Other measurement
7441	GCST000251	Male-pattern baldness	Male-pattern baldness	Other disease
7442	GCST000251	Male-pattern baldness	Male-pattern baldness	Other disease
7443	GCST000250	Male-pattern baldness	Male-pattern baldness	Other measurement
7444	GCST000250	Male-pattern baldness	Male-pattern baldness	Other disease
7445	GCST000250	Male-pattern baldness	Male-pattern baldness	Other disease
7446	GCST000248	Liver enzyme levels	Liver enzyme levels	Liver enzyme measurement
7447	GCST000248	Liver enzyme levels	Liver enzyme levels	Liver enzyme measurement
7448	GCST000248	Liver enzyme levels	Liver enzyme levels	Liver enzyme measurement
7449	GCST000248	Liver enzyme levels	Liver enzyme levels	Other measurement
7450	GCST000246	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
7451	GCST000245	Conduct disorder (maternal expressed emotions interaction)	Conduct disorder (maternal expressed emotions interaction)	Neurological disorder
7452	GCST000245	Conduct disorder (maternal expressed emotions interaction)	Conduct disorder (maternal expressed emotions interaction)	Other measurement
7453	GCST000247	Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	Neurological disorder
7454	GCST000247	Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	Other measurement
7455	GCST000244	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
7456	GCST000323	Response to treatment for acute lymphoblastic leukemia	Response to treatment for acute lymphoblastic leukemia	Response to drug
7457	GCST000323	Response to treatment for acute lymphoblastic leukemia	Response to treatment for acute lymphoblastic leukemia	Cancer
7458	GCST000322	Psoriasis	Psoriasis	Immune system disorder
7459	GCST000321	Psoriasis	Psoriasis	Immune system disorder
7460	GCST000320	Panic disorder	Panic disorder	Neurological disorder
7461	GCST000319	Adiponectin levels	Adiponectin levels	Other measurement
7462	GCST000317	Obesity	Obesity	Other measurement
7463	GCST000317	Obesity	Obesity	Metabolic disorder
7464	GCST000318	Basal cell carcinoma	Basal cell carcinoma	Cancer
7465	GCST000316	Polyunsaturated fatty acid levels	Polyunsaturated fatty acid levels	Other measurement
7466	GCST000315	Alzheimer's disease	Alzheimer's disease	Neurological disorder
7467	GCST000314	Kawasaki disease	Kawasaki disease	Immune system disorder
7468	GCST000264	Nicotine dependence	Nicotine dependence	Neurological disorder
7469	GCST000263	Multiple sclerosis	Multiple sclerosis	Immune system disorder
7470	GCST000261	Parkinson's disease (familial)	Parkinson's disease (familial)	Neurological disorder
7471	GCST000260	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
7472	GCST000259	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
7473	GCST000258	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
7474	GCST000257	Lung cancer	Lung cancer	Cancer
7475	GCST000257	Lung cancer	Lung cancer	Cancer
7476	GCST000257	Lung cancer	Lung cancer	Cancer
7477	GCST000256	Lung cancer	Lung cancer	Cancer
7478	GCST000256	Lung cancer	Lung cancer	Cancer
7479	GCST000256	Lung cancer	Lung cancer	Cancer
7480	GCST000255	Alzheimer's disease	Alzheimer's disease	Neurological disorder
7481	GCST000254	Height	Height	Other measurement
7482	GCST000254	Height	Height	Body measurement
7483	GCST000312	Lp (a) levels	Lp (a) levels	Lipid or lipoprotein measurement
7484	GCST000313	Alzheimer's disease	Alzheimer's disease	Neurological disorder
7485	GCST000311	Ulcerative colitis	Ulcerative colitis	Immune system disorder
7486	GCST000310	Alzheimer's disease	Alzheimer's disease	Neurological disorder
7487	GCST000309	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
7488	GCST000307	Prostate cancer	Prostate cancer	Cancer
7489	GCST000308	AIDS progression	AIDS progression	Immune system disorder
7490	GCST000306	Blood pressure	Blood pressure	Other measurement
7491	GCST000306	Blood pressure	Blood pressure	Other measurement
7492	GCST000306	Blood pressure	Blood pressure	Other measurement
7493	GCST000306	Blood pressure	Blood pressure	Other measurement
7494	GCST000306	Blood pressure	Blood pressure	Cardiovascular measurement
7495	GCST000305	Mean platelet volume	Mean platelet volume	Hematological measurement
7496	GCST000304	Major depressive disorder	Major depressive disorder	Neurological disorder
7497	GCST000273	Personality dimensions	Personality dimensions	Other trait
7498	GCST000272	Height	Height	Other measurement
7499	GCST000272	Height	Height	Body measurement
7500	GCST000271	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Neurological disorder
7501	GCST000271	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Other measurement
7502	GCST000271	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	Other measurement
7503	GCST000270	Colorectal cancer	Colorectal cancer	Cancer
7504	GCST000269	Multiple sclerosis	Multiple sclerosis	Immune system disorder
7505	GCST000266	Multiple sclerosis (severity)	Multiple sclerosis (severity)	Immune system disorder
7506	GCST000265	Brain lesion load	Brain lesion load	Immune system disorder
7507	GCST000268	Normalized brain volume	Normalized brain volume	Immune system disorder
7508	GCST000267	Multiple sclerosis (age of onset)	Multiple sclerosis (age of onset)	Immune system disorder
7509	GCST000267	Multiple sclerosis (age of onset)	Multiple sclerosis (age of onset)	Other measurement
7510	GCST000262	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
7511	GCST000293	Major depressive disorder	Major depressive disorder	Neurological disorder
7512	GCST000290	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
7513	GCST000288	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
7514	GCST000289	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
7515	GCST000282	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7516	GCST000282	LDL cholesterol	LDL cholesterol	Other measurement
7517	GCST000282	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7518	GCST000285	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
7519	GCST000243	Ulcerative colitis	Ulcerative colitis	Immune system disorder
7520	GCST000242	Urate levels	Urate levels	Metabolic disorder
7521	GCST000242	Urate levels	Urate levels	Other measurement
7522	GCST000239	Stroke (ischemic)	Stroke (ischemic)	Cardiovascular disease
7523	GCST000241	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
7524	GCST000241	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
7525	GCST000241	Lipid traits	Lipid traits	Other measurement
7526	GCST000241	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
7527	GCST000241	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
7528	GCST000240	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
7529	GCST000238	Idiopathic pulmonary fibrosis	Idiopathic pulmonary fibrosis	Cancer
7530	GCST000237	Alzheimer's disease	Alzheimer's disease	Neurological disorder
7531	GCST000236	Narcolepsy	Narcolepsy	Neurological disorder
7532	GCST000235	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
7533	GCST000234	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7534	GCST000234	LDL cholesterol	LDL cholesterol	Other measurement
7535	GCST000234	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7536	GCST000183	Alzheimer's disease	Alzheimer's disease	Neurological disorder
7537	GCST000182	Bone mineral density	Bone mineral density	Other measurement
7538	GCST000180	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
7539	GCST000180	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
7540	GCST000181	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
7541	GCST000181	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
7542	GCST000179	C-reactive protein	C-reactive protein	Inflammatory measurement
7543	GCST000178	C-reactive protein	C-reactive protein	Inflammatory measurement
7544	GCST000177	YKL-40 levels	YKL-40 levels	Inflammatory measurement
7545	GCST000176	Height	Height	Other measurement
7546	GCST000176	Height	Height	Body measurement
7547	GCST000174	Height	Height	Other measurement
7548	GCST000174	Height	Height	Body measurement
7549	GCST000175	Height	Height	Other measurement
7550	GCST000175	Height	Height	Body measurement
7551	GCST000198	Melanoma	Melanoma	Cancer
7552	GCST000190	Black vs. blond hair color	Black vs. blond hair color	Other trait
7553	GCST000191	Black vs. red hair color	Black vs. red hair color	Other trait
7554	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7555	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7556	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
7557	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7558	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7559	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7560	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
7561	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Liver enzyme measurement
7562	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7563	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Hematological measurement
7564	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7565	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Lipid or lipoprotein measurement
7566	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
7567	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7568	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7569	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7570	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7571	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Hematological measurement
7572	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7573	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7574	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Liver enzyme measurement
7575	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Liver enzyme measurement
7576	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
7577	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7578	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Hematological measurement
7579	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
7580	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
7581	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
7582	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7583	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
7584	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7585	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7586	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
7587	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7588	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7589	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7590	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7591	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Inflammatory measurement
7592	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7593	GCST000189	Protein quantitative trait loci	Protein quantitative trait loci	Other measurement
7594	GCST000188	Neuroblastoma	Neuroblastoma	Cancer
7595	GCST000187	Breast cancer	Breast cancer	Cancer
7596	GCST000186	Knee osteoarthritis	Knee osteoarthritis	Other disease
7597	GCST000184	Waist circumference and related phenotypes	Waist circumference and related phenotypes	Body measurement
7598	GCST000184	Waist circumference and related phenotypes	Waist circumference and related phenotypes	Lipid or lipoprotein measurement
7599	GCST000184	Waist circumference and related phenotypes	Waist circumference and related phenotypes	Lipid or lipoprotein measurement
7600	GCST000185	Body mass index	Body mass index	Body measurement
7601	GCST000185	Body mass index	Body mass index	Body measurement
7602	GCST000185	Body mass index	Body mass index	Other measurement
7603	GCST000173	Psoriasis	Psoriasis	Immune system disorder
7604	GCST000171	Nicotine dependence	Nicotine dependence	Neurological disorder
7605	GCST000172	Lung cancer	Lung cancer	Cancer
7606	GCST000172	Lung cancer	Lung cancer	Cancer
7607	GCST000172	Lung cancer	Lung cancer	Cancer
7608	GCST000170	Lung cancer	Lung cancer	Cancer
7609	GCST000170	Lung cancer	Lung cancer	Cancer
7610	GCST000170	Lung cancer	Lung cancer	Cancer
7611	GCST000167	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7612	GCST000168	Colorectal cancer	Colorectal cancer	Cancer
7613	GCST000169	Colorectal cancer	Colorectal cancer	Cancer
7614	GCST000166	Environmental confusion in the home	Environmental confusion in the home	Other measurement
7615	GCST000165	Psoriasis	Psoriasis	Immune system disorder
7616	GCST000164	Schizophrenia	Schizophrenia	Neurological disorder
7617	GCST000223	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
7618	GCST000222	IgE levels	IgE levels	Other measurement
7619	GCST000219	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7620	GCST000220	Bipolar disorder	Bipolar disorder	Neurological disorder
7621	GCST000221	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7622	GCST000218	Sarcoidosis	Sarcoidosis	Other disease
7623	GCST000217	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
7624	GCST000216	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7625	GCST000215	Schizophrenia	Schizophrenia	Neurological disorder
7626	GCST000214	Restless legs syndrome	Restless legs syndrome	Neurological disorder
7627	GCST000233	Lung cancer	Lung cancer	Cancer
7628	GCST000233	Lung cancer	Lung cancer	Cancer
7629	GCST000233	Lung cancer	Lung cancer	Cancer
7630	GCST000231	Urinary bladder cancer	Urinary bladder cancer	Cancer
7631	GCST000232	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
7632	GCST000230	Hearing impairment	Hearing impairment	Neurological disorder
7633	GCST000229	Hip bone size	Hip bone size	Body measurement
7634	GCST000228	Vitamin B12 levels	Vitamin B12 levels	Other measurement
7635	GCST000227	Uric acid levels	Uric acid levels	Cardiovascular measurement
7636	GCST000226	Neuroticism	Neuroticism	Neurological disorder
7637	GCST000226	Neuroticism	Neuroticism	Other measurement
7638	GCST000224	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
7639	GCST000225	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
7640	GCST000225	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
7641	GCST000225	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
7642	GCST000152	Prostate cancer	Prostate cancer	Cancer
7643	GCST000154	Prostate cancer	Prostate cancer	Cancer
7644	GCST000151	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7645	GCST000151	LDL cholesterol	LDL cholesterol	Other measurement
7646	GCST000151	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7647	GCST000150	Fetal hemoglobin levels	Fetal hemoglobin levels	Hematological measurement
7648	GCST000148	Recombination rate (males)	Recombination rate (males)	Other measurement
7649	GCST000149	Recombination rate (females)	Recombination rate (females)	Other measurement
7650	GCST000147	Nicotine dependence	Nicotine dependence	Neurological disorder
7651	GCST000146	Iris color	Iris color	Other trait
7652	GCST000145	General cognitive ability	General cognitive ability	Biological process
7653	GCST000142	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7654	GCST000213	Response to statin therapy	Response to statin therapy	Response to drug
7655	GCST000212	Crohn's disease and sarcoidosis (combined)	Crohn's disease and sarcoidosis (combined)	Digestive system disorder
7656	GCST000212	Crohn's disease and sarcoidosis (combined)	Crohn's disease and sarcoidosis (combined)	Other disease
7657	GCST000211	Response to TNF antagonist treatment	Response to TNF antagonist treatment	Response to drug
7658	GCST000210	Soluble ICAM-1	Soluble ICAM-1	Cardiovascular measurement
7659	GCST000209	Osteonecrosis of the jaw	Osteonecrosis of the jaw	Other disease
7660	GCST000208	Response to diuretic therapy	Response to diuretic therapy	Response to drug
7661	GCST000207	Crohn's disease	Crohn's disease	Digestive system disorder
7662	GCST000206	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
7663	GCST000205	Fasting plasma glucose	Fasting plasma glucose	Other measurement
7664	GCST000204	Warfarin maintenance dose	Warfarin maintenance dose	Response to drug
7665	GCST000163	Schizophrenia	Schizophrenia	Neurological disorder
7666	GCST000162	Breast cancer	Breast cancer	Cancer
7667	GCST000161	Urate levels	Urate levels	Metabolic disorder
7668	GCST000161	Urate levels	Urate levels	Other measurement
7669	GCST000160	Urate levels	Urate levels	Metabolic disorder
7670	GCST000160	Urate levels	Urate levels	Other measurement
7671	GCST000159	Obesity	Obesity	Other measurement
7672	GCST000159	Obesity	Obesity	Metabolic disorder
7673	GCST000158	Bipolar disorder	Bipolar disorder	Neurological disorder
7674	GCST000157	Celiac disease	Celiac disease	Immune system disorder
7675	GCST000156	Methamphetamine dependence	Methamphetamine dependence	Neurological disorder
7676	GCST000156	Methamphetamine dependence	Methamphetamine dependence	Neurological disorder
7677	GCST000155	Schizophrenia	Schizophrenia	Neurological disorder
7678	GCST000153	Prostate cancer	Prostate cancer	Cancer
7679	GCST000202	Fasting plasma glucose	Fasting plasma glucose	Other measurement
7680	GCST000203	Smoking cessation	Smoking cessation	Biological process
7681	GCST000200	Response to iloperidone treatment (PANSS-T score)	Response to iloperidone treatment (PANSS-T score)	Response to drug
7682	GCST000201	Response to iloperidone treatment (QT prolongation)	Response to iloperidone treatment (QT prolongation)	Response to drug
7683	GCST000199	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other measurement
7684	GCST000199	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other trait
7685	GCST000053	Colorectal cancer	Colorectal cancer	Cancer
7686	GCST000052	Colorectal cancer	Colorectal cancer	Cancer
7687	GCST000051	Atrial fibrillation/atrial flutter	Atrial fibrillation/atrial flutter	Cardiovascular disease
7688	GCST000050	Prostate cancer	Prostate cancer	Cancer
7689	GCST000049	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7690	GCST000048	Celiac disease	Celiac disease	Immune system disorder
7691	GCST000063	Neuroticism	Neuroticism	Neurological disorder
7692	GCST000063	Neuroticism	Neuroticism	Other measurement
7693	GCST000062	Multiple sclerosis	Multiple sclerosis	Immune system disorder
7694	GCST000061	Asthma	Asthma	Other disease
7695	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7696	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7697	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7698	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7699	GCST000060	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
7700	GCST000060	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
7701	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7702	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7703	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7704	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7705	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7706	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7707	GCST000060	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
7708	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7709	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7710	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7711	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7712	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7713	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7714	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7715	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7716	GCST000060	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7717	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7718	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7719	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7720	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7721	GCST000060	Obesity-related traits	Obesity-related traits	Biological process
7722	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7723	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7724	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7725	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7726	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7727	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7728	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7729	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7730	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7731	GCST000060	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7732	GCST000060	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7733	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7734	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7735	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7736	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7737	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7738	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7739	GCST000060	Obesity-related traits	Obesity-related traits	Body measurement
7740	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7741	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7742	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7743	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7744	GCST000060	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
7745	GCST000060	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7746	GCST000060	Obesity-related traits	Obesity-related traits	Metabolic disorder
7747	GCST000060	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
7748	GCST000060	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7749	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7750	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7751	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7752	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7753	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7754	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7755	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7756	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7757	GCST000060	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7758	GCST000060	Obesity-related traits	Obesity-related traits	Biological process
7759	GCST000060	Obesity-related traits	Obesity-related traits	Biological process
7760	GCST000060	Obesity-related traits	Obesity-related traits	Other measurement
7761	GCST000058	Restless legs syndrome	Restless legs syndrome	Neurological disorder
7762	GCST000059	HIV-1 viral setpoint	HIV-1 viral setpoint	Biological process
7763	GCST000059	HIV-1 viral setpoint	HIV-1 viral setpoint	Other measurement
7764	GCST000059	HIV-1 viral setpoint	HIV-1 viral setpoint	Other disease
7765	GCST000057	Coronary heart disease	Coronary heart disease	Cardiovascular disease
7766	GCST000056	Restless legs syndrome	Restless legs syndrome	Neurological disorder
7767	GCST000055	Gallstone disease	Gallstone disease	Digestive system disorder
7768	GCST000055	Gallstone disease	Gallstone disease	Digestive system disorder
7769	GCST000054	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
7770	GCST000074	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7771	GCST000072	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
7772	GCST000070	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
7773	GCST000071	Crohn's disease	Crohn's disease	Digestive system disorder
7774	GCST000069	F-cell distribution	F-cell distribution	Hematological measurement
7775	GCST000068	Height	Height	Other measurement
7776	GCST000068	Height	Height	Body measurement
7777	GCST000067	Glaucoma (exfoliation)	Glaucoma (exfoliation)	Neurological disorder
7778	GCST000066	Crohn's disease	Crohn's disease	Digestive system disorder
7779	GCST000065	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
7780	GCST000064	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
7781	GCST000064	Type 2 diabetes nephropathy	Type 2 diabetes nephropathy	Metabolic disorder
7782	GCST000143	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7783	GCST000144	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
7784	GCST000141	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
7785	GCST000140	Response to interferon beta therapy	Response to interferon beta therapy	Response to drug
7786	GCST000138	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
7787	GCST000133	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
7788	GCST000134	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7789	GCST000134	LDL cholesterol	LDL cholesterol	Other measurement
7790	GCST000134	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7791	GCST000136	Height	Height	Other measurement
7792	GCST000136	Height	Height	Body measurement
7793	GCST000137	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
7794	GCST000131	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7795	GCST000131	LDL cholesterol	LDL cholesterol	Other measurement
7796	GCST000131	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
7797	GCST000130	Urate levels	Urate levels	Metabolic disorder
7798	GCST000130	Urate levels	Urate levels	Other measurement
7799	GCST000129	Obesity (early onset extreme)	Obesity (early onset extreme)	Metabolic disorder
7800	GCST000128	Prostate cancer	Prostate cancer	Cancer
7801	GCST000127	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
7802	GCST000126	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
7803	GCST000125	Coronary spasm	Coronary spasm	Cardiovascular disease
7804	GCST000124	Alzheimer's disease	Alzheimer's disease	Neurological disorder
7805	GCST000084	Waist circumference	Waist circumference	Body measurement
7806	GCST000083	Select biomarker traits	Select biomarker traits	Other measurement
7807	GCST000083	Select biomarker traits	Select biomarker traits	Liver enzyme measurement
7808	GCST000083	Select biomarker traits	Select biomarker traits	Cardiovascular measurement
7809	GCST000083	Select biomarker traits	Select biomarker traits	Inflammatory measurement
7810	GCST000083	Select biomarker traits	Select biomarker traits	Other measurement
7811	GCST000083	Select biomarker traits	Select biomarker traits	Other measurement
7812	GCST000083	Select biomarker traits	Select biomarker traits	Inflammatory measurement
7813	GCST000083	Select biomarker traits	Select biomarker traits	Liver enzyme measurement
7814	GCST000083	Select biomarker traits	Select biomarker traits	Other measurement
7815	GCST000083	Select biomarker traits	Select biomarker traits	Inflammatory measurement
7816	GCST000073	Type 2 diabetes and 6 quantitative traits	Type 2 diabetes and 6 quantitative traits	Metabolic disorder
7817	GCST000073	Type 2 diabetes and 6 quantitative traits	Type 2 diabetes and 6 quantitative traits	Other measurement
7818	GCST000073	Type 2 diabetes and 6 quantitative traits	Type 2 diabetes and 6 quantitative traits	Other measurement
7819	GCST000075	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7820	GCST000123	Urate levels	Urate levels	Metabolic disorder
7821	GCST000123	Urate levels	Urate levels	Other measurement
7822	GCST000122	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
7823	GCST000121	Alzheimer's disease	Alzheimer's disease	Neurological disorder
7824	GCST000116	Skin sensitivity to sun	Skin sensitivity to sun	Immune system disorder
7825	GCST000120	Blue vs. brown eyes	Blue vs. brown eyes	Other trait
7826	GCST000117	Blue vs. green eyes	Blue vs. green eyes	Other trait
7827	GCST000118	Blond vs. brown hair color	Blond vs. brown hair color	Other trait
7828	GCST000119	Freckles	Freckles	Other trait
7829	GCST000115	Red vs non-red hair color	Red vs non-red hair color	Other trait
7830	GCST000114	Skin pigmentation	Skin pigmentation	Other trait
7831	GCST000114	Skin pigmentation	Skin pigmentation	Other measurement
7832	GCST000113	Colorectal cancer	Colorectal cancer	Cancer
7833	GCST000112	Lupus	Lupus	Immune system disorder
7834	GCST000090	Body mass index	Body mass index	Body measurement
7835	GCST000090	Body mass index	Body mass index	Body measurement
7836	GCST000090	Body mass index	Body mass index	Other measurement
7837	GCST000046	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
7838	GCST000046	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
7839	GCST000039	Crohn's disease	Crohn's disease	Digestive system disorder
7840	GCST000038	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
7841	GCST000036	Breast cancer	Breast cancer	Cancer
7842	GCST000035	Breast cancer	Breast cancer	Cancer
7843	GCST000037	Breast cancer	Breast cancer	Cancer
7844	GCST000034	Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	Liver enzyme measurement
7845	GCST000034	Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	Response to drug
7846	GCST000027	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7847	GCST000024	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7848	GCST000023	Crohn's disease	Crohn's disease	Digestive system disorder
7849	GCST000022	Body mass index	Body mass index	Body measurement
7850	GCST000022	Body mass index	Body mass index	Body measurement
7851	GCST000022	Body mass index	Body mass index	Other measurement
7852	GCST000021	Nicotine dependence	Nicotine dependence	Neurological disorder
7853	GCST000019	Prostate cancer	Prostate cancer	Cancer
7854	GCST000020	End-stage renal disease	End-stage renal disease	Other disease
7855	GCST000017	Prostate cancer	Prostate cancer	Cancer
7856	GCST000018	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
7857	GCST000018	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
7858	GCST000016	Schizophrenia	Schizophrenia	Neurological disorder
7859	GCST000015	Progressive supranuclear palsy	Progressive supranuclear palsy	Neurological disorder
7860	GCST000014	Crohn's disease	Crohn's disease	Digestive system disorder
7861	GCST000013	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
7862	GCST000012	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7863	GCST000011	Lung cancer	Lung cancer	Cancer
7864	GCST000011	Lung cancer	Lung cancer	Cancer
7865	GCST000011	Lung cancer	Lung cancer	Cancer
7866	GCST000010	Nicotine dependence	Nicotine dependence	Neurological disorder
7867	GCST000009	Addiction	Addiction	Neurological disorder
7868	GCST000008	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
7869	GCST000008	Inflammatory bowel disease	Inflammatory bowel disease	Immune system disorder
7870	GCST000008	Inflammatory bowel disease	Inflammatory bowel disease	Digestive system disorder
7871	GCST000007	Memory performance	Memory performance	Other measurement
7872	GCST000033	Bipolar disorder	Bipolar disorder	Neurological disorder
7873	GCST000032	Stroke	Stroke	Cardiovascular disease
7874	GCST000031	Coronary heart disease	Coronary heart disease	Cardiovascular disease
7875	GCST000030	Myocardial infarction	Myocardial infarction	Cardiovascular disease
7876	GCST000029	Episodic memory	Episodic memory	Biological process
7877	GCST000025	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7878	GCST000006	Age-related macular degeneration (wet)	Age-related macular degeneration (wet)	Neurological disorder
7879	GCST000005	Parkinson's disease	Parkinson's disease	Neurological disorder
7880	GCST000004	QT interval	QT interval	Cardiovascular measurement
7881	GCST000003	Obesity	Obesity	Other measurement
7882	GCST000003	Obesity	Obesity	Metabolic disorder
7883	GCST000002	Parkinson's disease	Parkinson's disease	Neurological disorder
7884	GCST000001	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
7885	GCST000001	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
7886	GCST001374	Uric acid levels	Uric acid levels	Cardiovascular measurement
7887	GCST001373	Breast cancer (survival)	Breast cancer (survival)	Other measurement
7888	GCST001373	Breast cancer (survival)	Breast cancer (survival)	Cancer
7889	GCST001373	Breast cancer (survival)	Breast cancer (survival)	Cancer
7890	GCST001373	Breast cancer (survival)	Breast cancer (survival)	Cancer
7891	GCST001373	Breast cancer (survival)	Breast cancer (survival)	Other measurement
7892	GCST001372	Alzheimer's disease	Alzheimer's disease	Neurological disorder
7893	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Other measurement
7894	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
7895	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
7896	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Response to drug
7897	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
7898	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
7899	GCST001371	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
7900	GCST001370	Prostate cancer (SNP x SNP interaction)	Prostate cancer (SNP x SNP interaction)	Cancer
7901	GCST001370	Prostate cancer (SNP x SNP interaction)	Prostate cancer (SNP x SNP interaction)	Other measurement
7902	GCST001369	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7903	GCST001368	Capecitabine sensitivity	Capecitabine sensitivity	Response to drug
7904	GCST001366	Prion diseases	Prion diseases	Neurological disorder
7905	GCST001367	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
7906	GCST006102	Interleukin-10 levels	Interleukin-10 levels	Inflammatory measurement
7907	GCST001339	Corneal astigmatism	Corneal astigmatism	Neurological disorder
7908	GCST001339	Corneal astigmatism	Corneal astigmatism	Other trait
7909	GCST001334	Creutzfeldt-Jakob disease (variant)	Creutzfeldt-Jakob disease (variant)	Neurological disorder
7910	GCST001337	Platelet count	Platelet count	Hematological measurement
7911	GCST001335	Mean platelet volume	Mean platelet volume	Hematological measurement
7912	GCST001336	Menarche and menopause (age at onset)	Menarche and menopause (age at onset)	Other measurement
7913	GCST001336	Menarche and menopause (age at onset)	Menarche and menopause (age at onset)	Other measurement
7914	GCST001333	Bilirubin levels	Bilirubin levels	Other measurement
7915	GCST001332	Cognitive function	Cognitive function	Biological process
7916	GCST001332	Cognitive function	Cognitive function	Biological process
7917	GCST001332	Cognitive function	Cognitive function	Other measurement
7918	GCST001332	Cognitive function	Cognitive function	Biological process
7919	GCST001331	Multiple myeloma	Multiple myeloma	Cancer
7920	GCST001329	Epilepsy	Epilepsy	Neurological disorder
7921	GCST001329	Epilepsy	Epilepsy	Neurological disorder
7922	GCST001329	Epilepsy	Epilepsy	Neurological disorder
7923	GCST001330	Ovarian reserve	Ovarian reserve	Other measurement
7924	GCST006104	Interleukin-1-receptor antagonist levels	Interleukin-1-receptor antagonist levels	Inflammatory measurement
7925	GCST006103	Interleukin-6 levels	Interleukin-6 levels	Inflammatory measurement
7926	GCST001365	Anticoagulant levels	Anticoagulant levels	Other measurement
7927	GCST001365	Anticoagulant levels	Anticoagulant levels	Hematological measurement
7928	GCST001365	Anticoagulant levels	Anticoagulant levels	Hematological measurement
7929	GCST001362	Non-obstructive azoospermia	Non-obstructive azoospermia	Other disease
7930	GCST001364	IgA nephropathy	IgA nephropathy	Other disease
7931	GCST001363	Atopic dermatitis	Atopic dermatitis	Immune system disorder
7932	GCST001361	Ankle-brachial index	Ankle-brachial index	Cardiovascular measurement
7933	GCST001359	Bipolar disorder	Bipolar disorder	Neurological disorder
7934	GCST001360	Asthma	Asthma	Other disease
7935	GCST001358	Bipolar disorder	Bipolar disorder	Neurological disorder
7936	GCST001321	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
7937	GCST001318	Serum ceruloplasmin levels	Serum ceruloplasmin levels	Other measurement
7938	GCST001316	IgE levels	IgE levels	Other measurement
7939	GCST001317	Aortic stiffness	Aortic stiffness	Cardiovascular measurement
7940	GCST001315	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
7941	GCST001315	Femoral neck bone geometry	Femoral neck bone geometry	Other measurement
7942	GCST001314	Adiponectin levels	Adiponectin levels	Other measurement
7943	GCST005523	Celiac disease	Celiac disease	Immune system disorder
7944	GCST001313	Depression and alcohol dependence	Depression and alcohol dependence	Neurological disorder
7945	GCST001312	Abdominal aortic aneurysm	Abdominal aortic aneurysm	Cardiovascular disease
7946	GCST001311	Cognitive decline	Cognitive decline	Other trait
7947	GCST001311	Cognitive decline	Cognitive decline	Biological process
7948	GCST001357	Response to tamoxifen in breast cancer	Response to tamoxifen in breast cancer	Response to drug
7949	GCST001356	Gout	Gout	Metabolic disorder
7950	GCST001354	Heart rate variability traits	Heart rate variability traits	Cardiovascular measurement
7951	GCST005046	N-glycan levels	N-glycan levels	Other measurement
7952	GCST001355	Psoriatic arthritis	Psoriatic arthritis	Immune system disorder
7953	GCST001352	HIV-1 viral setpoint	HIV-1 viral setpoint	Biological process
7954	GCST001352	HIV-1 viral setpoint	HIV-1 viral setpoint	Other measurement
7955	GCST001352	HIV-1 viral setpoint	HIV-1 viral setpoint	Other disease
7956	GCST001353	HIV-1 susceptibility	HIV-1 susceptibility	Immune system disorder
7957	GCST001353	HIV-1 susceptibility	HIV-1 susceptibility	Other disease
7958	GCST001350	Pancreatic cancer	Pancreatic cancer	Cancer
7959	GCST001351	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
7960	GCST001349	Brain development	Brain development	Body measurement
7961	GCST001289	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
7962	GCST001289	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
7963	GCST001289	Lipid traits	Lipid traits	Other measurement
7964	GCST001289	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
7965	GCST001289	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
7966	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7967	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7968	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7969	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7970	GCST001288	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
7971	GCST001288	Obesity-related traits	Obesity-related traits	Liver enzyme measurement
7972	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7973	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7974	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
7975	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
7976	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
7977	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
7978	GCST001288	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
7979	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
7980	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
7981	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7982	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7983	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7984	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
7985	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7986	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7987	GCST001288	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
7988	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7989	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7990	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
7991	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
7992	GCST001288	Obesity-related traits	Obesity-related traits	Biological process
7993	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7994	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7995	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
7996	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7997	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
7998	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
7999	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8000	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8001	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8002	GCST001288	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
8003	GCST001288	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
8004	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8005	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
8006	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8007	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8008	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8009	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8010	GCST001288	Obesity-related traits	Obesity-related traits	Body measurement
8011	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8012	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8013	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8014	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8015	GCST001288	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
8016	GCST001288	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
8017	GCST001288	Obesity-related traits	Obesity-related traits	Metabolic disorder
8018	GCST001288	Obesity-related traits	Obesity-related traits	Cardiovascular measurement
8019	GCST001288	Obesity-related traits	Obesity-related traits	Lipid or lipoprotein measurement
8020	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8021	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
8022	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
8023	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8024	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8025	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8026	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8027	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8028	GCST001288	Obesity-related traits	Obesity-related traits	Inflammatory measurement
8029	GCST001288	Obesity-related traits	Obesity-related traits	Biological process
8030	GCST001288	Obesity-related traits	Obesity-related traits	Biological process
8031	GCST001288	Obesity-related traits	Obesity-related traits	Other measurement
8032	GCST001287	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
8033	GCST001283	Renal cell carcinoma	Renal cell carcinoma	Cancer
8034	GCST001280	Alzheimer's disease (age of onset)	Alzheimer's disease (age of onset)	Neurological disorder
8035	GCST001280	Alzheimer's disease (age of onset)	Alzheimer's disease (age of onset)	Other measurement
8036	GCST001284	Premature ovarian failure	Premature ovarian failure	Other disease
8037	GCST001281	Alcohol dependence	Alcohol dependence	Other measurement
8038	GCST001281	Alcohol dependence	Alcohol dependence	Neurological disorder
8039	GCST001282	Psychosis in Alzheimer's disease	Psychosis in Alzheimer's disease	Neurological disorder
8040	GCST001282	Psychosis in Alzheimer's disease	Psychosis in Alzheimer's disease	Other trait
8041	GCST001285	Psychosis and Alzheimer's disease	Psychosis and Alzheimer's disease	Neurological disorder
8042	GCST001285	Psychosis and Alzheimer's disease	Psychosis and Alzheimer's disease	Other trait
8043	GCST001348	Hepatocellular carcinoma	Hepatocellular carcinoma	Cancer
8044	GCST001347	Coronary artery calcification	Coronary artery calcification	Other trait
8045	GCST001346	Response to gemcitabine in pancreatic cancer	Response to gemcitabine in pancreatic cancer	Response to drug
8046	GCST001346	Response to gemcitabine in pancreatic cancer	Response to gemcitabine in pancreatic cancer	Cancer
8047	GCST001345	Ankylosing spondylitis	Ankylosing spondylitis	Immune system disorder
8048	GCST001344	Testicular dysgenesis syndrome	Testicular dysgenesis syndrome	Other disease
8049	GCST001338	Prostate cancer	Prostate cancer	Cancer
8050	GCST001342	Alzheimer's disease	Alzheimer's disease	Neurological disorder
8051	GCST001341	Multiple sclerosis	Multiple sclerosis	Immune system disorder
8052	GCST001340	Pelvic organ prolapse	Pelvic organ prolapse	Other disease
8053	GCST001328	Vascular dementia	Vascular dementia	Cardiovascular disease
8054	GCST001327	Memory performance	Memory performance	Other measurement
8055	GCST001326	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
8056	GCST001325	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
8057	GCST001324	Bilirubin levels	Bilirubin levels	Other measurement
8058	GCST001323	Nodular sclerosis Hodgkin lymphoma	Nodular sclerosis Hodgkin lymphoma	Cancer
8059	GCST004371	Rate of cognitive decline in mild cognitive impairment (time interaction)	Rate of cognitive decline in mild cognitive impairment (time interaction)	Other measurement
8060	GCST004371	Rate of cognitive decline in mild cognitive impairment (time interaction)	Rate of cognitive decline in mild cognitive impairment (time interaction)	Other trait
8061	GCST004371	Rate of cognitive decline in mild cognitive impairment (time interaction)	Rate of cognitive decline in mild cognitive impairment (time interaction)	Other measurement
8062	GCST001322	Kawasaki disease	Kawasaki disease	Immune system disorder
8063	GCST001319	Alcohol withdrawal symptoms	Alcohol withdrawal symptoms	Neurological disorder
8064	GCST001302	White blood cell count	White blood cell count	Hematological measurement
8065	GCST001302	White blood cell count	White blood cell count	Inflammatory measurement
8066	GCST001302	White blood cell count	White blood cell count	Hematological measurement
8067	GCST001302	White blood cell count	White blood cell count	Hematological measurement
8068	GCST001302	White blood cell count	White blood cell count	Hematological measurement
8069	GCST001301	Schizophrenia	Schizophrenia	Neurological disorder
8070	GCST001297	Male-pattern baldness	Male-pattern baldness	Other measurement
8071	GCST001297	Male-pattern baldness	Male-pattern baldness	Other disease
8072	GCST001297	Male-pattern baldness	Male-pattern baldness	Other disease
8073	GCST001295	Alopecia areata	Alopecia areata	Other disease
8074	GCST001296	Suicidal ideation	Suicidal ideation	Biological process
8075	GCST001296	Suicidal ideation	Suicidal ideation	Other measurement
8076	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
8077	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Cardiovascular measurement
8078	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
8079	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other disease
8080	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
8081	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
8082	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
8083	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
8084	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
8085	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
8086	GCST001294	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Inflammatory measurement
8087	GCST001292	Leprosy	Leprosy	Neurological disorder
8088	GCST001293	Scoliosis	Scoliosis	Other disease
8089	GCST001290	Height	Height	Other measurement
8090	GCST001290	Height	Height	Body measurement
8091	GCST001291	Response to platinum-based agents	Response to platinum-based agents	Response to drug
8092	GCST001303	IgE grass sensitization	IgE grass sensitization	Immune system disorder
8093	GCST001310	Allergic rhinitis	Allergic rhinitis	Immune system disorder
8094	GCST001310	Allergic rhinitis	Allergic rhinitis	Immune system disorder
8095	GCST001306	Asthma	Asthma	Other disease
8096	GCST001307	Gamma glutamyl transferase levels	Gamma glutamyl transferase levels	Liver enzyme measurement
8097	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
8098	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
8099	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
8100	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Other trait
8101	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
8102	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Other trait
8103	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Other trait
8104	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Other trait
8105	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
8106	GCST001308	Response to anti-depressant treatment in major depressive disorder	Response to anti-depressant treatment in major depressive disorder	Response to drug
8107	GCST001309	Asthma	Asthma	Other disease
8108	GCST001304	Renal sinus fat	Renal sinus fat	Other measurement
8109	GCST001300	Gastric cancer	Gastric cancer	Cancer
8110	GCST001250	Basal cell carcinoma	Basal cell carcinoma	Cancer
8111	GCST001251	Pulmonary function	Pulmonary function	Other measurement
8112	GCST001251	Pulmonary function	Pulmonary function	Other measurement
8113	GCST001251	Pulmonary function	Pulmonary function	Other measurement
8114	GCST001251	Pulmonary function	Pulmonary function	Other measurement
8115	GCST001249	Spine bone size	Spine bone size	Other measurement
8116	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
8117	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Cardiovascular measurement
8118	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
8119	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other disease
8120	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
8121	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
8122	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
8123	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
8124	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
8125	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
8126	GCST001247	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Inflammatory measurement
8127	GCST001246	Stroke	Stroke	Cardiovascular disease
8128	GCST001245	Melanoma	Melanoma	Cancer
8129	GCST001243	Stroke	Stroke	Cardiovascular disease
8130	GCST001244	Dental caries	Dental caries	Digestive system disorder
8131	GCST001241	Bipolar disorder	Bipolar disorder	Neurological disorder
8132	GCST001242	Schizophrenia	Schizophrenia	Neurological disorder
8133	GCST001235	Blood pressure	Blood pressure	Other measurement
8134	GCST001235	Blood pressure	Blood pressure	Other measurement
8135	GCST001235	Blood pressure	Blood pressure	Other measurement
8136	GCST001235	Blood pressure	Blood pressure	Other measurement
8137	GCST001235	Blood pressure	Blood pressure	Cardiovascular measurement
8138	GCST001236	Blood pressure	Blood pressure	Other measurement
8139	GCST001236	Blood pressure	Blood pressure	Other measurement
8140	GCST001236	Blood pressure	Blood pressure	Other measurement
8141	GCST001236	Blood pressure	Blood pressure	Other measurement
8142	GCST001236	Blood pressure	Blood pressure	Cardiovascular measurement
8143	GCST001225	HPV seropositivity	HPV seropositivity	Other measurement
8144	GCST001226	Asthma	Asthma	Other disease
8145	GCST001223	Chronic fatigue syndrome	Chronic fatigue syndrome	Immune system disorder
8146	GCST001224	Breast cancer	Breast cancer	Cancer
8147	GCST001221	Permanent tooth development	Permanent tooth development	Biological process
8148	GCST001219	Graves' disease	Graves' disease	Immune system disorder
8149	GCST001220	Metabolite levels	Metabolite levels	Other trait
8150	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8151	GCST001220	Metabolite levels	Metabolite levels	Liver enzyme measurement
8152	GCST001220	Metabolite levels	Metabolite levels	Cardiovascular measurement
8153	GCST001220	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8154	GCST001220	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8155	GCST001220	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8156	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8157	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8158	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8159	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8160	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8161	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8162	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8163	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8164	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8165	GCST001220	Metabolite levels	Metabolite levels	Other measurement
8166	GCST001218	Lp (a) levels	Lp (a) levels	Lipid or lipoprotein measurement
8167	GCST001217	Metabolic traits	Metabolic traits	Other measurement
8168	GCST001217	Metabolic traits	Metabolic traits	Biological process
8169	GCST001217	Metabolic traits	Metabolic traits	Lipid or lipoprotein measurement
8170	GCST001217	Metabolic traits	Metabolic traits	Other measurement
8171	GCST001217	Metabolic traits	Metabolic traits	Other measurement
8172	GCST001215	Coffee consumption	Coffee consumption	Biological process
8173	GCST001215	Coffee consumption	Coffee consumption	Other measurement
8174	GCST001215	Coffee consumption	Coffee consumption	Other measurement
8175	GCST001216	Retinol levels	Retinol levels	Other measurement
8176	GCST001216	Retinol levels	Retinol levels	Other measurement
8177	GCST001214	Coronary restenosis	Coronary restenosis	Cardiovascular disease
8178	GCST001213	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
8179	GCST001211	Alcohol dependence	Alcohol dependence	Other measurement
8180	GCST001211	Alcohol dependence	Alcohol dependence	Neurological disorder
8181	GCST001212	Proinsulin levels	Proinsulin levels	Other measurement
8182	GCST001199	Iris characteristics	Iris characteristics	Other measurement
8183	GCST001198	Multiple sclerosis	Multiple sclerosis	Immune system disorder
8184	GCST001197	Bronchopulmonary dysplasia	Bronchopulmonary dysplasia	Other disease
8185	GCST001195	Intelligence	Intelligence	Biological process
8186	GCST001196	Tardive dyskinesia	Tardive dyskinesia	Neurological disorder
8187	GCST001194	Glioma	Glioma	Cancer
8188	GCST001194	Glioma	Glioma	Cancer
8189	GCST001193	Bladder cancer	Bladder cancer	Cancer
8190	GCST001192	Response to statin therapy	Response to statin therapy	Response to drug
8191	GCST001190	Coronary heart disease	Coronary heart disease	Cardiovascular disease
8192	GCST001210	Non-small cell lung cancer	Non-small cell lung cancer	Cancer
8193	GCST001209	Osteoarthritis	Osteoarthritis	Other disease
8194	GCST001208	Insulin resistance/response	Insulin resistance/response	Other trait
8195	GCST001207	Butyrylcholinesterase levels	Butyrylcholinesterase levels	Liver enzyme measurement
8196	GCST001206	Uric acid levels (SNP x SNP interaction)	Uric acid levels (SNP x SNP interaction)	Cardiovascular measurement
8197	GCST001205	Parkinson's disease (coffee consumption interaction)	Parkinson's disease (coffee consumption interaction)	Neurological disorder
8198	GCST001205	Parkinson's disease (coffee consumption interaction)	Parkinson's disease (coffee consumption interaction)	Biological process
8199	GCST001203	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
8200	GCST001201	Response to platinum-based chemotherapy (cisplatin)	Response to platinum-based chemotherapy (cisplatin)	Response to drug
8201	GCST001204	Response to platinum-based chemotherapy (carboplatin)	Response to platinum-based chemotherapy (carboplatin)	Response to drug
8202	GCST001200	Graves' disease	Graves' disease	Immune system disorder
8203	GCST001240	Obesity (extreme)	Obesity (extreme)	Metabolic disorder
8204	GCST001240	Obesity (extreme)	Obesity (extreme)	Body measurement
8205	GCST001239	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	Other disease
8206	GCST001239	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	Other disease
8207	GCST001232	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8208	GCST001232	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8209	GCST001286	Smoking behavior	Smoking behavior	Biological process
8210	GCST001279	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
8211	GCST001275	Liver enzyme levels (alanine transaminase)	Liver enzyme levels (alanine transaminase)	Liver enzyme measurement
8212	GCST001277	Liver enzyme levels (gamma-glutamyl transferase)	Liver enzyme levels (gamma-glutamyl transferase)	Liver enzyme measurement
8213	GCST001276	Liver enzyme levels (alkaline phosphatase)	Liver enzyme levels (alkaline phosphatase)	Liver enzyme measurement
8214	GCST001278	Dengue shock syndrome	Dengue shock syndrome	Other disease
8215	GCST001273	Lipoprotein-associated phospholipase A2 activity and mass	Lipoprotein-associated phospholipase A2 activity and mass	Lipid or lipoprotein measurement
8216	GCST001274	Corneal structure	Corneal structure	Other measurement
8217	GCST001274	Corneal structure	Corneal structure	Neurological disorder
8218	GCST001272	Cytomegalovirus antibody response	Cytomegalovirus antibody response	Biological process
8219	GCST001270	Blood pressure	Blood pressure	Other measurement
8220	GCST001270	Blood pressure	Blood pressure	Other measurement
8221	GCST001270	Blood pressure	Blood pressure	Other measurement
8222	GCST001270	Blood pressure	Blood pressure	Other measurement
8223	GCST001270	Blood pressure	Blood pressure	Cardiovascular measurement
8224	GCST001260	Coronary heart disease	Coronary heart disease	Cardiovascular disease
8225	GCST001259	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Response to drug
8226	GCST001259	Response to lithium treatment in bipolar disorder	Response to lithium treatment in bipolar disorder	Neurological disorder
8227	GCST001258	Ovarian cancer	Ovarian cancer	Cancer
8228	GCST001257	Hepatitis B	Hepatitis B	Digestive system disorder
8229	GCST001257	Hepatitis B	Hepatitis B	Other measurement
8230	GCST001256	Postoperative ventricular dysfunction	Postoperative ventricular dysfunction	Cardiovascular disease
8231	GCST001255	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
8232	GCST001254	Alcohol dependence	Alcohol dependence	Other measurement
8233	GCST001254	Alcohol dependence	Alcohol dependence	Neurological disorder
8234	GCST001253	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
8235	GCST001252	Asthma treatment response	Asthma treatment response	Response to drug
8236	GCST001248	Pulmonary function	Pulmonary function	Other measurement
8237	GCST001248	Pulmonary function	Pulmonary function	Other measurement
8238	GCST001248	Pulmonary function	Pulmonary function	Other measurement
8239	GCST001248	Pulmonary function	Pulmonary function	Other measurement
8240	GCST001271	Response to antipsychotic therapy (extrapyramidal side effects)	Response to antipsychotic therapy (extrapyramidal side effects)	Response to drug
8241	GCST001266	Melanoma	Melanoma	Cancer
8242	GCST001269	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
8243	GCST001268	Gout	Gout	Metabolic disorder
8244	GCST001267	Melanoma	Melanoma	Cancer
8245	GCST001265	Hypothyroidism	Hypothyroidism	Other disease
8246	GCST001262	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
8247	GCST001262	LDL cholesterol	LDL cholesterol	Other measurement
8248	GCST001262	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
8249	GCST001261	Corneal structure	Corneal structure	Other measurement
8250	GCST001261	Corneal structure	Corneal structure	Neurological disorder
8251	GCST001264	Testosterone levels	Testosterone levels	Other measurement
8252	GCST001264	Testosterone levels	Testosterone levels	Other measurement
8253	GCST001263	Height	Height	Other measurement
8254	GCST001263	Height	Height	Body measurement
8255	GCST001152	Schizophrenia	Schizophrenia	Neurological disorder
8256	GCST001151	Schizophrenia	Schizophrenia	Neurological disorder
8257	GCST001150	Hepatitis B	Hepatitis B	Digestive system disorder
8258	GCST001150	Hepatitis B	Hepatitis B	Other measurement
8259	GCST001153	Bladder cancer	Bladder cancer	Cancer
8260	GCST001149	Ankylosing spondylitis	Ankylosing spondylitis	Immune system disorder
8261	GCST001148	Prostate cancer	Prostate cancer	Cancer
8262	GCST001147	Prostate cancer	Prostate cancer	Cancer
8263	GCST001146	Systemic sclerosis	Systemic sclerosis	Neurological disorder
8264	GCST001144	Dupuytren's disease	Dupuytren's disease	Other disease
8265	GCST001145	Chemotherapeutic susceptibility	Chemotherapeutic susceptibility	Response to drug
8266	GCST001163	Urate levels	Urate levels	Metabolic disorder
8267	GCST001163	Urate levels	Urate levels	Other measurement
8268	GCST001162	Hepatitis B vaccine response	Hepatitis B vaccine response	Response to drug
8269	GCST001161	Colorectal cancer	Colorectal cancer	Cancer
8270	GCST001158	Fibrinogen	Fibrinogen	Hematological measurement
8271	GCST001156	Systemic sclerosis	Systemic sclerosis	Neurological disorder
8272	GCST001155	Vascular endothelial growth factor levels	Vascular endothelial growth factor levels	Cardiovascular measurement
8273	GCST001160	Systemic sclerosis	Systemic sclerosis	Neurological disorder
8274	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
8275	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Cardiovascular measurement
8276	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
8277	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other disease
8278	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
8279	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
8280	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
8281	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Lipid or lipoprotein measurement
8282	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Liver enzyme measurement
8283	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Other measurement
8284	GCST001157	Cardiovascular disease risk factors	Cardiovascular disease risk factors	Inflammatory measurement
8285	GCST001159	Restless legs syndrome	Restless legs syndrome	Neurological disorder
8286	GCST001154	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
8287	GCST001182	Asthma	Asthma	Other disease
8288	GCST001184	Meningioma	Meningioma	Cancer
8289	GCST001181	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
8290	GCST001181	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
8291	GCST001180	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	Lipid or lipoprotein measurement
8292	GCST001179	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	Lipid or lipoprotein measurement
8293	GCST001177	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	Lipid or lipoprotein measurement
8294	GCST001178	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	Lipid or lipoprotein measurement
8295	GCST001175	Epirubicin-induced leukopenia	Epirubicin-induced leukopenia	Other trait
8296	GCST001176	Schizophrenia	Schizophrenia	Neurological disorder
8297	GCST001174	Hepcidin levels	Hepcidin levels	Other measurement
8298	GCST001189	Parkinson's disease	Parkinson's disease	Neurological disorder
8299	GCST001188	vWF and FVIII levels	vWF and FVIII levels	Hematological measurement
8300	GCST001188	vWF and FVIII levels	vWF and FVIII levels	Other measurement
8301	GCST001188	vWF and FVIII levels	vWF and FVIII levels	Hematological measurement
8302	GCST001186	Nevirapine-induced rash	Nevirapine-induced rash	Response to drug
8303	GCST001185	Coronary heart disease	Coronary heart disease	Cardiovascular disease
8304	GCST001187	Cortical thickness	Cortical thickness	Other measurement
8305	GCST001183	Asthma	Asthma	Other disease
8306	GCST001142	Vitamin E levels	Vitamin E levels	Other measurement
8307	GCST001143	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
8308	GCST001141	Suicidal ideation	Suicidal ideation	Biological process
8309	GCST001141	Suicidal ideation	Suicidal ideation	Other measurement
8310	GCST001140	Lung cancer	Lung cancer	Cancer
8311	GCST001140	Lung cancer	Lung cancer	Cancer
8312	GCST001140	Lung cancer	Lung cancer	Cancer
8313	GCST001139	Chronic hepatitis C infection	Chronic hepatitis C infection	Digestive system disorder
8314	GCST001136	Interstitial lung disease	Interstitial lung disease	Other disease
8315	GCST001137	White blood cell count	White blood cell count	Hematological measurement
8316	GCST001137	White blood cell count	White blood cell count	Inflammatory measurement
8317	GCST001137	White blood cell count	White blood cell count	Hematological measurement
8318	GCST001137	White blood cell count	White blood cell count	Hematological measurement
8319	GCST001137	White blood cell count	White blood cell count	Hematological measurement
8320	GCST001138	Postoperative nausea and vomiting	Postoperative nausea and vomiting	Other trait
8321	GCST001135	Bipolar disorder	Bipolar disorder	Neurological disorder
8322	GCST001133	White blood cell count	White blood cell count	Hematological measurement
8323	GCST001133	White blood cell count	White blood cell count	Inflammatory measurement
8324	GCST001133	White blood cell count	White blood cell count	Hematological measurement
8325	GCST001133	White blood cell count	White blood cell count	Hematological measurement
8326	GCST001133	White blood cell count	White blood cell count	Hematological measurement
8327	GCST001134	White blood cell types	White blood cell types	Hematological measurement
8328	GCST001134	White blood cell types	White blood cell types	Inflammatory measurement
8329	GCST001134	White blood cell types	White blood cell types	Hematological measurement
8330	GCST001134	White blood cell types	White blood cell types	Hematological measurement
8331	GCST001134	White blood cell types	White blood cell types	Hematological measurement
8332	GCST001134	White blood cell types	White blood cell types	Hematological measurement
8333	GCST001131	Longevity	Longevity	Other measurement
8334	GCST001130	Obesity	Obesity	Other measurement
8335	GCST001130	Obesity	Obesity	Metabolic disorder
8336	GCST001128	Adiposity	Adiposity	Metabolic disorder
8337	GCST001129	Melanoma	Melanoma	Cancer
8338	GCST001127	Response to platinum-based agents	Response to platinum-based agents	Response to drug
8339	GCST001124	Basal cell carcinoma	Basal cell carcinoma	Cancer
8340	GCST001173	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
8341	GCST001171	HIV-1 progression	HIV-1 progression	Other disease
8342	GCST001170	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
8343	GCST001170	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
8344	GCST001170	Lipid traits	Lipid traits	Other measurement
8345	GCST001170	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
8346	GCST001170	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
8347	GCST001172	Asthma	Asthma	Other disease
8348	GCST001169	Response to platinum-based chemotherapy in small cell and non-small cell lung cancers	Response to platinum-based chemotherapy in small cell and non-small cell lung cancers	Response to drug
8349	GCST001166	Aging (time to event)	Aging (time to event)	Biological process
8350	GCST001168	Recombination measurement	Recombination measurement	Other measurement
8351	GCST001167	Aging (time to death)	Aging (time to death)	Other measurement
8352	GCST001167	Aging (time to death)	Aging (time to death)	Biological process
8353	GCST001164	Bipolar disorder	Bipolar disorder	Neurological disorder
8354	GCST001165	Adiponectin levels	Adiponectin levels	Other measurement
8355	GCST001107	End-stage renal disease	End-stage renal disease	Other disease
8356	GCST001112	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	Other disease
8357	GCST001112	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	Other measurement
8358	GCST001111	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other disease
8359	GCST001111	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
8360	GCST001111	Current cigarettes per day in chronic obstructive pulmonary disease	Current cigarettes per day in chronic obstructive pulmonary disease	Other measurement
8361	GCST001108	Smoking cessation in chronic obstructive pulmonary disease	Smoking cessation in chronic obstructive pulmonary disease	Other disease
8362	GCST001108	Smoking cessation in chronic obstructive pulmonary disease	Smoking cessation in chronic obstructive pulmonary disease	Biological process
8363	GCST001109	White matter hyperintensity burden	White matter hyperintensity burden	Other measurement
8364	GCST001109	White matter hyperintensity burden	White matter hyperintensity burden	Other measurement
8365	GCST001110	Schizophrenia	Schizophrenia	Neurological disorder
8366	GCST001113	Age at smoking initiation in chronic obstructive pulmonary disease	Age at smoking initiation in chronic obstructive pulmonary disease	Other disease
8367	GCST001113	Age at smoking initiation in chronic obstructive pulmonary disease	Age at smoking initiation in chronic obstructive pulmonary disease	Biological process
8368	GCST001106	Atopic dermatitis	Atopic dermatitis	Immune system disorder
8369	GCST001105	Migraine	Migraine	Cardiovascular disease
8370	GCST001102	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
8371	GCST001126	Parkinson's disease	Parkinson's disease	Neurological disorder
8372	GCST001122	Adiponectin levels	Adiponectin levels	Other measurement
8373	GCST001120	Erythrocyte sedimentation rate	Erythrocyte sedimentation rate	Inflammatory measurement
8374	GCST001121	Alcohol dependence	Alcohol dependence	Other measurement
8375	GCST001121	Alcohol dependence	Alcohol dependence	Neurological disorder
8376	GCST001118	Ulcerative colitis or Crohn's disease	Ulcerative colitis or Crohn's disease	Digestive system disorder
8377	GCST001118	Ulcerative colitis or Crohn's disease	Ulcerative colitis or Crohn's disease	Immune system disorder
8378	GCST001119	Schizophrenia	Schizophrenia	Neurological disorder
8379	GCST001117	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
8380	GCST001117	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
8381	GCST001116	Progressive supranuclear palsy	Progressive supranuclear palsy	Neurological disorder
8382	GCST001115	Schizophrenia (age at onset)	Schizophrenia (age at onset)	Neurological disorder
8383	GCST001115	Schizophrenia (age at onset)	Schizophrenia (age at onset)	Other measurement
8384	GCST001114	Schizophrenia (age at onset) (sex interaction)	Schizophrenia (age at onset) (sex interaction)	Neurological disorder
8385	GCST001114	Schizophrenia (age at onset) (sex interaction)	Schizophrenia (age at onset) (sex interaction)	Other measurement
8386	GCST000984	Idiopathic membranous nephropathy	Idiopathic membranous nephropathy	Other disease
8387	GCST000981	Vitiligo	Vitiligo	Immune system disorder
8388	GCST000980	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
8389	GCST000980	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
8390	GCST000982	F-cell distribution in sickle cell anaemia	F-cell distribution in sickle cell anaemia	Neurological disorder
8391	GCST000982	F-cell distribution in sickle cell anaemia	F-cell distribution in sickle cell anaemia	Hematological measurement
8392	GCST000979	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
8393	GCST000979	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
8394	GCST000977	Alcohol dependence	Alcohol dependence	Other measurement
8395	GCST000977	Alcohol dependence	Alcohol dependence	Neurological disorder
8396	GCST000978	Cortisol secretion	Cortisol secretion	Other measurement
8397	GCST000999	Coronary heart disease	Coronary heart disease	Cardiovascular disease
8398	GCST001001	Sick sinus syndrome	Sick sinus syndrome	Cardiovascular disease
8399	GCST001000	Coronary heart disease	Coronary heart disease	Cardiovascular disease
8400	GCST001002	Cerivastatin-induced rhabdomyolysis	Cerivastatin-induced rhabdomyolysis	Other disease
8401	GCST001002	Cerivastatin-induced rhabdomyolysis	Cerivastatin-induced rhabdomyolysis	Response to drug
8402	GCST000998	Coronary heart disease	Coronary heart disease	Cardiovascular disease
8403	GCST000997	Blood pressure	Blood pressure	Other measurement
8404	GCST000997	Blood pressure	Blood pressure	Other measurement
8405	GCST000997	Blood pressure	Blood pressure	Other measurement
8406	GCST000997	Blood pressure	Blood pressure	Other measurement
8407	GCST000997	Blood pressure	Blood pressure	Cardiovascular measurement
8408	GCST000996	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
8409	GCST000995	Personality traits in bipolar disorder	Personality traits in bipolar disorder	Neurological disorder
8410	GCST000995	Personality traits in bipolar disorder	Personality traits in bipolar disorder	Other trait
8411	GCST000994	Drinking behavior	Drinking behavior	Biological process
8412	GCST000971	PR interval	PR interval	Cardiovascular measurement
8413	GCST000970	Optic disc area	Optic disc area	Other measurement
8414	GCST000970	Optic disc area	Optic disc area	Other measurement
8415	GCST000969	Bipolar disorder (age of onset and psychotic symptoms)	Bipolar disorder (age of onset and psychotic symptoms)	Other trait
8416	GCST000969	Bipolar disorder (age of onset and psychotic symptoms)	Bipolar disorder (age of onset and psychotic symptoms)	Neurological disorder
8417	GCST000969	Bipolar disorder (age of onset and psychotic symptoms)	Bipolar disorder (age of onset and psychotic symptoms)	Other measurement
8418	GCST000967	Response to platinum-based chemotherapy in head and neck cancers	Response to platinum-based chemotherapy in head and neck cancers	Response to drug
8419	GCST000966	Diabetic retinopathy	Diabetic retinopathy	Metabolic disorder
8420	GCST000968	Response to platinum-based chemotherapy in head and neck cancers	Response to platinum-based chemotherapy in head and neck cancers	Response to drug
8421	GCST000965	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
8422	GCST000964	Ulcerative colitis	Ulcerative colitis	Immune system disorder
8423	GCST001013	Longevity	Longevity	Other measurement
8424	GCST001012	Breast cancer	Breast cancer	Cancer
8425	GCST001011	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
8426	GCST001011	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
8427	GCST001011	Oral cavity and pharyngeal cancer	Oral cavity and pharyngeal cancer	Cancer
8428	GCST001010	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
8429	GCST001010	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
8430	GCST001009	Nephropathy	Nephropathy	Other disease
8431	GCST001008	Nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	Digestive system disorder
8432	GCST000962	Kawasaki disease	Kawasaki disease	Immune system disorder
8433	GCST000963	Uric acid levels	Uric acid levels	Cardiovascular measurement
8434	GCST000961	Bipolar disorder	Bipolar disorder	Neurological disorder
8435	GCST000959	Parkinson's disease	Parkinson's disease	Neurological disorder
8436	GCST000960	Cardiac hypertrophy	Cardiac hypertrophy	Other trait
8437	GCST000958	Percent mammographic density	Percent mammographic density	Other measurement
8438	GCST000958	Percent mammographic density	Percent mammographic density	Cancer
8439	GCST000958	Percent mammographic density	Percent mammographic density	Other measurement
8440	GCST000957	Natriuretic peptide levels	Natriuretic peptide levels	Cardiovascular measurement
8441	GCST000956	Substance dependence	Substance dependence	Neurological disorder
8442	GCST000955	Crohn's disease and celiac disease	Crohn's disease and celiac disease	Digestive system disorder
8443	GCST000955	Crohn's disease and celiac disease	Crohn's disease and celiac disease	Immune system disorder
8444	GCST000954	Alcohol consumption	Alcohol consumption	Biological process
8445	GCST000954	Alcohol consumption	Alcohol consumption	Other measurement
8446	GCST000992	Coffee consumption	Coffee consumption	Biological process
8447	GCST000992	Coffee consumption	Coffee consumption	Other measurement
8448	GCST000992	Coffee consumption	Coffee consumption	Other measurement
8449	GCST000993	Vascular dementia	Vascular dementia	Cardiovascular disease
8450	GCST000988	Urinary albumin excretion	Urinary albumin excretion	Other trait
8451	GCST000989	Colorectal cancer	Colorectal cancer	Cancer
8452	GCST000990	HIV-1 replication	HIV-1 replication	Other disease
8453	GCST000991	Autism spectrum disorders (language delay)	Autism spectrum disorders (language delay)	Neurological disorder
8454	GCST000986	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
8455	GCST000986	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
8456	GCST000987	Celiac disease or Rheumatoid arthritis	Celiac disease or Rheumatoid arthritis	Other disease
8457	GCST000985	Bipolar disorder	Bipolar disorder	Neurological disorder
8458	GCST000983	5-HTT brain serotonin transporter levels	5-HTT brain serotonin transporter levels	Other measurement
8459	GCST000943	Aortic root size	Aortic root size	Cardiovascular measurement
8460	GCST000940	Stroke	Stroke	Cardiovascular disease
8461	GCST000941	Stroke (ischemic)	Stroke (ischemic)	Cardiovascular disease
8462	GCST000942	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
8463	GCST000942	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
8464	GCST000939	Kawasaki disease	Kawasaki disease	Immune system disorder
8465	GCST000937	Insulin-like growth factors	Insulin-like growth factors	Other measurement
8466	GCST000937	Insulin-like growth factors	Insulin-like growth factors	Other measurement
8467	GCST000938	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
8468	GCST000938	Adolescent idiopathic scoliosis	Adolescent idiopathic scoliosis	Other disease
8469	GCST000936	Cardiac muscle measurement	Cardiac muscle measurement	Other trait
8470	GCST000936	Cardiac muscle measurement	Cardiac muscle measurement	Other measurement
8471	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
8472	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
8473	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
8474	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
8475	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
8476	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
8477	GCST000935	Iron status biomarkers	Iron status biomarkers	Other measurement
8478	GCST000934	Asthma or atopy (farm exposure interaction)	Asthma or atopy (farm exposure interaction)	Other disease
8479	GCST000934	Asthma or atopy (farm exposure interaction)	Asthma or atopy (farm exposure interaction)	Other measurement
8480	GCST000953	Lapatinib-induced hepatotoxicity in breast cancer	Lapatinib-induced hepatotoxicity in breast cancer	Response to drug
8481	GCST000952	Breast cancer	Breast cancer	Cancer
8482	GCST000951	Nephrolithiasis	Nephrolithiasis	Other disease
8483	GCST000950	Parkinson's disease	Parkinson's disease	Neurological disorder
8484	GCST000949	Multiple sclerosis	Multiple sclerosis	Immune system disorder
8485	GCST000947	Lung adenocarcinoma (clinical stage)	Lung adenocarcinoma (clinical stage)	Cancer
8486	GCST000948	Colorectal cancer	Colorectal cancer	Cancer
8487	GCST000945	Coronary artery disease	Coronary artery disease	Cardiovascular disease
8488	GCST000945	Coronary artery disease	Coronary artery disease	Cardiovascular disease
8489	GCST000946	Myocardial infarction in coronary artery disease	Myocardial infarction in coronary artery disease	Cardiovascular disease
8490	GCST000946	Myocardial infarction in coronary artery disease	Myocardial infarction in coronary artery disease	Cardiovascular disease
8491	GCST000944	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
8492	GCST000933	C-reactive protein	C-reactive protein	Inflammatory measurement
8493	GCST000932	Hoarding	Hoarding	Neurological disorder
8494	GCST000927	Response to metformin in type 2 diabetes (glycemic)	Response to metformin in type 2 diabetes (glycemic)	Response to drug
8495	GCST000928	Waist-to-hip ratio (sex interaction)	Waist-to-hip ratio (sex interaction)	Body measurement
8496	GCST000928	Waist-to-hip ratio (sex interaction)	Waist-to-hip ratio (sex interaction)	Other measurement
8497	GCST000929	Body mass index	Body mass index	Body measurement
8498	GCST000929	Body mass index	Body mass index	Body measurement
8499	GCST000929	Body mass index	Body mass index	Other measurement
8500	GCST000931	Waist circumference (sex interaction)	Waist circumference (sex interaction)	Body measurement
8501	GCST000931	Waist circumference (sex interaction)	Waist circumference (sex interaction)	Other measurement
8502	GCST000930	Body mass index (sex interaction)	Body mass index (sex interaction)	Body measurement
8503	GCST000930	Body mass index (sex interaction)	Body mass index (sex interaction)	Other measurement
8504	GCST000925	N-glycan levels	N-glycan levels	Other measurement
8505	GCST000926	Maximal oxygen uptake response	Maximal oxygen uptake response	Other measurement
8506	GCST000924	Response to acetaminophen (hepatotoxicity)	Response to acetaminophen (hepatotoxicity)	Response to drug
8507	GCST000659	Optic nerve measurement (cup area)	Optic nerve measurement (cup area)	Other measurement
8508	GCST000655	Optic nerve measurement (cup-to-disc ratio)	Optic nerve measurement (cup-to-disc ratio)	Other measurement
8509	GCST000655	Optic nerve measurement (cup-to-disc ratio)	Optic nerve measurement (cup-to-disc ratio)	Other measurement
8510	GCST000657	Optic nerve measurement (disc area)	Optic nerve measurement (disc area)	Other measurement
8511	GCST000656	HIV-1 viral setpoint	HIV-1 viral setpoint	Biological process
8512	GCST000656	HIV-1 viral setpoint	HIV-1 viral setpoint	Other measurement
8513	GCST000656	HIV-1 viral setpoint	HIV-1 viral setpoint	Other disease
8514	GCST000658	Optic nerve measurement (rim area)	Optic nerve measurement (rim area)	Other measurement
8515	GCST000654	Bipolar I disorder	Bipolar I disorder	Neurological disorder
8516	GCST000654	Bipolar I disorder	Bipolar I disorder	Neurological disorder
8517	GCST000653	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8518	GCST000653	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8519	GCST000652	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8520	GCST000652	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8521	GCST000650	Systemic sclerosis	Systemic sclerosis	Neurological disorder
8522	GCST000579	Cognitive performance	Cognitive performance	Other measurement
8523	GCST000579	Cognitive performance	Cognitive performance	Other measurement
8524	GCST000578	Major depressive disorder	Major depressive disorder	Neurological disorder
8525	GCST000576	Asthma	Asthma	Other disease
8526	GCST000577	Multiple sclerosis (severity)	Multiple sclerosis (severity)	Immune system disorder
8527	GCST000575	Osteoporosis-related phenotypes	Osteoporosis-related phenotypes	Other disease
8528	GCST000574	Pancreatic cancer	Pancreatic cancer	Cancer
8529	GCST000573	Brain imaging	Brain imaging	Other measurement
8530	GCST000572	Bone mineral density	Bone mineral density	Other measurement
8531	GCST000621	C4b binding protein levels	C4b binding protein levels	Cardiovascular measurement
8532	GCST000620	Eosinophilic esophagitis (pediatric)	Eosinophilic esophagitis (pediatric)	Digestive system disorder
8533	GCST000619	Alcohol dependence	Alcohol dependence	Other measurement
8534	GCST000619	Alcohol dependence	Alcohol dependence	Neurological disorder
8535	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
8536	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
8537	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
8538	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
8539	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
8540	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
8541	GCST000618	Response to antipsychotic treatment	Response to antipsychotic treatment	Response to drug
8542	GCST000615	Brain structure (hippocampal volume)	Brain structure (hippocampal volume)	Other measurement
8543	GCST000615	Brain structure (hippocampal volume)	Brain structure (hippocampal volume)	Other measurement
8544	GCST000616	Smoking cessation	Smoking cessation	Biological process
8545	GCST000614	Brain structure (temporal lobe volume)	Brain structure (temporal lobe volume)	Neurological disorder
8546	GCST000617	Alcohol dependence	Alcohol dependence	Other measurement
8547	GCST000617	Alcohol dependence	Alcohol dependence	Neurological disorder
8548	GCST000613	HIV (mother-to-child transmission)	HIV (mother-to-child transmission)	Biological process
8549	GCST000612	Celiac disease	Celiac disease	Immune system disorder
8550	GCST000649	Chronic kidney disease	Chronic kidney disease	Other disease
8551	GCST000649	Chronic kidney disease	Chronic kidney disease	Other measurement
8552	GCST000649	Chronic kidney disease	Chronic kidney disease	Other measurement
8553	GCST000648	Birth weight	Birth weight	Body measurement
8554	GCST000647	Cholesterol	Cholesterol	Lipid or lipoprotein measurement
8555	GCST000646	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
8556	GCST000645	Glaucoma	Glaucoma	Neurological disorder
8557	GCST000642	Body mass index	Body mass index	Body measurement
8558	GCST000642	Body mass index	Body mass index	Body measurement
8559	GCST000642	Body mass index	Body mass index	Other measurement
8560	GCST000643	Response to antidepressants	Response to antidepressants	Response to drug
8561	GCST000644	Height	Height	Other measurement
8562	GCST000644	Height	Height	Body measurement
8563	GCST000629	Knee osteoarthritis	Knee osteoarthritis	Other disease
8564	GCST000630	Digit length ratio	Digit length ratio	Body measurement
8565	GCST000632	Longevity	Longevity	Other measurement
8566	GCST000628	Chemerin levels	Chemerin levels	Cardiovascular measurement
8567	GCST000626	Factor VIII levels	Factor VIII levels	Hematological measurement
8568	GCST000627	vWF levels	vWF levels	Hematological measurement
8569	GCST000625	Factor VII levels	Factor VII levels	Other measurement
8570	GCST000623	Ulcerative colitis	Ulcerative colitis	Immune system disorder
8571	GCST000624	Ulcerative colitis	Ulcerative colitis	Immune system disorder
8572	GCST000622	Creatinine levels	Creatinine levels	Other measurement
8573	GCST000640	Thyroid cancer (Papillary, radiation-related)	Thyroid cancer (Papillary, radiation-related)	Cancer
8574	GCST000639	Urinary bladder cancer	Urinary bladder cancer	Cancer
8575	GCST000638	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
8576	GCST000636	Brain cytoarchitecture	Brain cytoarchitecture	Other measurement
8577	GCST000637	Breast cancer (prognosis)	Breast cancer (prognosis)	Cancer
8578	GCST000635	Response to statin therapy	Response to statin therapy	Response to drug
8579	GCST000634	Cognitive ability	Cognitive ability	Biological process
8580	GCST000633	Lung cancer	Lung cancer	Cancer
8581	GCST000633	Lung cancer	Lung cancer	Cancer
8582	GCST000633	Lung cancer	Lung cancer	Cancer
8583	GCST000631	Activated partial thromboplastin time	Activated partial thromboplastin time	Hematological measurement
8584	GCST000601	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
8585	GCST000600	Neutrophil count	Neutrophil count	Hematological measurement
8586	GCST000599	Soluble levels of adhesion molecules	Soluble levels of adhesion molecules	Cardiovascular measurement
8587	GCST000599	Soluble levels of adhesion molecules	Soluble levels of adhesion molecules	Other measurement
8588	GCST000599	Soluble levels of adhesion molecules	Soluble levels of adhesion molecules	Cardiovascular measurement
8589	GCST000597	Brain structure	Brain structure	Other measurement
8590	GCST000597	Brain structure	Brain structure	Other measurement
8591	GCST000597	Brain structure	Brain structure	Other measurement
8592	GCST000598	Bone mineral density	Bone mineral density	Other measurement
8593	GCST000596	HIV-1 progression	HIV-1 progression	Other disease
8594	GCST000595	Frontotemporal lobar degeneration	Frontotemporal lobar degeneration	Neurological disorder
8595	GCST000594	Homocysteine levels	Homocysteine levels	Cardiovascular measurement
8596	GCST000593	Multiple sclerosis	Multiple sclerosis	Immune system disorder
8597	GCST000592	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
8598	GCST000611	Height	Height	Other measurement
8599	GCST000611	Height	Height	Body measurement
8600	GCST000609	Primary tooth development (time to first tooth eruption)	Primary tooth development (time to first tooth eruption)	Biological process
8601	GCST000609	Primary tooth development (time to first tooth eruption)	Primary tooth development (time to first tooth eruption)	Biological process
8602	GCST000610	Primary tooth development (number of teeth)	Primary tooth development (number of teeth)	Biological process
8603	GCST000608	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
8604	GCST000607	Schizophrenia	Schizophrenia	Neurological disorder
8605	GCST000606	E-selectin levels	E-selectin levels	Inflammatory measurement
8606	GCST000605	Soluble leptin receptor levels	Soluble leptin receptor levels	Other measurement
8607	GCST000603	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
8608	GCST000604	Chronic hepatitis C infection	Chronic hepatitis C infection	Digestive system disorder
8609	GCST000602	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
8610	GCST000590	Interleukin-18 levels	Interleukin-18 levels	Inflammatory measurement
8611	GCST000591	Fasting plasma glucose	Fasting plasma glucose	Other measurement
8612	GCST000586	Telomere length	Telomere length	Other measurement
8613	GCST002103	Telomere length	Telomere length	Other measurement
8614	GCST002104	Bronchopulmonary dysplasia	Bronchopulmonary dysplasia	Other disease
8615	GCST002102	Thyroid cancer	Thyroid cancer	Cancer
8616	GCST002101	HIV-1 susceptibility	HIV-1 susceptibility	Immune system disorder
8617	GCST002101	HIV-1 susceptibility	HIV-1 susceptibility	Other disease
8618	GCST002100	Atopic dermatitis	Atopic dermatitis	Immune system disorder
8619	GCST002099	Colorectal cancer	Colorectal cancer	Cancer
8620	GCST002098	Brugada syndrome	Brugada syndrome	Cardiovascular disease
8621	GCST002097	Coronary artery calcification	Coronary artery calcification	Other trait
8622	GCST002096	Psychosis	Psychosis	Neurological disorder
8623	GCST002095	Major depressive disorder	Major depressive disorder	Neurological disorder
8624	GCST001979	Circulating myeloperoxidase levels (serum)	Circulating myeloperoxidase levels (serum)	Cardiovascular measurement
8625	GCST001980	Circulating myeloperoxidase levels (plasma)	Circulating myeloperoxidase levels (plasma)	Cardiovascular measurement
8626	GCST001978	Malignant pleural mesothelioma	Malignant pleural mesothelioma	Cancer
8627	GCST005528	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Immune system disorder
8628	GCST005528	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Immune system disorder
8629	GCST005528	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	Immune system disorder
8630	GCST001976	Bilirubin levels	Bilirubin levels	Other measurement
8631	GCST001977	Diabetic retinopathy	Diabetic retinopathy	Metabolic disorder
8632	GCST001975	Psychosis (methamphetamine induced)	Psychosis (methamphetamine induced)	Neurological disorder
8633	GCST001974	Idiopathic pulmonary fibrosis	Idiopathic pulmonary fibrosis	Cancer
8634	GCST001972	Methamphetamine dependence	Methamphetamine dependence	Neurological disorder
8635	GCST001972	Methamphetamine dependence	Methamphetamine dependence	Neurological disorder
8636	GCST001973	Menarche (age at onset)	Menarche (age at onset)	Other measurement
8637	GCST001986	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8638	GCST001986	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8639	GCST001987	Age-related macular degeneration (extreme sampling)	Age-related macular degeneration (extreme sampling)	Neurological disorder
8640	GCST001990	Age-related macular degeneration (smoking status interaction)	Age-related macular degeneration (smoking status interaction)	Other measurement
8641	GCST001990	Age-related macular degeneration (smoking status interaction)	Age-related macular degeneration (smoking status interaction)	Neurological disorder
8642	GCST001989	Dietary macronutrient intake	Dietary macronutrient intake	Biological process
8643	GCST001988	Dietary macronutrient intake	Dietary macronutrient intake	Biological process
8644	GCST001985	Weight loss (gastric bypass surgery)	Weight loss (gastric bypass surgery)	Other trait
8645	GCST001985	Weight loss (gastric bypass surgery)	Weight loss (gastric bypass surgery)	Other trait
8646	GCST001984	Graves' disease	Graves' disease	Immune system disorder
8647	GCST001983	Job-related exhaustion	Job-related exhaustion	Neurological disorder
8648	GCST001982	Graves' disease	Graves' disease	Immune system disorder
8649	GCST001981	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
8650	GCST002058	DNA methylation (variation)	DNA methylation (variation)	Biological process
8651	GCST002056	Osteosarcoma	Osteosarcoma	Cancer
8652	GCST002055	Cognitive decline	Cognitive decline	Other trait
8653	GCST002055	Cognitive decline	Cognitive decline	Biological process
8654	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Digestive system disorder
8655	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Digestive system disorder
8656	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Immune system disorder
8657	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Immune system disorder
8658	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Immune system disorder
8659	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Other disease
8660	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Immune system disorder
8661	GCST005563	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)	Metabolic disorder
8662	GCST006670	Primary sclerosing cholangitis	Primary sclerosing cholangitis	Digestive system disorder
8663	GCST002048	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
8664	GCST002032	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Other measurement
8665	GCST002032	Non-small cell lung cancer (survival)	Non-small cell lung cancer (survival)	Cancer
8666	GCST002030	Primary tooth development (time to first tooth eruption)	Primary tooth development (time to first tooth eruption)	Biological process
8667	GCST002030	Primary tooth development (time to first tooth eruption)	Primary tooth development (time to first tooth eruption)	Biological process
8668	GCST002028	Serum selenium levels	Serum selenium levels	Other measurement
8669	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
8670	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
8671	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
8672	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
8673	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
8674	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
8675	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
8676	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
8677	GCST002027	Red blood cell traits	Red blood cell traits	Hematological measurement
8678	GCST002026	Coronary arterial lesions in patients with Kawasaki disease	Coronary arterial lesions in patients with Kawasaki disease	Immune system disorder
8679	GCST002026	Coronary arterial lesions in patients with Kawasaki disease	Coronary arterial lesions in patients with Kawasaki disease	Cardiovascular disease
8680	GCST002024	Prostate cancer	Prostate cancer	Cancer
8681	GCST002025	Cystic fibrosis-related diabetes	Cystic fibrosis-related diabetes	Digestive system disorder
8682	GCST002025	Cystic fibrosis-related diabetes	Cystic fibrosis-related diabetes	Metabolic disorder
8683	GCST002022	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
8684	GCST002022	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
8685	GCST002021	Body mass index	Body mass index	Body measurement
8686	GCST002021	Body mass index	Body mass index	Body measurement
8687	GCST002021	Body mass index	Body mass index	Other measurement
8688	GCST002045	Educational attainment	Educational attainment	Other measurement
8689	GCST008396	Educational attainment (years of education)	Educational attainment (years of education)	Other measurement
8690	GCST002047	Educational attainment (college completion)	Educational attainment (college completion)	Other measurement
8691	GCST002046	Response to antidepressant treatment (citalopram)	Response to antidepressant treatment (citalopram)	Response to drug
8692	GCST002039	Blood trace element (Se levels)	Blood trace element (Se levels)	Other measurement
8693	GCST002040	Blood trace element (Zn levels)	Blood trace element (Zn levels)	Other measurement
8694	GCST002041	Blood trace element (Cu levels)	Blood trace element (Cu levels)	Other measurement
8695	GCST002038	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
8696	GCST002037	Post-traumatic stress disorder (asjusted for relatedness)	Post-traumatic stress disorder (asjusted for relatedness)	Neurological disorder
8697	GCST002036	Congenital heart malformation	Congenital heart malformation	Cardiovascular disease
8698	GCST002034	Adverse response to radiation therapy	Adverse response to radiation therapy	Biological process
8699	GCST002035	Congenital heart disease	Congenital heart disease	Cardiovascular disease
8700	GCST002031	Primary tooth development (number of teeth)	Primary tooth development (number of teeth)	Biological process
8701	GCST001992	Vitiligo (non-segmental)	Vitiligo (non-segmental)	Immune system disorder
8702	GCST001991	Weight loss (gastric bypass surgery)	Weight loss (gastric bypass surgery)	Other trait
8703	GCST001991	Weight loss (gastric bypass surgery)	Weight loss (gastric bypass surgery)	Other trait
8704	GCST002020	Scoliosis	Scoliosis	Other disease
8705	GCST002019	IgE levels	IgE levels	Other measurement
8706	GCST002018	Crohn's disease (time to surgery)	Crohn's disease (time to surgery)	Digestive system disorder
8707	GCST002017	Crohn's disease (need for surgery)	Crohn's disease (need for surgery)	Digestive system disorder
8708	GCST002015	Personality dimensions	Personality dimensions	Other trait
8709	GCST002016	Personality dimensions	Personality dimensions	Other trait
8710	GCST002014	Helicobacter pylori serologic status	Helicobacter pylori serologic status	Other measurement
8711	GCST002013	Menarche (age at onset)	Menarche (age at onset)	Other measurement
8712	GCST002010	Esophageal squamous cell cancer (length of survival)	Esophageal squamous cell cancer (length of survival)	Cancer
8713	GCST002010	Esophageal squamous cell cancer (length of survival)	Esophageal squamous cell cancer (length of survival)	Other measurement
8714	GCST002010	Esophageal squamous cell cancer (length of survival)	Esophageal squamous cell cancer (length of survival)	Cancer
8715	GCST002012	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
8716	GCST001851	Schizophrenia	Schizophrenia	Neurological disorder
8717	GCST001852	Metabolite levels	Metabolite levels	Other trait
8718	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8719	GCST001852	Metabolite levels	Metabolite levels	Liver enzyme measurement
8720	GCST001852	Metabolite levels	Metabolite levels	Cardiovascular measurement
8721	GCST001852	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8722	GCST001852	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8723	GCST001852	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8724	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8725	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8726	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8727	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8728	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8729	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8730	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8731	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8732	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8733	GCST001852	Metabolite levels	Metabolite levels	Other measurement
8734	GCST001850	Major depressive disorder	Major depressive disorder	Neurological disorder
8735	GCST001848	IgG glycosylation	IgG glycosylation	Other measurement
8736	GCST001846	Bilirubin levels	Bilirubin levels	Other measurement
8737	GCST001845	Coronary heart disease	Coronary heart disease	Cardiovascular disease
8738	GCST001847	Urinary symptoms in response to radiotherapy in prostate cancer	Urinary symptoms in response to radiotherapy in prostate cancer	Cancer
8739	GCST001847	Urinary symptoms in response to radiotherapy in prostate cancer	Urinary symptoms in response to radiotherapy in prostate cancer	Biological process
8740	GCST001847	Urinary symptoms in response to radiotherapy in prostate cancer	Urinary symptoms in response to radiotherapy in prostate cancer	Other trait
8741	GCST001849	IgG glycosylation	IgG glycosylation	Other measurement
8742	GCST001842	Drinking behavior	Drinking behavior	Biological process
8743	GCST001882	Metabolite levels	Metabolite levels	Other trait
8744	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8745	GCST001882	Metabolite levels	Metabolite levels	Liver enzyme measurement
8746	GCST001882	Metabolite levels	Metabolite levels	Cardiovascular measurement
8747	GCST001882	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8748	GCST001882	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8749	GCST001882	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8750	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8751	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8752	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8753	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8754	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8755	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8756	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8757	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8758	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8759	GCST001882	Metabolite levels	Metabolite levels	Other measurement
8760	GCST001879	Breast cancer	Breast cancer	Cancer
8761	GCST001881	Myopia (pathological)	Myopia (pathological)	Other trait
8762	GCST001880	Addiction	Addiction	Neurological disorder
8763	GCST001876	Pubertal anthropometrics	Pubertal anthropometrics	Body measurement
8764	GCST001876	Pubertal anthropometrics	Pubertal anthropometrics	Body measurement
8765	GCST001876	Pubertal anthropometrics	Pubertal anthropometrics	Biological process
8766	GCST001877	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Neurological disorder
8767	GCST001877	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Neurological disorder
8768	GCST001877	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Neurological disorder
8769	GCST001877	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Neurological disorder
8770	GCST001877	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)	Neurological disorder
8771	GCST001878	Coronary arterial lesions in patients with Kawasaki disease	Coronary arterial lesions in patients with Kawasaki disease	Immune system disorder
8772	GCST001878	Coronary arterial lesions in patients with Kawasaki disease	Coronary arterial lesions in patients with Kawasaki disease	Cardiovascular disease
8773	GCST001874	Alcohol dependence	Alcohol dependence	Other measurement
8774	GCST001874	Alcohol dependence	Alcohol dependence	Neurological disorder
8775	GCST001875	Pubertal anthropometrics	Pubertal anthropometrics	Body measurement
8776	GCST001875	Pubertal anthropometrics	Pubertal anthropometrics	Body measurement
8777	GCST001875	Pubertal anthropometrics	Pubertal anthropometrics	Biological process
8778	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
8779	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
8780	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
8781	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
8782	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
8783	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
8784	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
8785	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
8786	GCST001873	Red blood cell traits	Red blood cell traits	Hematological measurement
8787	GCST001861	Confectionary intake	Confectionary intake	Biological process
8788	GCST001862	Sickle cell anemia (haemolysis)	Sickle cell anemia (haemolysis)	Neurological disorder
8789	GCST001860	Multiple sclerosis	Multiple sclerosis	Immune system disorder
8790	GCST001859	Thiazide-induced adverse metabolic effects in hypertensive patients	Thiazide-induced adverse metabolic effects in hypertensive patients	Response to drug
8791	GCST001859	Thiazide-induced adverse metabolic effects in hypertensive patients	Thiazide-induced adverse metabolic effects in hypertensive patients	Lipid or lipoprotein measurement
8792	GCST001859	Thiazide-induced adverse metabolic effects in hypertensive patients	Thiazide-induced adverse metabolic effects in hypertensive patients	Other measurement
8793	GCST001857	HIV-1 susceptibility	HIV-1 susceptibility	Immune system disorder
8794	GCST001857	HIV-1 susceptibility	HIV-1 susceptibility	Other disease
8795	GCST001858	Refractive error	Refractive error	Other trait
8796	GCST001856	Thyroid hormone levels	Thyroid hormone levels	Other measurement
8797	GCST001856	Thyroid hormone levels	Thyroid hormone levels	Other measurement
8798	GCST001856	Thyroid hormone levels	Thyroid hormone levels	Other measurement
8799	GCST001855	Response to antiplatelet therapy	Response to antiplatelet therapy	Biological process
8800	GCST001854	Retinopathy in non-diabetics	Retinopathy in non-diabetics	Neurological disorder
8801	GCST001853	Circulating vasoactive peptide levels	Circulating vasoactive peptide levels	Cardiovascular measurement
8802	GCST001811	Bipolar disorder (mania)	Bipolar disorder (mania)	Neurological disorder
8803	GCST001812	Epstein-Barr virus immune response (EBNA-1)	Epstein-Barr virus immune response (EBNA-1)	Other disease
8804	GCST001812	Epstein-Barr virus immune response (EBNA-1)	Epstein-Barr virus immune response (EBNA-1)	Other measurement
8805	GCST001810	Menopause (age at onset)	Menopause (age at onset)	Other measurement
8806	GCST001809	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
8807	GCST001808	Tumor biomarkers	Tumor biomarkers	Other measurement
8808	GCST001807	Tetralogy of Fallot	Tetralogy of Fallot	Other trait
8809	GCST001806	Corneal structure	Corneal structure	Other measurement
8810	GCST001806	Corneal structure	Corneal structure	Neurological disorder
8811	GCST001805	Leishmaniasis (visceral)	Leishmaniasis (visceral)	Other disease
8812	GCST001804	Behcet's disease	Behcet's disease	Cardiovascular disease
8813	GCST001803	Corneal curvature	Corneal curvature	Other measurement
8814	GCST001801	Uric acid levels	Uric acid levels	Cardiovascular measurement
8815	GCST001802	Depression (quantitative trait)	Depression (quantitative trait)	Neurological disorder
8816	GCST001800	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels	Other measurement
8817	GCST001799	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
8818	GCST005522	Narcolepsy	Narcolepsy	Neurological disorder
8819	GCST001798	End-stage coagulation	End-stage coagulation	Hematological measurement
8820	GCST001798	End-stage coagulation	End-stage coagulation	Other measurement
8821	GCST001798	End-stage coagulation	End-stage coagulation	Hematological measurement
8822	GCST001797	Cardiac structure and function	Cardiac structure and function	Other measurement
8823	GCST001796	Prostate-specific antigen levels	Prostate-specific antigen levels	Other measurement
8824	GCST001795	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
8825	GCST001794	Colorectal cancer (SNP x SNP interaction)	Colorectal cancer (SNP x SNP interaction)	Cancer
8826	GCST001872	Presence of antiphospholipid antibodies	Presence of antiphospholipid antibodies	Other measurement
8827	GCST001870	Bone mineral density	Bone mineral density	Other measurement
8828	GCST001871	Renal transplant outcome	Renal transplant outcome	Other measurement
8829	GCST001869	Breast cancer (menopausal hormone therapy interaction)	Breast cancer (menopausal hormone therapy interaction)	Cancer
8830	GCST001869	Breast cancer (menopausal hormone therapy interaction)	Breast cancer (menopausal hormone therapy interaction)	Other trait
8831	GCST001867	Chronic hepatitis C infection	Chronic hepatitis C infection	Digestive system disorder
8832	GCST001866	Mathematical ability in children with dyslexia	Mathematical ability in children with dyslexia	Biological process
8833	GCST001868	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
8834	GCST001868	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
8835	GCST001868	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
8836	GCST001868	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Neurological disorder
8837	GCST001868	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
8838	GCST001864	Mitral annular calcification	Mitral annular calcification	Other trait
8839	GCST001865	Aortic-valve calcification	Aortic-valve calcification	Cardiovascular disease
8840	GCST001863	Beta-2 microglubulin plasma levels	Beta-2 microglubulin plasma levels	Other measurement
8841	GCST001819	Corneal astigmatism	Corneal astigmatism	Neurological disorder
8842	GCST001819	Corneal astigmatism	Corneal astigmatism	Other trait
8843	GCST001816	Breast cancer (prognosis)	Breast cancer (prognosis)	Cancer
8844	GCST001815	Hepatitis C induced liver cirrhosis	Hepatitis C induced liver cirrhosis	Cancer
8845	GCST001814	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8846	GCST001814	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8847	GCST001813	Hematology traits	Hematology traits	Hematological measurement
8848	GCST001813	Hematology traits	Hematology traits	Hematological measurement
8849	GCST001813	Hematology traits	Hematology traits	Hematological measurement
8850	GCST001813	Hematology traits	Hematology traits	Cardiovascular measurement
8851	GCST001813	Hematology traits	Hematology traits	Hematological measurement
8852	GCST001843	Type 2 diabetes (dietary heme iron intake interaction)	Type 2 diabetes (dietary heme iron intake interaction)	Metabolic disorder
8853	GCST001843	Type 2 diabetes (dietary heme iron intake interaction)	Type 2 diabetes (dietary heme iron intake interaction)	Other measurement
8854	GCST001837	Intelligence (childhood)	Intelligence (childhood)	Biological process
8855	GCST001834	Oleic acid (18:1n-9) levels	Oleic acid (18:1n-9) levels	Lipid or lipoprotein measurement
8856	GCST001834	Oleic acid (18:1n-9) levels	Oleic acid (18:1n-9) levels	Lipid or lipoprotein measurement
8857	GCST001840	Stearic acid (18:0) levels	Stearic acid (18:0) levels	Lipid or lipoprotein measurement
8858	GCST001841	Palmitoleic acid (16:1n-7) levels	Palmitoleic acid (16:1n-7) levels	Lipid or lipoprotein measurement
8859	GCST001841	Palmitoleic acid (16:1n-7) levels	Palmitoleic acid (16:1n-7) levels	Lipid or lipoprotein measurement
8860	GCST001839	Schizophrenia	Schizophrenia	Neurological disorder
8861	GCST001833	Schizophrenia (cytomegalovirus infection interaction)	Schizophrenia (cytomegalovirus infection interaction)	Neurological disorder
8862	GCST001833	Schizophrenia (cytomegalovirus infection interaction)	Schizophrenia (cytomegalovirus infection interaction)	Other disease
8863	GCST001835	Response to cholinesterase inhibitors in Alzheimer's disease	Response to cholinesterase inhibitors in Alzheimer's disease	Response to drug
8864	GCST001835	Response to cholinesterase inhibitors in Alzheimer's disease	Response to cholinesterase inhibitors in Alzheimer's disease	Neurological disorder
8865	GCST001838	Palmitic acid (16:0) levels	Palmitic acid (16:0) levels	Lipid or lipoprotein measurement
8866	GCST001836	Schizophrenia (negative symptoms)	Schizophrenia (negative symptoms)	Neurological disorder
8867	GCST001832	Colorectal cancer	Colorectal cancer	Cancer
8868	GCST001831	Breast cancer	Breast cancer	Cancer
8869	GCST001830	Osteoporosis	Osteoporosis	Other disease
8870	GCST001829	Fat intake	Fat intake	Biological process
8871	GCST001828	Vascular constriction	Vascular constriction	Other disease
8872	GCST001826	Lymphoma	Lymphoma	Cancer
8873	GCST001827	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
8874	GCST001827	Squamous cell carcinoma	Squamous cell carcinoma	Cancer
8875	GCST001825	Beta-trace protein levels	Beta-trace protein levels	Other measurement
8876	GCST001640	Lentiform nucleus volume	Lentiform nucleus volume	Other measurement
8877	GCST001638	Lung cancer	Lung cancer	Cancer
8878	GCST001638	Lung cancer	Lung cancer	Cancer
8879	GCST001638	Lung cancer	Lung cancer	Cancer
8880	GCST001639	Metabolite levels	Metabolite levels	Other trait
8881	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8882	GCST001639	Metabolite levels	Metabolite levels	Liver enzyme measurement
8883	GCST001639	Metabolite levels	Metabolite levels	Cardiovascular measurement
8884	GCST001639	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8885	GCST001639	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8886	GCST001639	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
8887	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8888	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8889	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8890	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8891	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8892	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8893	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8894	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8895	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8896	GCST001639	Metabolite levels	Metabolite levels	Other measurement
8897	GCST001637	Malaria	Malaria	Digestive system disorder
8898	GCST001635	Tourette syndrome	Tourette syndrome	Neurological disorder
8899	GCST001636	Obsessive-compulsive disorder	Obsessive-compulsive disorder	Neurological disorder
8900	GCST001634	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
8901	GCST001633	Glioma	Glioma	Cancer
8902	GCST001633	Glioma	Glioma	Cancer
8903	GCST001632	Response to fenofibrate	Response to fenofibrate	Response to drug
8904	GCST001631	Schizophrenia	Schizophrenia	Neurological disorder
8905	GCST001619	Autism	Autism	Neurological disorder
8906	GCST001620	Resistin levels	Resistin levels	Other measurement
8907	GCST001616	Cannabis use (initiation)	Cannabis use (initiation)	Neurological disorder
8908	GCST001616	Cannabis use (initiation)	Cannabis use (initiation)	Biological process
8909	GCST001618	Neural processing (facial expression)	Neural processing (facial expression)	Other measurement
8910	GCST001617	Parkinson's disease	Parkinson's disease	Neurological disorder
8911	GCST001615	Sclerosing cholangitis and ulcerative colitis (combined)	Sclerosing cholangitis and ulcerative colitis (combined)	Digestive system disorder
8912	GCST001615	Sclerosing cholangitis and ulcerative colitis (combined)	Sclerosing cholangitis and ulcerative colitis (combined)	Immune system disorder
8913	GCST001614	Central corneal thickness	Central corneal thickness	Other measurement
8914	GCST001614	Central corneal thickness	Central corneal thickness	Other measurement
8915	GCST001613	Antineutrophil cytoplasmic antibody-associated vasculitis	Antineutrophil cytoplasmic antibody-associated vasculitis	Immune system disorder
8916	GCST001612	Sex hormone-binding globulin levels	Sex hormone-binding globulin levels	Other measurement
8917	GCST001611	Myasthenia gravis	Myasthenia gravis	Neurological disorder
8918	GCST001611	Myasthenia gravis	Myasthenia gravis	Other disease
8919	GCST001581	Coronary heart disease	Coronary heart disease	Cardiovascular disease
8920	GCST001579	Age-related macular degeneration (choroidal neovascularisation)	Age-related macular degeneration (choroidal neovascularisation)	Neurological disorder
8921	GCST001577	Age-related macular degeneration (CNV vs. GA)	Age-related macular degeneration (CNV vs. GA)	Neurological disorder
8922	GCST001577	Age-related macular degeneration (CNV vs. GA)	Age-related macular degeneration (CNV vs. GA)	Neurological disorder
8923	GCST001578	Age-related macular degeneration (geographic atrophy)	Age-related macular degeneration (geographic atrophy)	Neurological disorder
8924	GCST001575	Factor XI	Factor XI	Hematological measurement
8925	GCST001576	Nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	Digestive system disorder
8926	GCST001573	Prothrombin time	Prothrombin time	Hematological measurement
8927	GCST001574	Activated partial thromboplastin time	Activated partial thromboplastin time	Hematological measurement
8928	GCST001571	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8929	GCST001571	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
8930	GCST001590	Essential tremor	Essential tremor	Other trait
8931	GCST001588	Periodontal microbiota	Periodontal microbiota	Digestive system disorder
8932	GCST001586	Insomnia (caffeine-induced)	Insomnia (caffeine-induced)	Other measurement
8933	GCST001587	Coronary heart disease	Coronary heart disease	Cardiovascular disease
8934	GCST001589	Ovarian cancer	Ovarian cancer	Cancer
8935	GCST001585	Breast size	Breast size	Body measurement
8936	GCST001584	Lean body mass and age at menarche (combined)	Lean body mass and age at menarche (combined)	Other measurement
8937	GCST001584	Lean body mass and age at menarche (combined)	Lean body mass and age at menarche (combined)	Body measurement
8938	GCST001583	Adiposity	Adiposity	Metabolic disorder
8939	GCST001582	Hepatitis B (viral clearance)	Hepatitis B (viral clearance)	Biological process
8940	GCST001582	Hepatitis B (viral clearance)	Hepatitis B (viral clearance)	Digestive system disorder
8941	GCST001580	QT interval	QT interval	Cardiovascular measurement
8942	GCST001570	Chronic lymphocytic leukemia	Chronic lymphocytic leukemia	Cancer
8943	GCST001565	Schizophrenia	Schizophrenia	Neurological disorder
8944	GCST001569	Bipolar disorder	Bipolar disorder	Neurological disorder
8945	GCST001566	Bone mineral density (sex interaction)	Bone mineral density (sex interaction)	Other measurement
8946	GCST001566	Bone mineral density (sex interaction)	Bone mineral density (sex interaction)	Other measurement
8947	GCST001567	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
8948	GCST001567	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
8949	GCST001567	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
8950	GCST001568	Influenza (severity)	Influenza (severity)	Biological process
8951	GCST001564	Asthma	Asthma	Other disease
8952	GCST001563	Migraine	Migraine	Cardiovascular disease
8953	GCST001562	Migraine	Migraine	Cardiovascular disease
8954	GCST001561	Myopia (pathological)	Myopia (pathological)	Other trait
8955	GCST001610	Renal function-related traits (BUN)	Renal function-related traits (BUN)	Other measurement
8956	GCST001610	Renal function-related traits (BUN)	Renal function-related traits (BUN)	Other measurement
8957	GCST001609	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
8958	GCST001608	Renal function-related traits (urea)	Renal function-related traits (urea)	Other measurement
8959	GCST001608	Renal function-related traits (urea)	Renal function-related traits (urea)	Cardiovascular measurement
8960	GCST001607	Renal function-related traits (eGRFcrea)	Renal function-related traits (eGRFcrea)	Other measurement
8961	GCST001606	Renal function-related traits (sCR)	Renal function-related traits (sCR)	Other measurement
8962	GCST001605	C-reactive protein and white blood cell count	C-reactive protein and white blood cell count	Hematological measurement
8963	GCST001605	C-reactive protein and white blood cell count	C-reactive protein and white blood cell count	Inflammatory measurement
8964	GCST001603	Hepatocellular carcinoma	Hepatocellular carcinoma	Cancer
8965	GCST001604	Insulin-related traits	Insulin-related traits	Other measurement
8966	GCST001604	Insulin-related traits	Insulin-related traits	Other measurement
8967	GCST001604	Insulin-related traits	Insulin-related traits	Other trait
8968	GCST001601	Gambling	Gambling	Biological process
8969	GCST001602	Alzheimer's disease	Alzheimer's disease	Neurological disorder
8970	GCST001629	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to drug
8971	GCST001629	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to platinum-based chemotherapy in non-small-cell lung cancer	Cancer
8972	GCST001630	Post-traumatic stress disorder	Post-traumatic stress disorder	Neurological disorder
8973	GCST001628	Orofacial clefts	Orofacial clefts	Other trait
8974	GCST001628	Orofacial clefts	Orofacial clefts	Other measurement
8975	GCST001628	Orofacial clefts	Orofacial clefts	Other disease
8976	GCST001628	Orofacial clefts	Orofacial clefts	Other trait
8977	GCST001627	Thyrotoxic hypokalemic periodic paralysis	Thyrotoxic hypokalemic periodic paralysis	Metabolic disorder
8978	GCST001626	IgA levels	IgA levels	Other measurement
8979	GCST001624	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Response to drug
8980	GCST001624	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
8981	GCST001624	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Other measurement
8982	GCST001624	Paclitaxel-induced neuropathy	Paclitaxel-induced neuropathy	Neurological disorder
8983	GCST001625	Sex ratio at birth	Sex ratio at birth	Other measurement
8984	GCST001621	Airflow obstruction	Airflow obstruction	Other measurement
8985	GCST001560	Vitamin D levels	Vitamin D levels	Other measurement
8986	GCST001559	Cardiac repolarization	Cardiac repolarization	Cardiovascular measurement
8987	GCST001559	Cardiac repolarization	Cardiac repolarization	Cardiovascular measurement
8988	GCST001557	Venous thromboembolism	Venous thromboembolism	Cardiovascular disease
8989	GCST001558	Response to irinotecan in non-small-cell lung cancer	Response to irinotecan in non-small-cell lung cancer	Response to drug
8990	GCST001558	Response to irinotecan in non-small-cell lung cancer	Response to irinotecan in non-small-cell lung cancer	Cancer
8991	GCST001554	Sex hormone-binding globulin levels	Sex hormone-binding globulin levels	Other measurement
8992	GCST001555	Testosterone levels	Testosterone levels	Other measurement
8993	GCST001555	Testosterone levels	Testosterone levels	Other measurement
8994	GCST001553	Estradiol levels	Estradiol levels	Other measurement
8995	GCST001556	Pancreatic cancer	Pancreatic cancer	Cancer
8996	GCST001551	Amygdala reactivity	Amygdala reactivity	Other measurement
8997	GCST001552	Central corneal thickness	Central corneal thickness	Other measurement
8998	GCST001552	Central corneal thickness	Central corneal thickness	Other measurement
8999	GCST001599	Aging	Aging	Biological process
9000	GCST001600	IgG levels	IgG levels	Other measurement
9001	GCST001598	Blood pressure	Blood pressure	Other measurement
9002	GCST001598	Blood pressure	Blood pressure	Other measurement
9003	GCST001598	Blood pressure	Blood pressure	Other measurement
9004	GCST001598	Blood pressure	Blood pressure	Other measurement
9005	GCST001598	Blood pressure	Blood pressure	Cardiovascular measurement
9006	GCST001593	Cortical thickness	Cortical thickness	Other measurement
9007	GCST001597	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Response to drug
9008	GCST001597	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Other disease
9009	GCST001594	Bone mineral density	Bone mineral density	Other measurement
9010	GCST001595	Bone mineral density	Bone mineral density	Other measurement
9011	GCST001596	Glaucoma	Glaucoma	Neurological disorder
9012	GCST001591	Response to citalopram treatment	Response to citalopram treatment	Response to drug
9013	GCST001030	Attention deficit hyperactivity disorder motor coordination	Attention deficit hyperactivity disorder motor coordination	Neurological disorder
9014	GCST001032	Caffeine consumption	Caffeine consumption	Biological process
9015	GCST001033	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9016	GCST001031	Large B-cell lymphoma	Large B-cell lymphoma	Cancer
9017	GCST001029	Alcohol consumption	Alcohol consumption	Biological process
9018	GCST001029	Alcohol consumption	Alcohol consumption	Other measurement
9019	GCST001028	Prostate cancer	Prostate cancer	Cancer
9020	GCST001025	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9021	GCST001026	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9022	GCST001026	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9023	GCST001027	Uterine fibroids	Uterine fibroids	Cancer
9024	GCST001024	Telomere length	Telomere length	Other measurement
9025	GCST001046	Obesity	Obesity	Other measurement
9026	GCST001046	Obesity	Obesity	Metabolic disorder
9027	GCST001043	Response to interferon beta therapy	Response to interferon beta therapy	Response to drug
9028	GCST001041	Hepatocellular carcinoma	Hepatocellular carcinoma	Cancer
9029	GCST001040	Endometrial cancer	Endometrial cancer	Cancer
9030	GCST001040	Endometrial cancer	Endometrial cancer	Cancer
9031	GCST001039	Common variable immunodeficiency	Common variable immunodeficiency	Immune system disorder
9032	GCST001038	Dehydroepiandrosterone sulphate levels	Dehydroepiandrosterone sulphate levels	Other measurement
9033	GCST001038	Dehydroepiandrosterone sulphate levels	Dehydroepiandrosterone sulphate levels	Other measurement
9034	GCST001037	Neuranatomic and neurocognitive phenotypes	Neuranatomic and neurocognitive phenotypes	Other measurement
9035	GCST001037	Neuranatomic and neurocognitive phenotypes	Neuranatomic and neurocognitive phenotypes	Other measurement
9036	GCST001036	Drug-induced liver injury (amoxicillin-clavulanate)	Drug-induced liver injury (amoxicillin-clavulanate)	Digestive system disorder
9037	GCST001035	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to drug
9038	GCST001035	Response to platinum-based chemotherapy in non-small-cell lung cancer	Response to platinum-based chemotherapy in non-small-cell lung cancer	Cancer
9039	GCST001034	Cutaneous nevi	Cutaneous nevi	Cancer
9040	GCST001099	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
9041	GCST001101	Corneal curvature	Corneal curvature	Other measurement
9042	GCST001104	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
9043	GCST001100	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
9044	GCST001100	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
9045	GCST001098	Peripartum cardiomyopathy	Peripartum cardiomyopathy	Cardiovascular disease
9046	GCST001103	Alcohol consumption (transferrin glycosylation)	Alcohol consumption (transferrin glycosylation)	Biological process
9047	GCST001096	Multiple sclerosis	Multiple sclerosis	Immune system disorder
9048	GCST001097	Educational attainment	Educational attainment	Other measurement
9049	GCST001095	Response to antineoplastic agents	Response to antineoplastic agents	Response to drug
9050	GCST001094	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
9051	GCST001082	Orofacial clefts (maternal alcohol consumption interaction)	Orofacial clefts (maternal alcohol consumption interaction)	Other disease
9052	GCST001082	Orofacial clefts (maternal alcohol consumption interaction)	Orofacial clefts (maternal alcohol consumption interaction)	Other trait
9053	GCST001082	Orofacial clefts (maternal alcohol consumption interaction)	Orofacial clefts (maternal alcohol consumption interaction)	Other measurement
9054	GCST001083	Major depressive disorder	Major depressive disorder	Neurological disorder
9055	GCST001081	Longevity	Longevity	Other measurement
9056	GCST001080	Fracture-related traits	Fracture-related traits	Other measurement
9057	GCST001079	Coronary heart disease	Coronary heart disease	Cardiovascular disease
9058	GCST001078	Prostate cancer	Prostate cancer	Cancer
9059	GCST001077	Cystic fibrosis severity	Cystic fibrosis severity	Digestive system disorder
9060	GCST001075	Atopy	Atopy	Immune system disorder
9061	GCST001076	IFN-related cytopenia	IFN-related cytopenia	Digestive system disorder
9062	GCST001072	Blood pressure	Blood pressure	Other measurement
9063	GCST001072	Blood pressure	Blood pressure	Other measurement
9064	GCST001072	Blood pressure	Blood pressure	Other measurement
9065	GCST001072	Blood pressure	Blood pressure	Other measurement
9066	GCST001072	Blood pressure	Blood pressure	Cardiovascular measurement
9067	GCST001022	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9068	GCST001023	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
9069	GCST001023	Idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	Cardiovascular disease
9070	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
9071	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
9072	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
9073	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
9074	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
9075	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
9076	GCST001021	Iron status biomarkers	Iron status biomarkers	Other measurement
9077	GCST001020	Iron deficiency	Iron deficiency	Other trait
9078	GCST001019	Migraine	Migraine	Cardiovascular disease
9079	GCST001018	Nephrotic syndrome (acquired)	Nephrotic syndrome (acquired)	Other disease
9080	GCST001017	Diabetic retinopathy	Diabetic retinopathy	Metabolic disorder
9081	GCST001016	Vaccine-related adverse events	Vaccine-related adverse events	Response to drug
9082	GCST001015	Suicide attempts in bipolar disorder	Suicide attempts in bipolar disorder	Biological process
9083	GCST001015	Suicide attempts in bipolar disorder	Suicide attempts in bipolar disorder	Neurological disorder
9084	GCST001014	Adverse response to carbamazepine	Adverse response to carbamazepine	Response to drug
9085	GCST001093	C-reactive protein	C-reactive protein	Inflammatory measurement
9086	GCST001092	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9087	GCST001090	Schizophrenia	Schizophrenia	Neurological disorder
9088	GCST001091	Bilirubin levels	Bilirubin levels	Other measurement
9089	GCST001089	Esophageal cancer	Esophageal cancer	Cancer
9090	GCST001088	Myopia (pathological)	Myopia (pathological)	Other trait
9091	GCST001087	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9092	GCST001086	Paget's disease	Paget's disease	Other disease
9093	GCST001085	Hypertension (SNP x SNP interaction)	Hypertension (SNP x SNP interaction)	Cardiovascular disease
9094	GCST001084	Coronary heart disease (SNP X SNP interaction)	Coronary heart disease (SNP X SNP interaction)	Cardiovascular disease
9095	GCST001065	Platelet function and related traits	Platelet function and related traits	Hematological measurement
9096	GCST001061	Platelet count	Platelet count	Hematological measurement
9097	GCST001059	Neutrophil count	Neutrophil count	Hematological measurement
9098	GCST001062	Glaucoma	Glaucoma	Neurological disorder
9099	GCST001060	AIDS progression	AIDS progression	Immune system disorder
9100	GCST001058	Glioma	Glioma	Cancer
9101	GCST001058	Glioma	Glioma	Cancer
9102	GCST001057	Obesity	Obesity	Other measurement
9103	GCST001057	Obesity	Obesity	Metabolic disorder
9104	GCST001056	Major depressive disorder	Major depressive disorder	Neurological disorder
9105	GCST001048	Monocyte early outgrowth colony forming units	Monocyte early outgrowth colony forming units	Other measurement
9106	GCST001050	Bone mineral density	Bone mineral density	Other measurement
9107	GCST001049	D-dimer levels	D-dimer levels	Cardiovascular measurement
9108	GCST001051	Follicular lymphoma	Follicular lymphoma	Cancer
9109	GCST001047	Soluble ICAM-1	Soluble ICAM-1	Cardiovascular measurement
9110	GCST001042	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9111	GCST001070	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9112	GCST001071	Osteoporosis	Osteoporosis	Other disease
9113	GCST001073	Urinary metabolites	Urinary metabolites	Other measurement
9114	GCST001073	Urinary metabolites	Urinary metabolites	Other measurement
9115	GCST001074	Blood pressure	Blood pressure	Other measurement
9116	GCST001074	Blood pressure	Blood pressure	Other measurement
9117	GCST001074	Blood pressure	Blood pressure	Other measurement
9118	GCST001074	Blood pressure	Blood pressure	Other measurement
9119	GCST001074	Blood pressure	Blood pressure	Cardiovascular measurement
9120	GCST001069	Thyroid volume	Thyroid volume	Other measurement
9121	GCST001068	Telomere length	Telomere length	Other measurement
9122	GCST001067	Testicular cancer	Testicular cancer	Cancer
9123	GCST001066	Dialysis-related mortality	Dialysis-related mortality	Other disease
9124	GCST001064	Sarcoidosis	Sarcoidosis	Other disease
9125	GCST000669	Telomere length	Telomere length	Other measurement
9126	GCST000667	Smoking behavior	Smoking behavior	Biological process
9127	GCST000668	Smoking behavior	Smoking behavior	Biological process
9128	GCST000666	Smoking behavior	Smoking behavior	Biological process
9129	GCST000664	Vitamin D levels	Vitamin D levels	Other measurement
9130	GCST000665	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9131	GCST000663	Obesity (early onset extreme)	Obesity (early onset extreme)	Metabolic disorder
9132	GCST000662	Vitiligo	Vitiligo	Immune system disorder
9133	GCST000661	Mortality in heart failure	Mortality in heart failure	Other measurement
9134	GCST000661	Mortality in heart failure	Mortality in heart failure	Cardiovascular disease
9135	GCST000660	Anthropometric traits	Anthropometric traits	Other measurement
9136	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
9137	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
9138	GCST000660	Anthropometric traits	Anthropometric traits	Other measurement
9139	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
9140	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
9141	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
9142	GCST000660	Anthropometric traits	Anthropometric traits	Body measurement
9143	GCST000739	Serologic markers in systemic lupus erythematosus	Serologic markers in systemic lupus erythematosus	Immune system disorder
9144	GCST000737	Hypertriglyceridemia	Hypertriglyceridemia	Metabolic disorder
9145	GCST000737	Hypertriglyceridemia	Hypertriglyceridemia	Lipid or lipoprotein measurement
9146	GCST000736	Calcium levels	Calcium levels	Other measurement
9147	GCST000734	Follicular lymphoma	Follicular lymphoma	Cancer
9148	GCST000735	Lumiracoxib-related liver injury	Lumiracoxib-related liver injury	Digestive system disorder
9149	GCST000733	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
9150	GCST000733	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
9151	GCST000732	Nevus count	Nevus count	Other measurement
9152	GCST000731	Resting heart rate	Resting heart rate	Cardiovascular measurement
9153	GCST000730	Bilirubin levels	Bilirubin levels	Other measurement
9154	GCST000729	Ribavirin-induced anemia	Ribavirin-induced anemia	Other trait
9155	GCST000729	Ribavirin-induced anemia	Ribavirin-induced anemia	Response to drug
9156	GCST000717	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Neurological disorder
9157	GCST000717	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Neurological disorder
9158	GCST000717	Cataracts in type 2 diabetes	Cataracts in type 2 diabetes	Metabolic disorder
9159	GCST000718	Nephropathy	Nephropathy	Other disease
9160	GCST000719	Alopecia areata	Alopecia areata	Other disease
9161	GCST000715	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Cancer
9162	GCST000715	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Asparaginase hypersensitivity in acute lymphoblastic leukemia	Response to drug
9163	GCST000716	Multiple sclerosis	Multiple sclerosis	Immune system disorder
9164	GCST000712	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9165	GCST000714	Conduct disorder	Conduct disorder	Neurological disorder
9166	GCST000713	Conduct disorder (symptom count)	Conduct disorder (symptom count)	Neurological disorder
9167	GCST000711	Vitamin D levels	Vitamin D levels	Other measurement
9168	GCST000707	Hair color	Hair color	Other measurement
9169	GCST000707	Hair color	Hair color	Other trait
9170	GCST000679	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9171	GCST000677	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9172	GCST000680	Multiple sclerosis	Multiple sclerosis	Immune system disorder
9173	GCST000676	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9174	GCST000674	Bipolar disorder	Bipolar disorder	Neurological disorder
9175	GCST000675	Heart failure	Heart failure	Cardiovascular disease
9176	GCST000673	Cleft lip	Cleft lip	Other trait
9177	GCST000672	Paget's disease	Paget's disease	Other disease
9178	GCST000671	Lipoprotein-associated phospholipase A2 activity and mass	Lipoprotein-associated phospholipase A2 activity and mass	Lipid or lipoprotein measurement
9179	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
9180	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
9181	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
9182	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
9183	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
9184	GCST000670	Electroencephalogram traits	Electroencephalogram traits	Other measurement
9185	GCST000698	Osteoporosis-related phenotypes	Osteoporosis-related phenotypes	Other disease
9186	GCST000699	Optic disc parameters	Optic disc parameters	Other measurement
9187	GCST000697	Vitamin D insufficiency	Vitamin D insufficiency	Other trait
9188	GCST000696	End-stage renal disease (non-diabetic)	End-stage renal disease (non-diabetic)	Other disease
9189	GCST000695	Migraine in psychiatric disorder	Migraine in psychiatric disorder	Cardiovascular disease
9190	GCST000695	Migraine in psychiatric disorder	Migraine in psychiatric disorder	Neurological disorder
9191	GCST000694	Phytosterol levels	Phytosterol levels	Other measurement
9192	GCST000692	Vitiligo	Vitiligo	Immune system disorder
9193	GCST000693	Platelet aggregation	Platelet aggregation	Biological process
9194	GCST000691	Partial epilepsies	Partial epilepsies	Neurological disorder
9195	GCST000688	Response to platinum-based chemotherapy in small-cell lung cancer	Response to platinum-based chemotherapy in small-cell lung cancer	Response to drug
9196	GCST000689	Major depressive disorder	Major depressive disorder	Neurological disorder
9197	GCST000690	Heroin addiction	Heroin addiction	Neurological disorder
9198	GCST000687	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
9199	GCST000686	Pancreatic cancer	Pancreatic cancer	Cancer
9200	GCST000685	Eye color traits	Eye color traits	Other trait
9201	GCST000684	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
9202	GCST000683	Central corneal thickness	Central corneal thickness	Other measurement
9203	GCST000683	Central corneal thickness	Central corneal thickness	Other measurement
9204	GCST000682	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9205	GCST000681	Biliary atresia	Biliary atresia	Digestive system disorder
9206	GCST000678	Breast cancer	Breast cancer	Cancer
9207	GCST000748	Response to anti-TNF alpha therapy in inflammatory bowel disease	Response to anti-TNF alpha therapy in inflammatory bowel disease	Response to drug
9208	GCST000750	Prostate cancer	Prostate cancer	Cancer
9209	GCST000746	Bitter taste response	Bitter taste response	Biological process
9210	GCST000743	Major depressive disorder	Major depressive disorder	Neurological disorder
9211	GCST000742	Chronic kidney disease and serum creatinine levels	Chronic kidney disease and serum creatinine levels	Other disease
9212	GCST000742	Chronic kidney disease and serum creatinine levels	Chronic kidney disease and serum creatinine levels	Other measurement
9213	GCST000745	Pancreatic cancer	Pancreatic cancer	Cancer
9214	GCST000744	Height	Height	Other measurement
9215	GCST000744	Height	Height	Body measurement
9216	GCST000741	Glomerulosclerosis	Glomerulosclerosis	Other disease
9217	GCST000740	Autism	Autism	Neurological disorder
9218	GCST000738	Neonatal lupus	Neonatal lupus	Immune system disorder
9219	GCST000710	Eye color	Eye color	Other measurement
9220	GCST000710	Eye color	Eye color	Other trait
9221	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
9222	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
9223	GCST000706	Common traits (Other)	Common traits (Other)	Biological process
9224	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
9225	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
9226	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
9227	GCST000706	Common traits (Other)	Common traits (Other)	Biological process
9228	GCST000706	Common traits (Other)	Common traits (Other)	Biological process
9229	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
9230	GCST000706	Common traits (Other)	Common traits (Other)	Other trait
9231	GCST000708	Freckling	Freckling	Other trait
9232	GCST000709	Breast cancer	Breast cancer	Cancer
9233	GCST000704	Hemoglobin levels	Hemoglobin levels	Hematological measurement
9234	GCST000704	Hemoglobin levels	Hemoglobin levels	Hematological measurement
9235	GCST000704	Hemoglobin levels	Hemoglobin levels	Hematological measurement
9236	GCST000704	Hemoglobin levels	Hemoglobin levels	Hematological measurement
9237	GCST000705	Crohn's disease	Crohn's disease	Digestive system disorder
9238	GCST000702	Schizophrenia	Schizophrenia	Neurological disorder
9239	GCST000703	Phosphorus levels	Phosphorus levels	Other measurement
9240	GCST000701	Testicular germ cell cancer	Testicular germ cell cancer	Cancer
9241	GCST000700	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
9242	GCST000700	Vertical cup-disc ratio	Vertical cup-disc ratio	Other measurement
9243	GCST000726	Behcet's disease	Behcet's disease	Cardiovascular disease
9244	GCST000725	Ventricular fibrillation	Ventricular fibrillation	Cardiovascular disease
9245	GCST000728	Behcet's disease	Behcet's disease	Cardiovascular disease
9246	GCST000727	Abdominal aortic aneurysm	Abdominal aortic aneurysm	Cardiovascular disease
9247	GCST000724	Neuroticism (age interaction)	Neuroticism (age interaction)	Neurological disorder
9248	GCST000724	Neuroticism (age interaction)	Neuroticism (age interaction)	Other measurement
9249	GCST004569	Neuroticism	Neuroticism	Neurological disorder
9250	GCST004569	Neuroticism	Neuroticism	Other measurement
9251	GCST000723	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
9252	GCST000722	Colorectal cancer	Colorectal cancer	Cancer
9253	GCST000721	Endometriosis	Endometriosis	Other disease
9254	GCST000720	Peripheral artery disease	Peripheral artery disease	Cardiovascular disease
9255	GCST002085	Malignant mesothelioma	Malignant mesothelioma	Cancer
9256	GCST005530	Ankylosing spondylitis (SNP x SNP interaction)	Ankylosing spondylitis (SNP x SNP interaction)	Immune system disorder
9257	GCST005529	Ankylosing spondylitis	Ankylosing spondylitis	Immune system disorder
9258	GCST002083	Self-reported allergy	Self-reported allergy	Immune system disorder
9259	GCST002084	Allergic sensitization	Allergic sensitization	Other measurement
9260	GCST002082	Cervical cancer	Cervical cancer	Cancer
9261	GCST002078	Migraine without aura	Migraine without aura	Cardiovascular disease
9262	GCST002078	Migraine without aura	Migraine without aura	Cardiovascular disease
9263	GCST002079	Migraine - clinic-based	Migraine - clinic-based	Cardiovascular disease
9264	GCST002081	Migraine	Migraine	Cardiovascular disease
9265	GCST002080	Migraine with aura	Migraine with aura	Cardiovascular disease
9266	GCST002080	Migraine with aura	Migraine with aura	Cardiovascular disease
9267	GCST001960	Eating disorders	Eating disorders	Metabolic disorder
9268	GCST001960	Eating disorders	Eating disorders	Neurological disorder
9269	GCST001959	Eating disorders (purging via substances)	Eating disorders (purging via substances)	Metabolic disorder
9270	GCST001958	Bulimia nervosa	Bulimia nervosa	Metabolic disorder
9271	GCST001961	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
9272	GCST001961	Anorexia nervosa	Anorexia nervosa	Metabolic disorder
9273	GCST001957	Obesity (early onset extreme)	Obesity (early onset extreme)	Metabolic disorder
9274	GCST001956	Height	Height	Other measurement
9275	GCST001956	Height	Height	Body measurement
9276	GCST001955	Body mass index	Body mass index	Body measurement
9277	GCST001955	Body mass index	Body mass index	Body measurement
9278	GCST001955	Body mass index	Body mass index	Other measurement
9279	GCST001954	Waist-hip ratio	Waist-hip ratio	Other measurement
9280	GCST001954	Waist-hip ratio	Waist-hip ratio	Body measurement
9281	GCST001953	Obesity	Obesity	Other measurement
9282	GCST001953	Obesity	Obesity	Metabolic disorder
9283	GCST001951	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
9284	GCST001951	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
9285	GCST001951	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
9286	GCST001951	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Neurological disorder
9287	GCST001951	Alzheimer's disease biomarkers	Alzheimer's disease biomarkers	Other measurement
9288	GCST001918	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
9289	GCST001918	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
9290	GCST001918	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other measurement
9291	GCST001918	Pulmonary function in asthmatics	Pulmonary function in asthmatics	Other disease
9292	GCST007302	Breast cancer in BRCA2 mutation carriers	Breast cancer in BRCA2 mutation carriers	Cancer
9293	GCST001919	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9294	GCST001916	Breast Cancer in BRCA1 mutation carriers	Breast Cancer in BRCA1 mutation carriers	Cancer
9295	GCST001916	Breast Cancer in BRCA1 mutation carriers	Breast Cancer in BRCA1 mutation carriers	Other measurement
9296	GCST001917	Ovarian cancer in BRCA1 mutation carriers	Ovarian cancer in BRCA1 mutation carriers	Other measurement
9297	GCST001917	Ovarian cancer in BRCA1 mutation carriers	Ovarian cancer in BRCA1 mutation carriers	Cancer
9298	GCST001915	Alzheimer's disease (cognitive decline)	Alzheimer's disease (cognitive decline)	Neurological disorder
9299	GCST001914	Estradiol plasma levels (breast cancer)	Estradiol plasma levels (breast cancer)	Other measurement
9300	GCST001913	Venous thromboembolism (SNP x SNP interaction)	Venous thromboembolism (SNP x SNP interaction)	Cardiovascular disease
9301	GCST001893	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
9302	GCST001893	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
9303	GCST001893	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
9304	GCST001893	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
9305	GCST001893	Electrocardiographic conduction measures	Electrocardiographic conduction measures	Cardiovascular measurement
9306	GCST001890	QT interval (drug interaction)	QT interval (drug interaction)	Cardiovascular measurement
9307	GCST001890	QT interval (drug interaction)	QT interval (drug interaction)	Response to drug
9308	GCST001890	QT interval (drug interaction)	QT interval (drug interaction)	Response to drug
9309	GCST001890	QT interval (drug interaction)	QT interval (drug interaction)	Response to drug
9310	GCST001889	Brain connectivity	Brain connectivity	Other measurement
9311	GCST001888	Periodontitis	Periodontitis	Digestive system disorder
9312	GCST001884	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
9313	GCST001884	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
9314	GCST001885	Height	Height	Other measurement
9315	GCST001885	Height	Height	Body measurement
9316	GCST001887	Monocyte count	Monocyte count	Hematological measurement
9317	GCST001886	Melanoma	Melanoma	Cancer
9318	GCST001883	Alcohol dependence	Alcohol dependence	Other measurement
9319	GCST001883	Alcohol dependence	Alcohol dependence	Neurological disorder
9320	GCST001971	Hypersomnia (HLA-DQB1*06:02 negative)	Hypersomnia (HLA-DQB1*06:02 negative)	Neurological disorder
9321	GCST001970	Menopause (age at onset)	Menopause (age at onset)	Other measurement
9322	GCST001969	Heart rate	Heart rate	Cardiovascular measurement
9323	GCST001967	Body mass index	Body mass index	Body measurement
9324	GCST001967	Body mass index	Body mass index	Body measurement
9325	GCST001967	Body mass index	Body mass index	Other measurement
9326	GCST001968	Interstitial lung disease	Interstitial lung disease	Other disease
9327	GCST001966	Rhegmatogenous retinal detachment	Rhegmatogenous retinal detachment	Neurological disorder
9328	GCST001965	Glycemic traits	Glycemic traits	Metabolic disorder
9329	GCST001963	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9330	GCST001963	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9331	GCST001964	Anthropometric traits in newborns	Anthropometric traits in newborns	Other measurement
9332	GCST001964	Anthropometric traits in newborns	Anthropometric traits in newborns	Body measurement
9333	GCST001964	Anthropometric traits in newborns	Anthropometric traits in newborns	Other measurement
9334	GCST001964	Anthropometric traits in newborns	Anthropometric traits in newborns	Other measurement
9335	GCST001964	Anthropometric traits in newborns	Anthropometric traits in newborns	Other trait
9336	GCST001962	Bone mineral density	Bone mineral density	Other measurement
9337	GCST001941	Ovarian cancer	Ovarian cancer	Cancer
9338	GCST001942	Prostate cancer	Prostate cancer	Cancer
9339	GCST001936	Telomere length	Telomere length	Other measurement
9340	GCST001937	Breast cancer	Breast cancer	Cancer
9341	GCST001930	Breast cancer	Breast cancer	Cancer
9342	GCST001902	Coronary artery calcification	Coronary artery calcification	Other trait
9343	GCST001900	Cervical cancer	Cervical cancer	Cancer
9344	GCST001901	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	Response to drug
9345	GCST001901	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	Cancer
9346	GCST001899	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
9347	GCST001899	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
9348	GCST001897	Pit-and-Fissure caries	Pit-and-Fissure caries	Digestive system disorder
9349	GCST001896	Smooth-surface caries	Smooth-surface caries	Digestive system disorder
9350	GCST001898	Refractive error	Refractive error	Other trait
9351	GCST001895	Response to dabigatran etexilate treatment	Response to dabigatran etexilate treatment	Response to drug
9352	GCST001894	Endometriosis	Endometriosis	Other disease
9353	GCST001912	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
9354	GCST001911	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Response to drug
9355	GCST001911	Asthma (bronchodilator response)	Asthma (bronchodilator response)	Other disease
9356	GCST001909	Narcolepsy with cataplexy	Narcolepsy with cataplexy	Neurological disorder
9357	GCST001910	Aspirin hydrolysis (plasma)	Aspirin hydrolysis (plasma)	Other measurement
9358	GCST001908	Pulmonary arterial hypertension (without BMPR2 mutations)	Pulmonary arterial hypertension (without BMPR2 mutations)	Cardiovascular disease
9359	GCST001906	Multiple myeloma (IgH translocation)	Multiple myeloma (IgH translocation)	Cancer
9360	GCST001907	Multiple myeloma (hyperdiploidy)	Multiple myeloma (hyperdiploidy)	Cancer
9361	GCST001905	Hypertriglyceridemia	Hypertriglyceridemia	Metabolic disorder
9362	GCST001905	Hypertriglyceridemia	Hypertriglyceridemia	Lipid or lipoprotein measurement
9363	GCST001904	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
9364	GCST001903	Central corneal thickness	Central corneal thickness	Other measurement
9365	GCST001903	Central corneal thickness	Central corneal thickness	Other measurement
9366	GCST001950	Femoral neck bone geometry and menarche (age at onset)	Femoral neck bone geometry and menarche (age at onset)	Other measurement
9367	GCST001952	Self-employment	Self-employment	Other measurement
9368	GCST001947	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9369	GCST001947	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9370	GCST001949	Preeclampsia	Preeclampsia	Cardiovascular disease
9371	GCST001948	Anxiety	Anxiety	Other measurement
9372	GCST001948	Anxiety	Anxiety	Other trait
9373	GCST001924	Chronic kidney disease	Chronic kidney disease	Other disease
9374	GCST001924	Chronic kidney disease	Chronic kidney disease	Other measurement
9375	GCST001924	Chronic kidney disease	Chronic kidney disease	Other measurement
9376	GCST001927	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Immune system disorder
9377	GCST001927	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Response to drug
9378	GCST001928	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Cancer
9379	GCST001928	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Other measurement
9380	GCST001928	Pediatric non-alcoholic fatty liver disease activity score	Pediatric non-alcoholic fatty liver disease activity score	Digestive system disorder
9381	GCST001926	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Immune system disorder
9382	GCST001926	Response to anti-TNF therapy in rheumatoid arthritis	Response to anti-TNF therapy in rheumatoid arthritis	Response to drug
9383	GCST001697	Telomere length	Telomere length	Other measurement
9384	GCST001691	Monocyte chemoattractant protein-1 levels	Monocyte chemoattractant protein-1 levels	Other measurement
9385	GCST001692	Response to taxane treatment (docetaxel)	Response to taxane treatment (docetaxel)	Response to drug
9386	GCST001694	Response to taxane treatment (placlitaxel)	Response to taxane treatment (placlitaxel)	Response to drug
9387	GCST001693	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
9388	GCST001690	Breast cancer (male)	Breast cancer (male)	Cancer
9389	GCST001689	Stroke (pediatric)	Stroke (pediatric)	Cardiovascular disease
9390	GCST006519	Growth differentiation factor-15 levels	Growth differentiation factor-15 levels	Hematological measurement
9391	GCST001688	Type 1 diabetes nephropathy	Type 1 diabetes nephropathy	Metabolic disorder
9392	GCST001687	Disc degeneration (lumbar)	Disc degeneration (lumbar)	Other disease
9393	GCST001659	Stroke (ischemic)	Stroke (ischemic)	Cardiovascular disease
9394	GCST001657	Schizophrenia	Schizophrenia	Neurological disorder
9395	GCST005047	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9396	GCST001658	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9397	GCST001658	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9398	GCST001656	Comprehensive strength and appendicular lean mass	Comprehensive strength and appendicular lean mass	Other measurement
9399	GCST001656	Comprehensive strength and appendicular lean mass	Comprehensive strength and appendicular lean mass	Other measurement
9400	GCST001655	Autism	Autism	Neurological disorder
9401	GCST001654	Sarcoidosis	Sarcoidosis	Other disease
9402	GCST001653	Androgen levels	Androgen levels	Other measurement
9403	GCST001653	Androgen levels	Androgen levels	Other measurement
9404	GCST001652	Crohn's disease	Crohn's disease	Digestive system disorder
9405	GCST001651	Response to amphetamines	Response to amphetamines	Biological process
9406	GCST001685	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
9407	GCST001685	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
9408	GCST001684	Plasminogen activator inhibitor type 1 levels (PAI-1)	Plasminogen activator inhibitor type 1 levels (PAI-1)	Other measurement
9409	GCST001686	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
9410	GCST001677	Paraoxonase activity	Paraoxonase activity	Cardiovascular measurement
9411	GCST001682	Personality disorders	Personality disorders	Neurological disorder
9412	GCST001679	Complement C3 and C4 levels	Complement C3 and C4 levels	Other measurement
9413	GCST001679	Complement C3 and C4 levels	Complement C3 and C4 levels	Other measurement
9414	GCST001683	Breast cancer	Breast cancer	Cancer
9415	GCST001680	Corneal curvature	Corneal curvature	Other measurement
9416	GCST001681	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9417	GCST001678	Facial morphology	Facial morphology	Other trait
9418	GCST001678	Facial morphology	Facial morphology	Other measurement
9419	GCST001714	Prostate cancer	Prostate cancer	Cancer
9420	GCST001713	Dental caries	Dental caries	Digestive system disorder
9421	GCST001710	HbA2 levels	HbA2 levels	Hematological measurement
9422	GCST001711	Protein biomarker	Protein biomarker	Other measurement
9423	GCST001712	Myopia (pathological)	Myopia (pathological)	Other trait
9424	GCST001709	Atopic dermatitis	Atopic dermatitis	Immune system disorder
9425	GCST001708	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
9426	GCST001707	Behcet's disease	Behcet's disease	Cardiovascular disease
9427	GCST001706	Stroke (ischemic)	Stroke (ischemic)	Cardiovascular disease
9428	GCST001705	Platelet reactivity	Platelet reactivity	Cardiovascular measurement
9429	GCST001703	Apolipoprotein Levels	Apolipoprotein Levels	Other measurement
9430	GCST001704	Cholesterol and Triglycerides	Cholesterol and Triglycerides	Lipid or lipoprotein measurement
9431	GCST001704	Cholesterol and Triglycerides	Cholesterol and Triglycerides	Lipid or lipoprotein measurement
9432	GCST005581	Primary biliary cirrhosis	Primary biliary cirrhosis	Cancer
9433	GCST001702	Prostate cancer	Prostate cancer	Cancer
9434	GCST001701	Asthma	Asthma	Other disease
9435	GCST001700	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Cancer
9436	GCST001700	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Other disease
9437	GCST001700	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Biological process
9438	GCST001699	Serum albumin level	Serum albumin level	Other measurement
9439	GCST001698	Serum total protein level	Serum total protein level	Hematological measurement
9440	GCST001698	Serum total protein level	Serum total protein level	Other measurement
9441	GCST001695	Bipolar disorder (Negative mood delusions)	Bipolar disorder (Negative mood delusions)	Neurological disorder
9442	GCST001724	IgM levels	IgM levels	Other measurement
9443	GCST001722	Body mass (lean)	Body mass (lean)	Other measurement
9444	GCST001721	Lung Cancer (DNA repair capacity)	Lung Cancer (DNA repair capacity)	Cancer
9445	GCST001719	Prostate cancer	Prostate cancer	Cancer
9446	GCST001720	Endometriosis	Endometriosis	Other disease
9447	GCST001717	Otitis media (chronic/recurrent)	Otitis media (chronic/recurrent)	Neurological disorder
9448	GCST001718	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Cancer
9449	GCST001718	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Cancer
9450	GCST001718	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	Cancer
9451	GCST001716	Response to statin therapy	Response to statin therapy	Response to drug
9452	GCST001715	Bipolar disorder with mood-incongruent psychosis	Bipolar disorder with mood-incongruent psychosis	Neurological disorder
9453	GCST006249	Serum metabolite levels	Serum metabolite levels	Other measurement
9454	GCST001650	C-reactive protein	C-reactive protein	Inflammatory measurement
9455	GCST001649	Glaucoma (primary angle closure)	Glaucoma (primary angle closure)	Neurological disorder
9456	GCST001649	Glaucoma (primary angle closure)	Glaucoma (primary angle closure)	Neurological disorder
9457	GCST001648	Breast cancer	Breast cancer	Cancer
9458	GCST001647	Bipolar disorder	Bipolar disorder	Neurological disorder
9459	GCST001646	Prostate cancer	Prostate cancer	Cancer
9460	GCST001645	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
9461	GCST001645	LDL cholesterol	LDL cholesterol	Other measurement
9462	GCST001645	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
9463	GCST001644	Eating disorders	Eating disorders	Metabolic disorder
9464	GCST001644	Eating disorders	Eating disorders	Neurological disorder
9465	GCST001643	Depression (age of onset)	Depression (age of onset)	Neurological disorder
9466	GCST001643	Depression (age of onset)	Depression (age of onset)	Other measurement
9467	GCST001641	Response to antidepressants	Response to antidepressants	Response to drug
9468	GCST001642	Vaspin levels	Vaspin levels	Other measurement
9469	GCST001670	Vitiligo	Vitiligo	Immune system disorder
9470	GCST001669	Polycystic ovary syndrome	Polycystic ovary syndrome	Other disease
9471	GCST001663	Amyotrophic lateral sclerosis (age of onset)	Amyotrophic lateral sclerosis (age of onset)	Neurological disorder
9472	GCST001663	Amyotrophic lateral sclerosis (age of onset)	Amyotrophic lateral sclerosis (age of onset)	Other measurement
9473	GCST004792	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals	Neurological disorder
9474	GCST004793	Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals	Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals	Neurological disorder
9475	GCST004791	Amyotrophic lateral sclerosis (C9orf72 mutation interaction)	Amyotrophic lateral sclerosis (C9orf72 mutation interaction)	Neurological disorder
9476	GCST001664	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
9477	GCST001662	Generalized epilepsy	Generalized epilepsy	Neurological disorder
9478	GCST001662	Generalized epilepsy	Generalized epilepsy	Neurological disorder
9479	GCST001661	CYP3A4 enzyme activity	CYP3A4 enzyme activity	Liver enzyme measurement
9480	GCST001660	Neuroblastoma	Neuroblastoma	Cancer
9481	GCST001676	Body mass index	Body mass index	Body measurement
9482	GCST001676	Body mass index	Body mass index	Body measurement
9483	GCST001676	Body mass index	Body mass index	Other measurement
9484	GCST001674	Esophageal cancer (squamous cell)	Esophageal cancer (squamous cell)	Cancer
9485	GCST001674	Esophageal cancer (squamous cell)	Esophageal cancer (squamous cell)	Cancer
9486	GCST001675	Barrett's esophagus	Barrett's esophagus	Digestive system disorder
9487	GCST001672	Esophageal cancer  (alcohol interaction)	Esophageal cancer  (alcohol interaction)	Cancer
9488	GCST001673	Drug-induced liver injury	Drug-induced liver injury	Response to drug
9489	GCST001673	Drug-induced liver injury	Drug-induced liver injury	Digestive system disorder
9490	GCST001671	IgG levels	IgG levels	Other measurement
9491	GCST001667	Breast cancer	Breast cancer	Cancer
9492	GCST001665	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
9493	GCST001463	Adiponectin levels	Adiponectin levels	Other measurement
9494	GCST001466	Chronic kidney disease	Chronic kidney disease	Other disease
9495	GCST001466	Chronic kidney disease	Chronic kidney disease	Other measurement
9496	GCST001466	Chronic kidney disease	Chronic kidney disease	Other measurement
9497	GCST001461	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9498	GCST001460	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
9499	GCST001459	Multiple sclerosis	Multiple sclerosis	Immune system disorder
9500	GCST001457	Breast cancer	Breast cancer	Cancer
9501	GCST001458	Schizophrenia (treatment resistant)	Schizophrenia (treatment resistant)	Neurological disorder
9502	GCST001454	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9503	GCST001456	Kawasaki disease	Kawasaki disease	Immune system disorder
9504	GCST001455	Kawasaki disease	Kawasaki disease	Immune system disorder
9505	GCST001414	Phospholipid levels (plasma)	Phospholipid levels (plasma)	Lipid or lipoprotein measurement
9506	GCST001412	Facial morphology	Facial morphology	Other trait
9507	GCST001412	Facial morphology	Facial morphology	Other measurement
9508	GCST001411	Occipital cortical area (total cortical area interaction)	Occipital cortical area (total cortical area interaction)	Other measurement
9509	GCST001411	Occipital cortical area (total cortical area interaction)	Occipital cortical area (total cortical area interaction)	Other measurement
9510	GCST001413	Sphingolipid levels	Sphingolipid levels	Other measurement
9511	GCST001413	Sphingolipid levels	Sphingolipid levels	Lipid or lipoprotein measurement
9512	GCST001409	Body mass index (SNP x SNP interaction)	Body mass index (SNP x SNP interaction)	Body measurement
9513	GCST001410	Cardiac repolarization	Cardiac repolarization	Cardiovascular measurement
9514	GCST001410	Cardiac repolarization	Cardiac repolarization	Cardiovascular measurement
9515	GCST001408	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Lipid or lipoprotein measurement
9516	GCST001408	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Lipid or lipoprotein measurement
9517	GCST001408	Response to statins (LDL cholesterol change)	Response to statins (LDL cholesterol change)	Response to drug
9518	GCST001407	Ewing sarcoma	Ewing sarcoma	Cancer
9519	GCST001406	Premature ovarian failure	Premature ovarian failure	Other disease
9520	GCST001404	Gallbladder cancer	Gallbladder cancer	Cancer
9521	GCST001386	Acute graft versus host disease	Acute graft versus host disease	Immune system disorder
9522	GCST001383	Acute lung injury	Acute lung injury	Other disease
9523	GCST001382	Thyroid cancer	Thyroid cancer	Cancer
9524	GCST001381	Menopause (age at onset)	Menopause (age at onset)	Other measurement
9525	GCST001380	Gaucher disease severity	Gaucher disease severity	Metabolic disorder
9526	GCST001379	Longevity	Longevity	Other measurement
9527	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
9528	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Inflammatory measurement
9529	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Other measurement
9530	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Cardiovascular measurement
9531	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
9532	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
9533	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Other measurement
9534	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
9535	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Biological process
9536	GCST001378	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
9537	GCST001377	Tuberculosis	Tuberculosis	Other disease
9538	GCST001377	Tuberculosis	Tuberculosis	Other measurement
9539	GCST001377	Tuberculosis	Tuberculosis	Other measurement
9540	GCST001376	Life threatening arrhythmia	Life threatening arrhythmia	Cardiovascular disease
9541	GCST001375	Diabetes (gestational)	Diabetes (gestational)	Metabolic disorder
9542	GCST001442	Orofacial clefts	Orofacial clefts	Other trait
9543	GCST001442	Orofacial clefts	Orofacial clefts	Other measurement
9544	GCST001442	Orofacial clefts	Orofacial clefts	Other disease
9545	GCST001442	Orofacial clefts	Orofacial clefts	Other trait
9546	GCST001443	Preeclampsia	Preeclampsia	Cardiovascular disease
9547	GCST001441	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
9548	GCST001440	Body mass index and cholesterol (psychopharmacological treatment)	Body mass index and cholesterol (psychopharmacological treatment)	Body measurement
9549	GCST001440	Body mass index and cholesterol (psychopharmacological treatment)	Body mass index and cholesterol (psychopharmacological treatment)	Biological process
9550	GCST001440	Body mass index and cholesterol (psychopharmacological treatment)	Body mass index and cholesterol (psychopharmacological treatment)	Lipid or lipoprotein measurement
9551	GCST001439	Mean platelet volume	Mean platelet volume	Hematological measurement
9552	GCST008047	Platelet count	Platelet count	Hematological measurement
9553	GCST001437	Thyrotoxic hypokalemic periodic paralysis	Thyrotoxic hypokalemic periodic paralysis	Metabolic disorder
9554	GCST001438	Crohn's disease	Crohn's disease	Digestive system disorder
9555	GCST001436	Metabolic syndrome	Metabolic syndrome	Body measurement
9556	GCST001436	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
9557	GCST001436	Metabolic syndrome	Metabolic syndrome	Other measurement
9558	GCST001436	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
9559	GCST001436	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
9560	GCST001435	Haptoglobin levels	Haptoglobin levels	Hematological measurement
9561	GCST001395	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
9562	GCST001393	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
9563	GCST001391	Metabolite levels	Metabolite levels	Other trait
9564	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9565	GCST001391	Metabolite levels	Metabolite levels	Liver enzyme measurement
9566	GCST001391	Metabolite levels	Metabolite levels	Cardiovascular measurement
9567	GCST001391	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
9568	GCST001391	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
9569	GCST001391	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
9570	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9571	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9572	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9573	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9574	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9575	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9576	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9577	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9578	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9579	GCST001391	Metabolite levels	Metabolite levels	Other measurement
9580	GCST001392	Lipid metabolism phenotypes	Lipid metabolism phenotypes	Other measurement
9581	GCST001390	Response to gemcitabine in pancreatic cancer	Response to gemcitabine in pancreatic cancer	Response to drug
9582	GCST001390	Response to gemcitabine in pancreatic cancer	Response to gemcitabine in pancreatic cancer	Cancer
9583	GCST001389	Lymphocyte counts	Lymphocyte counts	Hematological measurement
9584	GCST001388	Intracranial aneurysm	Intracranial aneurysm	Cardiovascular disease
9585	GCST001387	Hodgkin's lymphoma	Hodgkin's lymphoma	Cancer
9586	GCST001384	Systemic lupus erythematosus	Systemic lupus erythematosus	Immune system disorder
9587	GCST001453	Sexual dysfunction (SSRI/SNRI-related)	Sexual dysfunction (SSRI/SNRI-related)	Other trait
9588	GCST001451	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
9589	GCST001452	Pemphigus vulgaris	Pemphigus vulgaris	Immune system disorder
9590	GCST001450	Response to Vitamin E supplementation	Response to Vitamin E supplementation	Biological process
9591	GCST001449	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9592	GCST001447	Endometrial cancer	Endometrial cancer	Cancer
9593	GCST001447	Endometrial cancer	Endometrial cancer	Cancer
9594	GCST001448	Body mass index	Body mass index	Body measurement
9595	GCST001448	Body mass index	Body mass index	Body measurement
9596	GCST001448	Body mass index	Body mass index	Other measurement
9597	GCST001444	Pulmonary function decline	Pulmonary function decline	Other measurement
9598	GCST001444	Pulmonary function decline	Pulmonary function decline	Other measurement
9599	GCST001445	Parkinson's disease	Parkinson's disease	Neurological disorder
9600	GCST001446	White matter integrity	White matter integrity	Other measurement
9601	GCST001434	Naphthyl-keratin adduct levels	Naphthyl-keratin adduct levels	Other measurement
9602	GCST001433	Duodenal ulcer	Duodenal ulcer	Digestive system disorder
9603	GCST001430	Parkinson's disease	Parkinson's disease	Neurological disorder
9604	GCST001431	Adverse response to lamotrigine and phenytoin	Adverse response to lamotrigine and phenytoin	Response to drug
9605	GCST001432	Nephrolithiasis	Nephrolithiasis	Other disease
9606	GCST001429	Drinking behavior	Drinking behavior	Biological process
9607	GCST001428	Intelligence	Intelligence	Biological process
9608	GCST001427	Nicotine dependence	Nicotine dependence	Neurological disorder
9609	GCST001426	Prostate cancer (SNP x SNP interaction)	Prostate cancer (SNP x SNP interaction)	Cancer
9610	GCST001426	Prostate cancer (SNP x SNP interaction)	Prostate cancer (SNP x SNP interaction)	Other measurement
9611	GCST001424	Vitamin B12 levels	Vitamin B12 levels	Other measurement
9612	GCST001423	Hypertension	Hypertension	Cardiovascular disease
9613	GCST001425	Response to statin therapy	Response to statin therapy	Response to drug
9614	GCST001420	Breast cancer	Breast cancer	Cancer
9615	GCST001422	Odorant perception	Odorant perception	Biological process
9616	GCST001421	Arsenic metabolism	Arsenic metabolism	Other measurement
9617	GCST001419	Temperament (bipolar disorder)	Temperament (bipolar disorder)	Other measurement
9618	GCST001419	Temperament (bipolar disorder)	Temperament (bipolar disorder)	Neurological disorder
9619	GCST001419	Temperament (bipolar disorder)	Temperament (bipolar disorder)	Other trait
9620	GCST001418	Lipid levels in hepatitis C treatment	Lipid levels in hepatitis C treatment	Lipid or lipoprotein measurement
9621	GCST001418	Lipid levels in hepatitis C treatment	Lipid levels in hepatitis C treatment	Digestive system disorder
9622	GCST001417	Arthritis (juvenile idiopathic)	Arthritis (juvenile idiopathic)	Immune system disorder
9623	GCST001415	Body mass index	Body mass index	Body measurement
9624	GCST001415	Body mass index	Body mass index	Body measurement
9625	GCST001415	Body mass index	Body mass index	Other measurement
9626	GCST001416	Body mass index (SNP x SNP interaction)	Body mass index (SNP x SNP interaction)	Body measurement
9627	GCST001405	Hypertension risk in short sleep duration	Hypertension risk in short sleep duration	Cardiovascular disease
9628	GCST001405	Hypertension risk in short sleep duration	Hypertension risk in short sleep duration	Other measurement
9629	GCST001402	Treatment response for severe sepsis	Treatment response for severe sepsis	Biological process
9630	GCST001401	Coronary heart disease	Coronary heart disease	Cardiovascular disease
9631	GCST001403	Fluorouracil treatment response in colorectal cancer	Fluorouracil treatment response in colorectal cancer	Response to drug
9632	GCST001399	Infantile hypertrophic pyloric stenosis	Infantile hypertrophic pyloric stenosis	Digestive system disorder
9633	GCST001398	Tuberculosis	Tuberculosis	Other disease
9634	GCST001398	Tuberculosis	Tuberculosis	Other measurement
9635	GCST001398	Tuberculosis	Tuberculosis	Other measurement
9636	GCST001400	Stroke	Stroke	Cardiovascular disease
9637	GCST000817	Height	Height	Other measurement
9638	GCST000817	Height	Height	Body measurement
9639	GCST000816	Suicidal ideation	Suicidal ideation	Biological process
9640	GCST000816	Suicidal ideation	Suicidal ideation	Other measurement
9641	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
9642	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
9643	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
9644	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
9645	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
9646	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
9647	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
9648	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
9649	GCST000814	Red blood cell traits	Red blood cell traits	Hematological measurement
9650	GCST000815	Non-small cell lung cancer	Non-small cell lung cancer	Cancer
9651	GCST000812	Adiponectin levels	Adiponectin levels	Other measurement
9652	GCST000813	Adverse response to aromatase inhibitors	Adverse response to aromatase inhibitors	Response to drug
9653	GCST000810	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
9654	GCST000811	Breast cancer	Breast cancer	Cancer
9655	GCST000809	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
9656	GCST000834	Psoriasis	Psoriasis	Immune system disorder
9657	GCST000835	Psoriatic arthritis	Psoriatic arthritis	Immune system disorder
9658	GCST000836	Psoriasis	Psoriasis	Immune system disorder
9659	GCST000833	Psoriasis	Psoriasis	Immune system disorder
9660	GCST000832	Stevens-Johnson syndrome	Stevens-Johnson syndrome	Other disease
9661	GCST000831	Tardive dyskinesia in schizophrenia	Tardive dyskinesia in schizophrenia	Neurological disorder
9662	GCST000829	Waist-hip ratio	Waist-hip ratio	Other measurement
9663	GCST000829	Waist-hip ratio	Waist-hip ratio	Body measurement
9664	GCST000830	Body mass index	Body mass index	Body measurement
9665	GCST000830	Body mass index	Body mass index	Body measurement
9666	GCST000830	Body mass index	Body mass index	Other measurement
9667	GCST000826	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
9668	GCST000826	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
9669	GCST000761	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
9670	GCST000756	Magnesium levels	Magnesium levels	Other measurement
9671	GCST000753	Metabolic syndrome	Metabolic syndrome	Body measurement
9672	GCST000753	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
9673	GCST000753	Metabolic syndrome	Metabolic syndrome	Other measurement
9674	GCST000753	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
9675	GCST000753	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
9676	GCST000754	Personality dimensions	Personality dimensions	Other trait
9677	GCST000749	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
9678	GCST000747	Self-rated health	Self-rated health	Other trait
9679	GCST000808	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9680	GCST000808	Alzheimer's disease (late onset)	Alzheimer's disease (late onset)	Neurological disorder
9681	GCST000804	Asthma	Asthma	Other disease
9682	GCST000805	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
9683	GCST000807	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
9684	GCST000807	LDL cholesterol	LDL cholesterol	Other measurement
9685	GCST000807	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
9686	GCST000803	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
9687	GCST000800	Ovarian cancer	Ovarian cancer	Cancer
9688	GCST000801	Breast cancer	Breast cancer	Cancer
9689	GCST000802	Ovarian cancer	Ovarian cancer	Cancer
9690	GCST000799	Hypertension	Hypertension	Cardiovascular disease
9691	GCST000796	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9692	GCST000766	Non-alcoholic fatty liver disease histology (lobular)	Non-alcoholic fatty liver disease histology (lobular)	Cancer
9693	GCST000766	Non-alcoholic fatty liver disease histology (lobular)	Non-alcoholic fatty liver disease histology (lobular)	Digestive system disorder
9694	GCST000767	Non-alcoholic fatty liver disease histology (AST)	Non-alcoholic fatty liver disease histology (AST)	Cancer
9695	GCST000767	Non-alcoholic fatty liver disease histology (AST)	Non-alcoholic fatty liver disease histology (AST)	Digestive system disorder
9696	GCST000765	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Liver enzyme measurement
9697	GCST000765	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Cancer
9698	GCST000765	Non-alcoholic fatty liver disease histology (other)	Non-alcoholic fatty liver disease histology (other)	Digestive system disorder
9699	GCST000768	Asthma	Asthma	Other disease
9700	GCST000764	Tuberculosis	Tuberculosis	Other disease
9701	GCST000764	Tuberculosis	Tuberculosis	Other measurement
9702	GCST000764	Tuberculosis	Tuberculosis	Other measurement
9703	GCST000762	Meningococcal disease	Meningococcal disease	Other disease
9704	GCST000763	Immunoglobulin A	Immunoglobulin A	Other measurement
9705	GCST000827	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
9706	GCST000827	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
9707	GCST000828	Adiponectin levels	Adiponectin levels	Other measurement
9708	GCST000825	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
9709	GCST000825	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
9710	GCST000824	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Cancer
9711	GCST000824	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Other disease
9712	GCST000824	Erectile dysfunction and prostate cancer treatment	Erectile dysfunction and prostate cancer treatment	Biological process
9713	GCST000822	Antipsychotic drug-induced QTc interval prolongation	Antipsychotic drug-induced QTc interval prolongation	Response to drug
9714	GCST000822	Antipsychotic drug-induced QTc interval prolongation	Antipsychotic drug-induced QTc interval prolongation	Response to drug
9715	GCST000822	Antipsychotic drug-induced QTc interval prolongation	Antipsychotic drug-induced QTc interval prolongation	Response to drug
9716	GCST000823	Radiation response	Radiation response	Biological process
9717	GCST000820	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
9718	GCST000819	Asthma	Asthma	Other disease
9719	GCST000821	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
9720	GCST000821	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
9721	GCST000821	Bipolar disorder and schizophrenia	Bipolar disorder and schizophrenia	Neurological disorder
9722	GCST000818	Urate levels	Urate levels	Metabolic disorder
9723	GCST000818	Urate levels	Urate levels	Other measurement
9724	GCST000778	Smoking cessation	Smoking cessation	Biological process
9725	GCST000776	Esophageal cancer	Esophageal cancer	Cancer
9726	GCST000777	Esophageal cancer and gastric cancer	Esophageal cancer and gastric cancer	Cancer
9727	GCST000777	Esophageal cancer and gastric cancer	Esophageal cancer and gastric cancer	Cancer
9728	GCST000775	Central corneal thickness	Central corneal thickness	Other measurement
9729	GCST000775	Central corneal thickness	Central corneal thickness	Other measurement
9730	GCST000774	Schizophrenia, bipolar disorder and depression (combined)	Schizophrenia, bipolar disorder and depression (combined)	Neurological disorder
9731	GCST000774	Schizophrenia, bipolar disorder and depression (combined)	Schizophrenia, bipolar disorder and depression (combined)	Neurological disorder
9732	GCST000774	Schizophrenia, bipolar disorder and depression (combined)	Schizophrenia, bipolar disorder and depression (combined)	Neurological disorder
9733	GCST000772	Parkinson's disease	Parkinson's disease	Neurological disorder
9734	GCST000771	Narcolepsy	Narcolepsy	Neurological disorder
9735	GCST000773	Keloid	Keloid	Other disease
9736	GCST000770	Emphysema-related traits	Emphysema-related traits	Other disease
9737	GCST000769	Calcium levels	Calcium levels	Other measurement
9738	GCST000788	Schizophrenia	Schizophrenia	Neurological disorder
9739	GCST000787	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9740	GCST000786	Diabetic retinopathy	Diabetic retinopathy	Metabolic disorder
9741	GCST000783	Multiple sclerosis--Brain Glutamate Levels	Multiple sclerosis--Brain Glutamate Levels	Immune system disorder
9742	GCST000785	Longevity	Longevity	Other measurement
9743	GCST000784	Pseudoexfoliation syndrome	Pseudoexfoliation syndrome	Neurological disorder
9744	GCST000782	Migraine	Migraine	Cardiovascular disease
9745	GCST000780	Protein C levels	Protein C levels	Hematological measurement
9746	GCST000781	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
9747	GCST000779	Depression (quantitative trait)	Depression (quantitative trait)	Neurological disorder
9748	GCST000798	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
9749	GCST000797	Endometriosis	Endometriosis	Other disease
9750	GCST000795	Refractive error	Refractive error	Other trait
9751	GCST000794	Refractive error	Refractive error	Other trait
9752	GCST000793	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
9753	GCST000792	Warfarin maintenance dose	Warfarin maintenance dose	Response to drug
9754	GCST000791	Thyroid function	Thyroid function	Other trait
9755	GCST000790	Fuchs's corneal dystrophy	Fuchs's corneal dystrophy	Neurological disorder
9756	GCST004704	Cardiovascular risk factors	Cardiovascular risk factors	Body measurement
9757	GCST004704	Cardiovascular risk factors	Cardiovascular risk factors	Other disease
9758	GCST004704	Cardiovascular risk factors	Cardiovascular risk factors	Lipid or lipoprotein measurement
9759	GCST004704	Cardiovascular risk factors	Cardiovascular risk factors	Lipid or lipoprotein measurement
9760	GCST004704	Cardiovascular risk factors	Cardiovascular risk factors	Lipid or lipoprotein measurement
9761	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Body measurement
9762	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Other disease
9763	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Lipid or lipoprotein measurement
9764	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Lipid or lipoprotein measurement
9765	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Lipid or lipoprotein measurement
9766	GCST000789	Cardiovascular risk factors (age interaction)	Cardiovascular risk factors (age interaction)	Other measurement
9767	GCST000431	Height	Height	Other measurement
9768	GCST000431	Height	Height	Body measurement
9769	GCST000435	Schizophrenia	Schizophrenia	Neurological disorder
9770	GCST000429	Kidney stones	Kidney stones	Other disease
9771	GCST000428	Adiposity	Adiposity	Metabolic disorder
9772	GCST000427	Waist circumference	Waist circumference	Body measurement
9773	GCST000426	Obesity (extreme)	Obesity (extreme)	Metabolic disorder
9774	GCST000426	Obesity (extreme)	Obesity (extreme)	Body measurement
9775	GCST000424	Multiple sclerosis	Multiple sclerosis	Immune system disorder
9776	GCST000425	Multiple sclerosis	Multiple sclerosis	Immune system disorder
9777	GCST000423	Homocysteine levels	Homocysteine levels	Cardiovascular measurement
9778	GCST000422	Premature ovarian failure	Premature ovarian failure	Other disease
9779	GCST000461	Hippocampal atrophy	Hippocampal atrophy	Neurological disorder
9780	GCST000460	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
9781	GCST000459	Lung cancer	Lung cancer	Cancer
9782	GCST000459	Lung cancer	Lung cancer	Cancer
9783	GCST000459	Lung cancer	Lung cancer	Cancer
9784	GCST000458	Orofacial clefts	Orofacial clefts	Other trait
9785	GCST000458	Orofacial clefts	Orofacial clefts	Other measurement
9786	GCST000458	Orofacial clefts	Orofacial clefts	Other disease
9787	GCST000458	Orofacial clefts	Orofacial clefts	Other trait
9788	GCST000457	Fasting plasma glucose	Fasting plasma glucose	Other measurement
9789	GCST000455	Ovarian cancer	Ovarian cancer	Cancer
9790	GCST000456	Pancreatic cancer	Pancreatic cancer	Cancer
9791	GCST000454	Bladder cancer	Bladder cancer	Cancer
9792	GCST000452	QT interval	QT interval	Cardiovascular measurement
9793	GCST000481	Amyotrophic lateral sclerosis	Amyotrophic lateral sclerosis	Neurological disorder
9794	GCST000480	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9795	GCST000478	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
9796	GCST000479	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9797	GCST000477	Cognitive performance	Cognitive performance	Other measurement
9798	GCST000477	Cognitive performance	Cognitive performance	Other measurement
9799	GCST000476	Soluble E-selectin levels	Soluble E-selectin levels	Inflammatory measurement
9800	GCST000475	Height	Height	Other measurement
9801	GCST000475	Height	Height	Body measurement
9802	GCST000474	Leisure-time exercise behaviour	Leisure-time exercise behaviour	Biological process
9803	GCST000471	Response to antidepressant treatment	Response to antidepressant treatment	Response to drug
9804	GCST000501	Hemoglobin	Hemoglobin	Hematological measurement
9805	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
9806	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
9807	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
9808	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
9809	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
9810	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
9811	GCST000505	Iron status biomarkers	Iron status biomarkers	Other measurement
9812	GCST000496	Autism	Autism	Neurological disorder
9813	GCST000495	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
9814	GCST000495	Bone mineral density (hip)	Bone mineral density (hip)	Other measurement
9815	GCST000494	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
9816	GCST000494	Bone mineral density (spine)	Bone mineral density (spine)	Other measurement
9817	GCST000493	Sphingolipid levels	Sphingolipid levels	Other measurement
9818	GCST000493	Sphingolipid levels	Sphingolipid levels	Lipid or lipoprotein measurement
9819	GCST000492	Speech perception in dyslexia	Speech perception in dyslexia	Biological process
9820	GCST000491	Myopia (pathological)	Myopia (pathological)	Other trait
9821	GCST000490	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Neurological disorder
9822	GCST000490	Parkinson's disease (age of onset)	Parkinson's disease (age of onset)	Other measurement
9823	GCST000488	Prostate cancer	Prostate cancer	Cancer
9824	GCST000489	Prostate cancer	Prostate cancer	Cancer
9825	GCST000487	AIDS	AIDS	Immune system disorder
9826	GCST000486	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
9827	GCST000485	Response to hepatitis C treatment	Response to hepatitis C treatment	Digestive system disorder
9828	GCST000484	Alzheimer's disease	Alzheimer's disease	Neurological disorder
9829	GCST000483	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
9830	GCST000483	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
9831	GCST000483	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
9832	GCST000483	Folate pathway vitamin levels	Folate pathway vitamin levels	Cardiovascular measurement
9833	GCST000483	Folate pathway vitamin levels	Folate pathway vitamin levels	Other measurement
9834	GCST000482	Amyotrophic lateral sclerosis (SNP x SNP interaction)	Amyotrophic lateral sclerosis (SNP x SNP interaction)	Neurological disorder
9835	GCST000450	Matrix metalloproteinase levels	Matrix metalloproteinase levels	Other measurement
9836	GCST000451	RR interval (heart rate)	RR interval (heart rate)	Cardiovascular measurement
9837	GCST000449	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
9838	GCST000448	Follicular lymphoma	Follicular lymphoma	Cancer
9839	GCST000447	Hypertension	Hypertension	Cardiovascular disease
9840	GCST000445	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
9841	GCST000446	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
9842	GCST000444	QT interval	QT interval	Cardiovascular measurement
9843	GCST000442	Aortic root size	Aortic root size	Cardiovascular measurement
9844	GCST000441	Cardiac structure and function	Cardiac structure and function	Other measurement
9845	GCST000440	Glioma (high-grade)	Glioma (high-grade)	Cancer
9846	GCST000437	Melanoma	Melanoma	Cancer
9847	GCST000438	Cutaneous nevi	Cutaneous nevi	Cancer
9848	GCST000439	Glioma	Glioma	Cancer
9849	GCST000439	Glioma	Glioma	Cancer
9850	GCST000436	Acenocoumarol maintenance dosage	Acenocoumarol maintenance dosage	Response to drug
9851	GCST000434	Schizophrenia	Schizophrenia	Neurological disorder
9852	GCST000433	Schizophrenia	Schizophrenia	Neurological disorder
9853	GCST000421	Osteoarthritis	Osteoarthritis	Other disease
9854	GCST000420	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
9855	GCST000419	Abdominal aortic aneurysm	Abdominal aortic aneurysm	Cardiovascular disease
9856	GCST000418	Uric acid levels	Uric acid levels	Cardiovascular measurement
9857	GCST000417	Bipolar disorder	Bipolar disorder	Neurological disorder
9858	GCST000414	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
9859	GCST000414	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
9860	GCST000416	Testicular cancer	Testicular cancer	Cancer
9861	GCST000415	Drug-induced liver injury (flucloxacillin)	Drug-induced liver injury (flucloxacillin)	Digestive system disorder
9862	GCST000413	Nasopharyngeal carcinoma	Nasopharyngeal carcinoma	Cancer
9863	GCST000412	Male infertility	Male infertility	Other disease
9864	GCST000588	Red blood cell count	Red blood cell count	Hematological measurement
9865	GCST000589	White blood cell count	White blood cell count	Hematological measurement
9866	GCST000589	White blood cell count	White blood cell count	Inflammatory measurement
9867	GCST000589	White blood cell count	White blood cell count	Hematological measurement
9868	GCST000589	White blood cell count	White blood cell count	Hematological measurement
9869	GCST000589	White blood cell count	White blood cell count	Hematological measurement
9870	GCST000582	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
9871	GCST000582	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
9872	GCST000584	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
9873	GCST000580	Platelet count	Platelet count	Hematological measurement
9874	GCST000587	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
9875	GCST000587	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
9876	GCST000581	Urate levels	Urate levels	Metabolic disorder
9877	GCST000581	Urate levels	Urate levels	Other measurement
9878	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Other measurement
9879	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Liver enzyme measurement
9880	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Liver enzyme measurement
9881	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Cardiovascular measurement
9882	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Hematological measurement
9883	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Lipid or lipoprotein measurement
9884	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Hematological measurement
9885	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Other measurement
9886	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Other measurement
9887	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Cardiovascular measurement
9888	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Liver enzyme measurement
9889	GCST000583	Hematological and biochemical traits	Hematological and biochemical traits	Liver enzyme measurement
9890	GCST000585	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
9891	GCST004720	Conotruncal heart defects (inherited effects)	Conotruncal heart defects (inherited effects)	Cardiovascular disease
9892	GCST004719	Left ventricular obstructive tract defect (inherited effect)	Left ventricular obstructive tract defect (inherited effect)	Cardiovascular disease
9893	GCST004723	Conotruncal heart defects (maternal effects)	Conotruncal heart defects (maternal effects)	Cardiovascular disease
9894	GCST004722	Left ventricular obstructive tract defect (maternal effect)	Left ventricular obstructive tract defect (maternal effect)	Cardiovascular disease
9895	GCST004718	Congenital heart disease (inherited effect)	Congenital heart disease (inherited effect)	Cardiovascular disease
9896	GCST004721	Congenital heart disease (maternal effect)	Congenital heart disease (maternal effect)	Cardiovascular disease
9897	GCST004987	Antipsychotic drug-induced QTc interval change in schizophrenia	Antipsychotic drug-induced QTc interval change in schizophrenia	Response to drug
9898	GCST004987	Antipsychotic drug-induced QTc interval change in schizophrenia	Antipsychotic drug-induced QTc interval change in schizophrenia	Neurological disorder
9899	GCST004987	Antipsychotic drug-induced QTc interval change in schizophrenia	Antipsychotic drug-induced QTc interval change in schizophrenia	Cardiovascular measurement
9900	GCST000806	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
9901	GCST000806	Age-related macular degeneration	Age-related macular degeneration	Neurological disorder
9902	GCST002754	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Other measurement
9903	GCST002754	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Other disease
9904	GCST002754	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	Response to drug
9905	GCST005389	Tooth agenesis	Tooth agenesis	Digestive system disorder
9906	GCST005390	Tooth agenesis (mandibular second premolars)	Tooth agenesis (mandibular second premolars)	Digestive system disorder
9907	GCST005391	Tooth agenesis (maxillary lateral incisors)	Tooth agenesis (maxillary lateral incisors)	Digestive system disorder
9908	GCST005392	Tooth agenesis (maxillary second premolars)	Tooth agenesis (maxillary second premolars)	Digestive system disorder
9909	GCST004257	Systolic blood pressure (long-term average)	Systolic blood pressure (long-term average)	Other measurement
9910	GCST004258	Diastolic blood pressure (long-term average)	Diastolic blood pressure (long-term average)	Other measurement
9911	GCST004260	Pulse pressure (long-term average)	Pulse pressure (long-term average)	Cardiovascular measurement
9912	GCST004259	Mean arterial pressure (long-term average)	Mean arterial pressure (long-term average)	Other measurement
9913	GCST003934	Carotenoid levels (cryptoxanthin)	Carotenoid levels (cryptoxanthin)	Other measurement
9914	GCST003938	Carotenoid levels (alpha-carotene)	Carotenoid levels (alpha-carotene)	Other measurement
9915	GCST003935	Vitamin E levels (alpha-tocopherol)	Vitamin E levels (alpha-tocopherol)	Other measurement
9916	GCST003931	Carotenoid levels (beta-carotene)	Carotenoid levels (beta-carotene)	Other measurement
9917	GCST003932	Carotenoid levels (lutein)	Carotenoid levels (lutein)	Other measurement
9918	GCST003933	Carotenoid levels (zeaxanthin)	Carotenoid levels (zeaxanthin)	Other measurement
9919	GCST003936	Vitamin E levels (gamma-tocopherol)	Vitamin E levels (gamma-tocopherol)	Other measurement
9920	GCST003937	Retinol levels	Retinol levels	Other measurement
9921	GCST003937	Retinol levels	Retinol levels	Other measurement
9922	GCST003199	Atrophic age-related macular degeneration	Atrophic age-related macular degeneration	Neurological disorder
9923	GCST004328	Facial morphology (factor 1, breadth of lateral portion of upper face)	Facial morphology (factor 1, breadth of lateral portion of upper face)	Other measurement
9924	GCST004314	Facial morphology (factor 10, width of nasal floor)	Facial morphology (factor 10, width of nasal floor)	Other measurement
9925	GCST004307	Facial morphology (factor 3, length of philtrum)	Facial morphology (factor 3, length of philtrum)	Other measurement
9926	GCST004319	Facial morphology (factor 15, philtrum width)	Facial morphology (factor 15, philtrum width)	Other measurement
9927	GCST004320	Facial morphology (factor 16)	Facial morphology (factor 16)	Other measurement
9928	GCST004321	Facial morphology (factor 17, height of vermillion upper lip)	Facial morphology (factor 17, height of vermillion upper lip)	Other measurement
9929	GCST004322	Facial morphology (factor 18)	Facial morphology (factor 18)	Other measurement
9930	GCST004323	Facial morphology (factor 19)	Facial morphology (factor 19)	Other measurement
9931	GCST004324	Facial morphology (factor 20)	Facial morphology (factor 20)	Other measurement
9932	GCST004306	Facial morphology (factor 2, vertical position of orbits relative to midface)	Facial morphology (factor 2, vertical position of orbits relative to midface)	Other measurement
9933	GCST004308	Facial morphology (factor 4, facial height related to vertical position of gnathion)	Facial morphology (factor 4, facial height related to vertical position of gnathion)	Other measurement
9934	GCST004309	Facial morphology (factor 5, width of mouth relative to central midface)	Facial morphology (factor 5, width of mouth relative to central midface)	Other measurement
9935	GCST004310	Facial morphology (factor 6, height of vermillion lower lip)	Facial morphology (factor 6, height of vermillion lower lip)	Other measurement
9936	GCST004311	Facial morphology (factor 7, width of cartilaginous portion of nose)	Facial morphology (factor 7, width of cartilaginous portion of nose)	Other measurement
9937	GCST004312	Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)	Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)	Other measurement
9938	GCST004313	Facial morphology (factor 9, facial height related to vertical position of nasion)	Facial morphology (factor 9, facial height related to vertical position of nasion)	Other measurement
9939	GCST004315	Facial morphology (factor 11, projection of the nose)	Facial morphology (factor 11, projection of the nose)	Other measurement
9940	GCST004316	Facial morphology (factor 12, vertical position of sublabial sulcus relative to central midface)	Facial morphology (factor 12, vertical position of sublabial sulcus relative to central midface)	Other measurement
9941	GCST004317	Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)	Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)	Other measurement
9942	GCST004317	Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)	Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)	Other measurement
9943	GCST004318	Facial morphology (factor 14, intercanthal width)	Facial morphology (factor 14, intercanthal width)	Other measurement
9944	GCST004325	Facial morphology (factor 21, depth of nasal alae)	Facial morphology (factor 21, depth of nasal alae)	Other measurement
9945	GCST004326	Facial morphology (factor 22)	Facial morphology (factor 22)	Other measurement
9946	GCST004327	Facial morphology (factor 23)	Facial morphology (factor 23)	Other measurement
9947	GCST006228	Systolic blood pressure	Systolic blood pressure	Other measurement
9948	GCST006228	Systolic blood pressure	Systolic blood pressure	Other measurement
9949	GCST006231	Mean arterial pressure	Mean arterial pressure	Other measurement
9950	GCST006227	Diastolic blood pressure	Diastolic blood pressure	Other measurement
9951	GCST006227	Diastolic blood pressure	Diastolic blood pressure	Other measurement
9952	GCST006230	Pulse pressure	Pulse pressure	Cardiovascular measurement
9953	GCST006229	Hypertension	Hypertension	Cardiovascular disease
9954	GCST005341	Idiopathic inflammatory myopathy	Idiopathic inflammatory myopathy	Immune system disorder
9955	GCST005340	Polymyositis	Polymyositis	Neurological disorder
9956	GCST005339	Dermatomyositis	Dermatomyositis	Neurological disorder
9957	GCST005338	Clinically amyopathic dermatomyositis	Clinically amyopathic dermatomyositis	Neurological disorder
9958	GCST001320	Acute lymphoblastic leukemia (childhood)	Acute lymphoblastic leukemia (childhood)	Cancer
9959	GCST000082	Factor VII	Factor VII	Other measurement
9960	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
9961	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Inflammatory measurement
9962	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Other measurement
9963	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Cardiovascular measurement
9964	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
9965	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
9966	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Other measurement
9967	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
9968	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Biological process
9969	GCST000080	Hemostatic factors and hematological phenotypes	Hemostatic factors and hematological phenotypes	Hematological measurement
9970	GCST003633	middle facial morphology traits (ordinal measurement)	middle facial morphology traits (ordinal measurement)	Other measurement
9971	GCST003633	middle facial morphology traits (ordinal measurement)	middle facial morphology traits (ordinal measurement)	Other measurement
9972	GCST003634	lower facial morphology traits (ordinal measurement)	lower facial morphology traits (ordinal measurement)	Other measurement
9973	GCST003634	lower facial morphology traits (ordinal measurement)	lower facial morphology traits (ordinal measurement)	Other measurement
9974	GCST003635	middle facial morphology traits (quantitative measurement)	middle facial morphology traits (quantitative measurement)	Other measurement
9975	GCST003636	lower facial morphology traits (quantitative measurement)	lower facial morphology traits (quantitative measurement)	Other measurement
9976	GCST003636	lower facial morphology traits (quantitative measurement)	lower facial morphology traits (quantitative measurement)	Other measurement
9977	GCST003637	facial morphology traits (multivariate analysis)	facial morphology traits (multivariate analysis)	Other measurement
9978	GCST003638	upper facial morphology traits (ordinal measurement)	upper facial morphology traits (ordinal measurement)	Other measurement
9979	GCST000096	Aging traits	Aging traits	Other measurement
9980	GCST000096	Aging traits	Aging traits	Cardiovascular measurement
9981	GCST000096	Aging traits	Aging traits	Biological process
9982	GCST000096	Aging traits	Aging traits	Other measurement
9983	GCST000103	Morbidity-free survival	Morbidity-free survival	Other measurement
9984	GCST000092	Bone mineral density	Bone mineral density	Other measurement
9985	GCST000101	Hip geometry	Hip geometry	Body measurement
9986	GCST000091	Cystatin C	Cystatin C	Other measurement
9987	GCST000100	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other measurement
9988	GCST000100	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other trait
9989	GCST000105	Urinary albumin excretion	Urinary albumin excretion	Other trait
9990	GCST004999	Chickenpox	Chickenpox	Other measurement
9991	GCST005001	Shingles	Shingles	Other disease
9992	GCST005001	Shingles	Shingles	Other measurement
9993	GCST005000	Cold sores	Cold sores	Other measurement
9994	GCST005003	Mumps	Mumps	Other measurement
9995	GCST005005	Plantar warts	Plantar warts	Other measurement
9996	GCST005006	Tuberculosis	Tuberculosis	Other disease
9997	GCST005006	Tuberculosis	Tuberculosis	Other measurement
9998	GCST005006	Tuberculosis	Tuberculosis	Other measurement
9999	GCST005010	Bacterial meningitis	Bacterial meningitis	Other measurement
10000	GCST005011	Yeast infection	Yeast infection	Other measurement
10001	GCST005015	Myringotomy	Myringotomy	Other measurement
10002	GCST005016	Measles	Measles	Other measurement
10003	GCST005017	Hepatitis A	Hepatitis A	Other measurement
10004	GCST005018	Rheumatic fever	Rheumatic fever	Other measurement
10005	GCST005019	Number of common colds	Number of common colds	Other measurement
10006	GCST005021	Chronic sinus infection	Chronic sinus infection	Other measurement
10007	GCST005012	Urinary tract infection frequency	Urinary tract infection frequency	Other measurement
10008	GCST005014	Tonsillectomy	Tonsillectomy	Other measurement
10009	GCST005013	Childhood ear infection	Childhood ear infection	Other measurement
10010	GCST005020	Rubella	Rubella	Other measurement
10011	GCST005002	Mononucleosis	Mononucleosis	Other measurement
10012	GCST005004	Hepatitis B	Hepatitis B	Digestive system disorder
10013	GCST005004	Hepatitis B	Hepatitis B	Other measurement
10014	GCST005007	Strep throat	Strep throat	Other measurement
10015	GCST005008	Scarlet fever	Scarlet fever	Other measurement
10016	GCST005009	Pneumonia	Pneumonia	Other measurement
10017	GCST004481	Low-grade serous and serous borderline ovarian cancer	Low-grade serous and serous borderline ovarian cancer	Cancer
10018	GCST004416	Ovarian cancer in BRCA2 mutation carriers	Ovarian cancer in BRCA2 mutation carriers	Other measurement
10019	GCST004416	Ovarian cancer in BRCA2 mutation carriers	Ovarian cancer in BRCA2 mutation carriers	Cancer
10020	GCST004462	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
10021	GCST004462	Epithelial ovarian cancer	Epithelial ovarian cancer	Cancer
10022	GCST004417	Ovarian clear cell cancer	Ovarian clear cell cancer	Cancer
10023	GCST004418	Endometrioid ovarian cancer	Endometrioid ovarian cancer	Cancer
10024	GCST004419	Mucinous ovarian carcinoma	Mucinous ovarian carcinoma	Cancer
10025	GCST004478	Serous invasive ovarian cancer	Serous invasive ovarian cancer	Cancer
10026	GCST004479	Serous borderline ovarian cancer	Serous borderline ovarian cancer	Cancer
10027	GCST004480	High-grade serous ovarian cancer	High-grade serous ovarian cancer	Cancer
10028	GCST004461	Low-grade serous ovarian cancer	Low-grade serous ovarian cancer	Cancer
10029	GCST004414	Ovarian cancer in BRCA1 mutation carriers	Ovarian cancer in BRCA1 mutation carriers	Other measurement
10030	GCST004414	Ovarian cancer in BRCA1 mutation carriers	Ovarian cancer in BRCA1 mutation carriers	Cancer
10031	GCST004415	Invasive epithelial ovarian cancer	Invasive epithelial ovarian cancer	Cancer
10032	GCST001234	Gamma glutamyl transpeptidase	Gamma glutamyl transpeptidase	Liver enzyme measurement
10033	GCST001237	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
10034	GCST001233	Metabolite levels	Metabolite levels	Other trait
10035	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10036	GCST001233	Metabolite levels	Metabolite levels	Liver enzyme measurement
10037	GCST001233	Metabolite levels	Metabolite levels	Cardiovascular measurement
10038	GCST001233	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10039	GCST001233	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10040	GCST001233	Metabolite levels	Metabolite levels	Lipid or lipoprotein measurement
10041	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10042	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10043	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10044	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10045	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10046	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10047	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10048	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10049	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10050	GCST001233	Metabolite levels	Metabolite levels	Other measurement
10051	GCST001230	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
10052	GCST001007	Metabolic syndrome (bivariate traits)	Metabolic syndrome (bivariate traits)	Metabolic disorder
10053	GCST001003	Metabolic syndrome	Metabolic syndrome	Body measurement
10054	GCST001003	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
10055	GCST001003	Metabolic syndrome	Metabolic syndrome	Other measurement
10056	GCST001003	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
10057	GCST001003	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
10058	GCST001006	Waist Circumference - Triglycerides (WC-TG)	Waist Circumference - Triglycerides (WC-TG)	Metabolic disorder
10059	GCST001006	Waist Circumference - Triglycerides (WC-TG)	Waist Circumference - Triglycerides (WC-TG)	Lipid or lipoprotein measurement
10060	GCST001005	HDL Cholesterol - Triglycerides (HDLC-TG)	HDL Cholesterol - Triglycerides (HDLC-TG)	Lipid or lipoprotein measurement
10061	GCST001005	HDL Cholesterol - Triglycerides (HDLC-TG)	HDL Cholesterol - Triglycerides (HDLC-TG)	Lipid or lipoprotein measurement
10062	GCST001004	Triglycerides-Blood Pressure (TG-BP)	Triglycerides-Blood Pressure (TG-BP)	Other measurement
10063	GCST001004	Triglycerides-Blood Pressure (TG-BP)	Triglycerides-Blood Pressure (TG-BP)	Lipid or lipoprotein measurement
10064	GCST002949	Epilepsy and lamotrigine-induced maculopapular eruptions	Epilepsy and lamotrigine-induced maculopapular eruptions	Response to drug
10065	GCST002949	Epilepsy and lamotrigine-induced maculopapular eruptions	Epilepsy and lamotrigine-induced maculopapular eruptions	Other disease
10066	GCST002949	Epilepsy and lamotrigine-induced maculopapular eruptions	Epilepsy and lamotrigine-induced maculopapular eruptions	Neurological disorder
10067	GCST002950	Epilepsy	Epilepsy	Neurological disorder
10068	GCST002950	Epilepsy	Epilepsy	Neurological disorder
10069	GCST002950	Epilepsy	Epilepsy	Neurological disorder
10070	GCST001666	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
10071	GCST001231	Carotid intima media thickness	Carotid intima media thickness	Other measurement
10072	GCST001231	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular measurement
10073	GCST001231	Carotid intima media thickness	Carotid intima media thickness	Cardiovascular disease
10074	GCST001668	Pain	Pain	Other trait
10075	GCST001123	Body mass index	Body mass index	Body measurement
10076	GCST001123	Body mass index	Body mass index	Body measurement
10077	GCST001123	Body mass index	Body mass index	Other measurement
10078	GCST004946	Schizophrenia	Schizophrenia	Neurological disorder
10079	GCST004950	Breast cancer	Breast cancer	Cancer
10080	GCST007236	Breast cancer	Breast cancer	Cancer
10081	GCST004573	Iron status biomarkers (ferritin levels)	Iron status biomarkers (ferritin levels)	Other measurement
10082	GCST004573	Iron status biomarkers (ferritin levels)	Iron status biomarkers (ferritin levels)	Other measurement
10083	GCST004570	Iron status biomarkers (iron levels)	Iron status biomarkers (iron levels)	Other measurement
10084	GCST004570	Iron status biomarkers (iron levels)	Iron status biomarkers (iron levels)	Other measurement
10085	GCST004571	Iron status biomarkers (total iron binding capacity)	Iron status biomarkers (total iron binding capacity)	Other measurement
10086	GCST004572	Iron status biomarkers (transferrin saturation)	Iron status biomarkers (transferrin saturation)	Other measurement
10087	GCST004572	Iron status biomarkers (transferrin saturation)	Iron status biomarkers (transferrin saturation)	Other measurement
10088	GCST004078	Drug-induced liver injury (terbinafine)	Drug-induced liver injury (terbinafine)	Digestive system disorder
10089	GCST004078	Drug-induced liver injury (terbinafine)	Drug-induced liver injury (terbinafine)	Response to drug
10090	GCST004079	Drug-induced hepatocellular liver injury	Drug-induced hepatocellular liver injury	Digestive system disorder
10091	GCST004080	Drug-induced liver injury (statins)	Drug-induced liver injury (statins)	Digestive system disorder
10092	GCST004080	Drug-induced liver injury (statins)	Drug-induced liver injury (statins)	Response to drug
10093	GCST004081	Drug-induced cholestatic/mixed liver injury	Drug-induced cholestatic/mixed liver injury	Digestive system disorder
10094	GCST004082	Drug-induced liver injury (nitrofurantoin)	Drug-induced liver injury (nitrofurantoin)	Digestive system disorder
10095	GCST004082	Drug-induced liver injury (nitrofurantoin)	Drug-induced liver injury (nitrofurantoin)	Response to drug
10096	GCST004083	Drug-induced liver injury (diclofenac)	Drug-induced liver injury (diclofenac)	Digestive system disorder
10097	GCST004083	Drug-induced liver injury (diclofenac)	Drug-induced liver injury (diclofenac)	Response to drug
10098	GCST004084	Drug-induced liver injury (anti-tuberculosis drugs)	Drug-induced liver injury (anti-tuberculosis drugs)	Digestive system disorder
10099	GCST004084	Drug-induced liver injury (anti-tuberculosis drugs)	Drug-induced liver injury (anti-tuberculosis drugs)	Response to drug
10100	GCST004085	Drug-induced liver injury (fluoroquinolones)	Drug-induced liver injury (fluoroquinolones)	Digestive system disorder
10101	GCST004085	Drug-induced liver injury (fluoroquinolones)	Drug-induced liver injury (fluoroquinolones)	Response to drug
10102	GCST004087	Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	Digestive system disorder
10103	GCST004087	Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	Response to drug
10104	GCST004086	Drug-induced liver injury	Drug-induced liver injury	Response to drug
10105	GCST004086	Drug-induced liver injury	Drug-induced liver injury	Digestive system disorder
10106	GCST004032	JT interval (sulfonylurea treatment interaction)	JT interval (sulfonylurea treatment interaction)	Response to drug
10107	GCST004032	JT interval (sulfonylurea treatment interaction)	JT interval (sulfonylurea treatment interaction)	Cardiovascular measurement
10108	GCST004031	QT interval (sulfonylurea treatment interaction)	QT interval (sulfonylurea treatment interaction)	Cardiovascular measurement
10109	GCST004031	QT interval (sulfonylurea treatment interaction)	QT interval (sulfonylurea treatment interaction)	Response to drug
10110	GCST004033	QRS interval (sulfonylurea treatment interaction)	QRS interval (sulfonylurea treatment interaction)	Cardiovascular measurement
10111	GCST004033	QRS interval (sulfonylurea treatment interaction)	QRS interval (sulfonylurea treatment interaction)	Response to drug
10112	GCST002571	Body mass index	Body mass index	Body measurement
10113	GCST002571	Body mass index	Body mass index	Body measurement
10114	GCST002571	Body mass index	Body mass index	Other measurement
10115	GCST002575	Body mass index (change over time)	Body mass index (change over time)	Body measurement
10116	GCST002573	Height	Height	Other measurement
10117	GCST002573	Height	Height	Body measurement
10118	GCST002569	Underweight status	Underweight status	Body measurement
10119	GCST002570	Overweight status	Overweight status	Body measurement
10120	GCST005134	Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	Response to drug
10121	GCST005134	Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	Cardiovascular measurement
10122	GCST005135	Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	Response to drug
10123	GCST005135	Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	Cardiovascular measurement
10124	GCST005140	Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	Response to drug
10125	GCST005140	Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	Cardiovascular measurement
10126	GCST005136	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Response to drug
10127	GCST005136	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Cardiovascular measurement
10128	GCST005136	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Cardiovascular measurement
10129	GCST005136	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	Cardiovascular measurement
10130	GCST005138	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Response to drug
10131	GCST005138	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Cardiovascular measurement
10132	GCST005138	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Cardiovascular measurement
10133	GCST005138	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	Cardiovascular measurement
10134	GCST005139	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Response to drug
10135	GCST005139	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Cardiovascular measurement
10136	GCST005139	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Cardiovascular measurement
10137	GCST005139	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	Cardiovascular measurement
10138	GCST005137	Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	Response to drug
10139	GCST005137	Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	Cardiovascular measurement
10140	GCST003449	Erythrocyte cadmium concentration	Erythrocyte cadmium concentration	Other measurement
10141	GCST003448	Erythrocyte cadmium concentration in never smokers	Erythrocyte cadmium concentration in never smokers	Other measurement
10142	GCST000848	Recombination measurement (females)	Recombination measurement (females)	Other measurement
10143	GCST000845	Recombination measurement (males)	Recombination measurement (males)	Other measurement
10144	GCST004576	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
10145	GCST004576	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
10146	GCST004561	Waist circumference adjusted for BMI (physical activity interaction)	Waist circumference adjusted for BMI (physical activity interaction)	Body measurement
10147	GCST004561	Waist circumference adjusted for BMI (physical activity interaction)	Waist circumference adjusted for BMI (physical activity interaction)	Other measurement
10148	GCST004565	Waist circumference adjusted for BMI in inactive individuals	Waist circumference adjusted for BMI in inactive individuals	Body measurement
10149	GCST004565	Waist circumference adjusted for BMI in inactive individuals	Waist circumference adjusted for BMI in inactive individuals	Other measurement
10150	GCST004558	Body mass index (joint analysis main effects and physical activity interaction)	Body mass index (joint analysis main effects and physical activity interaction)	Body measurement
10151	GCST004558	Body mass index (joint analysis main effects and physical activity interaction)	Body mass index (joint analysis main effects and physical activity interaction)	Other measurement
10152	GCST004567	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	Body measurement
10153	GCST004567	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	Other measurement
10154	GCST004557	Body mass index	Body mass index	Body measurement
10155	GCST004557	Body mass index	Body mass index	Body measurement
10156	GCST004557	Body mass index	Body mass index	Other measurement
10157	GCST004562	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Body measurement
10158	GCST004562	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Other measurement
10159	GCST004566	Waist-to-hip ratio adjusted for BMI (physical activity interaction)	Waist-to-hip ratio adjusted for BMI (physical activity interaction)	Body measurement
10160	GCST004566	Waist-to-hip ratio adjusted for BMI (physical activity interaction)	Waist-to-hip ratio adjusted for BMI (physical activity interaction)	Other measurement
10161	GCST004568	Body mass index (physical activity interaction)	Body mass index (physical activity interaction)	Body measurement
10162	GCST004568	Body mass index (physical activity interaction)	Body mass index (physical activity interaction)	Other measurement
10163	GCST004568	Body mass index (physical activity interaction)	Body mass index (physical activity interaction)	Biological process
10164	GCST004563	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	Body measurement
10165	GCST004563	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	Other measurement
10166	GCST004559	Body mass index in physically active individuals	Body mass index in physically active individuals	Body measurement
10167	GCST004559	Body mass index in physically active individuals	Body mass index in physically active individuals	Other measurement
10168	GCST004560	Body mass index in physically inactive individuals	Body mass index in physically inactive individuals	Body measurement
10169	GCST004560	Body mass index in physically inactive individuals	Body mass index in physically inactive individuals	Other measurement
10170	GCST004564	Waist circumference adjusted for BMI in active individuals	Waist circumference adjusted for BMI in active individuals	Body measurement
10171	GCST004564	Waist circumference adjusted for BMI in active individuals	Waist circumference adjusted for BMI in active individuals	Other measurement
10172	GCST004578	Waist-to-hip ratio adjusted for BMI in active individuals	Waist-to-hip ratio adjusted for BMI in active individuals	Body measurement
10173	GCST004578	Waist-to-hip ratio adjusted for BMI in active individuals	Waist-to-hip ratio adjusted for BMI in active individuals	Other measurement
10174	GCST004577	Waist-to-hip ratio adjusted for BMI in inactive individuals	Waist-to-hip ratio adjusted for BMI in inactive individuals	Body measurement
10175	GCST004577	Waist-to-hip ratio adjusted for BMI in inactive individuals	Waist-to-hip ratio adjusted for BMI in inactive individuals	Other measurement
10176	GCST005442	Apolipoprotein B levels	Apolipoprotein B levels	Lipid or lipoprotein measurement
10177	GCST005443	Ratio of apolipoprotein A1 to apolipoprotein B	Ratio of apolipoprotein A1 to apolipoprotein B	Lipid or lipoprotein measurement
10178	GCST005443	Ratio of apolipoprotein A1 to apolipoprotein B	Ratio of apolipoprotein A1 to apolipoprotein B	Lipid or lipoprotein measurement
10179	GCST005444	Esterified cholesterol levels	Esterified cholesterol levels	Lipid or lipoprotein measurement
10180	GCST005445	Free cholesterol levels	Free cholesterol levels	Lipid or lipoprotein measurement
10181	GCST005446	Total cholesterol levels in HDL	Total cholesterol levels in HDL	Lipid or lipoprotein measurement
10182	GCST005447	Total cholesterol levels in LDL	Total cholesterol levels in LDL	Lipid or lipoprotein measurement
10183	GCST005448	Serum total cholesterol levels	Serum total cholesterol levels	Lipid or lipoprotein measurement
10184	GCST005449	Total triglycerides levels	Total triglycerides levels	Lipid or lipoprotein measurement
10185	GCST005455	Mean diameter of HDL particles	Mean diameter of HDL particles	Lipid or lipoprotein measurement
10186	GCST005456	Mean diameter of LDL particles	Mean diameter of LDL particles	Lipid or lipoprotein measurement
10187	GCST005457	Mean diameter of VLDL particles	Mean diameter of VLDL particles	Lipid or lipoprotein measurement
10188	GCST005450	Very large VLDL particle concentration	Very large VLDL particle concentration	Lipid or lipoprotein measurement
10189	GCST005451	Phospholipid levels in very large VLDL	Phospholipid levels in very large VLDL	Lipid or lipoprotein measurement
10190	GCST005451	Phospholipid levels in very large VLDL	Phospholipid levels in very large VLDL	Lipid or lipoprotein measurement
10191	GCST005452	Triglyceride levels in very large VLDL	Triglyceride levels in very large VLDL	Lipid or lipoprotein measurement
10192	GCST005452	Triglyceride levels in very large VLDL	Triglyceride levels in very large VLDL	Lipid or lipoprotein measurement
10193	GCST005453	Very large VLDL particle concentration	Very large VLDL particle concentration	Lipid or lipoprotein measurement
10194	GCST005454	Phospholipid levels in large VLDL	Phospholipid levels in large VLDL	Lipid or lipoprotein measurement
10195	GCST005454	Phospholipid levels in large VLDL	Phospholipid levels in large VLDL	Lipid or lipoprotein measurement
10196	GCST005458	Total cholesterol levels in large VLDL	Total cholesterol levels in large VLDL	Lipid or lipoprotein measurement
10197	GCST005459	Free cholesterol levels in large VLDL	Free cholesterol levels in large VLDL	Lipid or lipoprotein measurement
10198	GCST005459	Free cholesterol levels in large VLDL	Free cholesterol levels in large VLDL	Lipid or lipoprotein measurement
10199	GCST005460	Triglyceride levels in large VLDL	Triglyceride levels in large VLDL	Lipid or lipoprotein measurement
10200	GCST005460	Triglyceride levels in large VLDL	Triglyceride levels in large VLDL	Lipid or lipoprotein measurement
10201	GCST005461	Cholesterol ester levels in large VLDL	Cholesterol ester levels in large VLDL	Lipid or lipoprotein measurement
10202	GCST005461	Cholesterol ester levels in large VLDL	Cholesterol ester levels in large VLDL	Lipid or lipoprotein measurement
10203	GCST005462	Medium VLDL particle concentration	Medium VLDL particle concentration	Lipid or lipoprotein measurement
10204	GCST005463	Phospholipid levels in medium VLDL	Phospholipid levels in medium VLDL	Lipid or lipoprotein measurement
10205	GCST005463	Phospholipid levels in medium VLDL	Phospholipid levels in medium VLDL	Lipid or lipoprotein measurement
10206	GCST005464	Total cholesterol levels in medium VLDL	Total cholesterol levels in medium VLDL	Lipid or lipoprotein measurement
10207	GCST005465	Cholesterol ester levels in medium VLDL	Cholesterol ester levels in medium VLDL	Lipid or lipoprotein measurement
10208	GCST005465	Cholesterol ester levels in medium VLDL	Cholesterol ester levels in medium VLDL	Lipid or lipoprotein measurement
10209	GCST005466	Free cholesterol levels in medium VLDL	Free cholesterol levels in medium VLDL	Lipid or lipoprotein measurement
10210	GCST005466	Free cholesterol levels in medium VLDL	Free cholesterol levels in medium VLDL	Lipid or lipoprotein measurement
10211	GCST005467	Triglyceride levels in medium VLDL	Triglyceride levels in medium VLDL	Lipid or lipoprotein measurement
10212	GCST005467	Triglyceride levels in medium VLDL	Triglyceride levels in medium VLDL	Lipid or lipoprotein measurement
10213	GCST005468	Small VLDL particle concentration	Small VLDL particle concentration	Lipid or lipoprotein measurement
10214	GCST005469	Phospholipid levels in small VLDL	Phospholipid levels in small VLDL	Lipid or lipoprotein measurement
10215	GCST005469	Phospholipid levels in small VLDL	Phospholipid levels in small VLDL	Lipid or lipoprotein measurement
10216	GCST005470	Total cholesterol levels in small VLDL	Total cholesterol levels in small VLDL	Lipid or lipoprotein measurement
10217	GCST005471	Free cholesterol levels in small VLDL	Free cholesterol levels in small VLDL	Lipid or lipoprotein measurement
10218	GCST005471	Free cholesterol levels in small VLDL	Free cholesterol levels in small VLDL	Lipid or lipoprotein measurement
10219	GCST005472	Triglyceride levels in small VLDL	Triglyceride levels in small VLDL	Lipid or lipoprotein measurement
10220	GCST005472	Triglyceride levels in small VLDL	Triglyceride levels in small VLDL	Lipid or lipoprotein measurement
10221	GCST005473	Very small VLDL particle concentration	Very small VLDL particle concentration	Lipid or lipoprotein measurement
10222	GCST005474	Phospholipid levels in very small VLDL	Phospholipid levels in very small VLDL	Lipid or lipoprotein measurement
10223	GCST005474	Phospholipid levels in very small VLDL	Phospholipid levels in very small VLDL	Lipid or lipoprotein measurement
10224	GCST005475	Triglyceride levels in very small VLDL	Triglyceride levels in very small VLDL	Lipid or lipoprotein measurement
10225	GCST005475	Triglyceride levels in very small VLDL	Triglyceride levels in very small VLDL	Lipid or lipoprotein measurement
10226	GCST005476	IDL particle concentration	IDL particle concentration	Lipid or lipoprotein measurement
10227	GCST005477	Phospholipid levels in IDL	Phospholipid levels in IDL	Lipid or lipoprotein measurement
10228	GCST005477	Phospholipid levels in IDL	Phospholipid levels in IDL	Lipid or lipoprotein measurement
10229	GCST005478	IDL particle concentration	IDL particle concentration	Lipid or lipoprotein measurement
10230	GCST005479	Free cholesterol levels in IDL	Free cholesterol levels in IDL	Lipid or lipoprotein measurement
10231	GCST005479	Free cholesterol levels in IDL	Free cholesterol levels in IDL	Lipid or lipoprotein measurement
10232	GCST005480	Triglyceride levels in IDL	Triglyceride levels in IDL	Lipid or lipoprotein measurement
10233	GCST005480	Triglyceride levels in IDL	Triglyceride levels in IDL	Lipid or lipoprotein measurement
10234	GCST005481	Large LDL particle concentration	Large LDL particle concentration	Lipid or lipoprotein measurement
10235	GCST005482	Phospholipid levels in large LDL	Phospholipid levels in large LDL	Lipid or lipoprotein measurement
10236	GCST005482	Phospholipid levels in large LDL	Phospholipid levels in large LDL	Lipid or lipoprotein measurement
10237	GCST005483	Total cholesterol levels in large LDL	Total cholesterol levels in large LDL	Lipid or lipoprotein measurement
10238	GCST005484	Cholesterol ester levels in large LDL	Cholesterol ester levels in large LDL	Lipid or lipoprotein measurement
10239	GCST005484	Cholesterol ester levels in large LDL	Cholesterol ester levels in large LDL	Lipid or lipoprotein measurement
10240	GCST005485	Free cholesterol levels in large LDL	Free cholesterol levels in large LDL	Lipid or lipoprotein measurement
10241	GCST005485	Free cholesterol levels in large LDL	Free cholesterol levels in large LDL	Lipid or lipoprotein measurement
10242	GCST005486	Medium LDL particle concentration	Medium LDL particle concentration	Lipid or lipoprotein measurement
10243	GCST005487	Phospholipid levels in medium LDL	Phospholipid levels in medium LDL	Lipid or lipoprotein measurement
10244	GCST005487	Phospholipid levels in medium LDL	Phospholipid levels in medium LDL	Lipid or lipoprotein measurement
10245	GCST005488	Total cholesterol levels in medium LDL	Total cholesterol levels in medium LDL	Lipid or lipoprotein measurement
10246	GCST005489	Cholesterol ester levels in medium LDL	Cholesterol ester levels in medium LDL	Lipid or lipoprotein measurement
10247	GCST005489	Cholesterol ester levels in medium LDL	Cholesterol ester levels in medium LDL	Lipid or lipoprotein measurement
10248	GCST005490	Small LDL particle concentration	Small LDL particle concentration	Lipid or lipoprotein measurement
10249	GCST005491	Total cholesterol levels in small LDL	Total cholesterol levels in small LDL	Lipid or lipoprotein measurement
10250	GCST005492	Very large HDL particle concentration	Very large HDL particle concentration	Lipid or lipoprotein measurement
10251	GCST005493	Phospholipid levels in very large HDL	Phospholipid levels in very large HDL	Lipid or lipoprotein measurement
10252	GCST005493	Phospholipid levels in very large HDL	Phospholipid levels in very large HDL	Lipid or lipoprotein measurement
10253	GCST005494	Total cholesterol levels in very large HDL	Total cholesterol levels in very large HDL	Lipid or lipoprotein measurement
10254	GCST005495	Cholesterol ester levels in very large HDL	Cholesterol ester levels in very large HDL	Lipid or lipoprotein measurement
10255	GCST005495	Cholesterol ester levels in very large HDL	Cholesterol ester levels in very large HDL	Lipid or lipoprotein measurement
10256	GCST005496	Free cholesterol levels in very large HDL	Free cholesterol levels in very large HDL	Lipid or lipoprotein measurement
10257	GCST005496	Free cholesterol levels in very large HDL	Free cholesterol levels in very large HDL	Lipid or lipoprotein measurement
10258	GCST005498	Triglyceride levels in very large HDL	Triglyceride levels in very large HDL	Lipid or lipoprotein measurement
10259	GCST005498	Triglyceride levels in very large HDL	Triglyceride levels in very large HDL	Lipid or lipoprotein measurement
10260	GCST005497	Large HDL particle concentration	Large HDL particle concentration	Lipid or lipoprotein measurement
10261	GCST005499	Phospholipid levels in large HDL	Phospholipid levels in large HDL	Lipid or lipoprotein measurement
10262	GCST005499	Phospholipid levels in large HDL	Phospholipid levels in large HDL	Lipid or lipoprotein measurement
10263	GCST005500	Total cholesterol levels in large HDL	Total cholesterol levels in large HDL	Lipid or lipoprotein measurement
10264	GCST005501	Cholesterol ester levels in very large HDL	Cholesterol ester levels in very large HDL	Lipid or lipoprotein measurement
10265	GCST005501	Cholesterol ester levels in very large HDL	Cholesterol ester levels in very large HDL	Lipid or lipoprotein measurement
10266	GCST005502	Free cholesterol levels in large HDL	Free cholesterol levels in large HDL	Lipid or lipoprotein measurement
10267	GCST005502	Free cholesterol levels in large HDL	Free cholesterol levels in large HDL	Lipid or lipoprotein measurement
10268	GCST005503	Medium HDL particle concentration	Medium HDL particle concentration	Lipid or lipoprotein measurement
10269	GCST005504	Phospholipid levels in medium HDL	Phospholipid levels in medium HDL	Lipid or lipoprotein measurement
10270	GCST005504	Phospholipid levels in medium HDL	Phospholipid levels in medium HDL	Lipid or lipoprotein measurement
10271	GCST005505	Total cholesterol levels in medium HDL	Total cholesterol levels in medium HDL	Lipid or lipoprotein measurement
10272	GCST005506	Cholesterol ester levels in medium HDL	Cholesterol ester levels in medium HDL	Lipid or lipoprotein measurement
10273	GCST005506	Cholesterol ester levels in medium HDL	Cholesterol ester levels in medium HDL	Lipid or lipoprotein measurement
10274	GCST005507	Free cholesterol levels in medium HDL	Free cholesterol levels in medium HDL	Lipid or lipoprotein measurement
10275	GCST005508	Small HDL particle concentration	Small HDL particle concentration	Lipid or lipoprotein measurement
10276	GCST005509	Triglyceride levels in small HDL	Triglyceride levels in small HDL	Lipid or lipoprotein measurement
10277	GCST005509	Triglyceride levels in small HDL	Triglyceride levels in small HDL	Lipid or lipoprotein measurement
10278	GCST005510	Chylomicron and largest VLDL particle concentration	Chylomicron and largest VLDL particle concentration	Lipid or lipoprotein measurement
10279	GCST005510	Chylomicron and largest VLDL particle concentration	Chylomicron and largest VLDL particle concentration	Lipid or lipoprotein measurement
10280	GCST005511	Phospholipid levels in chylomicrons and largest VLDL	Phospholipid levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
10281	GCST005511	Phospholipid levels in chylomicrons and largest VLDL	Phospholipid levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
10282	GCST005511	Phospholipid levels in chylomicrons and largest VLDL	Phospholipid levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
10283	GCST005512	Triglyceride levels in chylomicrons and largest VLDL	Triglyceride levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
10284	GCST005512	Triglyceride levels in chylomicrons and largest VLDL	Triglyceride levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
10285	GCST005512	Triglyceride levels in chylomicrons and largest VLDL	Triglyceride levels in chylomicrons and largest VLDL	Lipid or lipoprotein measurement
10286	GCST005513	Apolipoprotein A1 levels	Apolipoprotein A1 levels	Lipid or lipoprotein measurement
10287	GCST005158	Overall survival in osteosarcoma	Overall survival in osteosarcoma	Cancer
10288	GCST005158	Overall survival in osteosarcoma	Overall survival in osteosarcoma	Other measurement
10289	GCST003010	Gastric cancer	Gastric cancer	Cancer
10290	GCST003009	Cardia gastric cancer	Cardia gastric cancer	Cancer
10291	GCST003007	Non-cardia gastric cancer	Non-cardia gastric cancer	Cancer
10292	GCST006112	Diastolic blood pressure x sodium interaction (1df test)	Diastolic blood pressure x sodium interaction (1df test)	Other measurement
10293	GCST006112	Diastolic blood pressure x sodium interaction (1df test)	Diastolic blood pressure x sodium interaction (1df test)	Other measurement
10294	GCST006113	Systolic blood pressure x sodium interaction (2df test)	Systolic blood pressure x sodium interaction (2df test)	Other measurement
10295	GCST006113	Systolic blood pressure x sodium interaction (2df test)	Systolic blood pressure x sodium interaction (2df test)	Other measurement
10296	GCST006111	Diastolic blood pressure x sodium interaction (2df test)	Diastolic blood pressure x sodium interaction (2df test)	Other measurement
10297	GCST006111	Diastolic blood pressure x sodium interaction (2df test)	Diastolic blood pressure x sodium interaction (2df test)	Other measurement
10298	GCST006114	Mean arterial pressure x sodium interaction (2df test)	Mean arterial pressure x sodium interaction (2df test)	Other measurement
10299	GCST006114	Mean arterial pressure x sodium interaction (2df test)	Mean arterial pressure x sodium interaction (2df test)	Other measurement
10300	GCST006115	Systolic blood pressure x sodium interaction (1df test)	Systolic blood pressure x sodium interaction (1df test)	Other measurement
10301	GCST006115	Systolic blood pressure x sodium interaction (1df test)	Systolic blood pressure x sodium interaction (1df test)	Other measurement
10302	GCST006116	Mean arterial pressure x sodium interaction (1df test)	Mean arterial pressure x sodium interaction (1df test)	Other measurement
10303	GCST006116	Mean arterial pressure x sodium interaction (1df test)	Mean arterial pressure x sodium interaction (1df test)	Other measurement
10304	GCST006117	Pulse pressure x sodium interaction (1df test)	Pulse pressure x sodium interaction (1df test)	Other measurement
10305	GCST006117	Pulse pressure x sodium interaction (1df test)	Pulse pressure x sodium interaction (1df test)	Cardiovascular measurement
10306	GCST006118	Pulse pressure x sodium interaction (2df test)	Pulse pressure x sodium interaction (2df test)	Other measurement
10307	GCST006118	Pulse pressure x sodium interaction (2df test)	Pulse pressure x sodium interaction (2df test)	Cardiovascular measurement
10308	GCST003484	Periodontal disease-related phenotype (Socransky)	Periodontal disease-related phenotype (Socransky)	Other measurement
10309	GCST003484	Periodontal disease-related phenotype (Socransky)	Periodontal disease-related phenotype (Socransky)	Digestive system disorder
10310	GCST008439	Periodontal disease related phenotype (PCT2)	Periodontal disease related phenotype (PCT2)	Other measurement
10311	GCST008440	Periodontal disease related phenotype (PCT3)	Periodontal disease related phenotype (PCT3)	Other measurement
10312	GCST008441	Periodontal disease related phenotype (PCT4)	Periodontal disease related phenotype (PCT4)	Other measurement
10313	GCST008442	Periodontal disease related phenotype (PCT5)	Periodontal disease related phenotype (PCT5)	Other measurement
10314	GCST008443	Periodontal disease related phenotype (PCT6)	Periodontal disease related phenotype (PCT6)	Other measurement
10315	GCST003248	Body mass index	Body mass index	Body measurement
10316	GCST003248	Body mass index	Body mass index	Body measurement
10317	GCST003248	Body mass index	Body mass index	Other measurement
10318	GCST003249	Basal metabolic rate	Basal metabolic rate	Other measurement
10319	GCST002870	LDL cholesterol subfractions	LDL cholesterol subfractions	Lipid or lipoprotein measurement
10320	GCST002865	Response to statin therapy (LDL cholesterol subfractions)	Response to statin therapy (LDL cholesterol subfractions)	Lipid or lipoprotein measurement
10321	GCST002865	Response to statin therapy (LDL cholesterol subfractions)	Response to statin therapy (LDL cholesterol subfractions)	Response to drug
10322	GCST000453	Response to interferon beta therapy	Response to interferon beta therapy	Response to drug
10323	GCST003984	Parkinson's disease	Parkinson's disease	Neurological disorder
10324	GCST003985	Breast size	Breast size	Body measurement
10325	GCST003986	Migraine	Migraine	Cardiovascular disease
10326	GCST003987	Asthma	Asthma	Other disease
10327	GCST003989	Chin dimples	Chin dimples	Other measurement
10328	GCST003990	Allergy	Allergy	Immune system disorder
10329	GCST003991	Childhood ear infection	Childhood ear infection	Other measurement
10330	GCST003992	Photic sneeze reflex	Photic sneeze reflex	Other trait
10331	GCST003993	Menarche (age at onset)	Menarche (age at onset)	Other measurement
10332	GCST003994	Age at voice drop	Age at voice drop	Other measurement
10333	GCST003995	Tonsillectomy	Tonsillectomy	Other measurement
10334	GCST003996	Monobrow	Monobrow	Other measurement
10335	GCST003997	Myopia	Myopia	Other trait
10336	GCST003998	Joint mobility (Beighton score)	Joint mobility (Beighton score)	Other measurement
10337	GCST003999	Nose size	Nose size	Other measurement
10338	GCST003983	Male-pattern baldness	Male-pattern baldness	Other measurement
10339	GCST003983	Male-pattern baldness	Male-pattern baldness	Other disease
10340	GCST003983	Male-pattern baldness	Male-pattern baldness	Other disease
10341	GCST003988	Hypothyroidism	Hypothyroidism	Other disease
10342	GCST007094	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10343	GCST007094	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10344	GCST007096	Pulse pressure	Pulse pressure	Cardiovascular measurement
10345	GCST007099	Systolic blood pressure	Systolic blood pressure	Other measurement
10346	GCST007099	Systolic blood pressure	Systolic blood pressure	Other measurement
10347	GCST007098	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10348	GCST007098	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10349	GCST007097	Pulse pressure	Pulse pressure	Cardiovascular measurement
10350	GCST007095	Systolic blood pressure	Systolic blood pressure	Other measurement
10351	GCST007095	Systolic blood pressure	Systolic blood pressure	Other measurement
10352	GCST004004	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
10353	GCST004005	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10354	GCST004005	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10355	GCST004005	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10356	GCST004005	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10357	GCST004007	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
10358	GCST004007	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
10359	GCST004008	Red blood cell count	Red blood cell count	Hematological measurement
10360	GCST004006	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
10361	GCST004006	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
10362	GCST004003	Hematocrit	Hematocrit	Hematological measurement
10363	GCST004533	Fasting blood insulin	Fasting blood insulin	Other measurement
10364	GCST004530	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
10365	GCST004531	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10366	GCST004531	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10367	GCST004532	Fasting blood glucose	Fasting blood glucose	Other measurement
10368	GCST004762	Fasting blood insulin adjusted for BMI	Fasting blood insulin adjusted for BMI	Other measurement
10369	GCST004762	Fasting blood insulin adjusted for BMI	Fasting blood insulin adjusted for BMI	Other measurement
10370	GCST004534	Height	Height	Other measurement
10371	GCST004534	Height	Height	Body measurement
10372	GCST004543	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
10373	GCST004543	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
10374	GCST004544	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
10375	GCST004535	Hematocrit	Hematocrit	Hematological measurement
10376	GCST004759	Very low density lipoprotein cholesterol levels	Very low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
10377	GCST004551	Waist circumference	Waist circumference	Body measurement
10378	GCST004552	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Body measurement
10379	GCST004552	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Other measurement
10380	GCST004554	Weight	Weight	Body measurement
10381	GCST004555	Waist-hip ratio	Waist-hip ratio	Other measurement
10382	GCST004555	Waist-hip ratio	Waist-hip ratio	Body measurement
10383	GCST004556	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
10384	GCST004556	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
10385	GCST004536	Hemoglobin	Hemoglobin	Hematological measurement
10386	GCST004539	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other measurement
10387	GCST004539	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other trait
10388	GCST004540	Homeostasis model assessment of insulin resistance adjusted for BMI	Homeostasis model assessment of insulin resistance adjusted for BMI	Other measurement
10389	GCST004541	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
10390	GCST004542	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
10391	GCST004542	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
10392	GCST004545	Platelet count	Platelet count	Hematological measurement
10393	GCST004546	Red blood cell count	Red blood cell count	Hematological measurement
10394	GCST004547	Systolic blood pressure	Systolic blood pressure	Other measurement
10395	GCST004547	Systolic blood pressure	Systolic blood pressure	Other measurement
10396	GCST004548	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
10397	GCST004550	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
10398	GCST004553	White blood cell count	White blood cell count	Hematological measurement
10399	GCST004553	White blood cell count	White blood cell count	Inflammatory measurement
10400	GCST004553	White blood cell count	White blood cell count	Hematological measurement
10401	GCST004553	White blood cell count	White blood cell count	Hematological measurement
10402	GCST004553	White blood cell count	White blood cell count	Hematological measurement
10403	GCST004529	Body mass index	Body mass index	Body measurement
10404	GCST004529	Body mass index	Body mass index	Body measurement
10405	GCST004529	Body mass index	Body mass index	Other measurement
10406	GCST004537	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
10407	GCST004538	Hip bone size	Hip bone size	Body measurement
10408	GCST004760	Hip bone size adjusted for BMI	Hip bone size adjusted for BMI	Body measurement
10409	GCST004761	Fasting blood glucose adjusted for BMI	Fasting blood glucose adjusted for BMI	Other measurement
10410	GCST004761	Fasting blood glucose adjusted for BMI	Fasting blood glucose adjusted for BMI	Other measurement
10411	GCST005361	Attention deficit hyperactivity disorder (sex interaction)	Attention deficit hyperactivity disorder (sex interaction)	Neurological disorder
10412	GCST005361	Attention deficit hyperactivity disorder (sex interaction)	Attention deficit hyperactivity disorder (sex interaction)	Other measurement
10413	GCST005363	Sex difference in attention deficit hyperactivity disorder	Sex difference in attention deficit hyperactivity disorder	Neurological disorder
10414	GCST005363	Sex difference in attention deficit hyperactivity disorder	Sex difference in attention deficit hyperactivity disorder	Other trait
10415	GCST005362	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
10416	GCST004883	Neuroblastoma (11q deletion)	Neuroblastoma (11q deletion)	Cancer
10417	GCST004882	Neuroblastoma (11q deletion vs 11q undeleted and MYCN amplification)	Neuroblastoma (11q deletion vs 11q undeleted and MYCN amplification)	Cancer
10418	GCST004884	Neuroblastoma (1p deletion)	Neuroblastoma (1p deletion)	Cancer
10419	GCST004885	Neuroblastoma (MYCN amplification)	Neuroblastoma (MYCN amplification)	Cancer
10420	GCST005117	Activities of daily living score	Activities of daily living score	Other measurement
10421	GCST005121	Short physical performance battery score	Short physical performance battery score	Other measurement
10422	GCST005118	Mid-arm muscle circumference	Mid-arm muscle circumference	Other measurement
10423	GCST005120	Four meter walk test score	Four meter walk test score	Other measurement
10424	GCST005123	Cognitive performance	Cognitive performance	Other measurement
10425	GCST005123	Cognitive performance	Cognitive performance	Other measurement
10426	GCST005119	Calf circumference	Calf circumference	Other measurement
10427	GCST005122	Hand grip strength	Hand grip strength	Other measurement
10428	GCST000752	Hepatocellular carcinoma	Hepatocellular carcinoma	Cancer
10429	GCST002977	Advanced glycation end-product levels	Advanced glycation end-product levels	Other measurement
10430	GCST002977	Advanced glycation end-product levels	Advanced glycation end-product levels	Other measurement
10431	GCST002977	Advanced glycation end-product levels	Advanced glycation end-product levels	Metabolic disorder
10432	GCST001622	Sarcoidosis	Sarcoidosis	Other disease
10433	GCST008151	Waist circumference	Waist circumference	Body measurement
10434	GCST008152	Weight	Weight	Body measurement
10435	GCST008153	Lean body mass	Lean body mass	Other measurement
10436	GCST008154	Trunk fat mass	Trunk fat mass	Other measurement
10437	GCST008155	Waist-hip ratio	Waist-hip ratio	Other measurement
10438	GCST008155	Waist-hip ratio	Waist-hip ratio	Body measurement
10439	GCST008156	Hip circumference adjusted for BMI	Hip circumference adjusted for BMI	Body measurement
10440	GCST008163	Height	Height	Other measurement
10441	GCST008163	Height	Height	Body measurement
10442	GCST008157	Body fat mass	Body fat mass	Other measurement
10443	GCST008158	Body mass index	Body mass index	Body measurement
10444	GCST008158	Body mass index	Body mass index	Body measurement
10445	GCST008158	Body mass index	Body mass index	Other measurement
10446	GCST008159	Waist-to-hip ratio adjusted for BMI	Waist-to-hip ratio adjusted for BMI	Body measurement
10447	GCST008161	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Body measurement
10448	GCST008161	Waist circumference adjusted for body mass index	Waist circumference adjusted for body mass index	Other measurement
10449	GCST008160	Waist circumference	Waist circumference	Body measurement
10450	GCST008162	Hip circumference	Hip circumference	Body measurement
10451	GCST004653	Peak velocity of the mitral E-wave	Peak velocity of the mitral E-wave	Cardiovascular measurement
10452	GCST004649	Isovolumetric relaxation time	Isovolumetric relaxation time	Cardiovascular measurement
10453	GCST004658	Peak velocity of excursion of lateral mitral annulus in early diastolic phase	Peak velocity of excursion of lateral mitral annulus in early diastolic phase	Cardiovascular measurement
10454	GCST004652	Peak velocity of the mitral A-wave	Peak velocity of the mitral A-wave	Cardiovascular measurement
10455	GCST004656	Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.	Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.	Cardiovascular measurement
10456	GCST004654	Deceleration time of the mitral E-wave	Deceleration time of the mitral E-wave	Cardiovascular measurement
10457	GCST004657	Ratio of the peak velocity of the excursion of the lateral mitral annulus in the early diastolic phase and the peak velocity of the mitral E-wave	Ratio of the peak velocity of the excursion of the lateral mitral annulus in the early diastolic phase and the peak velocity of the mitral E-wave	Cardiovascular measurement
10458	GCST004650	Diastolic dysfunction with preserved ejection pressure	Diastolic dysfunction with preserved ejection pressure	Cardiovascular measurement
10459	GCST004660	Heart failure with preserved ejection fraction	Heart failure with preserved ejection fraction	Cardiovascular measurement
10460	GCST004651	Aortic root size	Aortic root size	Cardiovascular measurement
10461	GCST004647	Left atrial antero-posterior diameter	Left atrial antero-posterior diameter	Cardiovascular measurement
10462	GCST004655	Left ventricle diastolic internal dimension	Left ventricle diastolic internal dimension	Cardiovascular measurement
10463	GCST004646	Left ventricle wall thickness	Left ventricle wall thickness	Cardiovascular measurement
10464	GCST004659	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
10465	GCST004659	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
10466	GCST004645	Left ventricular fractional shortening	Left ventricular fractional shortening	Cardiovascular measurement
10467	GCST004648	Left  ventricle systolic dysfunction	Left  ventricle systolic dysfunction	Cardiovascular measurement
10468	GCST002961	Acylcarnitine levels	Acylcarnitine levels	Other measurement
10469	GCST002961	Acylcarnitine levels	Acylcarnitine levels	Other measurement
10470	GCST002966	Amino acid levels	Amino acid levels	Other measurement
10471	GCST002966	Amino acid levels	Amino acid levels	Other measurement
10472	GCST002965	Glycerophospholipid levels	Glycerophospholipid levels	Other measurement
10473	GCST002965	Glycerophospholipid levels	Glycerophospholipid levels	Lipid or lipoprotein measurement
10474	GCST002964	Sphingolipid levels	Sphingolipid levels	Other measurement
10475	GCST002964	Sphingolipid levels	Sphingolipid levels	Lipid or lipoprotein measurement
10476	GCST002959	Hexose levels	Hexose levels	Other measurement
10477	GCST002959	Hexose levels	Hexose levels	Other measurement
10478	GCST001935	Body mass index in non-asthmatics	Body mass index in non-asthmatics	Body measurement
10479	GCST001945	Body mass index in asthmatics	Body mass index in asthmatics	Body measurement
10480	GCST001945	Body mass index in asthmatics	Body mass index in asthmatics	Other disease
10481	GCST003850	Caffeine metabolism (plasma 1,3,7-trimethyluric acid level)	Caffeine metabolism (plasma 1,3,7-trimethyluric acid level)	Other measurement
10482	GCST003847	Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)	Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)	Other measurement
10483	GCST003849	Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)	Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)	Other measurement
10484	GCST003846	Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)	Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)	Other measurement
10485	GCST003848	Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)	Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)	Other measurement
10486	GCST003851	Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)	Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)	Other measurement
10487	GCST002360	Plasma amyloid beta peptide concentrations (ABx-40)	Plasma amyloid beta peptide concentrations (ABx-40)	Other measurement
10488	GCST002359	Plasma amyloid beta peptide concentrations (ABx-42)	Plasma amyloid beta peptide concentrations (ABx-42)	Other measurement
10489	GCST005279	Lumbar spondylosis (disc space narrowing)	Lumbar spondylosis (disc space narrowing)	Other disease
10490	GCST005278	Lumbar spondylosis (presence and severity of osteophytes)	Lumbar spondylosis (presence and severity of osteophytes)	Other disease
10491	GCST005277	Lumbar spondylosis (Kellgren-Lawrence grade)	Lumbar spondylosis (Kellgren-Lawrence grade)	Other disease
10492	GCST002196	Homoarginine levels	Homoarginine levels	Other measurement
10493	GCST001045	Caudate nucleus volume	Caudate nucleus volume	Other measurement
10494	GCST004941	Dehydroepiandrosterone sulphate levels	Dehydroepiandrosterone sulphate levels	Other measurement
10495	GCST004941	Dehydroepiandrosterone sulphate levels	Dehydroepiandrosterone sulphate levels	Other measurement
10496	GCST004939	Glycated hemoglobin levels	Glycated hemoglobin levels	Other measurement
10497	GCST004940	Alanine transaminase levels	Alanine transaminase levels	Liver enzyme measurement
10498	GCST005059	Serum albumin level	Serum albumin level	Other measurement
10499	GCST005061	Serum alkaline phosphatase levels	Serum alkaline phosphatase levels	Liver enzyme measurement
10500	GCST005062	Fibrinogen levels	Fibrinogen levels	Hematological measurement
10501	GCST005064	Aspartate aminotransferase levels	Aspartate aminotransferase levels	Liver enzyme measurement
10502	GCST005065	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
10503	GCST005066	Creatinine levels	Creatinine levels	Other measurement
10504	GCST005069	Gamma glutamyl transferase levels	Gamma glutamyl transferase levels	Liver enzyme measurement
10505	GCST005058	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
10506	GCST005060	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10507	GCST005060	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10508	GCST005060	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10509	GCST005060	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10510	GCST005067	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
10511	GCST005071	Insulin-like growth factor 1 levels	Insulin-like growth factor 1 levels	Other measurement
10512	GCST005072	Ferritin levels	Ferritin levels	Other measurement
10513	GCST005074	Testosterone levels	Testosterone levels	Other measurement
10514	GCST005074	Testosterone levels	Testosterone levels	Other measurement
10515	GCST005073	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
10516	GCST005070	Urea levels	Urea levels	Other measurement
10517	GCST005070	Urea levels	Urea levels	Other measurement
10518	GCST005068	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
10519	GCST005068	LDL cholesterol	LDL cholesterol	Other measurement
10520	GCST005068	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
10521	GCST005063	Glomerular filtration rate	Glomerular filtration rate	Other measurement
10522	GCST001818	Metabolite levels (HVA/5-HIAA ratio)	Metabolite levels (HVA/5-HIAA ratio)	Other measurement
10523	GCST001818	Metabolite levels (HVA/5-HIAA ratio)	Metabolite levels (HVA/5-HIAA ratio)	Other measurement
10524	GCST001817	Metabolite levels (HVA-5-HIAA Factor score)	Metabolite levels (HVA-5-HIAA Factor score)	Other measurement
10525	GCST001817	Metabolite levels (HVA-5-HIAA Factor score)	Metabolite levels (HVA-5-HIAA Factor score)	Other measurement
10526	GCST001824	Metabolite levels (HVA)	Metabolite levels (HVA)	Other measurement
10527	GCST001820	Metabolite levels (5-HIAA)	Metabolite levels (5-HIAA)	Other measurement
10528	GCST001822	Metabolite levels (MHPG)	Metabolite levels (MHPG)	Other measurement
10529	GCST001821	Metabolite levels (5-HIAA/ MHPG Ratio)	Metabolite levels (5-HIAA/ MHPG Ratio)	Other measurement
10530	GCST001821	Metabolite levels (5-HIAA/ MHPG Ratio)	Metabolite levels (5-HIAA/ MHPG Ratio)	Other measurement
10531	GCST001823	Metabolite levels (HVA/MHPG ratio)	Metabolite levels (HVA/MHPG ratio)	Other measurement
10532	GCST001823	Metabolite levels (HVA/MHPG ratio)	Metabolite levels (HVA/MHPG ratio)	Other measurement
10533	GCST004814	Interleukin-6 (red blood cell fatty acid level interaction)	Interleukin-6 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10534	GCST004814	Interleukin-6 (red blood cell fatty acid level interaction)	Interleukin-6 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10535	GCST004814	Interleukin-6 (red blood cell fatty acid level interaction)	Interleukin-6 (red blood cell fatty acid level interaction)	Inflammatory measurement
10536	GCST004814	Interleukin-6 (red blood cell fatty acid level interaction)	Interleukin-6 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10537	GCST004816	Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10538	GCST004816	Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10539	GCST004818	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10540	GCST004818	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10541	GCST004818	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	Cardiovascular measurement
10542	GCST004820	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10543	GCST004820	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10544	GCST004820	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Cellular adhesion molecule (red blood cell fatty acid level interaction)	Other measurement
10545	GCST004821	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Other measurement
10546	GCST004821	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10547	GCST004821	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10548	GCST004817	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10549	GCST004817	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10550	GCST004817	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	Other measurement
10551	GCST004815	C-reactive protein (red blood cell fatty acid level interaction)	C-reactive protein (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10552	GCST004815	C-reactive protein (red blood cell fatty acid level interaction)	C-reactive protein (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10553	GCST004815	C-reactive protein (red blood cell fatty acid level interaction)	C-reactive protein (red blood cell fatty acid level interaction)	Inflammatory measurement
10554	GCST004815	C-reactive protein (red blood cell fatty acid level interaction)	C-reactive protein (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10555	GCST004819	Osteoprotegerin (red blood cell fatty acid level interaction)	Osteoprotegerin (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10556	GCST004819	Osteoprotegerin (red blood cell fatty acid level interaction)	Osteoprotegerin (red blood cell fatty acid level interaction)	Cardiovascular measurement
10557	GCST004822	P-Selectin (red blood cell fatty acid level interaction)	P-Selectin (red blood cell fatty acid level interaction)	Lipid or lipoprotein measurement
10558	GCST004822	P-Selectin (red blood cell fatty acid level interaction)	P-Selectin (red blood cell fatty acid level interaction)	Other measurement
10559	GCST000510	Platelet count	Platelet count	Hematological measurement
10560	GCST008427	Basophil count	Basophil count	Inflammatory measurement
10561	GCST008428	Eosinophil counts	Eosinophil counts	Hematological measurement
10562	GCST008429	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10563	GCST008429	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10564	GCST008429	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10565	GCST008429	Hemoglobin levels	Hemoglobin levels	Hematological measurement
10566	GCST008430	Hematocrit	Hematocrit	Hematological measurement
10567	GCST008431	Lymphocyte counts	Lymphocyte counts	Hematological measurement
10568	GCST008432	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
10569	GCST008432	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
10570	GCST008418	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
10571	GCST008418	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
10572	GCST008420	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
10573	GCST008421	Monocyte count	Monocyte count	Hematological measurement
10574	GCST008425	Neutrophil count	Neutrophil count	Hematological measurement
10575	GCST008426	Red blood cell count	Red blood cell count	Hematological measurement
10576	GCST008419	White blood cell count	White blood cell count	Hematological measurement
10577	GCST008419	White blood cell count	White blood cell count	Inflammatory measurement
10578	GCST008419	White blood cell count	White blood cell count	Hematological measurement
10579	GCST008419	White blood cell count	White blood cell count	Hematological measurement
10580	GCST008419	White blood cell count	White blood cell count	Hematological measurement
10581	GCST003229	Survival in colorectal cancer	Survival in colorectal cancer	Other measurement
10582	GCST003229	Survival in colorectal cancer	Survival in colorectal cancer	Cancer
10583	GCST003231	Survival in colorectal cancer (non-distant metastatic)	Survival in colorectal cancer (non-distant metastatic)	Other measurement
10584	GCST003231	Survival in colorectal cancer (non-distant metastatic)	Survival in colorectal cancer (non-distant metastatic)	Other measurement
10585	GCST003231	Survival in colorectal cancer (non-distant metastatic)	Survival in colorectal cancer (non-distant metastatic)	Cancer
10586	GCST003230	Survival in colorectal cancer (distant metastatic)	Survival in colorectal cancer (distant metastatic)	Other measurement
10587	GCST003230	Survival in colorectal cancer (distant metastatic)	Survival in colorectal cancer (distant metastatic)	Other measurement
10588	GCST003230	Survival in colorectal cancer (distant metastatic)	Survival in colorectal cancer (distant metastatic)	Cancer
10589	GCST002979	Response to montelukast in asthma (change in FEV1)	Response to montelukast in asthma (change in FEV1)	Other measurement
10590	GCST002979	Response to montelukast in asthma (change in FEV1)	Response to montelukast in asthma (change in FEV1)	Other disease
10591	GCST002979	Response to montelukast in asthma (change in FEV1)	Response to montelukast in asthma (change in FEV1)	Response to drug
10592	GCST000751	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
10593	GCST000757	Attention deficit hyperactivity disorder	Attention deficit hyperactivity disorder	Neurological disorder
10594	GCST005189	Tanning	Tanning	Other trait
10595	GCST005188	Skin pigmentation	Skin pigmentation	Other trait
10596	GCST005188	Skin pigmentation	Skin pigmentation	Other measurement
10597	GCST005028	Pursuit maintenance gain in psychotic disorders	Pursuit maintenance gain in psychotic disorders	Neurological disorder
10598	GCST005028	Pursuit maintenance gain in psychotic disorders	Pursuit maintenance gain in psychotic disorders	Neurological disorder
10599	GCST005028	Pursuit maintenance gain in psychotic disorders	Pursuit maintenance gain in psychotic disorders	Neurological disorder
10600	GCST005028	Pursuit maintenance gain in psychotic disorders	Pursuit maintenance gain in psychotic disorders	Other measurement
10601	GCST005023	Initial pursuit acceleration	Initial pursuit acceleration	Other measurement
10602	GCST005024	Pursuit maintenance gain	Pursuit maintenance gain	Other measurement
10603	GCST005025	Anti-saccade response	Anti-saccade response	Other measurement
10604	GCST005026	Initial pursuit acceleration in psychotic disorders	Initial pursuit acceleration in psychotic disorders	Neurological disorder
10605	GCST005026	Initial pursuit acceleration in psychotic disorders	Initial pursuit acceleration in psychotic disorders	Neurological disorder
10606	GCST005026	Initial pursuit acceleration in psychotic disorders	Initial pursuit acceleration in psychotic disorders	Neurological disorder
10607	GCST005026	Initial pursuit acceleration in psychotic disorders	Initial pursuit acceleration in psychotic disorders	Other measurement
10608	GCST005027	Anti-saccade error rate in psychotic disorders	Anti-saccade error rate in psychotic disorders	Neurological disorder
10609	GCST005027	Anti-saccade error rate in psychotic disorders	Anti-saccade error rate in psychotic disorders	Neurological disorder
10610	GCST005027	Anti-saccade error rate in psychotic disorders	Anti-saccade error rate in psychotic disorders	Other measurement
10611	GCST005027	Anti-saccade error rate in psychotic disorders	Anti-saccade error rate in psychotic disorders	Neurological disorder
10612	GCST003126	Influenza A (H1N1) severity	Influenza A (H1N1) severity	Other measurement
10613	GCST003125	Influenza A (H1N1) infection	Influenza A (H1N1) infection	Other disease
10614	GCST003124	Mild influenza (H1N1) infection	Mild influenza (H1N1) infection	Other disease
10615	GCST003123	Severe influenza A (H1N1) infection	Severe influenza A (H1N1) infection	Other disease
10616	GCST001394	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
10617	GCST001397	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
10618	GCST001396	Crohn's disease	Crohn's disease	Digestive system disorder
10619	GCST001063	Chronic myeloid leukemia	Chronic myeloid leukemia	Cancer
10620	GCST001922	QT interval	QT interval	Cardiovascular measurement
10621	GCST001921	Heart rate	Heart rate	Cardiovascular measurement
10622	GCST001925	PR interval	PR interval	Cardiovascular measurement
10623	GCST001920	QRS duration	QRS duration	Cardiovascular measurement
10624	GCST001920	QRS duration	QRS duration	Cardiovascular measurement
10625	GCST001920	QRS duration	QRS duration	Cardiovascular measurement
10626	GCST005039	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Other measurement
10627	GCST005039	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
10628	GCST005039	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
10629	GCST005040	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
10630	GCST005040	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Other measurement
10631	GCST005040	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
10632	GCST005041	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
10633	GCST005041	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Other measurement
10634	GCST005041	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	Response to drug
10635	GCST003150	Staphylococcus aureus infection	Staphylococcus aureus infection	Other disease
10636	GCST003149	Skin and soft tissue Staphylococcus aureus infection	Skin and soft tissue Staphylococcus aureus infection	Other disease
10637	GCST001343	Fat distribution (HIV)	Fat distribution (HIV)	Body measurement
10638	GCST001343	Fat distribution (HIV)	Fat distribution (HIV)	Other disease
10639	GCST005201	Pulse pressure (dietary potassium intake interaction)	Pulse pressure (dietary potassium intake interaction)	Other measurement
10640	GCST005201	Pulse pressure (dietary potassium intake interaction)	Pulse pressure (dietary potassium intake interaction)	Cardiovascular measurement
10641	GCST005204	Systolic blood pressure (dietary potassium intake interaction)	Systolic blood pressure (dietary potassium intake interaction)	Other measurement
10642	GCST005204	Systolic blood pressure (dietary potassium intake interaction)	Systolic blood pressure (dietary potassium intake interaction)	Other measurement
10643	GCST005202	Diastolic blood pressure (dietary potassium intake interaction)	Diastolic blood pressure (dietary potassium intake interaction)	Other measurement
10644	GCST005202	Diastolic blood pressure (dietary potassium intake interaction)	Diastolic blood pressure (dietary potassium intake interaction)	Other measurement
10645	GCST005203	Mean arterial pressure (dietary potassium intake interaction)	Mean arterial pressure (dietary potassium intake interaction)	Other measurement
10646	GCST005203	Mean arterial pressure (dietary potassium intake interaction)	Mean arterial pressure (dietary potassium intake interaction)	Other measurement
10647	GCST003392	Parental longevity (father's age at death)	Parental longevity (father's age at death)	Other measurement
10648	GCST003393	Parental longevity (mother's age at death)	Parental longevity (mother's age at death)	Other measurement
10649	GCST003394	Parental longevity (combined parental age at death)	Parental longevity (combined parental age at death)	Other measurement
10650	GCST003395	Parental extreme longevity (95 years and older)	Parental extreme longevity (95 years and older)	Other measurement
10651	GCST001892	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Immune system disorder
10652	GCST001892	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Other measurement
10653	GCST001891	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Immune system disorder
10654	GCST001891	Multiple sclerosis (OCB status)	Multiple sclerosis (OCB status)	Other measurement
10655	GCST003324	Ischemic stroke	Ischemic stroke	Cardiovascular disease
10656	GCST003324	Ischemic stroke	Ischemic stroke	Other trait
10657	GCST003322	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Cardiovascular disease
10658	GCST003322	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Other trait
10659	GCST003320	Ischemic stroke (undetermined subtype)	Ischemic stroke (undetermined subtype)	Other trait
10660	GCST003323	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
10661	GCST003323	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
10662	GCST003323	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
10663	GCST003321	Small vessel stroke	Small vessel stroke	Cardiovascular disease
10664	GCST000284	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
10665	GCST000283	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
10666	GCST000283	LDL cholesterol	LDL cholesterol	Other measurement
10667	GCST000283	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
10668	GCST000292	Metabolic traits	Metabolic traits	Other measurement
10669	GCST000292	Metabolic traits	Metabolic traits	Biological process
10670	GCST000292	Metabolic traits	Metabolic traits	Lipid or lipoprotein measurement
10671	GCST000292	Metabolic traits	Metabolic traits	Other measurement
10672	GCST000292	Metabolic traits	Metabolic traits	Other measurement
10673	GCST004745	Immunoglobulin A vasculitis	Immunoglobulin A vasculitis	Immune system disorder
10674	GCST002050	Sleep time	Sleep time	Other measurement
10675	GCST002049	Sleep quality	Sleep quality	Other measurement
10676	GCST002054	Sleep depth	Sleep depth	Other measurement
10677	GCST002053	Sleep duration	Sleep duration	Other measurement
10678	GCST002052	Insomnia	Insomnia	Neurological disorder
10679	GCST002052	Insomnia	Insomnia	Other measurement
10680	GCST002051	Sleep latency	Sleep latency	Other measurement
10681	GCST001132	Sudden cardiac arrest	Sudden cardiac arrest	Cardiovascular disease
10682	GCST000291	Fasting plasma glucose	Fasting plasma glucose	Other measurement
10683	GCST001844	Dietary macronutrient intake	Dietary macronutrient intake	Biological process
10684	GCST004496	BMI (smoking interaction)	BMI (smoking interaction)	Biological process
10685	GCST004496	BMI (smoking interaction)	BMI (smoking interaction)	Body measurement
10686	GCST004500	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	Biological process
10687	GCST004500	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	Body measurement
10688	GCST004506	Waist-to-hip ratio adjusted for BMI (smoking interaction)	Waist-to-hip ratio adjusted for BMI (smoking interaction)	Biological process
10689	GCST004506	Waist-to-hip ratio adjusted for BMI (smoking interaction)	Waist-to-hip ratio adjusted for BMI (smoking interaction)	Body measurement
10690	GCST004501	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	Biological process
10691	GCST004501	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	Body measurement
10692	GCST004497	Body mass index (joint analysis main effects and smoking interaction)	Body mass index (joint analysis main effects and smoking interaction)	Biological process
10693	GCST004497	Body mass index (joint analysis main effects and smoking interaction)	Body mass index (joint analysis main effects and smoking interaction)	Body measurement
10694	GCST004502	Waist circumference adjusted for BMI (smoking interaction)	Waist circumference adjusted for BMI (smoking interaction)	Biological process
10695	GCST004502	Waist circumference adjusted for BMI (smoking interaction)	Waist circumference adjusted for BMI (smoking interaction)	Body measurement
10696	GCST004505	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	Biological process
10697	GCST004505	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	Body measurement
10698	GCST004504	Waist circumference adjusted for BMI in non-smokers	Waist circumference adjusted for BMI in non-smokers	Body measurement
10699	GCST004499	BMI in non-smokers	BMI in non-smokers	Body measurement
10700	GCST004503	Waist circumference adjusted for BMI in smokers	Waist circumference adjusted for BMI in smokers	Biological process
10701	GCST004503	Waist circumference adjusted for BMI in smokers	Waist circumference adjusted for BMI in smokers	Body measurement
10702	GCST004498	BMI in smokers	BMI in smokers	Biological process
10703	GCST004498	BMI in smokers	BMI in smokers	Body measurement
10704	GCST004508	Waist-to-hip ratio adjusted for BMI in non-smokers	Waist-to-hip ratio adjusted for BMI in non-smokers	Body measurement
10705	GCST004495	BMI (adjusted for smoking behaviour)	BMI (adjusted for smoking behaviour)	Biological process
10706	GCST004495	BMI (adjusted for smoking behaviour)	BMI (adjusted for smoking behaviour)	Body measurement
10707	GCST004507	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	Biological process
10708	GCST004507	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	Body measurement
10709	GCST004509	Waist-to-hip ratio adjusted for BMI in smokers	Waist-to-hip ratio adjusted for BMI in smokers	Biological process
10710	GCST004509	Waist-to-hip ratio adjusted for BMI in smokers	Waist-to-hip ratio adjusted for BMI in smokers	Body measurement
10711	GCST003800	Response to bupropion in depression	Response to bupropion in depression	Neurological disorder
10712	GCST003800	Response to bupropion in depression	Response to bupropion in depression	Neurological disorder
10713	GCST003800	Response to bupropion in depression	Response to bupropion in depression	Response to drug
10714	GCST003801	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Response to drug
10715	GCST003801	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Neurological disorder
10716	GCST003801	Response to selective serotonin reuptake inhibitors in depression	Response to selective serotonin reuptake inhibitors in depression	Neurological disorder
10717	GCST003802	Response to citalopram or escitalopram in depression	Response to citalopram or escitalopram in depression	Neurological disorder
10718	GCST003802	Response to citalopram or escitalopram in depression	Response to citalopram or escitalopram in depression	Neurological disorder
10719	GCST003802	Response to citalopram or escitalopram in depression	Response to citalopram or escitalopram in depression	Response to drug
10720	GCST003802	Response to citalopram or escitalopram in depression	Response to citalopram or escitalopram in depression	Response to drug
10721	GCST003803	Response to antidepressants in depression	Response to antidepressants in depression	Neurological disorder
10722	GCST003803	Response to antidepressants in depression	Response to antidepressants in depression	Neurological disorder
10723	GCST003803	Response to antidepressants in depression	Response to antidepressants in depression	Response to drug
10724	GCST003804	Non-response to bupropion and depression	Non-response to bupropion and depression	Neurological disorder
10725	GCST003804	Non-response to bupropion and depression	Non-response to bupropion and depression	Neurological disorder
10726	GCST003804	Non-response to bupropion and depression	Non-response to bupropion and depression	Response to drug
10727	GCST003806	Response to bupropion and depression	Response to bupropion and depression	Neurological disorder
10728	GCST003806	Response to bupropion and depression	Response to bupropion and depression	Neurological disorder
10729	GCST003806	Response to bupropion and depression	Response to bupropion and depression	Response to drug
10730	GCST003809	Response to selective serotonin reuptake inhibitors and depression	Response to selective serotonin reuptake inhibitors and depression	Response to drug
10731	GCST003809	Response to selective serotonin reuptake inhibitors and depression	Response to selective serotonin reuptake inhibitors and depression	Neurological disorder
10732	GCST003809	Response to selective serotonin reuptake inhibitors and depression	Response to selective serotonin reuptake inhibitors and depression	Neurological disorder
10733	GCST003810	Non-response to citalopram or escitalopram and depression	Non-response to citalopram or escitalopram and depression	Neurological disorder
10734	GCST003810	Non-response to citalopram or escitalopram and depression	Non-response to citalopram or escitalopram and depression	Neurological disorder
10735	GCST003810	Non-response to citalopram or escitalopram and depression	Non-response to citalopram or escitalopram and depression	Response to drug
10736	GCST003810	Non-response to citalopram or escitalopram and depression	Non-response to citalopram or escitalopram and depression	Response to drug
10737	GCST003811	Response to citalopram or escitalopram and depression	Response to citalopram or escitalopram and depression	Neurological disorder
10738	GCST003811	Response to citalopram or escitalopram and depression	Response to citalopram or escitalopram and depression	Neurological disorder
10739	GCST003811	Response to citalopram or escitalopram and depression	Response to citalopram or escitalopram and depression	Response to drug
10740	GCST003811	Response to citalopram or escitalopram and depression	Response to citalopram or escitalopram and depression	Response to drug
10741	GCST003812	Non-response to antidepressants and depression	Non-response to antidepressants and depression	Neurological disorder
10742	GCST003812	Non-response to antidepressants and depression	Non-response to antidepressants and depression	Neurological disorder
10743	GCST003812	Non-response to antidepressants and depression	Non-response to antidepressants and depression	Response to drug
10744	GCST003808	Non-response to selective serotonin reuptake inhibitors and depression	Non-response to selective serotonin reuptake inhibitors and depression	Response to drug
10745	GCST003808	Non-response to selective serotonin reuptake inhibitors and depression	Non-response to selective serotonin reuptake inhibitors and depression	Neurological disorder
10746	GCST003808	Non-response to selective serotonin reuptake inhibitors and depression	Non-response to selective serotonin reuptake inhibitors and depression	Neurological disorder
10747	GCST003813	Response to antidepressants and depression	Response to antidepressants and depression	Neurological disorder
10748	GCST003813	Response to antidepressants and depression	Response to antidepressants and depression	Neurological disorder
10749	GCST003813	Response to antidepressants and depression	Response to antidepressants and depression	Response to drug
10750	GCST001482	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
10751	GCST001482	Lumbar spine bone mineral density	Lumbar spine bone mineral density	Other measurement
10752	GCST007691	Femoral neck bone mineral density	Femoral neck bone mineral density	Other measurement
10753	GCST005535	Diffuse cutaneous systemic sclerosis	Diffuse cutaneous systemic sclerosis	Neurological disorder
10754	GCST005534	Systemic sclerosis	Systemic sclerosis	Neurological disorder
10755	GCST005533	Limited cutaneous systemic scleroderma	Limited cutaneous systemic scleroderma	Neurological disorder
10756	GCST005871	Metabolic syndrome	Metabolic syndrome	Body measurement
10757	GCST005871	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
10758	GCST005871	Metabolic syndrome	Metabolic syndrome	Other measurement
10759	GCST005871	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
10760	GCST005871	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
10761	GCST005872	Waist circumference	Waist circumference	Body measurement
10762	GCST005873	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
10763	GCST005874	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
10764	GCST005875	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10765	GCST005875	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10766	GCST005876	Systolic blood pressure	Systolic blood pressure	Other measurement
10767	GCST005876	Systolic blood pressure	Systolic blood pressure	Other measurement
10768	GCST005877	Fasting blood glucose	Fasting blood glucose	Other measurement
10769	GCST003527	Anti-thyroid drug induced agranulocytosis	Anti-thyroid drug induced agranulocytosis	Response to drug
10770	GCST003527	Anti-thyroid drug induced agranulocytosis	Anti-thyroid drug induced agranulocytosis	Other trait
10771	GCST003526	Non-chemotherapy drug induced agranulocytosis	Non-chemotherapy drug induced agranulocytosis	Other trait
10772	GCST003526	Non-chemotherapy drug induced agranulocytosis	Non-chemotherapy drug induced agranulocytosis	Biological process
10773	GCST004375	Resistance to antipsychotic treatment in schizophrenia	Resistance to antipsychotic treatment in schizophrenia	Response to drug
10774	GCST004375	Resistance to antipsychotic treatment in schizophrenia	Resistance to antipsychotic treatment in schizophrenia	Neurological disorder
10775	GCST004374	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Response to drug
10776	GCST004374	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Neurological disorder
10777	GCST004374	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	Other measurement
10778	GCST001481	Brain structure	Brain structure	Other measurement
10779	GCST001481	Brain structure	Brain structure	Other measurement
10780	GCST001481	Brain structure	Brain structure	Other measurement
10781	GCST002023	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
10782	GCST002023	Testicular germ cell tumor	Testicular germ cell tumor	Cancer
10783	GCST003263	Post bronchodilator FEV1 in COPD	Post bronchodilator FEV1 in COPD	Other disease
10784	GCST003263	Post bronchodilator FEV1 in COPD	Post bronchodilator FEV1 in COPD	Response to drug
10785	GCST003263	Post bronchodilator FEV1 in COPD	Post bronchodilator FEV1 in COPD	Other measurement
10786	GCST003264	Post bronchodilator FEV1/FVC ratio	Post bronchodilator FEV1/FVC ratio	Other measurement
10787	GCST003264	Post bronchodilator FEV1/FVC ratio	Post bronchodilator FEV1/FVC ratio	Response to drug
10788	GCST003262	Post bronchodilator FEV1	Post bronchodilator FEV1	Response to drug
10789	GCST003262	Post bronchodilator FEV1	Post bronchodilator FEV1	Other measurement
10790	GCST003265	Post bronchodilator FEV1/FVC ratio in COPD	Post bronchodilator FEV1/FVC ratio in COPD	Other disease
10791	GCST003265	Post bronchodilator FEV1/FVC ratio in COPD	Post bronchodilator FEV1/FVC ratio in COPD	Other measurement
10792	GCST003265	Post bronchodilator FEV1/FVC ratio in COPD	Post bronchodilator FEV1/FVC ratio in COPD	Response to drug
10793	GCST003266	Pre bronchodilator FEV1	Pre bronchodilator FEV1	Other measurement
10794	GCST003267	Pre bronchodilator FEV1/FVC ratio	Pre bronchodilator FEV1/FVC ratio	Other measurement
10795	GCST005336	Systemic sclerosis	Systemic sclerosis	Neurological disorder
10796	GCST005334	Limited cutaneous systemic scleroderma	Limited cutaneous systemic scleroderma	Neurological disorder
10797	GCST005335	Diffuse cutaneous systemic sclerosis	Diffuse cutaneous systemic sclerosis	Neurological disorder
10798	GCST005333	Systemic sclerosis (anti-centromere-positive)	Systemic sclerosis (anti-centromere-positive)	Neurological disorder
10799	GCST005332	Systemic sclerosis (anti-topoisomerase-positive)	Systemic sclerosis (anti-topoisomerase-positive)	Neurological disorder
10800	GCST005554	Systemic sclerosis	Systemic sclerosis	Neurological disorder
10801	GCST005555	Limited cutaneous systemic scleroderma	Limited cutaneous systemic scleroderma	Neurological disorder
10802	GCST005553	Diffuse cutaneous systemic sclerosis	Diffuse cutaneous systemic sclerosis	Neurological disorder
10803	GCST005552	Systemic sclerosis (anti-centromere-positive)	Systemic sclerosis (anti-centromere-positive)	Neurological disorder
10804	GCST005551	Systemic sclerosis (anti-topoisomerase-positive)	Systemic sclerosis (anti-topoisomerase-positive)	Neurological disorder
10805	GCST005192	Lobe attachment (rater-scored or self-reported)	Lobe attachment (rater-scored or self-reported)	Other trait
10806	GCST005193	Lobe attachment (rater scored)	Lobe attachment (rater scored)	Other trait
10807	GCST004061	Sjögren's syndrome	Sjögren's syndrome	Neurological disorder
10808	GCST004062	Sjögren's syndrome	Sjögren's syndrome	Neurological disorder
10809	GCST003674	Obstructive sleep apnea trait (apnea hypopnea index)	Obstructive sleep apnea trait (apnea hypopnea index)	Other measurement
10810	GCST003674	Obstructive sleep apnea trait (apnea hypopnea index)	Obstructive sleep apnea trait (apnea hypopnea index)	Neurological disorder
10811	GCST003673	Obstructive sleep apnea (average oxygen saturation during sleep)	Obstructive sleep apnea (average oxygen saturation during sleep)	Other measurement
10812	GCST003673	Obstructive sleep apnea (average oxygen saturation during sleep)	Obstructive sleep apnea (average oxygen saturation during sleep)	Neurological disorder
10813	GCST003675	Obstructive sleep apnea trait (average respiratory event duration)	Obstructive sleep apnea trait (average respiratory event duration)	Other measurement
10814	GCST003675	Obstructive sleep apnea trait (average respiratory event duration)	Obstructive sleep apnea trait (average respiratory event duration)	Neurological disorder
10815	GCST001572	Erectile dysfunction in type 1 diabetes	Erectile dysfunction in type 1 diabetes	Other disease
10816	GCST001572	Erectile dysfunction in type 1 diabetes	Erectile dysfunction in type 1 diabetes	Metabolic disorder
10817	GCST001933	Sunburns	Sunburns	Other disease
10818	GCST001929	Eye color	Eye color	Other measurement
10819	GCST001929	Eye color	Eye color	Other trait
10820	GCST001932	Hair color	Hair color	Other measurement
10821	GCST001932	Hair color	Hair color	Other trait
10822	GCST001940	Non-melanoma skin cancer	Non-melanoma skin cancer	Other trait
10823	GCST001940	Non-melanoma skin cancer	Non-melanoma skin cancer	Cancer
10824	GCST001939	Tanning	Tanning	Other trait
10825	GCST000651	Creatinine levels	Creatinine levels	Other measurement
10826	GCST003138	Juvenile osteochondritis dissecans	Juvenile osteochondritis dissecans	Other trait
10827	GCST004231	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
10828	GCST004233	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
10829	GCST004233	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
10830	GCST004234	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
10831	GCST004235	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
10832	GCST004236	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
10833	GCST004236	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
10834	GCST004237	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
10835	GCST004238	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
10836	GCST004232	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
10837	GCST002899	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
10838	GCST002897	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
10839	GCST002898	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
10840	GCST002898	LDL cholesterol	LDL cholesterol	Other measurement
10841	GCST002898	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
10842	GCST002896	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
10843	GCST004968	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Cardiovascular disease
10844	GCST004968	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Cardiovascular disease
10845	GCST004968	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Cardiovascular measurement
10846	GCST004968	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	Response to drug
10847	GCST004966	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Cardiovascular disease
10848	GCST004966	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Cardiovascular disease
10849	GCST004966	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Cardiovascular measurement
10850	GCST004966	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	Response to drug
10851	GCST004961	Major coronary event in placebo-treated cardiovascular disease (time to event)	Major coronary event in placebo-treated cardiovascular disease (time to event)	Cardiovascular measurement
10852	GCST004961	Major coronary event in placebo-treated cardiovascular disease (time to event)	Major coronary event in placebo-treated cardiovascular disease (time to event)	Cardiovascular disease
10853	GCST004961	Major coronary event in placebo-treated cardiovascular disease (time to event)	Major coronary event in placebo-treated cardiovascular disease (time to event)	Cardiovascular disease
10854	GCST004961	Major coronary event in placebo-treated cardiovascular disease (time to event)	Major coronary event in placebo-treated cardiovascular disease (time to event)	Biological process
10855	GCST004962	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10856	GCST004962	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10857	GCST004962	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Other trait
10858	GCST004962	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Diarrhoea in darapladib-treated cardiovascular disease (time to event)	Response to drug
10859	GCST004964	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10860	GCST004964	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10861	GCST004964	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10862	GCST004964	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	Response to drug
10863	GCST004965	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Cardiovascular disease
10864	GCST004965	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Cardiovascular disease
10865	GCST004965	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Cardiovascular disease
10866	GCST004965	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Myocardial infarction in placebo-treated cardiovascular disease (time to event)	Biological process
10867	GCST004958	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular measurement
10868	GCST004958	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular disease
10869	GCST004958	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular disease
10870	GCST004958	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	Response to drug
10871	GCST004960	Odor events in darapladib-treated cardiovascular disease (time to event)	Odor events in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10872	GCST004960	Odor events in darapladib-treated cardiovascular disease (time to event)	Odor events in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10873	GCST004960	Odor events in darapladib-treated cardiovascular disease (time to event)	Odor events in darapladib-treated cardiovascular disease (time to event)	Response to drug
10874	GCST004960	Odor events in darapladib-treated cardiovascular disease (time to event)	Odor events in darapladib-treated cardiovascular disease (time to event)	Other measurement
10875	GCST004957	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Cardiovascular measurement
10876	GCST004957	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10877	GCST004957	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10878	GCST004957	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Major coronary event in darapladib-treated cardiovascular disease (time to event)	Response to drug
10879	GCST004963	Lipoprotein phospholipase A2 activity in cardiovascular disease	Lipoprotein phospholipase A2 activity in cardiovascular disease	Lipid or lipoprotein measurement
10880	GCST004963	Lipoprotein phospholipase A2 activity in cardiovascular disease	Lipoprotein phospholipase A2 activity in cardiovascular disease	Cardiovascular disease
10881	GCST004963	Lipoprotein phospholipase A2 activity in cardiovascular disease	Lipoprotein phospholipase A2 activity in cardiovascular disease	Cardiovascular disease
10882	GCST004959	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular disease
10883	GCST004959	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular disease
10884	GCST004959	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Cardiovascular disease
10885	GCST004959	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	Response to drug
10886	GCST004967	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10887	GCST004967	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Cardiovascular disease
10888	GCST004967	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Other trait
10889	GCST004967	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	Response to drug
10890	GCST002677	Iron status biomarkers (ferritin levels)	Iron status biomarkers (ferritin levels)	Other measurement
10891	GCST002677	Iron status biomarkers (ferritin levels)	Iron status biomarkers (ferritin levels)	Other measurement
10892	GCST002680	Iron status biomarkers (transferrin saturation)	Iron status biomarkers (transferrin saturation)	Other measurement
10893	GCST002680	Iron status biomarkers (transferrin saturation)	Iron status biomarkers (transferrin saturation)	Other measurement
10894	GCST002679	Iron status biomarkers (iron levels)	Iron status biomarkers (iron levels)	Other measurement
10895	GCST002679	Iron status biomarkers (iron levels)	Iron status biomarkers (iron levels)	Other measurement
10896	GCST002678	Iron status biomarkers (transferrin levels)	Iron status biomarkers (transferrin levels)	Other measurement
10897	GCST002678	Iron status biomarkers (transferrin levels)	Iron status biomarkers (transferrin levels)	Other measurement
10898	GCST002433	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
10899	GCST002434	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
10900	GCST001592	Osteoarthritis	Osteoarthritis	Other disease
10901	GCST005086	Visceral adipose tissue (sex interaction)	Visceral adipose tissue (sex interaction)	Other measurement
10902	GCST005086	Visceral adipose tissue (sex interaction)	Visceral adipose tissue (sex interaction)	Other measurement
10903	GCST005092	Subcutaneous adipose tissue (sex interaction)	Subcutaneous adipose tissue (sex interaction)	Other measurement
10904	GCST005092	Subcutaneous adipose tissue (sex interaction)	Subcutaneous adipose tissue (sex interaction)	Other measurement
10905	GCST005091	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
10906	GCST005090	Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	Other measurement
10907	GCST005090	Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	Other measurement
10908	GCST005089	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
10909	GCST005089	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
10910	GCST005088	Visceral adipose tissue adjusted for BMI (sex interaction)	Visceral adipose tissue adjusted for BMI (sex interaction)	Other measurement
10911	GCST005088	Visceral adipose tissue adjusted for BMI (sex interaction)	Visceral adipose tissue adjusted for BMI (sex interaction)	Other measurement
10912	GCST005087	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
10913	GCST005087	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
10914	GCST005085	Visceral adipose tissue	Visceral adipose tissue	Other measurement
10915	GCST003921	Whole body bone mineral density and alcohol drinking	Whole body bone mineral density and alcohol drinking	Other measurement
10916	GCST003921	Whole body bone mineral density and alcohol drinking	Whole body bone mineral density and alcohol drinking	Other measurement
10917	GCST003920	Hip bone mineral density and alcohol drinking	Hip bone mineral density and alcohol drinking	Other measurement
10918	GCST003920	Hip bone mineral density and alcohol drinking	Hip bone mineral density and alcohol drinking	Other measurement
10919	GCST003919	Spine bone mineral density and alcohol drinking	Spine bone mineral density and alcohol drinking	Other measurement
10920	GCST003919	Spine bone mineral density and alcohol drinking	Spine bone mineral density and alcohol drinking	Other measurement
10921	GCST006054	High altitude adaptation	High altitude adaptation	Biological process
10922	GCST005194	Coronary artery disease	Coronary artery disease	Cardiovascular disease
10923	GCST005194	Coronary artery disease	Coronary artery disease	Cardiovascular disease
10924	GCST005195	Coronary artery disease	Coronary artery disease	Cardiovascular disease
10925	GCST005195	Coronary artery disease	Coronary artery disease	Cardiovascular disease
10926	GCST005196	Coronary artery disease	Coronary artery disease	Cardiovascular disease
10927	GCST005196	Coronary artery disease	Coronary artery disease	Cardiovascular disease
10928	GCST000758	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
10929	GCST000760	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
10930	GCST000759	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
10931	GCST000759	LDL cholesterol	LDL cholesterol	Other measurement
10932	GCST000759	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
10933	GCST000755	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
10934	GCST004203	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10935	GCST004203	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10936	GCST004204	Systolic blood pressure	Systolic blood pressure	Other measurement
10937	GCST004204	Systolic blood pressure	Systolic blood pressure	Other measurement
10938	GCST004205	Pulse pressure	Pulse pressure	Cardiovascular measurement
10939	GCST004206	Fasting plasma glucose	Fasting plasma glucose	Other measurement
10940	GCST004207	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
10941	GCST004208	Body mass index	Body mass index	Body measurement
10942	GCST004208	Body mass index	Body mass index	Body measurement
10943	GCST004208	Body mass index	Body mass index	Other measurement
10944	GCST004209	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
10945	GCST004210	Body fat percentage	Body fat percentage	Body measurement
10946	GCST004211	Urate levels	Urate levels	Metabolic disorder
10947	GCST004211	Urate levels	Urate levels	Other measurement
10948	GCST004212	Height	Height	Other measurement
10949	GCST004212	Height	Height	Body measurement
10950	GCST004213	Resting heart rate	Resting heart rate	Cardiovascular measurement
10951	GCST004214	Creatinine levels	Creatinine levels	Other measurement
10952	GCST004215	Urea levels	Urea levels	Other measurement
10953	GCST004215	Urea levels	Urea levels	Other measurement
10954	GCST004216	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Body measurement
10955	GCST004216	Waist-to-hip ratio adjusted for body mass index	Waist-to-hip ratio adjusted for body mass index	Other measurement
10956	GCST004385	Systolic blood pressure	Systolic blood pressure	Other measurement
10957	GCST004385	Systolic blood pressure	Systolic blood pressure	Other measurement
10958	GCST004386	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10959	GCST004386	Diastolic blood pressure	Diastolic blood pressure	Other measurement
10960	GCST004387	Pulse pressure	Pulse pressure	Cardiovascular measurement
10961	GCST004384	Hypertension	Hypertension	Cardiovascular disease
10962	GCST004388	Blood pressure traits (multi-trait analysis)	Blood pressure traits (multi-trait analysis)	Other measurement
10963	GCST004388	Blood pressure traits (multi-trait analysis)	Blood pressure traits (multi-trait analysis)	Other measurement
10964	GCST004388	Blood pressure traits (multi-trait analysis)	Blood pressure traits (multi-trait analysis)	Cardiovascular disease
10965	GCST004388	Blood pressure traits (multi-trait analysis)	Blood pressure traits (multi-trait analysis)	Cardiovascular measurement
10966	GCST001519	Economic and political preferences	Economic and political preferences	Other trait
10967	GCST001512	Economic and political preferences (environmentalism)	Economic and political preferences (environmentalism)	Other trait
10968	GCST001513	Economic and political preferences (fairness)	Economic and political preferences (fairness)	Other trait
10969	GCST001514	Economic and political preferences (feminism/equality)	Economic and political preferences (feminism/equality)	Other trait
10970	GCST001515	Economic and political preferences (immigration/crime)	Economic and political preferences (immigration/crime)	Other trait
10971	GCST001511	Economic and political preferences (time)	Economic and political preferences (time)	Other trait
10972	GCST002135	Nicotine use	Nicotine use	Biological process
10973	GCST002130	Alcohol consumption	Alcohol consumption	Biological process
10974	GCST002130	Alcohol consumption	Alcohol consumption	Other measurement
10975	GCST002134	Alcohol dependence	Alcohol dependence	Other measurement
10976	GCST002134	Alcohol dependence	Alcohol dependence	Neurological disorder
10977	GCST002133	Illicit drug use	Illicit drug use	Biological process
10978	GCST002132	Non-substance related behavioral disinhibition	Non-substance related behavioral disinhibition	Biological process
10979	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Biological process
10980	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Neurological disorder
10981	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Biological process
10982	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Biological process
10983	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Biological process
10984	GCST002131	Behavioural disinhibition (generation interaction)	Behavioural disinhibition (generation interaction)	Other measurement
10985	GCST004795	Brain volume in infants (white matter)	Brain volume in infants (white matter)	Other measurement
10986	GCST004796	Brain volume in infants (cerebrospinal fluid)	Brain volume in infants (cerebrospinal fluid)	Other measurement
10987	GCST004797	Brain volume in infants (grey matter)	Brain volume in infants (grey matter)	Other measurement
10988	GCST004794	Brain volume in infants (intracranial brain volume)	Brain volume in infants (intracranial brain volume)	Other measurement
10989	GCST004358	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Other disease
10990	GCST004358	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Immune system disorder
10991	GCST004358	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Methotrexate-induced interstitial lung disease in rheumatoid arthritis	Response to drug
10992	GCST004600	Eosinophil percentage of white cells	Eosinophil percentage of white cells	Hematological measurement
10993	GCST004602	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
10994	GCST004603	Platelet count	Platelet count	Hematological measurement
10995	GCST004604	Hematocrit	Hematocrit	Hematological measurement
10996	GCST004605	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
10997	GCST004605	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
10998	GCST004606	Eosinophil counts	Eosinophil counts	Hematological measurement
10999	GCST004607	Plateletcrit	Plateletcrit	Hematological measurement
11000	GCST004608	Granulocyte percentage of myeloid white cells	Granulocyte percentage of myeloid white cells	Hematological measurement
11001	GCST004609	Monocyte percentage of white cells	Monocyte percentage of white cells	Hematological measurement
11002	GCST004610	White blood cell count	White blood cell count	Hematological measurement
11003	GCST004610	White blood cell count	White blood cell count	Inflammatory measurement
11004	GCST004610	White blood cell count	White blood cell count	Hematological measurement
11005	GCST004610	White blood cell count	White blood cell count	Hematological measurement
11006	GCST004610	White blood cell count	White blood cell count	Hematological measurement
11007	GCST004611	High light scatter reticulocyte count	High light scatter reticulocyte count	Hematological measurement
11008	GCST004613	Sum neutrophil eosinophil counts	Sum neutrophil eosinophil counts	Hematological measurement
11009	GCST004613	Sum neutrophil eosinophil counts	Sum neutrophil eosinophil counts	Hematological measurement
11010	GCST004613	Sum neutrophil eosinophil counts	Sum neutrophil eosinophil counts	Hematological measurement
11011	GCST004614	Granulocyte count	Granulocyte count	Hematological measurement
11012	GCST004612	High light scatter reticulocyte percentage of red cells	High light scatter reticulocyte percentage of red cells	Hematological measurement
11013	GCST004615	Hemoglobin concentration	Hemoglobin concentration	Hematological measurement
11014	GCST004616	Platelet distribution width	Platelet distribution width	Hematological measurement
11015	GCST004617	Eosinophil percentage of granulocytes	Eosinophil percentage of granulocytes	Hematological measurement
11016	GCST004618	White blood cell count (basophil)	White blood cell count (basophil)	Inflammatory measurement
11017	GCST004619	Reticulocyte fraction of red cells	Reticulocyte fraction of red cells	Hematological measurement
11018	GCST004620	Sum basophil neutrophil counts	Sum basophil neutrophil counts	Inflammatory measurement
11019	GCST004620	Sum basophil neutrophil counts	Sum basophil neutrophil counts	Hematological measurement
11020	GCST004620	Sum basophil neutrophil counts	Sum basophil neutrophil counts	Hematological measurement
11021	GCST004621	Red cell distribution width	Red cell distribution width	Hematological measurement
11022	GCST004622	Reticulocyte count	Reticulocyte count	Hematological measurement
11023	GCST004623	Neutrophil percentage of granulocytes	Neutrophil percentage of granulocytes	Hematological measurement
11024	GCST004624	Sum eosinophil basophil counts	Sum eosinophil basophil counts	Inflammatory measurement
11025	GCST004624	Sum eosinophil basophil counts	Sum eosinophil basophil counts	Hematological measurement
11026	GCST004624	Sum eosinophil basophil counts	Sum eosinophil basophil counts	Hematological measurement
11027	GCST004625	Monocyte count	Monocyte count	Hematological measurement
11028	GCST004626	Myeloid white cell count	Myeloid white cell count	Hematological measurement
11029	GCST004627	Lymphocyte counts	Lymphocyte counts	Hematological measurement
11030	GCST004628	Immature fraction of reticulocytes	Immature fraction of reticulocytes	Hematological measurement
11031	GCST004629	Neutrophil count	Neutrophil count	Hematological measurement
11032	GCST004630	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
11033	GCST004630	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
11034	GCST004631	Basophil percentage of white cells	Basophil percentage of white cells	Inflammatory measurement
11035	GCST004632	Lymphocyte percentage of white cells	Lymphocyte percentage of white cells	Hematological measurement
11036	GCST004633	Neutrophil percentage of white cells	Neutrophil percentage of white cells	Hematological measurement
11037	GCST004634	Basophil percentage of granulocytes	Basophil percentage of granulocytes	Inflammatory measurement
11038	GCST004599	Mean platelet volume	Mean platelet volume	Hematological measurement
11039	GCST004601	Red blood cell count	Red blood cell count	Hematological measurement
11040	GCST003965	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
11041	GCST003966	Visceral adipose tissue	Visceral adipose tissue	Other measurement
11042	GCST003968	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
11043	GCST003968	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
11044	GCST003968	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Other measurement
11045	GCST003967	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
11046	GCST003967	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
11047	GCST003971	Pericardial fat	Pericardial fat	Other measurement
11048	GCST003970	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Other measurement
11049	GCST003969	Visceral adipose tissue attenuation (Hounslow unit scale)	Visceral adipose tissue attenuation (Hounslow unit scale)	Other measurement
11050	GCST003972	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11051	GCST003972	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11052	GCST003973	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Other measurement
11053	GCST003973	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Body measurement
11054	GCST006534	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
11055	GCST006534	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
11056	GCST006533	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
11057	GCST006533	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
11058	GCST006537	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
11059	GCST006538	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
11060	GCST006540	Visceral adipose tissue	Visceral adipose tissue	Other measurement
11061	GCST006542	Visceral adipose tissue	Visceral adipose tissue	Other measurement
11062	GCST006543	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
11063	GCST006543	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
11064	GCST006543	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Other measurement
11065	GCST006544	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
11066	GCST006544	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Body measurement
11067	GCST006544	Pericardial adipose tissue adjusted for height and weight	Pericardial adipose tissue adjusted for height and weight	Other measurement
11068	GCST006550	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Other measurement
11069	GCST006549	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Subcutaneous adipose tissue attenuation (Hounsfield unit scale)	Other measurement
11070	GCST006545	Pericardial fat	Pericardial fat	Other measurement
11071	GCST006546	Pericardial fat	Pericardial fat	Other measurement
11072	GCST006547	Visceral adipose tissue attenuation (Hounslow unit scale)	Visceral adipose tissue attenuation (Hounslow unit scale)	Other measurement
11073	GCST006548	Visceral adipose tissue attenuation (Hounslow unit scale)	Visceral adipose tissue attenuation (Hounslow unit scale)	Other measurement
11074	GCST006552	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11075	GCST006552	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11076	GCST006551	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11077	GCST006551	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11078	GCST006553	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Other measurement
11079	GCST006553	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Body measurement
11080	GCST006554	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Other measurement
11081	GCST006554	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Body measurement
11082	GCST001521	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
11083	GCST001525	Visceral fat	Visceral fat	Other measurement
11084	GCST001524	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11085	GCST001524	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11086	GCST001523	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
11087	GCST001523	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
11088	GCST000972	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11089	GCST000976	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11090	GCST000975	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
11091	GCST000975	LDL cholesterol	LDL cholesterol	Other measurement
11092	GCST000975	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
11093	GCST000974	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
11094	GCST000973	Hypertension	Hypertension	Cardiovascular disease
11095	GCST005965	B cell acute lymphoblastic leukaemia (normal cytogenetics)	B cell acute lymphoblastic leukaemia (normal cytogenetics)	Cancer
11096	GCST005966	B cell acute lymphoblastic leukaemia (hyperdiploid negative)	B cell acute lymphoblastic leukaemia (hyperdiploid negative)	Cancer
11097	GCST005967	B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)	B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)	Cancer
11098	GCST005968	B cell acute lymphoblastic leukaemia (abnormal cytogenetics)	B cell acute lymphoblastic leukaemia (abnormal cytogenetics)	Cancer
11099	GCST005969	Acute lymphoblastic leukemia in childhood (B cell precursor)	Acute lymphoblastic leukemia in childhood (B cell precursor)	Cancer
11100	GCST005970	B cell acute lymphoblastic leukaemia in young adulthood	B cell acute lymphoblastic leukaemia in young adulthood	Cancer
11101	GCST005971	B cell acute lymphoblastic leukaemia in adulthood	B cell acute lymphoblastic leukaemia in adulthood	Cancer
11102	GCST005972	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
11103	GCST005972	Acute lymphoblastic leukemia (B-cell precursor)	Acute lymphoblastic leukemia (B-cell precursor)	Cancer
11104	GCST000497	Mean platelet volume	Mean platelet volume	Hematological measurement
11105	GCST000498	Hematological parameters	Hematological parameters	Hematological measurement
11106	GCST000498	Hematological parameters	Hematological parameters	Hematological measurement
11107	GCST000498	Hematological parameters	Hematological parameters	Hematological measurement
11108	GCST000498	Hematological parameters	Hematological parameters	Hematological measurement
11109	GCST000498	Hematological parameters	Hematological parameters	Hematological measurement
11110	GCST005032	Early gestational weight gain (fetal effect)	Early gestational weight gain (fetal effect)	Other measurement
11111	GCST005032	Early gestational weight gain (fetal effect)	Early gestational weight gain (fetal effect)	Other measurement
11112	GCST005031	Gestational weight gain (fetal effect)	Gestational weight gain (fetal effect)	Other measurement
11113	GCST005031	Gestational weight gain (fetal effect)	Gestational weight gain (fetal effect)	Other measurement
11114	GCST005030	Late gestational weight gain (fetal effect)	Late gestational weight gain (fetal effect)	Other measurement
11115	GCST005030	Late gestational weight gain (fetal effect)	Late gestational weight gain (fetal effect)	Other measurement
11116	GCST005029	Early gestation weight gain (maternal effect)	Early gestation weight gain (maternal effect)	Other measurement
11117	GCST005034	Late gestational weight gain (maternal effect)	Late gestational weight gain (maternal effect)	Other measurement
11118	GCST005033	Gestational weight gain (maternal effect)	Gestational weight gain (maternal effect)	Other measurement
11119	GCST005154	Alloimmunization response to pregnancy (HLA class I and II)	Alloimmunization response to pregnancy (HLA class I and II)	Biological process
11120	GCST005156	Alloimmunization response to pregnancy (HLA class I)	Alloimmunization response to pregnancy (HLA class I)	Biological process
11121	GCST005157	Alloimmunization response to pregnancy (HLA class II)	Alloimmunization response to pregnancy (HLA class II)	Biological process
11122	GCST005155	Alloimmunization response to pregnancy	Alloimmunization response to pregnancy	Biological process
11123	GCST001464	Podoconiosis	Podoconiosis	Immune system disorder
11124	GCST001946	PCA3 expression level	PCA3 expression level	Other measurement
11125	GCST003720	Migraine	Migraine	Cardiovascular disease
11126	GCST003721	Migraine without aura	Migraine without aura	Cardiovascular disease
11127	GCST003721	Migraine without aura	Migraine without aura	Cardiovascular disease
11128	GCST003722	Migraine with aura	Migraine with aura	Cardiovascular disease
11129	GCST003722	Migraine with aura	Migraine with aura	Cardiovascular disease
11130	GCST005216	Corrected insulin response adjusted for insulin sensitivity index	Corrected insulin response adjusted for insulin sensitivity index	Other measurement
11131	GCST005216	Corrected insulin response adjusted for insulin sensitivity index	Corrected insulin response adjusted for insulin sensitivity index	Other measurement
11132	GCST005221	Insulin sensitivity index	Insulin sensitivity index	Other measurement
11133	GCST005220	Insulin levels	Insulin levels	Other measurement
11134	GCST005217	Insulin levels adjusted for BMI	Insulin levels adjusted for BMI	Other measurement
11135	GCST005223	Ratio of the area under the curve for insulin and the area under the curve for glucose	Ratio of the area under the curve for insulin and the area under the curve for glucose	Other measurement
11136	GCST005219	Incremental insulin	Incremental insulin	Other measurement
11137	GCST005215	Corrected insulin response	Corrected insulin response	Other measurement
11138	GCST005218	Area under the curve of insulin levels	Area under the curve of insulin levels	Other measurement
11139	GCST005222	Insulin disposition index	Insulin disposition index	Other measurement
11140	GCST000135	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
11141	GCST000132	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
11142	GCST000132	LDL cholesterol	LDL cholesterol	Other measurement
11143	GCST000132	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
11144	GCST000139	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
11145	GCST002069	Systemic lupus erythematosus and Systemic sclerosis	Systemic lupus erythematosus and Systemic sclerosis	Neurological disorder
11146	GCST002069	Systemic lupus erythematosus and Systemic sclerosis	Systemic lupus erythematosus and Systemic sclerosis	Immune system disorder
11147	GCST003616	Liver disease severity in Alagille syndrome	Liver disease severity in Alagille syndrome	Neurological disorder
11148	GCST003616	Liver disease severity in Alagille syndrome	Liver disease severity in Alagille syndrome	Digestive system disorder
11149	GCST004010	QT interval (tricyclic/tetracyclic antidepressant use interaction)	QT interval (tricyclic/tetracyclic antidepressant use interaction)	Cardiovascular measurement
11150	GCST004010	QT interval (tricyclic/tetracyclic antidepressant use interaction)	QT interval (tricyclic/tetracyclic antidepressant use interaction)	Response to drug
11151	GCST004010	QT interval (tricyclic/tetracyclic antidepressant use interaction)	QT interval (tricyclic/tetracyclic antidepressant use interaction)	Response to drug
11152	GCST004011	RR interval (tricyclic/tetracyclic antidepressant use interaction)	RR interval (tricyclic/tetracyclic antidepressant use interaction)	Cardiovascular measurement
11153	GCST004011	RR interval (tricyclic/tetracyclic antidepressant use interaction)	RR interval (tricyclic/tetracyclic antidepressant use interaction)	Response to drug
11154	GCST004011	RR interval (tricyclic/tetracyclic antidepressant use interaction)	RR interval (tricyclic/tetracyclic antidepressant use interaction)	Response to drug
11155	GCST000837	Weight	Weight	Body measurement
11156	GCST000838	Waist circumference	Waist circumference	Body measurement
11157	GCST000840	Body mass index	Body mass index	Body measurement
11158	GCST000840	Body mass index	Body mass index	Body measurement
11159	GCST000840	Body mass index	Body mass index	Other measurement
11160	GCST000839	Height	Height	Other measurement
11161	GCST000839	Height	Height	Body measurement
11162	GCST000472	Colorectal cancer	Colorectal cancer	Cancer
11163	GCST002011	Bone mineral density	Bone mineral density	Other measurement
11164	GCST004421	beta-nerve growth factor levels	beta-nerve growth factor levels	Other measurement
11165	GCST004422	Vascular endothelial growth factor levels	Vascular endothelial growth factor levels	Cardiovascular measurement
11166	GCST004420	CTACK levels	CTACK levels	Other measurement
11167	GCST004460	Eotaxin levels	Eotaxin levels	Other measurement
11168	GCST004459	Fibroblast growth factor basic levels	Fibroblast growth factor basic levels	Other measurement
11169	GCST004458	Granulocyte-colony stimulating factor levels	Granulocyte-colony stimulating factor levels	Other measurement
11170	GCST004457	Growth-regulated protein alpha levels	Growth-regulated protein alpha levels	Other measurement
11171	GCST004449	Hepatocyte growth factor levels	Hepatocyte growth factor levels	Cardiovascular measurement
11172	GCST004456	Interferon gamma levels	Interferon gamma levels	Other measurement
11173	GCST004448	Interleukin-1-beta levels	Interleukin-1-beta levels	Inflammatory measurement
11174	GCST004447	Interleukin-1-receptor antagonist levels	Interleukin-1-receptor antagonist levels	Inflammatory measurement
11175	GCST004455	Interleukin-2 levels	Interleukin-2 levels	Other measurement
11176	GCST004454	Interleukin-2 receptor antagonist levels	Interleukin-2 receptor antagonist levels	Other measurement
11177	GCST004453	Interleukin-4 levels	Interleukin-4 levels	Other measurement
11178	GCST004452	Interleukin-5 levels	Interleukin-5 levels	Other measurement
11179	GCST004446	Interleukin-6 levels	Interleukin-6 levels	Inflammatory measurement
11180	GCST004451	Interleukin-7 levels	Interleukin-7 levels	Other measurement
11181	GCST004445	Interleukin-8 levels	Interleukin-8 levels	Other measurement
11182	GCST004445	Interleukin-8 levels	Interleukin-8 levels	Inflammatory measurement
11183	GCST004450	Interleukin-9 levels	Interleukin-9 levels	Other measurement
11184	GCST004444	Interleukin-10 levels	Interleukin-10 levels	Inflammatory measurement
11185	GCST004443	Interleukin-13 levels	Interleukin-13 levels	Other measurement
11186	GCST004442	Interleukin-17 levels	Interleukin-17 levels	Other measurement
11187	GCST004441	Interleukin-18 levels	Interleukin-18 levels	Inflammatory measurement
11188	GCST004423	Macrophage Migration Inhibitory Factor levels	Macrophage Migration Inhibitory Factor levels	Other measurement
11189	GCST004440	Interferon gamma-induced protein 10 levels	Interferon gamma-induced protein 10 levels	Other measurement
11190	GCST004439	Interleukin-12p70 levels	Interleukin-12p70 levels	Other measurement
11191	GCST004430	Interleukin-16 levels	Interleukin-16 levels	Other measurement
11192	GCST004438	Monocyte chemoattractant protein-1 levels	Monocyte chemoattractant protein-1 levels	Other measurement
11193	GCST004437	Monocyte chemoattractant protein-3 levels	Monocyte chemoattractant protein-3 levels	Other measurement
11194	GCST004436	Macrophage colony stimulating factor levels	Macrophage colony stimulating factor levels	Other measurement
11195	GCST004435	Monokine induced by gamma interferon levels	Monokine induced by gamma interferon levels	Other measurement
11196	GCST004434	Macrophage inflammatory protein 1a levels	Macrophage inflammatory protein 1a levels	Other measurement
11197	GCST004433	Macrophage inflammatory protein 1b levels	Macrophage inflammatory protein 1b levels	Other measurement
11198	GCST004432	Platelet-derived growth factor BB levels	Platelet-derived growth factor BB levels	Other measurement
11199	GCST004431	RANTES levels	RANTES levels	Inflammatory measurement
11200	GCST004429	Stem cell factor levels	Stem cell factor levels	Other measurement
11201	GCST004428	Stem cell growth factor beta levels	Stem cell growth factor beta levels	Other measurement
11202	GCST004427	Stromal-cell-derived factor 1 alpha levels	Stromal-cell-derived factor 1 alpha levels	Other measurement
11203	GCST004426	Tumor necrosis factor alpha levels	Tumor necrosis factor alpha levels	Inflammatory measurement
11204	GCST004425	Tumor necrosis factor beta levels	Tumor necrosis factor beta levels	Other measurement
11205	GCST004424	TRAIL levels	TRAIL levels	Other measurement
11206	GCST004868	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
11207	GCST004868	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
11208	GCST004868	Advanced age-related macular degeneration	Advanced age-related macular degeneration	Neurological disorder
11209	GCST004869	Age-related macular degeneration (SNP x mitochondrial T5004C interaction)	Age-related macular degeneration (SNP x mitochondrial T5004C interaction)	Neurological disorder
11210	GCST004870	Age-related macular degeneration (SNP x mitochondrial A4917G interaction)	Age-related macular degeneration (SNP x mitochondrial A4917G interaction)	Neurological disorder
11211	GCST004871	Age-related macular degeneration (SNP x mitochondrial G12771A interaction)	Age-related macular degeneration (SNP x mitochondrial G12771A interaction)	Neurological disorder
11212	GCST004872	Age-related macular degeneration (SNP x mitochondrial C16069T interaction)	Age-related macular degeneration (SNP x mitochondrial C16069T interaction)	Neurological disorder
11213	GCST004740	Duloxetine response in major depressive disorder (remitter/non-remitter status)	Duloxetine response in major depressive disorder (remitter/non-remitter status)	Neurological disorder
11214	GCST004740	Duloxetine response in major depressive disorder (remitter/non-remitter status)	Duloxetine response in major depressive disorder (remitter/non-remitter status)	Response to drug
11215	GCST004741	Duloxetine response in major depressive disorder (responder/non-responder status)	Duloxetine response in major depressive disorder (responder/non-responder status)	Neurological disorder
11216	GCST004741	Duloxetine response in major depressive disorder (responder/non-responder status)	Duloxetine response in major depressive disorder (responder/non-responder status)	Response to drug
11217	GCST004742	Placebo response in major depressive disorder (remitter/non-remitter status)	Placebo response in major depressive disorder (remitter/non-remitter status)	Neurological disorder
11218	GCST004742	Placebo response in major depressive disorder (remitter/non-remitter status)	Placebo response in major depressive disorder (remitter/non-remitter status)	Biological process
11219	GCST004743	Placebo response in major depressive disorder (responder/non-responder status)	Placebo response in major depressive disorder (responder/non-responder status)	Neurological disorder
11220	GCST004743	Placebo response in major depressive disorder (responder/non-responder status)	Placebo response in major depressive disorder (responder/non-responder status)	Biological process
11221	GCST004738	Duloxetine response in major depressive disorder (% change in symptom score)	Duloxetine response in major depressive disorder (% change in symptom score)	Neurological disorder
11222	GCST004738	Duloxetine response in major depressive disorder (% change in symptom score)	Duloxetine response in major depressive disorder (% change in symptom score)	Response to drug
11223	GCST004739	Placebo response in major depressive disorder (% change in symptom score)	Placebo response in major depressive disorder (% change in symptom score)	Neurological disorder
11224	GCST004739	Placebo response in major depressive disorder (% change in symptom score)	Placebo response in major depressive disorder (% change in symptom score)	Biological process
11225	GCST004734	Heart rate variability traits (SDNN)	Heart rate variability traits (SDNN)	Cardiovascular measurement
11226	GCST004733	Heart rate variability traits (RMSSD)	Heart rate variability traits (RMSSD)	Cardiovascular measurement
11227	GCST004732	Heart rate variability traits (pvRSA/HF)	Heart rate variability traits (pvRSA/HF)	Cardiovascular measurement
11228	GCST005426	Intracranial haemorrhage in renal transplantation (donors)	Intracranial haemorrhage in renal transplantation (donors)	Cardiovascular disease
11229	GCST005427	End stage renal failure in renal transplantation (recipient effect)	End stage renal failure in renal transplantation (recipient effect)	Other disease
11230	GCST005427	End stage renal failure in renal transplantation (recipient effect)	End stage renal failure in renal transplantation (recipient effect)	Other measurement
11231	GCST005428	Graft survival time in renal transplantation (recipient effect)	Graft survival time in renal transplantation (recipient effect)	Other measurement
11232	GCST005429	Graft survival time in renal transplantation (donor effect)	Graft survival time in renal transplantation (donor effect)	Other measurement
11233	GCST005429	Graft survival time in renal transplantation (donor effect)	Graft survival time in renal transplantation (donor effect)	Other measurement
11234	GCST005430	Graft survival time in renal transplantation (donor-recipient interaction)	Graft survival time in renal transplantation (donor-recipient interaction)	Other measurement
11235	GCST005430	Graft survival time in renal transplantation (donor-recipient interaction)	Graft survival time in renal transplantation (donor-recipient interaction)	Other measurement
11236	GCST005431	Acute graft rejection in renal transplantation (recipient effect)	Acute graft rejection in renal transplantation (recipient effect)	Other measurement
11237	GCST005432	Acute graft rejection in renal transplantation (donor effect)	Acute graft rejection in renal transplantation (donor effect)	Other measurement
11238	GCST005432	Acute graft rejection in renal transplantation (donor effect)	Acute graft rejection in renal transplantation (donor effect)	Other measurement
11239	GCST005433	Acute graft rejection in renal transplantation (donor-recipient interaction)	Acute graft rejection in renal transplantation (donor-recipient interaction)	Other measurement
11240	GCST005433	Acute graft rejection in renal transplantation (donor-recipient interaction)	Acute graft rejection in renal transplantation (donor-recipient interaction)	Other measurement
11241	GCST005946	Cleft palate	Cleft palate	Other trait
11242	GCST005948	Cleft palate	Cleft palate	Other trait
11243	GCST005947	Cleft palate	Cleft palate	Other trait
11244	GCST002978	Metastasis at diagnosis in osteosarcoma	Metastasis at diagnosis in osteosarcoma	Other measurement
11245	GCST002978	Metastasis at diagnosis in osteosarcoma	Metastasis at diagnosis in osteosarcoma	Cancer
11246	GCST002978	Metastasis at diagnosis in osteosarcoma	Metastasis at diagnosis in osteosarcoma	Other measurement
11247	GCST004956	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Other measurement
11248	GCST004956	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Neurological disorder
11249	GCST004956	Risky sexual behaviors (alcohol dependence interaction)	Risky sexual behaviors (alcohol dependence interaction)	Other measurement
11250	GCST004955	Risky sexual behaviors in alcohol dependence	Risky sexual behaviors in alcohol dependence	Neurological disorder
11251	GCST004955	Risky sexual behaviors in alcohol dependence	Risky sexual behaviors in alcohol dependence	Other measurement
11252	GCST002029	Temporomandibular joint disorder	Temporomandibular joint disorder	Other disease
11253	GCST006034	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
11254	GCST005973	White blood cell count	White blood cell count	Hematological measurement
11255	GCST005973	White blood cell count	White blood cell count	Inflammatory measurement
11256	GCST005973	White blood cell count	White blood cell count	Hematological measurement
11257	GCST005973	White blood cell count	White blood cell count	Hematological measurement
11258	GCST005973	White blood cell count	White blood cell count	Hematological measurement
11259	GCST005974	Neutrophil count	Neutrophil count	Hematological measurement
11260	GCST005975	Eosinophil counts	Eosinophil counts	Hematological measurement
11261	GCST005976	White blood cell count (basophil)	White blood cell count (basophil)	Inflammatory measurement
11262	GCST005977	Monocyte count	Monocyte count	Hematological measurement
11263	GCST005997	Lymphocyte counts	Lymphocyte counts	Hematological measurement
11264	GCST005996	Red blood cell count	Red blood cell count	Hematological measurement
11265	GCST005995	Hemoglobin	Hemoglobin	Hematological measurement
11266	GCST005994	Hematocrit	Hematocrit	Hematological measurement
11267	GCST006011	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
11268	GCST005993	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
11269	GCST005993	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
11270	GCST005992	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
11271	GCST005992	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
11272	GCST005991	Platelet count	Platelet count	Hematological measurement
11273	GCST005990	Non-albumin protein levels	Non-albumin protein levels	Other measurement
11274	GCST005990	Non-albumin protein levels	Non-albumin protein levels	Other measurement
11275	GCST005990	Non-albumin protein levels	Non-albumin protein levels	Other measurement
11276	GCST005989	Serum total protein level	Serum total protein level	Hematological measurement
11277	GCST005989	Serum total protein level	Serum total protein level	Other measurement
11278	GCST005988	Serum albumin level	Serum albumin level	Other measurement
11279	GCST005987	Albumin-globulin ratio	Albumin-globulin ratio	Cardiovascular measurement
11280	GCST005986	Blood urea nitrogen levels	Blood urea nitrogen levels	Other measurement
11281	GCST005985	Creatinine levels	Creatinine levels	Other measurement
11282	GCST005984	Glomerular filtration rate	Glomerular filtration rate	Other measurement
11283	GCST005983	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
11284	GCST006032	Sodium levels	Sodium levels	Other measurement
11285	GCST006031	Potassium levels	Potassium levels	Other measurement
11286	GCST006030	Chloride levels	Chloride levels	Other measurement
11287	GCST005982	Calcium levels	Calcium levels	Other measurement
11288	GCST005981	Phosphorus levels	Phosphorus levels	Other measurement
11289	GCST005980	Total bilirubin levels	Total bilirubin levels	Other measurement
11290	GCST005979	Systolic blood pressure	Systolic blood pressure	Other measurement
11291	GCST005979	Systolic blood pressure	Systolic blood pressure	Other measurement
11292	GCST005978	Diastolic blood pressure	Diastolic blood pressure	Other measurement
11293	GCST005978	Diastolic blood pressure	Diastolic blood pressure	Other measurement
11294	GCST006010	Mean arterial pressure	Mean arterial pressure	Other measurement
11295	GCST006009	Pulse pressure	Pulse pressure	Cardiovascular measurement
11296	GCST006008	Left ventricular internal dimension in diastole	Left ventricular internal dimension in diastole	Cardiovascular measurement
11297	GCST006007	Left ventricular internal dimension in systole	Left ventricular internal dimension in systole	Cardiovascular measurement
11298	GCST006033	Relative wall thickness	Relative wall thickness	Cardiovascular measurement
11299	GCST006029	Fractional shortening	Fractional shortening	Cardiovascular measurement
11300	GCST006006	Ejection fraction	Ejection fraction	Cardiovascular measurement
11301	GCST006028	Interventricular septum thickness	Interventricular septum thickness	Cardiovascular measurement
11302	GCST006027	Posterior wall thickness	Posterior wall thickness	Cardiovascular measurement
11303	GCST006026	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
11304	GCST006026	Left ventricular mass	Left ventricular mass	Cardiovascular measurement
11305	GCST006025	Left ventricular mass index	Left ventricular mass index	Cardiovascular measurement
11306	GCST006024	E/A ratio	E/A ratio	Cardiovascular measurement
11307	GCST006005	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
11308	GCST006004	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
11309	GCST006003	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
11310	GCST006002	Blood sugar levels	Blood sugar levels	Other measurement
11311	GCST006001	Hemoglobin A1c levels	Hemoglobin A1c levels	Other measurement
11312	GCST006001	Hemoglobin A1c levels	Hemoglobin A1c levels	Hematological measurement
11313	GCST006000	Immunoglobulin measurement (zinc sulfate turbidity test)	Immunoglobulin measurement (zinc sulfate turbidity test)	Other measurement
11314	GCST005999	Aspartate aminotransferase levels	Aspartate aminotransferase levels	Liver enzyme measurement
11315	GCST005998	Alanine transaminase levels	Alanine transaminase levels	Liver enzyme measurement
11316	GCST006016	Serum alkaline phosphatase levels	Serum alkaline phosphatase levels	Liver enzyme measurement
11317	GCST006019	Gamma glutamyl transferase levels	Gamma glutamyl transferase levels	Liver enzyme measurement
11318	GCST006018	Activated partial thromboplastin time	Activated partial thromboplastin time	Hematological measurement
11319	GCST006017	Prothrombin time	Prothrombin time	Hematological measurement
11320	GCST006015	Fibrinogen levels	Fibrinogen levels	Hematological measurement
11321	GCST006014	Creatine kinase levels	Creatine kinase levels	Cardiovascular measurement
11322	GCST006013	Lactate dehydrogenase levels	Lactate dehydrogenase levels	Hematological measurement
11323	GCST006012	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
11324	GCST003073	Cerebral amyloid deposition (PET imaging)	Cerebral amyloid deposition (PET imaging)	Other measurement
11325	GCST003072	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
11326	GCST003072	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
11327	GCST003075	Cognitive decline rate in late mild cognitive impairment	Cognitive decline rate in late mild cognitive impairment	Other measurement
11328	GCST003075	Cognitive decline rate in late mild cognitive impairment	Cognitive decline rate in late mild cognitive impairment	Other trait
11329	GCST003074	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	Other measurement
11330	GCST003070	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
11331	GCST003070	Cerebrospinal T-tau levels	Cerebrospinal T-tau levels	Other measurement
11332	GCST003071	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
11333	GCST003071	Cerebrospinal P-tau181p levels	Cerebrospinal P-tau181p levels	Other measurement
11334	GCST003078	Cerebrospinal fluid p-Tau181p:AB1-42 ratio	Cerebrospinal fluid p-Tau181p:AB1-42 ratio	Other measurement
11335	GCST003079	Cerebrospinal fluid t-tau:AB1-42 ratio	Cerebrospinal fluid t-tau:AB1-42 ratio	Other measurement
11336	GCST003076	Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	Other measurement
11337	GCST003076	Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	Other measurement
11338	GCST003077	Cerebral amyloid deposition positivity (PET imaging)	Cerebral amyloid deposition positivity (PET imaging)	Other measurement
11339	GCST002002	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	Response to drug
11340	GCST002002	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	Response to drug
11341	GCST002001	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	Response to drug
11342	GCST002001	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	Response to drug
11343	GCST001999	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	Response to drug
11344	GCST001999	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	Response to drug
11345	GCST001995	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	Response to drug
11346	GCST001995	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	Response to drug
11347	GCST001994	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	Response to drug
11348	GCST001994	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	Response to drug
11349	GCST001993	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	Response to drug
11350	GCST001993	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	Response to drug
11351	GCST002000	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	Response to drug
11352	GCST002000	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	Response to drug
11353	GCST002004	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	Response to drug
11354	GCST002004	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	Response to drug
11355	GCST002005	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	Response to drug
11356	GCST002005	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	Response to drug
11357	GCST002006	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Response to drug
11358	GCST002006	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Response to drug
11359	GCST002006	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	Response to drug
11360	GCST002007	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	Response to drug
11361	GCST002007	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	Response to drug
11362	GCST002008	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	Response to drug
11363	GCST002008	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	Response to drug
11364	GCST002009	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	Response to drug
11365	GCST002009	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	Response to drug
11366	GCST001996	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	Response to drug
11367	GCST001996	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	Response to drug
11368	GCST001997	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	Response to drug
11369	GCST001997	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	Response to drug
11370	GCST001998	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	Response to drug
11371	GCST001998	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	Response to drug
11372	GCST002003	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	Response to drug
11373	GCST002003	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	Response to drug
11374	GCST005531	Multiple sclerosis	Multiple sclerosis	Immune system disorder
11375	GCST004804	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	Metabolic disorder
11376	GCST004804	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	Other measurement
11377	GCST004807	Immunoglobulin light chain (AL) amyloidosis (liver involvement)	Immunoglobulin light chain (AL) amyloidosis (liver involvement)	Metabolic disorder
11378	GCST004807	Immunoglobulin light chain (AL) amyloidosis (liver involvement)	Immunoglobulin light chain (AL) amyloidosis (liver involvement)	Other measurement
11379	GCST004806	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Metabolic disorder
11380	GCST004806	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Cardiovascular measurement
11381	GCST004806	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	Other measurement
11382	GCST004810	Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	Metabolic disorder
11383	GCST004810	Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	Other measurement
11384	GCST004811	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	Metabolic disorder
11385	GCST004811	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	Other measurement
11386	GCST004809	Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	Metabolic disorder
11387	GCST004809	Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	Other measurement
11388	GCST004805	Immunoglobulin light chain (AL) amyloidosis (heart involvement)	Immunoglobulin light chain (AL) amyloidosis (heart involvement)	Metabolic disorder
11389	GCST004805	Immunoglobulin light chain (AL) amyloidosis (heart involvement)	Immunoglobulin light chain (AL) amyloidosis (heart involvement)	Cardiovascular measurement
11390	GCST004812	Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	Metabolic disorder
11391	GCST004812	Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	Other measurement
11392	GCST004808	Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	Metabolic disorder
11393	GCST004808	Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	Other measurement
11394	GCST002182	End-stage renal disease in Type 1 diabetics	End-stage renal disease in Type 1 diabetics	Other disease
11395	GCST002182	End-stage renal disease in Type 1 diabetics	End-stage renal disease in Type 1 diabetics	Metabolic disorder
11396	GCST004261	Liver injury in anti-retroviral drug treated HIV	Liver injury in anti-retroviral drug treated HIV	Response to drug
11397	GCST004261	Liver injury in anti-retroviral drug treated HIV	Liver injury in anti-retroviral drug treated HIV	Other disease
11398	GCST004261	Liver injury in anti-retroviral drug treated HIV	Liver injury in anti-retroviral drug treated HIV	Digestive system disorder
11399	GCST004262	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Response to drug
11400	GCST004262	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Response to drug
11401	GCST004262	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Other disease
11402	GCST004262	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Other disease
11403	GCST004262	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	Digestive system disorder
11404	GCST002033	Malaria	Malaria	Digestive system disorder
11405	GCST001044	Myopia (pathological)	Myopia (pathological)	Other trait
11406	GCST004748	Lung cancer	Lung cancer	Cancer
11407	GCST004748	Lung cancer	Lung cancer	Cancer
11408	GCST004748	Lung cancer	Lung cancer	Cancer
11409	GCST004744	Lung adenocarcinoma	Lung adenocarcinoma	Cancer
11410	GCST004750	Squamous cell lung carcinoma	Squamous cell lung carcinoma	Cancer
11411	GCST004746	Small cell lung carcinoma	Small cell lung carcinoma	Cancer
11412	GCST004749	Lung cancer in ever smokers	Lung cancer in ever smokers	Other measurement
11413	GCST004749	Lung cancer in ever smokers	Lung cancer in ever smokers	Cancer
11414	GCST004747	Lung cancer in never smokers	Lung cancer in never smokers	Other measurement
11415	GCST004747	Lung cancer in never smokers	Lung cancer in never smokers	Cancer
11416	GCST006990	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Neurological disorder
11417	GCST006990	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Other measurement
11418	GCST006991	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	Other measurement
11419	GCST006991	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia	Neurological disorder
11420	GCST006992	Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	Other measurement
11421	GCST006992	Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia	Neurological disorder
11422	GCST006993	Hippocampal volume in Alzheimer's disease dementia	Hippocampal volume in Alzheimer's disease dementia	Neurological disorder
11423	GCST006993	Hippocampal volume in Alzheimer's disease dementia	Hippocampal volume in Alzheimer's disease dementia	Other measurement
11424	GCST006994	Logical memory (immediate recall) in Alzheimer's disease dementia	Logical memory (immediate recall) in Alzheimer's disease dementia	Neurological disorder
11425	GCST006994	Logical memory (immediate recall) in Alzheimer's disease dementia	Logical memory (immediate recall) in Alzheimer's disease dementia	Other measurement
11426	GCST006995	Logical memory (delayed recall) in Alzheimer's disease dementia	Logical memory (delayed recall) in Alzheimer's disease dementia	Neurological disorder
11427	GCST006995	Logical memory (delayed recall) in Alzheimer's disease dementia	Logical memory (delayed recall) in Alzheimer's disease dementia	Other measurement
11428	GCST006997	Cerebrospinal fluid t-tau levels in mild cognitive impairment	Cerebrospinal fluid t-tau levels in mild cognitive impairment	Other measurement
11429	GCST006997	Cerebrospinal fluid t-tau levels in mild cognitive impairment	Cerebrospinal fluid t-tau levels in mild cognitive impairment	Other measurement
11430	GCST006998	Cerebrospinal fluid p-tau levels in mild cognitive impairment	Cerebrospinal fluid p-tau levels in mild cognitive impairment	Other measurement
11431	GCST006998	Cerebrospinal fluid p-tau levels in mild cognitive impairment	Cerebrospinal fluid p-tau levels in mild cognitive impairment	Other measurement
11432	GCST006999	Logical memory (immediate recall) in mild cognitive impairment	Logical memory (immediate recall) in mild cognitive impairment	Other measurement
11433	GCST006999	Logical memory (immediate recall) in mild cognitive impairment	Logical memory (immediate recall) in mild cognitive impairment	Other measurement
11434	GCST007000	Logical memory (delayed recall) in mild cognitive impairment	Logical memory (delayed recall) in mild cognitive impairment	Other measurement
11435	GCST007000	Logical memory (delayed recall) in mild cognitive impairment	Logical memory (delayed recall) in mild cognitive impairment	Other measurement
11436	GCST007001	Cerebrospinal AB1-42 levels in normal cognition	Cerebrospinal AB1-42 levels in normal cognition	Other measurement
11437	GCST007002	Cerebrospinal fluid t-tau levels in normal cognition	Cerebrospinal fluid t-tau levels in normal cognition	Other measurement
11438	GCST007003	Cerebrospinal fluid p-tau levels in normal cognition	Cerebrospinal fluid p-tau levels in normal cognition	Other measurement
11439	GCST007004	Hippocampal volume in normal cognition	Hippocampal volume in normal cognition	Other measurement
11440	GCST007005	Logical memory (immediate recall) in normal cognition	Logical memory (immediate recall) in normal cognition	Other measurement
11441	GCST007007	Cerebrospinal fluid t-tau levels	Cerebrospinal fluid t-tau levels	Other measurement
11442	GCST007008	Cerebrospinal fluid p-tau levels	Cerebrospinal fluid p-tau levels	Other measurement
11443	GCST007009	Hippocampal volume	Hippocampal volume	Other measurement
11444	GCST007010	Logical memory (delayed recall)	Logical memory (delayed recall)	Other measurement
11445	GCST007011	Logical memory (immediate recall)	Logical memory (immediate recall)	Other measurement
11446	GCST006996	Cerebrospinal AB1-42 levels in mild cognitive impairment	Cerebrospinal AB1-42 levels in mild cognitive impairment	Other measurement
11447	GCST006996	Cerebrospinal AB1-42 levels in mild cognitive impairment	Cerebrospinal AB1-42 levels in mild cognitive impairment	Other measurement
11448	GCST007006	Logical memory (delayed recall) in normal cognition	Logical memory (delayed recall) in normal cognition	Other measurement
11449	GCST007012	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
11450	GCST007012	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
11451	GCST007013	Hippocampal volume in mild cognitive impairment	Hippocampal volume in mild cognitive impairment	Other measurement
11452	GCST007013	Hippocampal volume in mild cognitive impairment	Hippocampal volume in mild cognitive impairment	Other measurement
11453	GCST000641	Bipolar disorder or major depressive disorder	Bipolar disorder or major depressive disorder	Neurological disorder
11454	GCST000641	Bipolar disorder or major depressive disorder	Bipolar disorder or major depressive disorder	Neurological disorder
11455	GCST006865	Bipolar disorder	Bipolar disorder	Neurological disorder
11456	GCST006582	Major depressive disorder	Major depressive disorder	Neurological disorder
11457	GCST004992	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	Other measurement
11458	GCST004992	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	Neurological disorder
11459	GCST004992	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	Other measurement
11460	GCST004996	Total mean fractional anisotropy measurement in first episode schizophrenia	Total mean fractional anisotropy measurement in first episode schizophrenia	Other measurement
11461	GCST004996	Total mean fractional anisotropy measurement in first episode schizophrenia	Total mean fractional anisotropy measurement in first episode schizophrenia	Neurological disorder
11462	GCST004996	Total mean fractional anisotropy measurement in first episode schizophrenia	Total mean fractional anisotropy measurement in first episode schizophrenia	Other measurement
11463	GCST004995	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	Other measurement
11464	GCST004995	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	Neurological disorder
11465	GCST004995	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	Other measurement
11466	GCST004991	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	Other measurement
11467	GCST004991	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	Neurological disorder
11468	GCST004991	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	Other measurement
11469	GCST004997	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Other measurement
11470	GCST004997	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Neurological disorder
11471	GCST004997	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Other measurement
11472	GCST004997	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	Other measurement
11473	GCST004994	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	Other measurement
11474	GCST004994	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	Neurological disorder
11475	GCST004994	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	Other measurement
11476	GCST004993	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	Other measurement
11477	GCST004993	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	Neurological disorder
11478	GCST004993	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	Other measurement
11479	GCST002928	Nickel levels	Nickel levels	Other measurement
11480	GCST002929	Chromium levels	Chromium levels	Other measurement
11481	GCST002930	Cobalt levels	Cobalt levels	Other measurement
11482	GCST002931	Aluminium levels	Aluminium levels	Other measurement
11483	GCST002932	Manganese levels	Manganese levels	Other measurement
11484	GCST002937	Molybdenum levels	Molybdenum levels	Other measurement
11485	GCST002935	Lead levels	Lead levels	Other measurement
11486	GCST002934	Zinc levels	Zinc levels	Other measurement
11487	GCST002927	Mercury levels	Mercury levels	Other measurement
11488	GCST002936	Cadmium levels	Cadmium levels	Other measurement
11489	GCST002938	Copper levels	Copper levels	Other measurement
11490	GCST004695	Insomnia complaints	Insomnia complaints	Neurological disorder
11491	GCST004694	Sleep duration	Sleep duration	Other measurement
11492	GCST004700	Insomnia complaints (sex interaction)	Insomnia complaints (sex interaction)	Neurological disorder
11493	GCST004701	Insomnia complaints (continuous)	Insomnia complaints (continuous)	Neurological disorder
11494	GCST004702	Insomnia complaints (dichotomous)	Insomnia complaints (dichotomous)	Neurological disorder
11495	GCST004696	Chronotype	Chronotype	Biological process
11496	GCST004696	Chronotype	Chronotype	Other measurement
11497	GCST004697	Ease of getting up in the morning	Ease of getting up in the morning	Other measurement
11498	GCST004693	Daytime nap	Daytime nap	Other measurement
11499	GCST004698	Snoring	Snoring	Other measurement
11500	GCST004699	Daytime sleepiness	Daytime sleepiness	Other measurement
11501	GCST006487	Insomnia complaints	Insomnia complaints	Neurological disorder
11502	GCST006488	Insomnia complaints	Insomnia complaints	Neurological disorder
11503	GCST004890	Diastolic blood pressure	Diastolic blood pressure	Other measurement
11504	GCST004890	Diastolic blood pressure	Diastolic blood pressure	Other measurement
11505	GCST004891	Mean arterial pressure	Mean arterial pressure	Other measurement
11506	GCST004888	Systolic blood pressure	Systolic blood pressure	Other measurement
11507	GCST004888	Systolic blood pressure	Systolic blood pressure	Other measurement
11508	GCST004892	Pulse pressure	Pulse pressure	Cardiovascular measurement
11509	GCST004889	Hypertension	Hypertension	Cardiovascular disease
11510	GCST000192	Blue vs. green eyes	Blue vs. green eyes	Other trait
11511	GCST000196	Burning and freckling	Burning and freckling	Other disease
11512	GCST000196	Burning and freckling	Burning and freckling	Other trait
11513	GCST000197	Freckles	Freckles	Other trait
11514	GCST000195	Skin sensitivity to sun	Skin sensitivity to sun	Immune system disorder
11515	GCST000194	Blond vs. brown hair color	Blond vs. brown hair color	Other trait
11516	GCST000193	Red vs. non-red hair color	Red vs. non-red hair color	Other trait
11517	GCST000028	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11518	GCST000026	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
11519	GCST004919	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
11520	GCST004920	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
11521	GCST004920	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
11522	GCST004921	Apolipoprotein A1 levels	Apolipoprotein A1 levels	Lipid or lipoprotein measurement
11523	GCST004487	Peak insulin response	Peak insulin response	Other measurement
11524	GCST004575	Acute insulin response	Acute insulin response	Other measurement
11525	GCST004488	Insulin secretion rate	Insulin secretion rate	Other measurement
11526	GCST004489	Insulin disposition index	Insulin disposition index	Other measurement
11527	GCST006681	Insulin disposition index (BMI adjusted)	Insulin disposition index (BMI adjusted)	Other measurement
11528	GCST006675	Peak insulin response (BMI and insulin secretion adjusted)	Peak insulin response (BMI and insulin secretion adjusted)	Other measurement
11529	GCST006676	Peak insulin response (insulin secretion adjusted)	Peak insulin response (insulin secretion adjusted)	Other measurement
11530	GCST006678	Acute insulin response (insulin secretion and BMI adjusted)	Acute insulin response (insulin secretion and BMI adjusted)	Other measurement
11531	GCST006677	Acute insulin response (insulin secretion adjusted)	Acute insulin response (insulin secretion adjusted)	Other measurement
11532	GCST006679	insulin secretion rate (BMI adjusted)	insulin secretion rate (BMI adjusted)	Other measurement
11533	GCST004781	Sulfasalazine-induced agranulocytosis	Sulfasalazine-induced agranulocytosis	Other trait
11534	GCST004781	Sulfasalazine-induced agranulocytosis	Sulfasalazine-induced agranulocytosis	Response to drug
11535	GCST001298	Breast cancer	Breast cancer	Cancer
11536	GCST003837	Chronotype	Chronotype	Biological process
11537	GCST003837	Chronotype	Chronotype	Other measurement
11538	GCST003839	Sleep duration	Sleep duration	Other measurement
11539	GCST003838	Morning vs. evening chronotype	Morning vs. evening chronotype	Biological process
11540	GCST003840	Sleep duration (oversleepers vs undersleepers)	Sleep duration (oversleepers vs undersleepers)	Other measurement
11541	GCST006685	Sleep duration (oversleepers)	Sleep duration (oversleepers)	Other measurement
11542	GCST006686	Sleep duration (undersleepers)	Sleep duration (undersleepers)	Other measurement
11543	GCST001299	Schizophrenia	Schizophrenia	Neurological disorder
11544	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Other measurement
11545	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11546	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11547	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Response to drug
11548	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11549	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11550	GCST001385	Inflammatory biomarkers	Inflammatory biomarkers	Inflammatory measurement
11551	GCST003898	Cisplatin-induced ototoxicity	Cisplatin-induced ototoxicity	Other trait
11552	GCST003898	Cisplatin-induced ototoxicity	Cisplatin-induced ototoxicity	Response to drug
11553	GCST005173	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	Other trait
11554	GCST005173	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	Metabolic disorder
11555	GCST005174	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	Other trait
11556	GCST005174	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	Metabolic disorder
11557	GCST005175	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	Other trait
11558	GCST005175	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	Metabolic disorder
11559	GCST005231	Major depressive disorder	Major depressive disorder	Neurological disorder
11560	GCST005230	Recurrent major depressive disorder	Recurrent major depressive disorder	Neurological disorder
11561	GCST001931	Attention deficit hyperactivity disorder (combined symptoms)	Attention deficit hyperactivity disorder (combined symptoms)	Neurological disorder
11562	GCST001944	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	Neurological disorder
11563	GCST001943	Attention deficit hyperactivity disorder (inattention symptoms)	Attention deficit hyperactivity disorder (inattention symptoms)	Neurological disorder
11564	GCST001754	Waist-to-hip circumference ratio (ever vs never smoking interaction)	Waist-to-hip circumference ratio (ever vs never smoking interaction)	Other measurement
11565	GCST001754	Waist-to-hip circumference ratio (ever vs never smoking interaction)	Waist-to-hip circumference ratio (ever vs never smoking interaction)	Body measurement
11566	GCST001753	Body mass index (alcohol intake interaction)	Body mass index (alcohol intake interaction)	Body measurement
11567	GCST001753	Body mass index (alcohol intake interaction)	Body mass index (alcohol intake interaction)	Other measurement
11568	GCST004587	Body mass index (dietary energy interaction)	Body mass index (dietary energy interaction)	Body measurement
11569	GCST004587	Body mass index (dietary energy interaction)	Body mass index (dietary energy interaction)	Other measurement
11570	GCST004580	Body mass index (recreational physical activity interaction)	Body mass index (recreational physical activity interaction)	Body measurement
11571	GCST004580	Body mass index (recreational physical activity interaction)	Body mass index (recreational physical activity interaction)	Other measurement
11572	GCST004586	Body mass index (ever vs never smoking interaction)	Body mass index (ever vs never smoking interaction)	Body measurement
11573	GCST004586	Body mass index (ever vs never smoking interaction)	Body mass index (ever vs never smoking interaction)	Other measurement
11574	GCST004581	Body mass index  (smoking years interaction)	Body mass index  (smoking years interaction)	Body measurement
11575	GCST004581	Body mass index  (smoking years interaction)	Body mass index  (smoking years interaction)	Other measurement
11576	GCST004582	Waist-to-hip circumference ratio (dietary energy interaction)	Waist-to-hip circumference ratio (dietary energy interaction)	Body measurement
11577	GCST004582	Waist-to-hip circumference ratio (dietary energy interaction)	Waist-to-hip circumference ratio (dietary energy interaction)	Other measurement
11578	GCST004584	Waist-to-hip circumference ratio (smoking years interaction)	Waist-to-hip circumference ratio (smoking years interaction)	Other measurement
11579	GCST004584	Waist-to-hip circumference ratio (smoking years interaction)	Waist-to-hip circumference ratio (smoking years interaction)	Body measurement
11580	GCST004583	Waist-to-hip circumference ratio (recreational physical activity interaction)	Waist-to-hip circumference ratio (recreational physical activity interaction)	Body measurement
11581	GCST004583	Waist-to-hip circumference ratio (recreational physical activity interaction)	Waist-to-hip circumference ratio (recreational physical activity interaction)	Other measurement
11582	GCST004579	Waist-to-hip circumference ratio (alcohol intake interaction)	Waist-to-hip circumference ratio (alcohol intake interaction)	Body measurement
11583	GCST004579	Waist-to-hip circumference ratio (alcohol intake interaction)	Waist-to-hip circumference ratio (alcohol intake interaction)	Other measurement
11584	GCST003817	Mortality in sepsis	Mortality in sepsis	Other measurement
11585	GCST003817	Mortality in sepsis	Mortality in sepsis	Other trait
11586	GCST000076	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11587	GCST000430	C-reactive protein	C-reactive protein	Inflammatory measurement
11588	GCST001222	Aspartate aminotransferase levels	Aspartate aminotransferase levels	Liver enzyme measurement
11589	GCST000443	Body mass index and fat mass	Body mass index and fat mass	Other measurement
11590	GCST000443	Body mass index and fat mass	Body mass index and fat mass	Body measurement
11591	GCST002994	Ear protrusion	Ear protrusion	Other trait
11592	GCST003002	Tragus size	Tragus size	Other trait
11593	GCST003003	Antitragus size	Antitragus size	Other trait
11594	GCST003004	Crus helix expression	Crus helix expression	Other trait
11595	GCST003005	Superior crus of antihelix expression	Superior crus of antihelix expression	Other trait
11596	GCST003000	Darwin's tubercle	Darwin's tubercle	Other trait
11597	GCST003001	Ear morphology	Ear morphology	Other trait
11598	GCST002999	Lobe size	Lobe size	Other trait
11599	GCST002998	Lobe attachment	Lobe attachment	Other trait
11600	GCST002997	Helix rolling	Helix rolling	Other trait
11601	GCST002996	Folding of antihelix	Folding of antihelix	Other trait
11602	GCST000527	Ulcerative colitis	Ulcerative colitis	Immune system disorder
11603	GCST000085	Fasting plasma glucose	Fasting plasma glucose	Other measurement
11604	GCST000108	Diabetes (incident)	Diabetes (incident)	Metabolic disorder
11605	GCST000077	Diabetes related insulin traits	Diabetes related insulin traits	Other measurement
11606	GCST000077	Diabetes related insulin traits	Diabetes related insulin traits	Other measurement
11607	GCST000077	Diabetes related insulin traits	Diabetes related insulin traits	Other measurement
11608	GCST000077	Diabetes related insulin traits	Diabetes related insulin traits	Other trait
11609	GCST000531	Inflammatory bowel disease (early onset)	Inflammatory bowel disease (early onset)	Digestive system disorder
11610	GCST000088	Volumetric brain MRI	Volumetric brain MRI	Other measurement
11611	GCST000098	Cognitive test performance	Cognitive test performance	Other measurement
11612	GCST003926	Renal underexcretion gout	Renal underexcretion gout	Metabolic disorder
11613	GCST003925	Gout	Gout	Metabolic disorder
11614	GCST003924	Renal overload gout	Renal overload gout	Metabolic disorder
11615	GCST008436	Nonobstructive coronary artery disease	Nonobstructive coronary artery disease	Cardiovascular disease
11616	GCST003040	Hearing function (high tone)	Hearing function (high tone)	Other measurement
11617	GCST003040	Hearing function (high tone)	Hearing function (high tone)	Other measurement
11618	GCST003039	Hearing function (0.25 kHz)	Hearing function (0.25 kHz)	Other measurement
11619	GCST003039	Hearing function (0.25 kHz)	Hearing function (0.25 kHz)	Other measurement
11620	GCST003037	Hearing function (0.5 kHz)	Hearing function (0.5 kHz)	Other measurement
11621	GCST003037	Hearing function (0.5 kHz)	Hearing function (0.5 kHz)	Other measurement
11622	GCST003041	Hearing function (1 kHz)	Hearing function (1 kHz)	Other measurement
11623	GCST003041	Hearing function (1 kHz)	Hearing function (1 kHz)	Other measurement
11624	GCST003032	Hearing function (2 kHz)	Hearing function (2 kHz)	Other measurement
11625	GCST003032	Hearing function (2 kHz)	Hearing function (2 kHz)	Other measurement
11626	GCST003035	Hearing function (4 kHz)	Hearing function (4 kHz)	Other measurement
11627	GCST003035	Hearing function (4 kHz)	Hearing function (4 kHz)	Other measurement
11628	GCST003034	Hearing function (8 kHz)	Hearing function (8 kHz)	Other measurement
11629	GCST003034	Hearing function (8 kHz)	Hearing function (8 kHz)	Other measurement
11630	GCST003036	Hearing function (low tone)	Hearing function (low tone)	Other measurement
11631	GCST003036	Hearing function (low tone)	Hearing function (low tone)	Other measurement
11632	GCST003033	Hearing function (medium tone)	Hearing function (medium tone)	Other measurement
11633	GCST003033	Hearing function (medium tone)	Hearing function (medium tone)	Other measurement
11634	GCST000078	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11635	GCST000078	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11636	GCST000078	Lipid traits	Lipid traits	Other measurement
11637	GCST000078	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11638	GCST000078	Lipid traits	Lipid traits	Lipid or lipoprotein measurement
11639	GCST000093	Major CVD	Major CVD	Other disease
11640	GCST000109	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
11641	GCST000104	Heart failure	Heart failure	Cardiovascular disease
11642	GCST005159	Insulin levels in response to oral glucose tolerance test (fasting)	Insulin levels in response to oral glucose tolerance test (fasting)	Other measurement
11643	GCST005159	Insulin levels in response to oral glucose tolerance test (fasting)	Insulin levels in response to oral glucose tolerance test (fasting)	Other measurement
11644	GCST005162	Glucagon levels in response to oral glucose tolerance test (fasting)	Glucagon levels in response to oral glucose tolerance test (fasting)	Other measurement
11645	GCST005162	Glucagon levels in response to oral glucose tolerance test (fasting)	Glucagon levels in response to oral glucose tolerance test (fasting)	Other measurement
11646	GCST005167	GIP levels in response to oral glucose tolerance test (fasting)	GIP levels in response to oral glucose tolerance test (fasting)	Other measurement
11647	GCST005167	GIP levels in response to oral glucose tolerance test (fasting)	GIP levels in response to oral glucose tolerance test (fasting)	Other measurement
11648	GCST005164	GLP-1 levels in response to oral glucose tolerance test (fasting)	GLP-1 levels in response to oral glucose tolerance test (fasting)	Other measurement
11649	GCST005164	GLP-1 levels in response to oral glucose tolerance test (fasting)	GLP-1 levels in response to oral glucose tolerance test (fasting)	Other measurement
11650	GCST005160	Insulin levels in response to oral glucose tolerance test (30 minutes)	Insulin levels in response to oral glucose tolerance test (30 minutes)	Other measurement
11651	GCST005160	Insulin levels in response to oral glucose tolerance test (30 minutes)	Insulin levels in response to oral glucose tolerance test (30 minutes)	Other measurement
11652	GCST005161	Insulin levels in response to oral glucose tolerance test (120 minutes)	Insulin levels in response to oral glucose tolerance test (120 minutes)	Other measurement
11653	GCST005161	Insulin levels in response to oral glucose tolerance test (120 minutes)	Insulin levels in response to oral glucose tolerance test (120 minutes)	Other measurement
11654	GCST005165	GLP-1 levels in response to oral glucose tolerance test (120 minutes)	GLP-1 levels in response to oral glucose tolerance test (120 minutes)	Other measurement
11655	GCST005165	GLP-1 levels in response to oral glucose tolerance test (120 minutes)	GLP-1 levels in response to oral glucose tolerance test (120 minutes)	Other measurement
11656	GCST005166	GIP levels in response to oral glucose tolerance test (120 minutes)	GIP levels in response to oral glucose tolerance test (120 minutes)	Other measurement
11657	GCST005166	GIP levels in response to oral glucose tolerance test (120 minutes)	GIP levels in response to oral glucose tolerance test (120 minutes)	Other measurement
11658	GCST005163	Glucagon levels in response to oral glucose tolerance test (120 minutes)	Glucagon levels in response to oral glucose tolerance test (120 minutes)	Other measurement
11659	GCST005163	Glucagon levels in response to oral glucose tolerance test (120 minutes)	Glucagon levels in response to oral glucose tolerance test (120 minutes)	Other measurement
11660	GCST000095	Prostate cancer	Prostate cancer	Cancer
11661	GCST000079	Breast cancer	Breast cancer	Cancer
11662	GCST000099	Mean forced vital capacity from 2 exams	Mean forced vital capacity from 2 exams	Other measurement
11663	GCST000106	Pulmonary function	Pulmonary function	Other measurement
11664	GCST000106	Pulmonary function	Pulmonary function	Other measurement
11665	GCST000106	Pulmonary function	Pulmonary function	Other measurement
11666	GCST000106	Pulmonary function	Pulmonary function	Other measurement
11667	GCST000089	Exercise treadmill test traits	Exercise treadmill test traits	Cardiovascular measurement
11668	GCST000110	Echocardiographic traits	Echocardiographic traits	Other trait
11669	GCST000110	Echocardiographic traits	Echocardiographic traits	Other measurement
11670	GCST000110	Echocardiographic traits	Echocardiographic traits	Other trait
11671	GCST000102	Endothelial function traits	Endothelial function traits	Other measurement
11672	GCST000094	Blood pressure	Blood pressure	Other measurement
11673	GCST000094	Blood pressure	Blood pressure	Other measurement
11674	GCST000094	Blood pressure	Blood pressure	Other measurement
11675	GCST000094	Blood pressure	Blood pressure	Other measurement
11676	GCST000094	Blood pressure	Blood pressure	Cardiovascular measurement
11677	GCST000107	Tonometry	Tonometry	Other measurement
11678	GCST000087	Subclinical atherosclerosis traits (other)	Subclinical atherosclerosis traits (other)	Cardiovascular measurement
11679	GCST000087	Subclinical atherosclerosis traits (other)	Subclinical atherosclerosis traits (other)	Cardiovascular measurement
11680	GCST000087	Subclinical atherosclerosis traits (other)	Subclinical atherosclerosis traits (other)	Other trait
11681	GCST000087	Subclinical atherosclerosis traits (other)	Subclinical atherosclerosis traits (other)	Cardiovascular measurement
11682	GCST000087	Subclinical atherosclerosis traits (other)	Subclinical atherosclerosis traits (other)	Cardiovascular measurement
11683	GCST000097	Coronary artery calcification	Coronary artery calcification	Other trait
11684	GCST000086	Heart rate variability traits	Heart rate variability traits	Cardiovascular measurement
11685	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
11686	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
11687	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
11688	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
11689	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
11690	GCST000111	Electrocardiographic traits	Electrocardiographic traits	Cardiovascular measurement
11691	GCST000081	Sleep-related phenotypes	Sleep-related phenotypes	Other measurement
11692	GCST005323	Depressive symptoms (MTAG)	Depressive symptoms (MTAG)	Other measurement
11693	GCST005325	Subjective well-being (MTAG)	Subjective well-being (MTAG)	Other measurement
11694	GCST005326	Neuroticism (MTAG)	Neuroticism (MTAG)	Other measurement
11695	GCST005327	Neuroticism	Neuroticism	Neurological disorder
11696	GCST005327	Neuroticism	Neuroticism	Other measurement
11697	GCST005324	Depressive symptoms	Depressive symptoms	Neurological disorder
11698	GCST005324	Depressive symptoms	Depressive symptoms	Other measurement
11699	GCST005328	Subjective well-being	Subjective well-being	Other measurement
11700	GCST002593	Dementia and core Alzheimer's disease neuropathologic changes	Dementia and core Alzheimer's disease neuropathologic changes	Neurological disorder
11701	GCST002593	Dementia and core Alzheimer's disease neuropathologic changes	Dementia and core Alzheimer's disease neuropathologic changes	Other trait
11702	GCST002594	Neurofibrillary tangles	Neurofibrillary tangles	Other measurement
11703	GCST002592	Neuritic plaque	Neuritic plaque	Other measurement
11704	GCST002591	Lewy body disease	Lewy body disease	Other measurement
11705	GCST002591	Lewy body disease	Lewy body disease	Other trait
11706	GCST002590	Vascular brain injury	Vascular brain injury	Cardiovascular measurement
11707	GCST002590	Vascular brain injury	Vascular brain injury	Cardiovascular disease
11708	GCST002589	Hippocampal sclerosis	Hippocampal sclerosis	Neurological disorder
11709	GCST002588	Cerebral amyloid angiopathy	Cerebral amyloid angiopathy	Metabolic disorder
11710	GCST001191	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
11711	GCST004380	Glutamate decarboxylase autoantibody levels in type 1 diabetes	Glutamate decarboxylase autoantibody levels in type 1 diabetes	Other measurement
11712	GCST004380	Glutamate decarboxylase autoantibody levels in type 1 diabetes	Glutamate decarboxylase autoantibody levels in type 1 diabetes	Metabolic disorder
11713	GCST004381	Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	Other measurement
11714	GCST004381	Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	Metabolic disorder
11715	GCST004382	Gastric parietal cell autoantibody levels in type 1 diabetes	Gastric parietal cell autoantibody levels in type 1 diabetes	Other measurement
11716	GCST004382	Gastric parietal cell autoantibody levels in type 1 diabetes	Gastric parietal cell autoantibody levels in type 1 diabetes	Metabolic disorder
11717	GCST004383	Thyroid peroxidase autoantibody levels in type 1 diabetes	Thyroid peroxidase autoantibody levels in type 1 diabetes	Other measurement
11718	GCST004383	Thyroid peroxidase autoantibody levels in type 1 diabetes	Thyroid peroxidase autoantibody levels in type 1 diabetes	Metabolic disorder
11719	GCST003862	Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	Other disease
11720	GCST003862	Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	Metabolic disorder
11721	GCST003861	Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	Other disease
11722	GCST003861	Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	Metabolic disorder
11723	GCST003863	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	Other disease
11724	GCST003863	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	Metabolic disorder
11725	GCST003864	Kidney disease (early and late stages) in type 1 diabetes	Kidney disease (early and late stages) in type 1 diabetes	Other disease
11726	GCST003864	Kidney disease (early and late stages) in type 1 diabetes	Kidney disease (early and late stages) in type 1 diabetes	Metabolic disorder
11727	GCST003865	Kidney disease (early stage) in type 1 diabetes	Kidney disease (early stage) in type 1 diabetes	Other disease
11728	GCST003865	Kidney disease (early stage) in type 1 diabetes	Kidney disease (early stage) in type 1 diabetes	Metabolic disorder
11729	GCST003866	Kidney disease (late stage) in type 1 diabetes	Kidney disease (late stage) in type 1 diabetes	Other disease
11730	GCST003866	Kidney disease (late stage) in type 1 diabetes	Kidney disease (late stage) in type 1 diabetes	Metabolic disorder
11731	GCST003867	Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	Other disease
11732	GCST003867	Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	Metabolic disorder
11733	GCST003661	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
11734	GCST003662	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
11735	GCST003662	LDL cholesterol	LDL cholesterol	Other measurement
11736	GCST003662	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
11737	GCST003663	Cholesterol, total	Cholesterol, total	Lipid or lipoprotein measurement
11738	GCST003660	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
11739	GCST004491	Cerebrospinal fluid t-tau levels	Cerebrospinal fluid t-tau levels	Other measurement
11740	GCST004492	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
11741	GCST004492	Cerebrospinal fluid AB1-42 levels	Cerebrospinal fluid AB1-42 levels	Other measurement
11742	GCST004490	Cerebrospinal fluid t-tau:AB1-42 ratio	Cerebrospinal fluid t-tau:AB1-42 ratio	Other measurement
11743	GCST001467	Hypertension	Hypertension	Cardiovascular disease
11744	GCST001229	Thoracic aortic aneurysms and dissections	Thoracic aortic aneurysms and dissections	Cardiovascular disease
11745	GCST002933	Magnesium levels	Magnesium levels	Other measurement
11746	GCST000042	Crohn's disease	Crohn's disease	Digestive system disorder
11747	GCST000041	Hypertension	Hypertension	Cardiovascular disease
11748	GCST000047	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
11749	GCST000040	Rheumatoid arthritis	Rheumatoid arthritis	Immune system disorder
11750	GCST000045	Coronary heart disease	Coronary heart disease	Cardiovascular disease
11751	GCST000044	Bipolar disorder	Bipolar disorder	Neurological disorder
11752	GCST000043	Type 1 diabetes	Type 1 diabetes	Metabolic disorder
11753	GCST001227	Systolic blood pressure	Systolic blood pressure	Other measurement
11754	GCST001227	Systolic blood pressure	Systolic blood pressure	Other measurement
11755	GCST001238	Hypertension	Hypertension	Cardiovascular disease
11756	GCST001228	Diastolic blood pressure	Diastolic blood pressure	Other measurement
11757	GCST001228	Diastolic blood pressure	Diastolic blood pressure	Other measurement
11758	GCST004330	Hematocrit	Hematocrit	Hematological measurement
11759	GCST004329	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
11760	GCST004329	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
11761	GCST004332	Red blood cell count	Red blood cell count	Hematological measurement
11762	GCST004331	Hemoglobin	Hemoglobin	Hematological measurement
11763	GCST004333	Red cell distribution width	Red cell distribution width	Hematological measurement
11764	GCST004334	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
11765	GCST004334	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
11766	GCST004335	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
11767	GCST004239	Metabolic syndrome	Metabolic syndrome	Body measurement
11768	GCST004239	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
11769	GCST004239	Metabolic syndrome	Metabolic syndrome	Other measurement
11770	GCST004239	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
11771	GCST004239	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
11772	GCST004240	Fasting blood glucose	Fasting blood glucose	Other measurement
11773	GCST004241	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
11774	GCST004242	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
11775	GCST004243	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
11776	GCST004243	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
11777	GCST004244	Waist-hip ratio	Waist-hip ratio	Other measurement
11778	GCST004244	Waist-hip ratio	Waist-hip ratio	Body measurement
11779	GCST004245	Body mass index	Body mass index	Body measurement
11780	GCST004245	Body mass index	Body mass index	Body measurement
11781	GCST004245	Body mass index	Body mass index	Other measurement
11782	GCST003440	Response to carboplatin in ovarian cancer (MTT IC50)	Response to carboplatin in ovarian cancer (MTT IC50)	Other measurement
11783	GCST003440	Response to carboplatin in ovarian cancer (MTT IC50)	Response to carboplatin in ovarian cancer (MTT IC50)	Response to drug
11784	GCST003440	Response to carboplatin in ovarian cancer (MTT IC50)	Response to carboplatin in ovarian cancer (MTT IC50)	Cancer
11785	GCST003443	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Other measurement
11786	GCST003443	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to drug
11787	GCST003443	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to drug
11788	GCST003443	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Cancer
11789	GCST003439	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Other measurement
11790	GCST003439	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to drug
11791	GCST003439	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	Cancer
11792	GCST003442	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Other measurement
11793	GCST003442	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Response to drug
11794	GCST003442	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	Cancer
11795	GCST003441	Response to paclitaxel in ovarian cancer (MTT IC50)	Response to paclitaxel in ovarian cancer (MTT IC50)	Other measurement
11796	GCST003441	Response to paclitaxel in ovarian cancer (MTT IC50)	Response to paclitaxel in ovarian cancer (MTT IC50)	Response to drug
11797	GCST003441	Response to paclitaxel in ovarian cancer (MTT IC50)	Response to paclitaxel in ovarian cancer (MTT IC50)	Cancer
11798	GCST003444	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Other measurement
11799	GCST003444	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to drug
11800	GCST003444	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to drug
11801	GCST003444	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	Cancer
11802	GCST004678	Psychosis proneness (hypomanic personality scale)	Psychosis proneness (hypomanic personality scale)	Other measurement
11803	GCST004685	Psychosis proneness (perceptual aberration scale)	Psychosis proneness (perceptual aberration scale)	Other measurement
11804	GCST004680	Psychosis proneness (revised physical anhedonia scale)	Psychosis proneness (revised physical anhedonia scale)	Other measurement
11805	GCST004686	Psychosis proneness (revised social anhedonia scale)	Psychosis proneness (revised social anhedonia scale)	Other measurement
11806	GCST004679	Psychosis proneness (hypomanic personality scale and perceptual aberration scale)	Psychosis proneness (hypomanic personality scale and perceptual aberration scale)	Other measurement
11807	GCST004687	Psychosis proneness (schizoidia scale)	Psychosis proneness (schizoidia scale)	Other measurement
11808	GCST004681	Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)	Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)	Other measurement
11809	GCST004682	Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)	Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)	Other measurement
11810	GCST004688	Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)	Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)	Other measurement
11811	GCST004683	Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)	Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)	Other measurement
11812	GCST004684	Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)	Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)	Other measurement
11813	GCST002745	Total bilirubin levels in HIV-1 infection	Total bilirubin levels in HIV-1 infection	Other disease
11814	GCST002745	Total bilirubin levels in HIV-1 infection	Total bilirubin levels in HIV-1 infection	Other measurement
11815	GCST002743	Neutrophil count in HIV-infection	Neutrophil count in HIV-infection	Other disease
11816	GCST002743	Neutrophil count in HIV-infection	Neutrophil count in HIV-infection	Hematological measurement
11817	GCST002744	HDL Cholesterol in HIV-infection	HDL Cholesterol in HIV-infection	Lipid or lipoprotein measurement
11818	GCST002744	HDL Cholesterol in HIV-infection	HDL Cholesterol in HIV-infection	Other disease
11819	GCST004220	Adult onset asthma (smoking interaction)	Adult onset asthma (smoking interaction)	Biological process
11820	GCST004220	Adult onset asthma (smoking interaction)	Adult onset asthma (smoking interaction)	Other disease
11821	GCST004221	Adult onset asthma in non-smokers	Adult onset asthma in non-smokers	Other disease
11822	GCST004222	Adult onset asthma in ever-smokers	Adult onset asthma in ever-smokers	Biological process
11823	GCST004222	Adult onset asthma in ever-smokers	Adult onset asthma in ever-smokers	Other disease
11824	GCST001125	Body mass index	Body mass index	Body measurement
11825	GCST001125	Body mass index	Body mass index	Body measurement
11826	GCST001125	Body mass index	Body mass index	Other measurement
11827	GCST005949	Body mass index x sex interaction	Body mass index x sex interaction	Body measurement
11828	GCST005949	Body mass index x sex interaction	Body mass index x sex interaction	Other measurement
11829	GCST005950	Body mass index x sex x age interaction (4df test)	Body mass index x sex x age interaction (4df test)	Body measurement
11830	GCST005950	Body mass index x sex x age interaction (4df test)	Body mass index x sex x age interaction (4df test)	Other measurement
11831	GCST005950	Body mass index x sex x age interaction (4df test)	Body mass index x sex x age interaction (4df test)	Other measurement
11832	GCST005951	Body mass index	Body mass index	Body measurement
11833	GCST005951	Body mass index	Body mass index	Body measurement
11834	GCST005951	Body mass index	Body mass index	Other measurement
11835	GCST005952	Body mass index (age>50)	Body mass index (age>50)	Body measurement
11836	GCST005953	Body mass index (age <50)	Body mass index (age <50)	Body measurement
11837	GCST005954	Body mass index x age interaction	Body mass index x age interaction	Body measurement
11838	GCST005954	Body mass index x age interaction	Body mass index x age interaction	Other measurement
11839	GCST005955	Body mass index x sex x age interaction	Body mass index x sex x age interaction	Body measurement
11840	GCST005955	Body mass index x sex x age interaction	Body mass index x sex x age interaction	Other measurement
11841	GCST005955	Body mass index x sex x age interaction	Body mass index x sex x age interaction	Other measurement
11842	GCST005956	Waist-to-hip ratio adjusted for BMI	Waist-to-hip ratio adjusted for BMI	Body measurement
11843	GCST005957	Waist-to-hip ratio adjusted for BMI (age <50)	Waist-to-hip ratio adjusted for BMI (age <50)	Body measurement
11844	GCST005958	Waist-to-hip ratio adjusted for BMI (age >50)	Waist-to-hip ratio adjusted for BMI (age >50)	Body measurement
11845	GCST005959	Waist-to-hip ratio adjusted for BMI x sex interaction	Waist-to-hip ratio adjusted for BMI x sex interaction	Body measurement
11846	GCST005959	Waist-to-hip ratio adjusted for BMI x sex interaction	Waist-to-hip ratio adjusted for BMI x sex interaction	Other measurement
11847	GCST005960	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Body measurement
11848	GCST005960	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Other measurement
11849	GCST005960	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Waist-to-hip ratio adjusted for BMI x sex x age interaction	Other measurement
11850	GCST005961	Waist-to-hip ratio adjusted for BMI x age interaction	Waist-to-hip ratio adjusted for BMI x age interaction	Body measurement
11851	GCST005961	Waist-to-hip ratio adjusted for BMI x age interaction	Waist-to-hip ratio adjusted for BMI x age interaction	Other measurement
11852	GCST005962	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Body measurement
11853	GCST005962	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Other measurement
11854	GCST005962	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	Other measurement
11855	GCST003401	Glomerular filtration rate in non diabetics (creatinine)	Glomerular filtration rate in non diabetics (creatinine)	Other measurement
11856	GCST003401	Glomerular filtration rate in non diabetics (creatinine)	Glomerular filtration rate in non diabetics (creatinine)	Other measurement
11857	GCST003373	Glomerular filtration rate in diabetics (creatinine)	Glomerular filtration rate in diabetics (creatinine)	Other measurement
11858	GCST003373	Glomerular filtration rate in diabetics (creatinine)	Glomerular filtration rate in diabetics (creatinine)	Other measurement
11859	GCST003373	Glomerular filtration rate in diabetics (creatinine)	Glomerular filtration rate in diabetics (creatinine)	Metabolic disorder
11860	GCST003375	Glomerular filtration rate (cystatin C)	Glomerular filtration rate (cystatin C)	Other measurement
11861	GCST003375	Glomerular filtration rate (cystatin C)	Glomerular filtration rate (cystatin C)	Other measurement
11862	GCST003374	Chronic kidney disease	Chronic kidney disease	Other disease
11863	GCST003374	Chronic kidney disease	Chronic kidney disease	Other measurement
11864	GCST003374	Chronic kidney disease	Chronic kidney disease	Other measurement
11865	GCST003372	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
11866	GCST003372	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
11867	GCST003371	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
11868	GCST003371	Glomerular filtration rate (creatinine)	Glomerular filtration rate (creatinine)	Other measurement
11869	GCST005240	Caudate volume in trauma-exposed individuals	Caudate volume in trauma-exposed individuals	Biological process
11870	GCST005240	Caudate volume in trauma-exposed individuals	Caudate volume in trauma-exposed individuals	Other measurement
11871	GCST005241	Nucleus accumbens volume in trauma-exposed individuals	Nucleus accumbens volume in trauma-exposed individuals	Other measurement
11872	GCST005241	Nucleus accumbens volume in trauma-exposed individuals	Nucleus accumbens volume in trauma-exposed individuals	Biological process
11873	GCST005242	Pallidum volume in trauma-exposed individuals	Pallidum volume in trauma-exposed individuals	Other measurement
11874	GCST005242	Pallidum volume in trauma-exposed individuals	Pallidum volume in trauma-exposed individuals	Biological process
11875	GCST005239	Amygdala volume in trauma-exposed individuals	Amygdala volume in trauma-exposed individuals	Other measurement
11876	GCST005239	Amygdala volume in trauma-exposed individuals	Amygdala volume in trauma-exposed individuals	Biological process
11877	GCST005243	Hippocampal volume in trauma-exposed individuals	Hippocampal volume in trauma-exposed individuals	Other measurement
11878	GCST005243	Hippocampal volume in trauma-exposed individuals	Hippocampal volume in trauma-exposed individuals	Biological process
11879	GCST005244	Putamen volume in trauma-exposed individuals	Putamen volume in trauma-exposed individuals	Other measurement
11880	GCST005244	Putamen volume in trauma-exposed individuals	Putamen volume in trauma-exposed individuals	Biological process
11881	GCST005286	Lateral ventricle volume in trauma-exposed individuals	Lateral ventricle volume in trauma-exposed individuals	Biological process
11882	GCST005286	Lateral ventricle volume in trauma-exposed individuals	Lateral ventricle volume in trauma-exposed individuals	Other measurement
11883	GCST005245	Thalamus volume in trauma-exposed individuals	Thalamus volume in trauma-exposed individuals	Other measurement
11884	GCST005245	Thalamus volume in trauma-exposed individuals	Thalamus volume in trauma-exposed individuals	Biological process
11885	GCST005225	Osteoarthritis or lumbar spine bone mineral density	Osteoarthritis or lumbar spine bone mineral density	Other disease
11886	GCST005225	Osteoarthritis or lumbar spine bone mineral density	Osteoarthritis or lumbar spine bone mineral density	Other measurement
11887	GCST005226	Hip osteoarthritis or lumbar spine bone mineral density	Hip osteoarthritis or lumbar spine bone mineral density	Other measurement
11888	GCST005226	Hip osteoarthritis or lumbar spine bone mineral density	Hip osteoarthritis or lumbar spine bone mineral density	Other disease
11889	GCST005227	Knee osteoarthritis or lumbar spine bone mineral density	Knee osteoarthritis or lumbar spine bone mineral density	Other disease
11890	GCST005227	Knee osteoarthritis or lumbar spine bone mineral density	Knee osteoarthritis or lumbar spine bone mineral density	Other measurement
11891	GCST005228	Osteoarthritis or femoral neck bone mineral density	Osteoarthritis or femoral neck bone mineral density	Other disease
11892	GCST005228	Osteoarthritis or femoral neck bone mineral density	Osteoarthritis or femoral neck bone mineral density	Other measurement
11893	GCST005229	Hip osteoarthritis or femoral neck bone mineral density	Hip osteoarthritis or femoral neck bone mineral density	Other measurement
11894	GCST005229	Hip osteoarthritis or femoral neck bone mineral density	Hip osteoarthritis or femoral neck bone mineral density	Other disease
11895	GCST005224	Knee osteoarthritis or femoral neck bone mineral density	Knee osteoarthritis or femoral neck bone mineral density	Other measurement
11896	GCST005224	Knee osteoarthritis or femoral neck bone mineral density	Knee osteoarthritis or femoral neck bone mineral density	Other disease
11897	GCST004271	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	Neurological disorder
11898	GCST004271	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	Response to drug
11899	GCST004272	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	Neurological disorder
11900	GCST004272	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	Response to drug
11901	GCST004270	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	Neurological disorder
11902	GCST004270	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	Response to drug
11903	GCST004273	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	Neurological disorder
11904	GCST004273	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	Response to drug
11905	GCST004274	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	Neurological disorder
11906	GCST004274	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	Response to drug
11907	GCST004275	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	Neurological disorder
11908	GCST004275	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	Response to drug
11909	GCST005127	Lung function (maximal voluntary ventilation)	Lung function (maximal voluntary ventilation)	Other measurement
11910	GCST005127	Lung function (maximal voluntary ventilation)	Lung function (maximal voluntary ventilation)	Other measurement
11911	GCST005132	Lung function (forced expiratory volume in 1 second)	Lung function (forced expiratory volume in 1 second)	Other measurement
11912	GCST005129	Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)	Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)	Other measurement
11913	GCST005131	Lung function (forced vital capacity)	Lung function (forced vital capacity)	Other measurement
11914	GCST005130	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
11915	GCST004110	Gait speed in old age	Gait speed in old age	Other measurement
11916	GCST005828	Estradiol levels	Estradiol levels	Other measurement
11917	GCST005827	Estrone levels	Estrone levels	Other measurement
11918	GCST004861	Itch intensity from mosquito bite	Itch intensity from mosquito bite	Other measurement
11919	GCST004862	Itch intensity from mosquito bite adjusted by bite size	Itch intensity from mosquito bite adjusted by bite size	Other measurement
11920	GCST004862	Itch intensity from mosquito bite adjusted by bite size	Itch intensity from mosquito bite adjusted by bite size	Other measurement
11921	GCST004863	Mosquito bite size	Mosquito bite size	Other measurement
11922	GCST004864	Perceived unattractiveness to mosquitoes	Perceived unattractiveness to mosquitoes	Other measurement
11923	GCST004865	Itch intensity from mosquito bite adjusted by bite size	Itch intensity from mosquito bite adjusted by bite size	Other measurement
11924	GCST004865	Itch intensity from mosquito bite adjusted by bite size	Itch intensity from mosquito bite adjusted by bite size	Other measurement
11925	GCST006940	Neurociticism	Neurociticism	Other measurement
11926	GCST006941	Irritable mood	Irritable mood	Other measurement
11927	GCST006942	Feeling lonely	Feeling lonely	Other measurement
11928	GCST006943	Feeling miserable	Feeling miserable	Other measurement
11929	GCST006944	Experiencing mood swings	Experiencing mood swings	Other measurement
11930	GCST006945	Feeling guilty	Feeling guilty	Other measurement
11931	GCST006946	Worry too long after an embarrassing experience	Worry too long after an embarrassing experience	Other measurement
11932	GCST006947	Feeling fed-up	Feeling fed-up	Other measurement
11933	GCST006948	Feeling nervous	Feeling nervous	Other measurement
11934	GCST006949	Suffering from nerves	Suffering from nerves	Neurological disorder
11935	GCST006950	Feeling worry	Feeling worry	Other measurement
11936	GCST006951	Feeling hurt	Feeling hurt	Other measurement
11937	GCST006952	Feeling tense	Feeling tense	Other measurement
11938	GCST004100	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Other disease
11939	GCST004100	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Body measurement
11940	GCST004100	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	Cancer
11941	GCST004103	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Other disease
11942	GCST004103	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Cancer
11943	GCST004103	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	Body measurement
11944	GCST004104	Body mass index (change over time) in lung cancer	Body mass index (change over time) in lung cancer	Body measurement
11945	GCST004104	Body mass index (change over time) in lung cancer	Body mass index (change over time) in lung cancer	Cancer
11946	GCST004101	Body mass index (change over time) in gastrointestinal cancer	Body mass index (change over time) in gastrointestinal cancer	Body measurement
11947	GCST004101	Body mass index (change over time) in gastrointestinal cancer	Body mass index (change over time) in gastrointestinal cancer	Cancer
11948	GCST004105	Body mass index (change over time) in chronic obstructive pulmonary disease	Body mass index (change over time) in chronic obstructive pulmonary disease	Other disease
11949	GCST004105	Body mass index (change over time) in chronic obstructive pulmonary disease	Body mass index (change over time) in chronic obstructive pulmonary disease	Body measurement
11950	GCST004102	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Other disease
11951	GCST004102	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Body measurement
11952	GCST004102	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	Cancer
11953	GCST004106	Body mass index (change over time) in cancer	Body mass index (change over time) in cancer	Cancer
11954	GCST004106	Body mass index (change over time) in cancer	Body mass index (change over time) in cancer	Body measurement
11955	GCST004930	IgG sialylation phenotypes (multivariate analysis)	IgG sialylation phenotypes (multivariate analysis)	Other measurement
11956	GCST004931	IgG disialylation phenotypes (multivariate analysis)	IgG disialylation phenotypes (multivariate analysis)	Other measurement
11957	GCST004932	IgG monosialylation phenotypes (multivariate analysis)	IgG monosialylation phenotypes (multivariate analysis)	Other measurement
11958	GCST004929	IgG fucosylation phenotypes (multivariate analysis)	IgG fucosylation phenotypes (multivariate analysis)	Other measurement
11959	GCST004928	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)	Other measurement
11960	GCST004927	IgG galactosylation phenotypes (multivariate analysis)	IgG galactosylation phenotypes (multivariate analysis)	Other measurement
11961	GCST004924	IgG monogalactosylation phenotypes (multivariate analysis)	IgG monogalactosylation phenotypes (multivariate analysis)	Other measurement
11962	GCST004926	IgG digalactosylation phenotypes (multivariate analysis)	IgG digalactosylation phenotypes (multivariate analysis)	Other measurement
11963	GCST004925	IgG N-glycosylation phenotypes (multivariate analysis)	IgG N-glycosylation phenotypes (multivariate analysis)	Other measurement
11964	GCST004878	Sjögren's syndrome	Sjögren's syndrome	Neurological disorder
11965	GCST004879	Sjögren's syndrome	Sjögren's syndrome	Neurological disorder
11966	GCST005532	Sjögren's syndrome	Sjögren's syndrome	Neurological disorder
11967	GCST001934	Ulcerative colitis	Ulcerative colitis	Immune system disorder
11968	GCST001938	Ulcerative colitis	Ulcerative colitis	Immune system disorder
11969	GCST003162	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11970	GCST003162	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11971	GCST003165	Subcutaneous adipose tissue adjusted for BMI	Subcutaneous adipose tissue adjusted for BMI	Other measurement
11972	GCST003167	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
11973	GCST003167	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
11974	GCST003169	Total adipose tissue adjusted for BMI	Total adipose tissue adjusted for BMI	Other measurement
11975	GCST003163	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Other measurement
11976	GCST003163	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	Body measurement
11977	GCST003170	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
11978	GCST003171	Visceral adipose tissue	Visceral adipose tissue	Other measurement
11979	GCST003172	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Other measurement
11980	GCST003172	Visceral adipose tissue adjusted for BMI	Visceral adipose tissue adjusted for BMI	Body measurement
11981	GCST003173	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11982	GCST003173	Visceral adipose tissue/subcutaneous adipose tissue ratio	Visceral adipose tissue/subcutaneous adipose tissue ratio	Other measurement
11983	GCST003166	Visceral adipose tissue	Visceral adipose tissue	Other measurement
11984	GCST003168	Total adipose tissue	Total adipose tissue	Other measurement
11985	GCST003164	Subcutaneous adipose tissue	Subcutaneous adipose tissue	Other measurement
11986	GCST001623	Hepatitis C induced liver fibrosis	Hepatitis C induced liver fibrosis	Cancer
11987	GCST001623	Hepatitis C induced liver fibrosis	Hepatitis C induced liver fibrosis	Digestive system disorder
11988	GCST001052	Alcoholism (heaviness of drinking)	Alcoholism (heaviness of drinking)	Neurological disorder
11989	GCST001055	Alcoholism (12-month weekly alcohol consumption)	Alcoholism (12-month weekly alcohol consumption)	Neurological disorder
11990	GCST001053	Alcoholism (alcohol use disorder factor score)	Alcoholism (alcohol use disorder factor score)	Neurological disorder
11991	GCST001054	Alcoholism (alcohol dependence factor score)	Alcoholism (alcohol dependence factor score)	Neurological disorder
11992	GCST003453	Chronotype	Chronotype	Biological process
11993	GCST003453	Chronotype	Chronotype	Other measurement
11994	GCST003454	Morning vs. evening chronotype	Morning vs. evening chronotype	Biological process
11995	GCST001923	Glomerular filtration rate	Glomerular filtration rate	Other measurement
11996	GCST001696	Smoking behavior	Smoking behavior	Biological process
11997	GCST006186	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Other measurement
11998	GCST006186	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Other measurement
11999	GCST006195	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Other measurement
12000	GCST006195	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Other measurement
12001	GCST006194	Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Other measurement
12002	GCST006194	Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	Other measurement
12003	GCST006193	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Other measurement
12004	GCST006193	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	Other measurement
12005	GCST006192	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	Other measurement
12006	GCST006192	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	Other measurement
12007	GCST006191	Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	Other measurement
12008	GCST006191	Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	Other measurement
12009	GCST006190	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	Other measurement
12010	GCST006190	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	Other measurement
12011	GCST006189	Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	Other measurement
12012	GCST006189	Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	Other measurement
12013	GCST006188	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
12014	GCST006188	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
12015	GCST006188	Systolic blood pressure (cigarette smoking interaction)	Systolic blood pressure (cigarette smoking interaction)	Other measurement
12016	GCST006187	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
12017	GCST006187	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
12018	GCST006187	Diastolic blood pressure (cigarette smoking interaction)	Diastolic blood pressure (cigarette smoking interaction)	Other measurement
12019	GCST006292	Response to antipsychotic treatment in schizophrenia	Response to antipsychotic treatment in schizophrenia	Response to drug
12020	GCST006292	Response to antipsychotic treatment in schizophrenia	Response to antipsychotic treatment in schizophrenia	Neurological disorder
12021	GCST006298	Response to haloperidol in schizophrenia	Response to haloperidol in schizophrenia	Response to drug
12022	GCST006298	Response to haloperidol in schizophrenia	Response to haloperidol in schizophrenia	Neurological disorder
12023	GCST006297	Response to perphenazine in schizophrenia	Response to perphenazine in schizophrenia	Response to drug
12024	GCST006297	Response to perphenazine in schizophrenia	Response to perphenazine in schizophrenia	Neurological disorder
12025	GCST006296	Response to ziprazidone in schizophrenia	Response to ziprazidone in schizophrenia	Response to drug
12026	GCST006296	Response to ziprazidone in schizophrenia	Response to ziprazidone in schizophrenia	Neurological disorder
12027	GCST006295	Response to quetiapine in schizophrenia	Response to quetiapine in schizophrenia	Response to drug
12028	GCST006295	Response to quetiapine in schizophrenia	Response to quetiapine in schizophrenia	Neurological disorder
12029	GCST006285	Response to aripiprazole in schizophrenia	Response to aripiprazole in schizophrenia	Response to drug
12030	GCST006285	Response to aripiprazole in schizophrenia	Response to aripiprazole in schizophrenia	Neurological disorder
12031	GCST006285	Response to aripiprazole in schizophrenia	Response to aripiprazole in schizophrenia	Response to drug
12032	GCST006294	Response to risperidone in schizophrenia	Response to risperidone in schizophrenia	Response to drug
12033	GCST006294	Response to risperidone in schizophrenia	Response to risperidone in schizophrenia	Neurological disorder
12034	GCST006293	Response to olanzapine in schizophrenia	Response to olanzapine in schizophrenia	Response to drug
12035	GCST006293	Response to olanzapine in schizophrenia	Response to olanzapine in schizophrenia	Neurological disorder
12036	GCST004483	Multiple myeloma	Multiple myeloma	Cancer
12037	GCST005845	Heart rate increase in response to exercise	Heart rate increase in response to exercise	Cardiovascular measurement
12038	GCST005850	Heart rate response to recovery post exercise (30 sec)	Heart rate response to recovery post exercise (30 sec)	Cardiovascular measurement
12039	GCST005849	Heart rate response to recovery post exercise (40 sec)	Heart rate response to recovery post exercise (40 sec)	Cardiovascular measurement
12040	GCST005848	Heart rate response to recovery post exercise (50 sec)	Heart rate response to recovery post exercise (50 sec)	Cardiovascular measurement
12041	GCST005847	Heart rate response to recovery post exercise (20 sec)	Heart rate response to recovery post exercise (20 sec)	Cardiovascular measurement
12042	GCST005846	Heart rate response to recovery post exercise (10 sec)	Heart rate response to recovery post exercise (10 sec)	Cardiovascular measurement
12043	GCST005721	Food allergy (parent-of-origin effect)	Food allergy (parent-of-origin effect)	Other measurement
12044	GCST005721	Food allergy (parent-of-origin effect)	Food allergy (parent-of-origin effect)	Other measurement
12045	GCST005728	Egg allergy (maternal genetic effects)	Egg allergy (maternal genetic effects)	Other measurement
12046	GCST005728	Egg allergy (maternal genetic effects)	Egg allergy (maternal genetic effects)	Other measurement
12047	GCST005727	Peanut allergy (parent-of-origin effect)	Peanut allergy (parent-of-origin effect)	Other measurement
12048	GCST005727	Peanut allergy (parent-of-origin effect)	Peanut allergy (parent-of-origin effect)	Other measurement
12049	GCST005726	Milk allergy (parent-of-origin effect)	Milk allergy (parent-of-origin effect)	Other measurement
12050	GCST005726	Milk allergy (parent-of-origin effect)	Milk allergy (parent-of-origin effect)	Other measurement
12051	GCST005725	Egg allergy (parent-of-origin effect)	Egg allergy (parent-of-origin effect)	Other measurement
12052	GCST005725	Egg allergy (parent-of-origin effect)	Egg allergy (parent-of-origin effect)	Other measurement
12053	GCST005724	Food allergy (maternal genetic effects)	Food allergy (maternal genetic effects)	Other measurement
12054	GCST005724	Food allergy (maternal genetic effects)	Food allergy (maternal genetic effects)	Other measurement
12055	GCST005723	Peanut allergy (maternal genetic effects)	Peanut allergy (maternal genetic effects)	Other measurement
12056	GCST005723	Peanut allergy (maternal genetic effects)	Peanut allergy (maternal genetic effects)	Other measurement
12057	GCST005722	Milk allergy (maternal genetic effects)	Milk allergy (maternal genetic effects)	Other measurement
12058	GCST005722	Milk allergy (maternal genetic effects)	Milk allergy (maternal genetic effects)	Other measurement
12059	GCST005691	Major depressive disorder	Major depressive disorder	Neurological disorder
12060	GCST005690	Major depressive disorder (exposed to adversity)	Major depressive disorder (exposed to adversity)	Neurological disorder
12061	GCST005689	Major depressive disorder (unexposed to adversity)	Major depressive disorder (unexposed to adversity)	Neurological disorder
12062	GCST005514	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Metabolic disorder
12063	GCST005514	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Other measurement
12064	GCST005514	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Other measurement
12065	GCST005516	Neuritic plaques or neurofibrillary tangles (pleiotropy)	Neuritic plaques or neurofibrillary tangles (pleiotropy)	Other measurement
12066	GCST005516	Neuritic plaques or neurofibrillary tangles (pleiotropy)	Neuritic plaques or neurofibrillary tangles (pleiotropy)	Other measurement
12067	GCST005515	Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	Metabolic disorder
12068	GCST005515	Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	Other measurement
12069	GCST005517	Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Metabolic disorder
12070	GCST005517	Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	Other measurement
12071	GCST006906	Stroke	Stroke	Cardiovascular disease
12072	GCST005838	Stroke	Stroke	Cardiovascular disease
12073	GCST006907	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Cardiovascular disease
12074	GCST006907	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Other trait
12075	GCST006908	Ischemic stroke	Ischemic stroke	Cardiovascular disease
12076	GCST006908	Ischemic stroke	Ischemic stroke	Other trait
12077	GCST005840	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Cardiovascular disease
12078	GCST005840	Ischemic stroke (large artery atherosclerosis)	Ischemic stroke (large artery atherosclerosis)	Other trait
12079	GCST005841	Ischemic stroke (small-vessel)	Ischemic stroke (small-vessel)	Cardiovascular disease
12080	GCST005842	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
12081	GCST005842	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
12082	GCST005842	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
12083	GCST005843	Ischemic stroke	Ischemic stroke	Cardiovascular disease
12084	GCST005843	Ischemic stroke	Ischemic stroke	Other trait
12085	GCST006909	Ischemic stroke (small-vessel)	Ischemic stroke (small-vessel)	Cardiovascular disease
12086	GCST006910	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
12087	GCST006910	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Cardiovascular disease
12088	GCST006910	Ischemic stroke (cardioembolic)	Ischemic stroke (cardioembolic)	Other trait
12089	GCST005648	Serum metabolite concentrations in chronic kidney disease	Serum metabolite concentrations in chronic kidney disease	Other disease
12090	GCST005648	Serum metabolite concentrations in chronic kidney disease	Serum metabolite concentrations in chronic kidney disease	Other measurement
12091	GCST005649	Urinary metabolite ratios in chronic kidney disease	Urinary metabolite ratios in chronic kidney disease	Other disease
12092	GCST005649	Urinary metabolite ratios in chronic kidney disease	Urinary metabolite ratios in chronic kidney disease	Other measurement
12093	GCST005650	Serum metabolite ratios in chronic kidney disease	Serum metabolite ratios in chronic kidney disease	Other disease
12094	GCST005650	Serum metabolite ratios in chronic kidney disease	Serum metabolite ratios in chronic kidney disease	Other measurement
12095	GCST005651	Urinary metabolite concentrations in chronic kidney disease	Urinary metabolite concentrations in chronic kidney disease	Other disease
12096	GCST005651	Urinary metabolite concentrations in chronic kidney disease	Urinary metabolite concentrations in chronic kidney disease	Other measurement
12097	GCST005666	Fractional excretion of metabolites in chronic kidney disease	Fractional excretion of metabolites in chronic kidney disease	Other disease
12098	GCST005666	Fractional excretion of metabolites in chronic kidney disease	Fractional excretion of metabolites in chronic kidney disease	Other measurement
12099	GCST006807	ACPA-negative rheumatoid arthritis (smoking interaction)	ACPA-negative rheumatoid arthritis (smoking interaction)	Other measurement
12100	GCST006807	ACPA-negative rheumatoid arthritis (smoking interaction)	ACPA-negative rheumatoid arthritis (smoking interaction)	Immune system disorder
12101	GCST006807	ACPA-negative rheumatoid arthritis (smoking interaction)	ACPA-negative rheumatoid arthritis (smoking interaction)	Immune system disorder
12102	GCST006410	ACPA-positive rheumatoid arthritis (smoking interaction)	ACPA-positive rheumatoid arthritis (smoking interaction)	Other measurement
12103	GCST006410	ACPA-positive rheumatoid arthritis (smoking interaction)	ACPA-positive rheumatoid arthritis (smoking interaction)	Immune system disorder
12104	GCST006410	ACPA-positive rheumatoid arthritis (smoking interaction)	ACPA-positive rheumatoid arthritis (smoking interaction)	Immune system disorder
12105	GCST008583	Cognitive performance (processing speed) x major depressive disorder status interaction	Cognitive performance (processing speed) x major depressive disorder status interaction	Neurological disorder
12106	GCST008583	Cognitive performance (processing speed) x major depressive disorder status interaction	Cognitive performance (processing speed) x major depressive disorder status interaction	Biological process
12107	GCST008583	Cognitive performance (processing speed) x major depressive disorder status interaction	Cognitive performance (processing speed) x major depressive disorder status interaction	Other measurement
12108	GCST008584	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Other measurement
12109	GCST008584	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Neurological disorder
12110	GCST008584	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Other measurement
12111	GCST008585	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Other measurement
12112	GCST008585	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Neurological disorder
12113	GCST008585	Cognitive performance (language ability) x major depressive disorder status interaction	Cognitive performance (language ability) x major depressive disorder status interaction	Other measurement
12114	GCST008586	Cognitive performance (processing speed) x major depressive disorder type interaction	Cognitive performance (processing speed) x major depressive disorder type interaction	Neurological disorder
12115	GCST008586	Cognitive performance (processing speed) x major depressive disorder type interaction	Cognitive performance (processing speed) x major depressive disorder type interaction	Biological process
12116	GCST008586	Cognitive performance (processing speed) x major depressive disorder type interaction	Cognitive performance (processing speed) x major depressive disorder type interaction	Other measurement
12117	GCST008587	Cognitive performance (language ability)	Cognitive performance (language ability)	Other measurement
12118	GCST008587	Cognitive performance (language ability)	Cognitive performance (language ability)	Other measurement
12119	GCST008588	Cognitive performance (language ability)	Cognitive performance (language ability)	Other measurement
12120	GCST008588	Cognitive performance (language ability)	Cognitive performance (language ability)	Other measurement
12121	GCST008589	Cognitive performance (processing speed) in major depressive disorder	Cognitive performance (processing speed) in major depressive disorder	Neurological disorder
12122	GCST008589	Cognitive performance (processing speed) in major depressive disorder	Cognitive performance (processing speed) in major depressive disorder	Biological process
12123	GCST008589	Cognitive performance (processing speed) in major depressive disorder	Cognitive performance (processing speed) in major depressive disorder	Other measurement
12124	GCST008590	Cognitive performance (processing speed)	Cognitive performance (processing speed)	Biological process
12125	GCST008590	Cognitive performance (processing speed)	Cognitive performance (processing speed)	Other measurement
12126	GCST005924	Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	Other measurement
12127	GCST005924	Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	Response to drug
12128	GCST005925	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Response to drug
12129	GCST005925	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Response to drug
12130	GCST005925	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Other measurement
12131	GCST005925	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	Other disease
12132	GCST005926	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Response to drug
12133	GCST005926	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Response to drug
12134	GCST005926	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Other measurement
12135	GCST005926	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	Other disease
12136	GCST005927	Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	Other measurement
12137	GCST005927	Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	Response to drug
12138	GCST005815	Childhood onset ulcerative colitis	Childhood onset ulcerative colitis	Immune system disorder
12139	GCST005756	Dimensional psychopathology (Negative)	Dimensional psychopathology (Negative)	Other measurement
12140	GCST005757	Dimensional psychopathology (Positive)	Dimensional psychopathology (Positive)	Other measurement
12141	GCST005758	Dimensional psychopathology (Arousal)	Dimensional psychopathology (Arousal)	Other measurement
12142	GCST005759	Dimensional psychopathology (Social)	Dimensional psychopathology (Social)	Other measurement
12143	GCST005760	Dimensional psychopathology (Cognitive)	Dimensional psychopathology (Cognitive)	Other measurement
12144	GCST005791	Creatinine levels	Creatinine levels	Other measurement
12145	GCST005792	Glomerular filtration rate	Glomerular filtration rate	Other measurement
12146	GCST005793	Uric acid levels	Uric acid levels	Cardiovascular measurement
12147	GCST005794	Blood urea nitrogen levels	Blood urea nitrogen levels	Other measurement
12148	GCST005558	Plantar fascial disorders	Plantar fascial disorders	Other trait
12149	GCST005558	Plantar fascial disorders	Plantar fascial disorders	Cancer
12150	GCST007131	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
12151	GCST007140	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
12152	GCST007141	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
12153	GCST007132	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
12154	GCST007133	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
12155	GCST007134	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
12156	GCST007142	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
12157	GCST007143	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
12158	GCST005762	Death	Death	Other trait
12159	GCST005769	Body mass index	Body mass index	Body measurement
12160	GCST005769	Body mass index	Body mass index	Body measurement
12161	GCST005769	Body mass index	Body mass index	Other measurement
12162	GCST005770	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
12163	GCST005771	Creatinine levels	Creatinine levels	Other measurement
12164	GCST005772	Diastolic blood pressure	Diastolic blood pressure	Other measurement
12165	GCST005772	Diastolic blood pressure	Diastolic blood pressure	Other measurement
12166	GCST005773	Lung function (forced vital capacity)	Lung function (forced vital capacity)	Other measurement
12167	GCST005774	Heart rate	Heart rate	Cardiovascular measurement
12168	GCST005775	Hematocrit	Hematocrit	Hematological measurement
12169	GCST005776	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
12170	GCST005777	Systolic blood pressure	Systolic blood pressure	Other measurement
12171	GCST005777	Systolic blood pressure	Systolic blood pressure	Other measurement
12172	GCST005781	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
12173	GCST005780	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
12174	GCST005779	Alzheimer's disease	Alzheimer's disease	Neurological disorder
12175	GCST005778	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
12176	GCST005768	Cancer	Cancer	Cancer
12177	GCST005768	Cancer	Cancer	Cancer
12178	GCST005768	Cancer	Cancer	Cancer
12179	GCST005768	Cancer	Cancer	Cancer
12180	GCST005768	Cancer	Cancer	Cancer
12181	GCST005768	Cancer	Cancer	Cancer
12182	GCST005768	Cancer	Cancer	Cancer
12183	GCST005768	Cancer	Cancer	Cancer
12184	GCST005768	Cancer	Cancer	Cancer
12185	GCST005768	Cancer	Cancer	Cancer
12186	GCST005768	Cancer	Cancer	Cancer
12187	GCST005767	Coronary heart disease	Coronary heart disease	Cardiovascular disease
12188	GCST005766	Diabetes mellitus	Diabetes mellitus	Metabolic disorder
12189	GCST005765	Heart failure	Heart failure	Cardiovascular disease
12190	GCST005764	Stroke	Stroke	Cardiovascular disease
12191	GCST005763	Blood glucose levels	Blood glucose levels	Other measurement
12192	GCST005853	Autoimmune hepatitis in primary sclerosing cholangitis	Autoimmune hepatitis in primary sclerosing cholangitis	Immune system disorder
12193	GCST005853	Autoimmune hepatitis in primary sclerosing cholangitis	Autoimmune hepatitis in primary sclerosing cholangitis	Digestive system disorder
12194	GCST005854	Primary sclerosing cholangitis (small duct vs large duct)	Primary sclerosing cholangitis (small duct vs large duct)	Digestive system disorder
12195	GCST005859	Liver transplant-free survival in primary sclerosing cholangitis (time to event)	Liver transplant-free survival in primary sclerosing cholangitis (time to event)	Digestive system disorder
12196	GCST005859	Liver transplant-free survival in primary sclerosing cholangitis (time to event)	Liver transplant-free survival in primary sclerosing cholangitis (time to event)	Other measurement
12197	GCST005852	Colectomy in primary sclerosing cholangitis	Colectomy in primary sclerosing cholangitis	Digestive system disorder
12198	GCST005855	Cholangiocarcinoma in primary sclerosing cholangitis	Cholangiocarcinoma in primary sclerosing cholangitis	Digestive system disorder
12199	GCST005855	Cholangiocarcinoma in primary sclerosing cholangitis	Cholangiocarcinoma in primary sclerosing cholangitis	Cancer
12200	GCST005860	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Digestive system disorder
12201	GCST005860	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Other measurement
12202	GCST005860	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	Cancer
12203	GCST005856	Colorectal carcinoma in primary sclerosing cholangitis	Colorectal carcinoma in primary sclerosing cholangitis	Digestive system disorder
12204	GCST005856	Colorectal carcinoma in primary sclerosing cholangitis	Colorectal carcinoma in primary sclerosing cholangitis	Cancer
12205	GCST005857	Gallbladder carcinoma in primary sclerosing cholangitis	Gallbladder carcinoma in primary sclerosing cholangitis	Digestive system disorder
12206	GCST005857	Gallbladder carcinoma in primary sclerosing cholangitis	Gallbladder carcinoma in primary sclerosing cholangitis	Cancer
12207	GCST005858	Hepatocellular carcinoma in primary sclerosing cholangitis	Hepatocellular carcinoma in primary sclerosing cholangitis	Digestive system disorder
12208	GCST005858	Hepatocellular carcinoma in primary sclerosing cholangitis	Hepatocellular carcinoma in primary sclerosing cholangitis	Cancer
12209	GCST006138	Resting-state electroencephalogram vigilance	Resting-state electroencephalogram vigilance	Other measurement
12210	GCST005556	Pollinosis	Pollinosis	Immune system disorder
12211	GCST005809	Photic sneeze reflex	Photic sneeze reflex	Other trait
12212	GCST006796	Excitement-seeking behaviour	Excitement-seeking behaviour	Other measurement
12213	GCST005589	Vision loss in proton beam irradiation treatment of choroidal melanoma	Vision loss in proton beam irradiation treatment of choroidal melanoma	Cancer
12214	GCST005589	Vision loss in proton beam irradiation treatment of choroidal melanoma	Vision loss in proton beam irradiation treatment of choroidal melanoma	Biological process
12215	GCST005589	Vision loss in proton beam irradiation treatment of choroidal melanoma	Vision loss in proton beam irradiation treatment of choroidal melanoma	Other measurement
12216	GCST006217	Coronary heart disease events during statin therapy	Coronary heart disease events during statin therapy	Cardiovascular measurement
12217	GCST006217	Coronary heart disease events during statin therapy	Coronary heart disease events during statin therapy	Response to drug
12218	GCST005881	Diabetic kidney disease in diabetes	Diabetic kidney disease in diabetes	Metabolic disorder
12219	GCST005881	Diabetic kidney disease in diabetes	Diabetic kidney disease in diabetes	Metabolic disorder
12220	GCST005882	Chronic kidney disease in type 2 diabetes	Chronic kidney disease in type 2 diabetes	Other disease
12221	GCST005882	Chronic kidney disease in type 2 diabetes	Chronic kidney disease in type 2 diabetes	Metabolic disorder
12222	GCST005880	Chronic kidney disease in diabetes	Chronic kidney disease in diabetes	Other disease
12223	GCST005880	Chronic kidney disease in diabetes	Chronic kidney disease in diabetes	Metabolic disorder
12224	GCST005883	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Other disease
12225	GCST005883	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Metabolic disorder
12226	GCST005883	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	Metabolic disorder
12227	GCST005884	Chronic kidney disease and diabetic kidney disease in diabetes	Chronic kidney disease and diabetic kidney disease in diabetes	Other disease
12228	GCST005884	Chronic kidney disease and diabetic kidney disease in diabetes	Chronic kidney disease and diabetic kidney disease in diabetes	Metabolic disorder
12229	GCST005884	Chronic kidney disease and diabetic kidney disease in diabetes	Chronic kidney disease and diabetic kidney disease in diabetes	Metabolic disorder
12230	GCST005885	End-stage renal disease in type 2 diabetes	End-stage renal disease in type 2 diabetes	Other disease
12231	GCST005885	End-stage renal disease in type 2 diabetes	End-stage renal disease in type 2 diabetes	Metabolic disorder
12232	GCST005886	End-stage renal disease in diabetes	End-stage renal disease in diabetes	Other disease
12233	GCST005886	End-stage renal disease in diabetes	End-stage renal disease in diabetes	Metabolic disorder
12234	GCST005887	Late diabetic kidney disease in type 2 diabetes	Late diabetic kidney disease in type 2 diabetes	Metabolic disorder
12235	GCST005887	Late diabetic kidney disease in type 2 diabetes	Late diabetic kidney disease in type 2 diabetes	Metabolic disorder
12236	GCST005888	Late diabetic kidney disease in diabetes	Late diabetic kidney disease in diabetes	Metabolic disorder
12237	GCST005888	Late diabetic kidney disease in diabetes	Late diabetic kidney disease in diabetes	Metabolic disorder
12238	GCST005889	Early diabetic kidney disease in type 2 diabetes	Early diabetic kidney disease in type 2 diabetes	Metabolic disorder
12239	GCST005889	Early diabetic kidney disease in type 2 diabetes	Early diabetic kidney disease in type 2 diabetes	Metabolic disorder
12240	GCST005890	Early diabetic kidney disease in diabetes	Early diabetic kidney disease in diabetes	Metabolic disorder
12241	GCST005890	Early diabetic kidney disease in diabetes	Early diabetic kidney disease in diabetes	Metabolic disorder
12242	GCST005892	Glomerular filtration rate in type 2 diabetes	Glomerular filtration rate in type 2 diabetes	Other measurement
12243	GCST005892	Glomerular filtration rate in type 2 diabetes	Glomerular filtration rate in type 2 diabetes	Metabolic disorder
12244	GCST005891	Glomerular filtration rate in diabetes	Glomerular filtration rate in diabetes	Other measurement
12245	GCST005891	Glomerular filtration rate in diabetes	Glomerular filtration rate in diabetes	Metabolic disorder
12246	GCST005893	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	Other disease
12247	GCST005893	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	Metabolic disorder
12248	GCST005894	Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	Metabolic disorder
12249	GCST005894	Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	Metabolic disorder
12250	GCST005895	Diabetic kidney disease in type 2 diabetes	Diabetic kidney disease in type 2 diabetes	Metabolic disorder
12251	GCST005895	Diabetic kidney disease in type 2 diabetes	Diabetic kidney disease in type 2 diabetes	Metabolic disorder
12252	GCST006146	Behavioural changes in frontotemporal lobe dementia	Behavioural changes in frontotemporal lobe dementia	Neurological disorder
12253	GCST006146	Behavioural changes in frontotemporal lobe dementia	Behavioural changes in frontotemporal lobe dementia	Biological process
12254	GCST006147	Frontotemporal dementia (age at onset)	Frontotemporal dementia (age at onset)	Neurological disorder
12255	GCST006147	Frontotemporal dementia (age at onset)	Frontotemporal dementia (age at onset)	Other measurement
12256	GCST006148	Frontotemporal dementia with GRN mutation	Frontotemporal dementia with GRN mutation	Neurological disorder
12257	GCST006149	Frontotemporal dementia with GRN mutation (age at onset)	Frontotemporal dementia with GRN mutation (age at onset)	Neurological disorder
12258	GCST006149	Frontotemporal dementia with GRN mutation (age at onset)	Frontotemporal dementia with GRN mutation (age at onset)	Other measurement
12259	GCST006150	Frontotemporal dementia	Frontotemporal dementia	Neurological disorder
12260	GCST006151	Memory dysfunction in frontotemporal lobe dementia	Memory dysfunction in frontotemporal lobe dementia	Neurological disorder
12261	GCST006151	Memory dysfunction in frontotemporal lobe dementia	Memory dysfunction in frontotemporal lobe dementia	Other trait
12262	GCST006152	Language impairment in frontotemporal lobe dementia	Language impairment in frontotemporal lobe dementia	Neurological disorder
12263	GCST006152	Language impairment in frontotemporal lobe dementia	Language impairment in frontotemporal lobe dementia	Neurological disorder
12264	GCST006153	Parkinsonism in frontotemporal lobe dementia	Parkinsonism in frontotemporal lobe dementia	Neurological disorder
12265	GCST006153	Parkinsonism in frontotemporal lobe dementia	Parkinsonism in frontotemporal lobe dementia	Neurological disorder
12266	GCST006154	Frontotemporal dementia	Frontotemporal dementia	Neurological disorder
12267	GCST006041	Major depressive disorder	Major depressive disorder	Neurological disorder
12268	GCST005710	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Immune system disorder
12269	GCST005710	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Response to drug
12270	GCST005710	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	Other measurement
12271	GCST005706	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Immune system disorder
12272	GCST005706	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Response to drug
12273	GCST005706	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	Other measurement
12274	GCST005707	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Immune system disorder
12275	GCST005707	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Response to drug
12276	GCST005707	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	Other measurement
12277	GCST005708	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Immune system disorder
12278	GCST005708	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Response to drug
12279	GCST005708	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	Other measurement
12280	GCST005709	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Immune system disorder
12281	GCST005709	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Response to drug
12282	GCST005709	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	Other measurement
12283	GCST005907	Major depressive disorder	Major depressive disorder	Neurological disorder
12284	GCST006819	Emotional support seeking	Emotional support seeking	Other measurement
12285	GCST006820	Positive reappraisal	Positive reappraisal	Other measurement
12286	GCST006821	Problem solving	Problem solving	Other measurement
12287	GCST006822	Disengagement	Disengagement	Other measurement
12288	GCST006823	Emotional coping (emotional expression/emotional support seeking)	Emotional coping (emotional expression/emotional support seeking)	Other measurement
12289	GCST006824	Approach coping (positive reappraisal/problem solving)	Approach coping (positive reappraisal/problem solving)	Other measurement
12290	GCST006825	Perceived stress	Perceived stress	Other measurement
12291	GCST006826	Emotional expression	Emotional expression	Other measurement
12292	GCST005668	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	Other measurement
12293	GCST005668	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	Biological process
12294	GCST005669	Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	Other measurement
12295	GCST005669	Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	Biological process
12296	GCST005715	Myopic maculopathy	Myopic maculopathy	Other measurement
12297	GCST005626	Extremely high intelligence	Extremely high intelligence	Biological process
12298	GCST002282	Parasitemia in Tripanosoma cruzi seropositivity	Parasitemia in Tripanosoma cruzi seropositivity	Other measurement
12299	GCST002282	Parasitemia in Tripanosoma cruzi seropositivity	Parasitemia in Tripanosoma cruzi seropositivity	Other measurement
12300	GCST002284	QRS duration in Tripanosoma cruzi seropositivity	QRS duration in Tripanosoma cruzi seropositivity	Other measurement
12301	GCST002284	QRS duration in Tripanosoma cruzi seropositivity	QRS duration in Tripanosoma cruzi seropositivity	Cardiovascular measurement
12302	GCST002285	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Cardiovascular disease
12303	GCST002285	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Other measurement
12304	GCST002280	Antibody status in Tripanosoma cruzi seropositivity	Antibody status in Tripanosoma cruzi seropositivity	Other measurement
12305	GCST002280	Antibody status in Tripanosoma cruzi seropositivity	Antibody status in Tripanosoma cruzi seropositivity	Other measurement
12306	GCST002279	PR interval in Tripanosoma cruzi seropositivity	PR interval in Tripanosoma cruzi seropositivity	Other measurement
12307	GCST002279	PR interval in Tripanosoma cruzi seropositivity	PR interval in Tripanosoma cruzi seropositivity	Cardiovascular measurement
12308	GCST002278	QT interval in Tripanosoma cruzi seropositivity	QT interval in Tripanosoma cruzi seropositivity	Cardiovascular measurement
12309	GCST002278	QT interval in Tripanosoma cruzi seropositivity	QT interval in Tripanosoma cruzi seropositivity	Other measurement
12310	GCST002281	Ejection fraction in Tripanosoma cruzi seropositivity	Ejection fraction in Tripanosoma cruzi seropositivity	Cardiovascular measurement
12311	GCST002281	Ejection fraction in Tripanosoma cruzi seropositivity	Ejection fraction in Tripanosoma cruzi seropositivity	Other measurement
12312	GCST007362	Acute anterior uveitis (with or without ankylosing spondylitis)	Acute anterior uveitis (with or without ankylosing spondylitis)	Neurological disorder
12313	GCST007361	Acute anterior uveitis in ankylosing spondylitis	Acute anterior uveitis in ankylosing spondylitis	Immune system disorder
12314	GCST007361	Acute anterior uveitis in ankylosing spondylitis	Acute anterior uveitis in ankylosing spondylitis	Neurological disorder
12315	GCST000504	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
12316	GCST000504	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
12317	GCST000502	Hematocrit	Hematocrit	Hematological measurement
12318	GCST000503	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
12319	GCST000499	Hemoglobin	Hemoglobin	Hematological measurement
12320	GCST000500	Other erythrocyte phenotypes	Other erythrocyte phenotypes	Hematological measurement
12321	GCST000500	Other erythrocyte phenotypes	Other erythrocyte phenotypes	Hematological measurement
12322	GCST002335	Bone properties (heel)	Bone properties (heel)	Other measurement
12323	GCST002335	Bone properties (heel)	Bone properties (heel)	Other measurement
12324	GCST002335	Bone properties (heel)	Bone properties (heel)	Other measurement
12325	GCST002334	Bone properties (heel)	Bone properties (heel)	Other measurement
12326	GCST002334	Bone properties (heel)	Bone properties (heel)	Other measurement
12327	GCST002334	Bone properties (heel)	Bone properties (heel)	Other measurement
12328	GCST002333	Bone properties (heel)	Bone properties (heel)	Other measurement
12329	GCST002333	Bone properties (heel)	Bone properties (heel)	Other measurement
12330	GCST002333	Bone properties (heel)	Bone properties (heel)	Other measurement
12331	GCST004406	Neurocognitive impairment in HIV-1 infection (continuous)	Neurocognitive impairment in HIV-1 infection (continuous)	Other disease
12332	GCST004406	Neurocognitive impairment in HIV-1 infection (continuous)	Neurocognitive impairment in HIV-1 infection (continuous)	Other measurement
12333	GCST004411	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	Other measurement
12334	GCST004411	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	Other measurement
12335	GCST004411	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	Other measurement
12336	GCST004408	HIV-associated neurocognitive disorder (mild neurocognitive disorder)	HIV-associated neurocognitive disorder (mild neurocognitive disorder)	Other measurement
12337	GCST004408	HIV-associated neurocognitive disorder (mild neurocognitive disorder)	HIV-associated neurocognitive disorder (mild neurocognitive disorder)	Other measurement
12338	GCST004409	HIV-associated neurocognitive disorder	HIV-associated neurocognitive disorder	Other measurement
12339	GCST004407	Neurocognitive impairment in HIV-1 infection (dichotomous)	Neurocognitive impairment in HIV-1 infection (dichotomous)	Other disease
12340	GCST004407	Neurocognitive impairment in HIV-1 infection (dichotomous)	Neurocognitive impairment in HIV-1 infection (dichotomous)	Other measurement
12341	GCST004410	HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	Other measurement
12342	GCST004410	HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	Other measurement
12343	GCST005096	Iris color (b* coordinate)	Iris color (b* coordinate)	Other measurement
12344	GCST005096	Iris color (b* coordinate)	Iris color (b* coordinate)	Other trait
12345	GCST005095	Iris heterochromicity	Iris heterochromicity	Other measurement
12346	GCST005095	Iris heterochromicity	Iris heterochromicity	Other trait
12347	GCST005084	Skin pigmentation	Skin pigmentation	Other trait
12348	GCST005084	Skin pigmentation	Skin pigmentation	Other measurement
12349	GCST005094	Iris color (L* coordinate)	Iris color (L* coordinate)	Other measurement
12350	GCST005094	Iris color (L* coordinate)	Iris color (L* coordinate)	Other trait
12351	GCST005093	Iris color (a* coordinate)	Iris color (a* coordinate)	Other measurement
12352	GCST005093	Iris color (a* coordinate)	Iris color (a* coordinate)	Other trait
12353	GCST003745	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
12354	GCST004768	Motor development (prenatal lead exposure interaction)	Motor development (prenatal lead exposure interaction)	Other measurement
12355	GCST004768	Motor development (prenatal lead exposure interaction)	Motor development (prenatal lead exposure interaction)	Other measurement
12356	GCST004769	Mental development (prenatal lead exposure interaction)	Mental development (prenatal lead exposure interaction)	Other measurement
12357	GCST004769	Mental development (prenatal lead exposure interaction)	Mental development (prenatal lead exposure interaction)	Other measurement
12358	GCST002708	Acoustic startle blink response	Acoustic startle blink response	Other measurement
12359	GCST000894	Entorhinal cortical thickness	Entorhinal cortical thickness	Other measurement
12360	GCST000899	Entorhinal cortical volume	Entorhinal cortical volume	Other measurement
12361	GCST000891	Whole-brain volume	Whole-brain volume	Other measurement
12362	GCST000890	Hippocampal volume	Hippocampal volume	Other measurement
12363	GCST000889	Entorhinal cortical thickness (Alzheimer's disease interaction)	Entorhinal cortical thickness (Alzheimer's disease interaction)	Neurological disorder
12364	GCST000889	Entorhinal cortical thickness (Alzheimer's disease interaction)	Entorhinal cortical thickness (Alzheimer's disease interaction)	Other measurement
12365	GCST000898	Total ventricular volume	Total ventricular volume	Other measurement
12366	GCST000893	Entorhinal cortical volume (Alzheimer's disease interaction)	Entorhinal cortical volume (Alzheimer's disease interaction)	Neurological disorder
12367	GCST000893	Entorhinal cortical volume (Alzheimer's disease interaction)	Entorhinal cortical volume (Alzheimer's disease interaction)	Other measurement
12368	GCST000892	Total ventricular volume (Alzheimer's disease interaction)	Total ventricular volume (Alzheimer's disease interaction)	Other measurement
12369	GCST000892	Total ventricular volume (Alzheimer's disease interaction)	Total ventricular volume (Alzheimer's disease interaction)	Neurological disorder
12370	GCST000895	Whole-brain volume (Alzheimer's disease interaction)	Whole-brain volume (Alzheimer's disease interaction)	Neurological disorder
12371	GCST000895	Whole-brain volume (Alzheimer's disease interaction)	Whole-brain volume (Alzheimer's disease interaction)	Other measurement
12372	GCST000897	Hippocampal volume (Alzheimer's disease interaction)	Hippocampal volume (Alzheimer's disease interaction)	Neurological disorder
12373	GCST000897	Hippocampal volume (Alzheimer's disease interaction)	Hippocampal volume (Alzheimer's disease interaction)	Other measurement
12374	GCST002871	Psychotic symptoms and prion disease	Psychotic symptoms and prion disease	Neurological disorder
12375	GCST002871	Psychotic symptoms and prion disease	Psychotic symptoms and prion disease	Other trait
12376	GCST002862	Mood disorder and prion disease	Mood disorder and prion disease	Neurological disorder
12377	GCST002862	Mood disorder and prion disease	Mood disorder and prion disease	Neurological disorder
12378	GCST002866	Behavioral disturbance or psychiatric symptoms and prion disease	Behavioral disturbance or psychiatric symptoms and prion disease	Neurological disorder
12379	GCST002866	Behavioral disturbance or psychiatric symptoms and prion disease	Behavioral disturbance or psychiatric symptoms and prion disease	Other trait
12380	GCST002867	Psychotic symptoms in prion disease	Psychotic symptoms in prion disease	Neurological disorder
12381	GCST002867	Psychotic symptoms in prion disease	Psychotic symptoms in prion disease	Other trait
12382	GCST002864	Mood disorder in prion disease	Mood disorder in prion disease	Neurological disorder
12383	GCST002864	Mood disorder in prion disease	Mood disorder in prion disease	Neurological disorder
12384	GCST002863	Behavioral disturbance or psychiatric symptoms in prion disease	Behavioral disturbance or psychiatric symptoms in prion disease	Neurological disorder
12385	GCST002863	Behavioral disturbance or psychiatric symptoms in prion disease	Behavioral disturbance or psychiatric symptoms in prion disease	Other trait
12386	GCST006282	Diabetic macular edema in type 2 diabetes	Diabetic macular edema in type 2 diabetes	Metabolic disorder
12387	GCST006282	Diabetic macular edema in type 2 diabetes	Diabetic macular edema in type 2 diabetes	Metabolic disorder
12388	GCST006283	Proliferative diabetic retinopathy in type 2 diabetes	Proliferative diabetic retinopathy in type 2 diabetes	Metabolic disorder
12389	GCST006283	Proliferative diabetic retinopathy in type 2 diabetes	Proliferative diabetic retinopathy in type 2 diabetes	Metabolic disorder
12390	GCST003065	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	Other measurement
12391	GCST003066	Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)	Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)	Other measurement
12392	GCST003067	Exploratory eye movement dysfunction in schizophrenia (mean eye scanning length)	Exploratory eye movement dysfunction in schizophrenia (mean eye scanning length)	Other measurement
12393	GCST003068	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations)	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations)	Other measurement
12394	GCST003064	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	Other measurement
12395	GCST002042	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
12396	GCST002042	LDL cholesterol	LDL cholesterol	Other measurement
12397	GCST002042	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
12398	GCST002044	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
12399	GCST002043	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
12400	GCST004029	Angiotensin-converting enzyme inhibitor intolerance	Angiotensin-converting enzyme inhibitor intolerance	Response to drug
12401	GCST005052	Platelet-to-lymphocyte ratio	Platelet-to-lymphocyte ratio	Hematological measurement
12402	GCST005056	Neutrophil count	Neutrophil count	Hematological measurement
12403	GCST005055	Lymphocyte counts	Lymphocyte counts	Hematological measurement
12404	GCST005054	Platelet count	Platelet count	Hematological measurement
12405	GCST005053	Neutrophil-to-lymphocyte ratio	Neutrophil-to-lymphocyte ratio	Hematological measurement
12406	GCST000432	Alcohol dependence	Alcohol dependence	Other measurement
12407	GCST000432	Alcohol dependence	Alcohol dependence	Neurological disorder
12408	GCST003718	Hepatitis B (viral clearance)	Hepatitis B (viral clearance)	Biological process
12409	GCST003718	Hepatitis B (viral clearance)	Hepatitis B (viral clearance)	Digestive system disorder
12410	GCST006368	Body mass index	Body mass index	Body measurement
12411	GCST006368	Body mass index	Body mass index	Body measurement
12412	GCST006368	Body mass index	Body mass index	Other measurement
12413	GCST008371	Thyroid cancer	Thyroid cancer	Cancer
12414	GCST008370	Coronary artery disease	Coronary artery disease	Cardiovascular disease
12415	GCST008370	Coronary artery disease	Coronary artery disease	Cardiovascular disease
12416	GCST008373	Glaucoma	Glaucoma	Neurological disorder
12417	GCST008372	Colorectal cancer	Colorectal cancer	Cancer
12418	GCST006465	Endometrial cancer (endometrioid histology)	Endometrial cancer (endometrioid histology)	Cancer
12419	GCST006466	Endometrial cancer (Non-endometrioid histology)	Endometrial cancer (Non-endometrioid histology)	Cancer
12420	GCST006464	Endometrial cancer	Endometrial cancer	Cancer
12421	GCST006464	Endometrial cancer	Endometrial cancer	Cancer
12422	GCST006458	Eye movement (horizontal position gain)	Eye movement (horizontal position gain)	Other measurement
12423	GCST006459	Eye movement in schizophrenia (scanpath length)	Eye movement in schizophrenia (scanpath length)	Neurological disorder
12424	GCST006459	Eye movement in schizophrenia (scanpath length)	Eye movement in schizophrenia (scanpath length)	Other measurement
12425	GCST006457	Eye movement (horizontal position gain)	Eye movement (horizontal position gain)	Other measurement
12426	GCST006456	Eye movement (scanpath length)	Eye movement (scanpath length)	Other measurement
12427	GCST006455	Eye movement (scanpath length)	Eye movement (scanpath length)	Other measurement
12428	GCST006454	Eye movement in schizophrenia (duration of fixations)	Eye movement in schizophrenia (duration of fixations)	Neurological disorder
12429	GCST006454	Eye movement in schizophrenia (duration of fixations)	Eye movement in schizophrenia (duration of fixations)	Other measurement
12430	GCST006453	Eye movement (duration of fixations)	Eye movement (duration of fixations)	Other measurement
12431	GCST006452	Eye movement (duration of fixations)	Eye movement (duration of fixations)	Other measurement
12432	GCST006451	Eye movement in schizophrenia (integrated eye movement score)	Eye movement in schizophrenia (integrated eye movement score)	Neurological disorder
12433	GCST006451	Eye movement in schizophrenia (integrated eye movement score)	Eye movement in schizophrenia (integrated eye movement score)	Other measurement
12434	GCST006450	Eye movement (integrated eye movement score)	Eye movement (integrated eye movement score)	Other measurement
12435	GCST006449	Eye movement (integrated eye movement score)	Eye movement (integrated eye movement score)	Other measurement
12436	GCST006448	Eye movement in schizophrenia (horizontal position gain)	Eye movement in schizophrenia (horizontal position gain)	Neurological disorder
12437	GCST006448	Eye movement in schizophrenia (horizontal position gain)	Eye movement in schizophrenia (horizontal position gain)	Other measurement
12438	GCST006438	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
12439	GCST006437	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
12440	GCST006439	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
12441	GCST006436	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
12442	GCST006397	Relative amplitude of rest-activity cycles	Relative amplitude of rest-activity cycles	Biological process
12443	GCST006396	Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)	Biological process
12444	GCST006440	Motor composite score	Motor composite score	Other measurement
12445	GCST006441	Mental composite score	Mental composite score	Other measurement
12446	GCST006492	Obesity without metabolic disease	Obesity without metabolic disease	Metabolic disorder
12447	GCST006389	Brain imaging measurements	Brain imaging measurements	Other measurement
12448	GCST006624	Systolic blood pressure	Systolic blood pressure	Other measurement
12449	GCST006624	Systolic blood pressure	Systolic blood pressure	Other measurement
12450	GCST006630	Diastolic blood pressure	Diastolic blood pressure	Other measurement
12451	GCST006630	Diastolic blood pressure	Diastolic blood pressure	Other measurement
12452	GCST006629	Pulse pressure	Pulse pressure	Cardiovascular measurement
12453	GCST006628	Systolic blood pressure	Systolic blood pressure	Other measurement
12454	GCST006628	Systolic blood pressure	Systolic blood pressure	Other measurement
12455	GCST006627	Diastolic blood pressure	Diastolic blood pressure	Other measurement
12456	GCST006627	Diastolic blood pressure	Diastolic blood pressure	Other measurement
12457	GCST006626	Pulse pressure	Pulse pressure	Cardiovascular measurement
12458	GCST007040	Carotid intima media thickness in rheumatoid arthritis	Carotid intima media thickness in rheumatoid arthritis	Immune system disorder
12459	GCST007040	Carotid intima media thickness in rheumatoid arthritis	Carotid intima media thickness in rheumatoid arthritis	Other measurement
12460	GCST007041	Cardiovascular event in rheumatoid arthritis	Cardiovascular event in rheumatoid arthritis	Other disease
12461	GCST007041	Cardiovascular event in rheumatoid arthritis	Cardiovascular event in rheumatoid arthritis	Immune system disorder
12462	GCST007088	Ischemic heart disease in rheumatoid arthritis	Ischemic heart disease in rheumatoid arthritis	Immune system disorder
12463	GCST007088	Ischemic heart disease in rheumatoid arthritis	Ischemic heart disease in rheumatoid arthritis	Cardiovascular disease
12464	GCST007425	Carotid plaques in rheumatoid arthritis	Carotid plaques in rheumatoid arthritis	Immune system disorder
12465	GCST007425	Carotid plaques in rheumatoid arthritis	Carotid plaques in rheumatoid arthritis	Cardiovascular disease
12466	GCST007490	Anthropometric traits (multi-trait analysis)	Anthropometric traits (multi-trait analysis)	Other measurement
12467	GCST007485	Anthropometric traits	Anthropometric traits	Other measurement
12468	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
12469	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
12470	GCST007485	Anthropometric traits	Anthropometric traits	Other measurement
12471	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
12472	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
12473	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
12474	GCST007485	Anthropometric traits	Anthropometric traits	Body measurement
12475	GCST007480	Disorders of lipid metabolism	Disorders of lipid metabolism	Other trait
12476	GCST007489	Eye color traits	Eye color traits	Other trait
12477	GCST007488	Skin pigmentation traits	Skin pigmentation traits	Other trait
12478	GCST007488	Skin pigmentation traits	Skin pigmentation traits	Other trait
12479	GCST007488	Skin pigmentation traits	Skin pigmentation traits	Other trait
12480	GCST007486	Hair morphology traits	Hair morphology traits	Other measurement
12481	GCST007486	Hair morphology traits	Hair morphology traits	Other measurement
12482	GCST007486	Hair morphology traits	Hair morphology traits	Other measurement
12483	GCST007482	Handedness	Handedness	Other trait
12484	GCST007481	Heart rate	Heart rate	Cardiovascular measurement
12485	GCST006427	Depression in smokers	Depression in smokers	Biological process
12486	GCST006427	Depression in smokers	Depression in smokers	Neurological disorder
12487	GCST006463	Urinary albumin excretion (no hypertensive medication)	Urinary albumin excretion (no hypertensive medication)	Other trait
12488	GCST006586	Urinary albumin excretion	Urinary albumin excretion	Other trait
12489	GCST007548	Uterine fibroids	Uterine fibroids	Cancer
12490	GCST006703	Bitter taste perception (multivariate analysis)	Bitter taste perception (multivariate analysis)	Biological process
12491	GCST006704	Bitter taste perception	Bitter taste perception	Biological process
12492	GCST007658	Triglyceride levels (parental genotype effect)	Triglyceride levels (parental genotype effect)	Other measurement
12493	GCST007658	Triglyceride levels (parental genotype effect)	Triglyceride levels (parental genotype effect)	Lipid or lipoprotein measurement
12494	GCST007660	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Response to drug
12495	GCST007660	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Other measurement
12496	GCST007660	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Triglyceride levels in response to fenofibrate treatment (parental genotype effect)	Lipid or lipoprotein measurement
12497	GCST007659	Triglyceride change in response to fenofibrate (parental genotype effect)	Triglyceride change in response to fenofibrate (parental genotype effect)	Response to drug
12498	GCST007659	Triglyceride change in response to fenofibrate (parental genotype effect)	Triglyceride change in response to fenofibrate (parental genotype effect)	Other measurement
12499	GCST007659	Triglyceride change in response to fenofibrate (parental genotype effect)	Triglyceride change in response to fenofibrate (parental genotype effect)	Lipid or lipoprotein measurement
12500	GCST007661	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
12501	GCST007662	Triglyceride levels in response to fenofibrate	Triglyceride levels in response to fenofibrate	Response to drug
12502	GCST007662	Triglyceride levels in response to fenofibrate	Triglyceride levels in response to fenofibrate	Lipid or lipoprotein measurement
12503	GCST007663	Triglyceride change in response to fenofibrate treatment	Triglyceride change in response to fenofibrate treatment	Response to drug
12504	GCST007663	Triglyceride change in response to fenofibrate treatment	Triglyceride change in response to fenofibrate treatment	Lipid or lipoprotein measurement
12505	GCST007109	Diarrhoea-associated Entamoeba histolytica infection	Diarrhoea-associated Entamoeba histolytica infection	Other disease
12506	GCST006169	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
12507	GCST006169	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
12508	GCST006434	Systolic blood pressure x alcohol consumption interaction (2df test)	Systolic blood pressure x alcohol consumption interaction (2df test)	Biological process
12509	GCST006434	Systolic blood pressure x alcohol consumption interaction (2df test)	Systolic blood pressure x alcohol consumption interaction (2df test)	Other measurement
12510	GCST006170	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
12511	GCST006170	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
12512	GCST006168	Pulse pressure x alcohol consumption interaction (2df test)	Pulse pressure x alcohol consumption interaction (2df test)	Biological process
12513	GCST006168	Pulse pressure x alcohol consumption interaction (2df test)	Pulse pressure x alcohol consumption interaction (2df test)	Cardiovascular measurement
12514	GCST006167	Mean arterial pressure x alcohol consumption interaction (2df test)	Mean arterial pressure x alcohol consumption interaction (2df test)	Biological process
12515	GCST006167	Mean arterial pressure x alcohol consumption interaction (2df test)	Mean arterial pressure x alcohol consumption interaction (2df test)	Other measurement
12516	GCST006172	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
12517	GCST006172	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
12518	GCST006166	Diastolic blood pressure x alcohol consumption interaction (2df test)	Diastolic blood pressure x alcohol consumption interaction (2df test)	Biological process
12519	GCST006166	Diastolic blood pressure x alcohol consumption interaction (2df test)	Diastolic blood pressure x alcohol consumption interaction (2df test)	Other measurement
12520	GCST006171	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	Cardiovascular measurement
12521	GCST006171	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	Other measurement
12522	GCST006871	Total hippocampal volume	Total hippocampal volume	Other measurement
12523	GCST006872	Presubiculum volume (corrected for total hippocampal volume)	Presubiculum volume (corrected for total hippocampal volume)	Other measurement
12524	GCST006873	Subiculum volume (corrected for total hippocampal volume)	Subiculum volume (corrected for total hippocampal volume)	Other measurement
12525	GCST006874	Hippocampal subfield CA1 volume (corrected for total hippocampal volume)	Hippocampal subfield CA1 volume (corrected for total hippocampal volume)	Other measurement
12526	GCST006875	Hippocampal subfield CA3 volume (corrected for total hippocampal volume)	Hippocampal subfield CA3 volume (corrected for total hippocampal volume)	Other measurement
12527	GCST006876	Hippocampal subfield CA4 volume (corrected for total hippocampal volume)	Hippocampal subfield CA4 volume (corrected for total hippocampal volume)	Other measurement
12528	GCST006877	Dentate gyrus granule cell layer volume (corrected for total hippocampal volume)	Dentate gyrus granule cell layer volume (corrected for total hippocampal volume)	Other measurement
12529	GCST006878	Dentate gyrus molecular layer volume (corrected for total hippocampal volume)	Dentate gyrus molecular layer volume (corrected for total hippocampal volume)	Other measurement
12530	GCST006880	Hippocampal fissure volume (corrected for total hippocampal volume)	Hippocampal fissure volume (corrected for total hippocampal volume)	Other measurement
12531	GCST006881	Hippocampal tail volume (corrected for total hippocampal volume)	Hippocampal tail volume (corrected for total hippocampal volume)	Other measurement
12532	GCST006882	Fimbria volume (corrected for total hippocampal volume)	Fimbria volume (corrected for total hippocampal volume)	Other measurement
12533	GCST006883	HATA volume (corrected for total hippocampal volume)	HATA volume (corrected for total hippocampal volume)	Other measurement
12534	GCST006884	Parasubiculum volume (corrected for total hippocampal volume)	Parasubiculum volume (corrected for total hippocampal volume)	Other measurement
12535	GCST006885	Presubiculum volume	Presubiculum volume	Other measurement
12536	GCST006886	Subiculum volume	Subiculum volume	Other measurement
12537	GCST006887	Hippocampal subfield CA1 volume	Hippocampal subfield CA1 volume	Other measurement
12538	GCST006888	Hippocampal subfield CA3 volume	Hippocampal subfield CA3 volume	Other measurement
12539	GCST006889	Hippocampal subfield CA4 volume	Hippocampal subfield CA4 volume	Other measurement
12540	GCST006890	Dentate gyrus granule cell layer volume	Dentate gyrus granule cell layer volume	Other measurement
12541	GCST006891	Dentate gyrus molecular layer volume	Dentate gyrus molecular layer volume	Other measurement
12542	GCST006892	Hippocampal fissure volume	Hippocampal fissure volume	Other measurement
12543	GCST006870	Hippocampal tail volume	Hippocampal tail volume	Other measurement
12544	GCST006893	Fimbria volume	Fimbria volume	Other measurement
12545	GCST006894	HATA volume	HATA volume	Other measurement
12546	GCST006895	Parasubiculum volume	Parasubiculum volume	Other measurement
12547	GCST006859	Infant death in continuous marriage (Proportion of children died <1 year)	Infant death in continuous marriage (Proportion of children died <1 year)	Other measurement
12548	GCST006720	Hemoglobin levels	Hemoglobin levels	Hematological measurement
12549	GCST006720	Hemoglobin levels	Hemoglobin levels	Hematological measurement
12550	GCST006720	Hemoglobin levels	Hemoglobin levels	Hematological measurement
12551	GCST006720	Hemoglobin levels	Hemoglobin levels	Hematological measurement
12552	GCST006721	Infant and Child death (Number of children died <5 years)	Infant and Child death (Number of children died <5 years)	Other measurement
12553	GCST006722	Infant and Child death in continuous marriage (Number of children died <5 years)	Infant and Child death in continuous marriage (Number of children died <5 years)	Other measurement
12554	GCST006723	Infant and Child death (Proportion of children died <5 years)	Infant and Child death (Proportion of children died <5 years)	Other measurement
12555	GCST006724	Infant and Child death in continuous marriage (Proportion of children died <5 years)	Infant and Child death in continuous marriage (Proportion of children died <5 years)	Other measurement
12556	GCST006725	Infant, child and juvenile death (number of children died <15 years)	Infant, child and juvenile death (number of children died <15 years)	Other measurement
12557	GCST006726	Infant, child and juvenile death in continuous marriage (number of children died <15 years)	Infant, child and juvenile death in continuous marriage (number of children died <15 years)	Other measurement
12558	GCST006727	Infant, child and juvenile death (proportion of children died <15 years)	Infant, child and juvenile death (proportion of children died <15 years)	Other measurement
12559	GCST006730	Infant, child and juvenile death in continuous marriage (proportion of children died <15 years)	Infant, child and juvenile death in continuous marriage (proportion of children died <15 years)	Other measurement
12560	GCST006728	Infant death (Number of children died <1 year)	Infant death (Number of children died <1 year)	Other measurement
12561	GCST006729	Infant death in continuous marriage (Number of children died <1 year)	Infant death in continuous marriage (Number of children died <1 year)	Other measurement
12562	GCST006731	Infant death (Proportion of children died <1 year)	Infant death (Proportion of children died <1 year)	Other measurement
12563	GCST006733	Infant survival (Number of children surviving at 1 year)	Infant survival (Number of children surviving at 1 year)	Other measurement
12564	GCST006734	Infant survival in continuous marriage (Number of children surviving at 1 year)	Infant survival in continuous marriage (Number of children surviving at 1 year)	Other measurement
12565	GCST006735	Infant survival (Proportion of children surviving at 1 year)	Infant survival (Proportion of children surviving at 1 year)	Other measurement
12566	GCST006736	Infant survival in continuous marriage (Proportion of children surviving at 1 year)	Infant survival in continuous marriage (Proportion of children surviving at 1 year)	Other measurement
12567	GCST006737	Number of miscarriages	Number of miscarriages	Other measurement
12568	GCST006738	Number of miscarriages in continuous marriage	Number of miscarriages in continuous marriage	Other measurement
12569	GCST006739	Proportion of miscarriages	Proportion of miscarriages	Other measurement
12570	GCST006740	Proportion of miscarriages in continuous marriage	Proportion of miscarriages in continuous marriage	Other measurement
12571	GCST006741	Number of stillbirths	Number of stillbirths	Other measurement
12572	GCST006742	Number of stillbirths in continuous marriage	Number of stillbirths in continuous marriage	Other measurement
12573	GCST006743	Proportion of stillbirths	Proportion of stillbirths	Other measurement
12574	GCST006744	Proportion of stillbirths in continuous marriage	Proportion of stillbirths in continuous marriage	Other measurement
12575	GCST006745	Oxygen saturation of hemoglobin levels	Oxygen saturation of hemoglobin levels	Other measurement
12576	GCST006746	Pulse rate	Pulse rate	Cardiovascular measurement
12577	GCST006746	Pulse rate	Pulse rate	Cardiovascular measurement
12578	GCST006747	Oxygenated hemoglobin levels	Oxygenated hemoglobin levels	Hematological measurement
12579	GCST006748	Deoxygenated hemoglobin levels	Deoxygenated hemoglobin levels	Hematological measurement
12580	GCST006749	Child death (Number of children surviving at 1 year but died <5 years)	Child death (Number of children surviving at 1 year but died <5 years)	Other measurement
12581	GCST006750	Child death in continuous marriage (Number of children surviving at 1 year but died <5 years)	Child death in continuous marriage (Number of children surviving at 1 year but died <5 years)	Other measurement
12582	GCST006751	Child survival (Number of children surviving at 5 years)	Child survival (Number of children surviving at 5 years)	Other measurement
12583	GCST006752	Child survival in continuous marriage (Number of children surviving at 5 years)	Child survival in continuous marriage (Number of children surviving at 5 years)	Other measurement
12584	GCST006753	Child death (Proportion of children surviving at 1 year but died <5 years)	Child death (Proportion of children surviving at 1 year but died <5 years)	Other measurement
12585	GCST006754	Child death in continuous marriage (Proportion of children surviving at 1 year but died <5 years)	Child death in continuous marriage (Proportion of children surviving at 1 year but died <5 years)	Other measurement
12586	GCST006755	Child survival (Proportion of children surviving at 5 years)	Child survival (Proportion of children surviving at 5 years)	Other measurement
12587	GCST006756	Child survival in continuous marriage (Proportion of children surviving at 5 years)	Child survival in continuous marriage (Proportion of children surviving at 5 years)	Other measurement
12588	GCST006757	Juvenile death (Number of children surviving at 5 years but died <15 years)	Juvenile death (Number of children surviving at 5 years but died <15 years)	Other measurement
12589	GCST006758	Juvenile death in continuous marriage (Number of children surviving at 5 years but died <15 years)	Juvenile death in continuous marriage (Number of children surviving at 5 years but died <15 years)	Other measurement
12590	GCST006759	Juvenile death (Proportion of children surviving at 5 years but died <15 years)	Juvenile death (Proportion of children surviving at 5 years but died <15 years)	Other measurement
12591	GCST006760	Juvenile death in continuous marriage (Proportion of children surviving at 5 years but died <15 years)	Juvenile death in continuous marriage (Proportion of children surviving at 5 years but died <15 years)	Other measurement
12592	GCST006761	Juvenile survival (Number of children surviving at 15 years)	Juvenile survival (Number of children surviving at 15 years)	Other measurement
12593	GCST006762	Juvenile survival in continuous marriage (Number of children surviving at 15 years)	Juvenile survival in continuous marriage (Number of children surviving at 15 years)	Other measurement
12594	GCST006763	Juvenile survival (Proportion of children surviving at 15 years)	Juvenile survival (Proportion of children surviving at 15 years)	Other measurement
12595	GCST006764	Juvenile survival in continuous marriage (Proportion of children surviving at 15 years)	Juvenile survival in continuous marriage (Proportion of children surviving at 15 years)	Other measurement
12596	GCST006765	Number of live births	Number of live births	Other measurement
12597	GCST006766	Number of live births in continuous marriage	Number of live births in continuous marriage	Other measurement
12598	GCST006767	Proportion of live births	Proportion of live births	Other measurement
12599	GCST006768	Proportion of live births in continuous marriage	Proportion of live births in continuous marriage	Other measurement
12600	GCST006771	Number of pregnancies	Number of pregnancies	Other measurement
12601	GCST006771	Number of pregnancies	Number of pregnancies	Other trait
12602	GCST006771	Number of pregnancies	Number of pregnancies	Other measurement
12603	GCST006772	Number of pregnancies in continuous marriage	Number of pregnancies in continuous marriage	Other measurement
12604	GCST006773	Number of twin births	Number of twin births	Other measurement
12605	GCST006774	Number of twin births in continuous marriage	Number of twin births in continuous marriage	Other measurement
12606	GCST006775	Age at last pregnancy	Age at last pregnancy	Other measurement
12607	GCST006776	Age at last pregnancy in continuous marriage	Age at last pregnancy in continuous marriage	Other measurement
12608	GCST006769	Age at first birth	Age at first birth	Other measurement
12609	GCST006770	Age at first birth in continuous marriage	Age at first birth in continuous marriage	Other measurement
12610	GCST006497	Nose wing breadth	Nose wing breadth	Other measurement
12611	GCST006499	Nose length	Nose length	Other measurement
12612	GCST006500	Nosetip height	Nosetip height	Other measurement
12613	GCST006501	Nasal root breadth	Nasal root breadth	Other measurement
12614	GCST006502	Nasal root height	Nasal root height	Other measurement
12615	GCST006503	Eye length	Eye length	Other measurement
12616	GCST006504	Interorbital distance	Interorbital distance	Other measurement
12617	GCST006505	Labial fissure length	Labial fissure length	Other measurement
12618	GCST006506	Lip thickness	Lip thickness	Other measurement
12619	GCST006507	Lower face length	Lower face length	Other measurement
12620	GCST006498	Brow ridge morphology (principal component model)	Brow ridge morphology (principal component model)	Other measurement
12621	GCST006508	Eye morphology (principal component model)	Eye morphology (principal component model)	Other measurement
12622	GCST006509	Side of face morphology (principal component model)	Side of face morphology (principal component model)	Other measurement
12623	GCST006510	Cheek morphology (principal component model)	Cheek morphology (principal component model)	Other measurement
12624	GCST006511	Nose morphology (principal component model)	Nose morphology (principal component model)	Other measurement
12625	GCST006512	Mouth morphology (principal component model)	Mouth morphology (principal component model)	Other measurement
12626	GCST006513	Brow ridge morphology (partial least square model)	Brow ridge morphology (partial least square model)	Other measurement
12627	GCST006514	Eye morphology (partial least square model)	Eye morphology (partial least square model)	Other measurement
12628	GCST006515	Side of face morphology (partial least square model)	Side of face morphology (partial least square model)	Other measurement
12629	GCST006516	Cheek morphology (partial least square model)	Cheek morphology (partial least square model)	Other measurement
12630	GCST006517	Nose morphology (partial least square model)	Nose morphology (partial least square model)	Other measurement
12631	GCST006518	Mouth morphology (partial least square model)	Mouth morphology (partial least square model)	Other measurement
12632	GCST006108	Facial morphology	Facial morphology	Other trait
12633	GCST006108	Facial morphology	Facial morphology	Other measurement
12634	GCST006106	Forehead morphology	Forehead morphology	Other measurement
12635	GCST006105	Eye morphology	Eye morphology	Other measurement
12636	GCST006110	Nose morphology	Nose morphology	Other measurement
12637	GCST006109	Lip morphology	Lip morphology	Other measurement
12638	GCST006107	Upper eyelid morphology	Upper eyelid morphology	Other measurement
12639	GCST005964	Neuromyelitis optica	Neuromyelitis optica	Immune system disorder
12640	GCST006937	Neuromyelitis optica (AQP4-IgG-positive)	Neuromyelitis optica (AQP4-IgG-positive)	Immune system disorder
12641	GCST006938	Neuromyelitis optica (AQP4-IgG-negative)	Neuromyelitis optica (AQP4-IgG-negative)	Immune system disorder
12642	GCST005869	Circulating odd-numbered chain saturated fatty acid levels (C15:0)	Circulating odd-numbered chain saturated fatty acid levels (C15:0)	Lipid or lipoprotein measurement
12643	GCST005868	Circulating odd-numbered chain saturated fatty acid levels (C17:0)	Circulating odd-numbered chain saturated fatty acid levels (C17:0)	Lipid or lipoprotein measurement
12644	GCST005866	Circulating odd-numbered chain saturated fatty acid levels (C15:0+C17:0)	Circulating odd-numbered chain saturated fatty acid levels (C15:0+C17:0)	Lipid or lipoprotein measurement
12645	GCST005862	Circulating odd-numbered chain saturated fatty acid levels (C19:0)	Circulating odd-numbered chain saturated fatty acid levels (C19:0)	Lipid or lipoprotein measurement
12646	GCST005861	Circulating odd-numbered chain saturated fatty acid levels (C23:0)	Circulating odd-numbered chain saturated fatty acid levels (C23:0)	Lipid or lipoprotein measurement
12647	GCST006063	White matter integrity (fractional anisotropy)	White matter integrity (fractional anisotropy)	Other measurement
12648	GCST006064	White matter integrity (mean diffusivity)	White matter integrity (mean diffusivity)	Other measurement
12649	GCST006062	White matter hyperintensity volume	White matter hyperintensity volume	Other measurement
12650	GCST006536	Serum erythropoietin levels	Serum erythropoietin levels	Other measurement
12651	GCST006080	Prostate cancer aggressiveness (high vs low)	Prostate cancer aggressiveness (high vs low)	Cancer
12652	GCST006082	Prostate cancer aggressiveness (high vs low/intermediate)	Prostate cancer aggressiveness (high vs low/intermediate)	Cancer
12653	GCST006081	Prostate cancer (advanced vs non-advanced)	Prostate cancer (advanced vs non-advanced)	Cancer
12654	GCST006083	Prostate cancer (advanced)	Prostate cancer (advanced)	Cancer
12655	GCST006089	Prostate cancer (early onset)	Prostate cancer (early onset)	Cancer
12656	GCST006084	Prostate cancer (Gleason score)	Prostate cancer (Gleason score)	Cancer
12657	GCST006085	Prostate cancer	Prostate cancer	Cancer
12658	GCST006697	Parental longevity (combined parental attained age, Martingale residuals)	Parental longevity (combined parental attained age, Martingale residuals)	Other measurement
12659	GCST006698	Parental longevity (both parents in top 10%)	Parental longevity (both parents in top 10%)	Other measurement
12660	GCST006699	Parental longevity (mother's age at death)	Parental longevity (mother's age at death)	Other measurement
12661	GCST006696	Parental longevity (mother's attained age)	Parental longevity (mother's attained age)	Other measurement
12662	GCST006700	Parental longevity (father's age at death)	Parental longevity (father's age at death)	Other measurement
12663	GCST006701	Parental longevity (father's attained age)	Parental longevity (father's attained age)	Other measurement
12664	GCST006702	Parental longevity (combined parental age at death)	Parental longevity (combined parental age at death)	Other measurement
12665	GCST006066	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
12666	GCST006067	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
12667	GCST006065	Glaucoma (primary open-angle)	Glaucoma (primary open-angle)	Neurological disorder
12668	GCST006091	Freckles	Freckles	Other trait
12669	GCST006092	Double-edged eyelids	Double-edged eyelids	Other measurement
12670	GCST006093	Thick vs thin eyebrows	Thick vs thin eyebrows	Other measurement
12671	GCST006094	Straight vs curly hair	Straight vs curly hair	Other measurement
12672	GCST006094	Straight vs curly hair	Straight vs curly hair	Other trait
12673	GCST006095	Excessive hairiness	Excessive hairiness	Other trait
12674	GCST006090	Excessive sweating	Excessive sweating	Other trait
12675	GCST006096	Age spots	Age spots	Other measurement
12676	GCST006929	Attention function	Attention function	Other measurement
12677	GCST006930	Working memory	Working memory	Biological process
12678	GCST006931	Verbal memory	Verbal memory	Other measurement
12679	GCST006928	Visual memory	Visual memory	Other measurement
12680	GCST006932	Reasoning	Reasoning	Biological process
12681	GCST006933	Cognitive function	Cognitive function	Biological process
12682	GCST006933	Cognitive function	Cognitive function	Biological process
12683	GCST006933	Cognitive function	Cognitive function	Other measurement
12684	GCST006933	Cognitive function	Cognitive function	Biological process
12685	GCST006934	Information processing speed	Information processing speed	Biological process
12686	GCST006198	Giant cell arteritis	Giant cell arteritis	Cardiovascular disease
12687	GCST006620	Self-rated health	Self-rated health	Other trait
12688	GCST006566	Developmental dysplasia of the hip	Developmental dysplasia of the hip	Other disease
12689	GCST006856	Methadone dose in opioid dependence	Methadone dose in opioid dependence	Neurological disorder
12690	GCST006856	Methadone dose in opioid dependence	Methadone dose in opioid dependence	Other measurement
12691	GCST007614	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
12692	GCST007615	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
12693	GCST007219	Schizophrenia	Schizophrenia	Neurological disorder
12694	GCST007221	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
12695	GCST007223	Schizophrenia vs type 2 diabetes	Schizophrenia vs type 2 diabetes	Neurological disorder
12696	GCST007223	Schizophrenia vs type 2 diabetes	Schizophrenia vs type 2 diabetes	Metabolic disorder
12697	GCST007224	Type 2 diabetes vs schizophrenia and type 2 diabetes	Type 2 diabetes vs schizophrenia and type 2 diabetes	Neurological disorder
12698	GCST007224	Type 2 diabetes vs schizophrenia and type 2 diabetes	Type 2 diabetes vs schizophrenia and type 2 diabetes	Metabolic disorder
12699	GCST007220	Schizophrenia and type 2 diabetes	Schizophrenia and type 2 diabetes	Neurological disorder
12700	GCST007220	Schizophrenia and type 2 diabetes	Schizophrenia and type 2 diabetes	Metabolic disorder
12701	GCST007222	Schizophrenia vs schizophrenia and type 2 diabetes	Schizophrenia vs schizophrenia and type 2 diabetes	Neurological disorder
12702	GCST007222	Schizophrenia vs schizophrenia and type 2 diabetes	Schizophrenia vs schizophrenia and type 2 diabetes	Metabolic disorder
12703	GCST007744	Hyperglycemia	Hyperglycemia	Other measurement
12704	GCST007745	Hyperglycemia in obesity	Hyperglycemia in obesity	Metabolic disorder
12705	GCST007745	Hyperglycemia in obesity	Hyperglycemia in obesity	Other measurement
12706	GCST007746	Hyperglycemia in non-obese individuals	Hyperglycemia in non-obese individuals	Other measurement
12707	GCST007747	Hyperglycemia in lower physical activity	Hyperglycemia in lower physical activity	Other measurement
12708	GCST007747	Hyperglycemia in lower physical activity	Hyperglycemia in lower physical activity	Other measurement
12709	GCST007748	Hyperglycemia in higher physical activity	Hyperglycemia in higher physical activity	Other measurement
12710	GCST007748	Hyperglycemia in higher physical activity	Hyperglycemia in higher physical activity	Other measurement
12711	GCST007749	Hyperglycemia in more-fat diet	Hyperglycemia in more-fat diet	Lipid or lipoprotein measurement
12712	GCST007749	Hyperglycemia in more-fat diet	Hyperglycemia in more-fat diet	Other measurement
12713	GCST007750	Hyperglycemia in less-fat diet	Hyperglycemia in less-fat diet	Lipid or lipoprotein measurement
12714	GCST007750	Hyperglycemia in less-fat diet	Hyperglycemia in less-fat diet	Other measurement
12715	GCST007751	Homeostasis model assessment of insulin resistance in obesity	Homeostasis model assessment of insulin resistance in obesity	Metabolic disorder
12716	GCST007751	Homeostasis model assessment of insulin resistance in obesity	Homeostasis model assessment of insulin resistance in obesity	Other trait
12717	GCST007752	Homeostasis model assessment of insulin resistance in non-obese individuals	Homeostasis model assessment of insulin resistance in non-obese individuals	Other trait
12718	GCST007753	Homeostasis model assessment of insulin resistance in higher physical activity	Homeostasis model assessment of insulin resistance in higher physical activity	Other measurement
12719	GCST007753	Homeostasis model assessment of insulin resistance in higher physical activity	Homeostasis model assessment of insulin resistance in higher physical activity	Other trait
12720	GCST007754	Homeostasis model assessment of insulin resistance in lower physical activity	Homeostasis model assessment of insulin resistance in lower physical activity	Other measurement
12721	GCST007754	Homeostasis model assessment of insulin resistance in lower physical activity	Homeostasis model assessment of insulin resistance in lower physical activity	Other trait
12722	GCST007755	Homeostasis model assessment of insulin resistance in more-fat diet	Homeostasis model assessment of insulin resistance in more-fat diet	Lipid or lipoprotein measurement
12723	GCST007755	Homeostasis model assessment of insulin resistance in more-fat diet	Homeostasis model assessment of insulin resistance in more-fat diet	Other trait
12724	GCST007756	Homeostasis model assessment of insulin resistance in less-fat diet	Homeostasis model assessment of insulin resistance in less-fat diet	Lipid or lipoprotein measurement
12725	GCST007756	Homeostasis model assessment of insulin resistance in less-fat diet	Homeostasis model assessment of insulin resistance in less-fat diet	Other trait
12726	GCST007757	Hyperglycemia x BMI interaction	Hyperglycemia x BMI interaction	Body measurement
12727	GCST007757	Hyperglycemia x BMI interaction	Hyperglycemia x BMI interaction	Other measurement
12728	GCST007758	Hyperglycemia x physical activity interaction	Hyperglycemia x physical activity interaction	Other measurement
12729	GCST007758	Hyperglycemia x physical activity interaction	Hyperglycemia x physical activity interaction	Other measurement
12730	GCST007759	Hyperglycemia x saturated fatty acids interaction	Hyperglycemia x saturated fatty acids interaction	Lipid or lipoprotein measurement
12731	GCST007759	Hyperglycemia x saturated fatty acids interaction	Hyperglycemia x saturated fatty acids interaction	Other measurement
12732	GCST007760	Hyperinsulinemia	Hyperinsulinemia	Other measurement
12733	GCST007761	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other measurement
12734	GCST007761	Homeostasis model assessment of insulin resistance	Homeostasis model assessment of insulin resistance	Other trait
12735	GCST007762	Hyperinsulinemia x BMI interaction	Hyperinsulinemia x BMI interaction	Body measurement
12736	GCST007762	Hyperinsulinemia x BMI interaction	Hyperinsulinemia x BMI interaction	Other measurement
12737	GCST007763	Homeostasis model assessment of insulin resistance x BMI interaction	Homeostasis model assessment of insulin resistance x BMI interaction	Body measurement
12738	GCST007763	Homeostasis model assessment of insulin resistance x BMI interaction	Homeostasis model assessment of insulin resistance x BMI interaction	Other trait
12739	GCST007764	Hyperinsulinemia x physical activity interaction	Hyperinsulinemia x physical activity interaction	Other measurement
12740	GCST007764	Hyperinsulinemia x physical activity interaction	Hyperinsulinemia x physical activity interaction	Other measurement
12741	GCST007765	Homeostasis model assessment of insulin resistance x physical activity interaction	Homeostasis model assessment of insulin resistance x physical activity interaction	Other measurement
12742	GCST007765	Homeostasis model assessment of insulin resistance x physical activity interaction	Homeostasis model assessment of insulin resistance x physical activity interaction	Other trait
12743	GCST007766	Hyperinsulinemia x saturated fatty acids interaction	Hyperinsulinemia x saturated fatty acids interaction	Lipid or lipoprotein measurement
12744	GCST007766	Hyperinsulinemia x saturated fatty acids interaction	Hyperinsulinemia x saturated fatty acids interaction	Other measurement
12745	GCST007767	Homeostasis model assessment of insulin resistance x saturated fatty acids interaction	Homeostasis model assessment of insulin resistance x saturated fatty acids interaction	Lipid or lipoprotein measurement
12746	GCST007767	Homeostasis model assessment of insulin resistance x saturated fatty acids interaction	Homeostasis model assessment of insulin resistance x saturated fatty acids interaction	Other trait
12747	GCST007768	Hyperinsulinemia in obesity	Hyperinsulinemia in obesity	Metabolic disorder
12748	GCST007768	Hyperinsulinemia in obesity	Hyperinsulinemia in obesity	Other measurement
12749	GCST007769	Hyperinsulinemia in non-obese individuals	Hyperinsulinemia in non-obese individuals	Other measurement
12750	GCST007770	Hyperinsulinemia in higher physical activity	Hyperinsulinemia in higher physical activity	Other measurement
12751	GCST007770	Hyperinsulinemia in higher physical activity	Hyperinsulinemia in higher physical activity	Other measurement
12752	GCST007771	Hyperinsulinemia in lower physical activity	Hyperinsulinemia in lower physical activity	Other measurement
12753	GCST007771	Hyperinsulinemia in lower physical activity	Hyperinsulinemia in lower physical activity	Other measurement
12754	GCST007772	Hyperinsulinemia in more-fat diet	Hyperinsulinemia in more-fat diet	Lipid or lipoprotein measurement
12755	GCST007772	Hyperinsulinemia in more-fat diet	Hyperinsulinemia in more-fat diet	Other measurement
12756	GCST007773	Hyperinsulinemia in less-fat diet	Hyperinsulinemia in less-fat diet	Lipid or lipoprotein measurement
12757	GCST007773	Hyperinsulinemia in less-fat diet	Hyperinsulinemia in less-fat diet	Other measurement
12758	GCST007157	Corneal astigmatism	Corneal astigmatism	Neurological disorder
12759	GCST007157	Corneal astigmatism	Corneal astigmatism	Other trait
12760	GCST007158	Refractive astigmatism	Refractive astigmatism	Other trait
12761	GCST007159	Corneal astigmatism	Corneal astigmatism	Neurological disorder
12762	GCST007159	Corneal astigmatism	Corneal astigmatism	Other trait
12763	GCST007160	Refractive astigmatism	Refractive astigmatism	Other trait
12764	GCST006810	Self-reported risk-taking behaviour	Self-reported risk-taking behaviour	Biological process
12765	GCST006811	Body mass index	Body mass index	Body measurement
12766	GCST006811	Body mass index	Body mass index	Body measurement
12767	GCST006811	Body mass index	Body mass index	Other measurement
12768	GCST006812	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Biological process
12769	GCST006812	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Other measurement
12770	GCST007037	Educational attainment (years of education)	Educational attainment (years of education)	Other measurement
12771	GCST007038	Balding type 1	Balding type 1	Other measurement
12772	GCST007039	Body mass index	Body mass index	Body measurement
12773	GCST007039	Body mass index	Body mass index	Body measurement
12774	GCST007039	Body mass index	Body mass index	Other measurement
12775	GCST007066	Heel bone mineral density	Heel bone mineral density	Other measurement
12776	GCST007841	Height	Height	Other measurement
12777	GCST007841	Height	Height	Body measurement
12778	GCST007067	Waist-hip ratio	Waist-hip ratio	Other measurement
12779	GCST007067	Waist-hip ratio	Waist-hip ratio	Body measurement
12780	GCST007065	Eosinophil counts	Eosinophil counts	Hematological measurement
12781	GCST007068	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
12782	GCST007068	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
12783	GCST007069	Red blood cell count	Red blood cell count	Hematological measurement
12784	GCST007074	Red cell distribution width	Red cell distribution width	Hematological measurement
12785	GCST007070	White blood cell count	White blood cell count	Hematological measurement
12786	GCST007070	White blood cell count	White blood cell count	Inflammatory measurement
12787	GCST007070	White blood cell count	White blood cell count	Hematological measurement
12788	GCST007070	White blood cell count	White blood cell count	Hematological measurement
12789	GCST007070	White blood cell count	White blood cell count	Hematological measurement
12790	GCST007071	Autoimmune traits	Autoimmune traits	Immune system disorder
12791	GCST007072	Cardiovascular disease	Cardiovascular disease	Other disease
12792	GCST007075	Eczema	Eczema	Other trait
12793	GCST007073	Hypothyroidism	Hypothyroidism	Other disease
12794	GCST007076	Respiratory diseases	Respiratory diseases	Other disease
12795	GCST007077	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
12796	GCST007078	Menarche (age at onset)	Menarche (age at onset)	Other measurement
12797	GCST007079	Age at menopause	Age at menopause	Other measurement
12798	GCST007080	Lung function (FEV1/FVC)	Lung function (FEV1/FVC)	Other measurement
12799	GCST007081	Lung function (FVC)	Lung function (FVC)	Other measurement
12800	GCST007082	Hair color	Hair color	Other measurement
12801	GCST007082	Hair color	Hair color	Other trait
12802	GCST007083	Morning person	Morning person	Other measurement
12803	GCST007084	Neuroticism	Neuroticism	Neurological disorder
12804	GCST007084	Neuroticism	Neuroticism	Other measurement
12805	GCST007085	Smoking status	Smoking status	Other measurement
12806	GCST007086	Sunburns	Sunburns	Other disease
12807	GCST007087	Systolic blood pressure	Systolic blood pressure	Other measurement
12808	GCST007087	Systolic blood pressure	Systolic blood pressure	Other measurement
12809	GCST006442	Educational attainment (years of education)	Educational attainment (years of education)	Other measurement
12810	GCST006571	Educational attainment (MTAG)	Educational attainment (MTAG)	Other measurement
12811	GCST006572	Cognitive performance	Cognitive performance	Other measurement
12812	GCST006572	Cognitive performance	Cognitive performance	Other measurement
12813	GCST006570	Cognitive performance (MTAG)	Cognitive performance (MTAG)	Other measurement
12814	GCST006573	Self-reported math ability	Self-reported math ability	Biological process
12815	GCST006569	Self-reported math ability (MTAG)	Self-reported math ability (MTAG)	Biological process
12816	GCST006574	Highest math class taken	Highest math class taken	Biological process
12817	GCST006568	Highest math class taken (MTAG)	Highest math class taken (MTAG)	Biological process
12818	GCST008129	Body mass index	Body mass index	Body measurement
12819	GCST008129	Body mass index	Body mass index	Body measurement
12820	GCST008129	Body mass index	Body mass index	Other measurement
12821	GCST008128	Body mass index	Body mass index	Body measurement
12822	GCST008128	Body mass index	Body mass index	Body measurement
12823	GCST008128	Body mass index	Body mass index	Other measurement
12824	GCST008124	Body mass index	Body mass index	Body measurement
12825	GCST008124	Body mass index	Body mass index	Body measurement
12826	GCST008124	Body mass index	Body mass index	Other measurement
12827	GCST008126	Body mass index	Body mass index	Body measurement
12828	GCST008126	Body mass index	Body mass index	Body measurement
12829	GCST008126	Body mass index	Body mass index	Other measurement
12830	GCST008127	Body mass index	Body mass index	Body measurement
12831	GCST008127	Body mass index	Body mass index	Body measurement
12832	GCST008127	Body mass index	Body mass index	Other measurement
12833	GCST008125	Body mass index	Body mass index	Body measurement
12834	GCST008125	Body mass index	Body mass index	Body measurement
12835	GCST008125	Body mass index	Body mass index	Other measurement
12836	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
12837	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
12838	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
12839	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
12840	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
12841	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
12842	GCST008417	Psychiatric disorder	Psychiatric disorder	Metabolic disorder
12843	GCST008417	Psychiatric disorder	Psychiatric disorder	Neurological disorder
12844	GCST008416	Psychiatric disorder without cannabis use disorder	Psychiatric disorder without cannabis use disorder	Neurological disorder
12845	GCST008416	Psychiatric disorder without cannabis use disorder	Psychiatric disorder without cannabis use disorder	Neurological disorder
12846	GCST008416	Psychiatric disorder without cannabis use disorder	Psychiatric disorder without cannabis use disorder	Neurological disorder
12847	GCST008416	Psychiatric disorder without cannabis use disorder	Psychiatric disorder without cannabis use disorder	Neurological disorder
12848	GCST008416	Psychiatric disorder without cannabis use disorder	Psychiatric disorder without cannabis use disorder	Neurological disorder
12849	GCST008415	Cannabis use disorder vs schizophrenia	Cannabis use disorder vs schizophrenia	Neurological disorder
12850	GCST008415	Cannabis use disorder vs schizophrenia	Cannabis use disorder vs schizophrenia	Other disease
12851	GCST008415	Cannabis use disorder vs schizophrenia	Cannabis use disorder vs schizophrenia	Neurological disorder
12852	GCST008414	Cannabis use disorder	Cannabis use disorder	Other disease
12853	GCST008414	Cannabis use disorder	Cannabis use disorder	Neurological disorder
12854	GCST008568	IgA levels	IgA levels	Other measurement
12855	GCST008569	Composite immunoglobulin trait (IgA x IgG x IgM)	Composite immunoglobulin trait (IgA x IgG x IgM)	Other measurement
12856	GCST008570	Composite immunoglobulin trait (IgA x IgG/IgM)	Composite immunoglobulin trait (IgA x IgG/IgM)	Other measurement
12857	GCST008571	Composite immunoglobulin trait (IgA x IgG)	Composite immunoglobulin trait (IgA x IgG)	Other measurement
12858	GCST008572	Composite immunoglobulin trait (IgA/IgG)	Composite immunoglobulin trait (IgA/IgG)	Other measurement
12859	GCST008573	Composite immunoglobulin trait (IgA/IgM)	Composite immunoglobulin trait (IgA/IgM)	Other measurement
12860	GCST008574	Composite immunoglobulin trait (IgG/IgM)	Composite immunoglobulin trait (IgG/IgM)	Other measurement
12861	GCST008575	IgM levels	IgM levels	Other measurement
12862	GCST008576	IgG levels	IgG levels	Other measurement
12863	GCST008530	Neuropathy in Charcot-Marie-Tooth disease type 1A	Neuropathy in Charcot-Marie-Tooth disease type 1A	Neurological disorder
12864	GCST008530	Neuropathy in Charcot-Marie-Tooth disease type 1A	Neuropathy in Charcot-Marie-Tooth disease type 1A	Neurological disorder
12865	GCST008533	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)	Other trait
12866	GCST008533	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)	Neurological disorder
12867	GCST008534	Hearing loss in Charcot-Marie-Tooth disease 1A	Hearing loss in Charcot-Marie-Tooth disease 1A	Neurological disorder
12868	GCST008534	Hearing loss in Charcot-Marie-Tooth disease 1A	Hearing loss in Charcot-Marie-Tooth disease 1A	Neurological disorder
12869	GCST008537	Decreased sensory function in Charcot-Marie-Tooth disease type 1A	Decreased sensory function in Charcot-Marie-Tooth disease type 1A	Neurological disorder
12870	GCST008537	Decreased sensory function in Charcot-Marie-Tooth disease type 1A	Decreased sensory function in Charcot-Marie-Tooth disease type 1A	Other trait
12871	GCST008538	Balance difficulty in Charcot-Marie-Tooth disease type 1A	Balance difficulty in Charcot-Marie-Tooth disease type 1A	Neurological disorder
12872	GCST008538	Balance difficulty in Charcot-Marie-Tooth disease type 1A	Balance difficulty in Charcot-Marie-Tooth disease type 1A	Other trait
12873	GCST008540	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)	Other trait
12874	GCST008540	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)	Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)	Neurological disorder
12875	GCST008543	Walking difficulty in Charcot-Marie-Tooth disease 1A	Walking difficulty in Charcot-Marie-Tooth disease 1A	Other trait
12876	GCST008543	Walking difficulty in Charcot-Marie-Tooth disease 1A	Walking difficulty in Charcot-Marie-Tooth disease 1A	Neurological disorder
12877	GCST008544	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Neurological disorder
12878	GCST008544	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A	Other measurement
12879	GCST008542	First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A	First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A	Neurological disorder
12880	GCST008542	First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A	First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A	Other measurement
12881	GCST008541	Foot deformity in Charcot-Marie-Tooth disease 1A	Foot deformity in Charcot-Marie-Tooth disease 1A	Neurological disorder
12882	GCST008541	Foot deformity in Charcot-Marie-Tooth disease 1A	Foot deformity in Charcot-Marie-Tooth disease 1A	Other trait
12883	GCST008539	Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A	Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A	Neurological disorder
12884	GCST008539	Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A	Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A	Other measurement
12885	GCST008536	Scoliosis in Charcot-Marie-Tooth disease 1A	Scoliosis in Charcot-Marie-Tooth disease 1A	Other disease
12886	GCST008536	Scoliosis in Charcot-Marie-Tooth disease 1A	Scoliosis in Charcot-Marie-Tooth disease 1A	Neurological disorder
12887	GCST008535	Arthritic-like pain in Charcot-Marie-Tooth type 1A	Arthritic-like pain in Charcot-Marie-Tooth type 1A	Other trait
12888	GCST008535	Arthritic-like pain in Charcot-Marie-Tooth type 1A	Arthritic-like pain in Charcot-Marie-Tooth type 1A	Neurological disorder
12889	GCST008532	Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A	Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A	Neurological disorder
12890	GCST008532	Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A	Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A	Neurological disorder
12891	GCST008202	Soluble E-selectin levels	Soluble E-selectin levels	Inflammatory measurement
12892	GCST008210	Soluble ICAM-1	Soluble ICAM-1	Cardiovascular measurement
12893	GCST008196	Soluble VCAM-1 levels	Soluble VCAM-1 levels	Other measurement
12894	GCST008207	Interleukin-1-alpha levels	Interleukin-1-alpha levels	Other measurement
12895	GCST008208	Soluble CD40 ligand levels	Soluble CD40 ligand levels	Inflammatory measurement
12896	GCST008206	Plasminogen activator inhibitor-1 (PAI-1) levels	Plasminogen activator inhibitor-1 (PAI-1) levels	Other measurement
12897	GCST008198	Vascular endothelial growth factor levels	Vascular endothelial growth factor levels	Cardiovascular measurement
12898	GCST008205	Interleukin-17 levels	Interleukin-17 levels	Other measurement
12899	GCST008204	Monocyte chemoattractant protein-1 levels	Monocyte chemoattractant protein-1 levels	Other measurement
12900	GCST008209	Interleukin-1-beta levels	Interleukin-1-beta levels	Inflammatory measurement
12901	GCST008203	Interleukin-1-receptor antagonist levels	Interleukin-1-receptor antagonist levels	Inflammatory measurement
12902	GCST008201	Interleukin-4 levels	Interleukin-4 levels	Other measurement
12903	GCST008200	Interleukin-6 levels	Interleukin-6 levels	Inflammatory measurement
12904	GCST008197	Interleukin-8 levels	Interleukin-8 levels	Other measurement
12905	GCST008197	Interleukin-8 levels	Interleukin-8 levels	Inflammatory measurement
12906	GCST008199	Interferon gamma-induced protein 10 levels	Interferon gamma-induced protein 10 levels	Other measurement
12907	GCST008211	Tumor necrosis factor alpha levels	Tumor necrosis factor alpha levels	Inflammatory measurement
12908	GCST008412	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Other measurement
12909	GCST008412	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Biological process
12910	GCST008411	Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	Other measurement
12911	GCST008411	Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)	Biological process
12912	GCST008410	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Other measurement
12913	GCST008410	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Biological process
12914	GCST008409	Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Other measurement
12915	GCST008409	Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)	Biological process
12916	GCST008408	Systolic blood pressure x physical activity (less vs more active half) interaction (2df)	Systolic blood pressure x physical activity (less vs more active half) interaction (2df)	Other measurement
12917	GCST008408	Systolic blood pressure x physical activity (less vs more active half) interaction (2df)	Systolic blood pressure x physical activity (less vs more active half) interaction (2df)	Biological process
12918	GCST008402	Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Other measurement
12919	GCST008402	Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)	Biological process
12920	GCST008393	Systolic blood pressure x physical activity interaction (2df)	Systolic blood pressure x physical activity interaction (2df)	Other measurement
12921	GCST008393	Systolic blood pressure x physical activity interaction (2df)	Systolic blood pressure x physical activity interaction (2df)	Other measurement
12922	GCST008407	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Other measurement
12923	GCST008407	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Biological process
12924	GCST008406	Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	Other measurement
12925	GCST008406	Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)	Biological process
12926	GCST008405	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Other measurement
12927	GCST008405	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Biological process
12928	GCST008404	Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Other measurement
12929	GCST008404	Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)	Biological process
12930	GCST008401	Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	Other measurement
12931	GCST008401	Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	Systolic blood pressure x physical activity (less vs more active half) interaction (1df)	Biological process
12932	GCST008400	Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Other measurement
12933	GCST008400	Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)	Biological process
12934	GCST008392	Systolic blood pressure x physical activity interaction (1df)	Systolic blood pressure x physical activity interaction (1df)	Other measurement
12935	GCST008392	Systolic blood pressure x physical activity interaction (1df)	Systolic blood pressure x physical activity interaction (1df)	Other measurement
12936	GCST008389	Diastolic blood pressure x physical activity interaction (1df)	Diastolic blood pressure x physical activity interaction (1df)	Other measurement
12937	GCST008389	Diastolic blood pressure x physical activity interaction (1df)	Diastolic blood pressure x physical activity interaction (1df)	Other measurement
12938	GCST008390	DIastolic blood pressure x physical activity interaction (2df)	DIastolic blood pressure x physical activity interaction (2df)	Other measurement
12939	GCST008390	DIastolic blood pressure x physical activity interaction (2df)	DIastolic blood pressure x physical activity interaction (2df)	Other measurement
12940	GCST008387	Cognitive ability in schizophrenia	Cognitive ability in schizophrenia	Biological process
12941	GCST008387	Cognitive ability in schizophrenia	Cognitive ability in schizophrenia	Neurological disorder
12942	GCST008173	Alanine aminotransferase levels	Alanine aminotransferase levels	Liver enzyme measurement
12943	GCST008175	Gamma glutamyl transferase levels	Gamma glutamyl transferase levels	Liver enzyme measurement
12944	GCST008174	Aspartate aminotransferase levels	Aspartate aminotransferase levels	Liver enzyme measurement
12945	GCST008498	Meningococcal C IgG concentrations post childhood immunization	Meningococcal C IgG concentrations post childhood immunization	Response to drug
12946	GCST008498	Meningococcal C IgG concentrations post childhood immunization	Meningococcal C IgG concentrations post childhood immunization	Other measurement
12947	GCST008499	Meningococcal C functional antibody titers post childhood immunization	Meningococcal C functional antibody titers post childhood immunization	Response to drug
12948	GCST008499	Meningococcal C functional antibody titers post childhood immunization	Meningococcal C functional antibody titers post childhood immunization	Other measurement
12949	GCST008500	Tetanus toxoid IgG concentrations post childhood immunization	Tetanus toxoid IgG concentrations post childhood immunization	Response to drug
12950	GCST008500	Tetanus toxoid IgG concentrations post childhood immunization	Tetanus toxoid IgG concentrations post childhood immunization	Other measurement
12951	GCST008501	Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization	Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization	Response to drug
12952	GCST008501	Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization	Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization	Other measurement
12953	GCST007922	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	Other measurement
12954	GCST007923	Medication use (drugs used in diabetes)	Medication use (drugs used in diabetes)	Other measurement
12955	GCST007924	Medication use (antithrombotic agents)	Medication use (antithrombotic agents)	Other measurement
12956	GCST007925	Medication use (vasodilators used in cardiac diseases)	Medication use (vasodilators used in cardiac diseases)	Other measurement
12957	GCST007926	Medication use (antihypertensives)	Medication use (antihypertensives)	Other measurement
12958	GCST007928	Medication use (diuretics)	Medication use (diuretics)	Other measurement
12959	GCST007927	Medication use (beta blocking agents)	Medication use (beta blocking agents)	Other measurement
12960	GCST007929	Medication use (calcium channel blockers)	Medication use (calcium channel blockers)	Other measurement
12961	GCST007930	Medication use (agents acting on the renin-angiotensin system)	Medication use (agents acting on the renin-angiotensin system)	Other measurement
12962	GCST007931	Medication use (HMG CoA reductase inhibitors)	Medication use (HMG CoA reductase inhibitors)	Other measurement
12963	GCST007932	Medication use (thyroid preparations)	Medication use (thyroid preparations)	Other measurement
12964	GCST007933	Medication use (immunosuppressants)	Medication use (immunosuppressants)	Other measurement
12965	GCST007934	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	Other measurement
12966	GCST007935	Medication use (drugs affecting bone structure and mineralization)	Medication use (drugs affecting bone structure and mineralization)	Other measurement
12967	GCST007936	Medication use (opioids)	Medication use (opioids)	Other measurement
12968	GCST007937	Medication use (salicylic acid and derivatives)	Medication use (salicylic acid and derivatives)	Other measurement
12969	GCST007938	Medication use (anilides)	Medication use (anilides)	Other measurement
12970	GCST007939	Medication use (antimigraine preparations)	Medication use (antimigraine preparations)	Other measurement
12971	GCST007940	Medication use (antidepressants)	Medication use (antidepressants)	Other measurement
12972	GCST007941	Medication use (adrenergics, inhalants)	Medication use (adrenergics, inhalants)	Other measurement
12973	GCST007942	Medication use (glucocorticoids)	Medication use (glucocorticoids)	Other measurement
12974	GCST007943	Medication use (antihistamines for systemic use)	Medication use (antihistamines for systemic use)	Other measurement
12975	GCST007944	Medication use (antiglaucoma preparations and miotics)	Medication use (antiglaucoma preparations and miotics)	Other measurement
12976	GCST007993	Asthma (adult onset)	Asthma (adult onset)	Other disease
12977	GCST007995	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
12978	GCST007995	Asthma (childhood onset)	Asthma (childhood onset)	Other disease
12979	GCST007994	Asthma (age of onset)	Asthma (age of onset)	Other disease
12980	GCST007996	Chronic obstructive pulmonary disease	Chronic obstructive pulmonary disease	Other disease
12981	GCST007876	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
12982	GCST007877	Creatinine levels	Creatinine levels	Other measurement
12983	GCST007878	Urea levels	Urea levels	Other measurement
12984	GCST007878	Urea levels	Urea levels	Other measurement
12985	GCST007879	Chronic kidney disease	Chronic kidney disease	Other disease
12986	GCST007879	Chronic kidney disease	Chronic kidney disease	Other measurement
12987	GCST007879	Chronic kidney disease	Chronic kidney disease	Other measurement
12988	GCST008760	Perceived sweetness of sucrose		
12989	GCST008761	Sucrose liking		
12990	GCST008762	Intake of sweets		
12991	GCST008763	Perceived intensity of fructose		
12992	GCST008764	Perceived intensity of neohesperidin dihydrochalcone		
12993	GCST008765	Perceived intensity of aspartame		
12994	GCST008766	Perceived intensity of sweet substances		
12995	GCST008767	Perceived intensity of sucrose		
12996	GCST008768	Perceived intensity of sweet substances		
12997	GCST008759	Intake of total sugars		
12998	GCST008769	Perceived intensity of glucose		
12999	GCST008114	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13000	GCST007850	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
13001	GCST007848	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
13002	GCST007848	LDL cholesterol	LDL cholesterol	Other measurement
13003	GCST007848	LDL cholesterol	LDL cholesterol	Lipid or lipoprotein measurement
13004	GCST007849	Triglycerides	Triglycerides	Lipid or lipoprotein measurement
13005	GCST008018	Sweet taste perception in obesity with metabolic syndrome	Sweet taste perception in obesity with metabolic syndrome	Biological process
13006	GCST008024	Salty taste perception in obesity with metabolic syndrome	Salty taste perception in obesity with metabolic syndrome	Biological process
13007	GCST008023	Sour taste perception in obesity with metabolic syndrome	Sour taste perception in obesity with metabolic syndrome	Biological process
13008	GCST008022	Umami taste perception in obesity with metabolic syndrome	Umami taste perception in obesity with metabolic syndrome	Biological process
13009	GCST008020	Taste perception (total score including phenylthiocarbamide) in obesity with metabolic syndrome	Taste perception (total score including phenylthiocarbamide) in obesity with metabolic syndrome	Biological process
13010	GCST008021	Taste perception (total score including 6-n-propylthiouracil) in obesity with metabolic syndrome	Taste perception (total score including 6-n-propylthiouracil) in obesity with metabolic syndrome	Biological process
13011	GCST008017	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	Biological process
13012	GCST008019	Bitter taste perception (phenylthiocarbamide) in obesity with metabolic syndrome	Bitter taste perception (phenylthiocarbamide) in obesity with metabolic syndrome	Biological process
13013	GCST008272	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Other measurement
13014	GCST008272	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Other disease
13015	GCST008272	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma	Other measurement
13016	GCST008273	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Other measurement
13017	GCST008273	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Other disease
13018	GCST008273	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma	Other measurement
13019	GCST007829	Systolic blood pressure	Systolic blood pressure	Other measurement
13020	GCST007829	Systolic blood pressure	Systolic blood pressure	Other measurement
13021	GCST007828	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13022	GCST007828	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13023	GCST008721	Chronic lymphocytic leukemia or multiple sclerosis	Chronic lymphocytic leukemia or multiple sclerosis	Immune system disorder
13024	GCST008721	Chronic lymphocytic leukemia or multiple sclerosis	Chronic lymphocytic leukemia or multiple sclerosis	Cancer
13025	GCST008722	Diffuse large B-cell lymphoma or multiple sclerosis	Diffuse large B-cell lymphoma or multiple sclerosis	Immune system disorder
13026	GCST008722	Diffuse large B-cell lymphoma or multiple sclerosis	Diffuse large B-cell lymphoma or multiple sclerosis	Cancer
13027	GCST008718	Follicular lymphoma or multiple sclerosis	Follicular lymphoma or multiple sclerosis	Immune system disorder
13028	GCST008723	Marginal zone lymphoma or multiple sclerosis	Marginal zone lymphoma or multiple sclerosis	Immune system disorder
13029	GCST008723	Marginal zone lymphoma or multiple sclerosis	Marginal zone lymphoma or multiple sclerosis	Cancer
13030	GCST008724	Chronic lymphocytic leukemia or rheumatoid arthritis	Chronic lymphocytic leukemia or rheumatoid arthritis	Immune system disorder
13031	GCST008724	Chronic lymphocytic leukemia or rheumatoid arthritis	Chronic lymphocytic leukemia or rheumatoid arthritis	Cancer
13032	GCST008725	Diffuse large B-cell lymphoma or rheumatoid arthritis	Diffuse large B-cell lymphoma or rheumatoid arthritis	Immune system disorder
13033	GCST008725	Diffuse large B-cell lymphoma or rheumatoid arthritis	Diffuse large B-cell lymphoma or rheumatoid arthritis	Cancer
13034	GCST008719	Follicular lymphoma or rheumatoid arthritis	Follicular lymphoma or rheumatoid arthritis	Immune system disorder
13035	GCST008726	Marginal zone lymphoma or rheumatoid arthritis	Marginal zone lymphoma or rheumatoid arthritis	Immune system disorder
13036	GCST008726	Marginal zone lymphoma or rheumatoid arthritis	Marginal zone lymphoma or rheumatoid arthritis	Cancer
13037	GCST008727	Chronic lymphocytic leukemia or systemic lupus erythematosus	Chronic lymphocytic leukemia or systemic lupus erythematosus	Immune system disorder
13038	GCST008727	Chronic lymphocytic leukemia or systemic lupus erythematosus	Chronic lymphocytic leukemia or systemic lupus erythematosus	Cancer
13039	GCST008728	Diffuse large B-cell lymphoma or systemic lupus erythematosus	Diffuse large B-cell lymphoma or systemic lupus erythematosus	Immune system disorder
13040	GCST008728	Diffuse large B-cell lymphoma or systemic lupus erythematosus	Diffuse large B-cell lymphoma or systemic lupus erythematosus	Cancer
13041	GCST008720	Follicular lymphoma or systemic lupus erythematosus	Follicular lymphoma or systemic lupus erythematosus	Immune system disorder
13042	GCST008729	Marginal zone lymphoma or systemic lupus erythematosus	Marginal zone lymphoma or systemic lupus erythematosus	Cancer
13043	GCST008729	Marginal zone lymphoma or systemic lupus erythematosus	Marginal zone lymphoma or systemic lupus erythematosus	Immune system disorder
13044	GCST008647	Urinary sodium excretion	Urinary sodium excretion	Other measurement
13045	GCST008648	Urinary potassium excretion	Urinary potassium excretion	Other measurement
13046	GCST006200	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Digestive system disorder
13047	GCST006200	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Other trait
13048	GCST006200	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Response to drug
13049	GCST006201	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Digestive system disorder
13050	GCST006201	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Other trait
13051	GCST006201	Thiopurine-induced leukopenia in inflammatory bowel disease	Thiopurine-induced leukopenia in inflammatory bowel disease	Response to drug
13052	GCST006202	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Digestive system disorder
13053	GCST006202	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Other trait
13054	GCST006202	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Response to drug
13055	GCST006204	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Digestive system disorder
13056	GCST006204	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Other trait
13057	GCST006204	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Thiopurine-induced severe leukopenia in inflammatory bowel disease	Response to drug
13058	GCST006205	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Digestive system disorder
13059	GCST006205	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Other trait
13060	GCST006205	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	Response to drug
13061	GCST006206	Thiopurine-induced alopecia in inflammatory bowel disease	Thiopurine-induced alopecia in inflammatory bowel disease	Digestive system disorder
13062	GCST006206	Thiopurine-induced alopecia in inflammatory bowel disease	Thiopurine-induced alopecia in inflammatory bowel disease	Other disease
13063	GCST006206	Thiopurine-induced alopecia in inflammatory bowel disease	Thiopurine-induced alopecia in inflammatory bowel disease	Response to drug
13064	GCST006207	Thiopurine-induced severe alopecia in inflammatory bowel disease	Thiopurine-induced severe alopecia in inflammatory bowel disease	Digestive system disorder
13065	GCST006207	Thiopurine-induced severe alopecia in inflammatory bowel disease	Thiopurine-induced severe alopecia in inflammatory bowel disease	Other disease
13066	GCST006207	Thiopurine-induced severe alopecia in inflammatory bowel disease	Thiopurine-induced severe alopecia in inflammatory bowel disease	Response to drug
13067	GCST006208	Thiopurine-induced pancreatitis in inflammatory bowel disease	Thiopurine-induced pancreatitis in inflammatory bowel disease	Digestive system disorder
13068	GCST006208	Thiopurine-induced pancreatitis in inflammatory bowel disease	Thiopurine-induced pancreatitis in inflammatory bowel disease	Digestive system disorder
13069	GCST006208	Thiopurine-induced pancreatitis in inflammatory bowel disease	Thiopurine-induced pancreatitis in inflammatory bowel disease	Response to drug
13070	GCST006209	Thiopurine-induced fever in inflammatory bowel disease	Thiopurine-induced fever in inflammatory bowel disease	Other trait
13071	GCST006209	Thiopurine-induced fever in inflammatory bowel disease	Thiopurine-induced fever in inflammatory bowel disease	Digestive system disorder
13072	GCST006209	Thiopurine-induced fever in inflammatory bowel disease	Thiopurine-induced fever in inflammatory bowel disease	Response to drug
13073	GCST006210	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Digestive system disorder
13074	GCST006210	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Response to drug
13075	GCST006210	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Thiopurine-induced digestive symptoms in inflammatory bowel disease	Other disease
13076	GCST006211	Thiopurine-induced infection in inflammatory bowel disease	Thiopurine-induced infection in inflammatory bowel disease	Digestive system disorder
13077	GCST006211	Thiopurine-induced infection in inflammatory bowel disease	Thiopurine-induced infection in inflammatory bowel disease	Response to drug
13078	GCST006211	Thiopurine-induced infection in inflammatory bowel disease	Thiopurine-induced infection in inflammatory bowel disease	Other measurement
13079	GCST006212	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Digestive system disorder
13080	GCST006212	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Response to drug
13081	GCST006212	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Thiopurine-induced liver dysfunction in inflammatory bowel disease	Digestive system disorder
13082	GCST006213	Thiopurine-induced skin symptoms in inflammatory bowel disease	Thiopurine-induced skin symptoms in inflammatory bowel disease	Other disease
13083	GCST006213	Thiopurine-induced skin symptoms in inflammatory bowel disease	Thiopurine-induced skin symptoms in inflammatory bowel disease	Digestive system disorder
13084	GCST006213	Thiopurine-induced skin symptoms in inflammatory bowel disease	Thiopurine-induced skin symptoms in inflammatory bowel disease	Response to drug
13085	GCST006214	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Digestive system disorder
13086	GCST006214	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Other disease
13087	GCST006214	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Response to drug
13088	GCST006215	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Digestive system disorder
13089	GCST006215	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Other trait
13090	GCST006215	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	Response to drug
13091	GCST006199	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Digestive system disorder
13092	GCST006199	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Other disease
13093	GCST006199	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Response to drug
13094	GCST006584	Pemphigus vulgaris	Pemphigus vulgaris	Immune system disorder
13095	GCST005826	Sero-negative rheumatoid arthritis	Sero-negative rheumatoid arthritis	Immune system disorder
13096	GCST006808	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Neurological disorder
13097	GCST006808	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Response to drug
13098	GCST006808	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	Other measurement
13099	GCST007179	Fasting glucose in pregnancy (gestational week 14-16)	Fasting glucose in pregnancy (gestational week 14-16)	Other measurement
13100	GCST007180	Fasting glucose in pregnancy (gestational week 30-32)	Fasting glucose in pregnancy (gestational week 30-32)	Other measurement
13101	GCST007181	Two-hour glucose in pregnancy (gestational week 14-16)	Two-hour glucose in pregnancy (gestational week 14-16)	Other measurement
13102	GCST007182	Two-hour glucose in pregnancy (gestational week 30-32)	Two-hour glucose in pregnancy (gestational week 30-32)	Other measurement
13103	GCST007183	General glucose level in pregnancy (gestational week 14-16)	General glucose level in pregnancy (gestational week 14-16)	Other measurement
13104	GCST007184	General glucose level in pregnancy (gestational week 30-32)	General glucose level in pregnancy (gestational week 30-32)	Other measurement
13105	GCST007185	Timing of glucose curve peak in pregnancy (gestational week 14-16)	Timing of glucose curve peak in pregnancy (gestational week 14-16)	Other measurement
13106	GCST007186	Timing of glucose curve peak in pregnancy (gestational week 30-32)	Timing of glucose curve peak in pregnancy (gestational week 30-32)	Other measurement
13107	GCST007114	Cholesterol efflux capacity	Cholesterol efflux capacity	Lipid or lipoprotein measurement
13108	GCST007115	Cholesterol efflux capacity (cAMP stimulated assay)	Cholesterol efflux capacity (cAMP stimulated assay)	Lipid or lipoprotein measurement
13109	GCST007116	Cholesterol efflux capacity (ABCA-1 dependent assay)	Cholesterol efflux capacity (ABCA-1 dependent assay)	Lipid or lipoprotein measurement
13110	GCST007117	Cholesterol efflux capacity (BHK stimulated assay)	Cholesterol efflux capacity (BHK stimulated assay)	Lipid or lipoprotein measurement
13111	GCST006403	Energy expenditure	Energy expenditure	Other measurement
13112	GCST006402	Energy intake	Energy intake	Other measurement
13113	GCST006541	Axial length	Axial length	Other measurement
13114	GCST006539	Spherical error	Spherical error	Other measurement
13115	GCST006864	Axial length or spherical error (univariate decomposition analysis)	Axial length or spherical error (univariate decomposition analysis)	Other measurement
13116	GCST006864	Axial length or spherical error (univariate decomposition analysis)	Axial length or spherical error (univariate decomposition analysis)	Other measurement
13117	GCST007722	Chromosomal aberration frequency (total)	Chromosomal aberration frequency (total)	Other measurement
13118	GCST007723	Chromosomal aberration frequency (chromatid type)	Chromosomal aberration frequency (chromatid type)	Other measurement
13119	GCST007724	Chromosomal aberration frequency (chromosome type)	Chromosomal aberration frequency (chromosome type)	Other measurement
13120	GCST006430	Body mass index and waist-hip ratio (pleiotropy)	Body mass index and waist-hip ratio (pleiotropy)	Body measurement
13121	GCST006430	Body mass index and waist-hip ratio (pleiotropy)	Body mass index and waist-hip ratio (pleiotropy)	Body measurement
13122	GCST006068	Sub-foveal choroidal thickness	Sub-foveal choroidal thickness	Other measurement
13123	GCST007149	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Response to drug
13124	GCST007149	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Cancer
13125	GCST007149	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Other measurement
13126	GCST007150	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Response to drug
13127	GCST007150	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Cancer
13128	GCST007150	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Other measurement
13129	GCST007151	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Response to drug
13130	GCST007151	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Cancer
13131	GCST007151	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Other measurement
13132	GCST007148	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Response to drug
13133	GCST007148	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Cancer
13134	GCST007148	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia	Other measurement
13135	GCST007018	Serum bilirubin levels in metabolic syndrome	Serum bilirubin levels in metabolic syndrome	Metabolic disorder
13136	GCST007018	Serum bilirubin levels in metabolic syndrome	Serum bilirubin levels in metabolic syndrome	Other measurement
13137	GCST007016	Serum bilirubin levels x sex interaction in metabolic syndrome	Serum bilirubin levels x sex interaction in metabolic syndrome	Metabolic disorder
13138	GCST007016	Serum bilirubin levels x sex interaction in metabolic syndrome	Serum bilirubin levels x sex interaction in metabolic syndrome	Other measurement
13139	GCST007016	Serum bilirubin levels x sex interaction in metabolic syndrome	Serum bilirubin levels x sex interaction in metabolic syndrome	Other measurement
13140	GCST007017	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Other measurement
13141	GCST007017	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Metabolic disorder
13142	GCST007017	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome	Other measurement
13143	GCST007976	Postoperative myocardial infarction after cardiac surgery	Postoperative myocardial infarction after cardiac surgery	Cardiovascular disease
13144	GCST007976	Postoperative myocardial infarction after cardiac surgery	Postoperative myocardial infarction after cardiac surgery	Biological process
13145	GCST007977	Postoperative stroke after cardiac surgery	Postoperative stroke after cardiac surgery	Neurological disorder
13146	GCST007977	Postoperative stroke after cardiac surgery	Postoperative stroke after cardiac surgery	Biological process
13147	GCST007979	Postoperative acute renal failure after cardiac surgery	Postoperative acute renal failure after cardiac surgery	Other disease
13148	GCST007979	Postoperative acute renal failure after cardiac surgery	Postoperative acute renal failure after cardiac surgery	Biological process
13149	GCST007978	Postoperative atrial fibrillation after cardiac surgery	Postoperative atrial fibrillation after cardiac surgery	Biological process
13150	GCST007978	Postoperative atrial fibrillation after cardiac surgery	Postoperative atrial fibrillation after cardiac surgery	Cardiovascular disease
13151	GCST007980	Postoperative delirium after cardiac surgery	Postoperative delirium after cardiac surgery	Neurological disorder
13152	GCST007980	Postoperative delirium after cardiac surgery	Postoperative delirium after cardiac surgery	Biological process
13153	GCST007981	Postoperative complication after cardiac surgery	Postoperative complication after cardiac surgery	Biological process
13154	GCST007981	Postoperative complication after cardiac surgery	Postoperative complication after cardiac surgery	Other trait
13155	GCST007365	Progression-free survival response to gemcitabine in breast cancer	Progression-free survival response to gemcitabine in breast cancer	Cancer
13156	GCST007365	Progression-free survival response to gemcitabine in breast cancer	Progression-free survival response to gemcitabine in breast cancer	Other measurement
13157	GCST007365	Progression-free survival response to gemcitabine in breast cancer	Progression-free survival response to gemcitabine in breast cancer	Response to drug
13158	GCST007366	Homocysteine level response to multivitamin in cerebral infarction	Homocysteine level response to multivitamin in cerebral infarction	Cardiovascular disease
13159	GCST007366	Homocysteine level response to multivitamin in cerebral infarction	Homocysteine level response to multivitamin in cerebral infarction	Biological process
13160	GCST007366	Homocysteine level response to multivitamin in cerebral infarction	Homocysteine level response to multivitamin in cerebral infarction	Cardiovascular measurement
13161	GCST007664	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	Response to drug
13162	GCST007664	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	Cancer
13163	GCST008101	Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Other measurement
13164	GCST008101	Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Lipid or lipoprotein measurement
13165	GCST008100	Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Other measurement
13166	GCST008100	Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)	Lipid or lipoprotein measurement
13167	GCST008099	Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Other measurement
13168	GCST008099	Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Lipid or lipoprotein measurement
13169	GCST008102	Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Other measurement
13170	GCST008102	Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)	Lipid or lipoprotein measurement
13171	GCST007358	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Response to drug
13172	GCST007358	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Cancer
13173	GCST007358	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)	Other measurement
13174	GCST006978	Suicide attempts	Suicide attempts	Biological process
13175	GCST006977	Predicted suicide risk	Predicted suicide risk	Other measurement
13176	GCST006656	Dysmenorrheic pain severity	Dysmenorrheic pain severity	Other measurement
13177	GCST006636	Menstruation quality of life impact (dysmenorrhea)	Menstruation quality of life impact (dysmenorrhea)	Other measurement
13178	GCST006636	Menstruation quality of life impact (dysmenorrhea)	Menstruation quality of life impact (dysmenorrhea)	Other measurement
13179	GCST006637	Pain medicine use during menstruation	Pain medicine use during menstruation	Other measurement
13180	GCST006637	Pain medicine use during menstruation	Pain medicine use during menstruation	Other measurement
13181	GCST006638	Menstruation quality of life impact (fever)	Menstruation quality of life impact (fever)	Other trait
13182	GCST006638	Menstruation quality of life impact (fever)	Menstruation quality of life impact (fever)	Other measurement
13183	GCST006639	Heavy vaginal discharge	Heavy vaginal discharge	Other trait
13184	GCST006639	Heavy vaginal discharge	Heavy vaginal discharge	Other measurement
13185	GCST006640	Menstruation quality of life impact (acne)	Menstruation quality of life impact (acne)	Other disease
13186	GCST006640	Menstruation quality of life impact (acne)	Menstruation quality of life impact (acne)	Other measurement
13187	GCST006641	Menstruation quality of life impact (aggressiveness)	Menstruation quality of life impact (aggressiveness)	Biological process
13188	GCST006641	Menstruation quality of life impact (aggressiveness)	Menstruation quality of life impact (aggressiveness)	Other measurement
13189	GCST006642	Menstruation quality of life impact (increased appetite)	Menstruation quality of life impact (increased appetite)	Biological process
13190	GCST006642	Menstruation quality of life impact (increased appetite)	Menstruation quality of life impact (increased appetite)	Other measurement
13191	GCST006643	Menstruation quality of life impact (bowel movement)	Menstruation quality of life impact (bowel movement)	Other trait
13192	GCST006643	Menstruation quality of life impact (bowel movement)	Menstruation quality of life impact (bowel movement)	Other measurement
13193	GCST006644	Menstruation quality of life impact (depression)	Menstruation quality of life impact (depression)	Neurological disorder
13194	GCST006644	Menstruation quality of life impact (depression)	Menstruation quality of life impact (depression)	Other measurement
13195	GCST006645	Menstruation quality of life impact (edema)	Menstruation quality of life impact (edema)	Other measurement
13196	GCST006645	Menstruation quality of life impact (edema)	Menstruation quality of life impact (edema)	Other disease
13197	GCST006646	Menstruation quality of life impact (headache)	Menstruation quality of life impact (headache)	Other trait
13198	GCST006646	Menstruation quality of life impact (headache)	Menstruation quality of life impact (headache)	Other measurement
13199	GCST006647	Menstruation quality of life impact (joint pain)	Menstruation quality of life impact (joint pain)	Other trait
13200	GCST006647	Menstruation quality of life impact (joint pain)	Menstruation quality of life impact (joint pain)	Other measurement
13201	GCST006648	Menstruation quality of life impact (loss of concentration)	Menstruation quality of life impact (loss of concentration)	Neurological disorder
13202	GCST006648	Menstruation quality of life impact (loss of concentration)	Menstruation quality of life impact (loss of concentration)	Other measurement
13203	GCST006649	Menstruation quality of life impact (nervousness)	Menstruation quality of life impact (nervousness)	Neurological disorder
13204	GCST006649	Menstruation quality of life impact (nervousness)	Menstruation quality of life impact (nervousness)	Other measurement
13205	GCST006650	Menstruation quality of life impact (pressure in breast)	Menstruation quality of life impact (pressure in breast)	Body measurement
13206	GCST006650	Menstruation quality of life impact (pressure in breast)	Menstruation quality of life impact (pressure in breast)	Other measurement
13207	GCST006651	Menstruation quality of life impact (sleepiness)	Menstruation quality of life impact (sleepiness)	Neurological disorder
13208	GCST006651	Menstruation quality of life impact (sleepiness)	Menstruation quality of life impact (sleepiness)	Other measurement
13209	GCST006652	Menstruation quality of life impact (stiff neck)	Menstruation quality of life impact (stiff neck)	Other trait
13210	GCST006652	Menstruation quality of life impact (stiff neck)	Menstruation quality of life impact (stiff neck)	Other measurement
13211	GCST006653	Vaginal discharge (itching)	Vaginal discharge (itching)	Other trait
13212	GCST006657	Vaginal discharge (metrorrhagia)	Vaginal discharge (metrorrhagia)	Other trait
13213	GCST006657	Vaginal discharge (metrorrhagia)	Vaginal discharge (metrorrhagia)	Other trait
13214	GCST006654	Vaginal discharge (smell)	Vaginal discharge (smell)	Other trait
13215	GCST006655	Breast size	Breast size	Body measurement
13216	GCST006867	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13217	GCST006868	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13218	GCST006331	Anti-cytomegalovirus IgG seropositivity	Anti-cytomegalovirus IgG seropositivity	Other measurement
13219	GCST006332	Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG seropositivity	Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG seropositivity	Other measurement
13220	GCST006333	Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG seropositivity	Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG seropositivity	Other measurement
13221	GCST006330	Anti-Epstein-Barr virus early antigen (EA) IgG seropositivity	Anti-Epstein-Barr virus early antigen (EA) IgG seropositivity	Other measurement
13222	GCST006334	Anti-herpes simplex virus 1 IgG seropositivity	Anti-herpes simplex virus 1 IgG seropositivity	Other measurement
13223	GCST006335	Anti-herpes simplex virus 2 IgG seropositivity	Anti-herpes simplex virus 2 IgG seropositivity	Other measurement
13224	GCST006336	Anti-varicella zoster virus IgG seropositivity	Anti-varicella zoster virus IgG seropositivity	Other measurement
13225	GCST006337	Anti-Helicobacter pylori IgG seropositivity	Anti-Helicobacter pylori IgG seropositivity	Other measurement
13226	GCST006338	Anti-Toxoplasma gondii IgG seropositivity	Anti-Toxoplasma gondii IgG seropositivity	Other measurement
13227	GCST006339	Anti-influenza A virus IgG seropositivity	Anti-influenza A virus IgG seropositivity	Other measurement
13228	GCST006340	Anti-measles virus IgG seropositivity	Anti-measles virus IgG seropositivity	Other measurement
13229	GCST006341	Anti-mumps virus IgG seropositivity	Anti-mumps virus IgG seropositivity	Other measurement
13230	GCST006342	Anti-rubella virus IgG seropositivity	Anti-rubella virus IgG seropositivity	Other measurement
13231	GCST006356	Anti-hepatitis B virus surface antigen (HBs) IgG seropositivity	Anti-hepatitis B virus surface antigen (HBs) IgG seropositivity	Other measurement
13232	GCST006343	Anti-hepatitis B virus core antigen (HBc) IgG seropositivity	Anti-hepatitis B virus core antigen (HBc) IgG seropositivity	Other measurement
13233	GCST006357	IgG levels	IgG levels	Other measurement
13234	GCST006359	IgM levels	IgM levels	Other measurement
13235	GCST006360	IgA levels	IgA levels	Other measurement
13236	GCST006358	IgE levels	IgE levels	Other measurement
13237	GCST006344	Anti-cytomegalovirus IgG levels	Anti-cytomegalovirus IgG levels	Other measurement
13238	GCST006361	Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels	Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels	Other measurement
13239	GCST006362	Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG levels	Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG levels	Other measurement
13240	GCST006345	Anti-Epstein-Barr virus early antigen (EA) IgG levels	Anti-Epstein-Barr virus early antigen (EA) IgG levels	Other measurement
13241	GCST006346	Anti-herpes simplex virus 1 IgG levels	Anti-herpes simplex virus 1 IgG levels	Other measurement
13242	GCST006347	Anti-herpes simplex virus 2 IgG levels	Anti-herpes simplex virus 2 IgG levels	Other measurement
13243	GCST006348	Anti-varicella zoster virus IgG levels	Anti-varicella zoster virus IgG levels	Other measurement
13244	GCST006363	Anti-Helicobacter pylori IgG levels	Anti-Helicobacter pylori IgG levels	Other measurement
13245	GCST006349	Anti-Toxoplasma gondii IgG levels	Anti-Toxoplasma gondii IgG levels	Other measurement
13246	GCST006350	Anti-influenza A virus IgG levels	Anti-influenza A virus IgG levels	Other measurement
13247	GCST006351	Anti-measles virus IgG levels	Anti-measles virus IgG levels	Other measurement
13248	GCST006352	Anti-mumps virus IgG levels	Anti-mumps virus IgG levels	Other measurement
13249	GCST006353	Anti-rubella virus IgG levels	Anti-rubella virus IgG levels	Other measurement
13250	GCST006354	Anti-hepatitis B virus surface antigen (HBs) IgG levels	Anti-hepatitis B virus surface antigen (HBs) IgG levels	Other measurement
13251	GCST006355	Anti-hepatitis B virus core antigen (HBc) IgG levels	Anti-hepatitis B virus core antigen (HBc) IgG levels	Other measurement
13252	GCST006923	Loneliness	Loneliness	Other measurement
13253	GCST006918	Social isolation	Social isolation	Other measurement
13254	GCST006919	Ability to confide in someone	Ability to confide in someone	Other measurement
13255	GCST006920	Regular attendance at a gym or sports club	Regular attendance at a gym or sports club	Other measurement
13256	GCST006921	Regular attendance at a pub or social club	Regular attendance at a pub or social club	Other measurement
13257	GCST006922	Regular attendance at a religious group	Regular attendance at a religious group	Other measurement
13258	GCST006924	Loneliness (MTAG)	Loneliness (MTAG)	Other measurement
13259	GCST006218	Erosive tooth wear (severe vs non-severe)	Erosive tooth wear (severe vs non-severe)	Other measurement
13260	GCST006226	Erosive tooth wear (severe vs none or mild)	Erosive tooth wear (severe vs none or mild)	Other measurement
13261	GCST005963	Epstein Barr virus nuclear antigen 1 IgG levels	Epstein Barr virus nuclear antigen 1 IgG levels	Other measurement
13262	GCST005941	Epstein Barr virus nuclear antigen 1 IgG seropositivity	Epstein Barr virus nuclear antigen 1 IgG seropositivity	Other measurement
13263	GCST005942	Viral capsid antigen IgG levels	Viral capsid antigen IgG levels	Other measurement
13264	GCST005944	Viral capsid antigen IgG seropositivity	Viral capsid antigen IgG seropositivity	Other measurement
13265	GCST005943	Epstein-Barr virus immune response (multivariate analysis)	Epstein-Barr virus immune response (multivariate analysis)	Other measurement
13266	GCST006280	Velopharyngeal dysfunction	Velopharyngeal dysfunction	Other trait
13267	GCST006057	Percent glycated albumin	Percent glycated albumin	Other measurement
13268	GCST006058	Total glycated albumin levels	Total glycated albumin levels	Other measurement
13269	GCST006059	Fasting blood glucose	Fasting blood glucose	Other measurement
13270	GCST006060	Hemoglobin A1c levels	Hemoglobin A1c levels	Other measurement
13271	GCST006060	Hemoglobin A1c levels	Hemoglobin A1c levels	Hematological measurement
13272	GCST006056	Fructosamine levels	Fructosamine levels	Other measurement
13273	GCST007301	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13274	GCST007300	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Lipid or lipoprotein measurement
13275	GCST007300	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Response to drug
13276	GCST007300	Response to fenofibrate (HDL cholesterol levels)	Response to fenofibrate (HDL cholesterol levels)	Lipid or lipoprotein measurement
13277	GCST007299	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
13278	GCST007298	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Response to drug
13279	GCST007298	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Lipid or lipoprotein measurement
13280	GCST007298	Response to fenofibrate (triglyceride levels)	Response to fenofibrate (triglyceride levels)	Lipid or lipoprotein measurement
13281	GCST006253	Short-term memory (digit-span task)	Short-term memory (digit-span task)	Biological process
13282	GCST006253	Short-term memory (digit-span task)	Short-term memory (digit-span task)	Other measurement
13283	GCST006254	Short-term memory (visuospatial task)	Short-term memory (visuospatial task)	Other measurement
13284	GCST006255	Short-term memory (shared component of digit-span and visuospatial tasks)	Short-term memory (shared component of digit-span and visuospatial tasks)	Other measurement
13285	GCST006256	Long-term memory (delayed word recall task)	Long-term memory (delayed word recall task)	Other measurement
13286	GCST007621	Sensation seeking	Sensation seeking	Other measurement
13287	GCST007622	Impulsivity	Impulsivity	Other measurement
13288	GCST007623	Lack of premeditation	Lack of premeditation	Other measurement
13289	GCST007624	Positive urgency	Positive urgency	Other measurement
13290	GCST007625	Negative urgency	Negative urgency	Other measurement
13291	GCST007626	Lack of perseverance	Lack of perseverance	Other measurement
13292	GCST007627	Impulsivity (attentional)	Impulsivity (attentional)	Other measurement
13293	GCST007628	Impulsivity (motor)	Impulsivity (motor)	Other measurement
13294	GCST007629	Impulsivity (non-planning)	Impulsivity (non-planning)	Other measurement
13295	GCST007630	Drug experimentation measurement	Drug experimentation measurement	Other measurement
13296	GCST007637	Diffusing capacity of carbon monoxide	Diffusing capacity of carbon monoxide	Other measurement
13297	GCST007407	Depressive symptoms	Depressive symptoms	Neurological disorder
13298	GCST007407	Depressive symptoms	Depressive symptoms	Other measurement
13299	GCST007408	Depressive symptoms x stressful life events interaction (1df test)	Depressive symptoms x stressful life events interaction (1df test)	Other measurement
13300	GCST007408	Depressive symptoms x stressful life events interaction (1df test)	Depressive symptoms x stressful life events interaction (1df test)	Other measurement
13301	GCST007409	Depressive symptoms x stressful life events interaction (2df test)	Depressive symptoms x stressful life events interaction (2df test)	Other measurement
13302	GCST007409	Depressive symptoms x stressful life events interaction (2df test)	Depressive symptoms x stressful life events interaction (2df test)	Other measurement
13303	GCST007410	Depressive symptoms x dependent stressful life events interaction (1df test)	Depressive symptoms x dependent stressful life events interaction (1df test)	Other measurement
13304	GCST007410	Depressive symptoms x dependent stressful life events interaction (1df test)	Depressive symptoms x dependent stressful life events interaction (1df test)	Other measurement
13305	GCST007411	Depressive symptoms x dependent stressful life events interaction (2df test)	Depressive symptoms x dependent stressful life events interaction (2df test)	Other measurement
13306	GCST007411	Depressive symptoms x dependent stressful life events interaction (2df test)	Depressive symptoms x dependent stressful life events interaction (2df test)	Other measurement
13307	GCST007412	Depressive symptoms x independent stressful life events interaction (1df test)	Depressive symptoms x independent stressful life events interaction (1df test)	Other measurement
13308	GCST007412	Depressive symptoms x independent stressful life events interaction (1df test)	Depressive symptoms x independent stressful life events interaction (1df test)	Other measurement
13309	GCST007413	Depressive symptoms x independent stressful life events interaction (2df test)	Depressive symptoms x independent stressful life events interaction (2df test)	Other measurement
13310	GCST007413	Depressive symptoms x independent stressful life events interaction (2df test)	Depressive symptoms x independent stressful life events interaction (2df test)	Other measurement
13311	GCST007231	Tuberculosis	Tuberculosis	Other disease
13312	GCST007231	Tuberculosis	Tuberculosis	Other measurement
13313	GCST007231	Tuberculosis	Tuberculosis	Other measurement
13314	GCST007232	Tuberculosis (SNP x SNP interaction)	Tuberculosis (SNP x SNP interaction)	Other disease
13315	GCST007100	Asthma exacerbations in inhaled corticosteroid treatment	Asthma exacerbations in inhaled corticosteroid treatment	Response to drug
13316	GCST007100	Asthma exacerbations in inhaled corticosteroid treatment	Asthma exacerbations in inhaled corticosteroid treatment	Other measurement
13317	GCST007355	Antidepressant treatment resistance (> 2 drugs prescribed)	Antidepressant treatment resistance (> 2 drugs prescribed)	Response to drug
13318	GCST007356	Antidepressant treatment resistance (number of drugs prescribed)	Antidepressant treatment resistance (number of drugs prescribed)	Response to drug
13319	GCST007251	Postburn scar height	Postburn scar height	Other measurement
13320	GCST007252	Postburn scar pliability	Postburn scar pliability	Other measurement
13321	GCST007956	Maternal chorioamnionitis	Maternal chorioamnionitis	Other disease
13322	GCST008678	HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	Other measurement
13323	GCST008678	HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	Lipid or lipoprotein measurement
13324	GCST008679	HDL cholesterol levels in current smokers	HDL cholesterol levels in current smokers	Other measurement
13325	GCST008679	HDL cholesterol levels in current smokers	HDL cholesterol levels in current smokers	Lipid or lipoprotein measurement
13326	GCST008680	HDL cholesterol levels in non smokers	HDL cholesterol levels in non smokers	Other measurement
13327	GCST008680	HDL cholesterol levels in non smokers	HDL cholesterol levels in non smokers	Lipid or lipoprotein measurement
13328	GCST008681	HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	Other measurement
13329	GCST008681	HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	Lipid or lipoprotein measurement
13330	GCST008682	HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	Other measurement
13331	GCST008682	HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	Lipid or lipoprotein measurement
13332	GCST008683	HDL cholesterol levels in ever smokers	HDL cholesterol levels in ever smokers	Other measurement
13333	GCST008683	HDL cholesterol levels in ever smokers	HDL cholesterol levels in ever smokers	Lipid or lipoprotein measurement
13334	GCST008684	HDL cholesterol levels in never smokers	HDL cholesterol levels in never smokers	Other measurement
13335	GCST008684	HDL cholesterol levels in never smokers	HDL cholesterol levels in never smokers	Lipid or lipoprotein measurement
13336	GCST008685	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
13337	GCST008686	LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	Other measurement
13338	GCST008686	LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	Lipid or lipoprotein measurement
13339	GCST008687	LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	Other measurement
13340	GCST008687	LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)	Lipid or lipoprotein measurement
13341	GCST008688	LDL cholesterol levels in current smokers	LDL cholesterol levels in current smokers	Other measurement
13342	GCST008688	LDL cholesterol levels in current smokers	LDL cholesterol levels in current smokers	Lipid or lipoprotein measurement
13343	GCST008689	LDL cholesterol levels in non smokers	LDL cholesterol levels in non smokers	Other measurement
13344	GCST008689	LDL cholesterol levels in non smokers	LDL cholesterol levels in non smokers	Lipid or lipoprotein measurement
13345	GCST008690	LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	Other measurement
13346	GCST008690	LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)	Lipid or lipoprotein measurement
13347	GCST008691	LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	Other measurement
13348	GCST008691	LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)	Lipid or lipoprotein measurement
13349	GCST008692	LDL cholesterol levels in ever smokers	LDL cholesterol levels in ever smokers	Other measurement
13350	GCST008692	LDL cholesterol levels in ever smokers	LDL cholesterol levels in ever smokers	Lipid or lipoprotein measurement
13351	GCST008693	LDL cholesterol levels in never smokers	LDL cholesterol levels in never smokers	Other measurement
13352	GCST008693	LDL cholesterol levels in never smokers	LDL cholesterol levels in never smokers	Lipid or lipoprotein measurement
13353	GCST008676	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
13354	GCST008676	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
13355	GCST008694	Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	Other measurement
13356	GCST008694	Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	Triglyceride levels x smoking (current vs non smokers) interaction (1df test)	Lipid or lipoprotein measurement
13357	GCST008695	Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	Other measurement
13358	GCST008695	Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	Triglyceride levels x smoking (current vs non smokers) interaction (2df test)	Lipid or lipoprotein measurement
13359	GCST008696	Triglyceride levels in current smokers	Triglyceride levels in current smokers	Other measurement
13360	GCST008696	Triglyceride levels in current smokers	Triglyceride levels in current smokers	Lipid or lipoprotein measurement
13361	GCST008697	Triglyceride levels in non smokers	Triglyceride levels in non smokers	Other measurement
13362	GCST008697	Triglyceride levels in non smokers	Triglyceride levels in non smokers	Lipid or lipoprotein measurement
13363	GCST008698	Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	Other measurement
13364	GCST008698	Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)	Lipid or lipoprotein measurement
13365	GCST008699	Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)	Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)	Other measurement
13366	GCST008699	Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)	Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)	Lipid or lipoprotein measurement
13367	GCST008700	Triglyceride levels in ever smokers	Triglyceride levels in ever smokers	Other measurement
13368	GCST008700	Triglyceride levels in ever smokers	Triglyceride levels in ever smokers	Lipid or lipoprotein measurement
13369	GCST008701	Triglyceride levels in never smokers	Triglyceride levels in never smokers	Other measurement
13370	GCST008701	Triglyceride levels in never smokers	Triglyceride levels in never smokers	Lipid or lipoprotein measurement
13371	GCST008702	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
13372	GCST008677	HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	Other measurement
13373	GCST008677	HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)	Lipid or lipoprotein measurement
13374	GCST007556	Autism spectrum disorder	Autism spectrum disorder	Neurological disorder
13375	GCST007553	Autism and major depressive disorder (MTAG)	Autism and major depressive disorder (MTAG)	Neurological disorder
13376	GCST007553	Autism and major depressive disorder (MTAG)	Autism and major depressive disorder (MTAG)	Neurological disorder
13377	GCST007555	Autism and schizophrenia (MTAG)	Autism and schizophrenia (MTAG)	Neurological disorder
13378	GCST007555	Autism and schizophrenia (MTAG)	Autism and schizophrenia (MTAG)	Neurological disorder
13379	GCST007554	Autism and educational attainment (MTAG)	Autism and educational attainment (MTAG)	Other measurement
13380	GCST007554	Autism and educational attainment (MTAG)	Autism and educational attainment (MTAG)	Neurological disorder
13381	GCST007587	Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)	Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)	Neurological disorder
13382	GCST007587	Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)	Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)	Other measurement
13383	GCST007583	Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)	Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)	Other measurement
13384	GCST007583	Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)	Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)	Neurological disorder
13385	GCST007591	Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	Neurological disorder
13386	GCST007591	Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)	Other measurement
13387	GCST007590	Hippocampal volume	Hippocampal volume	Other measurement
13388	GCST007589	Intracranial volume	Intracranial volume	Other measurement
13389	GCST007586	Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	Neurological disorder
13390	GCST007586	Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)	Other measurement
13391	GCST007582	Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	Other measurement
13392	GCST007582	Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	Attention deficit hyperactivity disorder or putamen volume (pleiotropy)	Neurological disorder
13393	GCST007588	Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	Other measurement
13394	GCST007588	Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)	Neurological disorder
13395	GCST007585	Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)	Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)	Other measurement
13396	GCST007585	Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)	Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)	Neurological disorder
13397	GCST007584	Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)	Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)	Other measurement
13398	GCST007584	Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)	Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)	Neurological disorder
13399	GCST007387	Insomnia symptoms (never/rarely vs. sometimes/usually)	Insomnia symptoms (never/rarely vs. sometimes/usually)	Other measurement
13400	GCST007388	Insomnia symptoms (never/rarely vs. usually)	Insomnia symptoms (never/rarely vs. usually)	Other measurement
13401	GCST008240	Airway obstruction (FEV1/FVC<70%) in never smokers	Airway obstruction (FEV1/FVC<70%) in never smokers	Other measurement
13402	GCST008240	Airway obstruction (FEV1/FVC<70%) in never smokers	Airway obstruction (FEV1/FVC<70%) in never smokers	Other measurement
13403	GCST008242	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Other measurement
13404	GCST008242	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Other measurement
13405	GCST008241	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Other measurement
13406	GCST008241	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Other measurement
13407	GCST008243	Airway obstruction (FEV1/FVC<70%) in ever smokers	Airway obstruction (FEV1/FVC<70%) in ever smokers	Other measurement
13408	GCST008243	Airway obstruction (FEV1/FVC<70%) in ever smokers	Airway obstruction (FEV1/FVC<70%) in ever smokers	Other measurement
13409	GCST008244	Airway obstruction (FEV1/FVC<70%) in ever smokers	Airway obstruction (FEV1/FVC<70%) in ever smokers	Other measurement
13410	GCST008244	Airway obstruction (FEV1/FVC<70%) in ever smokers	Airway obstruction (FEV1/FVC<70%) in ever smokers	Other measurement
13411	GCST008247	Airway obstruction (FEV1/FVC<70%) in never smokers	Airway obstruction (FEV1/FVC<70%) in never smokers	Other measurement
13412	GCST008247	Airway obstruction (FEV1/FVC<70%) in never smokers	Airway obstruction (FEV1/FVC<70%) in never smokers	Other measurement
13413	GCST008245	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Other measurement
13414	GCST008245	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers	Other measurement
13415	GCST008246	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Other measurement
13416	GCST008246	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers	Other measurement
13417	GCST007830	Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis	Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis	Other measurement
13418	GCST007830	Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis	Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis	Immune system disorder
13419	GCST007831	Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Immune system disorder
13420	GCST007831	Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Other measurement
13421	GCST007851	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Other measurement
13422	GCST007851	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Immune system disorder
13423	GCST007851	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis	Other measurement
13424	GCST007683	Triiodothyronine levels	Triiodothyronine levels	Other measurement
13425	GCST007682	Thyroxine levels	Thyroxine levels	Other measurement
13426	GCST007681	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other measurement
13427	GCST007681	Thyroid stimulating hormone levels	Thyroid stimulating hormone levels	Other trait
13428	GCST007680	Triiodothyronine levels and thyroxine levels	Triiodothyronine levels and thyroxine levels	Other measurement
13429	GCST007680	Triiodothyronine levels and thyroxine levels	Triiodothyronine levels and thyroxine levels	Other measurement
13430	GCST007686	Plasma norclozapine levels in treatment-resistant schizophrenia	Plasma norclozapine levels in treatment-resistant schizophrenia	Response to drug
13431	GCST007686	Plasma norclozapine levels in treatment-resistant schizophrenia	Plasma norclozapine levels in treatment-resistant schizophrenia	Neurological disorder
13432	GCST007684	Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	Response to drug
13433	GCST007684	Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia	Neurological disorder
13434	GCST007685	Plasma clozapine levels in treatment-resistant schizophrenia	Plasma clozapine levels in treatment-resistant schizophrenia	Response to drug
13435	GCST007685	Plasma clozapine levels in treatment-resistant schizophrenia	Plasma clozapine levels in treatment-resistant schizophrenia	Neurological disorder
13436	GCST007639	Femoral neck length	Femoral neck length	Other measurement
13437	GCST007640	Narrowest width of the femoral neck	Narrowest width of the femoral neck	Other measurement
13438	GCST007641	Femoral neck section modulus	Femoral neck section modulus	Other measurement
13439	GCST007642	Femoral neck-shaft angle	Femoral neck-shaft angle	Other measurement
13440	GCST007458	Age of smoking initiation	Age of smoking initiation	Biological process
13441	GCST007458	Age of smoking initiation	Age of smoking initiation	Other measurement
13442	GCST007459	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
13443	GCST007460	Smoking cessation	Smoking cessation	Biological process
13444	GCST007474	Smoking initiation (ever regular vs never regular)	Smoking initiation (ever regular vs never regular)	Other measurement
13445	GCST007474	Smoking initiation (ever regular vs never regular)	Smoking initiation (ever regular vs never regular)	Biological process
13446	GCST007461	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Biological process
13447	GCST007461	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Other measurement
13448	GCST007462	Age of smoking initiation (MTAG)	Age of smoking initiation (MTAG)	Biological process
13449	GCST007463	Cigarettes smoked per day (MTAG)	Cigarettes smoked per day (MTAG)	Other measurement
13450	GCST007464	Smoking cessation (MTAG)	Smoking cessation (MTAG)	Biological process
13451	GCST007468	Smoking initiation (ever regular vs never regular) (MTAG)	Smoking initiation (ever regular vs never regular) (MTAG)	Other measurement
13452	GCST007472	Alcohol consumption (drinks per week) (MTAG)	Alcohol consumption (drinks per week) (MTAG)	Other measurement
13453	GCST007444	Chronic rhinosinusitis	Chronic rhinosinusitis	Neurological disorder
13454	GCST007443	Nasal polyps	Nasal polyps	Cancer
13455	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13456	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13457	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13458	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13459	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13460	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13461	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13462	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13463	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13464	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13465	GCST007382	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Plasma free amino acid levels (adjusted for twenty other PFAAs)	Other measurement
13466	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13467	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13468	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13469	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13470	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13471	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13472	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13473	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13474	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13475	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13476	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13477	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13478	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13479	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13480	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13481	GCST007383	Plasma free amino acid levels (adjusted for one other PFAA)	Plasma free amino acid levels (adjusted for one other PFAA)	Other measurement
13482	GCST007384	Plasma free proline levels	Plasma free proline levels	Other measurement
13483	GCST007386	Plasma free asparagine levels	Plasma free asparagine levels	Other measurement
13484	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13485	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13486	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13487	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13488	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13489	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13490	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13491	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13492	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13493	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13494	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13495	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13496	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13497	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13498	GCST007385	Plasma free amino acid levels	Plasma free amino acid levels	Other measurement
13499	GCST008234	Cognitive impairment and C-reactive protein levels (pleiotropy)	Cognitive impairment and C-reactive protein levels (pleiotropy)	Other trait
13500	GCST008234	Cognitive impairment and C-reactive protein levels (pleiotropy)	Cognitive impairment and C-reactive protein levels (pleiotropy)	Inflammatory measurement
13501	GCST008233	Cognitive impairment and LDL levels (pleiotropy)	Cognitive impairment and LDL levels (pleiotropy)	Lipid or lipoprotein measurement
13502	GCST008233	Cognitive impairment and LDL levels (pleiotropy)	Cognitive impairment and LDL levels (pleiotropy)	Other trait
13503	GCST008232	Cognitive impairment and total cholesterol levels (pleiotropy)	Cognitive impairment and total cholesterol levels (pleiotropy)	Lipid or lipoprotein measurement
13504	GCST008232	Cognitive impairment and total cholesterol levels (pleiotropy)	Cognitive impairment and total cholesterol levels (pleiotropy)	Other trait
13505	GCST008235	Cognitive impairment	Cognitive impairment	Other trait
13506	GCST008236	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
13507	GCST008237	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13508	GCST008238	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13509	GCST008239	Serum total cholesterol levels	Serum total cholesterol levels	Lipid or lipoprotein measurement
13510	GCST007036	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
13511	GCST007036	Primary biliary cholangitis	Primary biliary cholangitis	Cancer
13512	GCST008167	Mean platelet volume	Mean platelet volume	Hematological measurement
13513	GCST008166	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
13514	GCST008168	Platelet count	Platelet count	Hematological measurement
13515	GCST007363	Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age	Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age	Other measurement
13516	GCST008107	Radioiodine-refractory disease in thyroid cancer	Radioiodine-refractory disease in thyroid cancer	Biological process
13517	GCST008107	Radioiodine-refractory disease in thyroid cancer	Radioiodine-refractory disease in thyroid cancer	Cancer
13518	GCST008555	Breakfast cereal skipping frequency	Breakfast cereal skipping frequency	Other measurement
13519	GCST008556	Breakfast skipping	Breakfast skipping	Other measurement
13520	GCST008659	Lung function in heavy smokers (low FEV1 vs high FEV1)	Lung function in heavy smokers (low FEV1 vs high FEV1)	Other measurement
13521	GCST008659	Lung function in heavy smokers (low FEV1 vs high FEV1)	Lung function in heavy smokers (low FEV1 vs high FEV1)	Other measurement
13522	GCST008660	Lung function in never smokers (high FEV1 vs average FEV1)	Lung function in never smokers (high FEV1 vs average FEV1)	Other measurement
13523	GCST008660	Lung function in never smokers (high FEV1 vs average FEV1)	Lung function in never smokers (high FEV1 vs average FEV1)	Other measurement
13524	GCST008661	Lung function in heavy smokers (high FEV1 vs average FEV1)	Lung function in heavy smokers (high FEV1 vs average FEV1)	Other measurement
13525	GCST008661	Lung function in heavy smokers (high FEV1 vs average FEV1)	Lung function in heavy smokers (high FEV1 vs average FEV1)	Other measurement
13526	GCST008663	Lung function in never smokers (low FEV1 vs average FEV1)	Lung function in never smokers (low FEV1 vs average FEV1)	Other measurement
13527	GCST008663	Lung function in never smokers (low FEV1 vs average FEV1)	Lung function in never smokers (low FEV1 vs average FEV1)	Other measurement
13528	GCST008665	Lung function in heavy smokers (low FEV1 vs average FEV1)	Lung function in heavy smokers (low FEV1 vs average FEV1)	Other measurement
13529	GCST008665	Lung function in heavy smokers (low FEV1 vs average FEV1)	Lung function in heavy smokers (low FEV1 vs average FEV1)	Other measurement
13530	GCST008667	Smoking status (heavy vs never)	Smoking status (heavy vs never)	Other measurement
13531	GCST008666	Lung function (low FEV1 vs high FEV1) x smoking interaction	Lung function (low FEV1 vs high FEV1) x smoking interaction	Other measurement
13532	GCST008666	Lung function (low FEV1 vs high FEV1) x smoking interaction	Lung function (low FEV1 vs high FEV1) x smoking interaction	Other measurement
13533	GCST008664	Lung function (low FEV1 vs high FEV1)	Lung function (low FEV1 vs high FEV1)	Other measurement
13534	GCST008662	Lung function in never smokers (low FEV1 vs high FEV1)	Lung function in never smokers (low FEV1 vs high FEV1)	Other measurement
13535	GCST008662	Lung function in never smokers (low FEV1 vs high FEV1)	Lung function in never smokers (low FEV1 vs high FEV1)	Other measurement
13536	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13537	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13538	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13539	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13540	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13541	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Inflammatory measurement
13542	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13543	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13544	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13545	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13546	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13547	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13548	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13549	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13550	GCST008338	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13551	GCST008322	White blood cell count	White blood cell count	Hematological measurement
13552	GCST008322	White blood cell count	White blood cell count	Inflammatory measurement
13553	GCST008322	White blood cell count	White blood cell count	Hematological measurement
13554	GCST008322	White blood cell count	White blood cell count	Hematological measurement
13555	GCST008322	White blood cell count	White blood cell count	Hematological measurement
13556	GCST008329	Red blood cell count	Red blood cell count	Hematological measurement
13557	GCST008330	Mean corpuscular volume	Mean corpuscular volume	Hematological measurement
13558	GCST008331	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
13559	GCST008331	Mean corpuscular hemoglobin	Mean corpuscular hemoglobin	Hematological measurement
13560	GCST008332	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
13561	GCST008332	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
13562	GCST008333	Red cell distribution width	Red cell distribution width	Hematological measurement
13563	GCST008323	Hematocrit	Hematocrit	Hematological measurement
13564	GCST008324	Hemoglobin	Hemoglobin	Hematological measurement
13565	GCST008334	Neutrophil count	Neutrophil count	Hematological measurement
13566	GCST008325	Platelet count	Platelet count	Hematological measurement
13567	GCST008326	Lymphocyte counts	Lymphocyte counts	Hematological measurement
13568	GCST008327	Monocyte count	Monocyte count	Hematological measurement
13569	GCST008328	Basophil count	Basophil count	Inflammatory measurement
13570	GCST008335	Eosinophil counts	Eosinophil counts	Hematological measurement
13571	GCST008336	Mean platelet volume	Mean platelet volume	Hematological measurement
13572	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13573	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13574	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13575	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13576	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13577	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Inflammatory measurement
13578	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13579	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13580	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13581	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13582	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13583	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13584	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13585	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13586	GCST008337	Blood cell traits (multivariate analysis)	Blood cell traits (multivariate analysis)	Hematological measurement
13587	GCST008506	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Neurological disorder
13588	GCST008506	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Other measurement
13589	GCST008507	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Neurological disorder
13590	GCST008507	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Other measurement
13591	GCST008508	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Neurological disorder
13592	GCST008508	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	Other measurement
13593	GCST008509	Major depressive disorder	Major depressive disorder	Neurological disorder
13594	GCST008510	Neuroticism	Neuroticism	Neurological disorder
13595	GCST008510	Neuroticism	Neuroticism	Other measurement
13596	GCST008737	Esotropia	Esotropia	Other trait
13597	GCST008738	Accommodative esotropia		
13598	GCST008739	Amblyopia	Amblyopia	Neurological disorder
13599	GCST008740	Hyperopia	Hyperopia	Other trait
13600	GCST008740	Hyperopia	Hyperopia	Neurological disorder
13601	GCST008741	Non-accommodative esotropia		
13602	GCST008703	Occipital lobe volume		
13603	GCST008704	Parietal lobe volume		
13604	GCST008705	Temporal lobe volume		
13605	GCST008707	Occipital lobe volume		
13606	GCST008710	Parietal lobe volume		
13607	GCST008711	Temporal lobe volume		
13608	GCST008715	Frontal lobe volume		
13609	GCST008717	Frontal lobe volume		
13610	GCST008592	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13611	GCST008591	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
13612	GCST008593	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13613	GCST008594	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
13614	GCST007694	executive function (trail making test B)	executive function (trail making test B)	Other measurement
13615	GCST007695	perceptual and visual search speed and executive function (trail making test BA)	perceptual and visual search speed and executive function (trail making test BA)	Other measurement
13616	GCST007695	perceptual and visual search speed and executive function (trail making test BA)	perceptual and visual search speed and executive function (trail making test BA)	Biological process
13617	GCST007696	perceptual and visual search speed (trail making test A) (age interaction)	perceptual and visual search speed (trail making test A) (age interaction)	Biological process
13618	GCST007697	executive function (trail making test B) (age interaction)	executive function (trail making test B) (age interaction)	Other measurement
13619	GCST007698	perceptual and visual search speed and executive function (trail making test BA) (age interaction)	perceptual and visual search speed and executive function (trail making test BA) (age interaction)	Other measurement
13620	GCST007698	perceptual and visual search speed and executive function (trail making test BA) (age interaction)	perceptual and visual search speed and executive function (trail making test BA) (age interaction)	Biological process
13621	GCST007693	perceptual and visual search speed (trail making test A)	perceptual and visual search speed (trail making test A)	Biological process
13622	GCST008652	same-sex sexual behaviour		
13623	GCST008653	same-sex sexual behaviour		
13624	GCST008654	same-sex sexual behaviour		
13625	GCST008655	proportion of same-sex sexual behaviour among non-heterosexuals		
13626	GCST008656	proportion of same-sex sexual behaviour among non-heterosexuals		
13627	GCST008657	proportion of same-sex sexual behaviour among non-heterosexuals		
13628	GCST008649	same-sex sexual behaviour		
13629	GCST008650	same-sex sexual behaviour		
13630	GCST008651	same-sex sexual behaviour		
13631	GCST008486	Atrial fibrillation	Atrial fibrillation	Cardiovascular disease
13632	GCST008522	Bitter alcoholic beverage consumption	Bitter alcoholic beverage consumption	Other measurement
13633	GCST008524	Bitter non-alcoholic beverage consumption	Bitter non-alcoholic beverage consumption	Other measurement
13634	GCST008526	Coffee consumption	Coffee consumption	Biological process
13635	GCST008526	Coffee consumption	Coffee consumption	Other measurement
13636	GCST008526	Coffee consumption	Coffee consumption	Other measurement
13637	GCST008529	Tea consumption	Tea consumption	Other measurement
13638	GCST008531	Grapefruit juice consumption	Grapefruit juice consumption	Other measurement
13639	GCST008528	Sweet beverage consumption	Sweet beverage consumption	Other measurement
13640	GCST008527	Sugar-sweetened beverage consumption	Sugar-sweetened beverage consumption	Other measurement
13641	GCST008525	Artificially sweetened beverage consumption	Artificially sweetened beverage consumption	Other measurement
13642	GCST008523	Pure non-grapefruit juice consumption	Pure non-grapefruit juice consumption	Other measurement
13643	GCST008521	Bitter beverage consumption	Bitter beverage consumption	Other measurement
13644	GCST008383	Carbamazepine-induced liver injury	Carbamazepine-induced liver injury	Digestive system disorder
13645	GCST008383	Carbamazepine-induced liver injury	Carbamazepine-induced liver injury	Response to drug
13646	GCST008384	Carbamazepine-induced reaction with eosinophilia and systemic symptoms	Carbamazepine-induced reaction with eosinophilia and systemic symptoms	Immune system disorder
13647	GCST008384	Carbamazepine-induced reaction with eosinophilia and systemic symptoms	Carbamazepine-induced reaction with eosinophilia and systemic symptoms	Response to drug
13648	GCST008385	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
13649	GCST008385	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Other disease
13650	GCST008385	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Response to drug
13651	GCST008386	Carbamazepine-induced serious cutaneous adverse reaction	Carbamazepine-induced serious cutaneous adverse reaction	Other disease
13652	GCST008386	Carbamazepine-induced serious cutaneous adverse reaction	Carbamazepine-induced serious cutaneous adverse reaction	Response to drug
13653	GCST008364	Thyrotoxic hypokalemic periodic paralysis in Graves disease	Thyrotoxic hypokalemic periodic paralysis in Graves disease	Immune system disorder
13654	GCST008364	Thyrotoxic hypokalemic periodic paralysis in Graves disease	Thyrotoxic hypokalemic periodic paralysis in Graves disease	Metabolic disorder
13655	GCST008365	Thyrotoxic hypokalemic periodic paralysis and Graves disease	Thyrotoxic hypokalemic periodic paralysis and Graves disease	Immune system disorder
13656	GCST008365	Thyrotoxic hypokalemic periodic paralysis and Graves disease	Thyrotoxic hypokalemic periodic paralysis and Graves disease	Metabolic disorder
13657	GCST008278	Femoral neck size	Femoral neck size	Body measurement
13658	GCST008279	Trochanter size	Trochanter size	Body measurement
13659	GCST008280	Intertrochanteric region size	Intertrochanteric region size	Body measurement
13660	GCST008282	Spine bone size	Spine bone size	Other measurement
13661	GCST008281	Hip bone size	Hip bone size	Body measurement
13662	GCST008271	Anti-adalimumab antibody production in response to treatment in Crohn's disease	Anti-adalimumab antibody production in response to treatment in Crohn's disease	Digestive system disorder
13663	GCST008271	Anti-adalimumab antibody production in response to treatment in Crohn's disease	Anti-adalimumab antibody production in response to treatment in Crohn's disease	Response to drug
13664	GCST008307	Response to belimumab (SLE response index) in systemic lupus erythematosus	Response to belimumab (SLE response index) in systemic lupus erythematosus	Response to drug
13665	GCST008307	Response to belimumab (SLE response index) in systemic lupus erythematosus	Response to belimumab (SLE response index) in systemic lupus erythematosus	Immune system disorder
13666	GCST007997	Obesity (extreme) (SNP x SNP interaction)	Obesity (extreme) (SNP x SNP interaction)	Metabolic disorder
13667	GCST008260	group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	Other measurement
13668	GCST008260	group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	Inflammatory measurement
13669	GCST007881	Dementia with Lewy bodies	Dementia with Lewy bodies	Other trait
13670	GCST008058	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13671	GCST008059	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13672	GCST008060	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13673	GCST008061	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13674	GCST008062	Blood urea nitrogen levels	Blood urea nitrogen levels	Other measurement
13675	GCST008063	Blood urea nitrogen levels	Blood urea nitrogen levels	Other measurement
13676	GCST008064	Chronic kidney disease	Chronic kidney disease	Other disease
13677	GCST008064	Chronic kidney disease	Chronic kidney disease	Other measurement
13678	GCST008064	Chronic kidney disease	Chronic kidney disease	Other measurement
13679	GCST008065	Chronic kidney disease	Chronic kidney disease	Other disease
13680	GCST008065	Chronic kidney disease	Chronic kidney disease	Other measurement
13681	GCST008065	Chronic kidney disease	Chronic kidney disease	Other measurement
13682	GCST008066	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13683	GCST008118	Suicide attempts in major depressive disorder	Suicide attempts in major depressive disorder	Biological process
13684	GCST008118	Suicide attempts in major depressive disorder	Suicide attempts in major depressive disorder	Neurological disorder
13685	GCST008123	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Biological process
13686	GCST008123	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Neurological disorder
13687	GCST008123	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Neurological disorder
13688	GCST008123	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia	Neurological disorder
13689	GCST008119	Suicide attempts in bipolar disorder	Suicide attempts in bipolar disorder	Biological process
13690	GCST008119	Suicide attempts in bipolar disorder	Suicide attempts in bipolar disorder	Neurological disorder
13691	GCST008120	Suicide attempts in schizophrenia	Suicide attempts in schizophrenia	Biological process
13692	GCST008120	Suicide attempts in schizophrenia	Suicide attempts in schizophrenia	Neurological disorder
13693	GCST008121	Suicide attempts in major depressive disorder or bipolar disorder	Suicide attempts in major depressive disorder or bipolar disorder	Biological process
13694	GCST008121	Suicide attempts in major depressive disorder or bipolar disorder	Suicide attempts in major depressive disorder or bipolar disorder	Neurological disorder
13695	GCST008121	Suicide attempts in major depressive disorder or bipolar disorder	Suicide attempts in major depressive disorder or bipolar disorder	Neurological disorder
13696	GCST008122	Suicide attempts in bipolar disorder or schizophrenia	Suicide attempts in bipolar disorder or schizophrenia	Biological process
13697	GCST008122	Suicide attempts in bipolar disorder or schizophrenia	Suicide attempts in bipolar disorder or schizophrenia	Neurological disorder
13698	GCST008122	Suicide attempts in bipolar disorder or schizophrenia	Suicide attempts in bipolar disorder or schizophrenia	Neurological disorder
13699	GCST007725	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
13700	GCST007733	Serum uric acid levels	Serum uric acid levels	Cardiovascular measurement
13701	GCST008468	Nonalcoholic fatty liver disease	Nonalcoholic fatty liver disease	Digestive system disorder
13702	GCST008471	Non-alcoholic fatty liver disease activity score	Non-alcoholic fatty liver disease activity score	Other measurement
13703	GCST008469	Liver fibrosis in non-alcoholic fatty acid liver disease	Liver fibrosis in non-alcoholic fatty acid liver disease	Other trait
13704	GCST008469	Liver fibrosis in non-alcoholic fatty acid liver disease	Liver fibrosis in non-alcoholic fatty acid liver disease	Digestive system disorder
13705	GCST008467	Aspartate aminotransferase levels in non-alcoholic fatty liver disease	Aspartate aminotransferase levels in non-alcoholic fatty liver disease	Liver enzyme measurement
13706	GCST008467	Aspartate aminotransferase levels in non-alcoholic fatty liver disease	Aspartate aminotransferase levels in non-alcoholic fatty liver disease	Digestive system disorder
13707	GCST008466	Alanine aminotransferase levels in non-alcoholic fatty liver disease	Alanine aminotransferase levels in non-alcoholic fatty liver disease	Liver enzyme measurement
13708	GCST008466	Alanine aminotransferase levels in non-alcoholic fatty liver disease	Alanine aminotransferase levels in non-alcoholic fatty liver disease	Digestive system disorder
13709	GCST008470	Nonalcoholic fatty liver disease (SNP x SNP interaction)	Nonalcoholic fatty liver disease (SNP x SNP interaction)	Digestive system disorder
13710	GCST008140	Metabolic syndrome	Metabolic syndrome	Body measurement
13711	GCST008140	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
13712	GCST008140	Metabolic syndrome	Metabolic syndrome	Other measurement
13713	GCST008140	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
13714	GCST008140	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
13715	GCST008150	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
13716	GCST008141	HDL cholesterol	HDL cholesterol	Lipid or lipoprotein measurement
13717	GCST008142	Systolic blood pressure	Systolic blood pressure	Other measurement
13718	GCST008142	Systolic blood pressure	Systolic blood pressure	Other measurement
13719	GCST008143	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13720	GCST008143	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13721	GCST008144	Fasting plasma glucose	Fasting plasma glucose	Other measurement
13722	GCST008145	Waist circumference	Waist circumference	Body measurement
13723	GCST008146	Metabolic syndrome	Metabolic syndrome	Body measurement
13724	GCST008146	Metabolic syndrome	Metabolic syndrome	Lipid or lipoprotein measurement
13725	GCST008146	Metabolic syndrome	Metabolic syndrome	Other measurement
13726	GCST008146	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
13727	GCST008146	Metabolic syndrome	Metabolic syndrome	Metabolic disorder
13728	GCST008604	Urine specific gravity measurement		
13729	GCST008605	Glucosuria (moderate to severe)	Glucosuria (moderate to severe)	Other trait
13730	GCST008606	Glucosuria (mild)	Glucosuria (mild)	Other trait
13731	GCST008607	Ketonuria		
13732	GCST008608	Ketonuria (moderate to severe)		
13733	GCST008609	Ketonuria (mild)		
13734	GCST008610	Proteinuria	Proteinuria	Other trait
13735	GCST008611	Proteinuria (moderate to severe)	Proteinuria (moderate to severe)	Other trait
13736	GCST008612	Proteinuria (mild)	Proteinuria (mild)	Other trait
13737	GCST008613	Hematuria	Hematuria	Other trait
13738	GCST008617	Hematuria (moderate to severe)	Hematuria (moderate to severe)	Other trait
13739	GCST008618	Hematuria (mild)	Hematuria (mild)	Other trait
13740	GCST008616	Urine pH measurement		
13741	GCST008615	Low urine pH		
13742	GCST008619	Signs of urinary tract infection (nitrites and leukocyte esterase)		
13743	GCST008614	Glucosuria	Glucosuria	Other trait
13744	GCST008262	Psychological wellbeing index 1 (lack of subjective wellbeing and health)	Psychological wellbeing index 1 (lack of subjective wellbeing and health)	Other measurement
13745	GCST008263	Psychological wellbeing index 3 (fatigue and loss of appetite)	Psychological wellbeing index 3 (fatigue and loss of appetite)	Other measurement
13746	GCST008264	Psychological wellbeing index 12 (lack of enjoying daily life)	Psychological wellbeing index 12 (lack of enjoying daily life)	Other measurement
13747	GCST008265	Psychological wellbeing (social role performance and self-confidence)	Psychological wellbeing (social role performance and self-confidence)	Other measurement
13748	GCST008261	Psychological wellbeing (depressiveness)	Psychological wellbeing (depressiveness)	Other measurement
13749	GCST008266	Psychological wellbeing (health and vitality)	Psychological wellbeing (health and vitality)	Other measurement
13750	GCST008267	Psychological wellbeing index (total score)	Psychological wellbeing index (total score)	Other measurement
13751	GCST007862	Latent naming speed	Latent naming speed	Biological process
13752	GCST007861	Latent naming speed	Latent naming speed	Biological process
13753	GCST007859	Rapid automised naming and rapid alternating stimulus test performance	Rapid automised naming and rapid alternating stimulus test performance	Biological process
13754	GCST007860	Latent naming speed	Latent naming speed	Biological process
13755	GCST007865	Rapid automised naming of objects	Rapid automised naming of objects	Biological process
13756	GCST007864	Rapid automised naming of letters	Rapid automised naming of letters	Biological process
13757	GCST007863	Rapid alternating stimulus test for letters/numbers	Rapid alternating stimulus test for letters/numbers	Biological process
13758	GCST008446	Number of alcoholic drinks required to feel an effect (first five times drinking)	Number of alcoholic drinks required to feel an effect (first five times drinking)	Biological process
13759	GCST008447	Number of alcoholic drinks required to feel an effect (long-term average)	Number of alcoholic drinks required to feel an effect (long-term average)	Biological process
13760	GCST008070	HDL cholesterol levels	HDL cholesterol levels	Lipid or lipoprotein measurement
13761	GCST008086	LDL cholesterol levels in current drinkers	LDL cholesterol levels in current drinkers	Biological process
13762	GCST008086	LDL cholesterol levels in current drinkers	LDL cholesterol levels in current drinkers	Lipid or lipoprotein measurement
13763	GCST008085	HDL cholesterol levels in current drinkers	HDL cholesterol levels in current drinkers	Biological process
13764	GCST008085	HDL cholesterol levels in current drinkers	HDL cholesterol levels in current drinkers	Lipid or lipoprotein measurement
13765	GCST008087	Triglyceride levels in current drinkers	Triglyceride levels in current drinkers	Biological process
13766	GCST008087	Triglyceride levels in current drinkers	Triglyceride levels in current drinkers	Lipid or lipoprotein measurement
13767	GCST008084	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Biological process
13768	GCST008084	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Lipid or lipoprotein measurement
13769	GCST008083	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Biological process
13770	GCST008083	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Lipid or lipoprotein measurement
13771	GCST008082	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Biological process
13772	GCST008082	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Lipid or lipoprotein measurement
13773	GCST008081	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Biological process
13774	GCST008081	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Lipid or lipoprotein measurement
13775	GCST008080	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Biological process
13776	GCST008080	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)	Lipid or lipoprotein measurement
13777	GCST008079	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Biological process
13778	GCST008079	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)	Lipid or lipoprotein measurement
13779	GCST008078	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Lipid or lipoprotein measurement
13780	GCST008078	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Other measurement
13781	GCST008077	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
13782	GCST008077	LDL cholesterol levels	LDL cholesterol levels	Lipid or lipoprotein measurement
13783	GCST008076	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
13784	GCST008075	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Lipid or lipoprotein measurement
13785	GCST008075	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Other measurement
13786	GCST008074	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Lipid or lipoprotein measurement
13787	GCST008074	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)	Other measurement
13788	GCST008073	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Lipid or lipoprotein measurement
13789	GCST008073	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Other measurement
13790	GCST008072	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Lipid or lipoprotein measurement
13791	GCST008072	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Other measurement
13792	GCST008071	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Lipid or lipoprotein measurement
13793	GCST008071	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)	Other measurement
13794	GCST007988	Insomnia	Insomnia	Neurological disorder
13795	GCST007988	Insomnia	Insomnia	Other measurement
13796	GCST007987	Daytime nap	Daytime nap	Other measurement
13797	GCST007983	Morningness	Morningness	Other measurement
13798	GCST007982	Sleep duration	Sleep duration	Other measurement
13799	GCST007986	Ease of getting up in the morning	Ease of getting up in the morning	Other measurement
13800	GCST007984	Daytime sleepiness	Daytime sleepiness	Other measurement
13801	GCST007985	Snoring	Snoring	Other measurement
13802	GCST007484	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
13803	GCST007487	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
13804	GCST007483	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
13805	GCST007491	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
13806	GCST007492	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
13807	GCST007493	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
13808	GCST007494	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
13809	GCST007496	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
13810	GCST007500	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
13811	GCST007501	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
13812	GCST007502	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Waist-to-hip ratio adjusted for BMI (additive genetic model)	Body measurement
13813	GCST007503	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Waist-to-hip ratio adjusted for BMI (recessive genetic model)	Body measurement
13814	GCST007293	Body fat distribution (arm fat ratio)	Body fat distribution (arm fat ratio)	Body measurement
13815	GCST007295	Body fat distribution (leg fat ratio)	Body fat distribution (leg fat ratio)	Body measurement
13816	GCST007294	Body fat distribution (trunk fat ratio)	Body fat distribution (trunk fat ratio)	Body measurement
13817	GCST007825	Alzheimer's disease or fasting glucose levels (pleiotropy)	Alzheimer's disease or fasting glucose levels (pleiotropy)	Neurological disorder
13818	GCST007825	Alzheimer's disease or fasting glucose levels (pleiotropy)	Alzheimer's disease or fasting glucose levels (pleiotropy)	Other measurement
13819	GCST007826	Alzheimer's disease or fasting insulin levels (pleiotropy)	Alzheimer's disease or fasting insulin levels (pleiotropy)	Neurological disorder
13820	GCST007826	Alzheimer's disease or fasting insulin levels (pleiotropy)	Alzheimer's disease or fasting insulin levels (pleiotropy)	Other measurement
13821	GCST007827	Alzheimer's disease or HDL levels (pleiotropy)	Alzheimer's disease or HDL levels (pleiotropy)	Neurological disorder
13822	GCST007827	Alzheimer's disease or HDL levels (pleiotropy)	Alzheimer's disease or HDL levels (pleiotropy)	Lipid or lipoprotein measurement
13823	GCST007452	Skin pigmentation	Skin pigmentation	Other trait
13824	GCST007452	Skin pigmentation	Skin pigmentation	Other measurement
13825	GCST007457	Eye color (saturation)	Eye color (saturation)	Other measurement
13826	GCST007453	Eye color	Eye color	Other measurement
13827	GCST007453	Eye color	Eye color	Other trait
13828	GCST007454	Hair color	Hair color	Other measurement
13829	GCST007454	Hair color	Hair color	Other trait
13830	GCST007455	Eye color (brightness)	Eye color (brightness)	Other measurement
13831	GCST007456	Eye color (hue)	Eye color (hue)	Other measurement
13832	GCST007451	Skin, hair and eye pigmentation (multivariate analysis)	Skin, hair and eye pigmentation (multivariate analysis)	Other measurement
13833	GCST007451	Skin, hair and eye pigmentation (multivariate analysis)	Skin, hair and eye pigmentation (multivariate analysis)	Other measurement
13834	GCST007451	Skin, hair and eye pigmentation (multivariate analysis)	Skin, hair and eye pigmentation (multivariate analysis)	Other measurement
13835	GCST007497	Crohn's disease (time to progression)	Crohn's disease (time to progression)	Digestive system disorder
13836	GCST007497	Crohn's disease (time to progression)	Crohn's disease (time to progression)	Other measurement
13837	GCST007498	Crohn's disease (time to first abdominal surgery)	Crohn's disease (time to first abdominal surgery)	Digestive system disorder
13838	GCST007498	Crohn's disease (time to first abdominal surgery)	Crohn's disease (time to first abdominal surgery)	Other measurement
13839	GCST007499	Crohn's disease (indolent vs progressive)	Crohn's disease (indolent vs progressive)	Digestive system disorder
13840	GCST007499	Crohn's disease (indolent vs progressive)	Crohn's disease (indolent vs progressive)	Other measurement
13841	GCST007415	Breast cancer (estrogen-receptor positive)	Breast cancer (estrogen-receptor positive)	Cancer
13842	GCST007416	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
13843	GCST007416	Breast cancer (estrogen-receptor negative)	Breast cancer (estrogen-receptor negative)	Cancer
13844	GCST007420	Breast cancer (progesterone-receptor positive)	Breast cancer (progesterone-receptor positive)	Cancer
13845	GCST007417	Breast cancer (progesterone-receptor negative)	Breast cancer (progesterone-receptor negative)	Cancer
13846	GCST007419	Breast cancer (HER2 positive)	Breast cancer (HER2 positive)	Cancer
13847	GCST007418	Breast cancer (HER2 negative)	Breast cancer (HER2 negative)	Cancer
13848	GCST007414	Breast cancer	Breast cancer	Cancer
13849	GCST007669	Two-hour insulin response	Two-hour insulin response	Other measurement
13850	GCST007670	Fasting blood glucose	Fasting blood glucose	Other measurement
13851	GCST007671	Fasting blood insulin	Fasting blood insulin	Other measurement
13852	GCST007668	Two-hour glucose	Two-hour glucose	Other measurement
13853	GCST007287	Diastolic blood pressure x alcohol consumption interaction (1df test)	Diastolic blood pressure x alcohol consumption interaction (1df test)	Biological process
13854	GCST007287	Diastolic blood pressure x alcohol consumption interaction (1df test)	Diastolic blood pressure x alcohol consumption interaction (1df test)	Other measurement
13855	GCST007288	Systolic blood pressure x alcohol consumption interaction (1df test)	Systolic blood pressure x alcohol consumption interaction (1df test)	Biological process
13856	GCST007288	Systolic blood pressure x alcohol consumption interaction (1df test)	Systolic blood pressure x alcohol consumption interaction (1df test)	Other measurement
13857	GCST007703	Systolic blood pressure	Systolic blood pressure	Other measurement
13858	GCST007703	Systolic blood pressure	Systolic blood pressure	Other measurement
13859	GCST007704	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13860	GCST007704	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13861	GCST007705	Pulse pressure	Pulse pressure	Cardiovascular measurement
13862	GCST007706	Mean arterial pressure	Mean arterial pressure	Other measurement
13863	GCST007707	Hypertension	Hypertension	Cardiovascular disease
13864	GCST007203	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
13865	GCST007202	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13866	GCST007204	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13867	GCST006914	Sleep duration	Sleep duration	Other measurement
13868	GCST006913	Sedentary behaviour duration	Sedentary behaviour duration	Other measurement
13869	GCST007110	Physical activity (walking duration)	Physical activity (walking duration)	Other measurement
13870	GCST006915	Physical activity (moderate intensity activity duration)	Physical activity (moderate intensity activity duration)	Other measurement
13871	GCST006912	Physical activity (overall physical activity time)	Physical activity (overall physical activity time)	Other measurement
13872	GCST007051	Pulse rate	Pulse rate	Cardiovascular measurement
13873	GCST007051	Pulse rate	Pulse rate	Cardiovascular measurement
13874	GCST007052	Lipoprotein (a) levels	Lipoprotein (a) levels	Lipid or lipoprotein measurement
13875	GCST007053	Body mass index	Body mass index	Body measurement
13876	GCST007053	Body mass index	Body mass index	Body measurement
13877	GCST007053	Body mass index	Body mass index	Other measurement
13878	GCST007054	Weight	Weight	Body measurement
13879	GCST007055	Waist circumference	Waist circumference	Body measurement
13880	GCST007056	Waist-hip ratio	Waist-hip ratio	Other measurement
13881	GCST007056	Waist-hip ratio	Waist-hip ratio	Body measurement
13882	GCST007057	Height	Height	Other measurement
13883	GCST007057	Height	Height	Body measurement
13884	GCST007058	Hip circumference	Hip circumference	Body measurement
13885	GCST007620	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
13886	GCST007689	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13887	GCST007701	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13888	GCST007702	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
13889	GCST007688	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
13890	GCST007801	Sleep duration	Sleep duration	Other measurement
13891	GCST007802	Sleep duration (variability)	Sleep duration (variability)	Other measurement
13892	GCST007803	Sleep efficiency	Sleep efficiency	Other measurement
13893	GCST007804	Sleep (number of episodes)	Sleep (number of episodes)	Other measurement
13894	GCST007805	Sleep (time to least active 5 hours)	Sleep (time to least active 5 hours)	Other measurement
13895	GCST007806	Time to most active 10 hours	Time to most active 10 hours	Other measurement
13896	GCST007807	Sleep (time to midpoint)	Sleep (time to midpoint)	Other measurement
13897	GCST007808	Diurnal inactivity	Diurnal inactivity	Other measurement
13898	GCST007818	Facial attractiveness (female raters)	Facial attractiveness (female raters)	Other measurement
13899	GCST007817	Facial attractiveness (male raters)	Facial attractiveness (male raters)	Other measurement
13900	GCST007823	Facial attractiveness (male raters)	Facial attractiveness (male raters)	Other measurement
13901	GCST007822	Facial attractiveness (male raters)	Facial attractiveness (male raters)	Other measurement
13902	GCST007821	Facial attractiveness (female raters)	Facial attractiveness (female raters)	Other measurement
13903	GCST007820	Facial attractiveness (female raters)	Facial attractiveness (female raters)	Other measurement
13904	GCST007819	Facial attractiveness (male raters)	Facial attractiveness (male raters)	Other measurement
13905	GCST007652	Platelet count and reactivity phenotypes	Platelet count and reactivity phenotypes	Hematological measurement
13906	GCST007652	Platelet count and reactivity phenotypes	Platelet count and reactivity phenotypes	Cardiovascular measurement
13907	GCST007337	Life satisfaction	Life satisfaction	Other measurement
13908	GCST007338	Positive affect	Positive affect	Other measurement
13909	GCST007339	Neuroticism	Neuroticism	Neurological disorder
13910	GCST007339	Neuroticism	Neuroticism	Other measurement
13911	GCST007340	Depressive symptoms	Depressive symptoms	Neurological disorder
13912	GCST007340	Depressive symptoms	Depressive symptoms	Other measurement
13913	GCST007341	Well-being spectrum (multivariate analysis)	Well-being spectrum (multivariate analysis)	Other measurement
13914	GCST007324	Adventurousness	Adventurousness	Biological process
13915	GCST007329	Automobile speeding propensity	Automobile speeding propensity	Biological process
13916	GCST007328	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Biological process
13917	GCST007328	Alcohol consumption (drinks per week)	Alcohol consumption (drinks per week)	Other measurement
13918	GCST007327	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Biological process
13919	GCST007327	Smoking status (ever vs never smokers)	Smoking status (ever vs never smokers)	Other measurement
13920	GCST007326	Number of sexual partners	Number of sexual partners	Other measurement
13921	GCST007325	General risk tolerance (MTAG)	General risk tolerance (MTAG)	Biological process
13922	GCST007323	Risk-taking tendency (4-domain principal component model)	Risk-taking tendency (4-domain principal component model)	Biological process
13923	GCST007322	General risk tolerance	General risk tolerance	Biological process
13924	GCST007043	Psoriatic arthritis	Psoriatic arthritis	Immune system disorder
13925	GCST007343	Epilepsy	Epilepsy	Neurological disorder
13926	GCST007343	Epilepsy	Epilepsy	Neurological disorder
13927	GCST007343	Epilepsy	Epilepsy	Neurological disorder
13928	GCST007345	Childhood absence epilepsy	Childhood absence epilepsy	Neurological disorder
13929	GCST007346	Juvenile absence epilepsy	Juvenile absence epilepsy	Neurological disorder
13930	GCST007347	Juvenile myoclonic epilepsy	Juvenile myoclonic epilepsy	Neurological disorder
13931	GCST007348	Epilepsy (generalized, with tonic-clonic seizures alone)	Epilepsy (generalized, with tonic-clonic seizures alone)	Neurological disorder
13932	GCST007349	Focal epilepsy (lesion negative)	Focal epilepsy (lesion negative)	Neurological disorder
13933	GCST007350	Focal epilepsy (with hippocampal sclerosis)	Focal epilepsy (with hippocampal sclerosis)	Neurological disorder
13934	GCST007351	Focal epilepsy (with lesion other than hippocampal sclerosis)	Focal epilepsy (with lesion other than hippocampal sclerosis)	Neurological disorder
13935	GCST007352	Focal epilepsy	Focal epilepsy	Neurological disorder
13936	GCST007353	Generalized epilepsy	Generalized epilepsy	Neurological disorder
13937	GCST007353	Generalized epilepsy	Generalized epilepsy	Neurological disorder
13938	GCST007376	Gamma glutamyl transferase levels in excessive alcohol consumption	Gamma glutamyl transferase levels in excessive alcohol consumption	Liver enzyme measurement
13939	GCST007376	Gamma glutamyl transferase levels in excessive alcohol consumption	Gamma glutamyl transferase levels in excessive alcohol consumption	Other measurement
13940	GCST007381	Alanine aminotransferase levels in excessive alcohol consumption	Alanine aminotransferase levels in excessive alcohol consumption	Liver enzyme measurement
13941	GCST007381	Alanine aminotransferase levels in excessive alcohol consumption	Alanine aminotransferase levels in excessive alcohol consumption	Other measurement
13942	GCST007377	Aspartate aminotransferase levels in excessive alcohol consumption	Aspartate aminotransferase levels in excessive alcohol consumption	Liver enzyme measurement
13943	GCST007377	Aspartate aminotransferase levels in excessive alcohol consumption	Aspartate aminotransferase levels in excessive alcohol consumption	Other measurement
13944	GCST007380	Gamma glutamyl transferase levels in low alcohol consumption	Gamma glutamyl transferase levels in low alcohol consumption	Liver enzyme measurement
13945	GCST007380	Gamma glutamyl transferase levels in low alcohol consumption	Gamma glutamyl transferase levels in low alcohol consumption	Other measurement
13946	GCST007379	Alanine aminotransferase levels in low alcohol consumption	Alanine aminotransferase levels in low alcohol consumption	Liver enzyme measurement
13947	GCST007379	Alanine aminotransferase levels in low alcohol consumption	Alanine aminotransferase levels in low alcohol consumption	Other measurement
13948	GCST007378	Aspartate aminotransferase levels in low alcohol consumption	Aspartate aminotransferase levels in low alcohol consumption	Liver enzyme measurement
13949	GCST007378	Aspartate aminotransferase levels in low alcohol consumption	Aspartate aminotransferase levels in low alcohol consumption	Other measurement
13950	GCST007631	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Other trait
13951	GCST007631	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Digestive system disorder
13952	GCST007632	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Other trait
13953	GCST007632	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Digestive system disorder
13954	GCST007633	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Other trait
13955	GCST007633	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Digestive system disorder
13956	GCST007634	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Other trait
13957	GCST007634	Hepatitis C (spontaneous viral clearance)	Hepatitis C (spontaneous viral clearance)	Digestive system disorder
13958	GCST007104	QRS duration	QRS duration	Cardiovascular measurement
13959	GCST007104	QRS duration	QRS duration	Cardiovascular measurement
13960	GCST007104	QRS duration	QRS duration	Cardiovascular measurement
13961	GCST007103	QRS duration	QRS duration	Cardiovascular measurement
13962	GCST007103	QRS duration	QRS duration	Cardiovascular measurement
13963	GCST007103	QRS duration	QRS duration	Cardiovascular measurement
13964	GCST007105	QRS duration	QRS duration	Cardiovascular measurement
13965	GCST007105	QRS duration	QRS duration	Cardiovascular measurement
13966	GCST007105	QRS duration	QRS duration	Cardiovascular measurement
13967	GCST007402	Factor VII activity or levels	Factor VII activity or levels	Other measurement
13968	GCST007401	Factor VII activity	Factor VII activity	Other measurement
13969	GCST006985	Breast cancer	Breast cancer	Cancer
13970	GCST008025	Body mass index	Body mass index	Body measurement
13971	GCST008025	Body mass index	Body mass index	Body measurement
13972	GCST008025	Body mass index	Body mass index	Other measurement
13973	GCST008026	Chronic kidney disease	Chronic kidney disease	Other disease
13974	GCST008026	Chronic kidney disease	Chronic kidney disease	Other measurement
13975	GCST008026	Chronic kidney disease	Chronic kidney disease	Other measurement
13976	GCST008027	Smoking behaviour (cigarettes smoked per day)	Smoking behaviour (cigarettes smoked per day)	Other measurement
13977	GCST008028	Coffee consumption (cups per day)	Coffee consumption (cups per day)	Biological process
13978	GCST008028	Coffee consumption (cups per day)	Coffee consumption (cups per day)	Other measurement
13979	GCST008029	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13980	GCST008029	Diastolic blood pressure	Diastolic blood pressure	Other measurement
13981	GCST008030	Estimated glomerular filtration rate	Estimated glomerular filtration rate	Other measurement
13982	GCST008031	End-stage renal disease	End-stage renal disease	Other disease
13983	GCST008032	Fasting blood glucose	Fasting blood glucose	Other measurement
13984	GCST008033	Fasting blood insulin	Fasting blood insulin	Other measurement
13985	GCST008034	Hemoglobin A1c levels	Hemoglobin A1c levels	Other measurement
13986	GCST008034	Hemoglobin A1c levels	Hemoglobin A1c levels	Hematological measurement
13987	GCST008035	High density lipoprotein cholesterol levels	High density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13988	GCST008036	Hypertension	Hypertension	Cardiovascular disease
13989	GCST008037	Low density lipoprotein cholesterol levels	Low density lipoprotein cholesterol levels	Lipid or lipoprotein measurement
13990	GCST008038	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
13991	GCST008038	Mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	Hematological measurement
13992	GCST008039	Platelet count	Platelet count	Hematological measurement
13993	GCST008042	PR interval	PR interval	Cardiovascular measurement
13994	GCST008043	QT interval	QT interval	Cardiovascular measurement
13995	GCST008044	Systolic blood pressure	Systolic blood pressure	Other measurement
13996	GCST008044	Systolic blood pressure	Systolic blood pressure	Other measurement
13997	GCST008045	Total cholesterol levels	Total cholesterol levels	Lipid or lipoprotein measurement
13998	GCST008046	Triglyceride levels	Triglyceride levels	Lipid or lipoprotein measurement
13999	GCST008048	Type 2 diabetes	Type 2 diabetes	Metabolic disorder
14000	GCST008049	White blood cell count	White blood cell count	Hematological measurement
14001	GCST008049	White blood cell count	White blood cell count	Inflammatory measurement
14002	GCST008049	White blood cell count	White blood cell count	Hematological measurement
14003	GCST008049	White blood cell count	White blood cell count	Hematological measurement
14004	GCST008049	White blood cell count	White blood cell count	Hematological measurement
14005	GCST008050	Waist-hip ratio	Waist-hip ratio	Other measurement
14006	GCST008050	Waist-hip ratio	Waist-hip ratio	Body measurement
14007	GCST008051	Waist-hip ratio	Waist-hip ratio	Other measurement
14008	GCST008051	Waist-hip ratio	Waist-hip ratio	Body measurement
14009	GCST008052	Waist-hip ratio	Waist-hip ratio	Other measurement
14010	GCST008052	Waist-hip ratio	Waist-hip ratio	Body measurement
14011	GCST008053	Height	Height	Other measurement
14012	GCST008053	Height	Height	Body measurement
14013	GCST008040	Height	Height	Other measurement
14014	GCST008040	Height	Height	Body measurement
14015	GCST008041	Height	Height	Other measurement
14016	GCST008041	Height	Height	Body measurement
14017	GCST008054	QRS duration	QRS duration	Cardiovascular measurement
14018	GCST008054	QRS duration	QRS duration	Cardiovascular measurement
14019	GCST008054	QRS duration	QRS duration	Cardiovascular measurement
14020	GCST008055	C-reactive protein levels	C-reactive protein levels	Inflammatory measurement
14021	GCST008295	Number of decayed, missing and filled tooth surfaces or use of dentures	Number of decayed, missing and filled tooth surfaces or use of dentures	Digestive system disorder
14022	GCST008295	Number of decayed, missing and filled tooth surfaces or use of dentures	Number of decayed, missing and filled tooth surfaces or use of dentures	Other trait
14023	GCST008302	Number of decayed, missing and filled tooth surfaces	Number of decayed, missing and filled tooth surfaces	Digestive system disorder
14024	GCST008299	Number of decayed and filled tooth surfaces per available tooth surface	Number of decayed and filled tooth surfaces per available tooth surface	Digestive system disorder
14025	GCST008300	Periodontitis	Periodontitis	Digestive system disorder
14026	GCST008301	Bleeding gums	Bleeding gums	Other trait
14027	GCST008303	Painful gums	Painful gums	Other measurement
14028	GCST008306	Dentures	Dentures	Other trait
14029	GCST008305	Toothache	Toothache	Other trait
14030	GCST008304	Mouth ulcers	Mouth ulcers	Other trait
14031	GCST008298	Number of natural teeth	Number of natural teeth	Other measurement
14032	GCST008297	Loose teeth	Loose teeth	Other measurement
14033	GCST008296	Periodontitis or loose teeth	Periodontitis or loose teeth	Other measurement
14034	GCST008296	Periodontitis or loose teeth	Periodontitis or loose teeth	Digestive system disorder
14035	GCST008403	Arterial stiffness index	Arterial stiffness index	Cardiovascular measurement
14036	GCST008217	Non-muscle-invasive bladder cancer age at diagnosis	Non-muscle-invasive bladder cancer age at diagnosis	Cancer
14037	GCST008217	Non-muscle-invasive bladder cancer age at diagnosis	Non-muscle-invasive bladder cancer age at diagnosis	Other measurement
14038	GCST008218	Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs ≥ 70 years)	Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs ≥ 70 years)	Cancer
14039	GCST008218	Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs ≥ 70 years)	Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs ≥ 70 years)	Other measurement
14040	GCST008216	Non-muscle-invasive bladder cancer tumour size	Non-muscle-invasive bladder cancer tumour size	Cancer
14041	GCST008216	Non-muscle-invasive bladder cancer tumour size	Non-muscle-invasive bladder cancer tumour size	Other measurement
14042	GCST008219	Non-muscle-invasive bladder cancer tumour size (< 3 cm vs ≥ 3 cm)	Non-muscle-invasive bladder cancer tumour size (< 3 cm vs ≥ 3 cm)	Cancer
14043	GCST008219	Non-muscle-invasive bladder cancer tumour size (< 3 cm vs ≥ 3 cm)	Non-muscle-invasive bladder cancer tumour size (< 3 cm vs ≥ 3 cm)	Other measurement
14044	GCST008220	Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)	Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)	Cancer
14045	GCST008220	Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)	Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)	Other measurement
14046	GCST008221	Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)	Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)	Cancer
14047	GCST008221	Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)	Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)	Other measurement
14048	GCST008222	Non-muscle-invasive bladder cancer EORTC risk category	Non-muscle-invasive bladder cancer EORTC risk category	Cancer
14049	GCST008222	Non-muscle-invasive bladder cancer EORTC risk category	Non-muscle-invasive bladder cancer EORTC risk category	Other measurement
14050	GCST008517	Response to interferon treatment in hepatitis C virus genotype 3	Response to interferon treatment in hepatitis C virus genotype 3	Response to drug
14051	GCST008517	Response to interferon treatment in hepatitis C virus genotype 3	Response to interferon treatment in hepatitis C virus genotype 3	Digestive system disorder
14052	GCST008520	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	Response to drug
14053	GCST008520	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	Response to direct-acting antiviral treatment in hepatitis C virus genotype 3	Digestive system disorder
14054	GCST008515	Pre-treatment viral load in hepatitis C virus genotype 3	Pre-treatment viral load in hepatitis C virus genotype 3	Other measurement
14055	GCST008515	Pre-treatment viral load in hepatitis C virus genotype 3	Pre-treatment viral load in hepatitis C virus genotype 3	Digestive system disorder
14056	GCST008513	Health literacy	Health literacy	Other measurement
14057	GCST008435	Response to hepatitis B vaccine	Response to hepatitis B vaccine	Response to drug
14058	GCST008435	Response to hepatitis B vaccine	Response to hepatitis B vaccine	Other measurement
14059	GCST008106	Candidemia	Candidemia	Other disease
14060	GCST008424	Opioid dependence	Opioid dependence	Neurological disorder
